Phrase0:
our 
prp$ - 
Phrase1:
the idea 
dt - nn - 
Phrase2:
novel apoptosis-mediating 
jj - nn - 
Phrase3:
novel member 
jj - nn - 
Phrase4:
the tumor 
dt - nn - 
Phrase5:
the structural organization 
dt - jj - nn - 
Phrase6:
the 393 
dt - nn - 
Phrase7:
long human 
jj - nn - 
Phrase8:
its 
prp$ - 
Phrase9:
extracellular domain 
jj - nn - 
Phrase10:
cysteine-rich domains 
jj - nns - 
Phrase11:
the cytoplasmic region 
dt - jj - nn - 
Phrase12:
major responses 
jj - nns - 
Phrase13:
an inhibitor 
dt - nn - 
Phrase14:
the known apoptosis-inducing 
dt - jj - nn - 
Phrase15:
the tnf 
dt - nn - 
Phrase16:
the state 
dt - nn - 
Phrase17:
the effects 
dt - nns - 
Phrase18:
the molecular 
dt - nn - 
Phrase19:
the effects 
dt - nns - 
Phrase20:
they 
prp - 
Phrase21:
monocyte-derived macrophages 
jj - nns - 
Phrase22:
low passage 
jj - nn - 
Phrase23:
clinical strains 
jj - nns - 
Phrase24:
the expression 
dt - nn - 
Phrase25:
nuclear run-on assay 
jj - jj - nn - 
Phrase26:
nuclear factor-kappab 
jj - nn - 
Phrase27:
nuclear translocation 
jj - nn - 
Phrase28:
the transcriptional level 
dt - jj - nn - 
Phrase29:
monocyte-derived macrophages 
jj - nns - 
Phrase30:
these cytokines 
dt - nns - 
Phrase31:
the reversal 
dt - nn - 
Phrase32:
significant effect 
jj - nn - 
Phrase33:
the effect 
dt - nn - 
Phrase34:
both cytokines 
dt - nns - 
Phrase35:
the monocyte 
dt - nn - 
Phrase36:
other macrophage 
jj - nn - 
Phrase37:
similar effects 
jj - nns - 
Phrase38:
these cytokines 
dt - nns - 
Phrase39:
divergent effects 
jj - nns - 
Phrase40:
nuclear factor-kappab 
jj - nn - 
Phrase41:
the transcription 
dt - nn - 
Phrase42:
we 
prp - 
Phrase43:
critical regulator 
jj - nn - 
Phrase44:
our 
prp$ - 
Phrase45:
the deletion 
dt - nn - 
Phrase46:
the fact 
dt - nn - 
Phrase47:
we 
prp - 
Phrase48:
the neomycin-resistance 
dt - nn - 
Phrase49:
structural gene 
jj - nn - 
Phrase50:
the cre-loxp 
dt - nn - 
Phrase51:
our 
prp$ - 
Phrase52:
substantial number 
jj - nn - 
Phrase53:
the absence 
dt - nn - 
Phrase54:
dendritic cells 
jj - nns - 
Phrase55:
the ciita 
dt - nn - 
Phrase56:
the expression 
dt - nn - 
Phrase57:
recent results 
jj - nns - 
Phrase58:
the ifn-gamma-induced up-regulation 
dt - jj - nn - 
Phrase59:
inhibitory kappab-alpha 
jj - nn - 
Phrase60:
lethal endotoxemia 
jj - nn - 
Phrase61:
beneficial effect 
jj - nn - 
Phrase62:
inflammatory cytokine 
jj - nn - 
Phrase63:
the transcription 
dt - nn - 
Phrase64:
nuclear factor-kappab 
jj - nn - 
Phrase65:
an unknown mechanism 
dt - jj - nn - 
Phrase66:
inflammatory signals 
jj - nns - 
Phrase67:
its 
prp$ - 
Phrase68:
inhibitory peptide 
jj - nn - 
Phrase69:
inhibitory kappab-alpha 
jj - nn - 
Phrase70:
we 
prp - 
Phrase71:
resultant tnf-alpha 
jj - nn - 
Phrase72:
the purpose 
dt - nn - 
Phrase73:
this study 
dt - nn - 
Phrase74:
the effect 
dt - nn - 
Phrase75:
-induced human 
jj - nn - 
Phrase76:
electrophoretic mobility 
jj - nn - 
Phrase77:
we 
prp - 
Phrase78:
lps-stimulated tnf-alpha 
jj - nn - 
Phrase79:
lps-induced decreases 
jj - nns - 
Phrase80:
the ikaros 
dt - nn - 
Phrase81:
regulatory elements 
jj - nns - 
Phrase82:
the granzyme 
dt - nn - 
Phrase83:
the serine 
dt - nn - 
Phrase84:
an essential component 
dt - jj - nn - 
Phrase85:
the granule 
dt - nn - 
Phrase86:
major apoptotic mechanism 
jj - jj - nn - 
Phrase87:
cytotoxic t 
jj - nn - 
Phrase88:
natural killer 
jj - nn - 
Phrase89:
antigenic stimulation 
jj - nn - 
Phrase90:
several regulatory regions 
jj - jj - nns - 
Phrase91:
essential in 
jj - nn - 
Phrase92:
the control 
dt - nn - 
Phrase93:
anti-inflammatory agent 
jj - nn - 
Phrase94:
peripheral blood 
jj - nn - 
Phrase95:
the -148 
dt - nn - 
Phrase96:
the human 
dt - nn - 
Phrase97:
this region 
dt - nn - 
Phrase98:
the target 
dt - nn - 
Phrase99:
the context 
dt - nn - 
Phrase100:
the granzyme 
dt - nn - 
Phrase101:
both sites 
dt - nns - 
Phrase102:
the granzyme 
dt - nn - 
Phrase103:
the binding 
dt - nn - 
Phrase104:
nuclear transcription 
jj - nn - 
Phrase105:
the ikaros 
dt - nn - 
Phrase106:
these results 
dt - nns - 
Phrase107:
the transcriptional activity 
dt - jj - nn - 
Phrase108:
the human 
dt - nn - 
Phrase109:
the binding 
dt - nn - 
Phrase110:
nuclear factors 
jj - nn - 
Phrase111:
the ap-1 
dt - nn - 
Phrase112:
many studies 
jj - nns - 
Phrase113:
possible hormonal dysregulation 
jj - jj - nn - 
Phrase114:
this study 
dt - nn - 
Phrase115:
we 
prp - 
Phrase116:
the role 
dt - nn - 
Phrase117:
these abnormalities 
dt - nns - 
Phrase118:
this purpose 
dt - nn - 
Phrase119:
the number 
dt - nn - 
Phrase120:
peripheral mononuclear 
jj - nn - 
Phrase121:
healthy women 
jj - nns - 
Phrase122:
significant differences 
jj - nns - 
Phrase123:
the number 
dt - nn - 
Phrase124:
the pcos 
dt - nn - 
Phrase125:
the controls 
dt - nns - 
Phrase126:
these results 
dt - nns - 
Phrase127:
the alterations 
dt - nns - 
Phrase128:
the hpa 
dt - nn - 
Phrase129:
the cortisol 
dt - nn - 
Phrase130:
heterogeneous expression 
jj - nn - 
Phrase131:
the lipocalin 
dt - nn - 
Phrase132:
primary breast 
jj - nn - 
Phrase133:
we 
prp - 
Phrase134:
mammary carcinomas 
jj - nns - 
Phrase135:
the calycin 
dt - nn - 
Phrase136:
we 
prp - 
Phrase137:
the putative human 
dt - jj - nn - 
Phrase138:
gelatinase-associated lipocalin 
jj - nn - 
Phrase139:
moderate levels 
jj - nns - 
Phrase140:
they 
prp - 
Phrase141:
heterogeneous expression 
jj - nn - 
Phrase142:
these tumors 
dt - nns - 
Phrase143:
those in 
dt - nn - 
Phrase144:
normal breast 
jj - nn - 
Phrase145:
the presence 
dt - nn - 
Phrase146:
low levels 
jj - nns - 
Phrase147:
this protein 
dt - nn - 
Phrase148:
normal ductal epithelium 
jj - jj - nn - 
Phrase149:
large amounts 
jj - nns - 
Phrase150:
the protein 
dt - nn - 
Phrase151:
the lumen 
dt - nn - 
Phrase152:
normal breast 
jj - nn - 
Phrase153:
the vicinity 
dt - nn - 
Phrase154:
mammary carcinomas 
jj - nns - 
Phrase155:
significant association 
jj - nn - 
Phrase156:
significant correlation 
jj - nn - 
Phrase157:
several other markers 
jj - jj - nns - 
Phrase158:
poor prognosis 
jj - nn - 
Phrase159:
receptor-negative status 
jj - nn - 
Phrase160:
high proliferation 
jj - nn - 
Phrase161:
low in 
jj - nn - 
Phrase162:
significant association 
jj - nn - 
Phrase163:
novel signaling 
jj - nn - 
Phrase164:
the bursa 
dt - nn - 
Phrase165:
the bursa 
dt - nn - 
Phrase166:
lymphoid organ 
jj - nn - 
Phrase167:
the generation 
dt - nn - 
Phrase168:
the chicken 
dt - nn - 
Phrase169:
we 
prp - 
Phrase170:
novel gene 
jj - nn - 
Phrase171:
the gene 
dt - nn - 
Phrase172:
an 85-kda protein 
dt - jj - nn - 
Phrase173:
n-terminal acidic domains 
jj - jj - nns - 
Phrase174:
proline-rich domain 
jj - nn - 
Phrase175:
c-terminal sh2 
jj - nn - 
Phrase176:
substantial sequence 
jj - nn - 
Phrase177:
an adaptor 
dt - nn - 
Phrase178:
the b 
dt - nn - 
Phrase179:
putative chicken 
jj - nn - 
Phrase180:
the nf-at 
dt - nn - 
Phrase181:
these findings 
dt - nns - 
Phrase182:
critical role 
jj - nn - 
Phrase183:
the bursa 
dt - nn - 
Phrase184:
colony-stimulating factor 
jj - nn - 
Phrase185:
72-kda isoform 
jj - nn - 
Phrase186:
colony-stimulating factor 
jj - nn - 
Phrase187:
the dual function 
dt - jj - nn - 
Phrase188:
we 
prp - 
Phrase189:
distinct stat3-like 
jj - nn - 
Phrase190:
mature normal myeloid 
jj - jj - nn - 
Phrase191:
normal immature human 
jj - jj - nn - 
Phrase192:
cd34+ bone 
jj - nn - 
Phrase193:
the composition 
dt - nn - 
Phrase194:
mature normal human 
jj - jj - nn - 
Phrase195:
polymorphonuclear neutrophilic granulocytes 
jj - jj - nns - 
Phrase196:
these studies 
dt - nns - 
Phrase197:
the major protein 
dt - jj - nn - 
Phrase198:
the high-affinity 
dt - nn - 
Phrase199:
72-kda protein 
jj - nn - 
Phrase200:
monoclonal antibody 
jj - nn - 
Phrase201:
we 
prp - 
Phrase202:
limited proteolysis 
jj - nn - 
Phrase203:
the carboxyl-terminal portion 
dt - jj - nn - 
Phrase204:
this region 
dt - nn - 
Phrase205:
transcriptional activation 
jj - nn - 
Phrase206:
our 
prp$ - 
Phrase207:
the possibility 
dt - nn - 
Phrase208:
intercellular adhesion 
jj - nn - 
Phrase209:
it 
prp - 
Phrase210:
the expression 
dt - nn - 
Phrase211:
intercellular adhesion 
jj - nn - 
Phrase212:
those in 
dt - nn - 
Phrase213:
the factors 
dt - nn - 
Phrase214:
the induction 
dt - nn - 
Phrase215:
the expression 
dt - nn - 
Phrase216:
the integration 
dt - nn - 
Phrase217:
the levels 
dt - nns - 
Phrase218:
they 
prp - 
Phrase219:
low surface 
jj - nn - 
Phrase220:
other atl 
jj - nn - 
Phrase221:
these results 
dt - nns - 
Phrase222:
monoclonal integration 
jj - nn - 
Phrase223:
the genome 
dt - nn - 
Phrase224:
the number 
dt - nn - 
Phrase225:
the factors 
dt - nn - 
Phrase226:
the vimentin 
dt - nn - 
Phrase227:
promonocytic cells 
jj - nns - 
Phrase228:
the administration 
dt - nn - 
Phrase229:
the subsequent proliferation 
dt - jj - nn - 
Phrase230:
the expression 
dt - nn - 
Phrase231:
functional differentiation 
jj - nn - 
Phrase232:
an increase 
dt - nn - 
Phrase233:
the amount 
dt - nn - 
Phrase234:
the stress-responsive 
dt - nn - 
Phrase235:
promonocytic cells 
jj - nns - 
Phrase236:
an increase 
dt - nn - 
Phrase237:
the amount 
dt - nn - 
Phrase238:
the intermediate 
dt - nn - 
Phrase239:
the amounts 
dt - nns - 
Phrase240:
the amount 
dt - nn - 
Phrase241:
the protein 
dt - nn - 
Phrase242:
both protooncogene 
dt - nn - 
Phrase243:
the stress-induced vimentin 
dt - jj - nn - 
Phrase244:
the result 
dt - nn - 
Phrase245:
ap-1-mediated transcriptional activation 
jj - jj - nn - 
Phrase246:
it 
prp - 
Phrase247:
the rate 
dt - nn - 
Phrase248:
untreated cells 
jj - nns - 
Phrase249:
these results 
dt - nns - 
Phrase250:
an increase 
dt - nn - 
Phrase251:
promonocytic cells 
jj - nns - 
Phrase252:
least in 
jjs - nn - 
Phrase253:
cytotoxic t 
jj - nn - 
Phrase254:
the amino 
dt - nn - 
Phrase255:
the notch 
dt - nn - 
Phrase256:
this study 
dt - nn - 
Phrase257:
we 
prp - 
Phrase258:
ovarian tumor 
jj - nn - 
Phrase259:
the sequence 
dt - nn - 
Phrase260:
the aminoenhancer 
dt - nn - 
Phrase261:
these peptides 
dt - nns - 
Phrase262:
the wildtype 
dt - nn - 
Phrase263:
the fourth 
dt - nn - 
Phrase264:
the peptide 
dt - nn - 
Phrase265:
the n-terminal leu 
dt - jj - nn - 
Phrase266:
these sequences 
dt - nns - 
Phrase267:
active hplc 
jj - nn - 
Phrase268:
the presence 
dt - nn - 
Phrase269:
an ion 
dt - nn - 
Phrase270:
other ions 
jj - nns - 
Phrase271:
similar masses 
jj - nns - 
Phrase272:
the tentatively 
dt - nn - 
Phrase273:
the ion 
dt - nn - 
Phrase274:
the sequence 
dt - nn - 
Phrase275:
we 
prp - 
Phrase276:
these concentrations 
dt - nns - 
Phrase277:
other epithelial 
jj - nn - 
Phrase278:
cd8+ t 
jj - nn - 
Phrase279:
cross-reactive specificities 
jj - nns - 
Phrase280:
key role 
jj - nn - 
Phrase281:
the n-terminal residues 
dt - jj - nns - 
Phrase282:
the variant 
dt - nn - 
Phrase283:
the aes 
dt - nn - 
Phrase284:
transcriptional repressors 
jj - nns - 
Phrase285:
the enhancer 
dt - nn - 
Phrase286:
these repressors 
dt - nns - 
Phrase287:
the aes 
dt - nn - 
Phrase288:
novel class 
jj - nn - 
Phrase289:
the pro-myelocytic 
dt - nn - 
Phrase290:
the physiological role 
dt - jj - nn - 
Phrase291:
the pro-myelocytic 
dt - nn - 
Phrase292:
other functions 
jj - nns - 
Phrase293:
haematopoietic differentiation 
jj - nn - 
Phrase294:
we 
prp - 
Phrase295:
the regulation 
dt - nn - 
Phrase296:
various human 
jj - nn - 
Phrase297:
haematopoietic lines 
jj - nns - 
Phrase298:
diploid fibroblasts 
jj - nns - 
Phrase299:
peripheral blood 
jj - nn - 
Phrase300:
cytokine-induced modulation 
jj - nn - 
Phrase301:
our 
prp$ - 
Phrase302:
dose-dependent manner 
jj - nn - 
Phrase303:
marked increase 
jj - nn - 
Phrase304:
the number 
dt - nn - 
Phrase305:
the intensity 
dt - nn - 
Phrase306:
the staining 
dt - nn - 
Phrase307:
so-called pml 
jj - nn - 
Phrase308:
nuclear bodies 
jj - nns - 
Phrase309:
our 
prp$ - 
Phrase310:
inflammatory tissues 
jj - nns - 
Phrase311:
the position 
dt - nn - 
Phrase312:
the zebra 
dt - nn - 
Phrase313:
its 
prp$ - 
Phrase314:
biological activity 
jj - nn - 
Phrase315:
epstein-barr virus 
jj - nn - 
Phrase316:
unique transcriptional activator 
jj - jj - nn - 
Phrase317:
viral latency 
jj - nn - 
Phrase318:
lytic viral replication 
jj - jj - nn - 
Phrase319:
the ebv 
dt - nn - 
Phrase320:
lytic replication 
jj - nn - 
Phrase321:
viral dna 
jj - nn - 
Phrase322:
we 
prp - 
Phrase323:
heterologous activation 
jj - nn - 
Phrase324:
the zebra 
dt - nn - 
Phrase325:
we 
prp - 
Phrase326:
those results 
dt - nns - 
Phrase327:
the position 
dt - nn - 
Phrase328:
the zebra 
dt - nn - 
Phrase329:
heterologous replacement 
jj - nn - 
Phrase330:
its 
prp$ - 
Phrase331:
the disruption 
dt - nn - 
Phrase332:
this study 
dt - nn - 
Phrase333:
novel clones 
jj - nns - 
Phrase334:
the zebra 
dt - nn - 
Phrase335:
the carboxy 
dt - nn - 
Phrase336:
the protein 
dt - nn - 
Phrase337:
these mutants 
dt - nns - 
Phrase338:
the ability 
dt - nn - 
Phrase339:
wild type 
jj - nn - 
Phrase340:
the complex 
dt - nn - 
Phrase341:
biological process 
jj - nn - 
Phrase342:
its 
prp$ - 
Phrase343:
the protein 
dt - nn - 
Phrase344:
the modulation 
dt - nn - 
Phrase345:
healthy controls 
jj - nns - 
Phrase346:
whole-cell competitive binding 
jj - jj - nn - 
Phrase347:
4855 +/- 1389 
dt - jj - nn - 
Phrase348:
significant difference 
jj - nn - 
Phrase349:
the mean 
dt - nn - 
Phrase350:
their 
prp$ - 
Phrase351:
the healthy controls 
dt - jj - nns - 
Phrase352:
the other hand 
dt - jj - nn - 
Phrase353:
the receptor 
dt - nn - 
Phrase354:
the normal range 
dt - jj - nn - 
Phrase355:
the same time 
dt - jj - nn - 
Phrase356:
the same subjects 
dt - jj - nns - 
Phrase357:
the normal range 
dt - jj - nn - 
Phrase358:
this value 
dt - nn - 
Phrase359:
the healthy controls 
dt - jj - nns - 
Phrase360:
we 
prp - 
Phrase361:
positive correlation 
jj - nn - 
Phrase362:
= 0.89 
jj - nn - 
Phrase363:
we 
prp - 
Phrase364:
such a 
jj - nn - 
Phrase365:
= 0.60 
jj - nn - 
Phrase366:
these results 
dt - nns - 
Phrase367:
the gr 
dt - nn - 
Phrase368:
the changes 
dt - nns - 
Phrase369:
they 
prp - 
Phrase370:
these cytokines 
dt - nns - 
Phrase371:
the development 
dt - nn - 
Phrase372:
we 
prp - 
Phrase373:
the hypothesis 
dt - nn - 
Phrase374:
polymorphic nucleotides 
jj - nns - 
Phrase375:
the il-10 
dt - nn - 
Phrase376:
the expression 
dt - nn - 
Phrase377:
an asthmatic proband 
dt - jj - nn - 
Phrase378:
conformational polymorphism 
jj - nn - 
Phrase379:
we 
prp - 
Phrase380:
the presence 
dt - nn - 
Phrase381:
the promoter 
dt - nn - 
Phrase382:
the il-10 
dt - nn - 
Phrase383:
the tgf-beta 
dt - nn - 
Phrase384:
the il-10 
dt - nn - 
Phrase385:
the translation 
dt - nn - 
Phrase386:
elevated total 
jj - nn - 
Phrase387:
elevated total 
jj - nn - 
Phrase388:
this base 
dt - nn - 
Phrase389:
the base 
dt - nn - 
Phrase390:
the transcription 
dt - nn - 
Phrase391:
the tgf-beta 
dt - nn - 
Phrase392:
elevated total 
jj - nn - 
Phrase393:
the promoter 
dt - nn - 
Phrase394:
negative transcription 
jj - nn - 
Phrase395:
multiple signaling 
jj - nn - 
Phrase396:
the tpl-2 
dt - nn - 
Phrase397:
the nuclear factor 
dt - jj - nn - 
Phrase398:
we 
prp - 
Phrase399:
the activation 
dt - nn - 
Phrase400:
the il-2 
dt - nn - 
Phrase401:
the mitogen-activated protein 
dt - jj - nn - 
Phrase402:
the calcineurin/nfat 
dt - nn - 
Phrase403:
these pathways 
dt - nns - 
Phrase404:
we 
prp - 
Phrase405:
the convergence 
dt - nn - 
Phrase406:
the mapk 
dt - nn - 
Phrase407:
the calcineurin/nfat 
dt - nn - 
Phrase408:
the activation 
dt - nn - 
Phrase409:
the il-2 
dt - nn - 
Phrase410:
the activation 
dt - nn - 
Phrase411:
both il-2 
dt - nn - 
Phrase412:
an nfat-driven minimal promoter 
dt - jj - jj - nn - 
Phrase413:
it 
prp - 
Phrase414:
the il-2 
dt - nn - 
Phrase415:
the dominant negative mutant 
dt - jj - jj - nn - 
Phrase416:
the mek1/mek2 
dt - nn - 
Phrase417:
the activation 
dt - nn - 
Phrase418:
mapk-dependent findings 
dt - nns - 
Phrase419:
the activation 
dt - nn - 
Phrase420:
they 
prp - 
Phrase421:
the activation 
dt - nn - 
Phrase422:
the il-2 
dt - nn - 
Phrase423:
the control 
dt - nn - 
Phrase424:
both hypotheses 
dt - nns - 
Phrase425:
the second 
dt - nn - 
Phrase426:
the activation 
dt - nn - 
Phrase427:
the il-2 
dt - nn - 
Phrase428:
an nfat-driven minimal promoter 
dt - jj - jj - nn - 
Phrase429:
the dominant negative mutant 
dt - jj - jj - nn - 
Phrase430:
it 
prp - 
Phrase431:
the calcineurin 
dt - nn - 
Phrase432:
the tpl-2-mediated 
dt - nn - 
Phrase433:
the control 
dt - nn - 
Phrase434:
independent pathways 
jj - nns - 
Phrase435:
differential activation 
jj - nn - 
Phrase436:
distinct stat5 
jj - nn - 
Phrase437:
cd34+ hematopoietic stem 
jj - jj - nn - 
Phrase438:
important cytokines 
jj - nns - 
Phrase439:
the proliferation 
dt - nn - 
Phrase440:
the jak/stat 
dt - nn - 
Phrase441:
the signaling 
dt - nn - 
Phrase442:
biological responses 
jj - nns - 
Phrase443:
these cytokines 
dt - nns - 
Phrase444:
previous studies 
jj - nns - 
Phrase445:
these cytokines 
dt - nns - 
Phrase446:
mature granulocytes 
jj - nns - 
Phrase447:
the role 
dt - nn - 
Phrase448:
we 
prp - 
Phrase449:
cd34+ hematopoietic stem 
jj - jj - nn - 
Phrase450:
an early stage 
dt - jj - nn - 
Phrase451:
both differentiation 
dt - nn - 
Phrase452:
the 94 
dt - nn - 
Phrase453:
both il-5 
dt - nn - 
Phrase454:
both lineages 
dt - nns - 
Phrase455:
the 94 
dt - nn - 
Phrase456:
the finding 
dt - nn - 
Phrase457:
distinct isoforms 
jj - nns - 
Phrase458:
late differentiation 
jj - nn - 
Phrase459:
they 
prp - 
Phrase460:
different biological functions 
jj - jj - nns - 
Phrase461:
these cells 
dt - nns - 
Phrase462:
the t-cell 
dt - nn - 
Phrase463:
oncogenic protein 
jj - nn - 
Phrase464:
aldh1 expression 
dt - nn - 
Phrase465:
its 
prp$ - 
Phrase466:
the anlage 
dt - nn - 
Phrase467:
early embryonic development 
jj - jj - nn - 
Phrase468:
acute leukemias 
jj - nn - 
Phrase469:
specific chromosomal 
jj - nn - 
Phrase470:
the protein 
dt - nn - 
Phrase471:
it 
prp - 
Phrase472:
its 
prp$ - 
Phrase473:
representational difference 
jj - nn - 
Phrase474:
stable expression 
jj - nn - 
Phrase475:
the gene 
dt - nn - 
Phrase476:
the retinoic acid-synthesizing 
dt - jj - nn - 
Phrase477:
this system 
dt - nn - 
Phrase478:
the presence 
dt - nn - 
Phrase479:
elevated aldh1 
jj - nn - 
Phrase480:
the spleens 
dt - nns - 
Phrase481:
wild-type mice 
jj - nns - 
Phrase482:
abnormal expression 
jj - nn - 
Phrase483:
splenic precursor 
jj - nn - 
Phrase484:
retinoic acid 
jj - nn - 
Phrase485:
the x2 
dt - nn - 
Phrase486:
the dra 
dt - nn - 
Phrase487:
we 
prp - 
Phrase488:
the function 
dt - nn - 
Phrase489:
the promoter 
dt - nn - 
Phrase490:
the hla-dra 
dt - nn - 
Phrase491:
the human 
dt - nn - 
Phrase492:
major histocompatibility 
jj - nn - 
Phrase493:
the ap-1/atf/creb 
dt - nn - 
Phrase494:
the x2 
dt - nn - 
Phrase495:
the dra 
dt - nn - 
Phrase496:
the x2 
dt - nn - 
Phrase497:
sharp contrast 
jj - nn - 
Phrase498:
the phorbol 
dt - nn - 
Phrase499:
strong interactions 
jj - nns - 
Phrase500:
the x2 
dt - nn - 
Phrase501:
the activation 
dt - nn - 
Phrase502:
the wild-type dra 
dt - jj - nn - 
Phrase503:
the x2 
dt - nn - 
Phrase504:
the co-expression 
dt - nn - 
Phrase505:
dominant negative c-fos 
jj - jj - nn - 
Phrase506:
the responsiveness 
dt - nn - 
Phrase507:
we 
prp - 
Phrase508:
the dra 
dt - nn - 
Phrase509:
the x2 
dt - nn - 
Phrase510:
the cd4 
dt - nn - 
Phrase511:
mature t 
jj - nn - 
Phrase512:
we 
prp - 
Phrase513:
the activity 
dt - nn - 
Phrase514:
the enhancer 
dt - nn - 
Phrase515:
the promoter 
dt - nn - 
Phrase516:
the silencer 
dt - nn - 
Phrase517:
the human 
dt - nn - 
Phrase518:
transgenic mice 
jj - nns - 
Phrase519:
thymic populations 
jj - nns - 
Phrase520:
various combinations 
jj - nns - 
Phrase521:
these regulatory dna 
dt - jj - nn - 
Phrase522:
the cd4 
dt - nn - 
Phrase523:
different manner 
jj - nn - 
Phrase524:
mature peripheral t 
jj - jj - nn - 
Phrase525:
the 5'-positive 
dt - nn - 
Phrase526:
regulatory unit 
jj - nn - 
Phrase527:
the promoter 
dt - nn - 
Phrase528:
the 5' 
dt - nn - 
Phrase529:
active at 
jj - nn - 
Phrase530:
the cd4-cd8-double-negative 
dt - nn - 
Phrase531:
its 
prp$ - 
Phrase532:
lower in 
jjr - nn - 
Phrase533:
the cd4+ cd8int/- 
dt - jj - nn - 
Phrase534:
an additional enhancer 
dt - jj - nn - 
Phrase535:
located in 
jj - nn - 
Phrase536:
the third intron 
dt - jj - nn - 
Phrase537:
the cd4 
dt - nn - 
Phrase538:
this population 
dt - nn - 
Phrase539:
regulatory element 
jj - nn - 
Phrase540:
the minimal cd4 
dt - jj - nn - 
Phrase541:
peripheral cd8 
jj - nn - 
Phrase542:
inactive in 
jj - nn - 
Phrase543:
immature dn thymocytes 
jj - jj - nns - 
Phrase544:
distinct silencer 
jj - nn - 
Phrase545:
the cd4 
dt - nn - 
Phrase546:
active in 
jj - nn - 
Phrase547:
cd4+ cd8int/- 
jj - nn - 
Phrase548:
the thymus 
dt - nn - 
Phrase549:
an anti-silencer 
dt - nn - 
Phrase550:
this cell 
dt - nn - 
Phrase551:
the cd4 
dt - nn - 
Phrase552:
negative regulatory mechanisms 
jj - jj - nns - 
Phrase553:
physiological molecules 
jj - nns - 
Phrase554:
normal lymphoid cells 
jj - jj - nns - 
Phrase555:
key role 
jj - nn - 
Phrase556:
the physiology 
dt - nn - 
Phrase557:
thymic selection 
jj - nn - 
Phrase558:
these molecules 
dt - nns - 
Phrase559:
their 
prp$ - 
Phrase560:
malignant lymphoid cells 
jj - jj - nns - 
Phrase561:
their 
prp$ - 
Phrase562:
an intracellular receptor 
dt - jj - nn - 
Phrase563:
the steroid 
dt - nn - 
Phrase564:
the glucocorticoid 
dt - nn - 
Phrase565:
the gr 
dt - nn - 
Phrase566:
his effects 
dt - nns - 
Phrase567:
direct binding 
jj - nn - 
Phrase568:
the dna 
dt - nn - 
Phrase569:
the type 
dt - nn - 
Phrase570:
the mechanism 
dt - nn - 
Phrase571:
the case 
dt - nn - 
Phrase572:
thymic selection 
jj - nn - 
Phrase573:
the mechanism 
dt - nn - 
Phrase574:
the mutual repression 
dt - jj - nn - 
Phrase575:
direct suppression 
jj - nn - 
Phrase576:
adenoviral infection 
jj - nn - 
Phrase577:
the action 
dt - nn - 
Phrase578:
adenoviral e1a 
jj - nn - 
Phrase579:
immune-response genes 
jj - nns - 
Phrase580:
transcriptional coactivators 
jj - nns - 
Phrase581:
endogenous transcription 
jj - nn - 
Phrase582:
we 
prp - 
Phrase583:
longer bind 
jjr - nn - 
Phrase584:
c-terminal residues 
jj - nns - 
Phrase585:
stat1-dependent gene 
jj - nn - 
Phrase586:
consequent function 
jj - nn - 
Phrase587:
the natural host 
dt - jj - nn - 
Phrase588:
the results 
dt - nns - 
Phrase589:
specific mechanism 
jj - nn - 
Phrase590:
immune suppression 
jj - nn - 
Phrase591:
an alternative 
dt - nn - 
Phrase592:
other adaptors 
jj - nn - 
Phrase593:
the basal transcription 
dt - jj - nn - 
Phrase594:
environmental estrogens 
jj - nns - 
Phrase595:
environmental estrogens 
jj - nns - 
Phrase596:
great deal 
jj - nn - 
Phrase597:
their 
prp$ - 
Phrase598:
reproductive tissues 
jj - nns - 
Phrase599:
the impact 
dt - nn - 
Phrase600:
these compounds 
dt - nns - 
Phrase601:
the immune system 
dt - jj - nn - 
Phrase602:
we 
prp - 
Phrase603:
the activities 
dt - nns - 
Phrase604:
various environmental estrogens 
jj - jj - nns - 
Phrase605:
the modulation 
dt - nn - 
Phrase606:
the interleukin-1beta 
dt - nn - 
Phrase607:
monocytic cell 
jj - nn - 
Phrase608:
the human 
dt - nn - 
Phrase609:
an il-1beta 
dt - nn - 
Phrase610:
the cat 
dt - nn - 
Phrase611:
us 
prp - 
Phrase612:
the effect 
dt - nn - 
Phrase613:
estrogenic compounds 
jj - nns - 
Phrase614:
promoter-driven cat 
jj - nn - 
Phrase615:
dose-dependent manner 
jj - nn - 
Phrase616:
the mycotoxins 
dt - nn - 
Phrase617:
full agonist 
jj - nn - 
Phrase618:
lower potencies 
jjr - nns - 
Phrase619:
an ec50 
dt - nn - 
Phrase620:
the e2 
dt - nn - 
Phrase621:
the slope 
dt - nn - 
Phrase622:
positive cooperativity 
jj - nn - 
Phrase623:
the estrogenic response 
dt - jj - nn - 
Phrase624:
the activity 
dt - nn - 
Phrase625:
the mycotoxins 
dt - nn - 
Phrase626:
the estrogen 
dt - nn - 
Phrase627:
both antiestrogens 
dt - nns - 
Phrase628:
their 
prp$ - 
Phrase629:
dose-dependent manner 
jj - nn - 
Phrase630:
environmental estrogenic compounds 
jj - jj - nns - 
Phrase631:
the mycoestrogens 
dt - nn - 
Phrase632:
the compounds 
dt - nns - 
Phrase633:
the exception 
dt - nn - 
Phrase634:
the industrial 
dt - nn - 
Phrase635:
the response 
dt - nn - 
Phrase636:
the response 
dt - nn - 
Phrase637:
less potent 
jjr - nn - 
Phrase638:
the response 
dt - nn - 
Phrase639:
the results 
dt - nns - 
Phrase640:
some environmental estrogens 
dt - jj - nns - 
Phrase641:
reproductive tissue 
jj - nn - 
Phrase642:
an effect 
dt - nn - 
Phrase643:
dendritic cells 
jj - nns - 
Phrase644:
peripheral blood 
jj - nn - 
Phrase645:
an in 
dt - nn - 
Phrase646:
primary immune response 
jj - jj - nn - 
Phrase647:
dendritic cell-based 
jj - nn - 
Phrase648:
viral peptides 
jj - nns - 
Phrase649:
dendritic cells 
jj - nns - 
Phrase650:
autologous cd4+ t 
jj - jj - nn - 
Phrase651:
peripheral blood 
jj - nn - 
Phrase652:
magnetic bead 
jj - nn - 
Phrase653:
the immediate early protein 
dt - jj - jj - nn - 
Phrase654:
cellular immunity 
jj - nn - 
Phrase655:
naive donors 
jj - nns - 
Phrase656:
the assays 
dt - nn - 
Phrase657:
vzv-susceptible donors 
jj - nns - 
Phrase658:
an in 
dt - nn - 
Phrase659:
multiple vzv 
jj - nn - 
Phrase660:
the immunogenicity 
dt - nn - 
Phrase661:
viral antigens 
jj - nns - 
Phrase662:
naive donors 
jj - nns - 
Phrase663:
the activation 
dt - nn - 
Phrase664:
the transcription 
dt - nn - 
Phrase665:
consistent feature 
jj - nn - 
Phrase666:
discordant xenograft 
jj - nn - 
Phrase667:
we 
prp - 
Phrase668:
natural antibodies 
jj - nns - 
Phrase669:
consequent leukocyte 
jj - nn - 
Phrase670:
aortic endothelial 
jj - nn - 
Phrase671:
homologous porcine 
jj - nn - 
Phrase672:
adherent cells 
jj - nns - 
Phrase673:
the number 
dt - nn - 
Phrase674:
adherent leukocytes 
jj - nns - 
Phrase675:
similar adhesive response 
jj - jj - nn - 
Phrase676:
potent inducers 
jj - nns - 
Phrase677:
adhesive properties 
jj - nns - 
Phrase678:
positive control 
jj - nn - 
Phrase679:
possible mechanisms 
jj - nns - 
Phrase680:
we 
prp - 
Phrase681:
central regulator 
jj - nn - 
Phrase682:
the induction 
dt - nn - 
Phrase683:
different genes 
jj - nns - 
Phrase684:
adhesive molecules 
jj - nns - 
Phrase685:
confocal fluorescence 
jj - nn - 
Phrase686:
we 
prp - 
Phrase687:
positive staining 
jj - nn - 
Phrase688:
the nuclei 
dt - nns - 
Phrase689:
the homologous serum 
dt - jj - nn - 
Phrase690:
the cell 
dt - nn - 
Phrase691:
the nf-kappa 
dt - nn - 
Phrase692:
leukocyte-endothelium interaction 
dt - nn - 
Phrase693:
future therapeutic strategies 
jj - jj - nns - 
Phrase694:
nuclear factor 
jj - nn - 
Phrase695:
peripheral blood 
jj - nn - 
Phrase696:
the anaphylatoxins 
dt - nn - 
Phrase697:
the regulation 
dt - nn - 
Phrase698:
this study 
dt - nn - 
Phrase699:
the capability 
dt - nn - 
Phrase700:
peripheral blood 
jj - nn - 
Phrase701:
nuclear expression 
jj - nn - 
Phrase702:
the kappab 
dt - nn - 
Phrase703:
the p50 
dt - nn - 
Phrase704:
the prototypic nuclear factor 
dt - jj - jj - nn - 
Phrase705:
the dna-protein 
dt - nn - 
Phrase706:
detectable at 
jj - nn - 
Phrase707:
an initial decrease 
dt - jj - nn - 
Phrase708:
subsequent increase 
jj - nn - 
Phrase709:
the cytoplasmic ikappabalpha 
dt - jj - nn - 
Phrase710:
an anti-ikappabalpha 
dt - nn - 
Phrase711:
both c5a 
dt - nn - 
Phrase712:
inhibitory effect 
jj - nn - 
Phrase713:
the same cells 
dt - jj - nns - 
Phrase714:
these results 
dt - nns - 
Phrase715:
the anaphylatoxins 
dt - nn - 
Phrase716:
protein-coupled transcription 
jj - nn - 
Phrase717:
its 
prp$ - 
Phrase718:
the primary physiological regulator 
dt - jj - jj - nn - 
Phrase719:
lineage-specific factor 
jj - nn - 
Phrase720:
detailed studies 
jj - nns - 
Phrase721:
this cytokine 
dt - nn - 
Phrase722:
biological effects 
jj - nns - 
Phrase723:
broad spectrum 
jj - nn - 
Phrase724:
hematopoietic progenitor 
jj - nn - 
Phrase725:
the liver 
dt - nn - 
Phrase726:
the platelet 
dt - nn - 
Phrase727:
the mpl 
dt - nn - 
Phrase728:
the hematopoietin 
dt - nn - 
Phrase729:
intrinsic kinase 
jj - nn - 
Phrase730:
ligand-induced mpl 
jj - nn - 
Phrase731:
the major signaling 
dt - jj - nn - 
Phrase732:
the jak2/stat5 
dt - nn - 
Phrase733:
prolonged activation 
jj - nn - 
Phrase734:
the mapk 
dt - nn - 
Phrase735:
clinical studies 
jj - nns - 
Phrase736:
the potential 
dt - nn - 
Phrase737:
it 
prp - 
Phrase738:
its 
prp$ - 
Phrase739:
retinaldehyde dehydrogenase 
dt - nn - 
Phrase740:
acute lymphoblastic leukemia 
jj - jj - nn - 
Phrase741:
we 
prp - 
Phrase742:
the lim-only 
dt - nn - 
Phrase743:
acute lymphoblastic leukemia 
jj - jj - nn - 
Phrase744:
the findings 
dt - nns - 
Phrase745:
synergistic in 
jj - nn - 
Phrase746:
the molecular 
dt - nn - 
Phrase747:
functional synergy 
jj - nn - 
Phrase748:
transcriptional regulation 
jj - nn - 
Phrase749:
we 
prp - 
Phrase750:
downstream target 
jj - nn - 
Phrase751:
subtractive pcr 
jj - nn - 
Phrase752:
the t-all 
dt - nn - 
Phrase753:
the raldh2 
dt - nn - 
Phrase754:
the second 
dt - nn - 
Phrase755:
cryptic promoter 
jj - nn - 
Phrase756:
the second 
dt - nn - 
Phrase757:
the tal1- 
dt - nn - 
Phrase758:
transcriptional activation 
jj - nn - 
Phrase759:
this site 
dt - nn - 
Phrase760:
forced expression 
jj - nn - 
Phrase761:
the induction 
dt - nn - 
Phrase762:
the transcription 
dt - nn - 
Phrase763:
the presence 
dt - nn - 
Phrase764:
we 
prp - 
Phrase765:
the raldh2 
dt - nn - 
Phrase766:
first example 
jj - nn - 
Phrase767:
direct transcriptional target 
jj - jj - nn - 
Phrase768:
this case 
dt - nn - 
Phrase769:
the transcription 
dt - nn - 
Phrase770:
peripheral blood 
jj - nn - 
Phrase771:
ubiquitous molecules 
jj - nns - 
Phrase772:
the hippocampus 
dt - nn - 
Phrase773:
immune tissues 
jj - nns - 
Phrase774:
peripheral blood 
jj - nn - 
Phrase775:
good model 
jj - nn - 
Phrase776:
humoral homeostasis 
jj - nn - 
Phrase777:
key mediators 
jj - nns - 
Phrase778:
regulatory interactions 
jj - nns - 
Phrase779:
the increase 
dt - nn - 
Phrase780:
immune systems 
jj - nns - 
Phrase781:
healthy aged subjects 
jj - jj - nns - 
Phrase782:
these results 
dt - nns - 
Phrase783:
we 
prp - 
Phrase784:
possible relationship 
jj - nn - 
Phrase785:
the pbmcs 
dt - nns - 
Phrase786:
the same parameters 
dt - jj - nns - 
Phrase787:
the sedentary group 
dt - jj - nn - 
Phrase788:
higher in 
jjr - nn - 
Phrase789:
younger subjects 
jjr - nns - 
Phrase790:
older ones 
jjr - nns - 
Phrase791:
lower in 
jjr - nn - 
Phrase792:
the group 
dt - nn - 
Phrase793:
older sedentary subjects 
jjr - jj - nns - 
Phrase794:
the sedentary group 
dt - jj - nn - 
Phrase795:
negative correlation 
jj - nn - 
Phrase796:
lower in 
jjr - nn - 
Phrase797:
the athletes 
dt - nn - 
Phrase798:
they 
prp - 
Phrase799:
the sedentary subjects 
dt - jj - nns - 
Phrase800:
the results 
dt - nns - 
Phrase801:
their 
prp$ - 
Phrase802:
the mechanism 
dt - nn - 
Phrase803:
an involution 
dt - nn - 
Phrase804:
other possibilities 
jj - nn - 
Phrase805:
altered distribution 
jj - nn - 
Phrase806:
different receptor 
jj - nn - 
Phrase807:
different cytokine 
jj - nn - 
Phrase808:
several neuroendocrine-immune 
jj - nn - 
Phrase809:
reactive oxygen 
jj - nn - 
Phrase810:
the insulin 
dt - nn - 
Phrase811:
prolonged poor glycemic 
jj - jj - nn - 
Phrase812:
pancreatic beta 
jj - nn - 
Phrase813:
the insulin 
dt - nn - 
Phrase814:
the cells 
dt - nns - 
Phrase815:
the pathophysiological background 
dt - jj - nn - 
Phrase816:
the so-called glucose 
dt - jj - nn - 
Phrase817:
pancreatic beta 
jj - nn - 
Phrase818:
we 
prp - 
Phrase819:
strong deoxidizing 
jj - nn - 
Phrase820:
the effects 
dt - nns - 
Phrase821:
the results 
dt - nns - 
Phrase822:
the insulin 
dt - nn - 
Phrase823:
the control 
dt - nn - 
Phrase824:
the insulin 
dt - nn - 
Phrase825:
the cells 
dt - nns - 
Phrase826:
the presence 
dt - nn - 
Phrase827:
the insulin 
dt - nn - 
Phrase828:
the glycation-induced 
dt - nn - 
Phrase829:
specific antiserum 
jj - nn - 
Phrase830:
the dna-binding 
dt - nn - 
Phrase831:
an insulin 
dt - nn - 
Phrase832:
these effects 
dt - nns - 
Phrase833:
reactive oxygen 
jj - nn - 
Phrase834:
the glycation 
dt - nn - 
Phrase835:
the phenomena 
dt - nns - 
Phrase836:
these observations 
dt - nns - 
Phrase837:
pancreatic beta 
jj - nn - 
Phrase838:
chronic hyperglycemia 
jj - nn - 
Phrase839:
the beta 
dt - nn - 
Phrase840:
nuclear factor-kappa 
jj - nn - 
Phrase841:
rheumatic diseases 
jj - nns - 
Phrase842:
preliminary report 
jj - nn - 
Phrase843:
the nf-kappa 
dt - nn - 
Phrase844:
the expression 
dt - nn - 
Phrase845:
many genes 
jj - nns - 
Phrase846:
inflammatory response 
jj - nn - 
Phrase847:
the transcriptional level 
dt - jj - nn - 
Phrase848:
the aim 
dt - nn - 
Phrase849:
this study 
dt - nn - 
Phrase850:
distinctive patterns 
jj - nn - 
Phrase851:
different forms 
jj - nns - 
Phrase852:
the dna 
dt - nn - 
Phrase853:
these nucleoproteins 
dt - nn - 
Phrase854:
peripheral t 
jj - nn - 
Phrase855:
various chronic rheumatic diseases 
jj - jj - jj - nns - 
Phrase856:
electrophoretic mobility 
jj - nn - 
Phrase857:
specific complexes 
jj - nns - 
Phrase858:
specific 32p-labelled 
jj - nn - 
Phrase859:
peripheral blood 
jj - nn - 
Phrase860:
the complexes 
dt - nns - 
Phrase861:
peripheral t 
jj - nn - 
Phrase862:
the results 
dt - nns - 
Phrase863:
central part 
jj - nn - 
Phrase864:
the activation 
dt - nn - 
Phrase865:
chronic rheumatoid 
jj - nn - 
Phrase866:
the activation 
dt - nn - 
Phrase867:
this nuclear factor 
dt - jj - nn - 
Phrase868:
different in 
jj - nn - 
Phrase869:
that in 
dt - nn - 
Phrase870:
other forms 
jj - nns - 
Phrase871:
normal females 
jj - nns - 
Phrase872:
an early stage 
dt - jj - nn - 
Phrase873:
embryonic development 
jj - nn - 
Phrase874:
x-linked markers 
jj - nns - 
Phrase875:
the origin 
dt - nn - 
Phrase876:
various neoplastic disorders 
jj - jj - nns - 
Phrase877:
useful tool 
jj - nn - 
Phrase878:
the understanding 
dt - nn - 
Phrase879:
the mechanisms 
dt - nns - 
Phrase880:
the development 
dt - nn - 
Phrase881:
clonal analysis 
jj - nn - 
Phrase882:
polymorphic short tandem repeat 
jj - jj - jj - nn - 
Phrase883:
the x-linked human 
dt - jj - nn - 
Phrase884:
the rapid expansion 
dt - jj - nn - 
Phrase885:
the number 
dt - nn - 
Phrase886:
the possibility 
dt - nn - 
Phrase887:
the pattern 
dt - nn - 
Phrase888:
elderly women 
jj - nns - 
Phrase889:
the present 
dt - nn - 
Phrase890:
we 
prp - 
Phrase891:
the ar 
dt - nn - 
Phrase892:
healthy females 
jj - nns - 
Phrase893:
neoplastic familial disorders 
jj - jj - nns - 
Phrase894:
we 
prp - 
Phrase895:
any correlation 
dt - nn - 
Phrase896:
= 0.17 
jj - nn - 
Phrase897:
the subjects 
dt - nns - 
Phrase898:
different age 
jj - nn - 
Phrase899:
the criteria 
dt - nns - 
Phrase900:
other researchers 
jj - nns - 
Phrase901:
accurate criteria 
jj - nns - 
Phrase902:
unbalanced inactivation 
jj - nn - 
Phrase903:
the x 
dt - nn - 
Phrase904:
normal women 
jj - nns - 
Phrase905:
academic 
nnp - 
Phrase906:
press 
nnp - 
Phrase907:
the role 
dt - nn - 
Phrase908:
an important role 
dt - jj - nn - 
Phrase909:
the differentiation 
dt - nn - 
Phrase910:
we 
prp - 
Phrase911:
the need 
dt - nn - 
Phrase912:
il-12-induced signaling 
jj - nn - 
Phrase913:
the molecular 
dt - nn - 
Phrase914:
this species 
dt - nns - 
Phrase915:
the presence 
dt - nn - 
Phrase916:
the production 
dt - nn - 
Phrase917:
these results 
dt - nns - 
Phrase918:
the differentiation 
dt - nn - 
Phrase919:
naive t 
jj - nn - 
Phrase920:
we 
prp - 
Phrase921:
the expression 
dt - nn - 
Phrase922:
we 
prp - 
Phrase923:
differential display 
jj - nn - 
Phrase924:
the cdna 
dt - nn - 
Phrase925:
the characteristic 
dt - nn - 
Phrase926:
the forkhead 
dt - nn - 
Phrase927:
this cdna 
dt - nn - 
Phrase928:
we 
prp - 
Phrase929:
the in-vitro-translated 
dt - nn - 
Phrase930:
the fkhrl1 
dt - nn - 
Phrase931:
the mrna 
dt - nn - 
Phrase932:
elevated in 
jj - nn - 
Phrase933:
pha-stimulated t 
jj - nn - 
Phrase934:
its 
prp$ - 
Phrase935:
related family 
jj - nn - 
Phrase936:
the transcriptional mechanisms 
dt - jj - nns - 
Phrase937:
this fork 
dt - nn - 
Phrase938:
their 
prp$ - 
Phrase939:
an il-4-independent mechanism 
dt - jj - nn - 
Phrase940:
the transcription 
dt - nn - 
Phrase941:
th2-specific cytokines 
jj - nns - 
Phrase942:
we 
prp - 
Phrase943:
an absence 
dt - nn - 
Phrase944:
we 
prp - 
Phrase945:
novel role 
jj - nn - 
Phrase946:
its 
prp$ - 
Phrase947:
positive actions 
jj - nns - 
Phrase948:
th2-specific cytokines 
jj - nns - 
Phrase949:
rapid dominance 
jj - nn - 
Phrase950:
early th 
jj - nn - 
Phrase951:
stable divergence 
jj - nn - 
Phrase952:
tandem gata 
jj - nn - 
Phrase953:
erythroid-specific chromatin 
jj - nn - 
Phrase954:
the human 
dt - nn - 
Phrase955:
proper expression 
jj - nn - 
Phrase956:
the genes 
dt - nns - 
Phrase957:
the human 
dt - nn - 
Phrase958:
the lcr 
dt - nn - 
Phrase959:
the presence 
dt - nn - 
Phrase960:
erythroid-specific chromatin 
jj - nn - 
Phrase961:
these domains 
dt - nns - 
Phrase962:
hypersensitive sites 
jj - nns - 
Phrase963:
the active elements 
dt - jj - nns - 
Phrase964:
the lcr 
dt - nn - 
Phrase965:
the major focus 
dt - jj - nn - 
Phrase966:
this research 
dt - nn - 
Phrase967:
the cis -acting 
dt - nn - 
Phrase968:
the formation 
dt - nn - 
Phrase969:
these domains 
dt - nns - 
Phrase970:
unique chromatin 
jj - nn - 
Phrase971:
our 
prp$ - 
Phrase972:
previous investigations 
jj - nns - 
Phrase973:
the formation 
dt - nn - 
Phrase974:
the formation 
dt - nn - 
Phrase975:
the native hs 
dt - jj - nn - 
Phrase976:
tandem gata 
jj - nn - 
Phrase977:
the core 
dt - nn - 
Phrase978:
the other human 
dt - jj - nn - 
Phrase979:
site-directed mutagenesis 
jj - nn - 
Phrase980:
the hypothesis 
dt - nn - 
Phrase981:
these nf-e2 
dt - nn - 
Phrase982:
the formation 
dt - nn - 
Phrase983:
we 
prp - 
Phrase984:
these elements 
dt - nns - 
Phrase985:
the gata 
dt - nn - 
Phrase986:
complete loss 
jj - nn - 
Phrase987:
these data 
dt - nns - 
Phrase988:
the presence 
dt - nn - 
Phrase989:
structural elements 
jj - nns - 
Phrase990:
the core 
dt - nn - 
Phrase991:
each lcr 
dt - nn - 
Phrase992:
erythroid-specific chromatin 
jj - nn - 
Phrase993:
these motifs 
dt - nns - 
Phrase994:
regulatory sequences 
jj - nns - 
Phrase995:
the so-called au-rich 
dt - jj - nn - 
Phrase996:
3' untranslated regions 
jj - jj - nns - 
Phrase997:
an au-motif-directed 
dt - nn - 
Phrase998:
differential display 
jj - nn - 
Phrase999:
the identification 
dt - nn - 
Phrase1000:
it 
prp - 
Phrase1001:
peripheral blood 
jj - nn - 
Phrase1002:
unknown genes 
jj - nns - 
Phrase1003:
these data 
dt - nns - 
Phrase1004:
the efficiency 
dt - nn - 
Phrase1005:
the system 
dt - nn - 
Phrase1006:
the notion 
dt - nn - 
Phrase1007:
numerous genes 
jj - nns - 
Phrase1008:
those categories 
dt - nns - 
Phrase1009:
they 
prp - 
Phrase1010:
this method 
dt - nn - 
Phrase1011:
academic 
nnp - 
Phrase1012:
press 
nnp - 
Phrase1013:
renal fibrosis 
jj - nn - 
Phrase1014:
the etiology 
dt - nn - 
Phrase1015:
many kidney 
jj - nn - 
Phrase1016:
the tubulointerstitium 
dt - nn - 
Phrase1017:
the subsequent loss 
dt - jj - nn - 
Phrase1018:
renal function 
jj - nn - 
Phrase1019:
any disease 
dt - nn - 
Phrase1020:
any disease 
dt - nn - 
Phrase1021:
the transcription 
dt - nn - 
Phrase1022:
the nuclear factor-kappa 
dt - jj - nn - 
Phrase1023:
the nf-kappab 
dt - nn - 
Phrase1024:
the association 
dt - nn - 
Phrase1025:
renal inflammation 
jj - nn - 
Phrase1026:
erythroid differentiation 
jj - nn - 
Phrase1027:
we 
prp - 
Phrase1028:
an increase 
dt - nn - 
Phrase1029:
the cellular hemoglobin 
dt - jj - nn - 
Phrase1030:
similar increase 
jj - nn - 
Phrase1031:
the expression 
dt - nn - 
Phrase1032:
morphological studies 
jj - nns - 
Phrase1033:
erythroid differentiation 
jj - nn - 
Phrase1034:
the same time 
dt - jj - nn - 
Phrase1035:
the level 
dt - nn - 
Phrase1036:
the cell 
dt - nn - 
Phrase1037:
the level 
dt - nn - 
Phrase1038:
the erythroid transcription 
dt - jj - nn - 
Phrase1039:
untreated k562 
jj - nn - 
Phrase1040:
erythroid differentiation 
jj - nn - 
Phrase1041:
the expression 
dt - nn - 
Phrase1042:
the nuclear factors 
dt - jj - nn - 
Phrase1043:
erythroid differentiation 
jj - nn - 
Phrase1044:
we 
prp - 
Phrase1045:
the expression 
dt - nn - 
Phrase1046:
the erythroid transcription 
dt - jj - nn - 
Phrase1047:
the regulation 
dt - nn - 
Phrase1048:
beta-like globin 
jj - nn - 
Phrase1049:
b-cell-specific promoter 
jj - nn - 
Phrase1050:
the human 
dt - nn - 
Phrase1051:
the class 
dt - nn - 
Phrase1052:
the expression 
dt - nn - 
Phrase1053:
major histocompatibility 
jj - nn - 
Phrase1054:
the tissular 
dt - nn - 
Phrase1055:
we 
prp - 
Phrase1056:
b-lymphoblastoid cell 
jj - nn - 
Phrase1057:
the ciita 
dt - nn - 
Phrase1058:
strong similarity 
jj - nn - 
Phrase1059:
an initiator 
dt - nn - 
Phrase1060:
putative binding 
jj - nn - 
Phrase1061:
this promoter 
dt - nn - 
Phrase1062:
high luciferase 
jj - nn - 
Phrase1063:
the construct 
dt - nn - 
Phrase1064:
an induction 
dt - nn - 
Phrase1065:
the human 
dt - nn - 
Phrase1066:
the cells 
dt - nns - 
Phrase1067:
the human 
dt - nn - 
Phrase1068:
these data 
dt - nns - 
Phrase1069:
the existence 
dt - nn - 
Phrase1070:
an intragenic promoter 
dt - jj - nn - 
Phrase1071:
an ifn-gamma-inducible expression 
dt - jj - nn - 
Phrase1072:
functional studies 
jj - nns - 
Phrase1073:
the aetiology 
dt - nn - 
Phrase1074:
disabling disorder 
jj - nn - 
Phrase1075:
immune dysfunction 
jj - nn - 
Phrase1076:
ectopic endometrial fragments 
jj - jj - nns - 
Phrase1077:
the uterine 
dt - nn - 
Phrase1078:
these studies 
dt - nns - 
Phrase1079:
the relationship 
dt - nn - 
Phrase1080:
ectopic endometrium 
jj - nn - 
Phrase1081:
different phases 
jj - nns - 
Phrase1082:
the menstrual cycle 
dt - jj - nn - 
Phrase1083:
cd8+ leukocytes 
jj - nns - 
Phrase1084:
eutopic endometrium 
jj - nn - 
Phrase1085:
cd56+ endometrial granulated 
jj - jj - nn - 
Phrase1086:
ectopic endometrium 
jj - nn - 
Phrase1087:
apoptotic cells 
jj - nns - 
Phrase1088:
identical steroid 
jj - nn - 
Phrase1089:
eutopic endometrium 
jj - nn - 
Phrase1090:
different aetiologies 
jj - nn - 
Phrase1091:
these disorders 
dt - nns - 
Phrase1092:
the unusual cd56+ cd16- egls 
dt - jj - jj - jj - nn - 
Phrase1093:
large numbers 
jj - nns - 
Phrase1094:
late secretory phase 
jj - jj - nn - 
Phrase1095:
eutopic endometrium 
jj - nn - 
Phrase1096:
immunomagnetic separation 
jj - nn - 
Phrase1097:
negligible cytotoxic activity 
jj - jj - nn - 
Phrase1098:
early proliferative 
jj - nn - 
Phrase1099:
cytotoxic activity 
jj - nn - 
Phrase1100:
non-pregnant endometrium 
jj - nn - 
Phrase1101:
the menstrual cycle 
dt - jj - nn - 
Phrase1102:
those in 
dt - nn - 
Phrase1103:
peripheral blood 
jj - nn - 
Phrase1104:
cd56+ cd16+ 
jj - nn - 
Phrase1105:
natural killer 
jj - nn - 
Phrase1106:
non-pregnant endometrium 
jj - nn - 
Phrase1107:
early pregnancy 
jj - nn - 
Phrase1108:
variable proliferative 
jj - nn - 
Phrase1109:
important in 
jj - nn - 
Phrase1110:
the eutopic endometrium 
dt - jj - nn - 
Phrase1111:
their 
prp$ - 
Phrase1112:
endometriotic lesions 
jj - nns - 
Phrase1113:
significant effects 
jj - nns - 
Phrase1114:
the development 
dt - nn - 
Phrase1115:
epstein-barr virus 
jj - nn - 
Phrase1116:
latent proteins 
jj - nns - 
Phrase1117:
their 
prp$ - 
Phrase1118:
epstein-barr virus 
jj - nn - 
Phrase1119:
the outgrowth 
dt - nn - 
Phrase1120:
we 
prp - 
Phrase1121:
the use 
dt - nn - 
Phrase1122:
intracellular staining 
jj - nn - 
Phrase1123:
the influence 
dt - nn - 
Phrase1124:
the individual 
dt - nn - 
Phrase1125:
latent proteins 
jj - nns - 
Phrase1126:
the expression 
dt - nn - 
Phrase1127:
the up-regulation 
dt - nn - 
Phrase1128:
the latent membrane 
dt - jj - nn - 
Phrase1129:
nuclear proteins 
jj - nns - 
Phrase1130:
electrophoretic mobility 
jj - nn - 
Phrase1131:
the il-1beta 
dt - nn - 
Phrase1132:
nuclear factor-kappab 
jj - nn - 
Phrase1133:
functional rbp 
jj - nn - 
Phrase1134:
this site 
dt - nn - 
Phrase1135:
nuclear proteins 
jj - nns - 
Phrase1136:
these proteins 
dt - nns - 
Phrase1137:
its 
prp$ - 
Phrase1138:
transcriptional repression 
jj - nn - 
Phrase1139:
low levels 
jj - nns - 
Phrase1140:
high levels 
jj - nns - 
Phrase1141:
the expression 
dt - nn - 
Phrase1142:
latent membrane 
jj - nn - 
Phrase1143:
the il-1beta 
dt - nn - 
Phrase1144:
the study 
dt - nn - 
Phrase1145:
academic 
nnp - 
Phrase1146:
press 
nnp - 
Phrase1147:
the differentiation 
dt - nn - 
Phrase1148:
the induction 
dt - nn - 
Phrase1149:
several signals 
jj - nns - 
Phrase1150:
we 
prp - 
Phrase1151:
the role 
dt - nn - 
Phrase1152:
the addition 
dt - nn - 
Phrase1153:
the ige 
dt - nn - 
Phrase1154:
the presence 
dt - nn - 
Phrase1155:
anti-cd40 mab 
jj - nn - 
Phrase1156:
the effect 
dt - nn - 
Phrase1157:
the ability 
dt - nn - 
Phrase1158:
the presence 
dt - nn - 
Phrase1159:
the augmentation 
dt - nn - 
Phrase1160:
apparent in 
jj - nn - 
Phrase1161:
mild in 
jj - nn - 
Phrase1162:
the helper 
dt - nn - 
Phrase1163:
the cd27/cd70 
dt - nn - 
Phrase1164:
the enhancement 
dt - nn - 
Phrase1165:
morphological analyses 
jj - nns - 
Phrase1166:
the addition 
dt - nn - 
Phrase1167:
the presence 
dt - nn - 
Phrase1168:
the up-regulation 
dt - nn - 
Phrase1169:
positive regulatory domain 
jj - jj - nn - 
Phrase1170:
our 
prp$ - 
Phrase1171:
the generation 
dt - nn - 
Phrase1172:
positive regulatory domain 
jj - jj - nn - 
Phrase1173:
the 5'-untranslated leader 
dt - jj - nn - 
Phrase1174:
the interaction 
dt - nn - 
Phrase1175:
cis-regulatory dna 
jj - nn - 
Phrase1176:
the viral long terminal 
dt - jj - jj - nn - 
Phrase1177:
the series 
dt - nn - 
Phrase1178:
the transcriptional initiation 
dt - jj - nn - 
Phrase1179:
the u3 
dt - nn - 
Phrase1180:
the ltr 
dt - nn - 
Phrase1181:
the sp1 
dt - nn - 
Phrase1182:
recent studies 
jj - nns - 
Phrase1183:
5'-untranslated leader 
jj - nn - 
Phrase1184:
important transcriptional elements 
jj - jj - nns - 
Phrase1185:
these regulatory elements 
dt - jj - nns - 
Phrase1186:
inducible transcription 
jj - nn - 
Phrase1187:
cellular activation 
jj - nn - 
Phrase1188:
efficient hiv-1 
jj - nn - 
Phrase1189:
the 5'-utr 
dt - nn - 
Phrase1190:
the transcription 
dt - nn - 
Phrase1191:
these binding 
dt - nn - 
Phrase1192:
the viral response 
dt - jj - nn - 
Phrase1193:
viral replication 
jj - nn - 
Phrase1194:
the 5'-utr 
dt - nn - 
Phrase1195:
transcriptional activation 
jj - nn - 
Phrase1196:
the latent provirus 
dt - jj - nn - 
Phrase1197:
we 
prp - 
Phrase1198:
the inducible transcription 
dt - jj - nn - 
Phrase1199:
the 5'-utr 
dt - nn - 
Phrase1200:
downstream enhancer 
jj - nn - 
Phrase1201:
the ltr 
dt - nn - 
Phrase1202:
latent proviral transcription 
jj - jj - nn - 
Phrase1203:
this review 
dt - nn - 
Phrase1204:
we 
prp - 
Phrase1205:
the host-cell 
dt - nn - 
Phrase1206:
the 5'-utr 
dt - nn - 
Phrase1207:
their 
prp$ - 
Phrase1208:
the transcriptional regulation 
dt - jj - nn - 
Phrase1209:
the t 
dt - nn - 
Phrase1210:
the linker 
dt - nn - 
Phrase1211:
the t 
dt - nn - 
Phrase1212:
-associated protein 
jj - nn - 
Phrase1213:
we 
prp - 
Phrase1214:
the slp-76 
dt - nn - 
Phrase1215:
both nck 
dt - nn - 
Phrase1216:
an adaptor 
dt - nn - 
Phrase1217:
the assembly 
dt - nn - 
Phrase1218:
this tri-molecular 
dt - nn - 
Phrase1219:
this complex 
dt - nn - 
Phrase1220:
the enzymatic activation 
dt - jj - nn - 
Phrase1221:
the p21-activated 
dt - nn - 
Phrase1222:
the tcr-associated 
dt - nn - 
Phrase1223:
downstream effector 
jj - nn - 
Phrase1224:
distinct signaling 
jj - nn - 
Phrase1225:
epstein-barr virus 
jj - nn - 
Phrase1226:
-transformed b 
jj - nn - 
Phrase1227:
the high correlation 
dt - jj - nn - 
Phrase1228:
this issue 
dt - nn - 
Phrase1229:
we 
prp - 
Phrase1230:
peripheral b 
jj - nn - 
Phrase1231:
the expression 
dt - nn - 
Phrase1232:
latent membrane 
jj - nn - 
Phrase1233:
these b 
dt - nn - 
Phrase1234:
nuclear factor 
jj - nn - 
Phrase1235:
these results 
dt - nns - 
Phrase1236:
primary b 
jj - nn - 
Phrase1237:
academic 
nnp - 
Phrase1238:
press 
nnp - 
Phrase1239:
the human 
dt - nn - 
Phrase1240:
the lectin-type 
dt - nn - 
Phrase1241:
novel member 
jj - nn - 
Phrase1242:
the natural killer 
dt - jj - nn - 
Phrase1243:
unique expression 
jj - nn - 
Phrase1244:
an endothelial 
dt - nn - 
Phrase1245:
low-density lipoprotein 
jj - nn - 
Phrase1246:
essential roles 
jj - nns - 
Phrase1247:
the highest homology 
dt - jjs - nn - 
Phrase1248:
c-type lectin 
jj - nn - 
Phrase1249:
natural killer 
jj - nn - 
Phrase1250:
the present 
dt - nn - 
Phrase1251:
we 
prp - 
Phrase1252:
the human 
dt - nn - 
Phrase1253:
the gene 
dt - nn - 
Phrase1254:
the natural killer 
dt - jj - nn - 
Phrase1255:
artificial chromosome 
jj - nn - 
Phrase1256:
the human 
dt - nn - 
Phrase1257:
located in 
jj - nn - 
Phrase1258:
the natural killer 
dt - jj - nn - 
Phrase1259:
the genes 
dt - nns - 
Phrase1260:
the natural killer 
dt - jj - nn - 
Phrase1261:
the expression 
dt - nn - 
Phrase1262:
the natural killer 
dt - jj - nn - 
Phrase1263:
the 5' 
dt - nn - 
Phrase1264:
flanking region 
jj - nn - 
Phrase1265:
the lox-1 
dt - nn - 
Phrase1266:
functional promoter 
jj - nn - 
Phrase1267:
several transcription 
jj - nn - 
Phrase1268:
the stat 
dt - nn - 
Phrase1269:
the expression 
dt - nn - 
Phrase1270:
several cytokines 
jj - nns - 
Phrase1271:
these results 
dt - nns - 
Phrase1272:
the human 
dt - nn - 
Phrase1273:
the natural killer 
dt - jj - nn - 
Phrase1274:
unique expression 
jj - nn - 
Phrase1275:
academic 
nnp - 
Phrase1276:
press 
nnp - 
Phrase1277:
transcriptional regulation 
jj - nn - 
Phrase1278:
the beta-casein 
dt - nn - 
Phrase1279:
other signaling 
jj - nn - 
Phrase1280:
the beta-casein 
dt - nn - 
Phrase1281:
the activation 
dt - nn - 
Phrase1282:
the beta-casein 
dt - nn - 
Phrase1283:
it 
prp - 
Phrase1284:
other molecules 
jj - nns - 
Phrase1285:
this report 
dt - nn - 
Phrase1286:
we 
prp - 
Phrase1287:
the transcriptional regulation 
dt - jj - nn - 
Phrase1288:
the beta-casein 
dt - nn - 
Phrase1289:
we 
prp - 
Phrase1290:
the beta-casein 
dt - nn - 
Phrase1291:
cytotoxic t 
jj - nn - 
Phrase1292:
it 
prp - 
Phrase1293:
cytokine-inducible sh2-containing 
jj - nn - 
Phrase1294:
the function 
dt - nn - 
Phrase1295:
il-2-induced beta-casein 
jj - nn - 
Phrase1296:
this synergistic effect 
dt - jj - nn - 
Phrase1297:
the sequence 
dt - nn - 
Phrase1298:
the beta-casein 
dt - nn - 
Phrase1299:
this region 
dt - nn - 
Phrase1300:
the il-2-induced expression 
dt - jj - nn - 
Phrase1301:
an active form 
dt - jj - nn - 
Phrase1302:
the il-2-induced beta-casein 
dt - jj - nn - 
Phrase1303:
the negative effect 
dt - jj - nn - 
Phrase1304:
the region 
dt - nn - 
Phrase1305:
the beta-casein 
dt - nn - 
Phrase1306:
apparent contradiction 
jj - nn - 
Phrase1307:
dominant negative form 
jj - jj - nn - 
Phrase1308:
il-2-induced activation 
jj - nn - 
Phrase1309:
the promoter 
dt - nn - 
Phrase1310:
the minimal beta-casein 
dt - jj - nn - 
Phrase1311:
the promoters 
dt - nns - 
Phrase1312:
an erythropoietin 
dt - nn - 
Phrase1313:
defective in 
jj - nn - 
Phrase1314:
augmented activation 
jj - nn - 
Phrase1315:
the beta-casein 
dt - nn - 
Phrase1316:
the mutant 
dt - nn - 
Phrase1317:
possible role 
jj - nn - 
Phrase1318:
these results 
dt - nns - 
Phrase1319:
other signaling 
jj - nn - 
Phrase1320:
gp91phox gene 
dt - nn - 
Phrase1321:
the regulatory mechanism 
dt - jj - nn - 
Phrase1322:
we 
prp - 
Phrase1323:
negative element 
jj - nn - 
Phrase1324:
the gp91phox 
dt - nn - 
Phrase1325:
the deletion 
dt - nn - 
Phrase1326:
the gata 
dt - nn - 
Phrase1327:
the gata-3 
dt - nn - 
Phrase1328:
the bp 
dt - nn - 
Phrase1329:
the bp 
dt - nn - 
Phrase1330:
we 
prp - 
Phrase1331:
the gata 
dt - nn - 
Phrase1332:
the expression 
dt - nn - 
Phrase1333:
the gene 
dt - nn - 
Phrase1334:
activation-dependent hs1 
jj - nn - 
Phrase1335:
nuclear factor 
jj - nn - 
Phrase1336:
transcriptional activation 
jj - nn - 
Phrase1337:
differential signaling 
jj - nn - 
Phrase1338:
the costimulatory 
dt - nn - 
Phrase1339:
distinct receptors 
jj - nns - 
Phrase1340:
these receptors 
dt - nns - 
Phrase1341:
the rapid tyrosine 
dt - jj - nn - 
Phrase1342:
intracellular signaling 
jj - nn - 
Phrase1343:
the src 
dt - nn - 
Phrase1344:
the tyrosine 
dt - nn - 
Phrase1345:
hematopoietic cell-specific intracellular signaling 
jj - jj - jj - nn - 
Phrase1346:
unknown function 
jj - nn - 
Phrase1347:
we 
prp - 
Phrase1348:
differential stimulation 
jj - nn - 
Phrase1349:
its 
prp$ - 
Phrase1350:
the signaling 
dt - nn - 
Phrase1351:
these receptors 
dt - nns - 
Phrase1352:
the cd28 
dt - nn - 
Phrase1353:
mitogenic pairs 
jj - nns - 
Phrase1354:
the transcription 
dt - nn - 
Phrase1355:
nuclear factor 
jj - nn - 
Phrase1356:
the cd3-dependent phosphorylation 
dt - jj - nn - 
Phrase1357:
both src 
dt - nn - 
Phrase1358:
the tyrosine 
dt - nn - 
Phrase1359:
the same signaling 
dt - jj - nn - 
Phrase1360:
they 
prp - 
Phrase1361:
their 
prp$ - 
Phrase1362:
the tyrosine 
dt - nn - 
Phrase1363:
activation-dependent tyrosine 
jj - nn - 
Phrase1364:
transcriptional activation 
jj - nn - 
Phrase1365:
an analysis 
dt - nn - 
Phrase1366:
the neonatal immune response 
dt - jj - jj - nn - 
Phrase1367:
an antigenic challenge 
dt - jj - nn - 
Phrase1368:
normal cord 
jj - nn - 
Phrase1369:
normal adult 
jj - nn - 
Phrase1370:
peripheral blood 
jj - nn - 
Phrase1371:
either mitogen 
dt - nn - 
Phrase1372:
the monoclonal antibody 
dt - jj - nn - 
Phrase1373:
greater proliferation 
jjr - nn - 
Phrase1374:
= 0.0081 
jj - nn - 
Phrase1375:
similar maximal increases 
jj - jj - nns - 
Phrase1376:
= 0.0126 
jj - nn - 
Phrase1377:
= 0.0291 
jj - nn - 
Phrase1378:
an equivalent 
dt - nn - 
Phrase1379:
= 0.0354 
jj - nn - 
Phrase1380:
= 0.0112 
jj - nn - 
Phrase1381:
similar in 
jj - nn - 
Phrase1382:
we 
prp - 
Phrase1383:
an adult-type 
dt - nn - 
Phrase1384:
receptor-mediated mitogen-activated protein 
jj - jj - nn - 
Phrase1385:
the fc 
dt - nn - 
Phrase1386:
large number 
jj - nn - 
Phrase1387:
cellular responses 
jj - nns - 
Phrase1388:
important in 
jj - nn - 
Phrase1389:
inflammatory mediators 
jj - nns - 
Phrase1390:
the immune response 
dt - jj - nn - 
Phrase1391:
immune complexes 
jj - nns - 
Phrase1392:
protein-tyrosine kinases 
jj - nns - 
Phrase1393:
the molecular 
dt - nn - 
Phrase1394:
these receptors 
dt - nns - 
Phrase1395:
the nucleus 
dt - nn - 
Phrase1396:
we 
prp - 
Phrase1397:
the signal 
dt - nn - 
Phrase1398:
the thp-1 
dt - nn - 
Phrase1399:
monocytic cell 
jj - nn - 
Phrase1400:
immune complexes 
jj - nns - 
Phrase1401:
the transcription 
dt - nn - 
Phrase1402:
these responses 
dt - nns - 
Phrase1403:
dominant negative mutants 
jj - jj - nns - 
Phrase1404:
these cells 
dt - nns - 
Phrase1405:
any effect 
dt - nn - 
Phrase1406:
nuclear factor 
jj - nn - 
Phrase1407:
the mitogen-activated protein 
dt - jj - nn - 
Phrase1408:
these receptors 
dt - nns - 
Phrase1409:
immune complexes 
jj - nns - 
Phrase1410:
the specific mapk/extracellular 
dt - jj - nn - 
Phrase1411:
signal-regulated kinase 
jj - nn - 
Phrase1412:
we 
prp - 
Phrase1413:
the nuclear factor 
dt - jj - nn - 
Phrase1414:
these results 
dt - nns - 
Phrase1415:
the signaling 
dt - nn - 
Phrase1416:
different genes 
jj - nns - 
Phrase1417:
other tyrosine 
jj - nn - 
Phrase1418:
normal germinal center 
jj - jj - nn - 
Phrase1419:
somatic hypermutation 
jj - nn - 
Phrase1420:
the molecular 
dt - nn - 
Phrase1421:
the process 
dt - nn - 
Phrase1422:
somatic hypermutation 
jj - nn - 
Phrase1423:
it 
prp - 
Phrase1424:
this mechanism 
dt - nn - 
Phrase1425:
the ig 
dt - nn - 
Phrase1426:
multiple somatic mutations 
jj - jj - nns - 
Phrase1427:
the 5'-regulatory region 
dt - jj - nn - 
Phrase1428:
transcriptional repressor 
jj - nn - 
Phrase1429:
germinal center 
jj - nn - 
Phrase1430:
physiologic mechanism 
jj - nn - 
Phrase1431:
we 
prp - 
Phrase1432:
single human 
jj - nn - 
Phrase1433:
tonsillar gc 
jj - nn - 
Phrase1434:
the bcl-6 
dt - nn - 
Phrase1435:
the ig 
dt - nn - 
Phrase1436:
variable heavy chain 
jj - jj - nn - 
Phrase1437:
naive b 
jj - nn - 
Phrase1438:
the 742 
dt - nn - 
Phrase1439:
the first intron 
dt - jj - nn - 
Phrase1440:
overall frequency 
jj - nn - 
Phrase1441:
lymphoid malignancies 
jj - nns - 
Phrase1442:
post-gc phenotype 
jj - nn - 
Phrase1443:
variable heavy chain 
jj - jj - nn - 
Phrase1444:
these results 
dt - nns - 
Phrase1445:
the somatic hypermutation 
dt - jj - nn - 
Phrase1446:
active in 
jj - nn - 
Phrase1447:
non-ig sequences 
jj - nns - 
Phrase1448:
the ad1 
dt - nn - 
Phrase1449:
the antiapoptotic activity 
dt - jj - nn - 
Phrase1450:
the chimeric oncoprotein 
dt - jj - nn - 
Phrase1451:
the chimeric oncoprotein 
dt - jj - nn - 
Phrase1452:
the t(17;19) 
dt - nn - 
Phrase1453:
pro-b-cell acute lymphoblastic leukemia 
jj - jj - jj - nn - 
Phrase1454:
the transactivation 
dt - nn - 
Phrase1455:
the basic leucine 
dt - jj - nn - 
Phrase1456:
hepatic leukemic factor 
jj - jj - nn - 
Phrase1457:
the ability 
dt - nn - 
Phrase1458:
the survival 
dt - nn - 
Phrase1459:
-dependent murine 
jj - nn - 
Phrase1460:
it 
prp - 
Phrase1461:
the cells 
dt - nns - 
Phrase1462:
the structural motifs 
dt - jj - nns - 
Phrase1463:
this antiapoptotic effect 
dt - jj - nn - 
Phrase1464:
we 
prp - 
Phrase1465:
their 
prp$ - 
Phrase1466:
il-3-dependent murine 
jj - nn - 
Phrase1467:
the e12 
dt - nn - 
Phrase1468:
the e47 
dt - nn - 
Phrase1469:
the e2a 
dt - nn - 
Phrase1470:
the wild-type hlf 
dt - jj - nn - 
Phrase1471:
the cells 
dt - nns - 
Phrase1472:
different combinations 
jj - nns - 
Phrase1473:
disabling mutations 
jj - nns - 
Phrase1474:
the hlf 
dt - nn - 
Phrase1475:
little effect 
jj - nn - 
Phrase1476:
the antiapoptotic property 
dt - jj - nn - 
Phrase1477:
the chimeric protein 
dt - jj - nn - 
Phrase1478:
the amino-terminal portion 
dt - jj - nn - 
Phrase1479:
the context 
dt - nn - 
Phrase1480:
defective in 
jj - nn - 
Phrase1481:
the block 
dt - nn - 
Phrase1482:
the transactivating 
dt - nn - 
Phrase1483:
neither dna 
dt - nn - 
Phrase1484:
the bzip 
dt - nn - 
Phrase1485:
this effect 
dt - nn - 
Phrase1486:
we 
prp - 
Phrase1487:
protein-protein interactions 
jj - nns - 
Phrase1488:
the amino-terminal region 
dt - jj - nn - 
Phrase1489:
the chimera 
dt - nn - 
Phrase1490:
transcriptional cofactor 
jj - nn - 
Phrase1491:
the expression 
dt - nn - 
Phrase1492:
the apoptotic machinery 
dt - jj - nn - 
Phrase1493:
inflammatory cytokine 
jj - nn - 
Phrase1494:
the structure-activity 
dt - nn - 
Phrase1495:
the mechanism 
dt - nn - 
Phrase1496:
mn sod 
dt - nn - 
Phrase1497:
this study 
dt - nn - 
Phrase1498:
we 
prp - 
Phrase1499:
fatty acid 
jj - nn - 
Phrase1500:
the 3' r-3-hydroxymyristate 
dt - jj - nn - 
Phrase1501:
the lipid 
dt - nn - 
Phrase1502:
its 
prp$ - 
Phrase1503:
full capacity 
jj - nn - 
Phrase1504:
limulus amoebocyte 
dt - nn - 
Phrase1505:
the activation 
dt - nn - 
Phrase1506:
nuclear factor-kappab 
jj - nn - 
Phrase1507:
the induction 
dt - nn - 
Phrase1508:
the wild-type endotoxin 
dt - jj - nn - 
Phrase1509:
it 
prp - 
Phrase1510:
significant production 
jj - nn - 
Phrase1511:
inflammatory protein-1alpha 
jj - nn - 
Phrase1512:
the phosphorylation 
dt - nn - 
Phrase1513:
nuclear translocation 
jj - nn - 
Phrase1514:
mitogen-activated protein 
jj - nn - 
Phrase1515:
these results 
dt - nns - 
Phrase1516:
fatty acid 
jj - nn - 
Phrase1517:
it 
prp - 
Phrase1518:
the induction 
dt - nn - 
Phrase1519:
inflammatory cytokine 
jj - nn - 
Phrase1520:
the induction 
dt - nn - 
Phrase1521:
inflammatory cytokines 
jj - nns - 
Phrase1522:
least in 
jjs - nn - 
Phrase1523:
different signal 
jj - nn - 
Phrase1524:
the mutant 
dt - nn - 
Phrase1525:
least in 
jjs - nn - 
Phrase1526:
its 
prp$ - 
Phrase1527:
mitogen-activated protein 
jj - nn - 
Phrase1528:
the vitellogenin 
dt - nn - 
Phrase1529:
primary cultures 
jj - nns - 
Phrase1530:
tissue-specific regulation 
jj - nn - 
Phrase1531:
the xenopus 
dt - nn - 
Phrase1532:
primary culture 
jj - nn - 
Phrase1533:
an efficient hormonal control 
dt - jj - jj - nn - 
Phrase1534:
this promoter 
dt - nn - 
Phrase1535:
functional interaction 
jj - nn - 
Phrase1536:
the estrogen 
dt - nn - 
Phrase1537:
responsive elements 
jj - nns - 
Phrase1538:
the tata 
dt - nn - 
Phrase1539:
high density 
jj - nn - 
Phrase1540:
the transcription 
dt - nn - 
Phrase1541:
the chromosomal 
dt - nn - 
Phrase1542:
the vitellogenin 
dt - nn - 
Phrase1543:
the estrogen 
dt - nn - 
Phrase1544:
responsive unit 
jj - nn - 
Phrase1545:
the promoter 
dt - nn - 
Phrase1546:
these findings 
dt - nns - 
Phrase1547:
the notion 
dt - nn - 
Phrase1548:
the interplay 
dt - nn - 
Phrase1549:
proper hormone-dependent 
jj - nn - 
Phrase1550:
tissue-specific expression 
jj - nn - 
Phrase1551:
the b1 
dt - nn - 
Phrase1552:
differential induction 
jj - nn - 
Phrase1553:
primary human 
jj - nn - 
Phrase1554:
key regulators 
jj - nns - 
Phrase1555:
peripheral blood 
jj - nn - 
Phrase1556:
the precise mechanisms 
dt - jj - nns - 
Phrase1557:
their 
prp$ - 
Phrase1558:
differential activities 
jj - nns - 
Phrase1559:
these cells 
dt - nns - 
Phrase1560:
recent studies 
jj - nns - 
Phrase1561:
many cytokine 
jj - nn - 
Phrase1562:
we 
prp - 
Phrase1563:
the activation 
dt - nn - 
Phrase1564:
primary human 
jj - nn - 
Phrase1565:
specific cytokines 
jj - nns - 
Phrase1566:
we 
prp - 
Phrase1567:
primary nk 
jj - nn - 
Phrase1568:
primary t 
jj - nn - 
Phrase1569:
the lack 
dt - nn - 
Phrase1570:
the il-12 
dt - nn - 
Phrase1571:
different c 
jj - nn - 
Phrase1572:
their 
prp$ - 
Phrase1573:
own preferential gas-like 
jj - jj - nn - 
Phrase1574:
important factor 
jj - nn - 
Phrase1575:
specific gene 
jj - nn - 
Phrase1576:
their 
prp$ - 
Phrase1577:
we 
prp - 
Phrase1578:
multiple stat 
jj - nn - 
Phrase1579:
another unidentified fc 
dt - jj - nn - 
Phrase1580:
we 
prp - 
Phrase1581:
distinct fc 
jj - nn - 
Phrase1582:
they 
prp - 
Phrase1583:
different roles 
jj - nns - 
Phrase1584:
our 
prp$ - 
Phrase1585:
the differential responses 
dt - jj - nns - 
Phrase1586:
primary nk 
jj - nn - 
Phrase1587:
direct stimulation 
jj - nn - 
Phrase1588:
different cytokines 
jj - nns - 
Phrase1589:
direct result 
jj - nn - 
Phrase1590:
distinct activation 
jj - nn - 
Phrase1591:
regulatory element 
jj - nn - 
Phrase1592:
the cd95 
dt - nn - 
Phrase1593:
tcr-mediated activation 
jj - nn - 
Phrase1594:
the cd95 
dt - nn - 
Phrase1595:
major cause 
jj - nn - 
Phrase1596:
activation-induced apoptosis 
jj - nn - 
Phrase1597:
the molecular 
dt - nn - 
Phrase1598:
transcriptional control 
jj - nn - 
Phrase1599:
we 
prp - 
Phrase1600:
the human 
dt - nn - 
Phrase1601:
the cd95l 
dt - nn - 
Phrase1602:
the transcription 
dt - nn - 
Phrase1603:
this study 
dt - nn - 
Phrase1604:
we 
prp - 
Phrase1605:
novel regulatory element 
jj - jj - nn - 
Phrase1606:
located at 
jj - nn - 
Phrase1607:
the cd95l 
dt - nn - 
Phrase1608:
unknown inducible factor 
jj - jj - nn - 
Phrase1609:
the inducible factor 
dt - jj - nn - 
Phrase1610:
the biological function 
dt - jj - nn - 
Phrase1611:
the cd95l 
dt - nn - 
Phrase1612:
the dna 
dt - nn - 
Phrase1613:
the binding 
dt - nn - 
Phrase1614:
this element 
dt - nn - 
Phrase1615:
an nf-at 
dt - nn - 
Phrase1616:
strong inducible activity 
jj - jj - nn - 
Phrase1617:
the cd95l 
dt - nn - 
Phrase1618:
this regulatory region 
dt - jj - nn - 
Phrase1619:
our 
prp$ - 
Phrase1620:
the immunosuppressive agent 
dt - jj - nn - 
Phrase1621:
the function 
dt - nn - 
Phrase1622:
this positive regulatory element 
dt - jj - jj - nn - 
Phrase1623:
nongenomic mechanism 
jj - nn - 
Phrase1624:
the mechanism 
dt - nn - 
Phrase1625:
localized suppression 
jj - nn - 
Phrase1626:
the immune response 
dt - jj - nn - 
Phrase1627:
we 
prp - 
Phrase1628:
the placenta 
dt - nn - 
Phrase1629:
calcium-activated k+ 
jj - nn - 
Phrase1630:
the membrane 
dt - nn - 
Phrase1631:
nuclear factor 
jj - nn - 
Phrase1632:
-driven gene 
jj - nn - 
Phrase1633:
the initial steps 
dt - jj - nns - 
Phrase1634:
-mediated signal 
jj - nn - 
Phrase1635:
it 
prp - 
Phrase1636:
sustained ca2+ 
jj - nn - 
Phrase1637:
the ca2+ 
dt - nn - 
Phrase1638:
other steroid 
jj - nn - 
Phrase1639:
the progesterone 
dt - nn - 
Phrase1640:
broad spectrum 
jj - nn - 
Phrase1641:
both kv1.3 
dt - nn - 
Phrase1642:
current in 
jj - nn - 
Phrase1643:
an inward 
dt - nn - 
Phrase1644:
we 
prp - 
Phrase1645:
direct inhibition 
jj - nn - 
Phrase1646:
progesterone-induced immunosuppression 
jj - nn - 
Phrase1647:
genetic defect 
jj - nn - 
Phrase1648:
the choice 
dt - nn - 
Phrase1649:
transgenic mice 
jj - nns - 
Phrase1650:
early arrest 
jj - nn - 
Phrase1651:
the thymus 
dt - nn - 
Phrase1652:
the present 
dt - nn - 
Phrase1653:
the thymus 
dt - nn - 
Phrase1654:
the human 
dt - nn - 
Phrase1655:
transgenic mice 
jj - nns - 
Phrase1656:
the accumulation 
dt - nn - 
Phrase1657:
mature b 
jj - nn - 
Phrase1658:
the thymus 
dt - nn - 
Phrase1659:
other human 
jj - nn - 
Phrase1660:
transgenic mouse 
jj - nn - 
Phrase1661:
other t 
jj - nn - 
Phrase1662:
double knockout 
jj - nn - 
Phrase1663:
lymphoid progenitor 
jj - nn - 
Phrase1664:
stromal cells 
jj - nns - 
Phrase1665:
abnormal b 
jj - nn - 
Phrase1666:
fetal liver 
jj - nn - 
Phrase1667:
normal thymus 
jj - nn - 
Phrase1668:
the presence 
dt - nn - 
Phrase1669:
normal progenitor 
jj - nn - 
Phrase1670:
these results 
dt - nns - 
Phrase1671:
lymphoid progenitor 
jj - nn - 
Phrase1672:
defective in 
jj - nn - 
Phrase1673:
thymic choice 
jj - nn - 
Phrase1674:
normal thymus 
jj - nn - 
Phrase1675:
cell-specific transcription 
jj - nn - 
Phrase1676:
early t 
jj - nn - 
Phrase1677:
the cell 
dt - nn - 
Phrase1678:
novel mouse 
jj - nn - 
Phrase1679:
downstream activation 
jj - nn - 
Phrase1680:
tata-less promoter 
jj - nn - 
Phrase1681:
the homing 
dt - nn - 
Phrase1682:
mature b 
jj - nn - 
Phrase1683:
the chemokine 
dt - nn - 
Phrase1684:
major regulator 
jj - nn - 
Phrase1685:
the microenvironmental 
dt - nn - 
Phrase1686:
lymphoid organs 
jj - nns - 
Phrase1687:
essential elements 
jj - nns - 
Phrase1688:
the tata-less blr1 
dt - jj - nn - 
Phrase1689:
the b 
dt - nn - 
Phrase1690:
both humans 
dt - nns - 
Phrase1691:
functional promoter 
jj - nn - 
Phrase1692:
the transcription 
dt - nn - 
Phrase1693:
noncanonical octamer 
jj - nn - 
Phrase1694:
the importance 
dt - nn - 
Phrase1695:
these sites 
dt - nns - 
Phrase1696:
either oct-2 
dt - nn - 
Phrase1697:
both nf-kappab 
dt - nn - 
Phrase1698:
these animals 
dt - nns - 
Phrase1699:
the expression 
dt - nn - 
Phrase1700:
our 
prp$ - 
Phrase1701:
the nf-kappab/rel 
dt - nn - 
Phrase1702:
the impaired b 
dt - jj - nn - 
Phrase1703:
these factors 
dt - nn - 
Phrase1704:
the observation 
dt - nn - 
Phrase1705:
cd4(-) cells 
jj - nns - 
Phrase1706:
several years 
jj - nns - 
Phrase1707:
e. 
nnp - 
Phrase1708:
our 
prp$ - 
Phrase1709:
the mechanisms 
dt - nns - 
Phrase1710:
such phenomena 
jj - nns - 
Phrase1711:
the cd4 
dt - nn - 
Phrase1712:
we 
prp - 
Phrase1713:
such genetic elements 
jj - jj - nns - 
Phrase1714:
the cd4 
dt - nn - 
Phrase1715:
the presence 
dt - nn - 
Phrase1716:
the viral dna 
dt - jj - nn - 
Phrase1717:
early classes 
jj - nns - 
Phrase1718:
viral genes 
jj - nns - 
Phrase1719:
specific cd4 
jj - nn - 
Phrase1720:
we 
prp - 
Phrase1721:
an atf/cre 
dt - nn - 
Phrase1722:
located at 
jj - nn - 
Phrase1723:
the cd4 
dt - nn - 
Phrase1724:
the atf/cre 
dt - nn - 
Phrase1725:
an activator 
dt - nn - 
Phrase1726:
electrophoretic mobility 
jj - nn - 
Phrase1727:
specific antibodies 
jj - nns - 
Phrase1728:
we 
prp - 
Phrase1729:
the cd4 
dt - nn - 
Phrase1730:
we 
prp - 
Phrase1731:
the immediate-early locus 
dt - jj - nn - 
Phrase1732:
the cd4 
dt - nn - 
Phrase1733:
the cd4 
dt - nn - 
Phrase1734:
the cre 
dt - nn - 
Phrase1735:
additional hhv-6 
jj - nn - 
Phrase1736:
our 
prp$ - 
Phrase1737:
the complex 
dt - nn - 
Phrase1738:
the cd4 
dt - nn - 
Phrase1739:
additional information 
jj - nn - 
Phrase1740:
the class 
dt - nn - 
Phrase1741:
the control 
dt - nn - 
Phrase1742:
the pebp2betamyh11 
dt - nn - 
Phrase1743:
granulocytic dysplasia 
jj - nn - 
Phrase1744:
the genes 
dt - nns - 
Phrase1745:
the alpha 
dt - nn - 
Phrase1746:
the pebp2/cbf 
dt - nn - 
Phrase1747:
acute myeloid 
jj - nn - 
Phrase1748:
the preleukemic condition 
dt - jj - nn - 
Phrase1749:
the gene 
dt - nn - 
Phrase1750:
the beta 
dt - nn - 
Phrase1751:
the myh11 
dt - nn - 
Phrase1752:
heavy chain 
jj - nn - 
Phrase1753:
the effect 
dt - nn - 
Phrase1754:
the inv(16)(p13;q22) 
dt - nn - 
Phrase1755:
we 
prp - 
Phrase1756:
the hmrp8 
dt - nn - 
Phrase1757:
transgenic mice 
jj - nns - 
Phrase1758:
the pebp2betasmmhc 
dt - nn - 
Phrase1759:
chimeric fusion 
jj - nn - 
Phrase1760:
impaired in 
jj - nn - 
Phrase1761:
transgenic mice 
jj - nns - 
Phrase1762:
the transgenic mice 
dt - jj - nns - 
Phrase1763:
normal numbers 
jj - nns - 
Phrase1764:
their 
prp$ - 
Phrase1765:
immature neutrophilic cells 
jj - jj - nns - 
Phrase1766:
abnormal characteristics 
jj - nns - 
Phrase1767:
neutrophilic differentiation 
jj - nn - 
Phrase1768:
hematopoietic progenitors 
jj - nns - 
Phrase1769:
both pebp2betamyh11 
dt - nn - 
Phrase1770:
more severe phenotype 
jjr - jj - nn - 
Phrase1771:
abnormal nuclear morphology 
jj - jj - nn - 
Phrase1772:
granulocytic dysplasia 
jj - nn - 
Phrase1773:
these results 
dt - nns - 
Phrase1774:
the genesis 
dt - nn - 
Phrase1775:
tax-mediated apoptosis 
jj - nn - 
Phrase1776:
intracellular prooxidant state 
jj - jj - nn - 
Phrase1777:
we 
prp - 
Phrase1778:
an estradiol-dependent 
dt - nn - 
Phrase1779:
the inhibition 
dt - nn - 
Phrase1780:
the induction 
dt - nn - 
Phrase1781:
the present 
dt - nn - 
Phrase1782:
prooxidant state 
jj - nn - 
Phrase1783:
the intracellular levels 
dt - jj - nns - 
Phrase1784:
these changes 
dt - nns - 
Phrase1785:
apoptotic cell 
jj - nn - 
Phrase1786:
additional stimulation 
jj - nn - 
Phrase1787:
the cd3/tcr 
dt - nn - 
Phrase1788:
apoptotic effects 
jj - nns - 
Phrase1789:
tax-mediated apoptosis 
jj - nn - 
Phrase1790:
oxidative stress 
jj - nn - 
Phrase1791:
the administration 
dt - nn - 
Phrase1792:
leukemia-derived factor 
jj - nn - 
Phrase1793:
long-lasting activation 
jj - nn - 
Phrase1794:
major target 
jj - nn - 
Phrase1795:
reactive oxygen 
jj - nn - 
Phrase1796:
the long-term exposure 
dt - jj - nn - 
Phrase1797:
subsequent transfection 
jj - nn - 
Phrase1798:
the recovery 
dt - nn - 
Phrase1799:
these cells 
dt - nns - 
Phrase1800:
our 
prp$ - 
Phrase1801:
the intracellular redox 
dt - jj - nn - 
Phrase1802:
tax-mediated dna 
jj - nn - 
Phrase1803:
the long-term expression 
dt - jj - nn - 
Phrase1804:
an allosteric 
dt - nn - 
Phrase1805:
nuclear translocation 
jj - nn - 
Phrase1806:
both hiv-1 
dt - nn - 
Phrase1807:
the efficacy 
dt - nn - 
Phrase1808:
primary isolates 
jj - nns - 
Phrase1809:
simian immunodeficiency 
jj - nn - 
Phrase1810:
the replication 
dt - nn - 
Phrase1811:
primary isolates 
jj - nns - 
Phrase1812:
antiviral activity 
jj - nn - 
Phrase1813:
allosterically transited 
dt - nn - 
Phrase1814:
the reactive twisted 
dt - jj - nn - 
Phrase1815:
nuclear translocation 
jj - nn - 
Phrase1816:
both hiv-1 
dt - nn - 
Phrase1817:
the cellular transcriptional nuclear factor-kb 
dt - jj - jj - jj - nn - 
Phrase1818:
the suppression 
dt - nn - 
Phrase1819:
glucocorticoid-induced apoptosis 
jj - nn - 
Phrase1820:
leukemic t 
jj - nn - 
Phrase1821:
glucocorticoid-induced apoptosis 
jj - nn - 
Phrase1822:
glucocorticoid-sensitive 6tg1.1 
jj - nn - 
Phrase1823:
resistant icr27tk.3 
jj - nn - 
Phrase1824:
leukemic t 
jj - nn - 
Phrase1825:
the ability 
dt - nn - 
Phrase1826:
other systems 
jj - nns - 
Phrase1827:
ongoing protein 
jj - nn - 
Phrase1828:
effective in 
jj - nn - 
Phrase1829:
the entire period 
dt - jj - nn - 
Phrase1830:
rapid turnover 
jj - nn - 
Phrase1831:
nuclear factor-kappab 
jj - nn - 
Phrase1832:
an increase 
dt - nn - 
Phrase1833:
the amount 
dt - nn - 
Phrase1834:
immunoreactive ikappab 
jj - nn - 
Phrase1835:
sensitive 6tg1.1 
jj - nn - 
Phrase1836:
resistant icr27tk.3 
jj - nn - 
Phrase1837:
mild detergent 
jj - nn - 
Phrase1838:
substantial amount 
jj - nn - 
Phrase1839:
cytoplasmic nf-kappab 
jj - nn - 
Phrase1840:
some other inhibitory factor 
dt - jj - jj - nn - 
Phrase1841:
these results 
dt - nns - 
Phrase1842:
inhibitory factor 
jj - nn - 
Phrase1843:
glucocorticoid-induced apoptosis 
jj - nn - 
Phrase1844:
novel inhibitor 
jj - nn - 
Phrase1845:
the small molecule 
dt - jj - nn - 
Phrase1846:
an established tumor 
dt - jj - nn - 
Phrase1847:
the isopropylidine 
dt - nn - 
Phrase1848:
an inhibitor 
dt - nn - 
Phrase1849:
viral reverse 
jj - nn - 
Phrase1850:
prolonged appearance 
jj - nn - 
Phrase1851:
cd4+ lymphocytes 
jj - nns - 
Phrase1852:
peripheral blood 
jj - nn - 
Phrase1853:
primary hiv-1 
jj - nn - 
Phrase1854:
promoter-driven reporter 
jj - nn - 
Phrase1855:
it 
prp - 
Phrase1856:
the mechanism 
dt - nn - 
Phrase1857:
antiviral action 
jj - nn - 
Phrase1858:
the host 
dt - nn - 
Phrase1859:
tar-independent loop 
jj - nn - 
Phrase1860:
long terminal 
jj - nn - 
Phrase1861:
the first generation 
dt - jj - nn - 
Phrase1862:
the natural compound 
dt - jj - nn - 
Phrase1863:
further structure-based 
jj - nn - 
Phrase1864:
these compounds 
dt - nns - 
Phrase1865:
therapeutic approach 
jj - nn - 
Phrase1866:
the other a 
dt - jj - nn - 
Phrase1867:
viral target 
jj - nn - 
Phrase1868:
an approach 
dt - nn - 
Phrase1869:
the problem 
dt - nn - 
Phrase1870:
frequent emergence 
jj - nn - 
Phrase1871:
resistant variants 
jj - nns - 
Phrase1872:
intestinal epithelial 
jj - nn - 
Phrase1873:
the high concentration 
dt - jj - nn - 
Phrase1874:
foreign antigen 
jj - nn - 
Phrase1875:
the lumen 
dt - nn - 
Phrase1876:
the gastrointestinal 
dt - nn - 
Phrase1877:
the underlying lymphocytes 
dt - jj - nns - 
Phrase1878:
single cell 
jj - nn - 
Phrase1879:
intestinal epithelial 
jj - nn - 
Phrase1880:
antigen-presenting cells 
jj - nns - 
Phrase1881:
cd4(+) t 
jj - nn - 
Phrase1882:
the intestinal mucosa 
dt - jj - nn - 
Phrase1883:
hla-dr-restricted t 
jj - nn - 
Phrase1884:
we 
prp - 
Phrase1885:
intestinal epithelial 
jj - nn - 
Phrase1886:
their 
prp$ - 
Phrase1887:
the class 
dt - nn - 
Phrase1888:
these cells 
dt - nns - 
Phrase1889:
efficient class 
jj - nn - 
Phrase1890:
the characteristic 
dt - nn - 
Phrase1891:
the proinflammatory cytokine 
dt - jj - nn - 
Phrase1892:
the basolateral 
dt - nn - 
Phrase1893:
the basolateral 
dt - nn - 
Phrase1894:
these data 
dt - nns - 
Phrase1895:
functional architecture 
jj - nn - 
Phrase1896:
intestinal epithelial 
jj - nn - 
Phrase1897:
the functional outcome 
dt - jj - nn - 
Phrase1898:
the intestinal epithelium 
dt - jj - nn - 
Phrase1899:
the cellular surface 
dt - jj - nn - 
Phrase1900:
the foreign antigen 
dt - jj - nn - 
Phrase1901:
the underlying degree 
dt - jj - nn - 
Phrase1902:
mucosal inflammation 
jj - nn - 
Phrase1903:
major risk 
jj - nn - 
Phrase1904:
healthy smokers 
jj - nn - 
Phrase1905:
the synthesis 
dt - nn - 
Phrase1906:
we 
prp - 
Phrase1907:
the activation 
dt - nn - 
Phrase1908:
the hs 
dt - nn - 
Phrase1909:
we 
prp - 
Phrase1910:
the effects 
dt - nns - 
Phrase1911:
peripheral blood 
jj - nn - 
Phrase1912:
the respective transcription 
dt - jj - nn - 
Phrase1913:
the altered cytokine 
dt - jj - nn - 
Phrase1914:
an hsf/hsp70-mediated 
dt - nn - 
Phrase1915:
academic 
nnp - 
Phrase1916:
press 
nnp - 
Phrase1917:
several subsets 
jj - nns - 
Phrase1918:
their 
prp$ - 
Phrase1919:
distinct cytokine-production 
jj - nn - 
Phrase1920:
these subsets 
dt - nns - 
Phrase1921:
cellular immunity 
jj - nn - 
Phrase1922:
inflammatory response 
jj - nn - 
Phrase1923:
allergic responses 
jj - nns - 
Phrase1924:
their 
prp$ - 
Phrase1925:
their 
prp$ - 
Phrase1926:
distinct cytokine 
jj - nn - 
Phrase1927:
recent reports 
jj - nns - 
Phrase1928:
differential expression 
jj - nn - 
Phrase1929:
their 
prp$ - 
Phrase1930:
it 
prp - 
Phrase1931:
the mechanisms 
dt - nns - 
Phrase1932:
differential gene 
jj - nn - 
Phrase1933:
pathological immune responses 
jj - jj - nns - 
Phrase1934:
the t 
dt - nn - 
Phrase1935:
biochemical events 
jj - nns - 
Phrase1936:
them 
prp - 
Phrase1937:
the activation 
dt - nn - 
Phrase1938:
central role 
jj - nn - 
Phrase1939:
the signal 
dt - nn - 
Phrase1940:
the activities 
dt - nns - 
Phrase1941:
we 
prp - 
Phrase1942:
the targets 
dt - nns - 
Phrase1943:
the downstream pkc/ras-mediated 
dt - jj - nn - 
Phrase1944:
the t-cell 
dt - nn - 
Phrase1945:
the nuclear factor 
dt - jj - nn - 
Phrase1946:
an important role 
dt - jj - nn - 
Phrase1947:
the rapid calcineurin-dependent translocation 
dt - jj - jj - nn - 
Phrase1948:
the cytoplasm 
dt - nn - 
Phrase1949:
the nucleus 
dt - nn - 
Phrase1950:
the subsequent active maintenance 
dt - jj - jj - nn - 
Phrase1951:
the nucleus 
dt - nn - 
Phrase1952:
the induction 
dt - nn - 
Phrase1953:
several genes 
jj - nns - 
Phrase1954:
immune responses 
jj - nns - 
Phrase1955:
the molecular 
dt - nn - 
Phrase1956:
the nfat 
dt - nn - 
Phrase1957:
rapid progress 
jj - nn - 
Phrase1958:
the understanding 
dt - nn - 
Phrase1959:
the signalling 
dt - nn - 
Phrase1960:
the activity 
dt - nn - 
Phrase1961:
differential rna 
jj - nn - 
Phrase1962:
novel genes 
jj - nns - 
Phrase1963:
the function 
dt - nn - 
Phrase1964:
the intracellular vitamin 
dt - jj - nn - 
Phrase1965:
we 
prp - 
Phrase1966:
stable transfectant 
jj - nn - 
Phrase1967:
d-responsive cell 
jj - nn - 
Phrase1968:
this study 
dt - nn - 
Phrase1969:
we 
prp - 
Phrase1970:
this variable vdr 
dt - jj - nn - 
Phrase1971:
initial experiments 
jj - nns - 
Phrase1972:
similar rise 
jj - nn - 
Phrase1973:
differential rna 
jj - nn - 
Phrase1974:
the catalytic sub-unit 
dt - jj - nn - 
Phrase1975:
the peroxisomal 
dt - nn - 
Phrase1976:
both mrnas 
dt - nns - 
Phrase1977:
estrogenic pathways 
jj - nns - 
Phrase1978:
significant change 
jj - nn - 
Phrase1979:
both genes 
dt - nns - 
Phrase1980:
these data 
dt - nns - 
Phrase1981:
its 
prp$ - 
Phrase1982:
established role 
jj - nn - 
Phrase1983:
long terminal 
jj - nn - 
Phrase1984:
repeat-driven gene 
jj - nn - 
Phrase1985:
-independent signaling 
jj - nn - 
Phrase1986:
the state 
dt - nn - 
Phrase1987:
the infected cells 
dt - jj - nns - 
Phrase1988:
cellular factors 
jj - nn - 
Phrase1989:
pleiotropic immunomodulatory molecule 
jj - jj - nn - 
Phrase1990:
elevated levels 
jj - nns - 
Phrase1991:
the course 
dt - nn - 
Phrase1992:
other pathogenic infections 
jj - jj - nns - 
Phrase1993:
long terminal 
jj - nn - 
Phrase1994:
we 
prp - 
Phrase1995:
ltr-mediated reporter 
jj - nn - 
Phrase1996:
this pge2-dependent 
dt - nn - 
Phrase1997:
the regulatory element 
dt - jj - nn - 
Phrase1998:
this study 
dt - nn - 
Phrase1999:
we 
prp - 
Phrase2000:
the participation 
dt - nn - 
Phrase2001:
cyclic amp 
jj - nn - 
Phrase2002:
different hiv-1 
jj - nn - 
Phrase2003:
-independent signaling 
jj - nn - 
Phrase2004:
the involvement 
dt - nn - 
Phrase2005:
the pge2-dependent 
dt - nn - 
Phrase2006:
kappab-regulated luciferase 
jj - nn - 
Phrase2007:
electrophoretic mobility 
jj - nn - 
Phrase2008:
cytometric analyses 
jj - nns - 
Phrase2009:
the use 
dt - nn - 
Phrase2010:
selective antagonist 
jj - nn - 
Phrase2011:
ltr-driven reporter 
jj - nn - 
Phrase2012:
lymphoid cells 
jj - nns - 
Phrase2013:
the ep4 
dt - nn - 
Phrase2014:
these results 
dt - nns - 
Phrase2015:
inflammatory activators 
jj - nns - 
Phrase2016:
proviral dna 
jj - nn - 
Phrase2017:
distinct transcription 
jj - nn - 
Phrase2018:
bacterial lps 
jj - nn - 
Phrase2019:
the necessity 
dt - nn - 
Phrase2020:
the action 
dt - nn - 
Phrase2021:
endogenous proteases 
jj - nns - 
Phrase2022:
particular encoding 
jj - nn - 
Phrase2023:
the high-affinity 
dt - nn - 
Phrase2024:
the regulation 
dt - nn - 
Phrase2025:
several indications 
jj - nn - 
Phrase2026:
distinct transcription 
jj - nn - 
Phrase2027:
the nf-kappab 
dt - nn - 
Phrase2028:
this study 
dt - nn - 
Phrase2029:
we 
prp - 
Phrase2030:
these transcription 
dt - nn - 
Phrase2031:
stimulatory conditions 
jj - nns - 
Phrase2032:
we 
prp - 
Phrase2033:
conventional procedures 
jj - nns - 
Phrase2034:
cellular extracts 
jj - nns - 
Phrase2035:
the release 
dt - nn - 
Phrase2036:
proteolytic activities 
jj - nns - 
Phrase2037:
intracellular granules 
jj - nns - 
Phrase2038:
the degradation 
dt - nn - 
Phrase2039:
various nf-kappab/rel 
jj - nn - 
Phrase2040:
this problem 
dt - nn - 
Phrase2041:
we 
prp - 
Phrase2042:
an alternative 
dt - nn - 
Phrase2043:
us 
prp - 
Phrase2044:
the binding 
dt - nn - 
Phrase2045:
the ifngamma 
dt - nn - 
Phrase2046:
the fcgammari 
dt - nn - 
Phrase2047:
we 
prp - 
Phrase2048:
the formation 
dt - nn - 
Phrase2049:
the current findings 
dt - jj - nns - 
Phrase2050:
the procedure 
dt - nn - 
Phrase2051:
useful in 
jj - nn - 
Phrase2052:
other cell 
jj - nn - 
Phrase2053:
high levels 
jj - nns - 
Phrase2054:
endogenous proteases 
jj - nns - 
Phrase2055:
low cd3+cd28-induced 
jj - nn - 
Phrase2056:
reactive oxygen 
jj - nn - 
Phrase2057:
neonatal t 
jj - nn - 
Phrase2058:
the capacity 
dt - nn - 
Phrase2059:
neonatal t 
jj - nn - 
Phrase2060:
we 
prp - 
Phrase2061:
polyclonal activator 
jj - nn - 
Phrase2062:
receptor-mediated anti-cd3/anti-cd3+ 
jj - nn - 
Phrase2063:
high il-2 
jj - nn - 
Phrase2064:
monoclonal antibody 
jj - nn - 
Phrase2065:
the il-2 
dt - nn - 
Phrase2066:
neonatal cells 
jj - nns - 
Phrase2067:
low amounts 
jj - nns - 
Phrase2068:
the addition 
dt - nn - 
Phrase2069:
anti-cd3-stimulated cells 
jj - nns - 
Phrase2070:
neonatal t 
jj - nn - 
Phrase2071:
respective mean 
jj - nn - 
Phrase2072:
critical transcription 
jj - nn - 
Phrase2073:
the control 
dt - nn - 
Phrase2074:
we 
prp - 
Phrase2075:
its 
prp$ - 
Phrase2076:
nuclear translocation 
jj - nn - 
Phrase2077:
the electrophoretic mobility 
dt - jj - nn - 
Phrase2078:
reactive oxygen 
jj - nn - 
Phrase2079:
the activation 
dt - nn - 
Phrase2080:
we 
prp - 
Phrase2081:
intracellular roi 
jj - nn - 
Phrase2082:
these cells 
dt - nns - 
Phrase2083:
the roi-reactive 
dt - nn - 
Phrase2084:
neonatal t 
jj - nn - 
Phrase2085:
the cells 
dt - nns - 
Phrase2086:
similar roi 
jj - nn - 
Phrase2087:
our 
prp$ - 
Phrase2088:
neonatal t 
jj - nn - 
Phrase2089:
these activators 
dt - nns - 
Phrase2090:
the roi-nf-kappa 
dt - nn - 
Phrase2091:
neonatal t 
jj - nn - 
Phrase2092:
cd40-inducible molecule 
jj - nn - 
Phrase2093:
cd40-mediated immunoglobulin 
jj - nn - 
Phrase2094:
we 
prp - 
Phrase2095:
our 
prp$ - 
Phrase2096:
monoclonal model 
jj - nn - 
Phrase2097:
germinal center 
jj - nn - 
Phrase2098:
the role 
dt - nn - 
Phrase2099:
igm+ igd+ cd30+ 
jj - jj - nn - 
Phrase2100:
the cd40-mediated nf-kappab-dependent transcriptional activation 
dt - jj - jj - jj - nn - 
Phrase2101:
downstream c(h) 
jj - nn - 
Phrase2102:
the physiological relevance 
dt - jj - nn - 
Phrase2103:
this phenomenon 
dt - nn - 
Phrase2104:
similar cd30-mediated 
jj - nn - 
Phrase2105:
naive b 
jj - nn - 
Phrase2106:
these cells 
dt - nns - 
Phrase2107:
our 
prp$ - 
Phrase2108:
the cd40-mediated differentiation 
dt - jj - nn - 
Phrase2109:
the biological effect 
dt - jj - nn - 
Phrase2110:
the mechanism 
dt - nn - 
Phrase2111:
the immunosuppressive effect 
dt - jj - nn - 
Phrase2112:
the picture 
dt - nn - 
Phrase2113:
close relationship 
jj - nn - 
Phrase2114:
many puzzles 
jj - nn - 
Phrase2115:
the drugs 
dt - nns - 
Phrase2116:
the role 
dt - nn - 
Phrase2117:
the activation 
dt - nn - 
Phrase2118:
non t 
jj - nn - 
Phrase2119:
they 
prp - 
Phrase2120:
them 
prp - 
Phrase2121:
the nfatc 
dt - nn - 
Phrase2122:
it 
prp - 
Phrase2123:
the inhibitory effects 
dt - jj - nns - 
Phrase2124:
negative regulatory events 
jj - jj - nns - 
Phrase2125:
many genes 
jj - nns - 
Phrase2126:
certain genes 
jj - nns - 
Phrase2127:
the gene 
dt - nn - 
Phrase2128:
nonstimulated ramos 
jj - nn - 
Phrase2129:
simultaneous analysis 
jj - nn - 
Phrase2130:
highest increase 
jjs - nn - 
Phrase2131:
the expression 
dt - nn - 
Phrase2132:
certain transcription 
jj - nn - 
Phrase2133:
these genes 
dt - nns - 
Phrase2134:
the stimulated 
dt - nn - 
Phrase2135:
large part 
jj - nn - 
Phrase2136:
stringent regulation 
jj - nn - 
Phrase2137:
the mechanism 
dt - nn - 
Phrase2138:
short form 
jj - nn - 
Phrase2139:
longer form 
jjr - nn - 
Phrase2140:
transcriptional activity 
jj - nn - 
Phrase2141:
it 
prp - 
Phrase2142:
cytokine-induced activation 
jj - nn - 
Phrase2143:
cd4(+) human 
jj - nn - 
Phrase2144:
different regions 
jj - nns - 
Phrase2145:
nuclear translocation 
jj - nn - 
Phrase2146:
an hsie-oligonucleotide 
dt - nn - 
Phrase2147:
migrating isoform 
jj - nn - 
Phrase2148:
cd4(+) t 
jj - nn - 
Phrase2149:
this way 
dt - nn - 
Phrase2150:
the expression 
dt - nn - 
Phrase2151:
additional means 
jj - nn - 
Phrase2152:
cytokine-induced t 
jj - nn - 
Phrase2153:
academic 
nnp - 
Phrase2154:
press 
nnp - 
Phrase2155:
transcriptional regulation 
jj - nn - 
Phrase2156:
lysosomal acid 
jj - nn - 
Phrase2157:
lysosomal acid 
jj - nn - 
Phrase2158:
the cleavage 
dt - nn - 
Phrase2159:
it 
prp - 
Phrase2160:
the expression 
dt - nn - 
Phrase2161:
the cell 
dt - nn - 
Phrase2162:
type-specific increase 
jj - nn - 
Phrase2163:
the thp-1 
dt - nn - 
Phrase2164:
transcriptional regulation 
jj - nn - 
Phrase2165:
the human 
dt - nn - 
Phrase2166:
monocytic leukemia 
jj - nn - 
Phrase2167:
macrophage-like cells 
jj - nns - 
Phrase2168:
the cis-acting elements 
dt - jj - nns - 
Phrase2169:
we 
prp - 
Phrase2170:
responsive element 
jj - nn - 
Phrase2171:
the major transcription 
dt - jj - nn - 
Phrase2172:
the lal 
dt - nn - 
Phrase2173:
the important role 
dt - jj - nn - 
Phrase2174:
these transcription 
dt - nn - 
Phrase2175:
our 
prp$ - 
Phrase2176:
dependent increase 
jj - nn - 
Phrase2177:
lysosomal acid 
jj - nn - 
Phrase2178:
concerted action 
jj - nn - 
Phrase2179:
constitutive expression 
jj - nn - 
Phrase2180:
ebv-infected lymphoblastoid 
jj - nn - 
Phrase2181:
the role 
dt - nn - 
Phrase2182:
we 
prp - 
Phrase2183:
the loss 
dt - nn - 
Phrase2184:
the constitutive expression 
dt - jj - nn - 
Phrase2185:
the transgenic ikappabalpha 
dt - jj - nn - 
Phrase2186:
intracytoplasmic content 
jj - nn - 
Phrase2187:
apoptotic cells 
jj - nns - 
Phrase2188:
intracytoplasmic tnfalpha 
jj - nn - 
Phrase2189:
strong reduction 
jj - nn - 
Phrase2190:
our 
prp$ - 
Phrase2191:
the tnfalpha 
dt - nn - 
Phrase2192:
the targets 
dt - nns - 
Phrase2193:
infected cells 
jj - nns - 
Phrase2194:
ebv-infected cells 
jj - nns - 
Phrase2195:
the proliferative 
dt - nn - 
Phrase2196:
this cytokine 
dt - nn - 
Phrase2197:
postmenopausal woman 
jj - nn - 
Phrase2198:
peripheral blood 
jj - nn - 
Phrase2199:
mosaic pattern 
jj - nn - 
Phrase2200:
we 
prp - 
Phrase2201:
an unusual case 
dt - jj - nn - 
Phrase2202:
old japanese woman 
jj - jj - nn - 
Phrase2203:
normal menses 
jj - nn - 
Phrase2204:
the patient 
dt - nn - 
Phrase2205:
phenotypic female 
jj - nn - 
Phrase2206:
late onset 
jj - nn - 
Phrase2207:
the first year 
dt - jj - nn - 
Phrase2208:
slight flow 
jj - nn - 
Phrase2209:
an otherwise normal menstrual history 
dt - jj - jj - jj - nn - 
Phrase2210:
typical seminoma 
jj - nn - 
Phrase2211:
the left 
dt - nn - 
Phrase2212:
an immature testis 
dt - jj - nn - 
Phrase2213:
karyotypic studies 
jj - nns - 
Phrase2214:
peripheral blood 
jj - nn - 
Phrase2215:
cytogenetic examination 
jj - nn - 
Phrase2216:
the patient 
dt - nn - 
Phrase2217:
healthy children 
jj - nns - 
Phrase2218:
an identical karyotype 
dt - jj - nn - 
Phrase2219:
the patient 
dt - nn - 
Phrase2220:
genital regions 
jj - nns - 
Phrase2221:
clinical stigmata 
jj - nn - 
Phrase2222:
genital skin 
jj - nn - 
Phrase2223:
direct dna 
jj - nn - 
Phrase2224:
neither patient 
dt - nn - 
Phrase2225:
her 
prp$ - 
Phrase2226:
detectable deletion 
jj - nn - 
Phrase2227:
other abnormalities 
jj - nns - 
Phrase2228:
the sry 
dt - nn - 
Phrase2229:
the y 
dt - nn - 
Phrase2230:
these findings 
dt - nns - 
Phrase2231:
the 45,x 
dt - nn - 
Phrase2232:
this atypical presentation 
dt - jj - nn - 
Phrase2233:
an xy 
dt - nn - 
Phrase2234:
we 
prp - 
Phrase2235:
other genes 
jj - nns - 
Phrase2236:
an antiinflammatory alkaloid 
dt - jj - nn - 
Phrase2237:
monocytic cells 
jj - nns - 
Phrase2238:
immunomodulatory activities 
jj - nns - 
Phrase2239:
several inflammatory cytokines 
jj - jj - nns - 
Phrase2240:
oxidative stresses 
jj - nns - 
Phrase2241:
the pathogenesis 
dt - nn - 
Phrase2242:
we 
prp - 
Phrase2243:
the inhibitory effects 
dt - jj - nns - 
Phrase2244:
-induced hiv-1 
jj - nn - 
Phrase2245:
hiv-1-infected cell 
jj - nn - 
Phrase2246:
the presence 
dt - nn - 
Phrase2247:
various concentrations 
jj - nns - 
Phrase2248:
the compound 
dt - nn - 
Phrase2249:
the inhibitory effects 
dt - jj - nns - 
Phrase2250:
long terminal 
jj - nn - 
Phrase2251:
-driven gene 
jj - nn - 
Phrase2252:
nuclear factor 
jj - nn - 
Phrase2253:
pma-stimulated u1 
jj - nn - 
Phrase2254:
its 
prp$ - 
Phrase2255:
cytotoxic concentrations 
jj - nns - 
Phrase2256:
pma-stimulated u1 
jj - nn - 
Phrase2257:
ltr-driven gene 
jj - nn - 
Phrase2258:
the inhibition 
dt - nn - 
Phrase2259:
these results 
dt - nns - 
Phrase2260:
monocytic cell 
jj - nn - 
Phrase2261:
major component 
jj - nn - 
Phrase2262:
the treatment 
dt - nn - 
Phrase2263:
various inflammatory diseases 
jj - jj - nns - 
Phrase2264:
its 
prp$ - 
Phrase2265:
chemotherapeutic potential 
jj - nn - 
Phrase2266:
hiv-1-infected patients 
jj - nns - 
Phrase2267:
epstein-barr virus 
jj - nn - 
Phrase2268:
latent membrane 
jj - nn - 
Phrase2269:
the latent membrane 
dt - jj - nn - 
Phrase2270:
epstein-barr virus 
jj - nn - 
Phrase2271:
tumorigenic transformation 
jj - nn - 
Phrase2272:
phenotypic changes 
jj - nns - 
Phrase2273:
the transcription 
dt - nn - 
Phrase2274:
the tradd 
dt - nn - 
Phrase2275:
the purpose 
dt - nn - 
Phrase2276:
the present 
dt - nn - 
Phrase2277:
the importance 
dt - nn - 
Phrase2278:
the up-regulation 
dt - nn - 
Phrase2279:
the b 
dt - nn - 
Phrase2280:
this activity 
dt - nn - 
Phrase2281:
dominant inhibitory ikappab 
jj - jj - nn - 
Phrase2282:
primary b 
jj - nn - 
Phrase2283:
the dominant ikappab 
dt - jj - nn - 
Phrase2284:
lmp1-induced cell 
jj - nn - 
Phrase2285:
primary b 
jj - nn - 
Phrase2286:
it 
prp - 
Phrase2287:
it 
prp - 
Phrase2288:
certain characteristics 
jj - nns - 
Phrase2289:
hematopoietic development 
jj - nn - 
Phrase2290:
myeloid-committed eosinophil 
jj - nn - 
Phrase2291:
trilineage potential 
dt - nn - 
Phrase2292:
an eosinophilic phenotype 
dt - jj - nn - 
Phrase2293:
the peripheral blood 
dt - jj - nn - 
Phrase2294:
chronic myelomonocytic leukemia 
jj - jj - nn - 
Phrase2295:
fetal bovine 
jj - nn - 
Phrase2296:
yj cells 
jj - nns - 
Phrase2297:
small number 
jj - nn - 
Phrase2298:
the cells 
dt - nns - 
Phrase2299:
eosinophilic granules 
jj - nns - 
Phrase2300:
the yj 
dt - nn - 
Phrase2301:
the eosinophilic characteristics 
dt - jj - nns - 
Phrase2302:
histochemical staining 
jj - nn - 
Phrase2303:
the expression 
dt - nn - 
Phrase2304:
eosinophil-derived neurotoxin 
jj - nn - 
Phrase2305:
major basic protein 
jj - jj - nn - 
Phrase2306:
the charcot-leyden 
dt - nn - 
Phrase2307:
the yj 
dt - nn - 
Phrase2308:
monocytic differentiation 
jj - nn - 
Phrase2309:
the monocytic characteristics 
dt - jj - nns - 
Phrase2310:
morphological analysis 
jj - nn - 
Phrase2311:
alpha-naphthyl butyrate 
jj - nn - 
Phrase2312:
the neutrophil 
dt - nn - 
Phrase2313:
all-trans retinoic acid 
jj - jj - nn - 
Phrase2314:
the number 
dt - nn - 
Phrase2315:
nitroblue tetrazolium 
jj - nn - 
Phrase2316:
-positive cells 
jj - nns - 
Phrase2317:
the yj 
dt - nn - 
Phrase2318:
eosinophilic characteristics 
jj - nns - 
Phrase2319:
neutrophilic lineages 
jj - nns - 
Phrase2320:
the expression 
dt - nn - 
Phrase2321:
neutrophilic differentiation 
jj - nn - 
Phrase2322:
the yj 
dt - nn - 
Phrase2323:
the molecular 
dt - nn - 
Phrase2324:
the eosinophil 
dt - nn - 
Phrase2325:
an inflammatory cascade 
dt - jj - nn - 
Phrase2326:
the production 
dt - nn - 
Phrase2327:
acute respiratory 
jj - nn - 
Phrase2328:
the hypothesis 
dt - nn - 
Phrase2329:
we 
prp - 
Phrase2330:
the lungs 
dt - nns - 
Phrase2331:
the production 
dt - nn - 
Phrase2332:
semiquantitative rt-pcr 
jj - nn - 
Phrase2333:
we 
prp - 
Phrase2334:
striking increase 
jj - nn - 
Phrase2335:
electrophoretic mobility 
jj - nn - 
Phrase2336:
an increase 
dt - nn - 
Phrase2337:
normal rats 
jj - nns - 
Phrase2338:
marked elevation 
jj - nn - 
Phrase2339:
bronchoalveolar lavage 
jj - nn - 
Phrase2340:
these findings 
dt - nns - 
Phrase2341:
early in 
jj - nn - 
Phrase2342:
the mhc 
dt - nn - 
Phrase2343:
the class 
dt - nn - 
Phrase2344:
transcriptional activation 
jj - nn - 
Phrase2345:
the major histocompatibility 
dt - jj - nn - 
Phrase2346:
an n-terminal acidic transcriptional activation 
dt - jj - jj - jj - nn - 
Phrase2347:
this factor 
dt - nn - 
Phrase2348:
extensive mutagenesis 
jj - nn - 
Phrase2349:
structural motifs 
jj - nns - 
Phrase2350:
the ability 
dt - nn - 
Phrase2351:
the control 
dt - nn - 
Phrase2352:
regulatory elements 
jj - nns - 
Phrase2353:
differential activity 
jj - nn - 
Phrase2354:
the w-x-y 
dt - nn - 
Phrase2355:
the x-y 
dt - nn - 
Phrase2356:
their 
prp$ - 
Phrase2357:
wild-type ciita 
jj - nn - 
Phrase2358:
wild-type ciita 
jj - nn - 
Phrase2359:
these mutants 
dt - nns - 
Phrase2360:
functional motifs 
jj - nns - 
Phrase2361:
the acidic activation 
dt - jj - nn - 
Phrase2362:
putative gtp-binding motif 
jj - jj - nn - 
Phrase2363:
the characterization 
dt - nn - 
Phrase2364:
the w 
dt - nn - 
Phrase2365:
such interactions 
jj - nns - 
Phrase2366:
the identification 
dt - nn - 
Phrase2367:
undefined role 
jj - nn - 
Phrase2368:
these motifs 
dt - nns - 
Phrase2369:
the peroxisome 
dt - nn - 
Phrase2370:
proliferator-activated receptor 
jj - nn - 
Phrase2371:
proliferator-activated receptors 
jj - nns - 
Phrase2372:
discrete genes 
jj - nns - 
Phrase2373:
fatty acid 
jj - nn - 
Phrase2374:
it 
prp - 
Phrase2375:
the alpha 
dt - nn - 
Phrase2376:
the potent 
dt - nn - 
Phrase2377:
proinflammatory mediator 
jj - nn - 
Phrase2378:
this eicosanoid 
dt - nn - 
Phrase2379:
we 
prp - 
Phrase2380:
the selective agonist 
dt - jj - nn - 
Phrase2381:
pivotal in 
jj - nn - 
Phrase2382:
the regulation 
dt - nn - 
Phrase2383:
inflammatory responses 
jj - nns - 
Phrase2384:
we 
prp - 
Phrase2385:
any effect 
dt - nn - 
Phrase2386:
the number 
dt - nn - 
Phrase2387:
adhering pmn 
jj - nn - 
Phrase2388:
the response 
dt - nn - 
Phrase2389:
this study 
dt - nn - 
Phrase2390:
regulatory function 
jj - nn - 
Phrase2391:
adhesive interactions 
jj - nns - 
Phrase2392:
the presence 
dt - nn - 
Phrase2393:
conditioned medium 
jj - nn - 
Phrase2394:
transendothelial migration 
jj - nn - 
Phrase2395:
the abnormal adherence 
dt - jj - nn - 
Phrase2396:
red blood 
jj - nn - 
Phrase2397:
vascular occlusion 
jj - nn - 
Phrase2398:
major cause 
jj - nn - 
Phrase2399:
we 
prp - 
Phrase2400:
the interaction 
dt - nn - 
Phrase2401:
cellular oxidant 
jj - nn - 
Phrase2402:
the adhesion 
dt - nn - 
Phrase2403:
the adherence 
dt - nn - 
Phrase2404:
we 
prp - 
Phrase2405:
the interaction 
dt - nn - 
Phrase2406:
the presence 
dt - nn - 
Phrase2407:
cell-derived conditioned medium 
jj - jj - nn - 
Phrase2408:
umbilical vein 
jj - nn - 
Phrase2409:
the transcription 
dt - nn - 
Phrase2410:
cellular oxidant 
jj - nn - 
Phrase2411:
normal rbc 
jj - nn - 
Phrase2412:
these phenomena 
dt - nns - 
Phrase2413:
the oxidant 
dt - nn - 
Phrase2414:
stress-induced signaling 
jj - nn - 
Phrase2415:
the addition 
dt - nn - 
Phrase2416:
these events 
dt - nns - 
Phrase2417:
synthetic peptide 
jj - nn - 
Phrase2418:
vwf-mediated adhesion 
dt - nn - 
Phrase2419:
the surface 
dt - nn - 
Phrase2420:
the transendothelial migration 
dt - jj - nn - 
Phrase2421:
both monocyte-like hl-60 
dt - jj - nn - 
Phrase2422:
peripheral blood 
jj - nn - 
Phrase2423:
these results 
dt - nns - 
Phrase2424:
the adherence/contact 
dt - nn - 
Phrase2425:
large vessel 
jj - nn - 
Phrase2426:
advanced renal carcinoma 
jj - jj - nn - 
Phrase2427:
clinical relevance 
jj - nn - 
Phrase2428:
the cd3/t-cell 
dt - nn - 
Phrase2429:
advanced malignancy 
jj - nn - 
Phrase2430:
the tcr 
dt - nn - 
Phrase2431:
nuclear localization 
jj - nn - 
Phrase2432:
nuclear factor 
jj - nn - 
Phrase2433:
these defects 
dt - nns - 
Phrase2434:
malignant melanoma 
jj - nn - 
Phrase2435:
renal cell 
jj - nn - 
Phrase2436:
ovarian cancer 
jj - nn - 
Phrase2437:
colorectal cancer 
jj - nn - 
Phrase2438:
preliminary observations 
jj - nns - 
Phrase2439:
possible correlation 
jj - nn - 
Phrase2440:
clinical variables 
jj - nns - 
Phrase2441:
impaired activation 
jj - nn - 
Phrase2442:
the majority 
dt - nn - 
Phrase2443:
these patients 
dt - nns - 
Phrase2444:
clinical variables 
jj - nns - 
Phrase2445:
another group 
dt - nn - 
Phrase2446:
the first group 
dt - jj - nn - 
Phrase2447:
the frequency 
dt - nn - 
Phrase2448:
abnormal nfkappab 
jj - nn - 
Phrase2449:
electrophoretic mobility 
jj - nn - 
Phrase2450:
monoclonal antibody 
jj - nn - 
Phrase2451:
these signaling 
dt - nn - 
Phrase2452:
the peripheral blood 
dt - jj - nn - 
Phrase2453:
significant decreases 
jj - nns - 
Phrase2454:
= 0.131 
jj - nn - 
Phrase2455:
the baseline 
dt - nn - 
Phrase2456:
the presence 
dt - nn - 
Phrase2457:
abnormal nfkappab 
jj - nn - 
Phrase2458:
monoclonal antibody 
jj - nn - 
Phrase2459:
the advanced age 
dt - jj - nn - 
Phrase2460:
the study 
dt - nn - 
Phrase2461:
peripheral blood 
jj - nn - 
Phrase2462:
impaired nfkappab 
jj - nn - 
Phrase2463:
impaired activation 
jj - nn - 
Phrase2464:
normal tcrzeta 
jj - nn - 
Phrase2465:
the majority 
dt - nn - 
Phrase2466:
advanced rcc 
jj - nn - 
Phrase2467:
peripheral blood 
jj - nn - 
Phrase2468:
these tcrzeta 
dt - nn - 
Phrase2469:
abnormal activation 
jj - nn - 
Phrase2470:
the presence 
dt - nn - 
Phrase2471:
normal expression 
jj - nn - 
Phrase2472:
the clinical significance 
dt - jj - nn - 
Phrase2473:
these findings 
dt - nns - 
Phrase2474:
atra-induced neutrophil 
jj - nn - 
Phrase2475:
recent clinical therapeutic initiative 
jj - jj - jj - nn - 
Phrase2476:
the use 
dt - nn - 
Phrase2477:
chemical agents 
jj - nns - 
Phrase2478:
the leukaemic cells 
dt - jj - nns - 
Phrase2479:
their 
prp$ - 
Phrase2480:
this block 
dt - nn - 
Phrase2481:
the cascade 
dt - nn - 
Phrase2482:
haemopoietic differentiation 
jj - nn - 
Phrase2483:
the level 
dt - nn - 
Phrase2484:
an array 
dt - nn - 
Phrase2485:
many transcription 
jj - nn - 
Phrase2486:
similar structural protein 
jj - jj - nn - 
Phrase2487:
we 
prp - 
Phrase2488:
an rt-pcr-based 
dt - nn - 
Phrase2489:
similar domains 
jj - nns - 
Phrase2490:
degenerate primers 
jj - nns - 
Phrase2491:
the tfiiia 
dt - nn - 
Phrase2492:
the pou-homeodomain 
dt - nn - 
Phrase2493:
pou-specific domain 
jj - nn - 
Phrase2494:
the basis 
dt - nn - 
Phrase2495:
they 
prp - 
Phrase2496:
structural motifs 
jj - nns - 
Phrase2497:
these families 
dt - nns - 
Phrase2498:
the neutrophil 
dt - nn - 
Phrase2499:
all-trans retinoic acid 
jj - jj - nn - 
Phrase2500:
this lineage 
dt - nn - 
Phrase2501:
these cells 
dt - nns - 
Phrase2502:
atra-induced cd38+ 
jj - nn - 
Phrase2503:
the degenerate primers 
dt - jj - nns - 
Phrase2504:
homologous groups 
jj - nns - 
Phrase2505:
the group 
dt - nn - 
Phrase2506:
the genbank 
dt - nn - 
Phrase2507:
the oct 
dt - nn - 
Phrase2508:
close homologue 
jj - nn - 
Phrase2509:
the pou 
dt - nn - 
Phrase2510:
the zinc-finger 
dt - nn - 
Phrase2511:
the pattern 
dt - nn - 
Phrase2512:
the number 
dt - nn - 
Phrase2513:
each group 
dt - nn - 
Phrase2514:
the differential expression 
dt - jj - nn - 
Phrase2515:
the genes 
dt - nns - 
Phrase2516:
the zinc 
dt - nn - 
Phrase2517:
better understanding 
jjr - nn - 
Phrase2518:
the cascade 
dt - nn - 
Phrase2519:
atra-induced differentiation 
jj - nn - 
Phrase2520:
we 
prp - 
Phrase2521:
the proximal 
dt - nn - 
Phrase2522:
th2-specific activity 
jj - nn - 
Phrase2523:
some th2-selective 
dt - nn - 
Phrase2524:
transgenic mice 
jj - nns - 
Phrase2525:
this region 
dt - nn - 
Phrase2526:
low reporter 
jj - nn - 
Phrase2527:
endogenous il-4 
jj - nn - 
Phrase2528:
full gene 
jj - nn - 
Phrase2529:
additional enhancer 
jj - nn - 
Phrase2530:
we 
prp - 
Phrase2531:
large genomic il-4 
jj - jj - nn - 
Phrase2532:
the proximal 
dt - nn - 
Phrase2533:
certain genomic regions 
jj - jj - nns - 
Phrase2534:
th2-specific complexes 
jj - nns - 
Phrase2535:
retroviral transduction 
jj - nn - 
Phrase2536:
full th2 
jj - nn - 
Phrase2537:
we 
prp - 
Phrase2538:
full il-4 
jj - nn - 
Phrase2539:
the il-13/il-4 
dt - nn - 
Phrase2540:
the inactive x 
dt - jj - nn - 
Phrase2541:
physical linkage 
jj - nn - 
Phrase2542:
the xist 
dt - nn - 
Phrase2543:
early embryonic development 
jj - jj - nn - 
Phrase2544:
the lack 
dt - nn - 
Phrase2545:
x- chromosome-specific 
jj - nn - 
Phrase2546:
the inactive state 
dt - jj - nn - 
Phrase2547:
the possibility 
dt - nn - 
Phrase2548:
autosomal material 
jj - nn - 
Phrase2549:
an inactive x 
dt - jj - nn - 
Phrase2550:
we 
prp - 
Phrase2551:
the xi 
dt - nn - 
Phrase2552:
the maintenance 
dt - nn - 
Phrase2553:
the position 
dt - nn - 
Phrase2554:
the x-inactivation 
dt - nn - 
Phrase2555:
the activation 
dt - nn - 
Phrase2556:
the chromosomes 
dt - nns - 
Phrase2557:
the translocation 
dt - nn - 
Phrase2558:
simultaneous immunocytogenetic 
jj - nn - 
Phrase2559:
either brdu 
dt - nn - 
Phrase2560:
late s 
jj - nn - 
Phrase2561:
the position 
dt - nn - 
Phrase2562:
the reciprocal products 
dt - jj - nns - 
Phrase2563:
the translocation 
dt - nn - 
Phrase2564:
other experiments 
jj - nns - 
Phrase2565:
the xq13 
dt - nn - 
Phrase2566:
the dapi 
dt - nn - 
Phrase2567:
our 
prp$ - 
Phrase2568:
physical separation 
jj - nn - 
Phrase2569:
inactive x-chromosome 
jj - nn - 
Phrase2570:
the position 
dt - nn - 
Phrase2571:
physical linkage 
jj - nn - 
Phrase2572:
autosomal material 
jj - nn - 
Phrase2573:
the murine 
dt - nn - 
Phrase2574:
the involvement 
dt - nn - 
Phrase2575:
the presence 
dt - nn - 
Phrase2576:
the expression 
dt - nn - 
Phrase2577:
the reticulocyte-type 
dt - nn - 
Phrase2578:
both lipoxygenase 
dt - nn - 
Phrase2579:
similar regulatory response 
jj - jj - nn - 
Phrase2580:
we 
prp - 
Phrase2581:
the regulation 
dt - nn - 
Phrase2582:
the leukocyte-type 
dt - nn - 
Phrase2583:
the activity 
dt - nn - 
Phrase2584:
this enzyme 
dt - nn - 
Phrase2585:
dose-dependent manner 
jj - nn - 
Phrase2586:
the cells 
dt - nns - 
Phrase2587:
the presence 
dt - nn - 
Phrase2588:
the il-4 
dt - nn - 
Phrase2589:
peripheral murine 
jj - nn - 
Phrase2590:
the lipoxygenase 
dt - nn - 
Phrase2591:
the lipoxygenase 
dt - nn - 
Phrase2592:
the macrophages 
dt - nns - 
Phrase2593:
homozygous stat6-deficient mice 
jj - jj - nns - 
Phrase2594:
transgenic mice 
jj - nns - 
Phrase2595:
similar upregulation 
jj - nn - 
Phrase2596:
the transgenic animals 
dt - jj - nns - 
Phrase2597:
strong induction 
jj - nn - 
Phrase2598:
the enzyme 
dt - nn - 
Phrase2599:
red cells 
jj - nns - 
Phrase2600:
experimental anemia 
jj - nn - 
Phrase2601:
the data 
dt - nns - 
Phrase2602:
the 12-lipoxygenase 
dt - nn - 
Phrase2603:
this upregulation 
dt - nn - 
Phrase2604:
the transcription 
dt - nn - 
Phrase2605:
the constitutive expression 
dt - jj - nn - 
Phrase2606:
the enzyme 
dt - nn - 
Phrase2607:
the cytokine-dependent upregulation 
dt - jj - nn - 
Phrase2608:
the murine 
dt - nn - 
Phrase2609:
its 
prp$ - 
Phrase2610:
experimental anemia 
jj - nn - 
Phrase2611:
its 
prp$ - 
Phrase2612:
close relatedness 
jj - nn - 
Phrase2613:
the human 
dt - nn - 
Phrase2614:
their 
prp$ - 
Phrase2615:
the positional specificity 
dt - jj - nn - 
Phrase2616:
arachidonic acid 
jj - nn - 
Phrase2617:
interferon-gamma-induced factor 
jj - nn - 
Phrase2618:
the interleukin-4-responsive 
dt - nn - 
Phrase2619:
tonsillar mononuclear 
jj - nn - 
Phrase2620:
the interleukin-4-induced cd23b 
dt - jj - nn - 
Phrase2621:
tonsillar mononuclear 
jj - nn - 
Phrase2622:
the activation 
dt - nn - 
Phrase2623:
distinct nuclear factors 
jj - jj - nn - 
Phrase2624:
different mobilities 
jj - nns - 
Phrase2625:
the il-4 
dt - nn - 
Phrase2626:
electrophoretic mobility 
jj - nn - 
Phrase2627:
distinct complexes 
jj - nns - 
Phrase2628:
an intermediate 
dt - nn - 
Phrase2629:
the il-4-induced complex 
dt - jj - nn - 
Phrase2630:
the formation 
dt - nn - 
Phrase2631:
the ifn-gamma-induced complex 
dt - jj - nn - 
Phrase2632:
the intermediate 
dt - nn - 
Phrase2633:
the il-4-induced cd23 
dt - jj - nn - 
Phrase2634:
these tonsillar cells 
dt - jj - nns - 
Phrase2635:
the results 
dt - nns - 
Phrase2636:
the il-4re 
dt - nn - 
Phrase2637:
the il-4-inducible gene 
dt - jj - nn - 
Phrase2638:
both il-4- 
dt - nn - 
Phrase2639:
ifn-gamma-activated factors 
jj - nn - 
Phrase2640:
heterodimeric forms 
jj - nns - 
Phrase2641:
the binding 
dt - nn - 
Phrase2642:
these different proteins 
dt - jj - nns - 
Phrase2643:
the respective promoter 
dt - jj - nn - 
Phrase2644:
regulatory role 
jj - nn - 
Phrase2645:
the il-4- 
dt - nn - 
Phrase2646:
inducible gene 
jj - nn - 
Phrase2647:
the p56 
dt - nn - 
Phrase2648:
the absence 
dt - nn - 
Phrase2649:
we 
prp - 
Phrase2650:
the t 
dt - nn - 
Phrase2651:
cd2-mediated interleukin-2 
jj - nn - 
Phrase2652:
the binding 
dt - nn - 
Phrase2653:
the ap-1 
dt - nn - 
Phrase2654:
the subsequent transcriptional activity 
dt - jj - jj - nn - 
Phrase2655:
the interleukin-2 
dt - nn - 
Phrase2656:
these data 
dt - nns - 
Phrase2657:
the same t 
dt - jj - nn - 
Phrase2658:
e2f-mediated transcription 
jj - nn - 
Phrase2659:
-negative t-cell 
jj - nn - 
Phrase2660:
the human 
dt - nn - 
Phrase2661:
causative agent 
jj - nn - 
Phrase2662:
the exact mechanism 
dt - jj - nn - 
Phrase2663:
the tax 
dt - nn - 
Phrase2664:
major role 
jj - nn - 
Phrase2665:
this process 
dt - nn - 
Phrase2666:
40-kda polypeptide 
jj - nn - 
Phrase2667:
the tumor 
dt - nn - 
Phrase2668:
the signaling 
dt - nn - 
Phrase2669:
the release 
dt - nn - 
Phrase2670:
this paper 
dt - nn - 
Phrase2671:
we 
prp - 
Phrase2672:
e2f-mediated transcription 
jj - nn - 
Phrase2673:
the e2f-1 
dt - nn - 
Phrase2674:
it 
prp - 
Phrase2675:
the e2f-dependent activation 
dt - jj - nn - 
Phrase2676:
the e2f-binding 
dt - nn - 
Phrase2677:
the transcription 
dt - nn - 
Phrase2678:
the e2f-1 
dt - nn - 
Phrase2679:
itself 
prp - 
Phrase2680:
either atf- 
dt - nn - 
Phrase2681:
nf-kappab-dependent promoters 
jj - nns - 
Phrase2682:
different 5' 
jj - nn - 
Phrase2683:
the e2f-1 
dt - nn - 
Phrase2684:
we 
prp - 
Phrase2685:
the tax-dependent transcriptional control 
dt - jj - jj - nn - 
Phrase2686:
the e2f1 
dt - nn - 
Phrase2687:
least in 
jjs - nn - 
Phrase2688:
the atf 
dt - nn - 
Phrase2689:
located in 
jj - nn - 
Phrase2690:
the e2f-1 
dt - nn - 
Phrase2691:
inducible nitric oxide 
jj - jj - nn - 
Phrase2692:
an autoregulatory 
dt - nn - 
Phrase2693:
vascular inflammation 
jj - nn - 
Phrase2694:
inducible nitric oxide 
jj - jj - nn - 
Phrase2695:
vascular inflammation 
jj - nn - 
Phrase2696:
vascular wall 
jj - nn - 
Phrase2697:
its 
prp$ - 
Phrase2698:
the inflammatory process 
dt - jj - nn - 
Phrase2699:
this study 
dt - nn - 
Phrase2700:
we 
prp - 
Phrase2701:
novel function 
jj - nn - 
Phrase2702:
inflammatory processes 
jj - nns - 
Phrase2703:
we 
prp - 
Phrase2704:
macrophage-like cells 
jj - nns - 
Phrase2705:
cytokine-induced endothelial 
jj - nn - 
Phrase2706:
mixed endothelial-raw264.7 
jj - nn - 
Phrase2707:
bacterial lps 
jj - nn - 
Phrase2708:
the endothelial 
dt - nn - 
Phrase2709:
various vcam-1 
jj - nn - 
Phrase2710:
inhibitory effects 
jj - nns - 
Phrase2711:
inhibitory effects 
jj - nns - 
Phrase2712:
cis-acting elements 
jj - nns - 
Phrase2713:
an ab 
dt - nn - 
Phrase2714:
the rela 
dt - nn - 
Phrase2715:
nuclear factor-kappa 
jj - nn - 
Phrase2716:
the activation 
dt - nn - 
Phrase2717:
nuclear factor-kappa 
jj - nn - 
Phrase2718:
these studies 
dt - nns - 
Phrase2719:
an important autoregulatory 
dt - jj - nn - 
Phrase2720:
vascular inflammation 
jj - nn - 
Phrase2721:
peripheral blood 
jj - nn - 
Phrase2722:
regulatory effects 
jj - nns - 
Phrase2723:
various organs 
jj - nns - 
Phrase2724:
its 
prp$ - 
Phrase2725:
nuclear receptor 
jj - nn - 
Phrase2726:
the presence 
dt - nn - 
Phrase2727:
normal mammary glands 
jj - jj - nns - 
Phrase2728:
their 
prp$ - 
Phrase2729:
we 
prp - 
Phrase2730:
the use 
dt - nn - 
Phrase2731:
the reverse 
dt - nn - 
Phrase2732:
the possible existence 
dt - jj - nn - 
Phrase2733:
other normal oestrogen 
jj - jj - nn - 
Phrase2734:
peripheral blood 
jj - nn - 
Phrase2735:
benign uterus 
jj - nn - 
Phrase2736:
we 
prp - 
Phrase2737:
these samples 
dt - nns - 
Phrase2738:
the variant 
dt - nn - 
Phrase2739:
wild-type er 
jj - nn - 
Phrase2740:
peripheral blood 
jj - nn - 
Phrase2741:
these results 
dt - nns - 
Phrase2742:
previous findings 
jj - nns - 
Phrase2743:
the presence 
dt - nn - 
Phrase2744:
the physiological significance 
dt - jj - nn - 
Phrase2745:
possible clinical relevance 
jj - jj - nn - 
Phrase2746:
the variant 
dt - nn - 
Phrase2747:
the t 
dt - nn - 
Phrase2748:
important signaling 
jj - nn - 
Phrase2749:
this guanine 
dt - nn - 
Phrase2750:
the serine/threonine 
dt - nn - 
Phrase2751:
the ras-related gtpase 
dt - jj - nn - 
Phrase2752:
an important effector 
dt - jj - nn - 
Phrase2753:
the ras 
dt - nn - 
Phrase2754:
this lipid 
dt - nn - 
Phrase2755:
critical rac-1 
jj - nn - 
Phrase2756:
the serine/threonine 
dt - nn - 
Phrase2757:
the role 
dt - nn - 
Phrase2758:
the present 
dt - nn - 
Phrase2759:
we 
prp - 
Phrase2760:
the ability 
dt - nn - 
Phrase2761:
the rac-1 
dt - nn - 
Phrase2762:
we 
prp - 
Phrase2763:
the possibility 
dt - nn - 
Phrase2764:
the results 
dt - nns - 
Phrase2765:
the transcriptional function 
dt - jj - nn - 
Phrase2766:
the rac 
dt - nn - 
Phrase2767:
transcriptional activation 
jj - nn - 
Phrase2768:
the t 
dt - nn - 
Phrase2769:
this tcr 
dt - nn - 
Phrase2770:
akt/pkb activity 
dt - nn - 
Phrase2771:
the tcr 
dt - nn - 
Phrase2772:
the present 
dt - nn - 
Phrase2773:
universal ras 
jj - nn - 
Phrase2774:
the context 
dt - nn - 
Phrase2775:
the modulatory effects 
dt - jj - nns - 
Phrase2776:
secretory responses 
jj - nns - 
Phrase2777:
differentiation-promoting substances 
jj - nns - 
Phrase2778:
the present 
dt - nn - 
Phrase2779:
we 
prp - 
Phrase2780:
peripheral blood 
jj - nn - 
Phrase2781:
solid tumours 
jj - nns - 
Phrase2782:
the lncap 
dt - nn - 
Phrase2783:
this purpose 
dt - nn - 
Phrase2784:
prostate-specific antigen 
jj - nn - 
Phrase2785:
conditioned medium 
jj - nn - 
Phrase2786:
dose-dependent manner 
jj - nn - 
Phrase2787:
we 
prp - 
Phrase2788:
the contribution 
dt - nn - 
Phrase2789:
major products 
jj - nns - 
Phrase2790:
the mcm 
dt - nn - 
Phrase2791:
modulatory action 
jj - nn - 
Phrase2792:
neither a 
dt - nn - 
Phrase2793:
the effects 
dt - nns - 
Phrase2794:
cellular proliferation 
jj - nn - 
Phrase2795:
the inhibition 
dt - nn - 
Phrase2796:
the il-1beta 
dt - nn - 
Phrase2797:
our 
prp$ - 
Phrase2798:
monocyte-derived il-1beta 
jj - nn - 
Phrase2799:
the proliferation 
dt - nn - 
Phrase2800:
differential responsiveness 
jj - nn - 
Phrase2801:
the il-5 
dt - nn - 
Phrase2802:
the cytokines 
dt - nns - 
Phrase2803:
it 
prp - 
Phrase2804:
similar molecular 
jj - nn - 
Phrase2805:
we 
prp - 
Phrase2806:
the transcription 
dt - nn - 
Phrase2807:
the il-5 
dt - nn - 
Phrase2808:
different stimuli 
jj - nns - 
Phrase2809:
different study 
jj - nn - 
Phrase2810:
the expression 
dt - nn - 
Phrase2811:
other th2 
jj - nn - 
Phrase2812:
we 
prp - 
Phrase2813:
ectopic expression 
jj - nn - 
Phrase2814:
antisense gata-3 
jj - nn - 
Phrase2815:
the induction 
dt - nn - 
Phrase2816:
high affinity 
jj - nn - 
Phrase2817:
the il-5 
dt - nn - 
Phrase2818:
the interleukin 
dt - nn - 
Phrase2819:
nuclear factor 
jj - nn - 
Phrase2820:
the expression 
dt - nn - 
Phrase2821:
the murine 
dt - nn - 
Phrase2822:
the transcriptional level 
dt - jj - nn - 
Phrase2823:
we 
prp - 
Phrase2824:
nuclear factor 
jj - nn - 
Phrase2825:
the control 
dt - nn - 
Phrase2826:
the proximal 
dt - nn - 
Phrase2827:
these nf-at 
dt - nn - 
Phrase2828:
nonconsensus sites 
jj - nns - 
Phrase2829:
the binding 
dt - nn - 
Phrase2830:
ap-1-like factors 
jj - nn - 
Phrase2831:
the induction 
dt - nn - 
Phrase2832:
strong nf-atp-mediated 
jj - nn - 
Phrase2833:
the cd25 
dt - nn - 
Phrase2834:
nf-atp-deficient mice 
jj - nns - 
Phrase2835:
the expression 
dt - nn - 
Phrase2836:
our 
prp$ - 
Phrase2837:
an important role 
dt - jj - nn - 
Phrase2838:
the faithful 
dt - nn - 
Phrase2839:
high affinity 
jj - nn - 
Phrase2840:
close link 
jj - nn - 
Phrase2841:
the tcr-mediated induction 
dt - jj - nn - 
Phrase2842:
novel mutation 
jj - nn - 
Phrase2843:
the coding 
dt - nn - 
Phrase2844:
the fy*b 
dt - nn - 
Phrase2845:
the duffy 
dt - nn - 
Phrase2846:
an altered erythrocyte 
dt - jj - nn - 
Phrase2847:
the duffy 
dt - nn - 
Phrase2848:
biological significance 
jj - nn - 
Phrase2849:
some cases 
dt - nns - 
Phrase2850:
newborn hemolytic 
jj - nn - 
Phrase2851:
the duffy 
dt - nn - 
Phrase2852:
the plasmodium 
dt - nn - 
Phrase2853:
various chemokines 
jj - nns - 
Phrase2854:
polymorphic antigens 
jj - nns - 
Phrase2855:
the fy*a 
dt - nn - 
Phrase2856:
the fy(a-b-) 
dt - nn - 
Phrase2857:
the predominant one 
dt - jj - nn - 
Phrase2858:
black people 
jj - nn - 
Phrase2859:
other populations 
jj - nns - 
Phrase2860:
some non-ashkenazi 
dt - nn - 
Phrase2861:
the fy(a-b-) 
dt - nn - 
Phrase2862:
the fy*b 
dt - nn - 
Phrase2863:
the gata 
dt - nn - 
Phrase2864:
the expression 
dt - nn - 
Phrase2865:
we 
prp - 
Phrase2866:
novel mutation 
jj - nn - 
Phrase2867:
the fy*b 
dt - nn - 
Phrase2868:
some fy(b-) 
dt - nn - 
Phrase2869:
the mutation 
dt - nn - 
Phrase2870:
wild-type fy*b 
jj - nn - 
Phrase2871:
the 271c 
dt - nn - 
Phrase2872:
the 271c 
dt - nn - 
Phrase2873:
considerable change 
jj - nn - 
Phrase2874:
chemical nature 
jj - nn - 
Phrase2875:
the antigenic determinants 
dt - jj - nns - 
Phrase2876:
clinical significance 
jj - nn - 
Phrase2877:
the mutation 
dt - nn - 
Phrase2878:
some physiological roles 
dt - jj - nns - 
Phrase2879:
ebv-negative primary effusion 
jj - jj - nn - 
Phrase2880:
this study 
dt - nn - 
Phrase2881:
we 
prp - 
Phrase2882:
the establishment 
dt - nn - 
Phrase2883:
novel lymphoma 
jj - nn - 
Phrase2884:
aids-related primary effusion 
jj - jj - nn - 
Phrase2885:
different virologic subtypes 
jj - jj - nns - 
Phrase2886:
the case 
dt - nn - 
Phrase2887:
the case 
dt - nn - 
Phrase2888:
the diagnosis 
dt - nn - 
Phrase2889:
their 
prp$ - 
Phrase2890:
genetic lesions 
jj - nns - 
Phrase2891:
gross rearrangements 
jj - nns - 
Phrase2892:
detailed histogenetic 
jj - nn - 
Phrase2893:
these novel pel 
dt - jj - nn - 
Phrase2894:
post-germinal centre 
jj - nn - 
Phrase2895:
the cro-ap/3 
dt - nn - 
Phrase2896:
valuable model 
jj - nn - 
Phrase2897:
the pathogenesis 
dt - nn - 
Phrase2898:
these cell 
dt - nn - 
Phrase2899:
the relative 
dt - nn - 
Phrase2900:
the identification 
dt - nn - 
Phrase2901:
recurrent cytogenetic abnormalities 
jj - jj - nns - 
Phrase2902:
putative novel cancer 
jj - jj - nn - 
Phrase2903:
related loci 
jj - nns - 
Phrase2904:
nuclear factor 
jj - nn - 
Phrase2905:
the nuclear factor 
dt - jj - nn - 
Phrase2906:
the expression 
dt - nn - 
Phrase2907:
other inducible genes 
jj - jj - nns - 
Phrase2908:
the immune response 
dt - jj - nn - 
Phrase2909:
the functions 
dt - nns - 
Phrase2910:
the calcium- 
dt - nn - 
Phrase2911:
calmodulin-dependent phosphatase 
jj - nn - 
Phrase2912:
we 
prp - 
Phrase2913:
the binding 
dt - nn - 
Phrase2914:
drug-immunophilin complexes 
jj - nns - 
Phrase2915:
the interaction 
dt - nn - 
Phrase2916:
they 
prp - 
Phrase2917:
the interaction 
dt - nn - 
Phrase2918:
inactive calcineurin 
jj - nn - 
Phrase2919:
the interaction 
dt - nn - 
Phrase2920:
the enzyme 
dt - nn - 
Phrase2921:
active site 
jj - nn - 
Phrase2922:
we 
prp - 
Phrase2923:
inactive calcineurin 
jj - nn - 
Phrase2924:
the calcineurin 
dt - nn - 
Phrase2925:
active site 
jj - nn - 
Phrase2926:
j. 
nnp - 
Phrase2927:
f. 
nnp - 
Phrase2928:
j. 
nnp - 
Phrase2929:
a. 
nnp - 
Phrase2930:
h. 
nnp - 
Phrase2931:
a. 
nnp - 
Phrase2932:
p. 
nnp - 
Phrase2933:
g. 
nnp - 
Phrase2934:
this region 
dt - nn - 
Phrase2935:
an nfat 
dt - nn - 
Phrase2936:
the calcineurin 
dt - nn - 
Phrase2937:
the interacting 
dt - nn - 
Phrase2938:
the catalytic domain 
dt - jj - nn - 
Phrase2939:
the calcineurin 
dt - nn - 
Phrase2940:
an 86-amino 
dt - nn - 
Phrase2941:
the nfat 
dt - nn - 
Phrase2942:
regulatory domain 
jj - nn - 
Phrase2943:
the calcineurin 
dt - nn - 
Phrase2944:
catalytic domain 
jj - nn - 
Phrase2945:
the calcineurin 
dt - nn - 
Phrase2946:
autoinhibitory domain 
jj - nn - 
Phrase2947:
the rii 
dt - nn - 
Phrase2948:
the calcineurin 
dt - nn - 
Phrase2949:
active site 
jj - nn - 
Phrase2950:
the nfat 
dt - nn - 
Phrase2951:
the active site 
dt - jj - nn - 
Phrase2952:
we 
prp - 
Phrase2953:
the calcineurin 
dt - nn - 
Phrase2954:
catalytic domain 
jj - nn - 
Phrase2955:
the calcineurin 
dt - nn - 
Phrase2956:
active site 
jj - nn - 
Phrase2957:
the autoinhibitory domain 
dt - jj - nn - 
Phrase2958:
the calcineurin 
dt - nn - 
Phrase2959:
active site 
jj - nn - 
Phrase2960:
immediate dephosphorylation 
jj - nn - 
Phrase2961:
functional phosphoserine 
jj - nn - 
Phrase2962:
nuclear factor-kappab 
jj - nn - 
Phrase2963:
cd45ra+ t 
jj - nn - 
Phrase2964:
an increase 
dt - nn - 
Phrase2965:
the ratio 
dt - nn - 
Phrase2966:
naive t 
jj - nn - 
Phrase2967:
immune hyporesponsiveness 
jj - nn - 
Phrase2968:
our 
prp$ - 
Phrase2969:
the induction 
dt - nn - 
Phrase2970:
nuclear factor-kappab 
jj - nn - 
Phrase2971:
elderly donors 
jj - nns - 
Phrase2972:
their 
prp$ - 
Phrase2973:
tnf-alpha-mediated induction 
jj - nn - 
Phrase2974:
nuclear localization 
jj - nn - 
Phrase2975:
naive t 
jj - nn - 
Phrase2976:
the age 
dt - nn - 
Phrase2977:
the donor 
dt - nn - 
Phrase2978:
the levels 
dt - nns - 
Phrase2979:
lower in 
jjr - nn - 
Phrase2980:
those in 
dt - nn - 
Phrase2981:
tnf-alpha-mediated degradation 
jj - nn - 
Phrase2982:
naive t 
jj - nn - 
Phrase2983:
the lowered induction 
dt - jj - nn - 
Phrase2984:
this age-related decrease 
dt - jj - nn - 
Phrase2985:
nuclear nfkappab 
jj - nn - 
Phrase2986:
intracellular il-2 
jj - nn - 
Phrase2987:
anti-cd3-induced proliferation 
jj - nn - 
Phrase2988:
both memory 
dt - nn - 
Phrase2989:
naive t 
jj - nn - 
Phrase2990:
our 
prp$ - 
Phrase2991:
the age-related hyporesponsiveness 
dt - jj - nn - 
Phrase2992:
the t 
dt - nn - 
Phrase2993:
a-resistant transactivation 
jj - nn - 
Phrase2994:
the il-2 
dt - nn - 
Phrase2995:
okadaic acid-sensitive 
jj - nn - 
Phrase2996:
the il-2 
dt - nn - 
Phrase2997:
the tcr 
dt - nn - 
Phrase2998:
we 
prp - 
Phrase2999:
okadaic acid-sensitive 
jj - nn - 
Phrase3000:
a-insensitive pathway 
jj - nn - 
Phrase3001:
this study 
dt - nn - 
Phrase3002:
we 
prp - 
Phrase3003:
these phosphatases 
dt - nns - 
Phrase3004:
the expression 
dt - nn - 
Phrase3005:
the il-2 
dt - nn - 
Phrase3006:
peripheral blood 
jj - nn - 
Phrase3007:
tumorigenic t 
jj - nn - 
Phrase3008:
the transcriptional level 
dt - jj - nn - 
Phrase3009:
okadaic acid 
jj - nn - 
Phrase3010:
the transcription 
dt - nn - 
Phrase3011:
active at 
jj - nn - 
Phrase3012:
the il-2 
dt - nn - 
Phrase3013:
okadaic acid-sensitive 
jj - nn - 
Phrase3014:
the glucose 
dt - nn - 
Phrase3015:
the purpose 
dt - nn - 
Phrase3016:
this study 
dt - nn - 
Phrase3017:
the effects 
dt - nns - 
Phrase3018:
proliferator-activated receptor 
jj - nn - 
Phrase3019:
the 2-deoxyglucose 
dt - nn - 
Phrase3020:
the insulin-stimulated 
dt - nn - 
Phrase3021:
the mrna 
dt - nn - 
Phrase3022:
fatty acid-binding 
jj - nn - 
Phrase3023:
the mrna 
dt - nn - 
Phrase3024:
the ppargamma 
dt - nn - 
Phrase3025:
the nuclear receptor 
dt - jj - nn - 
Phrase3026:
the possible involvement 
dt - jj - nn - 
Phrase3027:
the enzyme 
dt - nn - 
Phrase3028:
the phosphatidylinositol-3,4,5-trisphosphate 
dt - nn - 
Phrase3029:
monocytic cells 
jj - nns - 
Phrase3030:
the pi-3,4,5-p3 
dt - nn - 
Phrase3031:
significant effect 
jj - nn - 
Phrase3032:
the insulin-dependent 
dt - nn - 
Phrase3033:
-independent pi 
jj - nn - 
Phrase3034:
these results 
dt - nns - 
Phrase3035:
the mechanism 
dt - nn - 
Phrase3036:
the enhancement 
dt - nn - 
Phrase3037:
the nuclear receptor 
dt - jj - nn - 
Phrase3038:
the past 
dt - nn - 
Phrase3039:
the mechanisms 
dt - nns - 
Phrase3040:
the nuclear receptor 
dt - jj - nn - 
Phrase3041:
proliferator-activated receptor 
jj - nn - 
Phrase3042:
systemic glucose 
jj - nn - 
Phrase3043:
the biology 
dt - nn - 
Phrase3044:
cell-cycle regulation 
jj - nn - 
Phrase3045:
polyunsaturated fatty acids 
jj - jj - nns - 
Phrase3046:
these lipids 
dt - nns - 
Phrase3047:
hormonal regulators 
jj - nns - 
Phrase3048:
biological processes 
jj - nns - 
Phrase3049:
the role 
dt - nn - 
Phrase3050:
the control 
dt - nn - 
Phrase3051:
immune responses 
jj - nns - 
Phrase3052:
the removal 
dt - nn - 
Phrase3053:
thymic selection 
jj - nn - 
Phrase3054:
the periphery 
dt - nn - 
Phrase3055:
specific families 
jj - nns - 
Phrase3056:
the apoptotic cascade 
dt - jj - nn - 
Phrase3057:
specific substrates 
jj - nns - 
Phrase3058:
morphological changes 
jj - nns - 
Phrase3059:
the apoptotic cascade 
dt - jj - nn - 
Phrase3060:
different cell 
jj - nn - 
Phrase3061:
it 
prp - 
Phrase3062:
cell-specific factors 
jj - nn - 
Phrase3063:
the response 
dt - nn - 
Phrase3064:
apoptotic stimuli 
jj - nns - 
Phrase3065:
the basic mechanisms 
dt - jj - nns - 
Phrase3066:
the different pathways 
dt - jj - nns - 
Phrase3067:
novel ways 
jj - nns - 
Phrase3068:
inappropriate apoptosis 
jj - nn - 
Phrase3069:
several diseases 
jj - nns - 
Phrase3070:
antigenic peptides 
jj - nns - 
Phrase3071:
the endoplasmic 
dt - nn - 
Phrase3072:
it 
prp - 
Phrase3073:
the cross-priming 
dt - nn - 
Phrase3074:
the transfer 
dt - nn - 
Phrase3075:
antigenic peptides 
jj - nns - 
Phrase3076:
the endoplasmic 
dt - nn - 
Phrase3077:
infected cells 
jj - nns - 
Phrase3078:
we 
prp - 
Phrase3079:
this possibility 
dt - nn - 
Phrase3080:
antigenic er 
jj - nn - 
Phrase3081:
the human 
dt - nn - 
Phrase3082:
early regions 
jj - nns - 
Phrase3083:
both proteins 
dt - nns - 
Phrase3084:
the cells 
dt - nns - 
Phrase3085:
the relevant epitope 
dt - jj - nn - 
Phrase3086:
synthetic peptide 
jj - nn - 
Phrase3087:
the er 
dt - nn - 
Phrase3088:
the absence 
dt - nn - 
Phrase3089:
these er 
dt - nn - 
Phrase3090:
the tap1-/- 
dt - nn - 
Phrase3091:
these results 
dt - nns - 
Phrase3092:
the mechanism 
dt - nn - 
Phrase3093:
antigenic peptides 
jj - nns - 
Phrase3094:
the er 
dt - nn - 
Phrase3095:
critical role 
jj - nn - 
Phrase3096:
the p75 
dt - nn - 
Phrase3097:
the p55tnf-r 
dt - nn - 
Phrase3098:
the p75 
dt - nn - 
Phrase3099:
specific human 
jj - nn - 
Phrase3100:
inflammatory pathologies 
jj - nns - 
Phrase3101:
inflammatory liver 
jj - nn - 
Phrase3102:
the function 
dt - nn - 
Phrase3103:
this receptor 
dt - nn - 
Phrase3104:
we 
prp - 
Phrase3105:
the human 
dt - nn - 
Phrase3106:
transgenic mice 
jj - nns - 
Phrase3107:
severe inflammatory syndrome 
jj - jj - nn - 
Phrase3108:
the pancreas 
dt - nn - 
Phrase3109:
the peripheral blood 
dt - jj - nn - 
Phrase3110:
the presence 
dt - nn - 
Phrase3111:
the p55tnf-r 
dt - nn - 
Phrase3112:
these results 
dt - nns - 
Phrase3113:
an independent role 
dt - jj - nn - 
Phrase3114:
the pathogenesis 
dt - nn - 
Phrase3115:
inflammatory disease 
jj - nn - 
Phrase3116:
the direct involvement 
dt - jj - nn - 
Phrase3117:
this receptor 
dt - nn - 
Phrase3118:
inflammatory pathologies 
jj - nns - 
Phrase3119:
distinct histogenetic 
jj - nn - 
Phrase3120:
the tumor 
dt - nn - 
Phrase3121:
the b-cell 
dt - nn - 
Phrase3122:
their 
prp$ - 
Phrase3123:
precise differentiation 
jj - nn - 
Phrase3124:
we 
prp - 
Phrase3125:
the histogenesis 
dt - nn - 
Phrase3126:
the expression 
dt - nn - 
Phrase3127:
germinal center 
jj - nn - 
Phrase3128:
this study 
dt - nn - 
Phrase3129:
we 
prp - 
Phrase3130:
the study 
dt - nn - 
Phrase3131:
we 
prp - 
Phrase3132:
nodular lymphocyte 
jj - nn - 
Phrase3133:
the bcl-6(+)/syn-1(-) 
dt - nn - 
Phrase3134:
their 
prp$ - 
Phrase3135:
classic hd 
jj - nn - 
Phrase3136:
the tumor 
dt - nn - 
Phrase3137:
the bcl-6(-)/syn-1(+) phenotype 
dt - jj - nn - 
Phrase3138:
post-gc b-cells 
jj - nns - 
Phrase3139:
another fraction 
dt - nn - 
Phrase3140:
the gc 
dt - nn - 
Phrase3141:
bcl-6(-)/syn-1(+) tumor 
jj - nn - 
Phrase3142:
the observation 
dt - nn - 
Phrase3143:
these data 
dt - nns - 
Phrase3144:
the phenotype 
dt - nn - 
Phrase3145:
the surrounding 
dt - nn - 
Phrase3146:
cellular background 
jj - nn - 
Phrase3147:
cd40l+ reactive t 
jj - jj - nn - 
Phrase3148:
cellular analysis 
jj - nn - 
Phrase3149:
virus-induced apoptosis 
jj - nn - 
Phrase3150:
we 
prp - 
Phrase3151:
the presence 
dt - nn - 
Phrase3152:
the cd4 
dt - nn - 
Phrase3153:
cytoplasmic tail 
jj - nn - 
Phrase3154:
-induced apoptosis 
jj - nn - 
Phrase3155:
we 
prp - 
Phrase3156:
our 
prp$ - 
Phrase3157:
the role 
dt - nn - 
Phrase3158:
the cd4 
dt - nn - 
Phrase3159:
the cd4 
dt - nn - 
Phrase3160:
cytoplasmic tail 
jj - nn - 
Phrase3161:
the lymphoblastoid 
dt - nn - 
Phrase3162:
the dicysteine 
dt - nn - 
Phrase3163:
the cytoplasmic tail 
dt - jj - nn - 
Phrase3164:
the differences 
dt - nns - 
Phrase3165:
the induction 
dt - nn - 
Phrase3166:
initial signaling 
jj - nn - 
Phrase3167:
the cd4 
dt - nn - 
Phrase3168:
major role 
jj - nn - 
Phrase3169:
the sensitization 
dt - nn - 
Phrase3170:
hiv-infected t 
jj - nn - 
Phrase3171:
hiv-infected cells 
jj - nns - 
Phrase3172:
monoclonal antibody 
jj - nn - 
Phrase3173:
the receptor 
dt - nn - 
Phrase3174:
the apoptotic process 
dt - jj - nn - 
Phrase3175:
an antagonistic anti-fas mab 
dt - jj - jj - nn - 
Phrase3176:
hiv-infected cells 
jj - nns - 
Phrase3177:
uninfected cells 
jj - nns - 
Phrase3178:
these observations 
dt - nns - 
Phrase3179:
hiv-induced apoptosis 
dt - nn - 
Phrase3180:
critical region 
jj - nn - 
Phrase3181:
we 
prp - 
Phrase3182:
the phosphorylation 
dt - nn - 
Phrase3183:
the retinoblastoma 
dt - nn - 
Phrase3184:
the change 
dt - nn - 
Phrase3185:
the cell 
dt - nn - 
Phrase3186:
they 
prp - 
Phrase3187:
the cell 
dt - nn - 
Phrase3188:
an e2f 
dt - nn - 
Phrase3189:
both e2f-4 
dt - nn - 
Phrase3190:
the phosphorylated forms 
dt - jj - nns - 
Phrase3191:
the e2f 
dt - nn - 
Phrase3192:
primary hemopoietic cells 
jj - jj - nns - 
Phrase3193:
we 
prp - 
Phrase3194:
primary hemopoietic cells 
jj - jj - nns - 
Phrase3195:
the transcription 
dt - nn - 
Phrase3196:
the monocytic/myeloic 
dt - nn - 
Phrase3197:
the entry 
dt - nn - 
Phrase3198:
the body 
dt - nn - 
Phrase3199:
inflammatory processes 
jj - nns - 
Phrase3200:
this process 
dt - nn - 
Phrase3201:
specific actions 
jj - nns - 
Phrase3202:
the infection 
dt - nn - 
Phrase3203:
the cellular components 
dt - jj - nns - 
Phrase3204:
non-specific immunoreaction 
jj - nn - 
Phrase3205:
inhibitory related protein 
jj - jj - nn - 
Phrase3206:
high concentrations 
jj - nns - 
Phrase3207:
these cells 
dt - nns - 
Phrase3208:
the transcriptional regulation 
dt - jj - nn - 
Phrase3209:
these genes 
dt - nns - 
Phrase3210:
we 
prp - 
Phrase3211:
the mrp14 
dt - nn - 
Phrase3212:
massive enhancement 
jj - nn - 
Phrase3213:
the mrp14 
dt - nn - 
Phrase3214:
mrp14 promoter 
dt - nn - 
Phrase3215:
the c/ebp 
dt - nn - 
Phrase3216:
mrp14 expression 
dt - nn - 
Phrase3217:
the context 
dt - nn - 
Phrase3218:
the whole genome 
dt - jj - nn - 
Phrase3219:
the cd28-specific mab 
dt - jj - nn - 
Phrase3220:
further requirement 
jj - nn - 
Phrase3221:
us 
prp - 
Phrase3222:
this putative function 
dt - jj - nn - 
Phrase3223:
particular signaling 
jj - nn - 
Phrase3224:
we 
prp - 
Phrase3225:
early signaling 
jj - nn - 
Phrase3226:
the stimulatory mab 
dt - jj - nn - 
Phrase3227:
the nonstimulating 
dt - nn - 
Phrase3228:
an increase 
dt - nn - 
Phrase3229:
intracellular ca2+ 
jj - nn - 
Phrase3230:
detectable activation 
jj - nn - 
Phrase3231:
the protein 
dt - nn - 
Phrase3232:
the induction 
dt - nn - 
Phrase3233:
the transcription 
dt - nn - 
Phrase3234:
the cd28 
dt - nn - 
Phrase3235:
the il-2 
dt - nn - 
Phrase3236:
the other hand 
dt - jj - nn - 
Phrase3237:
the level 
dt - nn - 
Phrase3238:
intracellular ca2+ 
jj - nn - 
Phrase3239:
the activation 
dt - nn - 
Phrase3240:
the binding 
dt - nn - 
Phrase3241:
the il-2 
dt - nn - 
Phrase3242:
the differential signaling 
dt - jj - nn - 
Phrase3243:
similar pattern 
jj - nn - 
Phrase3244:
early signaling 
jj - nn - 
Phrase3245:
the signaling 
dt - nn - 
Phrase3246:
these data 
dt - nns - 
Phrase3247:
the view 
dt - nn - 
Phrase3248:
some effector 
dt - nn - 
Phrase3249:
this capacity 
dt - nn - 
Phrase3250:
particular pattern 
jj - nn - 
Phrase3251:
early signaling 
jj - nn - 
Phrase3252:
salicylic acid-mediated 
jj - nn - 
Phrase3253:
heterodimeric cytokine 
jj - nn - 
Phrase3254:
pro-inflammatory cytokine 
jj - nn - 
Phrase3255:
prominent role 
jj - nn - 
Phrase3256:
the development 
dt - nn - 
Phrase3257:
cell-mediated immune responses 
jj - jj - nns - 
Phrase3258:
cell-mediated immune responses 
jj - jj - nns - 
Phrase3259:
the pathogenesis 
dt - nn - 
Phrase3260:
chronic inflammatory autoimmune diseases 
jj - jj - jj - nns - 
Phrase3261:
critical factor 
jj - nn - 
Phrase3262:
the generation 
dt - nn - 
Phrase3263:
chronic inflammatory conditions 
jj - jj - nns - 
Phrase3264:
this study 
dt - nn - 
Phrase3265:
we 
prp - 
Phrase3266:
the effects 
dt - nns - 
Phrase3267:
anti-inflammatory drug 
jj - nn - 
Phrase3268:
salicylic acid 
jj - nn - 
Phrase3269:
the il-12 
dt - nn - 
Phrase3270:
monocytic cells 
jj - nns - 
Phrase3271:
the down-regulation 
dt - nn - 
Phrase3272:
the regulation 
dt - nn - 
Phrase3273:
the p40 
dt - nn - 
Phrase3274:
the p40-kappab 
dt - nn - 
Phrase3275:
the p40 
dt - nn - 
Phrase3276:
transcriptional repression 
jj - nn - 
Phrase3277:
the p40 
dt - nn - 
Phrase3278:
an in 
dt - nn - 
Phrase3279:
anti-inflammatory therapy 
jj - nn - 
Phrase3280:
these results 
dt - nns - 
Phrase3281:
the inhibition 
dt - nn - 
Phrase3282:
intracellular sequestration 
jj - nn - 
Phrase3283:
immature class 
jj - nn - 
Phrase3284:
the surface 
dt - nn - 
Phrase3285:
this effect 
dt - nn - 
Phrase3286:
steady state 
jj - nn - 
Phrase3287:
infected cells 
jj - nns - 
Phrase3288:
metabolic labeling 
jj - nn - 
Phrase3289:
biochemical analysis 
jj - nn - 
Phrase3290:
the majority 
dt - nn - 
Phrase3291:
infected cells 
jj - nns - 
Phrase3292:
normal golgi 
jj - nn - 
Phrase3293:
intracellular staining 
jj - nn - 
Phrase3294:
dual color 
jj - nn - 
Phrase3295:
confocal microscopy 
jj - nn - 
Phrase3296:
significant defect 
jj - nn - 
Phrase3297:
the endocytic 
dt - nn - 
Phrase3298:
infected cells 
jj - nns - 
Phrase3299:
minimal extent 
jj - nn - 
Phrase3300:
infected cells 
jj - nns - 
Phrase3301:
this marker 
dt - nn - 
Phrase3302:
late endosomes 
jj - nn - 
Phrase3303:
the mhc 
dt - nn - 
Phrase3304:
defective transport 
jj - nn - 
Phrase3305:
the endocytic 
dt - nn - 
Phrase3306:
the maturation 
dt - nn - 
Phrase3307:
the mhc 
dt - nn - 
Phrase3308:
impaired in 
jj - nn - 
Phrase3309:
these findings 
dt - nns - 
Phrase3310:
defective transport 
jj - nn - 
Phrase3311:
the endosomal/lysosomal 
dt - nn - 
Phrase3312:
upstream regulatory elements 
jj - jj - nns - 
Phrase3313:
beta-like globin 
jj - nn - 
Phrase3314:
primitive erythroid environment 
jj - jj - nn - 
Phrase3315:
our 
prp$ - 
Phrase3316:
the down 
dt - nn - 
Phrase3317:
the adult 
dt - nn - 
Phrase3318:
beta-like globin 
jj - nn - 
Phrase3319:
primitive erythroid tissues 
jj - jj - nns - 
Phrase3320:
we 
prp - 
Phrase3321:
their 
prp$ - 
Phrase3322:
an erythroleukemia 
dt - nn - 
Phrase3323:
an embryonic-fetal phenotype 
dt - jj - nn - 
Phrase3324:
flanking regions 
jj - nns - 
Phrase3325:
flanking regions 
jj - nns - 
Phrase3326:
chimeric promoter 
jj - nn - 
Phrase3327:
distal delta 
jj - nn - 
Phrase3328:
appreciable level 
jj - nn - 
Phrase3329:
the beta 
dt - nn - 
Phrase3330:
low level 
jj - nn - 
Phrase3331:
the delta 
dt - nn - 
Phrase3332:
the beta 
dt - nn - 
Phrase3333:
the upstream portion 
dt - jj - nn - 
Phrase3334:
the delta 
dt - nn - 
Phrase3335:
the upstream beta 
dt - jj - nn - 
Phrase3336:
negative regulatory effect 
jj - jj - nn - 
Phrase3337:
the beta 
dt - nn - 
Phrase3338:
upstream element 
jj - nn - 
Phrase3339:
the upstream portion 
dt - jj - nn - 
Phrase3340:
the delta 
dt - nn - 
Phrase3341:
modest increase 
jj - nn - 
Phrase3342:
the presence 
dt - nn - 
Phrase3343:
positive transcriptional element 
jj - jj - nn - 
Phrase3344:
the upstream delta 
dt - jj - nn - 
Phrase3345:
regulatory region 
jj - nn - 
Phrase3346:
site-directed mutagenesis 
jj - nn - 
Phrase3347:
the repressor 
dt - nn - 
Phrase3348:
the upstream portion 
dt - jj - nn - 
Phrase3349:
the beta 
dt - nn - 
Phrase3350:
flanking region 
jj - nn - 
Phrase3351:
the upstream delta-globin 
dt - jj - nn - 
Phrase3352:
these results 
dt - nns - 
Phrase3353:
the upstream promoter 
dt - jj - nn - 
Phrase3354:
the adult 
dt - nn - 
Phrase3355:
its 
prp$ - 
Phrase3356:
early in 
jj - nn - 
Phrase3357:
its 
prp$ - 
Phrase3358:
later stage 
jjr - nn - 
Phrase3359:
extrinsic asthma 
jj - nn - 
Phrase3360:
recent data 
jj - nns - 
Phrase3361:
the regulation 
dt - nn - 
Phrase3362:
the induction 
dt - nn - 
Phrase3363:
the activation 
dt - nn - 
Phrase3364:
the intracellular signal-transducing protein 
dt - jj - jj - nn - 
Phrase3365:
the inhibition 
dt - nn - 
Phrase3366:
the activation 
dt - nn - 
Phrase3367:
we 
prp - 
Phrase3368:
extrinsic asthma 
jj - nn - 
Phrase3369:
the cytokine 
dt - nn - 
Phrase3370:
the activation 
dt - nn - 
Phrase3371:
extrinsic asthma 
jj - nn - 
Phrase3372:
nonatopic control 
jj - nn - 
Phrase3373:
the mean 
dt - nn - 
Phrase3374:
greater in 
jjr - nn - 
Phrase3375:
= .005 
jj - nn - 
Phrase3376:
both asthma 
dt - nn - 
Phrase3377:
the patients 
dt - nns - 
Phrase3378:
either hie 
dt - nn - 
Phrase3379:
acute asthma 
jj - nn - 
Phrase3380:
the presence 
dt - nn - 
Phrase3381:
several patients 
jj - nns - 
Phrase3382:
these results 
dt - nns - 
Phrase3383:
elevated levels 
jj - nns - 
Phrase3384:
the peripheral blood 
dt - jj - nn - 
Phrase3385:
elevated ige 
jj - nn - 
Phrase3386:
high levels 
jj - nns - 
Phrase3387:
these patients 
dt - nns - 
Phrase3388:
carboxyl-terminal 15-amino 
jj - nn - 
Phrase3389:
tissue-specific splicing 
jj - nn - 
Phrase3390:
other immunoregulatory genes 
jj - jj - nns - 
Phrase3391:
we 
prp - 
Phrase3392:
the nfat 
dt - nn - 
Phrase3393:
the thymus 
dt - nn - 
Phrase3394:
peripheral blood 
jj - nn - 
Phrase3395:
an isoform 
dt - nn - 
Phrase3396:
we 
prp - 
Phrase3397:
the carboxyl-terminal end 
dt - jj - nn - 
Phrase3398:
its 
prp$ - 
Phrase3399:
the gal4 
dt - nn - 
Phrase3400:
the gal4 
dt - nn - 
Phrase3401:
this 15-amino 
dt - nn - 
Phrase3402:
the sequences 
dt - nns - 
Phrase3403:
the carboxyl-terminal regions 
dt - jj - nns - 
Phrase3404:
the nfat 
dt - nn - 
Phrase3405:
we 
prp - 
Phrase3406:
additional isoforms 
jj - nns - 
Phrase3407:
tissue-specific alternative 
jj - nn - 
Phrase3408:
lower transactivation 
jjr - nn - 
Phrase3409:
the thymus 
dt - nn - 
Phrase3410:
peripheral blood 
jj - nn - 
Phrase3411:
the skeletal muscle 
dt - jj - nn - 
Phrase3412:
the nfat 
dt - nn - 
Phrase3413:
the il-2 
dt - nn - 
Phrase3414:
these data 
dt - nns - 
Phrase3415:
the 15-amino 
dt - nn - 
Phrase3416:
major transactivation 
jj - nn - 
Phrase3417:
tissue-specific alternative 
jj - nn - 
Phrase3418:
altered dna-binding 
jj - nn - 
Phrase3419:
an activator 
dt - nn - 
Phrase3420:
the beta-globin 
dt - nn - 
Phrase3421:
the locus 
dt - nn - 
Phrase3422:
the beta-globin 
dt - nn - 
Phrase3423:
hypersensitive sites 
jj - nns - 
Phrase3424:
g-rich motifs 
jj - nns - 
Phrase3425:
its 
prp$ - 
Phrase3426:
these motifs 
dt - nns - 
Phrase3427:
it 
prp - 
Phrase3428:
we 
prp - 
Phrase3429:
the function 
dt - nn - 
Phrase3430:
related proteins 
jj - nns - 
Phrase3431:
the zinc 
dt - nn - 
Phrase3432:
their 
prp$ - 
Phrase3433:
transgenic mice 
jj - nns - 
Phrase3434:
direct activator 
jj - nn - 
Phrase3435:
the epstein-barr virus 
dt - jj - nn - 
Phrase3436:
lytic cycle 
jj - nn - 
Phrase3437:
the transition 
dt - nn - 
Phrase3438:
epstein-barr virus 
jj - nn - 
Phrase3439:
the lytic cycle 
dt - jj - nn - 
Phrase3440:
the expression 
dt - nn - 
Phrase3441:
immediate-early viral genes 
jj - jj - nns - 
Phrase3442:
the product 
dt - nn - 
Phrase3443:
lytic cycle 
jj - nn - 
Phrase3444:
the brlf1 
dt - nn - 
Phrase3445:
transcriptional activator 
jj - nn - 
Phrase3446:
an epithelial 
dt - nn - 
Phrase3447:
specific manner 
jj - nn - 
Phrase3448:
s. 
nnp - 
Phrase3449:
s. 
nnp - 
Phrase3450:
we 
prp - 
Phrase3451:
permissive b-cell 
jj - nn - 
Phrase3452:
viral dna 
jj - nn - 
Phrase3453:
late gene 
jj - nn - 
Phrase3454:
itself 
prp - 
Phrase3455:
the ability 
dt - nn - 
Phrase3456:
late lytic cycle 
jj - jj - nn - 
Phrase3457:
previous work 
jj - nn - 
Phrase3458:
the activation 
dt - nn - 
Phrase3459:
we 
prp - 
Phrase3460:
cooperative model 
jj - nn - 
Phrase3461:
the lytic cycle 
dt - jj - nn - 
Phrase3462:
either bzlf1 
dt - nn - 
Phrase3463:
the other immediate-early factor 
dt - jj - jj - nn - 
Phrase3464:
these activators 
dt - nns - 
Phrase3465:
downstream targets 
jj - nns - 
Phrase3466:
the viral lytic cycle 
dt - jj - jj - nn - 
Phrase3467:
minimal promoter 
jj - nn - 
Phrase3468:
the nf-il6 
dt - nn - 
Phrase3469:
promonocytic cells 
jj - nns - 
Phrase3470:
an important transcriptional regulator 
dt - jj - jj - nn - 
Phrase3471:
ccaat/enhancer-binding protein 
jj - nn - 
Phrase3472:
we 
prp - 
Phrase3473:
the nf-il6 
dt - nn - 
Phrase3474:
least in 
jjs - nn - 
Phrase3475:
promonocytic cells 
jj - nns - 
Phrase3476:
we 
prp - 
Phrase3477:
minimal promoter 
jj - nn - 
Phrase3478:
the nf-il6 
dt - nn - 
Phrase3479:
activation-dependent induction 
jj - nn - 
Phrase3480:
the camp 
dt - nn - 
Phrase3481:
each site 
dt - nn - 
Phrase3482:
the nf-il6 
dt - nn - 
Phrase3483:
b-cell-specific promoter 
jj - nn - 
Phrase3484:
this study 
dt - nn - 
Phrase3485:
various sets 
jj - nns - 
Phrase3486:
somatic cell 
jj - nn - 
Phrase3487:
the fusion 
dt - nn - 
Phrase3488:
b-lymphoblastoid cell 
jj - nn - 
Phrase3489:
the expression 
dt - nn - 
Phrase3490:
major histocompatibility 
jj - nn - 
Phrase3491:
we 
prp - 
Phrase3492:
the coordinate 
dt - nn - 
Phrase3493:
invariant chain 
jj - nn - 
Phrase3494:
the release 
dt - nn - 
Phrase3495:
the silencing 
dt - nn - 
Phrase3496:
the addition 
dt - nn - 
Phrase3497:
interspecies hybrids 
jj - nns - 
Phrase3498:
the segregation 
dt - nn - 
Phrase3499:
us 
prp - 
Phrase3500:
the presence 
dt - nn - 
Phrase3501:
the hybrids 
dt - nns - 
Phrase3502:
the chromosomes 
dt - nns - 
Phrase3503:
the epithelial 
dt - nn - 
Phrase3504:
our 
prp$ - 
Phrase3505:
the expression 
dt - nn - 
Phrase3506:
the class 
dt - nn - 
Phrase3507:
the actual target 
dt - jj - nn - 
Phrase3508:
the silencing 
dt - nn - 
Phrase3509:
the suppression 
dt - nn - 
Phrase3510:
we 
prp - 
Phrase3511:
the activity 
dt - nn - 
Phrase3512:
the b-cell-specific promoter 
dt - jj - nn - 
Phrase3513:
these results 
dt - nns - 
Phrase3514:
the mhc 
dt - nn - 
Phrase3515:
somatic cell 
jj - nn - 
Phrase3516:
an active suppression 
dt - jj - nn - 
Phrase3517:
the promoters 
dt - nns - 
Phrase3518:
the ciita 
dt - nn - 
Phrase3519:
the epithelial 
dt - nn - 
Phrase3520:
the surface 
dt - nn - 
Phrase3521:
allogeneic endothelial 
jj - nn - 
Phrase3522:
an adhesion-dependent 
dt - nn - 
Phrase3523:
we 
prp - 
Phrase3524:
the surface 
dt - nn - 
Phrase3525:
defective in 
jj - nn - 
Phrase3526:
ifn-gamma-induced mhc 
jj - nn - 
Phrase3527:
these cells 
dt - nns - 
Phrase3528:
defective in 
jj - nn - 
Phrase3529:
cell-induced hla-dr 
jj - nn - 
Phrase3530:
the janus 
dt - nn - 
Phrase3531:
these cells 
dt - nns - 
Phrase3532:
these data 
dt - nns - 
Phrase3533:
the ifn-gamma-independent 
dt - nn - 
Phrase3534:
the target 
dt - nn - 
Phrase3535:
the ifn-gamma-dependent mechanism 
dt - jj - nn - 
Phrase3536:
receptor-associated kinase 
jj - nn - 
Phrase3537:
stress-activated protein 
jj - nn - 
Phrase3538:
the murine 
dt - nn - 
Phrase3539:
the association 
dt - nn - 
Phrase3540:
the il-1 
dt - nn - 
Phrase3541:
receptor-associated protein 
jj - nn - 
Phrase3542:
the il-1 
dt - nn - 
Phrase3543:
the earliest events 
dt - jjs - nns - 
Phrase3544:
detectable in 
jj - nn - 
Phrase3545:
we 
prp - 
Phrase3546:
permanent clones 
jj - nns - 
Phrase3547:
the murine 
dt - nn - 
Phrase3548:
the role 
dt - nn - 
Phrase3549:
this kinase 
dt - nn - 
Phrase3550:
the transcription 
dt - nn - 
Phrase3551:
weak constitutive activation 
jj - jj - nn - 
Phrase3552:
low basal il-2 
jj - jj - nn - 
Phrase3553:
an il-1-dependent 
dt - nn - 
Phrase3554:
the parental cell 
dt - jj - nn - 
Phrase3555:
the dose-response 
dt - nn - 
Phrase3556:
il-1-induced il-2 
jj - nn - 
Phrase3557:
these results 
dt - nns - 
Phrase3558:
nfkappab-mediated gene 
jj - nn - 
Phrase3559:
different effects 
jj - nns - 
Phrase3560:
the il-1-induced activation 
dt - jj - nn - 
Phrase3561:
stress-activated protein 
jj - nn - 
Phrase3562:
permanent overexpression 
jj - nn - 
Phrase3563:
the dose 
dt - nn - 
Phrase3564:
prolonged kinetics 
jj - nn - 
Phrase3565:
il-1-induced activation 
jj - nn - 
Phrase3566:
this signaling 
dt - nn - 
Phrase3567:
distinct mechanisms 
jj - nns - 
Phrase3568:
the role 
dt - nn - 
Phrase3569:
restricted protein 
jj - nn - 
Phrase3570:
this report 
dt - nn - 
Phrase3571:
the selective pkc 
dt - jj - nn - 
Phrase3572:
cellular fractions 
jj - nns - 
Phrase3573:
abundant expression 
jj - nn - 
Phrase3574:
classical pkc-alpha 
jj - nn - 
Phrase3575:
atypical pkc-zeta 
jj - nn - 
Phrase3576:
sustained translocation 
jj - nn - 
Phrase3577:
the cytosolic compartment 
dt - jj - nn - 
Phrase3578:
the distribution 
dt - nn - 
Phrase3579:
atypical pkc-zeta 
jj - nn - 
Phrase3580:
the tpa-mediated 
dt - nn - 
Phrase3581:
functional activation 
jj - nn - 
Phrase3582:
selective in 
jj - nn - 
Phrase3583:
these results 
dt - nns - 
Phrase3584:
the x2 
dt - nn - 
Phrase3585:
the dra 
dt - nn - 
Phrase3586:
selective inhibition 
jj - nn - 
Phrase3587:
enzymatic activity 
jj - nn - 
Phrase3588:
subcellular localization 
jj - nn - 
Phrase3589:
the translocation 
dt - nn - 
Phrase3590:
these cells 
dt - nns - 
Phrase3591:
synthetic dna-binding 
jj - nn - 
Phrase3592:
sequence-specific dna-binding 
jj - nn - 
Phrase3593:
small molecules 
jj - nns - 
Phrase3594:
specific genes 
jj - nns - 
Phrase3595:
multiple cellular dna-binding 
jj - jj - nn - 
Phrase3596:
the transcription 
dt - nn - 
Phrase3597:
these synthetic ligands 
dt - jj - nns - 
Phrase3598:
each transcription 
dt - nn - 
Phrase3599:
cell-free assays 
jj - nn - 
Phrase3600:
the polyamides 
dt - nn - 
Phrase3601:
peripheral blood 
jj - nn - 
Phrase3602:
detectable cell 
jj - nn - 
Phrase3603:
the ability 
dt - nn - 
Phrase3604:
small molecules 
jj - nns - 
Phrase3605:
general approach 
jj - nn - 
Phrase3606:
the inhibition 
dt - nn - 
Phrase3607:
viral replication 
jj - nn - 
Phrase3608:
basic helix-loop-helix transcription 
jj - jj - nn - 
Phrase3609:
embryonic skeletal muscle 
jj - jj - nn - 
Phrase3610:
we 
prp - 
Phrase3611:
the embryonic expression 
dt - jj - nn - 
Phrase3612:
the bhlh family 
dt - jj - nn - 
Phrase3613:
the embryonic skeletal muscle 
dt - jj - jj - nn - 
Phrase3614:
skeletal muscles 
jj - nn - 
Phrase3615:
the gene 
dt - nn - 
Phrase3616:
each muscle 
dt - nn - 
Phrase3617:
fetal muscle 
jj - nn - 
Phrase3618:
science 
nnp - 
Phrase3619:
ireland 
nnp - 
Phrase3620:
high concentrations 
jj - nns - 
Phrase3621:
immunodominant native peptide 
jj - jj - nn - 
Phrase3622:
the ability 
dt - nn - 
Phrase3623:
antigen-specific t 
jj - nn - 
Phrase3624:
therapeutic value 
jj - nn - 
Phrase3625:
pathologic immune responses 
jj - jj - nns - 
Phrase3626:
intracellular signaling 
jj - nn - 
Phrase3627:
high concentrations 
jj - nns - 
Phrase3628:
native peptide 
jj - nn - 
Phrase3629:
basic protein 
jj - nn - 
Phrase3630:
-specific human 
jj - nn - 
Phrase3631:
the tt-selected 
dt - nn - 
Phrase3632:
its 
prp$ - 
Phrase3633:
dominant epitope 
jj - nn - 
Phrase3634:
dose-dependent manner 
jj - nn - 
Phrase3635:
= 0.03 
jj - nn - 
Phrase3636:
the tt-selected 
dt - nn - 
Phrase3637:
this line 
dt - nn - 
Phrase3638:
high concentrations 
jj - nns - 
Phrase3639:
the immunodominant epitope 
dt - jj - nn - 
Phrase3640:
enzymatic activity 
jj - nn - 
Phrase3641:
the mbp-selected 
dt - nn - 
Phrase3642:
immunodominant peptide 
jj - nn - 
Phrase3643:
the autopresentation 
dt - nn - 
Phrase3644:
native peptide 
jj - nn - 
Phrase3645:
fresh antigen-presenting cells 
jj - jj - nns - 
Phrase3646:
the mitogen-activated protein 
dt - jj - nn - 
Phrase3647:
high concentrations 
jj - nns - 
Phrase3648:
soluble peptide 
jj - nn - 
Phrase3649:
academic 
nnp - 
Phrase3650:
press 
nnp - 
Phrase3651:
colony-stimulating factor 
jj - nn - 
Phrase3652:
lineage-specific transcription 
jj - nn - 
Phrase3653:
we 
prp - 
Phrase3654:
colony-stimulating factor 
jj - nn - 
Phrase3655:
other genes 
jj - nns - 
Phrase3656:
we 
prp - 
Phrase3657:
il-6-responsive colony-forming units 
jj - jj - nns - 
Phrase3658:
the addition 
dt - nn - 
Phrase3659:
soluble il-6 
jj - nn - 
Phrase3660:
retroviral transduction 
jj - nn - 
Phrase3661:
these receptors 
dt - nns - 
Phrase3662:
the absolute block 
dt - jj - nn - 
Phrase3663:
hematopoietic cells 
jj - nns - 
Phrase3664:
the results 
dt - nns - 
Phrase3665:
other studies 
jj - nns - 
Phrase3666:
additional c/ebpalpha 
jj - nn - 
Phrase3667:
other cytokine 
jj - nn - 
Phrase3668:
the block 
dt - nn - 
Phrase3669:
bacterial lipopolysaccharide 
jj - nn - 
Phrase3670:
bacterial lipopolysaccharides 
jj - nns - 
Phrase3671:
several other microbial agonists 
jj - jj - jj - nns - 
Phrase3672:
we 
prp - 
Phrase3673:
other phosphatidylinositides 
jj - nn - 
Phrase3674:
another anionic glycerophospholipid 
dt - jj - nn - 
Phrase3675:
lower apparent affinity 
jjr - jj - nn - 
Phrase3676:
both ps- 
dt - nn - 
Phrase3677:
monoclonal antibodies 
jj - nns - 
Phrase3678:
both lps-mcd14 
dt - nn - 
Phrase3679:
lps-induced responses 
jj - nns - 
Phrase3680:
the possibility 
dt - nn - 
Phrase3681:
endogenous ptdins 
jj - nn - 
Phrase3682:
cellular responses 
jj - nns - 
Phrase3683:
other mcd14 
jj - nn - 
Phrase3684:
the tnf/neuron 
dt - nn - 
Phrase3685:
specific abs 
jj - nn - 
Phrase3686:
rapid apoptotic cell 
jj - jj - nn - 
Phrase3687:
the death 
dt - nn - 
Phrase3688:
the mechanisms 
dt - nns - 
Phrase3689:
our 
prp$ - 
Phrase3690:
we 
prp - 
Phrase3691:
specific protein 
jj - nn - 
Phrase3692:
activation-induced fas 
jj - nn - 
Phrase3693:
the activation 
dt - nn - 
Phrase3694:
the tcr 
dt - nn - 
Phrase3695:
the expression 
dt - nn - 
Phrase3696:
pkc-dependent fas 
jj - nn - 
Phrase3697:
several murine 
jj - nn - 
Phrase3698:
the inhibition 
dt - nn - 
Phrase3699:
an inhibitor 
dt - nn - 
Phrase3700:
intracellular ca2+ 
jj - nn - 
Phrase3701:
tcr-induced fasl 
jj - nn - 
Phrase3702:
the expression 
dt - nn - 
Phrase3703:
the activity 
dt - nn - 
Phrase3704:
wild-type tdag51 
jj - nn - 
Phrase3705:
retinoic acid 
jj - nn - 
Phrase3706:
the role 
dt - nn - 
Phrase3707:
retinoic acid 
jj - nn - 
Phrase3708:
-mediated b-cell 
jj - nn - 
Phrase3709:
the effect 
dt - nn - 
Phrase3710:
-mediated proliferation 
jj - nn - 
Phrase3711:
peripheral blood 
jj - nn - 
Phrase3712:
healthy donors 
jj - nns - 
Phrase3713:
il-4-mediated proliferation 
jj - nn - 
Phrase3714:
dose-dependent manner 
jj - nn - 
Phrase3715:
maximal inhibition 
jj - nn - 
Phrase3716:
all-trans ra 
jj - nn - 
Phrase3717:
maximal inhibition 
jj - nn - 
Phrase3718:
all-trans ra 
jj - nn - 
Phrase3719:
low concentrations 
jj - nns - 
Phrase3720:
neither b-cell 
dt - nn - 
Phrase3721:
the production 
dt - nn - 
Phrase3722:
the mechanism 
dt - nn - 
Phrase3723:
this inhibition 
dt - nn - 
Phrase3724:
the presence 
dt - nn - 
Phrase3725:
the ra 
dt - nn - 
Phrase3726:
the expression 
dt - nn - 
Phrase3727:
the retinoic acid 
dt - jj - nn - 
Phrase3728:
the data 
dt - nns - 
Phrase3729:
unstimulated human 
jj - nn - 
Phrase3730:
peripheral b 
jj - nn - 
Phrase3731:
the ra 
dt - nn - 
Phrase3732:
different receptor 
jj - nn - 
Phrase3733:
dose-dependent inhibition 
jj - nn - 
Phrase3734:
an ra 
dt - nn - 
Phrase3735:
the alpha 
dt - nn - 
Phrase3736:
high specificity 
jj - nn - 
Phrase3737:
this study 
dt - nn - 
Phrase3738:
il-4-stimulated b 
jj - nn - 
Phrase3739:
the american 
dt - nn - 
Phrase3740:
the ikappab 
dt - nn - 
Phrase3741:
cellular kinases 
jj - nns - 
Phrase3742:
40-kda transforming 
jj - nn - 
Phrase3743:
the pathogenic retrovirus 
dt - jj - nn - 
Phrase3744:
nuclear expression 
jj - nn - 
Phrase3745:
the nf-kappab/rel 
dt - nn - 
Phrase3746:
an unknown mechanism 
dt - jj - nn - 
Phrase3747:
n-terminal phosphorylation 
jj - nn - 
Phrase3748:
principal cytoplasmic inhibitor 
jj - jj - nn - 
Phrase3749:
our 
prp$ - 
Phrase3750:
cellular kinases 
jj - nns - 
Phrase3751:
its 
prp$ - 
Phrase3752:
n-terminal regulatory serines 
jj - jj - nns - 
Phrase3753:
either ikkalpha 
dt - nn - 
Phrase3754:
endogenous ikk 
jj - nn - 
Phrase3755:
enzymatic activity 
jj - nn - 
Phrase3756:
tax-expressing t-cell 
jj - nn - 
Phrase3757:
either human 
dt - nn - 
Phrase3758:
nf-kappab-dependent reporter 
jj - nn - 
Phrase3759:
nf-kappab-inducing kinase 
jj - nn - 
Phrase3760:
an upstream kinase 
dt - jj - nn - 
Phrase3761:
the tnf-alpha 
dt - nn - 
Phrase3762:
membrane-proximal elements 
jj - nns - 
Phrase3763:
these proinflammatory cytokine 
dt - jj - nn - 
Phrase3764:
dominant negative mutants 
jj - jj - nns - 
Phrase3765:
the traf2 
dt - nn - 
Phrase3766:
the cytoplasmic tails 
dt - jj - nn - 
Phrase3767:
the tnf-alpha 
dt - nn - 
Phrase3768:
these studies 
dt - nns - 
Phrase3769:
distal part 
jj - nn - 
Phrase3770:
the proinflammatory cytokine 
dt - jj - nn - 
Phrase3771:
the pathological alteration 
dt - jj - nn - 
Phrase3772:
this cytokine 
dt - nn - 
Phrase3773:
central role 
jj - nn - 
Phrase3774:
the adult 
dt - nn - 
Phrase3775:
monocytic cells 
jj - nns - 
Phrase3776:
major role 
jj - nn - 
Phrase3777:
inflammatory responses 
jj - nns - 
Phrase3778:
bacterial lipopolysaccharide 
jj - nn - 
Phrase3779:
the nf-kappab/rel 
dt - nn - 
Phrase3780:
we 
prp - 
Phrase3781:
the tumor 
dt - nn - 
Phrase3782:
the ikappab 
dt - nn - 
Phrase3783:
cytoplasmic inhibitors 
jj - nns - 
Phrase3784:
these kinases 
dt - nns - 
Phrase3785:
proteolytic degradation 
jj - nn - 
Phrase3786:
the release 
dt - nn - 
Phrase3787:
the nucleus 
dt - nn - 
Phrase3788:
the role 
dt - nn - 
Phrase3789:
the ikks 
dt - nn - 
Phrase3790:
we 
prp - 
Phrase3791:
monocytic cells 
jj - nns - 
Phrase3792:
the kinetics 
dt - nn - 
Phrase3793:
monocytic cells 
jj - nns - 
Phrase3794:
maximal activity 
jj - nn - 
Phrase3795:
the degradation 
dt - nn - 
Phrase3796:
the nuclear translocation 
dt - jj - nn - 
Phrase3797:
wild type 
jj - nn - 
Phrase3798:
dominant negative mutant 
jj - jj - nn - 
Phrase3799:
wild type 
jj - nn - 
Phrase3800:
lps-induced kappab-dependent transcription 
jj - jj - nn - 
Phrase3801:
monocytic cells 
jj - nns - 
Phrase3802:
dominant negative mutant 
jj - jj - nn - 
Phrase3803:
kappab-dependent transcription 
jj - nn - 
Phrase3804:
dose-dependent manner 
jj - nn - 
Phrase3805:
these results 
dt - nns - 
Phrase3806:
kappab-dependent gene 
jj - nn - 
Phrase3807:
monocytic cells 
jj - nns - 
Phrase3808:
multiple aspects 
jj - nns - 
Phrase3809:
the mechanism 
dt - nn - 
Phrase3810:
lymphoid cells 
jj - nns - 
Phrase3811:
previous studies 
jj - nns - 
Phrase3812:
constitutive activation 
jj - nn - 
Phrase3813:
these cytokine 
dt - nn - 
Phrase3814:
important in 
jj - nn - 
Phrase3815:
the cellular events 
dt - jj - nns - 
Phrase3816:
the abelson 
dt - nn - 
Phrase3817:
the effects 
dt - nns - 
Phrase3818:
temperature-sensitive v-abl 
jj - nn - 
Phrase3819:
the apoptosis 
dt - nn - 
Phrase3820:
the decreases 
dt - nns - 
Phrase3821:
the levels 
dt - nns - 
Phrase3822:
v-abl-mediated differentiation 
dt - nn - 
Phrase3823:
the pre-b 
dt - nn - 
Phrase3824:
these results 
dt - nns - 
Phrase3825:
an active v-abl 
dt - jj - nn - 
Phrase3826:
differential regulation 
jj - nn - 
Phrase3827:
nonerythroid cells 
jj - nns - 
Phrase3828:
the sixth 
dt - nn - 
Phrase3829:
the heme 
dt - nn - 
Phrase3830:
the tissue-specific regulation 
dt - jj - nn - 
Phrase3831:
the cpo 
dt - nn - 
Phrase3832:
genomic dna 
jj - nn - 
Phrase3833:
structural analysis 
jj - nn - 
Phrase3834:
the mouse 
dt - nn - 
Phrase3835:
its 
prp$ - 
Phrase3836:
functional analysis 
jj - nn - 
Phrase3837:
the promoter 
dt - nn - 
Phrase3838:
synergistic action 
jj - nn - 
Phrase3839:
an sp-1-like 
dt - nn - 
Phrase3840:
novel regulatory element 
jj - jj - nn - 
Phrase3841:
the promoter 
dt - nn - 
Phrase3842:
nonerythroid nih3t3 
jj - nn - 
Phrase3843:
the gata 
dt - nn - 
Phrase3844:
specific dna-protein 
jj - nn - 
Phrase3845:
each element 
dt - nn - 
Phrase3846:
cell-specific differences 
jj - nns - 
Phrase3847:
the sp-1-like 
dt - nn - 
Phrase3848:
these results 
dt - nns - 
Phrase3849:
differential regulation 
jj - nn - 
Phrase3850:
the promoter 
dt - nn - 
Phrase3851:
nonerythroid cells 
jj - nns - 
Phrase3852:
the american 
dt - nn - 
Phrase3853:
the products 
dt - nns - 
Phrase3854:
the tumor 
dt - nn - 
Phrase3855:
specific inhibitors 
jj - nns - 
Phrase3856:
this communication 
dt - nn - 
Phrase3857:
we 
prp - 
Phrase3858:
these proteins 
dt - nns - 
Phrase3859:
the activation 
dt - nn - 
Phrase3860:
the ml-1 
dt - nn - 
Phrase3861:
myeloblastic leukemia 
jj - nn - 
Phrase3862:
this study 
dt - nn - 
Phrase3863:
macrophage-like cells 
jj - nns - 
Phrase3864:
both cytokines 
dt - nns - 
Phrase3865:
25-fold increase 
jj - nn - 
Phrase3866:
the nuclear level 
dt - jj - nn - 
Phrase3867:
the dna 
dt - nn - 
Phrase3868:
the proliferation-specific 
dt - nn - 
Phrase3869:
the nuclear level 
dt - jj - nn - 
Phrase3870:
the tumor 
dt - nn - 
Phrase3871:
wild type 
jj - nn - 
Phrase3872:
the p53-dependent 
dt - nn - 
Phrase3873:
the expression 
dt - nn - 
Phrase3874:
the expression 
dt - nn - 
Phrase3875:
this function 
dt - nn - 
Phrase3876:
the tumor 
dt - nn - 
Phrase3877:
the capacity 
dt - nn - 
Phrase3878:
the sustained proliferation 
dt - jj - nn - 
Phrase3879:
the cancer 
dt - nn - 
Phrase3880:
the cytokine 
dt - nn - 
Phrase3881:
therapeutic benefits 
jj - nns - 
Phrase3882:
renal cell 
jj - nn - 
Phrase3883:
we 
prp - 
Phrase3884:
an analysis 
dt - nn - 
Phrase3885:
the transcription 
dt - nn - 
Phrase3886:
gel-shift assay 
jj - nn - 
Phrase3887:
the incubation 
dt - nn - 
Phrase3888:
fresh peripheral blood 
jj - jj - nn - 
Phrase3889:
healthy individuals 
jj - nns - 
Phrase3890:
several days 
jj - nns - 
Phrase3891:
the production 
dt - nn - 
Phrase3892:
lymphokine-activated killer 
jj - nn - 
Phrase3893:
these cultures 
dt - nns - 
Phrase3894:
this study 
dt - nn - 
Phrase3895:
the profile 
dt - nn - 
Phrase3896:
these different populations 
dt - jj - nns - 
Phrase3897:
the patterns 
dt - nn - 
Phrase3898:
functional differences 
jj - nns - 
Phrase3899:
these cells 
dt - nns - 
Phrase3900:
the typical binding 
dt - jj - nn - 
Phrase3901:
fresh pbmc 
jj - nn - 
Phrase3902:
healthy individuals 
jj - nns - 
Phrase3903:
the binding 
dt - nn - 
Phrase3904:
the cells 
dt - nns - 
Phrase3905:
il-2-treated patients 
jj - nns - 
Phrase3906:
low-level constitutive expression 
jj - jj - nn - 
Phrase3907:
these patient 
dt - nn - 
Phrase3908:
additional differences 
jj - nns - 
Phrase3909:
these data 
dt - nns - 
Phrase3910:
the molecular 
dt - nn - 
Phrase3911:
immune cells 
jj - nns - 
Phrase3912:
precise congruence 
jj - nn - 
Phrase3913:
intercellular adhesion 
jj - nn - 
Phrase3914:
an important role 
dt - jj - nn - 
Phrase3915:
the pathophysiology 
dt - nn - 
Phrase3916:
the role 
dt - nn - 
Phrase3917:
intercellular adhesion 
jj - nn - 
Phrase3918:
umbilical vein 
jj - nn - 
Phrase3919:
the presence 
dt - nn - 
Phrase3920:
nonstimulated platelets 
jj - nns - 
Phrase3921:
the transcription 
dt - nn - 
Phrase3922:
nuclear factor-kappab 
jj - nn - 
Phrase3923:
electrophoretic mobility 
jj - nn - 
Phrase3924:
kappab-dependent transcriptional activity 
jj - jj - nn - 
Phrase3925:
the presence 
dt - nn - 
Phrase3926:
promoter-dependent transcription 
jj - nn - 
Phrase3927:
liposomal transfection 
jj - nn - 
Phrase3928:
double-stranded kappab 
jj - nn - 
Phrase3929:
the present 
dt - nn - 
Phrase3930:
an nf-kappab-dependent mechanism 
dt - jj - nn - 
Phrase3931:
the nf-kappab 
dt - nn - 
Phrase3932:
early inflammatory events 
jj - jj - nns - 
Phrase3933:
erythroid cell 
jj - nn - 
Phrase3934:
nuclear receptors 
jj - nns - 
Phrase3935:
important regulators 
jj - nns - 
Phrase3936:
erythroid cell 
jj - nn - 
Phrase3937:
we 
prp - 
Phrase3938:
the impact 
dt - nn - 
Phrase3939:
retinoic acid 
jj - nn - 
Phrase3940:
the c-erba/thyroid 
dt - nn - 
Phrase3941:
erythroid cells 
jj - nns - 
Phrase3942:
an in 
dt - nn - 
Phrase3943:
factor-dependent erythroid progenitors 
jj - jj - nns - 
Phrase3944:
erythroid-specific gene 
jj - nn - 
Phrase3945:
erythroid differentiation 
jj - nn - 
Phrase3946:
ligand-activated c-erba/tr 
jj - nn - 
Phrase3947:
sustained progenitor 
jj - nn - 
Phrase3948:
erythroid cell 
jj - nn - 
Phrase3949:
ligand-activated c-erba/tr 
jj - nn - 
Phrase3950:
the impact 
dt - nn - 
Phrase3951:
erythroid cell 
jj - nn - 
Phrase3952:
the transcriptional activator 
dt - jj - nn - 
Phrase3953:
the entire dna-binding 
dt - jj - nn - 
Phrase3954:
erythroid progenitor 
jj - nn - 
Phrase3955:
rxr-specific effects 
jj - nns - 
Phrase3956:
it 
prp - 
Phrase3957:
wild-type rxr 
jj - nn - 
Phrase3958:
the rxr 
dt - nn - 
Phrase3959:
erythroid cells 
jj - nns - 
Phrase3960:
marked contrast 
jj - nn - 
Phrase3961:
the entire dna-binding 
dt - jj - nn - 
Phrase3962:
erythroid cell 
jj - nn - 
Phrase3963:
pivotal role 
jj - nn - 
Phrase3964:
erythroid cell 
jj - nn - 
Phrase3965:
peripheral t 
jj - nn - 
Phrase3966:
abnormal protein 
jj - nn - 
Phrase3967:
several signaling 
jj - nn - 
Phrase3968:
we 
prp - 
Phrase3969:
peripheral blood 
jj - nn - 
Phrase3970:
an impaired ability 
dt - jj - nn - 
Phrase3971:
nfeb p65 
dt - nn - 
Phrase3972:
normal cytoplasmic levels 
jj - jj - nns - 
Phrase3973:
the rel-a 
dt - nn - 
Phrase3974:
we 
prp - 
Phrase3975:
low levels 
jj - nns - 
Phrase3976:
the signaling 
dt - nn - 
Phrase3977:
the dual specificity 
dt - jj - nn - 
Phrase3978:
the activation 
dt - nn - 
Phrase3979:
our 
prp$ - 
Phrase3980:
the detection 
dt - nn - 
Phrase3981:
the analysis 
dt - nn - 
Phrase3982:
significant defects 
jj - nns - 
Phrase3983:
impaired rel-a 
jj - nn - 
Phrase3984:
the translocation 
dt - nn - 
Phrase3985:
the nfkb 
dt - nn - 
Phrase3986:
the transcription 
dt - nn - 
Phrase3987:
the peripheral t 
dt - jj - nn - 
Phrase3988:
specific glucocorticoid 
jj - nn - 
Phrase3989:
different levels 
jj - nns - 
Phrase3990:
we 
prp - 
Phrase3991:
the number 
dt - nn - 
Phrase3992:
the hypothalamic-hypophyseal-adrenocortical 
dt - nn - 
Phrase3993:
experimental series 
jj - nn - 
Phrase3994:
physical exercise 
jj - nn - 
Phrase3995:
the first series 
dt - jj - nn - 
Phrase3996:
we 
prp - 
Phrase3997:
the number 
dt - nn - 
Phrase3998:
the season 
dt - nn - 
Phrase3999:
the age 
dt - nn - 
Phrase4000:
the second 
dt - nn - 
Phrase4001:
we 
prp - 
Phrase4002:
the following 
dt - nn - 
Phrase4003:
the end 
dt - nn - 
Phrase4004:
the first month 
dt - jj - nn - 
Phrase4005:
the number 
dt - nn - 
Phrase4006:
the third month 
dt - jj - nn - 
Phrase4007:
specific glucocorticoid 
jj - nn - 
Phrase4008:
the end 
dt - nn - 
Phrase4009:
the sixth 
dt - nn - 
Phrase4010:
the number 
dt - nn - 
Phrase4011:
the third series 
dt - jj - nn - 
Phrase4012:
physical exercises 
jj - nn - 
Phrase4013:
an activation 
dt - nn - 
Phrase4014:
the hypothalamic-hypophyseal-adrenocortical 
dt - nn - 
Phrase4015:
maximal physical exercises 
jj - jj - nn - 
Phrase4016:
prolonged submaximal exercises 
jj - jj - nn - 
Phrase4017:
maximal oxygen 
jj - nn - 
Phrase4018:
significant increase 
jj - nn - 
Phrase4019:
the number 
dt - nn - 
Phrase4020:
these results 
dt - nns - 
Phrase4021:
both a 
dt - nn - 
Phrase4022:
an increase 
dt - nn - 
Phrase4023:
significant changes 
jj - nns - 
Phrase4024:
specific glucocorticoid 
jj - nn - 
Phrase4025:
some other factors 
dt - jj - nn - 
Phrase4026:
physical activity 
jj - nn - 
Phrase4027:
the small gtp-binding protein 
dt - jj - jj - nn - 
Phrase4028:
the rho 
dt - nn - 
Phrase4029:
small gtp-binding proteins 
jj - jj - nns - 
Phrase4030:
the regulation 
dt - nn - 
Phrase4031:
cytoskeletal structure 
jj - nn - 
Phrase4032:
specific cell 
jj - nn - 
Phrase4033:
we 
prp - 
Phrase4034:
this report 
dt - nn - 
Phrase4035:
the presence 
dt - nn - 
Phrase4036:
similar conditions 
jj - nns - 
Phrase4037:
transcriptional activation 
jj - nn - 
Phrase4038:
the effect 
dt - nn - 
Phrase4039:
the mitogen-activated protein 
dt - jj - nn - 
Phrase4040:
dominant-negative mek 
jj - nn - 
Phrase4041:
the caax 
dt - nn - 
Phrase4042:
this association 
dt - nn - 
Phrase4043:
an effector 
dt - nn - 
Phrase4044:
the observation 
dt - nn - 
Phrase4045:
the n-terminal domain 
dt - jj - nn - 
Phrase4046:
the effects 
dt - nns - 
Phrase4047:
transcriptional activity 
jj - nn - 
Phrase4048:
these data 
dt - nns - 
Phrase4049:
an important role 
dt - jj - nn - 
Phrase4050:
other types 
jj - nns - 
Phrase4051:
inflammatory processes 
jj - nns - 
Phrase4052:
the lung 
dt - nn - 
Phrase4053:
these cells 
dt - nns - 
Phrase4054:
many alterations 
jj - nns - 
Phrase4055:
their 
prp$ - 
Phrase4056:
these differences 
dt - nns - 
Phrase4057:
we 
prp - 
Phrase4058:
we 
prp - 
Phrase4059:
an increase 
dt - nn - 
Phrase4060:
ca2+-dependent pkc 
jj - nn - 
Phrase4061:
we 
prp - 
Phrase4062:
differential expression 
jj - nn - 
Phrase4063:
the ca2+-independent 
dt - nn - 
Phrase4064:
the activation 
dt - nn - 
Phrase4065:
mitogen-activated protein 
jj - nn - 
Phrase4066:
we 
prp - 
Phrase4067:
the map 
dt - nn - 
Phrase4068:
extracellular signal-regulated kinase 
jj - jj - nn - 
Phrase4069:
the phorbol 
dt - nn - 
Phrase4070:
greater activation 
jjr - nn - 
Phrase4071:
another known consequence 
dt - jj - nn - 
Phrase4072:
the activation 
dt - nn - 
Phrase4073:
subsequent activation 
jj - nn - 
Phrase4074:
the transcription 
dt - nn - 
Phrase4075:
we 
prp - 
Phrase4076:
the activation 
dt - nn - 
Phrase4077:
we 
prp - 
Phrase4078:
little detectable activation 
jj - jj - nn - 
Phrase4079:
substantial activation 
jj - nn - 
Phrase4080:
these studies 
dt - nns - 
Phrase4081:
the differential expression 
dt - jj - nn - 
Phrase4082:
important functional alterations 
jj - jj - nns - 
Phrase4083:
the cells 
dt - nns - 
Phrase4084:
responsive genes 
jj - nns - 
Phrase4085:
we 
prp - 
Phrase4086:
the macrophage 
dt - nn - 
Phrase4087:
extensive xanthomatosis 
jj - nn - 
Phrase4088:
differential display 
jj - nn - 
Phrase4089:
we 
prp - 
Phrase4090:
high expression 
jj - nn - 
Phrase4091:
the signal 
dt - nn - 
Phrase4092:
the proband 
dt - nn - 
Phrase4093:
inducible protein 
jj - nn - 
Phrase4094:
inflammatory response 
jj - nn - 
Phrase4095:
the monocytes 
dt - nns - 
Phrase4096:
both genes 
dt - nns - 
Phrase4097:
unaffected family 
jj - nn - 
Phrase4098:
inducible dna 
jj - nn - 
Phrase4099:
the human 
dt - nn - 
Phrase4100:
these results 
dt - nns - 
Phrase4101:
the ip-10 
dt - nn - 
Phrase4102:
familial hypercholesterolemic 
jj - nn - 
Phrase4103:
significant number 
jj - nn - 
Phrase4104:
elevated stat1alpha 
jj - nn - 
Phrase4105:
our 
prp$ - 
Phrase4106:
the inflammatory effects 
dt - jj - nns - 
Phrase4107:
the response 
dt - nn - 
Phrase4108:
the redox 
dt - nn - 
Phrase4109:
an important role 
dt - jj - nn - 
Phrase4110:
immune function 
jj - nn - 
Phrase4111:
the activation 
dt - nn - 
Phrase4112:
normal t 
jj - nn - 
Phrase4113:
several t 
jj - nn - 
Phrase4114:
impaired activation 
jj - nn - 
Phrase4115:
cellular senescence 
jj - nn - 
Phrase4116:
the immunopathogenesis 
dt - nn - 
Phrase4117:
inflammatory processes 
jj - nns - 
Phrase4118:
the role 
dt - nn - 
Phrase4119:
other reactive oxygen 
jj - jj - nn - 
Phrase4120:
an integratory 
dt - nn - 
Phrase4121:
secondary messenger 
jj - nn - 
Phrase4122:
divergent t 
jj - nn - 
Phrase4123:
the fact 
dt - nn - 
Phrase4124:
various t 
jj - nn - 
Phrase4125:
peripheral blood 
jj - nn - 
Phrase4126:
the levels 
dt - nns - 
Phrase4127:
indirect evidence 
jj - nn - 
Phrase4128:
active nf-kappab 
jj - nn - 
Phrase4129:
complete activation 
jj - nn - 
Phrase4130:
an increase 
dt - nn - 
Phrase4131:
intracellular calcium 
jj - nn - 
Phrase4132:
enzymatic processes 
jj - nns - 
Phrase4133:
substantial evidence 
jj - nn - 
Phrase4134:
full activation 
jj - nn - 
Phrase4135:
dual signals 
jj - nns - 
Phrase4136:
the ability 
dt - nn - 
Phrase4137:
other ros 
jj - nn - 
Phrase4138:
functional responses 
jj - nns - 
Phrase4139:
the specific response 
dt - jj - nn - 
Phrase4140:
the redox 
dt - nn - 
Phrase4141:
an slp-76-deficient 
dt - nn - 
Phrase4142:
the function 
dt - nn - 
Phrase4143:
tcr-induced tyrosine 
jj - nn - 
Phrase4144:
most proteins 
jjs - nns - 
Phrase4145:
optimal tyrosine 
jj - nn - 
Phrase4146:
tcr-regulated ptks 
jj - nn - 
Phrase4147:
downstream signaling 
jj - nn - 
Phrase4148:
novel function 
jj - nn - 
Phrase4149:
erythropoietin-induced erythroid differentiation 
jj - jj - nn - 
Phrase4150:
we 
prp - 
Phrase4151:
the signal 
dt - nn - 
Phrase4152:
the human 
dt - nn - 
Phrase4153:
epo-dependent cell 
jj - nn - 
Phrase4154:
biol 
nnp - 
Phrase4155:
chem 
nnp - 
Phrase4156:
we 
prp - 
Phrase4157:
epo-induced cellular proliferation 
jj - jj - nn - 
Phrase4158:
this study 
dt - nn - 
Phrase4159:
we 
prp - 
Phrase4160:
the roles 
dt - nns - 
Phrase4161:
epo-induced erythroid differentiation 
jj - jj - nn - 
Phrase4162:
this cell 
dt - nn - 
Phrase4163:
we 
prp - 
Phrase4164:
both stat1alpha 
dt - nn - 
Phrase4165:
the induction 
dt - nn - 
Phrase4166:
erythroid-specific 5-aminolevulinate 
jj - nn - 
Phrase4167:
the percentage 
dt - nn - 
Phrase4168:
dominant negative forms 
jj - jj - nns - 
Phrase4169:
the epo-induced erythroid differentiation 
dt - jj - jj - nn - 
Phrase4170:
the presence 
dt - nn - 
Phrase4171:
colony-stimulating factor 
jj - nn - 
Phrase4172:
this cytokine 
dt - nn - 
Phrase4173:
erythroid differentiation 
jj - nn - 
Phrase4174:
the parent 
dt - nn - 
Phrase4175:
the constitutive activation 
dt - jj - nn - 
Phrase4176:
the period 
dt - nn - 
Phrase4177:
our 
prp$ - 
Phrase4178:
negative regulators 
jj - nns - 
Phrase4179:
epo-induced erythroid differentiation 
jj - jj - nn - 
Phrase4180:
the entry 
dt - nn - 
Phrase4181:
the cell 
dt - nn - 
Phrase4182:
anti-proliferative effects 
jj - nns - 
Phrase4183:
high throughput 
jj - nn - 
Phrase4184:
microbial broths 
jj - nn - 
Phrase4185:
we 
prp - 
Phrase4186:
peripheral blood 
jj - nn - 
Phrase4187:
an ic50 
dt - nn - 
Phrase4188:
antigen-induced il-2 
jj - nn - 
Phrase4189:
an ic50 
dt - nn - 
Phrase4190:
the mechanism 
dt - nn - 
Phrase4191:
we 
prp - 
Phrase4192:
effective inhibition 
jj - nn - 
Phrase4193:
we 
prp - 
Phrase4194:
ap1-dependent reporter 
jj - nn - 
Phrase4195:
ras-induced ap1 
dt - nn - 
Phrase4196:
an activator 
dt - nn - 
Phrase4197:
we 
prp - 
Phrase4198:
different kinases 
jj - nns - 
Phrase4199:
selective inhibitor 
jj - nn - 
Phrase4200:
critical regions 
jj - nns - 
Phrase4201:
general cofactors 
jj - nn - 
Phrase4202:
the b-cell-specific transcription 
dt - jj - nn - 
Phrase4203:
distinct regions 
jj - nns - 
Phrase4204:
subsequent coactivator 
jj - nn - 
Phrase4205:
general coactivator 
jj - nn - 
Phrase4206:
selective removal 
jj - nn - 
Phrase4207:
the essential usa 
dt - jj - nn - 
Phrase4208:
cell-free system 
jj - nn - 
Phrase4209:
full activity 
jj - nn - 
Phrase4210:
the combined action 
dt - jj - nn - 
Phrase4211:
the pc4-depleted 
dt - nn - 
Phrase4212:
optimal function 
jj - nn - 
Phrase4213:
the function 
dt - nn - 
Phrase4214:
intact usa 
jj - nn - 
Phrase4215:
the assay 
dt - nn - 
Phrase4216:
the requirement 
dt - nn - 
Phrase4217:
the unfractionated nuclear extract 
dt - jj - jj - nn - 
Phrase4218:
detrimental effect 
jj - nn - 
Phrase4219:
these results 
dt - nns - 
Phrase4220:
general model 
jj - nn - 
Phrase4221:
the synergistic function 
dt - jj - nn - 
Phrase4222:
the combined action 
dt - jj - nn - 
Phrase4223:
the multiple usa 
dt - jj - nn - 
Phrase4224:
functional redundancy 
jj - nn - 
Phrase4225:
general coactivators 
jj - nns - 
Phrase4226:
the induction 
dt - nn - 
Phrase4227:
major histocompatibility 
jj - nn - 
Phrase4228:
major histocompatibility 
jj - nn - 
Phrase4229:
the transcription 
dt - nn - 
Phrase4230:
the cytoplasm 
dt - nn - 
Phrase4231:
the cell 
dt - nn - 
Phrase4232:
electrophoretic mobility 
jj - nn - 
Phrase4233:
the human 
dt - nn - 
Phrase4234:
the interferon-gamma 
dt - nn - 
Phrase4235:
the c-fos 
dt - nn - 
Phrase4236:
nuclear extracts 
jj - nns - 
Phrase4237:
the function 
dt - nn - 
Phrase4238:
the transactivating 
dt - nn - 
Phrase4239:
dominant-negative acting 
jj - nn - 
Phrase4240:
our 
prp$ - 
Phrase4241:
the involvement 
dt - nn - 
Phrase4242:
the jak/stat 
dt - nn - 
Phrase4243:
il-2-induced growth 
jj - nn - 
Phrase4244:
cd8+ t 
jj - nn - 
Phrase4245:
the binding 
dt - nn - 
Phrase4246:
its 
prp$ - 
Phrase4247:
normal t 
jj - nn - 
Phrase4248:
nuclear expression 
jj - nn - 
Phrase4249:
nuclear factor 
jj - nn - 
Phrase4250:
the il-2 
dt - nn - 
Phrase4251:
the present 
dt - nn - 
Phrase4252:
the role 
dt - nn - 
Phrase4253:
the growth 
dt - nn - 
Phrase4254:
cd8+ t 
jj - nn - 
Phrase4255:
primary leukemia 
jj - nn - 
Phrase4256:
cd8+ t-pll 
jj - nn - 
Phrase4257:
the cells 
dt - nns - 
Phrase4258:
an increase 
dt - nn - 
Phrase4259:
electrophoretic mobility-shift 
jj - nn - 
Phrase4260:
nuclear extracts 
jj - nns - 
Phrase4261:
the leukemia 
dt - nn - 
Phrase4262:
the abundance 
dt - nn - 
Phrase4263:
the nf-kappab 
dt - nn - 
Phrase4264:
these cells 
dt - nns - 
Phrase4265:
the number 
dt - nn - 
Phrase4266:
low affinity 
jj - nn - 
Phrase4267:
the leukemia 
dt - nn - 
Phrase4268:
an effect 
dt - nn - 
Phrase4269:
the number 
dt - nn - 
Phrase4270:
these results 
dt - nns - 
Phrase4271:
the nuclear expression 
dt - jj - nn - 
Phrase4272:
primary cd8+ t-pll 
jj - jj - nn - 
Phrase4273:
this effect 
dt - nn - 
Phrase4274:
least in 
jjs - nn - 
Phrase4275:
primary human 
jj - nn - 
Phrase4276:
cd4+ t 
jj - nn - 
Phrase4277:
diverse group 
jj - nn - 
Phrase4278:
therapeutic chemicals 
jj - nn - 
Phrase4279:
the immune system 
dt - jj - nn - 
Phrase4280:
these apparent inconsistencies 
dt - jj - nn - 
Phrase4281:
the complexity 
dt - nn - 
Phrase4282:
the dtcs 
dt - nns - 
Phrase4283:
biological activities 
jj - nns - 
Phrase4284:
due in 
jj - nn - 
Phrase4285:
specific compound 
jj - nn - 
Phrase4286:
the studies 
dt - nns - 
Phrase4287:
the immunotoxicity 
dt - nn - 
Phrase4288:
this family 
dt - nn - 
Phrase4289:
we 
prp - 
Phrase4290:
tnf-alpha-induced activation 
jj - nn - 
Phrase4291:
primary human 
jj - nn - 
Phrase4292:
cd4+ t 
jj - nn - 
Phrase4293:
other active signaling 
jj - jj - nn - 
Phrase4294:
the exposure 
dt - nn - 
Phrase4295:
the inhibition 
dt - nn - 
Phrase4296:
normal tnf-alpha 
jj - nn - 
Phrase4297:
nuclear extracts 
jj - nns - 
Phrase4298:
this protein 
dt - nn - 
Phrase4299:
we 
prp - 
Phrase4300:
intracellular il-2 
jj - nn - 
Phrase4301:
the alpha 
dt - nn - 
Phrase4302:
the il-2 
dt - nn - 
Phrase4303:
these data 
dt - nns - 
Phrase4304:
immunosuppressive compound 
jj - nn - 
Phrase4305:
il-13-induced regulatory factors 
jj - jj - nn - 
Phrase4306:
the transcriptional control 
dt - jj - nn - 
Phrase4307:
we 
prp - 
Phrase4308:
the human 
dt - nn - 
Phrase4309:
the 15-lo 
dt - nn - 
Phrase4310:
the 5'-end 
dt - nn - 
Phrase4311:
the gene 
dt - nn - 
Phrase4312:
putative sp1 
jj - nn - 
Phrase4313:
major site 
jj - nn - 
Phrase4314:
we 
prp - 
Phrase4315:
an active promoter 
dt - jj - nn - 
Phrase4316:
gel-shift assays 
jj - nn - 
Phrase4317:
transcriptional factor 
jj - nn - 
Phrase4318:
peripheral blood 
jj - nn - 
Phrase4319:
the 15-lo 
dt - nn - 
Phrase4320:
the promoter 
dt - nn - 
Phrase4321:
peripheral monocytes 
jj - nns - 
Phrase4322:
nuclear extracts 
jj - nns - 
Phrase4323:
specific nuclear factor 
jj - jj - nn - 
Phrase4324:
peripheral monocyte 
jj - nn - 
Phrase4325:
nuclear extracts 
jj - nns - 
Phrase4326:
fluorescent in 
jj - nn - 
Phrase4327:
refined previous localization 
dt - jj - nn - 
Phrase4328:
the adoptive transfer 
dt - jj - nn - 
Phrase4329:
the regression 
dt - nn - 
Phrase4330:
immunogenic murine 
jj - nn - 
Phrase4331:
the efficacy 
dt - nn - 
Phrase4332:
ln cells 
dt - nns - 
Phrase4333:
adoptive transfer 
jj - nn - 
Phrase4334:
therapeutic activity 
jj - nn - 
Phrase4335:
the acquisition 
dt - nn - 
Phrase4336:
the protein 
dt - nn - 
Phrase4337:
the nf-kappab 
dt - nn - 
Phrase4338:
the levels 
dt - nns - 
Phrase4339:
lower in 
jjr - nn - 
Phrase4340:
normal ln 
jj - nn - 
Phrase4341:
tyrosine-phosphorylated substrates 
jj - nns - 
Phrase4342:
depressed following 
jj - nn - 
Phrase4343:
5-day anti-cd3/il-2 
jj - nn - 
Phrase4344:
the levels 
dt - nns - 
Phrase4345:
higher in 
jjr - nn - 
Phrase4346:
they 
prp - 
Phrase4347:
the cytoplasmic levels 
dt - jj - nns - 
Phrase4348:
normal in 
jj - nn - 
Phrase4349:
nuclear kappab 
jj - nn - 
Phrase4350:
the nuclear translocation 
dt - jj - nn - 
Phrase4351:
these findings 
dt - nns - 
Phrase4352:
the recovery 
dt - nn - 
Phrase4353:
the t 
dt - nn - 
Phrase4354:
the acquisition 
dt - nn - 
Phrase4355:
immune responses 
jj - nns - 
Phrase4356:
major histocompatibility 
jj - nn - 
Phrase4357:
the amino 
dt - nn - 
Phrase4358:
the class 
dt - nn - 
Phrase4359:
multifunctional domain 
jj - nn - 
Phrase4360:
transcriptional activator 
jj - nn - 
Phrase4361:
critical role 
jj - nn - 
Phrase4362:
the expression 
dt - nn - 
Phrase4363:
we 
prp - 
Phrase4364:
the human 
dt - nn - 
Phrase4365:
the amino 
dt - nn - 
Phrase4366:
dominant-negative suppressor 
jj - nn - 
Phrase4367:
direct t-cell 
jj - nn - 
Phrase4368:
cd4+ t 
jj - nn - 
Phrase4369:
an important role 
dt - jj - nn - 
Phrase4370:
the rejection 
dt - nn - 
Phrase4371:
transgenic pig 
jj - nn - 
Phrase4372:
clinical xenotransplantation 
jj - nn - 
Phrase4373:
we 
prp - 
Phrase4374:
their 
prp$ - 
Phrase4375:
stable transfectants 
jj - nns - 
Phrase4376:
the porcine 
dt - nn - 
Phrase4377:
vascular endothelial 
jj - nn - 
Phrase4378:
the porcine 
dt - nn - 
Phrase4379:
the suppression 
dt - nn - 
Phrase4380:
constitutive sla-dr 
jj - nn - 
Phrase4381:
cd4+ t 
jj - nn - 
Phrase4382:
preliminary studies 
jj - nns - 
Phrase4383:
we 
prp - 
Phrase4384:
the piec 
dt - nn - 
Phrase4385:
strong expression 
jj - nn - 
Phrase4386:
the cross-species 
dt - nn - 
Phrase4387:
the pig 
dt - nn - 
Phrase4388:
the pig 
dt - nn - 
Phrase4389:
these constructs 
dt - nns - 
Phrase4390:
marked suppression 
jj - nn - 
Phrase4391:
the porcine 
dt - nn - 
Phrase4392:
constitutive sla-dr 
jj - nn - 
Phrase4393:
functional studies 
jj - nns - 
Phrase4394:
cd4+ t 
jj - nn - 
Phrase4395:
differentiation-dependent peroxisomal 
jj - nn - 
Phrase4396:
proliferator-activated receptor 
jj - nn - 
Phrase4397:
an important role 
dt - jj - nn - 
Phrase4398:
its 
prp$ - 
Phrase4399:
their 
prp$ - 
Phrase4400:
proliferator-activated receptor 
jj - nn - 
Phrase4401:
the nuclear receptor 
dt - jj - nn - 
Phrase4402:
various activators 
jj - nns - 
Phrase4403:
the antidiabetic 
dt - nn - 
Phrase4404:
the role 
dt - nn - 
Phrase4405:
we 
prp - 
Phrase4406:
atherosclerotic lesions 
jj - nns - 
Phrase4407:
normal artery 
jj - nn - 
Phrase4408:
minimal immunoreactive ppargamma 
jj - jj - nn - 
Phrase4409:
monocyte-derived macrophages 
jj - nns - 
Phrase4410:
monocyte-derived macrophages 
jj - nns - 
Phrase4411:
concentration-dependent fashion 
jj - nn - 
Phrase4412:
atherosclerotic lesions 
jj - nns - 
Phrase4413:
an enzyme 
dt - nn - 
Phrase4414:
an important regulator 
dt - jj - nn - 
Phrase4415:
atherosclerotic disease 
jj - nn - 
Phrase4416:
erythroid precursors 
jj - nns - 
Phrase4417:
we 
prp - 
Phrase4418:
cd34(+) cells 
jj - nns - 
Phrase4419:
we 
prp - 
Phrase4420:
the translocation 
dt - nn - 
Phrase4421:
the nucleus 
dt - nn - 
Phrase4422:
electrophoretic mobility 
jj - nn - 
Phrase4423:
the beta-casein 
dt - nn - 
Phrase4424:
erythroid precursors 
jj - nns - 
Phrase4425:
an sh2/sh3 
dt - nn - 
Phrase4426:
erythroid cells 
jj - nns - 
Phrase4427:
it 
prp - 
Phrase4428:
the studies 
dt - nns - 
Phrase4429:
erythroid precursors 
jj - nns - 
Phrase4430:
sufficient numbers 
jj - nns - 
Phrase4431:
its 
prp$ - 
Phrase4432:
further studies 
jj - nns - 
Phrase4433:
erythroid precursors 
jj - nns - 
Phrase4434:
our 
prp$ - 
Phrase4435:
better understanding 
jjr - nn - 
Phrase4436:
the differentiation 
dt - nn - 
Phrase4437:
their 
prp$ - 
Phrase4438:
oxidative stress 
jj - nn - 
Phrase4439:
oxidative stress 
jj - nn - 
Phrase4440:
quiescent human 
jj - nn - 
Phrase4441:
acute exposure 
jj - nn - 
Phrase4442:
chronic exposure 
jj - nn - 
Phrase4443:
acute exposure 
jj - nn - 
Phrase4444:
the cells 
dt - nns - 
Phrase4445:
the electrophoretic mobility 
dt - jj - nn - 
Phrase4446:
the lymphocytes 
dt - nns - 
Phrase4447:
oxidative stress 
jj - nn - 
Phrase4448:
the lymphocytes 
dt - nns - 
Phrase4449:
the lowest level 
dt - jjs - nn - 
Phrase4450:
oxidative stress 
jj - nn - 
Phrase4451:
the lymphocytes 
dt - nns - 
Phrase4452:
we 
prp - 
Phrase4453:
specific transcription 
jj - nn - 
Phrase4454:
oxidative stress 
jj - nn - 
Phrase4455:
its 
prp$ - 
Phrase4456:
detectable in 
jj - nn - 
Phrase4457:
weak oxidative stress 
jj - jj - nn - 
Phrase4458:
oxidative stress 
jj - nn - 
Phrase4459:
il-4-dependent regulation 
jj - nn - 
Phrase4460:
important roles 
jj - nns - 
Phrase4461:
we 
prp - 
Phrase4462:
different pathologic processes 
jj - jj - nns - 
Phrase4463:
cutaneous wounds 
jj - nn - 
Phrase4464:
this study 
dt - nn - 
Phrase4465:
we 
prp - 
Phrase4466:
the biologic mediators 
dt - jj - nns - 
Phrase4467:
the expression 
dt - nn - 
Phrase4468:
the peripheral blood 
dt - jj - nn - 
Phrase4469:
healthy donors 
jj - nns - 
Phrase4470:
the absence 
dt - nn - 
Phrase4471:
these cultures 
dt - nns - 
Phrase4472:
the ability 
dt - nn - 
Phrase4473:
the observation 
dt - nn - 
Phrase4474:
the expression 
dt - nn - 
Phrase4475:
physiologic molecular 
jj - nn - 
Phrase4476:
the infiltrating eosinophils 
dt - jj - nns - 
Phrase4477:
distinct subsets 
jj - nns - 
Phrase4478:
acute leukemia 
jj - nn - 
Phrase4479:
both rearrangements 
dt - nns - 
Phrase4480:
poor prognosis 
jj - nn - 
Phrase4481:
the translocation 
dt - nn - 
Phrase4482:
acute lymphoblastic leukemia 
jj - jj - nn - 
Phrase4483:
acute myeloid 
jj - nn - 
Phrase4484:
recent study 
jj - nn - 
Phrase4485:
various breakpoints 
jj - nns - 
Phrase4486:
we 
prp - 
Phrase4487:
lymphoid myeloid 
jj - nn - 
Phrase4488:
the fusion 
dt - nn - 
Phrase4489:
the monocytic cell 
dt - jj - nn - 
Phrase4490:
the role 
dt - nn - 
Phrase4491:
these genes 
dt - nns - 
Phrase4492:
acute leukemias 
jj - nn - 
Phrase4493:
well-characterized morphology 
jj - nn - 
Phrase4494:
clinical course 
jj - nn - 
Phrase4495:
flanking calm 
jj - nn - 
Phrase4496:
the mll 
dt - nn - 
Phrase4497:
the af10 
dt - nn - 
Phrase4498:
least one 
jjs - nn - 
Phrase4499:
these genes 
dt - nns - 
Phrase4500:
balanced t(10;11) 
jj - nn - 
Phrase4501:
immature morphology 
jj - nn - 
Phrase4502:
the signals 
dt - nns - 
Phrase4503:
the calm 
dt - nn - 
Phrase4504:
the calm 
dt - nn - 
Phrase4505:
myelomonocytic differentiation 
jj - nn - 
Phrase4506:
secondary aml 
jj - nn - 
Phrase4507:
detectable calm 
jj - nn - 
Phrase4508:
poor prognosis 
jj - nn - 
Phrase4509:
the amlcg86/92 
dt - nn - 
Phrase4510:
the overall study 
dt - jj - nn - 
Phrase4511:
we 
prp - 
Phrase4512:
the t(10;11)(p13;q14) 
dt - nn - 
Phrase4513:
distinct subsets 
jj - nns - 
Phrase4514:
acute leukemia 
jj - nn - 
Phrase4515:
poor prognosis 
jj - nn - 
Phrase4516:
the role 
dt - nn - 
Phrase4517:
hematopoietic stem 
jj - nn - 
Phrase4518:
the activity 
dt - nn - 
Phrase4519:
transcriptional regulatory proteins 
jj - jj - nns - 
Phrase4520:
helix-loop-helix proteins 
jj - nns - 
Phrase4521:
the regulation 
dt - nn - 
Phrase4522:
recent analysis 
jj - nn - 
Phrase4523:
direct assessment 
jj - nn - 
Phrase4524:
the functional roles 
dt - jj - nns - 
Phrase4525:
several e-protein 
jj - nn - 
Phrase4526:
this review 
dt - nn - 
Phrase4527:
we 
prp - 
Phrase4528:
the defects 
dt - nns - 
Phrase4529:
the e-protein 
dt - nn - 
Phrase4530:
our 
prp$ - 
Phrase4531:
current understanding 
jj - nn - 
Phrase4532:
the role 
dt - nn - 
Phrase4533:
these proteins 
dt - nns - 
Phrase4534:
lymphoid development 
jj - nn - 
Phrase4535:
epstein-barr virus-transforming 
jj - nn - 
Phrase4536:
latent infection 
jj - nn - 
Phrase4537:
the nf-kappab-inducing kinase 
dt - jj - nn - 
Phrase4538:
the ikappab 
dt - nn - 
Phrase4539:
the epstein-barr virus 
dt - jj - nn - 
Phrase4540:
latent infection 
jj - nn - 
Phrase4541:
aggregated pseudo-tumor 
jj - nn - 
Phrase4542:
its 
prp$ - 
Phrase4543:
c-terminal cytoplasmic domain 
jj - jj - nn - 
Phrase4544:
tnfr-associated factors 
jj - nn - 
Phrase4545:
the second 
dt - nn - 
Phrase4546:
the tnfri 
dt - nn - 
Phrase4547:
the nf-kappab-inducing kinase 
dt - jj - nn - 
Phrase4548:
the ikappab 
dt - nn - 
Phrase4549:
its 
prp$ - 
Phrase4550:
this report 
dt - nn - 
Phrase4551:
we 
prp - 
Phrase4552:
its 
prp$ - 
Phrase4553:
dominant negative mutants 
jj - jj - nns - 
Phrase4554:
its 
prp$ - 
Phrase4555:
the myd88 
dt - nn - 
Phrase4556:
primary response 
jj - nn - 
Phrase4557:
an adaptor 
dt - nn - 
Phrase4558:
both il-1 
dt - nn - 
Phrase4559:
receptor-associated kinase 
jj - nn - 
Phrase4560:
acute phase 
jj - nn - 
Phrase4561:
natural killer 
jj - nn - 
Phrase4562:
n-terminal kinase 
jj - nn - 
Phrase4563:
these results 
dt - nns - 
Phrase4564:
critical component 
jj - nn - 
Phrase4565:
the signaling 
dt - nn - 
Phrase4566:
an immunomodulatory stress 
dt - jj - nn - 
Phrase4567:
adverse environmental conditions 
jj - jj - nns - 
Phrase4568:
the induction 
dt - nn - 
Phrase4569:
specific genes 
jj - nns - 
Phrase4570:
the present 
dt - nn - 
Phrase4571:
the effect 
dt - nn - 
Phrase4572:
primary human 
jj - nn - 
Phrase4573:
peripheral blood 
jj - nn - 
Phrase4574:
transcriptional activity 
jj - nn - 
Phrase4575:
electrophoretic mobility 
jj - nn - 
Phrase4576:
the concentration 
dt - nn - 
Phrase4577:
peripheral blood 
jj - nn - 
Phrase4578:
that in 
dt - nn - 
Phrase4579:
untreated controls 
jj - nns - 
Phrase4580:
the il-2 
dt - nn - 
Phrase4581:
the transcription 
dt - nn - 
Phrase4582:
drug-free controls 
jj - nns - 
Phrase4583:
the levels 
dt - nns - 
Phrase4584:
immediate-early transcripts 
jj - nns - 
Phrase4585:
primary lymphocytes 
jj - nns - 
Phrase4586:
mammalian stress 
jj - nn - 
Phrase4587:
novel retinoic acid 
jj - jj - nn - 
Phrase4588:
leukemic cells 
jj - nns - 
Phrase4589:
retinoic acid 
jj - nn - 
Phrase4590:
mature granulocytes 
jj - nns - 
Phrase4591:
the biological effects 
dt - jj - nns - 
Phrase4592:
distinct families 
jj - nns - 
Phrase4593:
retinoic acid 
jj - nn - 
Phrase4594:
we 
prp - 
Phrase4595:
novel rar-selective 
jj - nn - 
Phrase4596:
this rar-selective 
dt - nn - 
Phrase4597:
we 
prp - 
Phrase4598:
the rar-mediated 
dt - nn - 
Phrase4599:
leukemic cells 
jj - nns - 
Phrase4600:
simple activation 
jj - nn - 
Phrase4601:
the cells 
dt - nns - 
Phrase4602:
the combination 
dt - nn - 
Phrase4603:
the rar-selective 
dt - nn - 
Phrase4604:
9-cis ra 
jj - nn - 
Phrase4605:
partial differentiation 
jj - nn - 
Phrase4606:
the rar 
dt - nn - 
Phrase4607:
all-trans ra-induced differentiation 
jj - jj - nn - 
Phrase4608:
the cells 
dt - nns - 
Phrase4609:
additional experiments 
jj - nns - 
Phrase4610:
leukemic cells 
jj - nns - 
Phrase4611:
the same differentiation 
dt - jj - nn - 
Phrase4612:
parental hl-60 
jj - nn - 
Phrase4613:
these bcl-2-transduced 
dt - nn - 
Phrase4614:
leukemic cells 
jj - nns - 
Phrase4615:
erythroid differentiation 
jj - nn - 
Phrase4616:
its 
prp$ - 
Phrase4617:
specific receptor 
jj - nn - 
Phrase4618:
we 
prp - 
Phrase4619:
novel subline 
jj - nn - 
Phrase4620:
the human 
dt - nn - 
Phrase4621:
small population 
jj - nn - 
Phrase4622:
7-day exposure 
jj - nn - 
Phrase4623:
we 
prp - 
Phrase4624:
the tpo 
dt - nn - 
Phrase4625:
the erythropoietin 
dt - nn - 
Phrase4626:
these findings 
dt - nns - 
Phrase4627:
direct effect 
jj - nn - 
Phrase4628:
specific receptor 
jj - nn - 
Phrase4629:
our 
prp$ - 
Phrase4630:
distinct action 
jj - nn - 
Phrase4631:
megakaryocytic cells 
jj - nns - 
Phrase4632:
the contributions 
dt - nns - 
Phrase4633:
definitive hematopoiesis 
jj - nn - 
Phrase4634:
we 
prp - 
Phrase4635:
defective in 
jj - nn - 
Phrase4636:
biol 
nnp - 
Phrase4637:
chem 
nnp - 
Phrase4638:
the gata-1 
dt - nn - 
Phrase4639:
the x 
dt - nn - 
Phrase4640:
every cell 
dt - nn - 
Phrase4641:
variable anemic severity 
jj - jj - nn - 
Phrase4642:
these heterozygous 
dt - nn - 
Phrase4643:
they 
prp - 
Phrase4644:
marked splenomegaly 
jj - nn - 
Phrase4645:
the spleens 
dt - nns - 
Phrase4646:
the heterozygotes 
dt - nns - 
Phrase4647:
we 
prp - 
Phrase4648:
the neomycin 
dt - nn - 
Phrase4649:
the positive selection 
dt - jj - nn - 
Phrase4650:
abundant cells 
jj - nns - 
Phrase4651:
the gata-1.05 
dt - nn - 
Phrase4652:
we 
prp - 
Phrase4653:
the bone 
dt - nn - 
Phrase4654:
these data 
dt - nns - 
Phrase4655:
small number 
jj - nn - 
Phrase4656:
hematopoietic progenitor 
jj - nn - 
Phrase4657:
early adulthood 
jj - nn - 
Phrase4658:
the cells 
dt - nns - 
Phrase4659:
the spleen 
dt - nn - 
Phrase4660:
important in 
jj - nn - 
Phrase4661:
definitive hematopoietic progenitors 
jj - jj - nns - 
Phrase4662:
megakaryocytic pathways 
jj - nns - 
Phrase4663:
the gata-1 
dt - nn - 
Phrase4664:
myelodysplastic syndrome 
jj - nn - 
Phrase4665:
useful model 
jj - nn - 
Phrase4666:
this disorder 
dt - nn - 
Phrase4667:
differential regulation 
jj - nn - 
Phrase4668:
the janus 
dt - nn - 
Phrase4669:
biologic function 
jj - nn - 
Phrase4670:
primary human 
jj - nn - 
Phrase4671:
comparative study 
jj - nn - 
Phrase4672:
biologic effects 
jj - nns - 
Phrase4673:
primary human 
jj - nn - 
Phrase4674:
we 
prp - 
Phrase4675:
primary nk 
jj - nn - 
Phrase4676:
low levels 
jj - nns - 
Phrase4677:
it 
prp - 
Phrase4678:
the effect 
dt - nn - 
Phrase4679:
il-2-induced ifn-gamma 
jj - nn - 
Phrase4680:
marked contrast 
jj - nn - 
Phrase4681:
the strong inhibition 
dt - jj - nn - 
Phrase4682:
il-2-induced nk 
jj - nn - 
Phrase4683:
cytolytic potential 
jj - nn - 
Phrase4684:
we 
prp - 
Phrase4685:
distinct stat6-dna 
jj - nn - 
Phrase4686:
we 
prp - 
Phrase4687:
unique domains 
jj - nns - 
Phrase4688:
differential effects 
jj - nns - 
Phrase4689:
different stat6 
jj - nn - 
Phrase4690:
these findings 
dt - nns - 
Phrase4691:
the ability 
dt - nn - 
Phrase4692:
these cell 
dt - nn - 
Phrase4693:
the human 
dt - nn - 
Phrase4694:
nuclear factor 
jj - nn - 
Phrase4695:
receptor-associated factor 
jj - nn - 
Phrase4696:
the human 
dt - nn - 
Phrase4697:
the interleukin 
dt - nn - 
Phrase4698:
the activation 
dt - nn - 
Phrase4699:
adaptive immunity 
jj - nn - 
Phrase4700:
sequential recruitment 
jj - nn - 
Phrase4701:
the adapter 
dt - nn - 
Phrase4702:
the il-1r-associated kinase 
dt - jj - nn - 
Phrase4703:
the nuclear factor 
dt - jj - nn - 
Phrase4704:
subsequent steps 
jj - nns - 
Phrase4705:
dominant negative version 
jj - jj - nn - 
Phrase4706:
stress-activated protein 
jj - nn - 
Phrase4707:
nh2-terminal kinases 
jj - nns - 
Phrase4708:
an early divergence 
dt - jj - nn - 
Phrase4709:
nuclear factor 
jj - nn - 
Phrase4710:
lymphoid cells 
jj - nns - 
Phrase4711:
death-inducing ligands 
jj - nns - 
Phrase4712:
the cytotoxic drug 
dt - jj - nn - 
Phrase4713:
nuclear factor 
jj - nn - 
Phrase4714:
-dependent program 
jj - nn - 
Phrase4715:
we 
prp - 
Phrase4716:
lymphoid cell 
jj - nn - 
Phrase4717:
the influence 
dt - nn - 
Phrase4718:
the proteasome 
dt - nn - 
Phrase4719:
these treatments 
dt - nns - 
Phrase4720:
sensitive cell 
jj - nn - 
Phrase4721:
primary leukemia 
jj - nn - 
Phrase4722:
these data 
dt - nns - 
Phrase4723:
an important role 
dt - jj - nn - 
Phrase4724:
the start 
dt - nn - 
Phrase4725:
the transcription 
dt - nn - 
Phrase4726:
the mouse 
dt - nn - 
Phrase4727:
differential dependency 
jj - nn - 
Phrase4728:
this transcription 
dt - nn - 
Phrase4729:
the fetal liver 
dt - jj - nn - 
Phrase4730:
an early pro-b 
dt - jj - nn - 
Phrase4731:
the characterization 
dt - nn - 
Phrase4732:
an important role 
dt - jj - nn - 
Phrase4733:
the regulation 
dt - nn - 
Phrase4734:
the cd19 
dt - nn - 
Phrase4735:
the developmental pathway 
dt - jj - nn - 
Phrase4736:
the immunoglobulin 
dt - nn - 
Phrase4737:
the human 
dt - nn - 
Phrase4738:
the igh 
dt - nn - 
Phrase4739:
the chromosomal 
dt - nn - 
Phrase4740:
small subset 
jj - nn - 
Phrase4741:
non-hodgkin lymphomas 
jj - nns - 
Phrase4742:
the insertion 
dt - nn - 
Phrase4743:
regulatory elements 
jj - nns - 
Phrase4744:
its 
prp$ - 
Phrase4745:
the shut-down 
dt - nn - 
Phrase4746:
the completion 
dt - nn - 
Phrase4747:
erythroid kruppel-like factor 
jj - jj - nn - 
Phrase4748:
erythroid kruppel-like factor 
jj - jj - nn - 
Phrase4749:
red cell-specific transcriptional activator 
jj - jj - jj - nn - 
Phrase4750:
the switch 
dt - nn - 
Phrase4751:
high levels 
jj - nns - 
Phrase4752:
erythroid ontogeny 
jj - nn - 
Phrase4753:
the chromatin 
dt - nn - 
Phrase4754:
the beta-like globin 
dt - jj - nn - 
Phrase4755:
it 
prp - 
Phrase4756:
positive-acting factor 
jj - nn - 
Phrase4757:
we 
prp - 
Phrase4758:
it 
prp - 
Phrase4759:
its 
prp$ - 
Phrase4760:
these histone 
dt - nn - 
Phrase4761:
its 
prp$ - 
Phrase4762:
the functional effects 
dt - jj - nns - 
Phrase4763:
these interactions 
dt - nns - 
Phrase4764:
transcriptional activation 
jj - nn - 
Phrase4765:
the beta-globin 
dt - nn - 
Phrase4766:
erythroid cells 
jj - nns - 
Phrase4767:
these results 
dt - nns - 
Phrase4768:
tissue-specific transcription 
jj - nn - 
Phrase4769:
post-translational acetylation 
jj - nn - 
Phrase4770:
the beta-like globin 
dt - jj - nn - 
Phrase4771:
genital herpes 
jj - nn - 
Phrase4772:
the local cellular immune response 
dt - jj - jj - jj - nn - 
Phrase4773:
important in 
jj - nn - 
Phrase4774:
the control 
dt - nn - 
Phrase4775:
recurrent hsv 
jj - nn - 
Phrase4776:
the antiviral functions 
dt - jj - nns - 
Phrase4777:
viral growth 
jj - nn - 
Phrase4778:
the antigens 
dt - nns - 
Phrase4779:
many hsv-specific cd4 
jj - jj - nn - 
Phrase4780:
genital hsv-2 
jj - nn - 
Phrase4781:
this region 
dt - nn - 
Phrase4782:
the viral dutpase 
dt - jj - nn - 
Phrase4783:
separate epitopes 
jj - nns - 
Phrase4784:
the tegument 
dt - nn - 
Phrase4785:
an additional patient 
dt - jj - nn - 
Phrase4786:
some tegument-specific 
dt - nn - 
Phrase4787:
cytotoxic activity 
jj - nn - 
Phrase4788:
these results 
dt - nns - 
Phrase4789:
possible candidate 
jj - nn - 
Phrase4790:
extracellular matrices 
jj - nns - 
Phrase4791:
the mechanisms 
dt - nns - 
Phrase4792:
provisional matrix 
dt - nn - 
Phrase4793:
inflammatory foci 
jj - nns - 
Phrase4794:
this study 
dt - nn - 
Phrase4795:
nonadherent culture 
jj - nn - 
Phrase4796:
lesser extent 
jjr - nn - 
Phrase4797:
electrophoretic mobility 
jj - nn - 
Phrase4798:
minimal in 
jj - nn - 
Phrase4799:
unstimulated cells 
jj - nns - 
Phrase4800:
the effects 
dt - nns - 
Phrase4801:
transcriptional regulation 
jj - nn - 
Phrase4802:
the hiv-1 
dt - nn - 
Phrase4803:
the cat 
dt - nn - 
Phrase4804:
we 
prp - 
Phrase4805:
selective activation 
jj - nn - 
Phrase4806:
transcriptional regulatory factors 
jj - jj - nn - 
Phrase4807:
peripheral blood 
jj - nn - 
Phrase4808:
normal cells 
jj - nns - 
Phrase4809:
immune cells 
jj - nns - 
Phrase4810:
systemic lupus 
jj - nn - 
Phrase4811:
healthy donors 
jj - nns - 
Phrase4812:
peripheral blood 
jj - nn - 
Phrase4813:
healthy donors 
jj - nns - 
Phrase4814:
some monocytes 
dt - nns - 
Phrase4815:
epstein-barr virus-transformed b 
jj - jj - nn - 
Phrase4816:
healthy individual 
jj - nn - 
Phrase4817:
these cells 
dt - nns - 
Phrase4818:
prior in 
jj - nn - 
Phrase4819:
partial sequences 
jj - nns - 
Phrase4820:
the human 
dt - nn - 
Phrase4821:
notable differences 
jj - nns - 
Phrase4822:
the er 
dt - nn - 
Phrase4823:
healthy controls 
jj - nns - 
Phrase4824:
the hormone 
dt - nn - 
Phrase4825:
the majority 
dt - nn - 
Phrase4826:
the cells 
dt - nns - 
Phrase4827:
precise deletion 
jj - nn - 
Phrase4828:
the exons 
dt - nns - 
Phrase4829:
they 
prp - 
Phrase4830:
functional receptor 
jj - nn - 
Phrase4831:
the presence 
dt - nn - 
Phrase4832:
the normal wild type 
dt - jj - jj - nn - 
Phrase4833:
the hormone 
dt - nn - 
Phrase4834:
subsequent apoptosis 
jj - nn - 
Phrase4835:
the activation 
dt - nn - 
Phrase4836:
other stresses 
jj - nns - 
Phrase4837:
its 
prp$ - 
Phrase4838:
we 
prp - 
Phrase4839:
both fasl 
dt - nn - 
Phrase4840:
these stimuli 
dt - nns - 
Phrase4841:
the stress-activated kinase 
dt - jj - nn - 
Phrase4842:
the maximal induction 
dt - jj - nn - 
Phrase4843:
the relevant nf-kappa 
dt - jj - nn - 
Phrase4844:
these responses 
dt - nns - 
Phrase4845:
stress-induced apoptosis 
jj - nn - 
Phrase4846:
the expression 
dt - nn - 
Phrase4847:
granulocyte-colony-stimulating factor 
jj - nn - 
Phrase4848:
small molecule 
jj - nn - 
Phrase4849:
granulocyte-colony-stimulating factor 
jj - nn - 
Phrase4850:
multiple signaling 
jj - nn - 
Phrase4851:
primary murine 
jj - nn - 
Phrase4852:
granulocytic colonies 
jj - nns - 
Phrase4853:
it 
prp - 
Phrase4854:
peripheral blood 
jj - nn - 
Phrase4855:
the extracellular domain 
dt - jj - nn - 
Phrase4856:
the murine 
dt - nn - 
Phrase4857:
the activity 
dt - nn - 
Phrase4858:
the compound 
dt - nn - 
Phrase4859:
the results 
dt - nns - 
Phrase4860:
small molecule 
jj - nn - 
Phrase4861:
large protein 
jj - nn - 
Phrase4862:
minimal residual disease 
jj - jj - nn - 
Phrase4863:
acute myelogenous leukemia 
jj - jj - nn - 
Phrase4864:
phenotypic analysis 
jj - nn - 
Phrase4865:
possible t 
jj - nn - 
Phrase4866:
natural killer 
jj - nn - 
Phrase4867:
we 
prp - 
Phrase4868:
minimal residual disease 
jj - jj - nn - 
Phrase4869:
acute myeloid 
jj - nn - 
Phrase4870:
the phenotypic analysis 
dt - jj - nn - 
Phrase4871:
the reverse 
dt - nn - 
Phrase4872:
the aml1/eto 
dt - nn - 
Phrase4873:
the peripheral blood 
dt - jj - nn - 
Phrase4874:
cytometric analysis 
jj - nn - 
Phrase4875:
the total 
dt - nn - 
Phrase4876:
possible t-cell 
jj - nn - 
Phrase4877:
natural killer 
jj - nn - 
Phrase4878:
the bm 
dt - nns - 
Phrase4879:
the cd8+ cd28+ population 
dt - jj - jj - nn - 
Phrase4880:
the same tendency 
dt - jj - nn - 
Phrase4881:
the t/nk 
dt - nn - 
Phrase4882:
the bm 
dt - nns - 
Phrase4883:
similar numbers 
jj - nns - 
Phrase4884:
normal volunteers 
jj - nns - 
Phrase4885:
the total 
dt - nn - 
Phrase4886:
cd56+ cell 
jj - nn - 
Phrase4887:
the bm 
dt - nns - 
Phrase4888:
the following 
dt - nn - 
Phrase4889:
normal volunteers 
jj - nns - 
Phrase4890:
the percentages 
dt - nn - 
Phrase4891:
the t/nk-cell subsets 
dt - jj - nns - 
Phrase4892:
the pb 
dt - nn - 
Phrase4893:
these groups 
dt - nns - 
Phrase4894:
the difference 
dt - nn - 
Phrase4895:
the possible t/nk-cell phenotype 
dt - jj - jj - nn - 
Phrase4896:
the bm 
dt - nns - 
Phrase4897:
these results 
dt - nns - 
Phrase4898:
further studies 
jj - nns - 
Phrase4899:
the functional anti-tumor immunity 
dt - jj - jj - nn - 
Phrase4900:
nf-kappab-dependent activation 
jj - nn - 
Phrase4901:
long terminal 
jj - nn - 
Phrase4902:
an epidemic 
dt - nn - 
Phrase4903:
the large number 
dt - jj - nn - 
Phrase4904:
the major goal 
dt - jj - nn - 
Phrase4905:
this study 
dt - nn - 
Phrase4906:
the mycobacterial cell 
dt - jj - nn - 
Phrase4907:
the use 
dt - nn - 
Phrase4908:
an in 
dt - nn - 
Phrase4909:
these experiments 
dt - nns - 
Phrase4910:
prime importance 
jj - nn - 
Phrase4911:
the major virus 
dt - jj - nn - 
Phrase4912:
the peripheral blood 
dt - jj - nn - 
Phrase4913:
infected individuals 
jj - nns - 
Phrase4914:
the 1g5 
dt - nn - 
Phrase4915:
the luciferase 
dt - nn - 
Phrase4916:
the control 
dt - nn - 
Phrase4917:
the hiv-1 
dt - nn - 
Phrase4918:
it 
prp - 
Phrase4919:
the implication 
dt - nn - 
Phrase4920:
the abrogation 
dt - nn - 
Phrase4921:
the manlam-mediated 
dt - nn - 
Phrase4922:
ltr-driven gene 
jj - nn - 
Phrase4923:
it 
prp - 
Phrase4924:
the nuclear translocation 
dt - jj - nn - 
Phrase4925:
the transcription 
dt - nn - 
Phrase4926:
clear induction 
jj - nn - 
Phrase4927:
the luciferase 
dt - nn - 
Phrase4928:
the control 
dt - nn - 
Phrase4929:
the kappab-mutated 
dt - nn - 
Phrase4930:
the manlam-mediated 
dt - nn - 
Phrase4931:
the autocrine 
dt - nn - 
Phrase4932:
endogenous tnf-alpha 
jj - nn - 
Phrase4933:
the results 
dt - nns - 
Phrase4934:
the potential 
dt - nn - 
Phrase4935:
the pathogenesis 
dt - nn - 
Phrase4936:
long terminal 
jj - nn - 
Phrase4937:
basal transcription 
jj - nn - 
Phrase4938:
nuclear factor 
jj - nn - 
Phrase4939:
glial cells 
jj - nns - 
Phrase4940:
the generation 
dt - nn - 
Phrase4941:
genomic diversity 
jj - nn - 
Phrase4942:
the course 
dt - nn - 
Phrase4943:
the potential 
dt - nn - 
Phrase4944:
the proviral genome 
dt - jj - nn - 
Phrase4945:
better understanding 
jjr - nn - 
Phrase4946:
the impact 
dt - nn - 
Phrase4947:
long terminal 
jj - nn - 
Phrase4948:
ltr-directed gene 
jj - nn - 
Phrase4949:
the central nervous system 
dt - jj - jj - nn - 
Phrase4950:
immune system 
jj - nn - 
Phrase4951:
we 
prp - 
Phrase4952:
proviral dna 
jj - nn - 
Phrase4953:
hiv-1-infected peripheral blood 
jj - jj - nn - 
Phrase4954:
pediatric patients 
jj - nns - 
Phrase4955:
an average 
dt - nn - 
Phrase4956:
the sequence 
dt - nn - 
Phrase4957:
the lai 
dt - nn - 
Phrase4958:
the 455-bp 
dt - nn - 
Phrase4959:
lymphocytic origin 
jj - nn - 
Phrase4960:
these ltrs 
dt - nns - 
Phrase4961:
the lai 
dt - nn - 
Phrase4962:
an astrocytoma 
dt - nn - 
Phrase4963:
positive lymphocyte 
jj - nn - 
Phrase4964:
the highest activities 
dt - jjs - nns - 
Phrase4965:
high activities 
jj - nns - 
Phrase4966:
the ltrs 
dt - nns - 
Phrase4967:
active in 
jj - nn - 
Phrase4968:
the lai 
dt - nn - 
Phrase4969:
cis-acting sites 
jj - nns - 
Phrase4970:
the u3 
dt - nn - 
Phrase4971:
the ltr 
dt - nn - 
Phrase4972:
electrophoretic mobility 
jj - nn - 
Phrase4973:
an activating 
dt - nn - 
Phrase4974:
the lef-1 
dt - nn - 
Phrase4975:
distal nf-kappab 
jj - nn - 
Phrase4976:
we 
prp - 
Phrase4977:
previous studies 
jj - nns - 
Phrase4978:
the hiv-1 
dt - nn - 
Phrase4979:
these findings 
dt - nns - 
Phrase4980:
basal ltr 
jj - nn - 
Phrase4981:
the course 
dt - nn - 
Phrase4982:
viral replication 
jj - nn - 
Phrase4983:
immune system 
jj - nn - 
Phrase4984:
the identification 
dt - nn - 
Phrase4985:
the mammalian sex-determining gene 
dt - jj - jj - nn - 
Phrase4986:
the discovery 
dt - nn - 
Phrase4987:
large family 
jj - nn - 
Phrase4988:
developmental events 
jj - nns - 
Phrase4989:
several hmg 
jj - nn - 
Phrase4990:
early b-cell 
jj - nn - 
Phrase4991:
crucial role 
jj - nn - 
Phrase4992:
early thymocyte 
jj - nn - 
Phrase4993:
downstream component 
jj - nn - 
Phrase4994:
the wingless/wnt 
dt - nn - 
Phrase4995:
this pathway 
dt - nn - 
Phrase4996:
it 
prp - 
Phrase4997:
the definition 
dt - nn - 
Phrase4998:
the body 
dt - nn - 
Phrase4999:
the pathway 
dt - nn - 
Phrase5000:
several human 
jj - nn - 
Phrase5001:
these insights 
dt - nns - 
Phrase5002:
the molecular 
dt - nn - 
Phrase5003:
these organisms 
dt - nns - 
Phrase5004:
the understanding 
dt - nn - 
Phrase5005:
the function 
dt - nn - 
Phrase5006:
these hmg 
dt - nn - 
Phrase5007:
lymphoid development 
jj - nn - 
Phrase5008:
single strand 
jj - nn - 
Phrase5009:
genetic counseling 
jj - nn - 
Phrase5010:
recent studies 
jj - nns - 
Phrase5011:
the androgen 
dt - nn - 
Phrase5012:
heterogeneous group 
jj - nn - 
Phrase5013:
related disorders 
jj - nns - 
Phrase5014:
defective sexual differentiation 
jj - jj - nn - 
Phrase5015:
karyotypic males 
jj - nns - 
Phrase5016:
this report 
dt - nn - 
Phrase5017:
we 
prp - 
Phrase5018:
the possibility 
dt - nn - 
Phrase5019:
rapid mutational analysis 
jj - jj - nn - 
Phrase5020:
the androgen 
dt - nn - 
Phrase5021:
initial diagnosis 
jj - nn - 
Phrase5022:
genetic counseling 
jj - nn - 
Phrase5023:
their 
prp$ - 
Phrase5024:
peripheral blood 
jj - nn - 
Phrase5025:
various degrees 
jj - nns - 
Phrase5026:
the androgen 
dt - nn - 
Phrase5027:
single strand 
jj - nn - 
Phrase5028:
direct dna 
jj - nn - 
Phrase5029:
heterozygote carriers 
dt - nns - 
Phrase5030:
the ar 
dt - nn - 
Phrase5031:
incomplete androgen 
jj - nn - 
Phrase5032:
the mutation 
dt - nn - 
Phrase5033:
young sister 
jj - nn - 
Phrase5034:
the mutation 
dt - nn - 
Phrase5035:
our 
prp$ - 
Phrase5036:
the androgen 
dt - nn - 
Phrase5037:
sporadic androgen 
jj - nn - 
Phrase5038:
genetic characterization 
jj - nn - 
Phrase5039:
the variant 
dt - nn - 
Phrase5040:
primary tool 
jj - nn - 
Phrase5041:
subsequent therapy 
jj - nn - 
Phrase5042:
familial androgen 
jj - nn - 
Phrase5043:
the identification 
dt - nn - 
Phrase5044:
substantial clinical importance 
jj - jj - nn - 
Phrase5045:
genetic counseling 
jj - nn - 
Phrase5046:
prognostic marker 
jj - nn - 
Phrase5047:
the proliferative 
dt - nn - 
Phrase5048:
different approaches 
jj - nns - 
Phrase5049:
the use 
dt - nn - 
Phrase5050:
the monoclonal antibody 
dt - jj - nn - 
Phrase5051:
an easy 
dt - nn - 
Phrase5052:
reliable means 
jj - nn - 
Phrase5053:
this study 
dt - nn - 
Phrase5054:
the proliferative 
dt - nn - 
Phrase5055:
primary breast 
jj - nn - 
Phrase5056:
the results 
dt - nns - 
Phrase5057:
an immunohistochemical procedure 
dt - jj - nn - 
Phrase5058:
the median 
dt - nn - 
Phrase5059:
the probability 
dt - nn - 
Phrase5060:
disease-free survival 
jj - nn - 
Phrase5061:
high ki-67 
jj - nn - 
Phrase5062:
= 0.00005 
jj - nn - 
Phrase5063:
low ki-67 
jj - nn - 
Phrase5064:
this proliferative 
dt - nn - 
Phrase5065:
its 
prp$ - 
Phrase5066:
prognostic significance 
jj - nn - 
Phrase5067:
the patients 
dt - nns - 
Phrase5068:
menopausal status 
jj - nn - 
Phrase5069:
nuclear estrogen 
jj - nn - 
Phrase5070:
the monoclonal antibody 
dt - jj - nn - 
Phrase5071:
an effective indicator 
dt - jj - nn - 
Phrase5072:
the ets-related transcription 
dt - jj - nn - 
Phrase5073:
the retinoblastoma 
dt - nn - 
Phrase5074:
the retinoblastoma 
dt - nn - 
Phrase5075:
nuclear phosphoprotein 
jj - nn - 
Phrase5076:
lymphoid-specific ets 
jj - nn - 
Phrase5077:
inducible gene 
jj - nn - 
Phrase5078:
this report 
dt - nn - 
Phrase5079:
it 
prp - 
Phrase5080:
the rb 
dt - nn - 
Phrase5081:
several viral oncoproteins 
jj - jj - nns - 
Phrase5082:
the pocket 
dt - nn - 
Phrase5083:
the underphosphorylated form 
dt - jj - nn - 
Phrase5084:
an association 
dt - nn - 
Phrase5085:
normal human 
jj - nn - 
Phrase5086:
the phosphorylation 
dt - nn - 
Phrase5087:
the release 
dt - nn - 
Phrase5088:
the activation 
dt - nn - 
Phrase5089:
these results 
dt - nns - 
Phrase5090:
lineage-restricted ets 
jj - nn - 
Phrase5091:
the coordination 
dt - nn - 
Phrase5092:
lineage-specific effector 
jj - nn - 
Phrase5093:
natural killer 
jj - nn - 
Phrase5094:
the hgata-3 
dt - nn - 
Phrase5095:
an unrearranged 2.3-kb tcr 
dt - jj - jj - nn - 
Phrase5096:
this study 
dt - nn - 
Phrase5097:
we 
prp - 
Phrase5098:
the t 
dt - nn - 
Phrase5099:
we 
prp - 
Phrase5100:
these cells 
dt - nns - 
Phrase5101:
the hgata-3 
dt - nn - 
Phrase5102:
the recombination-activating 
dt - nn - 
Phrase5103:
multiple tcr 
jj - nn - 
Phrase5104:
an unrearranged tcr 
dt - jj - nn - 
Phrase5105:
clonal cd3-cd16+ 
jj - nn - 
Phrase5106:
natural killer 
jj - nn - 
Phrase5107:
unrearranged tcr 
jj - nn - 
Phrase5108:
the functional tcr 
dt - jj - nn - 
Phrase5109:
different 2.3-kb cdna 
jj - jj - nn - 
Phrase5110:
they 
prp - 
Phrase5111:
an unrearranged tcr 
dt - jj - nn - 
Phrase5112:
these cdna 
dt - nn - 
Phrase5113:
their 
prp$ - 
Phrase5114:
the j 
dt - nn - 
Phrase5115:
the sequence 
dt - nn - 
Phrase5116:
the j 
dt - nn - 
Phrase5117:
the j 
dt - nn - 
Phrase5118:
the fourth 
dt - nn - 
Phrase5119:
located at 
jj - nn - 
Phrase5120:
the 3' end 
dt - jj - nn - 
Phrase5121:
the 2.3-kb cdna 
dt - jj - nn - 
Phrase5122:
the expression 
dt - nn - 
Phrase5123:
cell-specific factor 
jj - nn - 
Phrase5124:
the regulation 
dt - nn - 
Phrase5125:
the transcription 
dt - nn - 
Phrase5126:
the regulation 
dt - nn - 
Phrase5127:
the unrearranged tcr 
dt - jj - nn - 
Phrase5128:
the rag-1 
dt - nn - 
Phrase5129:
negative transcriptional regulation 
jj - jj - nn - 
Phrase5130:
nuclear transcription 
jj - nn - 
Phrase5131:
several nuclear proteins 
jj - jj - nns - 
Phrase5132:
we 
prp - 
Phrase5133:
the activity 
dt - nn - 
Phrase5134:
nuclear proteins 
jj - nns - 
Phrase5135:
the il-2 
dt - nn - 
Phrase5136:
nuclear extracts 
jj - nns - 
Phrase5137:
primary human 
jj - nn - 
Phrase5138:
electrophoretic dna 
jj - nn - 
Phrase5139:
the binding 
dt - nn - 
Phrase5140:
their 
prp$ - 
Phrase5141:
corresponding sites 
jj - nns - 
Phrase5142:
the il-2 
dt - nn - 
Phrase5143:
nuclear factor 
jj - nn - 
Phrase5144:
transcriptional activity 
jj - nn - 
Phrase5145:
the structural requirements 
dt - jj - nns - 
Phrase5146:
we 
prp - 
Phrase5147:
the intact il-2 
dt - jj - nn - 
Phrase5148:
its 
prp$ - 
Phrase5149:
the il-2 
dt - nn - 
Phrase5150:
the ap-1 
dt - nn - 
Phrase5151:
the nf-at 
dt - nn - 
Phrase5152:
the il-2 
dt - nn - 
Phrase5153:
the nf-at 
dt - nn - 
Phrase5154:
the ap-1 
dt - nn - 
Phrase5155:
these results 
dt - nns - 
Phrase5156:
we 
prp - 
Phrase5157:
both transcription 
dt - nn - 
Phrase5158:
the primary target 
dt - jj - nn - 
Phrase5159:
nuclear factor 
jj - nn - 
Phrase5160:
certain cell 
jj - nn - 
Phrase5161:
bacterial lipopolysaccharide 
jj - nn - 
Phrase5162:
nuclear factor 
jj - nn - 
Phrase5163:
an inducible transcription 
dt - jj - nn - 
Phrase5164:
unique properties 
jj - nns - 
Phrase5165:
its 
prp$ - 
Phrase5166:
posttranslational activation 
jj - nn - 
Phrase5167:
an inhibitory subunit 
dt - jj - nn - 
Phrase5168:
cytoplasmic form 
jj - nn - 
Phrase5169:
various other conditions 
jj - jj - nns - 
Phrase5170:
biomedical importance 
jj - nn - 
Phrase5171:
other bacterial toxins 
jj - jj - nns - 
Phrase5172:
oxidative stress 
jj - nn - 
Phrase5173:
immediate early genes 
jj - jj - nns - 
Phrase5174:
the target 
dt - nn - 
Phrase5175:
the immune response 
dt - jj - nn - 
Phrase5176:
those encoding 
dt - nn - 
Phrase5177:
acute phase 
jj - nn - 
Phrase5178:
viral genomes 
jj - nns - 
Phrase5179:
we 
prp - 
Phrase5180:
recent experimental evidences 
jj - jj - nns - 
Phrase5181:
other inducers 
jj - nns - 
Phrase5182:
the factor 
dt - nn - 
Phrase5183:
reactive oxygen 
jj - nn - 
Phrase5184:
the trend 
dt - nn - 
Phrase5185:
many investigators 
jj - nns - 
Phrase5186:
the study 
dt - nn - 
Phrase5187:
the molecular 
dt - nn - 
Phrase5188:
the commitment 
dt - nn - 
Phrase5189:
the eosinophil 
dt - nn - 
Phrase5190:
the mechanism 
dt - nn - 
Phrase5191:
eosinophil-specific genes 
jj - nns - 
Phrase5192:
secondary granule 
jj - nn - 
Phrase5193:
this paper 
dt - nn - 
Phrase5194:
the characterization 
dt - nn - 
Phrase5195:
the mrna 
dt - nn - 
Phrase5196:
cytoplasmic components 
jj - nns - 
Phrase5197:
the lymphoid-specific nuclear factor 
dt - jj - jj - nn - 
Phrase5198:
the lymphoid-specific transcription 
dt - jj - nn - 
Phrase5199:
early gene 
jj - nn - 
Phrase5200:
restricted cytoplasmic factor 
jj - jj - nn - 
Phrase5201:
an inducible ubiquitous nuclear component 
dt - jj - jj - jj - nn - 
Phrase5202:
the antigen 
dt - nn - 
Phrase5203:
recent studies 
jj - nns - 
Phrase5204:
the family 
dt - nn - 
Phrase5205:
the murine 
dt - nn - 
Phrase5206:
the nuclear component 
dt - jj - nn - 
Phrase5207:
the phorbol 
dt - nn - 
Phrase5208:
ester-inducible transcription 
jj - nn - 
Phrase5209:
we 
prp - 
Phrase5210:
this role 
dt - nn - 
Phrase5211:
an oligonucleotide 
dt - nn - 
Phrase5212:
constitutive expression 
jj - nn - 
Phrase5213:
lesser extent 
jjr - nn - 
Phrase5214:
the requirement 
dt - nn - 
Phrase5215:
the requirement 
dt - nn - 
Phrase5216:
fos-related proteins 
jj - nns - 
Phrase5217:
nf-at-dependent transcription 
jj - nn - 
Phrase5218:
the presence 
dt - nn - 
Phrase5219:
the cytoplasmic component 
dt - jj - nn - 
Phrase5220:
this reconstitution 
dt - nn - 
Phrase5221:
it 
prp - 
Phrase5222:
the nf-at 
dt - nn - 
Phrase5223:
we 
prp - 
Phrase5224:
the cytoplasmic component 
dt - jj - nn - 
Phrase5225:
sds-polyacrylamide gel 
jj - nn - 
Phrase5226:
it 
prp - 
Phrase5227:
hormone-binding activity 
jj - nn - 
Phrase5228:
whole-cell method 
jj - nn - 
Phrase5229:
peripheral blood 
jj - nn - 
Phrase5230:
the hemodynamic compensatory 
dt - jj - nn - 
Phrase5231:
the gr 
dt - nn - 
Phrase5232:
the patients 
dt - nns - 
Phrase5233:
the mean 
dt - nn - 
Phrase5234:
septic patients 
jj - nns - 
Phrase5235:
those in 
dt - nn - 
Phrase5236:
normal controls 
jj - nns - 
Phrase5237:
effective in 
jj - nn - 
Phrase5238:
the hemodynamic compensatory 
dt - jj - nn - 
Phrase5239:
the impaired transcription 
dt - jj - nn - 
Phrase5240:
some symptoms 
dt - nns - 
Phrase5241:
premature aging 
jj - nn - 
Phrase5242:
the study 
dt - nn - 
Phrase5243:
premature aging 
jj - nn - 
Phrase5244:
the mechanisms 
dt - nns - 
Phrase5245:
cellular senescence 
jj - nn - 
Phrase5246:
the main feature 
dt - jj - nn - 
Phrase5247:
cellular senescence 
jj - nn - 
Phrase5248:
neuronal ceroid-lypofuscinosis 
jj - nn - 
Phrase5249:
the premature onset 
dt - jj - nn - 
Phrase5250:
numerous features 
jj - nns - 
Phrase5251:
healthy individuals 
jj - nns - 
Phrase5252:
we 
prp - 
Phrase5253:
the electrophoretic mobility 
dt - jj - nn - 
Phrase5254:
impaired ap-1 
jj - nn - 
Phrase5255:
strong in 
jj - nn - 
Phrase5256:
our 
prp$ - 
Phrase5257:
the same molecular 
dt - jj - nn - 
Phrase5258:
premature aging 
jj - nn - 
Phrase5259:
differential contribution 
jj - nn - 
Phrase5260:
cellular factors 
jj - nn - 
Phrase5261:
the activation 
dt - nn - 
Phrase5262:
we 
prp - 
Phrase5263:
the human 
dt - nn - 
Phrase5264:
the hiv-1 
dt - nn - 
Phrase5265:
the activation 
dt - nn - 
Phrase5266:
85-kda proteins 
jj - nns - 
Phrase5267:
the kappa 
dt - nn - 
Phrase5268:
the 50-kda 
dt - nn - 
Phrase5269:
the lbp-1 
dt - nn - 
Phrase5270:
the hiv-1 
dt - nn - 
Phrase5271:
long terminal 
jj - nn - 
Phrase5272:
this system 
dt - nn - 
Phrase5273:
the inhibition 
dt - nn - 
Phrase5274:
the antiviral drug 
dt - jj - nn - 
Phrase5275:
hsv-1-mediated induction 
dt - nn - 
Phrase5276:
the nf-kappa 
dt - nn - 
Phrase5277:
the transient-transfection 
dt - nn - 
Phrase5278:
the hiv-1 
dt - nn - 
Phrase5279:
long terminal 
jj - nn - 
Phrase5280:
the effect 
dt - nn - 
Phrase5281:
the presence 
dt - nn - 
Phrase5282:
the nf-kappa 
dt - nn - 
Phrase5283:
the hiv-1 
dt - nn - 
Phrase5284:
the hsv-1-activated 
dt - nn - 
Phrase5285:
cellular factor 
jj - nn - 
Phrase5286:
the virus-encoded transactivator 
dt - jj - nn - 
Phrase5287:
transcriptional activation 
jj - nn - 
Phrase5288:
the macrophage 
dt - nn - 
Phrase5289:
colony-stimulating factor 
jj - nn - 
Phrase5290:
bioactive macrophage 
jj - nn - 
Phrase5291:
colony-stimulating factor 
jj - nn - 
Phrase5292:
the transcription 
dt - nn - 
Phrase5293:
peripheral blood 
jj - nn - 
Phrase5294:
the beta-chain 
dt - nn - 
Phrase5295:
the receptor 
dt - nn - 
Phrase5296:
the il-2r 
dt - nn - 
Phrase5297:
we 
prp - 
Phrase5298:
its 
prp$ - 
Phrase5299:
transcriptional activation 
jj - nn - 
Phrase5300:
the macrophage 
dt - nn - 
Phrase5301:
subsequent release 
jj - nn - 
Phrase5302:
bioactive m-csf 
jj - nn - 
Phrase5303:
an activity-stimulating 
dt - nn - 
Phrase5304:
transcriptional activation 
jj - nn - 
Phrase5305:
the m-csf 
dt - nn - 
Phrase5306:
the transcription 
dt - nn - 
Phrase5307:
its 
prp$ - 
Phrase5308:
the 5' 
dt - nn - 
Phrase5309:
regulatory enhancer 
jj - nn - 
Phrase5310:
the m-csf 
dt - nn - 
Phrase5311:
heterologous promoter 
jj - nn - 
Phrase5312:
the nf-kappa 
dt - nn - 
Phrase5313:
it 
prp - 
Phrase5314:
an il-2-induced monocyte-derived nuclear protein 
dt - jj - jj - jj - nn - 
Phrase5315:
our 
prp$ - 
Phrase5316:
blood-derived mo 
jj - nn - 
Phrase5317:
transcriptional regulation 
jj - nn - 
Phrase5318:
this gene 
dt - nn - 
Phrase5319:
the interleukin-1 
dt - nn - 
Phrase5320:
mycobacterial components 
jj - nns - 
Phrase5321:
nuclear factor-il6 
jj - nn - 
Phrase5322:
the cytokines 
dt - nns - 
Phrase5323:
pathophysiologic events 
jj - nns - 
Phrase5324:
systemic symptoms 
jj - nns - 
Phrase5325:
we 
prp - 
Phrase5326:
the mycobacterium 
dt - nn - 
Phrase5327:
the mechanism 
dt - nn - 
Phrase5328:
this effect 
dt - nn - 
Phrase5329:
we 
prp - 
Phrase5330:
the lam- 
dt - nn - 
Phrase5331:
tnf-alpha-inducible promoter 
jj - nn - 
Phrase5332:
the il-1 
dt - nn - 
Phrase5333:
this dna 
dt - nn - 
Phrase5334:
novel 9-bp 
jj - nn - 
Phrase5335:
high homology 
jj - nn - 
Phrase5336:
the nuclear factor-il6 
dt - jj - nn - 
Phrase5337:
site-directed mutagenesis 
jj - nn - 
Phrase5338:
they 
prp - 
Phrase5339:
an orientation-independent manner 
dt - jj - nn - 
Phrase5340:
specific binding 
jj - nn - 
Phrase5341:
nuclear protein 
jj - nn - 
Phrase5342:
tnf-alpha-stimulated thp-1 
jj - nn - 
Phrase5343:
the nf-il6 
dt - nn - 
Phrase5344:
we 
prp - 
Phrase5345:
the stimuli 
dt - nns - 
Phrase5346:
the recruitment 
dt - nn - 
Phrase5347:
the human 
dt - nn - 
Phrase5348:
long terminal 
jj - nn - 
Phrase5349:
several cellular transcription 
jj - jj - nn - 
Phrase5350:
our 
prp$ - 
Phrase5351:
previous studies 
jj - nns - 
Phrase5352:
the function 
dt - nn - 
Phrase5353:
the hiv-1-encoded 
dt - nn - 
Phrase5354:
an inhibitor 
dt - nn - 
Phrase5355:
the binding 
dt - nn - 
Phrase5356:
cellular factors 
jj - nn - 
Phrase5357:
32p-labeled oligonucleotides 
jj - nns - 
Phrase5358:
the binding 
dt - nn - 
Phrase5359:
nuclear extracts 
jj - nns - 
Phrase5360:
we 
prp - 
Phrase5361:
the recruitment 
dt - nn - 
Phrase5362:
mitogen-stimulated human 
jj - nn - 
Phrase5363:
the chloramphenicol 
dt - nn - 
Phrase5364:
mitogen-mediated transcriptional activation 
jj - jj - nn - 
Phrase5365:
the cat 
dt - nn - 
Phrase5366:
this construct 
dt - nn - 
Phrase5367:
these studies 
dt - nns - 
Phrase5368:
infected t-cells 
jj - nns - 
Phrase5369:
the beta-globin 
dt - nn - 
Phrase5370:
the human 
dt - nn - 
Phrase5371:
upstream regulatory sequences 
jj - jj - nns - 
Phrase5372:
the locus 
dt - nn - 
Phrase5373:
recent studies 
jj - nns - 
Phrase5374:
the individual 
dt - nn - 
Phrase5375:
the cluster 
dt - nn - 
Phrase5376:
the crux 
dt - nn - 
Phrase5377:
transcriptional activation 
jj - nn - 
Phrase5378:
the locus 
dt - nn - 
Phrase5379:
the gene-proximal 
dt - nn - 
Phrase5380:
regulatory elements 
jj - nns - 
Phrase5381:
the in 
dt - nn - 
Phrase5382:
the proliferation 
dt - nn - 
Phrase5383:
the enhancement 
dt - nn - 
Phrase5384:
an antagonist 
dt - nn - 
Phrase5385:
the contrary 
dt - nn - 
Phrase5386:
other steroid 
jj - nn - 
Phrase5387:
independent assays 
jj - nn - 
Phrase5388:
other hematopoietic cell 
jj - jj - nn - 
Phrase5389:
large granular lymphocytes 
jj - jj - nns - 
Phrase5390:
normal subjects 
jj - nns - 
Phrase5391:
it 
prp - 
Phrase5392:
these data 
dt - nns - 
Phrase5393:
the activating 
dt - nn - 
Phrase5394:
the serum 
dt - nn - 
Phrase5395:
the human 
dt - nn - 
Phrase5396:
the expression 
dt - nn - 
Phrase5397:
the tsp 
dt - nn - 
Phrase5398:
we 
prp - 
Phrase5399:
the ability 
dt - nn - 
Phrase5400:
transcriptional elements 
jj - nns - 
Phrase5401:
the tsp 
dt - nn - 
Phrase5402:
distal element 
jj - nn - 
Phrase5403:
the response 
dt - nn - 
Phrase5404:
the human 
dt - nn - 
Phrase5405:
the distal element 
dt - jj - nn - 
Phrase5406:
the 5'-cc(a + t)6gg-3' 
dt - nn - 
Phrase5407:
this element 
dt - nn - 
Phrase5408:
the serum 
dt - nn - 
Phrase5409:
the tsp 
dt - nn - 
Phrase5410:
gel-shift assays 
jj - nn - 
Phrase5411:
the -1280 
dt - nn - 
Phrase5412:
the c-fos 
dt - nn - 
Phrase5413:
their 
prp$ - 
Phrase5414:
the proximal 
dt - nn - 
Phrase5415:
the sequence 
dt - nn - 
Phrase5416:
the consensus 
dt - nn - 
Phrase5417:
the ccaat-binding 
dt - nn - 
Phrase5418:
this element 
dt - nn - 
Phrase5419:
the serum 
dt - nn - 
Phrase5420:
nuclear factors 
jj - nn - 
Phrase5421:
an nf-y-binding 
dt - nn - 
Phrase5422:
the proximal 
dt - nn - 
Phrase5423:
gel-shift assays 
jj - nn - 
Phrase5424:
their 
prp$ - 
Phrase5425:
an abbreviated 
dt - nn - 
Phrase5426:
the sre- 
dt - nn - 
Phrase5427:
close in 
jj - nn - 
Phrase5428:
the parent 
dt - nn - 
Phrase5429:
we 
prp - 
Phrase5430:
the serum 
dt - nn - 
Phrase5431:
the human 
dt - nn - 
Phrase5432:
an sre- 
dt - nn - 
Phrase5433:
cell-type-specific transactivation 
jj - nn - 
Phrase5434:
the parathyroid hormone-related 
dt - jj - nn - 
Phrase5435:
the human 
dt - nn - 
Phrase5436:
the human 
dt - nn - 
Phrase5437:
cellular gene 
jj - nn - 
Phrase5438:
the downstream parathyroid hormone-related 
dt - jj - jj - nn - 
Phrase5439:
both htlv-i 
dt - nn - 
Phrase5440:
the ap1/c-jun 
dt - nn - 
Phrase5441:
deficient in 
jj - nn - 
Phrase5442:
both pthrp 
dt - nn - 
Phrase5443:
the htlv-i 
dt - nn - 
Phrase5444:
long terminal 
jj - nn - 
Phrase5445:
exogenous provision 
jj - nn - 
Phrase5446:
the pthrp 
dt - nn - 
Phrase5447:
the pathogenesis 
dt - nn - 
Phrase5448:
the cell-specific regulation 
dt - jj - nn - 
Phrase5449:
the gamma 
dt - nn - 
Phrase5450:
the fc 
dt - nn - 
Phrase5451:
hematopoietic cells 
jj - nns - 
Phrase5452:
they 
prp - 
Phrase5453:
critical role 
jj - nn - 
Phrase5454:
they 
prp - 
Phrase5455:
the high affinity 
dt - jj - nn - 
Phrase5456:
other cells 
jj - nns - 
Phrase5457:
the low affinity 
dt - jj - nn - 
Phrase5458:
natural killer 
jj - nn - 
Phrase5459:
the t 
dt - nn - 
Phrase5460:
we 
prp - 
Phrase5461:
the transcriptional regulation 
dt - jj - nn - 
Phrase5462:
the gamma 
dt - nn - 
Phrase5463:
the 2.5-kilobase 
dt - nn - 
Phrase5464:
the transcription 
dt - nn - 
Phrase5465:
hematopoietic lineage 
jj - nn - 
Phrase5466:
the tissue 
dt - nn - 
Phrase5467:
this promoter 
dt - nn - 
Phrase5468:
it 
prp - 
Phrase5469:
active in 
jj - nn - 
Phrase5470:
the hematopoietic cells 
dt - jj - nns - 
Phrase5471:
they 
prp - 
Phrase5472:
we 
prp - 
Phrase5473:
adjacent cis-acting regulatory elements 
jj - jj - jj - nns - 
Phrase5474:
an alu 
dt - nn - 
Phrase5475:
positive element 
jj - nn - 
Phrase5476:
active in 
jj - nn - 
Phrase5477:
the second 
dt - nn - 
Phrase5478:
nuclear factors 
jj - nn - 
Phrase5479:
different in 
jj - nn - 
Phrase5480:
negative element 
jj - nn - 
Phrase5481:
positive one 
jj - nn - 
Phrase5482:
this alu 
dt - nn - 
Phrase5483:
both a 
dt - nn - 
Phrase5484:
negative regulator 
jj - nn - 
Phrase5485:
the human 
dt - nn - 
Phrase5486:
immune system 
jj - nn - 
Phrase5487:
monoclonal antibodies 
jj - nns - 
Phrase5488:
we 
prp - 
Phrase5489:
other polychlorinated 
jj - nn - 
Phrase5490:
the hypothesis 
dt - nn - 
Phrase5491:
similar susceptibility 
jj - nn - 
Phrase5492:
the surface 
dt - nn - 
Phrase5493:
small doses 
jj - nns - 
Phrase5494:
cd20+ b 
jj - nn - 
Phrase5495:
cytotoxic t 
jj - nn - 
Phrase5496:
the cells 
dt - nns - 
Phrase5497:
each volunteer 
dt - nn - 
Phrase5498:
it 
prp - 
Phrase5499:
the variables 
dt - nns - 
Phrase5500:
this class 
dt - nn - 
Phrase5501:
main goals 
jj - nns - 
Phrase5502:
the surface 
dt - nn - 
Phrase5503:
white blood 
jj - nn - 
Phrase5504:
previous studies 
jj - nns - 
Phrase5505:
the upper 
dt - nn - 
Phrase5506:
the body 
dt - nn - 
Phrase5507:
detectable deviations 
jj - nns - 
Phrase5508:
these immunological variables 
dt - jj - nns - 
Phrase5509:
these body 
dt - nn - 
Phrase5510:
our 
prp$ - 
Phrase5511:
slight trends 
jj - nn - 
Phrase5512:
the biomarkers 
dt - nns - 
Phrase5513:
the alterations 
dt - nns - 
Phrase5514:
medical relevance 
jj - nn - 
Phrase5515:
the slight increase 
dt - jj - nn - 
Phrase5516:
the percentage 
dt - nn - 
Phrase5517:
age-related changes 
jj - nns - 
Phrase5518:
the data 
dt - nns - 
Phrase5519:
any evidence 
dt - nn - 
Phrase5520:
an assumption 
dt - nn - 
Phrase5521:
the cellular components 
dt - jj - nns - 
Phrase5522:
the human 
dt - nn - 
Phrase5523:
immune system 
jj - nn - 
Phrase5524:
this action 
dt - nn - 
Phrase5525:
adolescent callithrix 
jj - nn - 
Phrase5526:
an analog 
dt - nn - 
Phrase5527:
the initial infection 
dt - jj - nn - 
Phrase5528:
the establishment 
dt - nn - 
Phrase5529:
chronic infection 
jj - nn - 
Phrase5530:
eventual progression 
jj - nn - 
Phrase5531:
persistent infection 
jj - nn - 
Phrase5532:
some t 
dt - nn - 
Phrase5533:
minimal constitutive virus 
jj - jj - nn - 
Phrase5534:
the t 
dt - nn - 
Phrase5535:
various gene 
jj - nn - 
Phrase5536:
other viruses 
jj - nns - 
Phrase5537:
long terminal 
jj - nn - 
Phrase5538:
-driven reporter 
jj - nn - 
Phrase5539:
the basis 
dt - nn - 
Phrase5540:
these observations 
dt - nns - 
Phrase5541:
it 
prp - 
Phrase5542:
latent hiv-1 
jj - nn - 
Phrase5543:
an important role 
dt - jj - nn - 
Phrase5544:
the pathogenesis 
dt - nn - 
Phrase5545:
low levels 
jj - nns - 
Phrase5546:
constitutive virus 
jj - nn - 
Phrase5547:
productive infection 
jj - nn - 
Phrase5548:
the cells 
dt - nns - 
Phrase5549:
the ach-2 
dt - nn - 
Phrase5550:
good candidate 
jj - nn - 
Phrase5551:
the effects 
dt - nns - 
Phrase5552:
we 
prp - 
Phrase5553:
synthetic analogs 
jj - nns - 
Phrase5554:
modest inhibitors 
jj - nns - 
Phrase5555:
phytohemagglutinin-stimulated peripheral blood 
jj - jj - nn - 
Phrase5556:
the interleukin-2 
dt - nn - 
Phrase5557:
the immune system 
dt - jj - nn - 
Phrase5558:
the first activation 
dt - jj - nn - 
Phrase5559:
naive t 
jj - nn - 
Phrase5560:
key step 
jj - nn - 
Phrase5561:
the shaping 
dt - nn - 
Phrase5562:
the peripheral t 
dt - jj - nn - 
Phrase5563:
the present 
dt - nn - 
Phrase5564:
the interleukin-2 
dt - nn - 
Phrase5565:
naive human 
jj - nn - 
Phrase5566:
cd4+ t 
jj - nn - 
Phrase5567:
both a 
dt - nn - 
Phrase5568:
an activator 
dt - nn - 
Phrase5569:
the purine-rich il-2 
dt - jj - nn - 
Phrase5570:
cd4+ t 
jj - nn - 
Phrase5571:
longer have 
jjr - nn - 
Phrase5572:
their 
prp$ - 
Phrase5573:
the transition 
dt - nn - 
Phrase5574:
active functional state 
jj - jj - nn - 
Phrase5575:
positive transcription 
jj - nn - 
Phrase5576:
these promoter 
dt - nn - 
Phrase5577:
its 
prp$ - 
Phrase5578:
nuclear location 
jj - nn - 
Phrase5579:
the activator 
dt - nn - 
Phrase5580:
located in 
jj - nn - 
Phrase5581:
the cytoplasm 
dt - nn - 
Phrase5582:
it 
prp - 
Phrase5583:
functional in 
jj - nn - 
Phrase5584:
the nucleus 
dt - nn - 
Phrase5585:
the regulation 
dt - nn - 
Phrase5586:
the gene 
dt - nn - 
Phrase5587:
the main t 
dt - jj - nn - 
Phrase5588:
the first encounter 
dt - jj - nn - 
Phrase5589:
it 
prp - 
Phrase5590:
the presence 
dt - nn - 
Phrase5591:
stringent activation 
jj - nn - 
Phrase5592:
naive cd4+ t 
jj - jj - nn - 
Phrase5593:
the gata-binding 
dt - nn - 
Phrase5594:
the expression 
dt - nn - 
Phrase5595:
the hematopoietic transcription 
dt - jj - nn - 
Phrase5596:
eosinophilic sublines 
jj - nn - 
Phrase5597:
either interleukin-5 
dt - nn - 
Phrase5598:
butyric acid 
jj - nn - 
Phrase5599:
the expression 
dt - nn - 
Phrase5600:
the expression 
dt - nn - 
Phrase5601:
eosinophil-specific genes 
jj - nns - 
Phrase5602:
the presence 
dt - nn - 
Phrase5603:
these proteins 
dt - nns - 
Phrase5604:
these lineages 
dt - nns - 
Phrase5605:
nuclear factor 
jj - nn - 
Phrase5606:
we 
prp - 
Phrase5607:
an oxidoreductive 
dt - nn - 
Phrase5608:
regulatory pathway 
jj - nn - 
Phrase5609:
the dna 
dt - nn - 
Phrase5610:
pleiotropic cellular transcription 
jj - jj - nn - 
Phrase5611:
nuclear factor 
jj - nn - 
Phrase5612:
the nucleus 
dt - nn - 
Phrase5613:
the cytosol 
dt - nn - 
Phrase5614:
the primary human 
dt - jj - nn - 
Phrase5615:
we 
prp - 
Phrase5616:
major role 
jj - nn - 
Phrase5617:
the dna 
dt - nn - 
Phrase5618:
the nf 
dt - nn - 
Phrase5619:
b-dependent gene 
jj - nn - 
Phrase5620:
we 
prp - 
Phrase5621:
the inhibitory molecule 
dt - jj - nn - 
Phrase5622:
the effect 
dt - nn - 
Phrase5623:
intact cells 
jj - nns - 
Phrase5624:
we 
prp - 
Phrase5625:
the control 
dt - nn - 
Phrase5626:
long terminal 
jj - nn - 
Phrase5627:
an effector 
dt - nn - 
Phrase5628:
the promoter 
dt - nn - 
Phrase5629:
long terminal 
jj - nn - 
Phrase5630:
the trx-expressing 
dt - nn - 
Phrase5631:
the nf 
dt - nn - 
Phrase5632:
these findings 
dt - nns - 
Phrase5633:
the dna-recognition 
dt - nn - 
Phrase5634:
the redox 
dt - nn - 
Phrase5635:
regulatory role 
jj - nn - 
Phrase5636:
the nf 
dt - nn - 
Phrase5637:
b-mediated gene 
jj - nn - 
Phrase5638:
these results 
dt - nns - 
Phrase5639:
the molecular 
dt - nn - 
Phrase5640:
its 
prp$ - 
Phrase5641:
possible biochemical intervention 
jj - jj - nn - 
Phrase5642:
the cd3 
dt - nn - 
Phrase5643:
the level 
dt - nn - 
Phrase5644:
the inhibitory activity 
dt - jj - nn - 
Phrase5645:
we 
prp - 
Phrase5646:
the crosslinkage 
dt - nn - 
Phrase5647:
the cd3/tcr 
dt - nn - 
Phrase5648:
the cd2 
dt - nn - 
Phrase5649:
the proliferation 
dt - nn - 
Phrase5650:
normal human 
jj - nn - 
Phrase5651:
the effect 
dt - nn - 
Phrase5652:
this synergism 
dt - nn - 
Phrase5653:
the level 
dt - nn - 
Phrase5654:
the il-2 
dt - nn - 
Phrase5655:
the molecular 
dt - nn - 
Phrase5656:
nuclear basis 
jj - nn - 
Phrase5657:
this synergism 
dt - nn - 
Phrase5658:
we 
prp - 
Phrase5659:
the induction 
dt - nn - 
Phrase5660:
normal human 
jj - nn - 
Phrase5661:
the cd3 
dt - nn - 
Phrase5662:
the effect 
dt - nn - 
Phrase5663:
the emergence 
dt - nn - 
Phrase5664:
nuclear binding 
jj - nn - 
Phrase5665:
specific oligonucleotide 
jj - nn - 
Phrase5666:
the electrophoretic mobility 
dt - jj - nn - 
Phrase5667:
our 
prp$ - 
Phrase5668:
the first time 
dt - jj - nn - 
Phrase5669:
synergistic in 
jj - nn - 
Phrase5670:
the emergence 
dt - nn - 
Phrase5671:
the nf-at1 
dt - nn - 
Phrase5672:
located in 
jj - nn - 
Phrase5673:
the promoter/enhancer 
dt - nn - 
Phrase5674:
the il-2 
dt - nn - 
Phrase5675:
clinical practice 
jj - nn - 
Phrase5676:
the emergence 
dt - nn - 
Phrase5677:
these dna-binding 
dt - nn - 
Phrase5678:
normal human 
jj - nn - 
Phrase5679:
cellular calcium 
jj - nn - 
Phrase5680:
megakaryocytic transcription 
jj - nn - 
Phrase5681:
novel experimental model 
jj - jj - nn - 
Phrase5682:
hemopoietic lineage 
jj - nn - 
Phrase5683:
the human 
dt - nn - 
Phrase5684:
megakaryocytic lineages 
jj - nns - 
Phrase5685:
we 
prp - 
Phrase5686:
third pathway 
jj - nn - 
Phrase5687:
lineage-restricted transcription 
jj - nn - 
Phrase5688:
the k562 
dt - nn - 
Phrase5689:
clonal assay 
jj - nn - 
Phrase5690:
the suppression 
dt - nn - 
Phrase5691:
the commitment 
dt - nn - 
Phrase5692:
macrophage-like morphology 
jj - nn - 
Phrase5693:
complete failure 
jj - nn - 
Phrase5694:
benzidine-positive cells 
jj - nns - 
Phrase5695:
marked increase 
jj - nn - 
Phrase5696:
lymphoid markers 
jj - nns - 
Phrase5697:
the response 
dt - nn - 
Phrase5698:
useful experimental system 
jj - jj - nn - 
Phrase5699:
the molecular 
dt - nn - 
Phrase5700:
lineage-restricted transcription 
jj - nn - 
Phrase5701:
hemopoietic lineage 
jj - nn - 
Phrase5702:
primary human 
jj - nn - 
Phrase5703:
long-term nuclear expression 
jj - jj - nn - 
Phrase5704:
-dependent activation 
jj - nn - 
Phrase5705:
long-lasting il-2 
jj - nn - 
Phrase5706:
high-level expression 
jj - nn - 
Phrase5707:
the inducible il-2 
dt - jj - nn - 
Phrase5708:
posttranscriptional levels 
jj - nns - 
Phrase5709:
the transcription 
dt - nn - 
Phrase5710:
its 
prp$ - 
Phrase5711:
the 5'-regulatory region 
dt - jj - nn - 
Phrase5712:
the il-2r 
dt - nn - 
Phrase5713:
the molecular 
dt - nn - 
Phrase5714:
persistent transcription 
jj - nn - 
Phrase5715:
the il-2r 
dt - nn - 
Phrase5716:
we 
prp - 
Phrase5717:
nuclear nf-kappa 
jj - nn - 
Phrase5718:
b-specific oligonucleotide 
jj - nn - 
Phrase5719:
the time 
dt - nn - 
Phrase5720:
nuclear extracts 
jj - nns - 
Phrase5721:
b-specific complexes 
jj - nns - 
Phrase5722:
putative c-rel 
jj - nn - 
Phrase5723:
inducible complexes 
jj - nns - 
Phrase5724:
their 
prp$ - 
Phrase5725:
the duration 
dt - nn - 
Phrase5726:
significant intracellular thiol 
jj - jj - nn - 
Phrase5727:
the signaling 
dt - nn - 
Phrase5728:
micromolar amounts 
jj - nns - 
Phrase5729:
an oxygen 
dt - nn - 
Phrase5730:
the nuclear appearance 
dt - jj - nn - 
Phrase5731:
these results 
dt - nns - 
Phrase5732:
an important role 
dt - jj - nn - 
Phrase5733:
long-term activation 
jj - nn - 
Phrase5734:
primary t-lymphocytes 
jj - nns - 
Phrase5735:
magnetic separation 
jj - nn - 
Phrase5736:
magnetic beads 
jj - nns - 
Phrase5737:
the dna-binding 
dt - nn - 
Phrase5738:
enzymatic means 
jj - nn - 
Phrase5739:
either deoxyribonuclease 
dt - nn - 
Phrase5740:
the results 
dt - nns - 
Phrase5741:
the first time 
dt - jj - nn - 
Phrase5742:
bacterial lysates 
jj - nns - 
Phrase5743:
immunomagnetic separation 
jj - nn - 
Phrase5744:
the approach 
dt - nn - 
Phrase5745:
the efficient recovery 
dt - jj - nn - 
Phrase5746:
peripheral blood 
jj - nn - 
Phrase5747:
an interleukin-2 
dt - nn - 
Phrase5748:
the lymphokine 
dt - nn - 
Phrase5749:
suboptimal activation 
jj - nn - 
Phrase5750:
an ionophore 
dt - nn - 
Phrase5751:
oncogenic rats 
jj - nns - 
Phrase5752:
the need 
dt - nn - 
Phrase5753:
the calcium 
dt - nn - 
Phrase5754:
the requirement 
dt - nn - 
Phrase5755:
the t-cell 
dt - nn - 
Phrase5756:
dominant inhibitory ras 
jj - jj - nn - 
Phrase5757:
an inhibitor 
dt - nn - 
Phrase5758:
the tat 
dt - nn - 
Phrase5759:
promonocytic u937 
jj - nn - 
Phrase5760:
numerous studies 
jj - nns - 
Phrase5761:
promonocytic u937 
jj - nn - 
Phrase5762:
the viral proteins 
dt - jj - nns - 
Phrase5763:
this process 
dt - nn - 
Phrase5764:
the tat 
dt - nn - 
Phrase5765:
this viral protein 
dt - jj - nn - 
Phrase5766:
productive infection 
jj - nn - 
Phrase5767:
immunomodulatory activities 
jj - nns - 
Phrase5768:
the role 
dt - nn - 
Phrase5769:
the hiv1 
dt - nn - 
Phrase5770:
the differentiation 
dt - nn - 
Phrase5771:
we 
prp - 
Phrase5772:
this gene 
dt - nn - 
Phrase5773:
them 
prp - 
Phrase5774:
retroviral particles 
jj - nns - 
Phrase5775:
the effect 
dt - nn - 
Phrase5776:
the tat 
dt - nn - 
Phrase5777:
these cells 
dt - nns - 
Phrase5778:
their 
prp$ - 
Phrase5779:
the expression 
dt - nn - 
Phrase5780:
the c-fos 
dt - nn - 
Phrase5781:
the c-fms 
dt - nn - 
Phrase5782:
the differentiation 
dt - nn - 
Phrase5783:
myelomonoblastic cells 
jj - nns - 
Phrase5784:
these cells 
dt - nns - 
Phrase5785:
an increase 
dt - nn - 
Phrase5786:
the transcription 
dt - nn - 
Phrase5787:
this increase 
dt - nn - 
Phrase5788:
such increase 
jj - nn - 
Phrase5789:
these results 
dt - nns - 
Phrase5790:
the tat 
dt - nn - 
Phrase5791:
monocytic differentiation 
jj - nn - 
Phrase5792:
this viral protein 
dt - jj - nn - 
Phrase5793:
the monocyte/macrophage 
dt - nn - 
Phrase5794:
viral antigens 
jj - nns - 
Phrase5795:
nuclear forms 
jj - nns - 
Phrase5796:
nuclear factor 
jj - nn - 
Phrase5797:
the nuclear factor 
dt - jj - nn - 
Phrase5798:
an inducible dna-binding 
dt - jj - nn - 
Phrase5799:
transcriptional induction 
jj - nn - 
Phrase5800:
the il-2 
dt - nn - 
Phrase5801:
inducible nuclear component 
jj - jj - nn - 
Phrase5802:
we 
prp - 
Phrase5803:
cell-specific component 
jj - nn - 
Phrase5804:
the target 
dt - nn - 
Phrase5805:
the immunosuppressive agents 
dt - jj - nns - 
Phrase5806:
we 
prp - 
Phrase5807:
nuclear extracts 
jj - nns - 
Phrase5808:
inducible nf-at 
jj - nn - 
Phrase5809:
an oligonucleotide 
dt - nn - 
Phrase5810:
the distal nf-at 
dt - jj - nn - 
Phrase5811:
the murine 
dt - nn - 
Phrase5812:
hypotonic extracts 
jj - nns - 
Phrase5813:
unstimulated t 
jj - nn - 
Phrase5814:
single complex 
jj - nn - 
Phrase5815:
we 
prp - 
Phrase5816:
the ability 
dt - nn - 
Phrase5817:
biochemical studies 
jj - nns - 
Phrase5818:
this protein 
dt - nn - 
Phrase5819:
the precise sequence 
dt - jj - nn - 
Phrase5820:
the nf-at 
dt - nn - 
Phrase5821:
we 
prp - 
Phrase5822:
the component 
dt - nn - 
Phrase5823:
nuclear nf-at 
jj - nn - 
Phrase5824:
posttranslational modification 
jj - nn - 
Phrase5825:
its 
prp$ - 
Phrase5826:
the results 
dt - nns - 
Phrase5827:
the context 
dt - nn - 
Phrase5828:
nuclear nf-at 
jj - nn - 
Phrase5829:
primary human 
jj - nn - 
Phrase5830:
novel e2f 
jj - nn - 
Phrase5831:
distinct forms 
jj - nns - 
Phrase5832:
free e2f 
jj - nn - 
Phrase5833:
the transcription 
dt - nn - 
Phrase5834:
the expression 
dt - nn - 
Phrase5835:
multiple genes 
jj - nns - 
Phrase5836:
the dihydrofolate reductase 
dt - jj - nn - 
Phrase5837:
its 
prp$ - 
Phrase5838:
other cellular proteins 
jj - jj - nns - 
Phrase5839:
the retinoblastoma 
dt - nn - 
Phrase5840:
the rb-related 
dt - nn - 
Phrase5841:
we 
prp - 
Phrase5842:
detailed analysis 
jj - nn - 
Phrase5843:
their 
prp$ - 
Phrase5844:
primary human 
jj - nn - 
Phrase5845:
these activities 
dt - nns - 
Phrase5846:
prominent e2f 
jj - nn - 
Phrase5847:
abundant in 
jj - nn - 
Phrase5848:
possible role 
jj - nn - 
Phrase5849:
an intact e1a 
dt - jj - nn - 
Phrase5850:
the involvement 
dt - nn - 
Phrase5851:
an e1a-binding 
dt - nn - 
Phrase5852:
these novel e2f 
dt - jj - nn - 
Phrase5853:
distinct forms 
jj - nns - 
Phrase5854:
these species 
dt - nns - 
Phrase5855:
different cell 
jj - nn - 
Phrase5856:
distinct e2f 
jj - nn - 
Phrase5857:
the s-phase 
dt - nn - 
Phrase5858:
these results 
dt - nns - 
Phrase5859:
distinct dna-binding 
jj - nn - 
Phrase5860:
different points 
jj - nns - 
Phrase5861:
the cell 
dt - nn - 
Phrase5862:
defective translocation 
jj - nn - 
Phrase5863:
reversible loss 
jj - nn - 
Phrase5864:
ester-induced monocytic differentiation 
jj - jj - nn - 
Phrase5865:
previous studies 
jj - nns - 
Phrase5866:
the c-jun 
dt - nn - 
Phrase5867:
early response 
jj - nn - 
Phrase5868:
monocytic phenotype 
jj - nn - 
Phrase5869:
the present 
dt - nn - 
Phrase5870:
the effects 
dt - nns - 
Phrase5871:
-induced hl-60 
jj - nn - 
Phrase5872:
the results 
dt - nns - 
Phrase5873:
an increase 
dt - nn - 
Phrase5874:
other phenotypic characteristics 
jj - jj - nns - 
Phrase5875:
monocytic differentiation 
jj - nn - 
Phrase5876:
okadaic acid 
jj - nn - 
Phrase5877:
an inhibitor 
dt - nn - 
Phrase5878:
the c-fms 
dt - nn - 
Phrase5879:
an hl-60/vinc 
dt - nn - 
Phrase5880:
regained partial sensitivity 
dt - jj - nn - 
Phrase5881:
the finding 
dt - nn - 
Phrase5882:
monocytic phenotype 
jj - nn - 
Phrase5883:
monocytic differentiation 
jj - nn - 
Phrase5884:
other studies 
jj - nns - 
Phrase5885:
the jun-b 
dt - nn - 
Phrase5886:
the hl-60/vinc 
dt - nn - 
Phrase5887:
we 
prp - 
Phrase5888:
the cytosol 
dt - nn - 
Phrase5889:
the membrane 
dt - nn - 
Phrase5890:
this subcellular redistribution 
dt - jj - nn - 
Phrase5891:
undetectable in 
jj - nn - 
Phrase5892:
the mitogen-activated protein 
dt - jj - nn - 
Phrase5893:
tpa-treated hl-60/vinc 
jj - nn - 
Phrase5894:
okadaic acid 
jj - nn - 
Phrase5895:
these findings 
dt - nns - 
Phrase5896:
tpa-induced differentiation 
jj - nn - 
Phrase5897:
pkc-mediated signaling 
jj - nn - 
Phrase5898:
early response 
jj - nn - 
Phrase5899:
multiple lymphokine 
jj - nn - 
Phrase5900:
severe combined immunodeficiency 
jj - jj - nn - 
Phrase5901:
we 
prp - 
Phrase5902:
the t 
dt - nn - 
Phrase5903:
severe combined immunodeficiency 
jj - jj - nn - 
Phrase5904:
defective in 
jj - nn - 
Phrase5905:
the transcription 
dt - nn - 
Phrase5906:
several lymphokine 
jj - nn - 
Phrase5907:
the defect 
dt - nn - 
Phrase5908:
the patient 
dt - nn - 
Phrase5909:
trans-acting factor 
jj - nn - 
Phrase5910:
we 
prp - 
Phrase5911:
the ability 
dt - nn - 
Phrase5912:
nuclear factors 
jj - nn - 
Phrase5913:
the patient 
dt - nn - 
Phrase5914:
the regulatory region 
dt - jj - nn - 
Phrase5915:
nuclear factor 
jj - nn - 
Phrase5916:
the binding 
dt - nn - 
Phrase5917:
the nuclear factor 
dt - jj - nn - 
Phrase5918:
its 
prp$ - 
Phrase5919:
the il2 
dt - nn - 
Phrase5920:
an nf-at-like response 
dt - jj - nn - 
Phrase5921:
the il4 
dt - nn - 
Phrase5922:
the abnormal nf-at 
dt - jj - nn - 
Phrase5923:
an impaired function 
dt - jj - nn - 
Phrase5924:
we 
prp - 
Phrase5925:
the reporter 
dt - nn - 
Phrase5926:
the control 
dt - nn - 
Phrase5927:
the entire il2 
dt - jj - nn - 
Phrase5928:
regulatory region 
jj - nn - 
Phrase5929:
the il2 
dt - nn - 
Phrase5930:
regulatory region 
jj - nn - 
Phrase5931:
the nf-at-binding site 
dt - jj - nn - 
Phrase5932:
lower in 
jjr - nn - 
Phrase5933:
the patient 
dt - nn - 
Phrase5934:
the oct-1 
dt - nn - 
Phrase5935:
-binding site 
jj - nn - 
Phrase5936:
these results 
dt - nns - 
Phrase5937:
an abnormality 
dt - nn - 
Phrase5938:
the multiple lymphokine 
dt - jj - nn - 
Phrase5939:
this patient 
dt - nn - 
Phrase5940:
intracellular signal 
jj - nn - 
Phrase5941:
the immunosuppressants 
dt - nns - 
Phrase5942:
the ca(2+)-dependent signal-transduction pathway 
dt - jj - jj - nn - 
Phrase5943:
the t-cell 
dt - nn - 
Phrase5944:
the activation 
dt - nn - 
Phrase5945:
these drugs 
dt - nns - 
Phrase5946:
uncovered several intracellular signalling 
jj - jj - jj - nn - 
Phrase5947:
the generation 
dt - nn - 
Phrase5948:
the transcriptional activation 
dt - jj - nn - 
Phrase5949:
the nuclear factor 
dt - jj - nn - 
Phrase5950:
the binding 
dt - nn - 
Phrase5951:
the cytoplasmic subunit 
dt - jj - nn - 
Phrase5952:
its 
prp$ - 
Phrase5953:
the cytoplasm 
dt - nn - 
Phrase5954:
the nucleus 
dt - nn - 
Phrase5955:
competent transcriptional activator 
jj - jj - nn - 
Phrase5956:
these drugs 
dt - nns - 
Phrase5957:
their 
prp$ - 
Phrase5958:
an unprecedented fashion 
dt - jj - nn - 
Phrase5959:
they 
prp - 
Phrase5960:
intracellular signalling 
jj - nn - 
Phrase5961:
they 
prp - 
Phrase5962:
tight complexes 
jj - nns - 
Phrase5963:
different classes 
jj - nns - 
Phrase5964:
abundant cytosolic receptors 
jj - jj - nns - 
Phrase5965:
the cell 
dt - nn - 
Phrase5966:
their 
prp$ - 
Phrase5967:
distinct immunophilin-drug 
jj - nn - 
Phrase5968:
the phosphatase 
dt - nn - 
Phrase5969:
an active role 
dt - jj - nn - 
Phrase5970:
b-mediated signal 
jj - nn - 
Phrase5971:
the rel/nf-kappa 
dt - nn - 
Phrase5972:
distinct subgroups 
jj - nns - 
Phrase5973:
proteolytic processing 
jj - nn - 
Phrase5974:
their 
prp$ - 
Phrase5975:
such repeats 
jj - nns - 
Phrase5976:
we 
prp - 
Phrase5977:
the p105 
dt - nn - 
Phrase5978:
functional properties 
jj - nns - 
Phrase5979:
the i 
dt - nn - 
Phrase5980:
swi6/ankyrin repeats 
dt - nns - 
Phrase5981:
stable complexes 
jj - nns - 
Phrase5982:
other rel/nf-kappa 
jj - nn - 
Phrase5983:
the precursors 
dt - nns - 
Phrase5984:
cytoplasmic retention 
jj - nn - 
Phrase5985:
either p65 
dt - nn - 
Phrase5986:
these complexes 
dt - nns - 
Phrase5987:
active p50/c-rel 
jj - nn - 
Phrase5988:
these observations 
dt - nns - 
Phrase5989:
the precursors 
dt - nns - 
Phrase5990:
major role 
jj - nn - 
Phrase5991:
an inducible autoregulatory 
dt - jj - nn - 
Phrase5992:
the eukaryotic transcription 
dt - jj - nn - 
Phrase5993:
nuclear factor-kappa 
jj - nn - 
Phrase5994:
many parts 
jj - nns - 
Phrase5995:
the genetic program 
dt - jj - nn - 
Phrase5996:
nuclear expression 
jj - nn - 
Phrase5997:
its 
prp$ - 
Phrase5998:
its 
prp$ - 
Phrase5999:
cytoplasmic inhibitor 
jj - nn - 
Phrase6000:
nuclear nf-kappa 
jj - nn - 
Phrase6001:
both degradation 
dt - nn - 
Phrase6002:
the activation 
dt - nn - 
Phrase6003:
the i 
dt - nn - 
Phrase6004:
the 65-kilodalton 
dt - nn - 
Phrase6005:
intracellular inhibition 
jj - nn - 
Phrase6006:
the survival 
dt - nn - 
Phrase6007:
this labile 
dt - nn - 
Phrase6008:
these results 
dt - nns - 
Phrase6009:
the expression 
dt - nn - 
Phrase6010:
an inducible autoregulatory 
dt - jj - nn - 
Phrase6011:
the human 
dt - nn - 
Phrase6012:
the transcription 
dt - nn - 
Phrase6013:
tissue-specific induction 
jj - nn - 
Phrase6014:
these studies 
dt - nns - 
Phrase6015:
we 
prp - 
Phrase6016:
specific protein 
jj - nn - 
Phrase6017:
transcriptional regulation 
jj - nn - 
Phrase6018:
the human 
dt - nn - 
Phrase6019:
-responsive enhancer 
jj - nn - 
Phrase6020:
the transcription 
dt - nn - 
Phrase6021:
discrete subregions 
jj - nns - 
Phrase6022:
the maximal induction 
dt - jj - nn - 
Phrase6023:
the enhancer 
dt - nn - 
Phrase6024:
the enhancer 
dt - nn - 
Phrase6025:
functional protein 
jj - nn - 
Phrase6026:
the essential proteins 
dt - jj - nns - 
Phrase6027:
the enhancer 
dt - nn - 
Phrase6028:
the c/ebp 
dt - nn - 
Phrase6029:
both il-1- 
dt - nn - 
Phrase6030:
lps-specific induction 
jj - nn - 
Phrase6031:
the il-6 
dt - nn - 
Phrase6032:
the nf-il6 
dt - nn - 
Phrase6033:
the proil-1 
dt - nn - 
Phrase6034:
the proil-1 
dt - nn - 
Phrase6035:
the simian virus 
dt - jj - nn - 
Phrase6036:
the murine 
dt - nn - 
Phrase6037:
the proil-1 
dt - nn - 
Phrase6038:
inducible in 
jj - nn - 
Phrase6039:
the existence 
dt - nn - 
Phrase6040:
promoter-proximal requirement 
jj - nn - 
Phrase6041:
the site 
dt - nn - 
Phrase6042:
recurrent inflammatory arthritis 
jj - jj - nn - 
Phrase6043:
the assessment 
dt - nn - 
Phrase6044:
recurrent inflammatory arthritis 
jj - jj - nn - 
Phrase6045:
the 3h-thymidine 
dt - nn - 
Phrase6046:
multiple microbiological 
jj - nn - 
Phrase6047:
repeated maximal responses 
jj - jj - nns - 
Phrase6048:
these adenovirus 
dt - nn - 
Phrase6049:
it 
prp - 
Phrase6050:
recurrent inflammatory arthritis 
jj - jj - nn - 
Phrase6051:
putative transcription 
jj - nn - 
Phrase6052:
sensitive in 
jj - nn - 
Phrase6053:
few known genes 
jj - jj - nns - 
Phrase6054:
the il-8 
dt - nn - 
Phrase6055:
the combined effect 
dt - jj - nn - 
Phrase6056:
myristic acetate 
jj - nn - 
Phrase6057:
these genes 
dt - nns - 
Phrase6058:
we 
prp - 
Phrase6059:
putative transcription 
jj - nn - 
Phrase6060:
an identical dual signal 
dt - jj - jj - nn - 
Phrase6061:
the pilot 
dt - nn - 
Phrase6062:
detectable in 
jj - nn - 
Phrase6063:
the presence 
dt - nn - 
Phrase6064:
the pilot 
dt - nn - 
Phrase6065:
the c2h2-type 
dt - nn - 
Phrase6066:
the carboxyl-terminus 
dt - nn - 
Phrase6067:
the zinc 
dt - nn - 
Phrase6068:
the transcription 
dt - nn - 
Phrase6069:
the existence 
dt - nn - 
Phrase6070:
regulatory element 
jj - nn - 
Phrase6071:
some genes 
dt - nns - 
Phrase6072:
differential expression 
jj - nn - 
Phrase6073:
valuable in 
jj - nn - 
Phrase6074:
the dissection 
dt - nn - 
Phrase6075:
the dual signal 
dt - jj - nn - 
Phrase6076:
the effects 
dt - nns - 
Phrase6077:
it 
prp - 
Phrase6078:
antisense oligonucleotides 
jj - nns - 
Phrase6079:
the p65 
dt - nn - 
Phrase6080:
pleiotropic regulator 
jj - nn - 
Phrase6081:
the cellular response 
dt - jj - nn - 
Phrase6082:
distinct regions 
jj - nns - 
Phrase6083:
the promoter 
dt - nn - 
Phrase6084:
numerous genes 
jj - nns - 
Phrase6085:
antisense phosphorothioate 
jj - nn - 
Phrase6086:
the p50 
dt - nn - 
Phrase6087:
the nf-kappa 
dt - nn - 
Phrase6088:
the physiologic role 
dt - jj - nn - 
Phrase6089:
this transcription 
dt - nn - 
Phrase6090:
the expression 
dt - nn - 
Phrase6091:
the phosphorothioate 
dt - nn - 
Phrase6092:
antisense oligodeoxynucleotide 
jj - nn - 
Phrase6093:
rapid changes 
jj - nns - 
Phrase6094:
the cellular adhesion 
dt - jj - nn - 
Phrase6095:
these effects 
dt - nns - 
Phrase6096:
marked reduction 
jj - nn - 
Phrase6097:
the surface 
dt - nn - 
Phrase6098:
the p65 
dt - nn - 
Phrase6099:
antisense oligomer 
jj - nn - 
Phrase6100:
an upregulation 
dt - nn - 
Phrase6101:
the p65 
dt - nn - 
Phrase6102:
antisense phosphorothioate 
jj - nn - 
Phrase6103:
significant effect 
jj - nn - 
Phrase6104:
the production 
dt - nn - 
Phrase6105:
reactive oxygen 
jj - nn - 
Phrase6106:
these cells 
dt - nns - 
Phrase6107:
these findings 
dt - nns - 
Phrase6108:
antisense oligomers 
jj - nns - 
Phrase6109:
the role 
dt - nn - 
Phrase6110:
the activation 
dt - nn - 
Phrase6111:
the p65 
dt - nn - 
Phrase6112:
distinct mechanisms 
jj - nns - 
Phrase6113:
the cytoplasm 
dt - nn - 
Phrase6114:
its 
prp$ - 
Phrase6115:
endogenous i 
jj - nn - 
Phrase6116:
lymphoid cells 
jj - nns - 
Phrase6117:
the i 
dt - nn - 
Phrase6118:
the cytoplasm 
dt - nn - 
Phrase6119:
an autoregulatory 
dt - nn - 
Phrase6120:
held in 
dt - nn - 
Phrase6121:
the cytoplasm 
dt - nn - 
Phrase6122:
it 
prp - 
Phrase6123:
the nucleus 
dt - nn - 
Phrase6124:
related nf-kappa 
jj - nn - 
Phrase6125:
monocytic thp-1 
jj - nn - 
Phrase6126:
many effects 
jj - nns - 
Phrase6127:
monocytic cells 
jj - nns - 
Phrase6128:
the specific members 
dt - jj - nns - 
Phrase6129:
the nf-kappa 
dt - nn - 
Phrase6130:
the lps 
dt - nn - 
Phrase6131:
the mechanisms 
dt - nns - 
Phrase6132:
we 
prp - 
Phrase6133:
nuclear expression 
jj - nn - 
Phrase6134:
monocytic thp-1 
jj - nn - 
Phrase6135:
nuclear localization 
jj - nn - 
Phrase6136:
these proteins 
dt - nns - 
Phrase6137:
rapid decrease 
jj - nn - 
Phrase6138:
their 
prp$ - 
Phrase6139:
cytosolic levels 
jj - nns - 
Phrase6140:
striking increase 
jj - nn - 
Phrase6141:
the levels 
dt - nns - 
Phrase6142:
the cytosol 
dt - nn - 
Phrase6143:
these proteins 
dt - nns - 
Phrase6144:
the amounts 
dt - nns - 
Phrase6145:
their 
prp$ - 
Phrase6146:
an i 
dt - nn - 
Phrase6147:
b-like protein 
jj - nn - 
Phrase6148:
rapid increase 
jj - nn - 
Phrase6149:
an increase 
dt - nn - 
Phrase6150:
monocytic cells 
jj - nns - 
Phrase6151:
nuclear expression 
jj - nn - 
Phrase6152:
chimeric type 
jj - nn - 
Phrase6153:
the type 
dt - nn - 
Phrase6154:
the cytoplasmic domain 
dt - jj - nn - 
Phrase6155:
the type 
dt - nn - 
Phrase6156:
the type 
dt - nn - 
Phrase6157:
small cytoplasmic tail 
jj - jj - nn - 
Phrase6158:
it 
prp - 
Phrase6159:
this receptor 
dt - nn - 
Phrase6160:
regulatory molecule 
jj - nn - 
Phrase6161:
we 
prp - 
Phrase6162:
the type 
dt - nn - 
Phrase6163:
the human 
dt - nn - 
Phrase6164:
the cytoplasmic domain 
dt - jj - nn - 
Phrase6165:
the human 
dt - nn - 
Phrase6166:
the membrane 
dt - nn - 
Phrase6167:
the type 
dt - nn - 
Phrase6168:
our 
prp$ - 
Phrase6169:
the extracellular domain 
dt - jj - nn - 
Phrase6170:
the type 
dt - nn - 
Phrase6171:
heterologous cytoplasmic domain 
jj - jj - nn - 
Phrase6172:
the glucocorticoid 
dt - nn - 
Phrase6173:
primary cortisol 
jj - nn - 
Phrase6174:
the precise molecular 
dt - jj - nn - 
Phrase6175:
primary cortisol 
jj - nn - 
Phrase6176:
primary cortisol 
jj - nn - 
Phrase6177:
we 
prp - 
Phrase6178:
we 
prp - 
Phrase6179:
the hgr 
dt - nn - 
Phrase6180:
the cause 
dt - nn - 
Phrase6181:
the index 
dt - nn - 
Phrase6182:
first strand 
jj - nn - 
Phrase6183:
the entire hgr 
dt - jj - nn - 
Phrase6184:
homozygous a 
jj - nn - 
Phrase6185:
an isoleucine 
dt - nn - 
Phrase6186:
the wild-type hgr 
dt - jj - nn - 
Phrase6187:
the dissociation 
dt - nn - 
Phrase6188:
the wild-type hgr 
dt - jj - nn - 
Phrase6189:
the mouse 
dt - nn - 
Phrase6190:
mammary tumor 
jj - nn - 
Phrase6191:
long terminal 
jj - nn - 
Phrase6192:
the chloramphenicol 
dt - nn - 
Phrase6193:
the hgr-ile 
dt - nn - 
Phrase6194:
apparent potency 
jj - nn - 
Phrase6195:
the isoleucine 
dt - nn - 
Phrase6196:
the function 
dt - nn - 
Phrase6197:
the hgr 
dt - nn - 
Phrase6198:
the likely cause 
dt - jj - nn - 
Phrase6199:
primary cortisol 
jj - nn - 
Phrase6200:
this subject 
dt - nn - 
Phrase6201:
active factors 
jj - nn - 
Phrase6202:
the effect 
dt - nn - 
Phrase6203:
the htlv-i 
dt - nn - 
Phrase6204:
the il-2r 
dt - nn - 
Phrase6205:
the product 
dt - nn - 
Phrase6206:
the c-rel 
dt - nn - 
Phrase6207:
the transactivator 
dt - nn - 
Phrase6208:
the promoter 
dt - nn - 
Phrase6209:
the gene 
dt - nn - 
Phrase6210:
the interleukin 
dt - nn - 
Phrase6211:
several protein 
jj - nn - 
Phrase6212:
the rel 
dt - nn - 
Phrase6213:
the enhancer 
dt - nn - 
Phrase6214:
this motif 
dt - nn - 
Phrase6215:
lymphoid jurkat 
jj - nn - 
Phrase6216:
undifferentiated embryocarcinoma 
jj - nn - 
Phrase6217:
the p50 
dt - nn - 
Phrase6218:
these cells 
dt - nns - 
Phrase6219:
significant activation 
jj - nn - 
Phrase6220:
the il-2r 
dt - nn - 
Phrase6221:
both tax 
dt - nn - 
Phrase6222:
the binding 
dt - nn - 
Phrase6223:
the il-2r 
dt - nn - 
Phrase6224:
the dna 
dt - nn - 
Phrase6225:
we 
prp - 
Phrase6226:
the binding 
dt - nn - 
Phrase6227:
clear difference 
jj - nn - 
Phrase6228:
both stimuli 
dt - nns - 
Phrase6229:
active factor 
jj - nn - 
Phrase6230:
we 
prp - 
Phrase6231:
these results 
dt - nns - 
Phrase6232:
the functional activity 
dt - jj - nn - 
Phrase6233:
the rel 
dt - nn - 
Phrase6234:
their 
prp$ - 
Phrase6235:
transcriptional activator 
jj - nn - 
Phrase6236:
specific kappa 
jj - nn - 
Phrase6237:
transcriptional regulation 
jj - nn - 
Phrase6238:
primary human 
jj - nn - 
Phrase6239:
octamer-binding proteins 
jj - nns - 
Phrase6240:
we 
prp - 
Phrase6241:
the molecular 
dt - nn - 
Phrase6242:
biochemical basis 
jj - nn - 
Phrase6243:
primary human 
jj - nn - 
Phrase6244:
primary t 
jj - nn - 
Phrase6245:
we 
prp - 
Phrase6246:
octamer-binding proteins 
jj - nns - 
Phrase6247:
major role 
jj - nn - 
Phrase6248:
transcriptional activation 
jj - nn - 
Phrase6249:
the il3 
dt - nn - 
Phrase6250:
their 
prp$ - 
Phrase6251:
specific regions 
jj - nns - 
Phrase6252:
the il3 
dt - nn - 
Phrase6253:
5'-flanking sequence 
jj - nn - 
Phrase6254:
the region 
dt - nn - 
Phrase6255:
the il3 
dt - nn - 
Phrase6256:
putative ap-2 
jj - nn - 
Phrase6257:
basal level 
jj - nn - 
Phrase6258:
the il3 
dt - nn - 
Phrase6259:
the data 
dt - nns - 
Phrase6260:
trans-activating signals 
jj - nns - 
Phrase6261:
these results 
dt - nns - 
Phrase6262:
better understanding 
jjr - nn - 
Phrase6263:
the regulation 
dt - nn - 
Phrase6264:
transcriptional activation 
jj - nn - 
Phrase6265:
an i 
dt - nn - 
Phrase6266:
inducible expression 
jj - nn - 
Phrase6267:
cellular transcription 
jj - nn - 
Phrase6268:
nuclear factor 
jj - nn - 
Phrase6269:
distinct subunits 
jj - nns - 
Phrase6270:
independent genes 
jj - nns - 
Phrase6271:
related proteins 
jj - nns - 
Phrase6272:
we 
prp - 
Phrase6273:
the hiv 
dt - nn - 
Phrase6274:
we 
prp - 
Phrase6275:
the biochemical basis 
dt - jj - nn - 
Phrase6276:
the transcriptional regulation 
dt - jj - nn - 
Phrase6277:
we 
prp - 
Phrase6278:
the dissociation 
dt - nn - 
Phrase6279:
homodimeric p49 
jj - nn - 
Phrase6280:
heterodimeric p49/p65 
jj - nn - 
Phrase6281:
the hiv 
dt - nn - 
Phrase6282:
the hiv 
dt - nn - 
Phrase6283:
= 69.1 
jj - nn - 
Phrase6284:
the affinity 
dt - nn - 
Phrase6285:
heterodimeric nfkb2 
jj - nn - 
Phrase6286:
this site 
dt - nn - 
Phrase6287:
= 11.8 
jj - nn - 
Phrase6288:
these findings 
dt - nns - 
Phrase6289:
the addition 
dt - nn - 
Phrase6290:
heterodimeric nfkb2 
jj - nn - 
Phrase6291:
transcriptional activation 
jj - nn - 
Phrase6292:
the hiv 
dt - nn - 
Phrase6293:
the dna 
dt - nn - 
Phrase6294:
the binding 
dt - nn - 
Phrase6295:
functional activation 
jj - nn - 
Phrase6296:
an hiv 
dt - nn - 
Phrase6297:
the c-rel 
dt - nn - 
Phrase6298:
transcriptional activation 
jj - nn - 
Phrase6299:
the long terminal 
dt - jj - nn - 
Phrase6300:
the long terminal 
dt - jj - nn - 
Phrase6301:
the type 
dt - nn - 
Phrase6302:
the 5' 
dt - nn - 
Phrase6303:
regulatory region 
jj - nn - 
Phrase6304:
the gene 
dt - nn - 
Phrase6305:
the interleukin 
dt - nn - 
Phrase6306:
functional kappa 
jj - nn - 
Phrase6307:
the regulation 
dt - nn - 
Phrase6308:
these inducible transcription 
dt - jj - nn - 
Phrase6309:
these kappa 
dt - nn - 
Phrase6310:
related family 
jj - nn - 
Phrase6311:
interactive proteins 
jj - nns - 
Phrase6312:
the product 
dt - nn - 
Phrase6313:
the c-rel 
dt - nn - 
Phrase6314:
recent biochemical studies 
jj - jj - nns - 
Phrase6315:
the prototypical nf-kappa 
dt - jj - nn - 
Phrase6316:
the cytoplasm 
dt - nn - 
Phrase6317:
the nucleus 
dt - nn - 
Phrase6318:
intracellular signaling 
jj - nn - 
Phrase6319:
b-directed transcription 
jj - nn - 
Phrase6320:
either hiv-1 
dt - nn - 
Phrase6321:
the il-2r 
dt - nn - 
Phrase6322:
the strong transactivation 
dt - jj - nn - 
Phrase6323:
we 
prp - 
Phrase6324:
nuclear expression 
jj - nn - 
Phrase6325:
either phorbol 
dt - nn - 
Phrase6326:
p65-mediated activation 
dt - nn - 
Phrase6327:
these transcription 
dt - nn - 
Phrase6328:
these inhibitory effects 
dt - jj - nns - 
Phrase6329:
its 
prp$ - 
Phrase6330:
its 
prp$ - 
Phrase6331:
the kappa 
dt - nn - 
Phrase6332:
these findings 
dt - nns - 
Phrase6333:
physiologic repressor 
jj - nn - 
Phrase6334:
the hiv-1 
dt - nn - 
Phrase6335:
the strong transcriptional activating 
dt - jj - jj - nn - 
Phrase6336:
the p21ras 
dt - nn - 
Phrase6337:
small gtp 
jj - nn - 
Phrase6338:
neoplastic transformation 
jj - nn - 
Phrase6339:
many different cell 
jj - jj - nn - 
Phrase6340:
the present 
dt - nn - 
Phrase6341:
we 
prp - 
Phrase6342:
the relationship 
dt - nn - 
Phrase6343:
we 
prp - 
Phrase6344:
the constitutive expression 
dt - jj - nn - 
Phrase6345:
the t24 
dt - nn - 
Phrase6346:
ebv-immortalized b 
jj - nn - 
Phrase6347:
the induction 
dt - nn - 
Phrase6348:
the interleukin 
dt - nn - 
Phrase6349:
an impaired immunoglobulin 
dt - jj - nn - 
Phrase6350:
altered adhesion 
jj - nn - 
Phrase6351:
serum-free medium 
jj - nn - 
Phrase6352:
the il-2 
dt - nn - 
Phrase6353:
we 
prp - 
Phrase6354:
the ras-transformed 
dt - nn - 
Phrase6355:
functional il-2r 
jj - nn - 
Phrase6356:
they 
prp - 
Phrase6357:
this lymphokine 
dt - nn - 
Phrase6358:
the ras 
dt - nn - 
Phrase6359:
the activity 
dt - nn - 
Phrase6360:
lymphocyte-specific transcription 
jj - nn - 
Phrase6361:
the constitutive p21ras 
dt - jj - nn - 
Phrase6362:
comparative analysis 
jj - nn - 
Phrase6363:
nuclear factor 
jj - nn - 
Phrase6364:
nuclear factor 
jj - nn - 
Phrase6365:
transcriptional activator 
jj - nn - 
Phrase6366:
the interleukin-2 
dt - nn - 
Phrase6367:
the t 
dt - nn - 
Phrase6368:
cell-specific inducibility 
jj - nn - 
Phrase6369:
electrophoretic mobility 
jj - nn - 
Phrase6370:
specific nfat 
jj - nn - 
Phrase6371:
the b 
dt - nn - 
Phrase6372:
it 
prp - 
Phrase6373:
an nfat-driven chloramphenicol 
dt - jj - nn - 
Phrase6374:
an ap-1 
dt - nn - 
Phrase6375:
anti-fos antibodies 
jj - nns - 
Phrase6376:
the nfat 
dt - nn - 
Phrase6377:
the nfat 
dt - nn - 
Phrase6378:
unstimulated b 
jj - nn - 
Phrase6379:
an nfat 
dt - nn - 
Phrase6380:
the presence 
dt - nn - 
Phrase6381:
nuclear factor 
jj - nn - 
Phrase6382:
the formation 
dt - nn - 
Phrase6383:
the nfat 
dt - nn - 
Phrase6384:
the 5' 
dt - nn - 
Phrase6385:
purine-rich part 
jj - nn - 
Phrase6386:
the nfat 
dt - nn - 
Phrase6387:
the wild type 
dt - jj - nn - 
Phrase6388:
we 
prp - 
Phrase6389:
constitutive nuclear factor 
jj - jj - nn - 
Phrase6390:
an additional factor 
dt - jj - nn - 
Phrase6391:
post-translational modification 
jj - nn - 
Phrase6392:
differential autoregulation 
jj - nn - 
Phrase6393:
its 
prp$ - 
Phrase6394:
the glucocorticoid-sensitive human 
dt - jj - nn - 
Phrase6395:
leukemic t-cell 
jj - nn - 
Phrase6396:
the human 
dt - nn - 
Phrase6397:
the decrease 
dt - nn - 
Phrase6398:
an 8-fold 
dt - nn - 
Phrase6399:
half-maximal induction 
jj - nn - 
Phrase6400:
the effects 
dt - nns - 
Phrase6401:
positive autoregulation 
jj - nn - 
Phrase6402:
receptor-mediated response 
jj - nn - 
Phrase6403:
positive autoregulation 
jj - nn - 
Phrase6404:
glucocorticoid-resistant cem-c1 
jj - nn - 
Phrase6405:
functional gr 
jj - nn - 
Phrase6406:
positive autoregulation 
jj - nn - 
Phrase6407:
neither a 
dt - nn - 
Phrase6408:
the sole cause 
dt - jj - nn - 
Phrase6409:
the degree 
dt - nn - 
Phrase6410:
negative autoregulation 
jj - nn - 
Phrase6411:
positive autoregulation 
jj - nn - 
Phrase6412:
similar half-life 
jj - nn - 
Phrase6413:
these results 
dt - nns - 
Phrase6414:
the interpretation 
dt - nn - 
Phrase6415:
glucocorticoid-mediated autoregulation 
jj - nn - 
Phrase6416:
tissue-specific primary transcriptional response 
jj - jj - jj - nn - 
Phrase6417:
leukemic cell 
jj - nn - 
Phrase6418:
the relationship 
dt - nn - 
Phrase6419:
leukemic cell 
jj - nn - 
Phrase6420:
the reactivity 
dt - nn - 
Phrase6421:
monoclonal antibodies 
jj - nns - 
Phrase6422:
the suppressor 
dt - nn - 
Phrase6423:
peripheral blood 
jj - nn - 
Phrase6424:
leukemic cell 
jj - nn - 
Phrase6425:
an increase 
dt - nn - 
Phrase6426:
the surface 
dt - nn - 
Phrase6427:
cytotoxic t-lymphocytes 
jj - nns - 
Phrase6428:
the expression 
dt - nn - 
Phrase6429:
high levels 
jj - nns - 
Phrase6430:
these cells 
dt - nns - 
Phrase6431:
untreated cells 
jj - nns - 
Phrase6432:
either cd8 
dt - nn - 
Phrase6433:
the leukemic clone 
dt - jj - nn - 
Phrase6434:
the suppressor 
dt - nn - 
Phrase6435:
the human 
dt - nn - 
Phrase6436:
leukemic cells 
jj - nns - 
Phrase6437:
the ability 
dt - nn - 
Phrase6438:
cd4+ cells 
jj - nns - 
Phrase6439:
the ability 
dt - nn - 
Phrase6440:
positive cell 
jj - nn - 
Phrase6441:
ifn-induced resistance 
jj - nn - 
Phrase6442:
natural killer 
jj - nn - 
Phrase6443:
cytopathic viruses 
jj - nns - 
Phrase6444:
cytolytic resistance 
jj - nn - 
Phrase6445:
cell-mediated cytolysis 
jj - nn - 
Phrase6446:
it 
prp - 
Phrase6447:
the shutdown 
dt - nn - 
Phrase6448:
cellular macromolecular 
jj - nn - 
Phrase6449:
cytopathic virus 
jj - nn - 
Phrase6450:
both ifn-mcp 
dt - nn - 
Phrase6451:
cellular protein 
jj - nn - 
Phrase6452:
the ad5-induced 
dt - nn - 
Phrase6453:
the expression 
dt - nn - 
Phrase6454:
the ad 
dt - nn - 
Phrase6455:
early region 
jj - nn - 
Phrase6456:
this hypothesis 
dt - nn - 
Phrase6457:
ifn-gamma-treated human 
jj - nn - 
Phrase6458:
an ad5 
dt - nn - 
Phrase6459:
the ad5 
dt - nn - 
Phrase6460:
the production 
dt - nn - 
Phrase6461:
large amounts 
jj - nns - 
Phrase6462:
parental cell 
jj - nn - 
Phrase6463:
genetic mapping 
jj - nn - 
Phrase6464:
the e1a 
dt - nn - 
Phrase6465:
the first exon 
dt - jj - nn - 
Phrase6466:
different ad 
jj - nn - 
Phrase6467:
the first exon 
dt - jj - nn - 
Phrase6468:
the e1a-conserved 
dt - nn - 
Phrase6469:
the expression 
dt - nn - 
Phrase6470:
the net 
dt - nn - 
Phrase6471:
the selective nk 
dt - jj - nn - 
Phrase6472:
cell-mediated clearance 
jj - nn - 
Phrase6473:
the ap-1 
dt - nn - 
Phrase6474:
nuclear factor 
jj - nn - 
Phrase6475:
nuclear factor 
jj - nn - 
Phrase6476:
transcriptional activator 
jj - nn - 
Phrase6477:
the induction 
dt - nn - 
Phrase6478:
the response 
dt - nn - 
Phrase6479:
the il-2 
dt - nn - 
Phrase6480:
regulatory region 
jj - nn - 
Phrase6481:
the composition 
dt - nn - 
Phrase6482:
we 
prp - 
Phrase6483:
normal human 
jj - nn - 
Phrase6484:
an ap-1 
dt - nn - 
Phrase6485:
the nf-at 
dt - nn - 
Phrase6486:
the ability 
dt - nn - 
Phrase6487:
the ap-1 
dt - nn - 
Phrase6488:
the nf-at 
dt - nn - 
Phrase6489:
the capacity 
dt - nn - 
Phrase6490:
anti-fos antibodies 
jj - nns - 
Phrase6491:
nf-at-binding activity 
jj - nn - 
Phrase6492:
nuclear extracts 
jj - nns - 
Phrase6493:
detectable binding 
jj - nn - 
Phrase6494:
the nf-at 
dt - nn - 
Phrase6495:
the nf-at 
dt - nn - 
Phrase6496:
the binding 
dt - nn - 
Phrase6497:
the ap-1 
dt - nn - 
Phrase6498:
the presence 
dt - nn - 
Phrase6499:
an ap-1 
dt - nn - 
Phrase6500:
the nf-at 
dt - nn - 
Phrase6501:
nf-at-binding activity 
jj - nn - 
Phrase6502:
protein-protein interaction 
jj - nn - 
Phrase6503:
factor-binding elements 
jj - nns - 
Phrase6504:
an interleukin-2 
dt - nn - 
Phrase6505:
we 
prp - 
Phrase6506:
short enhancer 
jj - nn - 
Phrase6507:
the nf-kappa 
dt - nn - 
Phrase6508:
the interleukin-2 
dt - nn - 
Phrase6509:
the il-2r 
dt - nn - 
Phrase6510:
the nf-kappa 
dt - nn - 
Phrase6511:
the nf-kappa 
dt - nn - 
Phrase6512:
the il-2r 
dt - nn - 
Phrase6513:
both sites 
dt - nns - 
Phrase6514:
strong transcriptional activity 
jj - jj - nn - 
Phrase6515:
the levels 
dt - nns - 
Phrase6516:
other cell 
jj - nn - 
Phrase6517:
the il-2r 
dt - nn - 
Phrase6518:
it 
prp - 
Phrase6519:
the high level 
dt - jj - nn - 
Phrase6520:
mutual regulation 
jj - nn - 
Phrase6521:
the transcriptional activator 
dt - jj - nn - 
Phrase6522:
its 
prp$ - 
Phrase6523:
the nk-kappa 
dt - nn - 
Phrase6524:
the cytoplasm 
dt - nn - 
Phrase6525:
the inhibitory protein 
dt - jj - nn - 
Phrase6526:
various cellular stimuli 
jj - jj - nns - 
Phrase6527:
this inhibition 
dt - nn - 
Phrase6528:
nuclear localization 
jj - nn - 
Phrase6529:
its 
prp$ - 
Phrase6530:
it 
prp - 
Phrase6531:
different stimuli 
jj - nns - 
Phrase6532:
rapid degradation 
jj - nn - 
Phrase6533:
concomitant activation 
jj - nn - 
Phrase6534:
dramatic increase 
jj - nn - 
Phrase6535:
the i 
dt - nn - 
Phrase6536:
we 
prp - 
Phrase6537:
each other in 
dt - jj - nn - 
Phrase6538:
saturating amounts 
jj - nns - 
Phrase6539:
the inhibitory i 
dt - jj - nn - 
Phrase6540:
rapid activation 
jj - nn - 
Phrase6541:
an equilibrium 
dt - nn - 
Phrase6542:
the -201 
dt - nn - 
Phrase6543:
the long terminal 
dt - jj - nn - 
Phrase6544:
previous transfection 
jj - nn - 
Phrase6545:
the chloramphenicol 
dt - nn - 
Phrase6546:
we 
prp - 
Phrase6547:
the transcription 
dt - nn - 
Phrase6548:
the human 
dt - nn - 
Phrase6549:
long terminal 
jj - nn - 
Phrase6550:
moderate decreases 
jj - nns - 
Phrase6551:
transcriptional activity 
jj - nn - 
Phrase6552:
the significance 
dt - nn - 
Phrase6553:
this region 
dt - nn - 
Phrase6554:
the context 
dt - nn - 
Phrase6555:
viral replication 
jj - nn - 
Phrase6556:
we 
prp - 
Phrase6557:
these ls 
dt - nn - 
Phrase6558:
viral stocks 
jj - nns - 
Phrase6559:
they 
prp - 
Phrase6560:
the nuclear factor 
dt - jj - nn - 
Phrase6561:
sp1-binding sites 
jj - nns - 
Phrase6562:
viral replication 
jj - nn - 
Phrase6563:
our 
prp$ - 
Phrase6564:
an adequate 
dt - nn - 
Phrase6565:
the effects 
dt - nns - 
Phrase6566:
the ls 
dt - nn - 
Phrase6567:
the analysis 
dt - nn - 
Phrase6568:
viral replication 
jj - nn - 
Phrase6569:
viral stock 
jj - nn - 
Phrase6570:
more accurate picture 
jjr - jj - nn - 
Phrase6571:
the transfection 
dt - nn - 
Phrase6572:
viral replication 
jj - nn - 
Phrase6573:
the effects 
dt - nns - 
Phrase6574:
their 
prp$ - 
Phrase6575:
the effects 
dt - nns - 
Phrase6576:
their 
prp$ - 
Phrase6577:
we 
prp - 
Phrase6578:
type-specific permissiveness 
jj - nn - 
Phrase6579:
some mutant 
dt - nn - 
Phrase6580:
the cell 
dt - nn - 
Phrase6581:
the ls 
dt - nn - 
Phrase6582:
an apparent requirement 
dt - jj - nn - 
Phrase6583:
the intact nf-kappa 
dt - jj - nn - 
Phrase6584:
sp1-binding sites 
jj - nns - 
Phrase6585:
several regions 
jj - nns - 
Phrase6586:
viral infectivity 
jj - nn - 
Phrase6587:
erythroid development 
jj - nn - 
Phrase6588:
we 
prp - 
Phrase6589:
derived experimental system 
jj - jj - nn - 
Phrase6590:
us 
prp - 
Phrase6591:
the function 
dt - nn - 
Phrase6592:
red cell 
jj - nn - 
Phrase6593:
genetic level 
jj - nn - 
Phrase6594:
we 
prp - 
Phrase6595:
the essential nature 
dt - jj - nn - 
Phrase6596:
definitive erythropoiesis 
jj - nn - 
Phrase6597:
the expression 
dt - nn - 
Phrase6598:
the endogenous gata-1 
dt - jj - nn - 
Phrase6599:
we 
prp - 
Phrase6600:
subtle modifications 
jj - nns - 
Phrase6601:
protein-coding sequences 
jj - nns - 
Phrase6602:
we 
prp - 
Phrase6603:
regulatory regions 
jj - nns - 
Phrase6604:
functional domains 
jj - nns - 
Phrase6605:
the protein 
dt - nn - 
Phrase6606:
the context 
dt - nn - 
Phrase6607:
true erythroid environment 
jj - jj - nn - 
Phrase6608:
possible heretofore 
jj - nn - 
Phrase6609:
the assay 
dt - nn - 
Phrase6610:
the dramatic loss 
dt - jj - nn - 
Phrase6611:
red cell 
jj - nn - 
Phrase6612:
it 
prp - 
Phrase6613:
important regulatory domains 
jj - jj - nns - 
Phrase6614:
stringent systems 
jj - nns - 
Phrase6615:
cell-free extracts 
jj - nns - 
Phrase6616:
the ideal 
dt - nn - 
Phrase6617:
these cells 
dt - nns - 
Phrase6618:
the requirement 
dt - nn - 
Phrase6619:
red cell 
jj - nn - 
Phrase6620:
s. 
nnp - 
Phrase6621:
it 
prp - 
Phrase6622:
such cells 
jj - nns - 
Phrase6623:
first expressing 
jj - nn - 
Phrase6624:
the epo 
dt - nn - 
Phrase6625:
the influence 
dt - nn - 
Phrase6626:
constitutive promoter 
jj - nn - 
Phrase6627:
the gata-1 
dt - nn - 
Phrase6628:
the analyses 
dt - nns - 
Phrase6629:
the actual transcription 
dt - jj - nn - 
Phrase6630:
the globin 
dt - nn - 
Phrase6631:
structure-function studies 
jj - nns - 
Phrase6632:
the gata-1 
dt - nn - 
Phrase6633:
larger number 
jjr - nn - 
Phrase6634:
the es 
dt - nn - 
Phrase6635:
an alternative 
dt - nn - 
Phrase6636:
other applications 
jj - nns - 
Phrase6637:
the introduction 
dt - nn - 
Phrase6638:
other gata-binding 
jj - nn - 
Phrase6639:
they 
prp - 
Phrase6640:
the mutation 
dt - nn - 
Phrase6641:
they 
prp - 
Phrase6642:
chimeric proteins 
jj - nns - 
Phrase6643:
the different family 
dt - jj - nn - 
Phrase6644:
we 
prp - 
Phrase6645:
these experiments 
dt - nns - 
Phrase6646:
the function 
dt - nn - 
Phrase6647:
erythroid ontogeny 
jj - nn - 
Phrase6648:
red cell 
jj - nn - 
Phrase6649:
the epo 
dt - nn - 
Phrase6650:
we 
prp - 
Phrase6651:
the functional domains 
dt - jj - nns - 
Phrase6652:
the gata-binding 
dt - nn - 
Phrase6653:
we 
prp - 
Phrase6654:
the basic transcription 
dt - jj - nn - 
Phrase6655:
the locus 
dt - nn - 
Phrase6656:
different globin 
jj - nn - 
Phrase6657:
we 
prp - 
Phrase6658:
the protein 
dt - nn - 
Phrase6659:
embryonic expression 
jj - nn - 
Phrase6660:
putative lymphocyte 
jj - nn - 
Phrase6661:
rodent gene 
jj - nn - 
Phrase6662:
putative g0/g1 
jj - nn - 
Phrase6663:
regulatory genes 
jj - nns - 
Phrase6664:
the addition 
dt - nn - 
Phrase6665:
the corresponding genomic sequence 
dt - jj - jj - nn - 
Phrase6666:
an open 
dt - nn - 
Phrase6667:
the sequence 
dt - nn - 
Phrase6668:
an rna 
dt - nn - 
Phrase6669:
the cell 
dt - nn - 
Phrase6670:
rodent homologs 
jj - nns - 
Phrase6671:
the rat 
dt - nn - 
Phrase6672:
this group 
dt - nn - 
Phrase6673:
the carboxyl 
dt - nn - 
Phrase6674:
putative zinc 
jj - nn - 
Phrase6675:
the large subunit 
dt - jj - nn - 
Phrase6676:
eukaryotic rna 
jj - nn - 
Phrase6677:
genomic sequences 
jj - nns - 
Phrase6678:
high conservation 
jj - nn - 
Phrase6679:
the 5' 
dt - nn - 
Phrase6680:
the germ 
dt - nn - 
Phrase6681:
the 5' 
dt - nn - 
Phrase6682:
genomic sequences 
jj - nns - 
Phrase6683:
the g0s24 
dt - nn - 
Phrase6684:
similar role 
jj - nn - 
Phrase6685:
lymphoid-specific immunoglobulin 
jj - nn - 
Phrase6686:
heavy chain 
jj - nn - 
Phrase6687:
the enhancer 
dt - nn - 
Phrase6688:
the immunoglobulin 
dt - nn - 
Phrase6689:
heavy chain 
jj - nn - 
Phrase6690:
heterologous gene 
jj - nn - 
Phrase6691:
the pre-b 
dt - nn - 
Phrase6692:
lymphoid-specific element 
jj - nn - 
Phrase6693:
the pu.1/spi-1 
dt - nn - 
Phrase6694:
another sequence 
dt - nn - 
Phrase6695:
the mu 
dt - nn - 
Phrase6696:
the product 
dt - nn - 
Phrase6697:
the ets-1 
dt - nn - 
Phrase6698:
the microa 
dt - nn - 
Phrase6699:
minimal b 
jj - nn - 
Phrase6700:
cell-specific enhancer 
jj - nn - 
Phrase6701:
both pu.1 
dt - nn - 
Phrase6702:
both pu.1 
dt - nn - 
Phrase6703:
nonlymphoid cells 
jj - nns - 
Phrase6704:
the minimal mu 
dt - jj - nn - 
Phrase6705:
these results 
dt - nns - 
Phrase6706:
the ets 
dt - nn - 
Phrase6707:
the activation 
dt - nn - 
Phrase6708:
monocytic cell 
jj - nn - 
Phrase6709:
monocytic differentiation 
jj - nn - 
Phrase6710:
histiocytic lymphoma 
jj - nn - 
Phrase6711:
an otherwise ineffective dose 
dt - jj - jj - nn - 
Phrase6712:
both agents 
dt - nns - 
Phrase6713:
the kinetics 
dt - nn - 
Phrase6714:
specific cellular response 
jj - jj - nn - 
Phrase6715:
the metabolic cascade 
dt - jj - nn - 
Phrase6716:
possible need 
jj - nn - 
Phrase6717:
transcriptional activators 
jj - nns - 
Phrase6718:
ectopic expression 
jj - nn - 
Phrase6719:
conditional gata-2/estrogen 
jj - nn - 
Phrase6720:
erythroid differentiation 
jj - nn - 
Phrase6721:
the gata 
dt - nn - 
Phrase6722:
transcriptional regulatory proteins 
jj - jj - nns - 
Phrase6723:
extensive homology 
jj - nn - 
Phrase6724:
their 
prp$ - 
Phrase6725:
several gata 
jj - nn - 
Phrase6726:
the same dna-binding 
dt - jj - nn - 
Phrase6727:
erythroid cells 
jj - nns - 
Phrase6728:
the roles 
dt - nns - 
Phrase6729:
conditional alleles 
jj - nns - 
Phrase6730:
the factors 
dt - nn - 
Phrase6731:
the hormone-binding domain 
dt - jj - nn - 
Phrase6732:
the human 
dt - nn - 
Phrase6733:
these gata/er 
dt - nn - 
Phrase6734:
chimeric factors 
jj - nn - 
Phrase6735:
hormone-inducible trans-activating proteins 
dt - jj - nns - 
Phrase6736:
primary erythroblasts 
jj - nns - 
Phrase6737:
erythroid progenitors 
jj - nns - 
Phrase6738:
exogenous gata-2/er 
jj - nn - 
Phrase6739:
an estrogen-dependent manner 
dt - jj - nn - 
Phrase6740:
these phenotypic effects 
dt - jj - nns - 
Phrase6741:
the action 
dt - nn - 
Phrase6742:
exogenous gata-2 
jj - nn - 
Phrase6743:
erythroid progenitors 
jj - nns - 
Phrase6744:
the gata-2 
dt - nn - 
Phrase6745:
the self-renewal 
dt - nn - 
Phrase6746:
early erythroid progenitor 
jj - jj - nn - 
Phrase6747:
endotoxic shock 
jj - nn - 
Phrase6748:
the multiple biological activities 
dt - jj - jj - nns - 
Phrase6749:
distinct cell 
jj - nn - 
Phrase6750:
we 
prp - 
Phrase6751:
normal numbers 
jj - nns - 
Phrase6752:
high affinity 
jj - nn - 
Phrase6753:
clonal deletion 
jj - nn - 
Phrase6754:
self-reactive t 
jj - nn - 
Phrase6755:
the failure 
dt - nn - 
Phrase6756:
the loss 
dt - nn - 
Phrase6757:
lethal dosages 
jj - nn - 
Phrase6758:
either lipopolysaccharides 
dt - nns - 
Phrase6759:
s. 
nnp - 
Phrase6760:
the host 
dt - nn - 
Phrase6761:
their 
prp$ - 
Phrase6762:
pathogenic factors 
jj - nn - 
Phrase6763:
peripheral blood 
jj - nn - 
Phrase6764:
important roles 
jj - nns - 
Phrase6765:
the pathogenesis 
dt - nn - 
Phrase6766:
we 
prp - 
Phrase6767:
umbilical vein 
jj - nn - 
Phrase6768:
pha-stimulated pbl 
jj - nn - 
Phrase6769:
an unidentified ligand 
dt - jj - nn - 
Phrase6770:
the physiologic relevance 
dt - jj - nn - 
Phrase6771:
this increase 
dt - nn - 
Phrase6772:
the proliferative 
dt - nn - 
Phrase6773:
we 
prp - 
Phrase6774:
we 
prp - 
Phrase6775:
the effects 
dt - nns - 
Phrase6776:
nuclear factors 
jj - nn - 
Phrase6777:
the transcription 
dt - nn - 
Phrase6778:
the level 
dt - nn - 
Phrase6779:
the absence 
dt - nn - 
Phrase6780:
the level 
dt - nn - 
Phrase6781:
pha-activated t 
jj - nn - 
Phrase6782:
the cd2 
dt - nn - 
Phrase6783:
gel-shift analysis 
jj - nn - 
Phrase6784:
the constitutive presence 
dt - jj - nn - 
Phrase6785:
nuclear factors 
jj - nn - 
Phrase6786:
the proximal 
dt - nn - 
Phrase6787:
the il-2 
dt - nn - 
Phrase6788:
immunoreactive c-jun 
jj - nn - 
Phrase6789:
pha-activated cells 
jj - nns - 
Phrase6790:
low levels 
jj - nns - 
Phrase6791:
dramatic increase 
jj - nn - 
Phrase6792:
the c-fos 
dt - nn - 
Phrase6793:
other nuclear factors 
jj - jj - nn - 
Phrase6794:
different mobility 
jj - nn - 
Phrase6795:
our 
prp$ - 
Phrase6796:
the composition 
dt - nn - 
Phrase6797:
key molecular 
jj - nn - 
Phrase6798:
the phenomenon 
dt - nn - 
Phrase6799:
transcriptional activation 
jj - nn - 
Phrase6800:
the alpha 
dt - nn - 
Phrase6801:
regulatory element 
jj - nn - 
Phrase6802:
functional role 
jj - nn - 
Phrase6803:
specific nuclear factor-dna 
jj - jj - nn - 
Phrase6804:
we 
prp - 
Phrase6805:
the functional interaction 
dt - jj - nn - 
Phrase6806:
embryonic zeta 
jj - nn - 
Phrase6807:
the alpha 
dt - nn - 
Phrase6808:
regulatory element 
jj - nn - 
Phrase6809:
the zeta 
dt - nn - 
Phrase6810:
it 
prp - 
Phrase6811:
an authentic enhancer 
dt - jj - nn - 
Phrase6812:
high-level zeta 
jj - nn - 
Phrase6813:
an erythroid cell 
dt - jj - nn - 
Phrase6814:
fetal origin 
jj - nn - 
Phrase6815:
the zeta 
dt - nn - 
Phrase6816:
its 
prp$ - 
Phrase6817:
enhancerless plasmids 
jj - nns - 
Phrase6818:
they 
prp - 
Phrase6819:
the hs-40 
dt - nn - 
Phrase6820:
enhancer-mediated activity 
jj - nn - 
Phrase6821:
the zeta 
dt - nn - 
Phrase6822:
site-directed mutagenesis 
jj - nn - 
Phrase6823:
this hs-40 
dt - nn - 
Phrase6824:
located at 
jj - nn - 
Phrase6825:
the functional domains 
dt - jj - nns - 
Phrase6826:
the functional core 
dt - jj - nn - 
Phrase6827:
the erythroid-specific activation 
dt - jj - nn - 
Phrase6828:
the zeta 
dt - nn - 
Phrase6829:
site-directed mutagenesis 
jj - nn - 
Phrase6830:
the enhancer 
dt - nn - 
Phrase6831:
its 
prp$ - 
Phrase6832:
we 
prp - 
Phrase6833:
genomic footprinting 
jj - nn - 
Phrase6834:
the hs-40 
dt - nn - 
Phrase6835:
nucleated erythroblasts 
jj - nns - 
Phrase6836:
different nonerythroid cells 
jj - jj - nns - 
Phrase6837:
the functional core 
dt - jj - nn - 
Phrase6838:
nuclear factor 
jj - nn - 
Phrase6839:
nonerythroid cells 
jj - nns - 
Phrase6840:
the other hand 
dt - jj - nn - 
Phrase6841:
nonfunctional sequence 
jj - nn - 
Phrase6842:
nucleated erythroblasts 
jj - nns - 
Phrase6843:
nuclear factor 
jj - nn - 
Phrase6844:
the hs-40 
dt - nn - 
Phrase6845:
these data 
dt - nns - 
Phrase6846:
transcriptional activation 
jj - nn - 
Phrase6847:
embryonic zeta 
jj - nn - 
Phrase6848:
the fetal/adult 
dt - nn - 
Phrase6849:
developmental stage-specific nuclear factor-dna 
jj - jj - jj - nn - 
Phrase6850:
the enhancer 
dt - nn - 
Phrase6851:
the globin 
dt - nn - 
Phrase6852:
transcriptional regulation 
jj - nn - 
Phrase6853:
the pyruvate 
dt - nn - 
Phrase6854:
erythroid-specific promoter 
jj - nn - 
Phrase6855:
the l 
dt - nn - 
Phrase6856:
the alternative 
dt - nn - 
Phrase6857:
we 
prp - 
Phrase6858:
the characterization 
dt - nn - 
Phrase6859:
trans-acting elements 
jj - nns - 
Phrase6860:
the tissue-specific activity 
dt - jj - nn - 
Phrase6861:
the l 
dt - nn - 
Phrase6862:
erythroid promoter 
jj - nn - 
Phrase6863:
the cap 
dt - nn - 
Phrase6864:
erythroid specificity 
jj - nn - 
Phrase6865:
this region 
dt - nn - 
Phrase6866:
we 
prp - 
Phrase6867:
minimal promoter 
jj - nn - 
Phrase6868:
erythroid-specific activity 
jj - nn - 
Phrase6869:
located at 
jj - nn - 
Phrase6870:
the ccacc/sp1 
dt - nn - 
Phrase6871:
located at 
jj - nn - 
Phrase6872:
the erythroid factor 
dt - jj - nn - 
Phrase6873:
it 
prp - 
Phrase6874:
the substitution 
dt - nn - 
Phrase6875:
this gata 
dt - nn - 
Phrase6876:
canonical tfiid 
jj - nn - 
Phrase6877:
the promoter 
dt - nn - 
Phrase6878:
both sites 
dt - nns - 
Phrase6879:
the association 
dt - nn - 
Phrase6880:
tissue-specific expression 
jj - nn - 
Phrase6881:
this r-pk 
dt - nn - 
Phrase6882:
minimal promoter 
jj - nn - 
Phrase6883:
we 
prp - 
Phrase6884:
the elements 
dt - nns - 
Phrase6885:
the hgata-1 
dt - nn - 
Phrase6886:
the r-pk 
dt - nn - 
Phrase6887:
nuclear extracts 
jj - nns - 
Phrase6888:
the x 
dt - nn - 
Phrase6889:
the expression 
dt - nn - 
Phrase6890:
major histocompatibility 
jj - nn - 
Phrase6891:
several class 
jj - nn - 
Phrase6892:
the x 
dt - nn - 
Phrase6893:
genetic correlation 
jj - nn - 
Phrase6894:
deficient in 
jj - nn - 
Phrase6895:
some b 
dt - nn - 
Phrase6896:
congenital immunodeficiency 
jj - nn - 
Phrase6897:
the role 
dt - nn - 
Phrase6898:
the role 
dt - nn - 
Phrase6899:
the x 
dt - nn - 
Phrase6900:
-negative lymphoid cells 
jj - jj - nns - 
Phrase6901:
the wild-type b 
dt - jj - nn - 
Phrase6902:
transcriptional mutant 
jj - nn - 
Phrase6903:
negative t 
jj - nn - 
Phrase6904:
wild-type b 
jj - nn - 
Phrase6905:
the class 
dt - nn - 
Phrase6906:
the x 
dt - nn - 
Phrase6907:
the expression 
dt - nn - 
Phrase6908:
the x 
dt - nn - 
Phrase6909:
transcriptional pathway 
jj - nn - 
Phrase6910:
defective in 
jj - nn - 
Phrase6911:
these cells 
dt - nns - 
Phrase6912:
the binding 
dt - nn - 
Phrase6913:
the x1 
dt - nn - 
Phrase6914:
wild-type b 
jj - nn - 
Phrase6915:
the mutant 
dt - nn - 
Phrase6916:
absent in 
jj - nn - 
Phrase6917:
other x1 
jj - nn - 
Phrase6918:
these cell 
dt - nn - 
Phrase6919:
these different x1 
dt - jj - nn - 
Phrase6920:
distinct dna 
jj - nn - 
Phrase6921:
the same factor 
dt - jj - nn - 
Phrase6922:
the crude nuclear extracts 
dt - jj - jj - nns - 
Phrase6923:
similar comparison 
jj - nn - 
Phrase6924:
the presence 
dt - nn - 
Phrase6925:
the band 
dt - nn - 
Phrase6926:
an absence 
dt - nn - 
Phrase6927:
the native rfx 
dt - jj - nn - 
Phrase6928:
detectable levels 
jj - nns - 
Phrase6929:
the band 
dt - nn - 
Phrase6930:
these results 
dt - nns - 
Phrase6931:
multiple x1 
jj - nn - 
Phrase6932:
lymphoid cells 
jj - nns - 
Phrase6933:
the presence 
dt - nn - 
Phrase6934:
heterologous enhancer/promoters 
jj - nn - 
Phrase6935:
different lymphocyte 
jj - nn - 
Phrase6936:
the human 
dt - nn - 
Phrase6937:
long terminal 
jj - nn - 
Phrase6938:
nuclear factor 
jj - nn - 
Phrase6939:
simian immunodeficiency 
jj - nn - 
Phrase6940:
the effects 
dt - nns - 
Phrase6941:
these motifs 
dt - nns - 
Phrase6942:
the replicative 
dt - nn - 
Phrase6943:
the possibility 
dt - nn - 
Phrase6944:
the virus 
dt - nn - 
Phrase6945:
heterologous enhancer/promoters 
jj - nn - 
Phrase6946:
the hiv-1 
dt - nn - 
Phrase6947:
the nf-kappa 
dt - nn - 
Phrase6948:
the effects 
dt - nns - 
Phrase6949:
these substitutions 
dt - nns - 
Phrase6950:
viral replication 
jj - nn - 
Phrase6951:
peripheral blood 
jj - nn - 
Phrase6952:
continuous t-leukemia 
jj - nn - 
Phrase6953:
the nf- 
dt - nn - 
Phrase6954:
the downstream tata 
dt - jj - nn - 
Phrase6955:
heterologous enhancer/promoters 
jj - nn - 
Phrase6956:
the human 
dt - nn - 
Phrase6957:
immediate-early enhancer 
jj - nn - 
Phrase6958:
infectious kinetics 
jj - nn - 
Phrase6959:
wild-type hiv 
jj - nn - 
Phrase6960:
peripheral blood 
jj - nn - 
Phrase6961:
these studies 
dt - nns - 
Phrase6962:
heterologous enhancer 
jj - nn - 
Phrase6963:
the hiv 
dt - nn - 
Phrase6964:
the context 
dt - nn - 
Phrase6965:
the production 
dt - nn - 
Phrase6966:
infectious progeny 
jj - nn - 
Phrase6967:
mandatory proximal 
jj - nn - 
Phrase6968:
the protein 
dt - nn - 
Phrase6969:
proc 
nnp - 
Phrase6970:
acad 
nnp - 
Phrase6971:
sci 
nnp - 
Phrase6972:
an active protein-tyrosine kinase 
dt - jj - jj - nn - 
Phrase6973:
regulatory pathway 
jj - nn - 
Phrase6974:
we 
prp - 
Phrase6975:
downstream activation 
jj - nn - 
Phrase6976:
covalent modification 
jj - nn - 
Phrase6977:
multiple serine-specific 
jj - nn - 
Phrase6978:
nuclear factor 
jj - nn - 
Phrase6979:
the radiation-induced 
dt - nn - 
Phrase6980:
the protein-tyrosine kinase 
dt - jj - nn - 
Phrase6981:
mandatory proximal 
jj - nn - 
Phrase6982:
the activation 
dt - nn - 
Phrase6983:
the protein 
dt - nn - 
Phrase6984:
our 
prp$ - 
Phrase6985:
current knowledge 
jj - nn - 
Phrase6986:
the radiation-induced 
dt - nn - 
Phrase6987:
the chronological 
dt - nn - 
Phrase6988:
biochemical events 
jj - nns - 
Phrase6989:
peripheral blood 
jj - nn - 
Phrase6990:
persistent infections 
jj - nns - 
Phrase6991:
immunocompromised hosts 
jj - nns - 
Phrase6992:
adenoviral persistence 
jj - nn - 
Phrase6993:
the ability 
dt - nn - 
Phrase6994:
peripheral blood 
jj - nn - 
Phrase6995:
this hypothesis 
dt - nn - 
Phrase6996:
specific polymerase 
jj - nn - 
Phrase6997:
nested primers 
jj - nns - 
Phrase6998:
the adenovirus 
dt - nn - 
Phrase6999:
the e1a 
dt - nn - 
Phrase7000:
adenoviral serotypes 
jj - nns - 
Phrase7001:
adenoviral groups 
jj - nns - 
Phrase7002:
single copy 
jj - nn - 
Phrase7003:
the adenovirus 
dt - nn - 
Phrase7004:
the group 
dt - nn - 
Phrase7005:
healthy adults 
jj - nns - 
Phrase7006:
pediatric samples 
jj - nns - 
Phrase7007:
low level 
jj - nn - 
Phrase7008:
nested pcr 
jj - nn - 
Phrase7009:
fatal adenoviral infection 
jj - jj - nn - 
Phrase7010:
it 
prp - 
Phrase7011:
previous study 
jj - nn - 
Phrase7012:
persistent group 
jj - nn - 
Phrase7013:
adenoviral infection 
jj - nn - 
Phrase7014:
the adenovirus-specific pcr 
dt - jj - nn - 
Phrase7015:
early invasive disease 
jj - jj - nn - 
Phrase7016:
hiv-1-infected cells 
jj - nns - 
Phrase7017:
the inter-relationship 
dt - nn - 
Phrase7018:
the cell 
dt - nn - 
Phrase7019:
an immunoregulatory cytokine 
dt - jj - nn - 
Phrase7020:
promonocytic cells 
jj - nns - 
Phrase7021:
they 
prp - 
Phrase7022:
specific monoclonal antibody 
jj - jj - nn - 
Phrase7023:
the om-10.1 
dt - nn - 
Phrase7024:
promyelocytic model 
jj - nn - 
Phrase7025:
chronic infection 
jj - nn - 
Phrase7026:
tnf-alpha-induced hiv-1 
jj - nn - 
Phrase7027:
substantial increase 
jj - nn - 
Phrase7028:
uninfected parental hl-60 
jj - jj - nn - 
Phrase7029:
the same tnf-alpha-dose 
dt - jj - nn - 
Phrase7030:
the peak 
dt - nn - 
Phrase7031:
an acute hiv-1 
dt - jj - nn - 
Phrase7032:
tnf-alpha-induced hiv 
jj - nn - 
Phrase7033:
this receptor 
dt - nn - 
Phrase7034:
the viral activation 
dt - jj - nn - 
Phrase7035:
the absence 
dt - nn - 
Phrase7036:
exogenous tnf-alpha 
jj - nn - 
Phrase7037:
maximal hiv-1 
jj - nn - 
Phrase7038:
an up-modulation 
dt - nn - 
Phrase7039:
nuclear nf-kappa 
jj - nn - 
Phrase7040:
the case 
dt - nn - 
Phrase7041:
an antagonistic anti-tr55 
dt - jj - nn - 
Phrase7042:
promonocytic cultures 
jj - nns - 
Phrase7043:
tnf-alpha-induced hiv-1 
jj - nn - 
Phrase7044:
our 
prp$ - 
Phrase7045:
the surface 
dt - nn - 
Phrase7046:
its 
prp$ - 
Phrase7047:
own expression 
jj - nn - 
Phrase7048:
normal immunoregulatory signal 
jj - jj - nn - 
Phrase7049:
comparative mapping 
jj - nn - 
Phrase7050:
the great apes 
dt - jj - nn - 
Phrase7051:
cytogenetic studies 
jj - nns - 
Phrase7052:
the primate 
dt - nn - 
Phrase7053:
extensive rearrangements 
jj - nns - 
Phrase7054:
the great apes 
dt - jj - nn - 
Phrase7055:
we 
prp - 
Phrase7056:
these rearrangements 
dt - nns - 
Phrase7057:
the molecular 
dt - nn - 
Phrase7058:
the sex 
dt - nn - 
Phrase7059:
the y 
dt - nn - 
Phrase7060:
great apes 
jj - nn - 
Phrase7061:
the low copy 
dt - jj - nn - 
Phrase7062:
the probe 
dt - nn - 
Phrase7063:
these results 
dt - nns - 
Phrase7064:
previous studies 
jj - nns - 
Phrase7065:
the y 
dt - nn - 
Phrase7066:
great apes 
jj - nn - 
Phrase7067:
the pseudoautosomal 
dt - nn - 
Phrase7068:
the testis-determining 
dt - nn - 
Phrase7069:
the rest 
dt - nn - 
Phrase7070:
the y 
dt - nn - 
Phrase7071:
several rearrangements 
jj - nns - 
Phrase7072:
the different great apes 
dt - jj - jj - nn - 
Phrase7073:
dependent activation 
jj - nn - 
Phrase7074:
the nf-at 
dt - nn - 
Phrase7075:
the control 
dt - nn - 
Phrase7076:
these signals 
dt - nns - 
Phrase7077:
the reporter 
dt - nn - 
Phrase7078:
the tyrosine 
dt - nn - 
Phrase7079:
the reporter 
dt - nn - 
Phrase7080:
the calcium 
dt - nn - 
Phrase7081:
the activation 
dt - nn - 
Phrase7082:
the immunosuppressant 
dt - nn - 
Phrase7083:
the proliferative 
dt - nn - 
Phrase7084:
an established erythroid differentiation 
dt - jj - jj - nn - 
Phrase7085:
hematopoietic cell 
jj - nn - 
Phrase7086:
erythroid differentiation 
jj - nn - 
Phrase7087:
the activation 
dt - nn - 
Phrase7088:
erythroid-specific genes 
jj - nns - 
Phrase7089:
the globin 
dt - nn - 
Phrase7090:
the erythropoietin 
dt - nn - 
Phrase7091:
least in 
jjs - nn - 
Phrase7092:
the transcription 
dt - nn - 
Phrase7093:
the relationship 
dt - nn - 
Phrase7094:
erythroid differentiation 
jj - nn - 
Phrase7095:
we 
prp - 
Phrase7096:
the expression 
dt - nn - 
Phrase7097:
an epo-dependent human 
dt - jj - nn - 
Phrase7098:
the results 
dt - nns - 
Phrase7099:
the parental granulocyte-macrophage 
dt - jj - nn - 
Phrase7100:
colony-stimulating factor 
jj - nn - 
Phrase7101:
-dependent cell 
jj - nn - 
Phrase7102:
megakaryoblastic phenotype 
jj - nn - 
Phrase7103:
the presence 
dt - nn - 
Phrase7104:
similar levels 
jj - nns - 
Phrase7105:
comparable levels 
jj - nns - 
Phrase7106:
the number 
dt - nn - 
Phrase7107:
the number 
dt - nn - 
Phrase7108:
the number 
dt - nn - 
Phrase7109:
the parental ut-7 
dt - jj - nn - 
Phrase7110:
detectable levels 
jj - nns - 
Phrase7111:
higher levels 
jjr - nns - 
Phrase7112:
the frequency 
dt - nn - 
Phrase7113:
the cells 
dt - nns - 
Phrase7114:
gamma-specific antibodies 
jj - nns - 
Phrase7115:
the number 
dt - nn - 
Phrase7116:
their 
prp$ - 
Phrase7117:
higher in 
jjr - nn - 
Phrase7118:
positive cells 
jj - nns - 
Phrase7119:
positive cells 
jj - nns - 
Phrase7120:
the increase 
dt - nn - 
Phrase7121:
both increase 
dt - nn - 
Phrase7122:
an increase 
dt - nn - 
Phrase7123:
the levels 
dt - nns - 
Phrase7124:
24-hour incubation 
jj - nn - 
Phrase7125:
either cell 
dt - nn - 
Phrase7126:
the sp1 
dt - nn - 
Phrase7127:
the cd11b 
dt - nn - 
Phrase7128:
myeloid-specific promoter 
jj - nn - 
Phrase7129:
the myeloid 
dt - nn - 
Phrase7130:
the surface 
dt - nn - 
Phrase7131:
mature macrophages 
jj - nns - 
Phrase7132:
natural killer 
jj - nn - 
Phrase7133:
lineage-specific expression 
jj - nn - 
Phrase7134:
the level 
dt - nn - 
Phrase7135:
recent isolation 
jj - nn - 
Phrase7136:
the cd11b 
dt - nn - 
Phrase7137:
5'-flanking dna 
jj - nn - 
Phrase7138:
myeloid-specific expression 
jj - nn - 
Phrase7139:
regulatory sequences 
jj - nns - 
Phrase7140:
we 
prp - 
Phrase7141:
the 92-bp 
dt - nn - 
Phrase7142:
we 
prp - 
Phrase7143:
this sequence 
dt - nn - 
Phrase7144:
the transcription 
dt - nn - 
Phrase7145:
the sp1 
dt - nn - 
Phrase7146:
cervical carcinoma 
jj - nn - 
Phrase7147:
the macrophage 
dt - nn - 
Phrase7148:
the cd11b 
dt - nn - 
Phrase7149:
the sp1 
dt - nn - 
Phrase7150:
we 
prp - 
Phrase7151:
myeloid-specific factor 
jj - nn - 
Phrase7152:
general factor 
jj - nn - 
Phrase7153:
tissue-specific fashion 
jj - nn - 
Phrase7154:
the myeloid-specific expression 
dt - jj - nn - 
Phrase7155:
autoreactive t-cells 
jj - nns - 
Phrase7156:
putative glycolipid 
jj - nn - 
Phrase7157:
some iddm 
dt - nn - 
Phrase7158:
high titer 
jj - nn - 
Phrase7159:
placental clones 
jj - nns - 
Phrase7160:
the nuclear transcription 
dt - jj - nn - 
Phrase7161:
peripheral blood 
jj - nn - 
Phrase7162:
significant proliferation 
jj - nn - 
Phrase7163:
other autoimmune disease 
jj - jj - nn - 
Phrase7164:
healthy control 
jj - nn - 
Phrase7165:
the groups 
dt - nns - 
Phrase7166:
autoreactive t-cells 
jj - nns - 
Phrase7167:
novel antigen 
jj - nn - 
Phrase7168:
the development 
dt - nn - 
Phrase7169:
clinical disease 
jj - nn - 
Phrase7170:
important in 
jj - nn - 
Phrase7171:
cellular functions 
jj - nns - 
Phrase7172:
the phosphorylation 
dt - nn - 
Phrase7173:
their 
prp$ - 
Phrase7174:
the inhibitors 
dt - nns - 
Phrase7175:
these phosphatases 
dt - nns - 
Phrase7176:
okadaic acid 
jj - nn - 
Phrase7177:
the mrna 
dt - nn - 
Phrase7178:
the increase 
dt - nn - 
Phrase7179:
the transcription 
dt - nn - 
Phrase7180:
the interleukin-1 
dt - nn - 
Phrase7181:
the stimulation 
dt - nn - 
Phrase7182:
these protein 
dt - nn - 
Phrase7183:
okadaic acid 
jj - nn - 
Phrase7184:
the synthesis 
dt - nn - 
Phrase7185:
the interleukin-1 
dt - nn - 
Phrase7186:
mature forms 
jj - nns - 
Phrase7187:
their 
prp$ - 
Phrase7188:
the stimulation 
dt - nn - 
Phrase7189:
the stimulation 
dt - nn - 
Phrase7190:
okadaic acid 
jj - nn - 
Phrase7191:
the phosphorylation 
dt - nn - 
Phrase7192:
the precursor 
dt - nn - 
Phrase7193:
these results 
dt - nns - 
Phrase7194:
multiple effects 
jj - nns - 
Phrase7195:
important roles 
jj - nns - 
Phrase7196:
the interleukin 
dt - nn - 
Phrase7197:
cd28-responsive complex 
jj - nn - 
Phrase7198:
the nf 
dt - nn - 
Phrase7199:
optimal activation 
jj - nn - 
Phrase7200:
the antigen-specific t-cell 
dt - jj - nn - 
Phrase7201:
the second 
dt - nn - 
Phrase7202:
the costimulatory 
dt - nn - 
Phrase7203:
the antigen-presenting cell 
dt - jj - nn - 
Phrase7204:
this protein 
dt - nn - 
Phrase7205:
an important role 
dt - jj - nn - 
Phrase7206:
the second 
dt - nn - 
Phrase7207:
this report 
dt - nn - 
Phrase7208:
we 
prp - 
Phrase7209:
peripheral blood 
jj - nn - 
Phrase7210:
cd28-mediated signal 
jj - nn - 
Phrase7211:
the rel 
dt - nn - 
Phrase7212:
peripheral blood 
jj - nn - 
Phrase7213:
monoclonal antibody 
jj - nn - 
Phrase7214:
nuclear c-rel 
jj - nn - 
Phrase7215:
this augmentation 
dt - nn - 
Phrase7216:
the presence 
dt - nn - 
Phrase7217:
the immunosuppressant 
dt - nn - 
Phrase7218:
it 
prp - 
Phrase7219:
this report 
dt - nn - 
Phrase7220:
cd28-responsive element 
jj - nn - 
Phrase7221:
the promoter 
dt - nn - 
Phrase7222:
the human 
dt - nn - 
Phrase7223:
the functional significance 
dt - jj - nn - 
Phrase7224:
the cd28-responsive complex 
dt - jj - nn - 
Phrase7225:
the level 
dt - nn - 
Phrase7226:
the cd28-responsive element 
dt - jj - nn - 
Phrase7227:
acute lymphoblastic leukemia 
jj - jj - nn - 
Phrase7228:
putative transcription 
jj - nn - 
Phrase7229:
basic helix-loop-helix domain 
jj - jj - nn - 
Phrase7230:
hematopoietic cells 
jj - nns - 
Phrase7231:
we 
prp - 
Phrase7232:
the pattern 
dt - nn - 
Phrase7233:
hematopoietic cells 
jj - nns - 
Phrase7234:
the tal-1 
dt - nn - 
Phrase7235:
our 
prp$ - 
Phrase7236:
the tal-1 
dt - nn - 
Phrase7237:
these lineages 
dt - nns - 
Phrase7238:
the gata-1 
dt - nn - 
Phrase7239:
several genes 
jj - nns - 
Phrase7240:
we 
prp - 
Phrase7241:
hematopoietic cells 
jj - nns - 
Phrase7242:
we 
prp - 
Phrase7243:
the expression 
dt - nn - 
Phrase7244:
both genes 
dt - nns - 
Phrase7245:
megakaryocytic terminal 
jj - nn - 
Phrase7246:
immature hematopoietic cells 
jj - jj - nns - 
Phrase7247:
they 
prp - 
Phrase7248:
detectable in 
jj - nn - 
Phrase7249:
primitive cells 
jj - nns - 
Phrase7250:
primitive ones 
jj - nns - 
Phrase7251:
our 
prp$ - 
Phrase7252:
the transcription 
dt - nn - 
Phrase7253:
the differentiation 
dt - nn - 
Phrase7254:
the lytic transition 
dt - jj - nn - 
Phrase7255:
epstein-barr virus 
jj - nn - 
Phrase7256:
lytic transition 
jj - nn - 
Phrase7257:
epstein-barr virus 
jj - nn - 
Phrase7258:
distinct immediate early regulators 
jj - jj - jj - nns - 
Phrase7259:
the viral cycle 
dt - jj - nn - 
Phrase7260:
permissive conditions 
jj - nns - 
Phrase7261:
we 
prp - 
Phrase7262:
eukaryotic vectors 
jj - nns - 
Phrase7263:
the processes 
dt - nns - 
Phrase7264:
lytic transition 
jj - nn - 
Phrase7265:
stable b 
jj - nn - 
Phrase7266:
lytic ebv 
jj - nn - 
Phrase7267:
constitutive manner 
jj - nn - 
Phrase7268:
the production 
dt - nn - 
Phrase7269:
the bzlf 
dt - nn - 
Phrase7270:
the other hand 
dt - jj - nn - 
Phrase7271:
the lytic origin 
dt - jj - nn - 
Phrase7272:
different modes 
jj - nns - 
Phrase7273:
chemical induction 
jj - nn - 
Phrase7274:
lytic superinfection 
jj - nn - 
Phrase7275:
single gene 
jj - nn - 
Phrase7276:
the recombinant 
dt - nn - 
Phrase7277:
sufficient in 
jj - nn - 
Phrase7278:
the viral lytic cycle 
dt - jj - jj - nn - 
Phrase7279:
these experiments 
dt - nns - 
Phrase7280:
the r7-57 
dt - nn - 
Phrase7281:
lytic effect 
jj - nn - 
Phrase7282:
the reporter 
dt - nn - 
Phrase7283:
exogenous virus 
jj - nn - 
Phrase7284:
the cell 
dt - nn - 
Phrase7285:
these experiments 
dt - nns - 
Phrase7286:
the detection 
dt - nn - 
Phrase7287:
the potential 
dt - nn - 
Phrase7288:
the lytic regulatory gene 
dt - jj - jj - nn - 
Phrase7289:
the cd3-dependent t 
dt - jj - nn - 
Phrase7290:
persistent expression 
jj - nn - 
Phrase7291:
the ap-1 
dt - nn - 
Phrase7292:
the effects 
dt - nns - 
Phrase7293:
combined stimulation 
jj - nn - 
Phrase7294:
-dependent pathways 
jj - nns - 
Phrase7295:
different cellular systems 
jj - jj - nns - 
Phrase7296:
it 
prp - 
Phrase7297:
they 
prp - 
Phrase7298:
each other in 
dt - jj - nn - 
Phrase7299:
this report 
dt - nn - 
Phrase7300:
we 
prp - 
Phrase7301:
the stimulation 
dt - nn - 
Phrase7302:
both pathways 
dt - nns - 
Phrase7303:
the cd3/t 
dt - nn - 
Phrase7304:
deficient proliferative 
jj - nn - 
Phrase7305:
either bt2camp 
dt - nn - 
Phrase7306:
untreated samples 
jj - nns - 
Phrase7307:
we 
prp - 
Phrase7308:
an association 
dt - nn - 
Phrase7309:
mitogenic response 
jj - nn - 
Phrase7310:
low expression 
jj - nn - 
Phrase7311:
both interleukin-2 
dt - nn - 
Phrase7312:
the alpha 
dt - nn - 
Phrase7313:
the il-2 
dt - nn - 
Phrase7314:
intracellular ca2+ 
jj - nn - 
Phrase7315:
the cd3/tcr-dependent 
dt - nn - 
Phrase7316:
impaired in 
jj - nn - 
Phrase7317:
we 
prp - 
Phrase7318:
these samples 
dt - nns - 
Phrase7319:
persistent expression 
jj - nn - 
Phrase7320:
the c-fos 
dt - nn - 
Phrase7321:
these sustained effects 
dt - jj - nns - 
Phrase7322:
the interplay 
dt - nn - 
Phrase7323:
both metabolic stimuli 
dt - jj - nns - 
Phrase7324:
the data 
dt - nns - 
Phrase7325:
the evidence 
dt - nn - 
Phrase7326:
both pathways 
dt - nns - 
Phrase7327:
each other in 
dt - jj - nn - 
Phrase7328:
the tcr 
dt - nn - 
Phrase7329:
the lymphotoxin 
dt - nn - 
Phrase7330:
the htlv-i 
dt - nn - 
Phrase7331:
transcriptional activator 
jj - nn - 
Phrase7332:
the mechanism 
dt - nn - 
Phrase7333:
tax-expressing cell 
jj - nn - 
Phrase7334:
biologic activity 
jj - nn - 
Phrase7335:
an nf-kappa 
dt - nn - 
Phrase7336:
active in 
jj - nn - 
Phrase7337:
the lt-producing 
dt - nn - 
Phrase7338:
defective htlv-i 
jj - nn - 
Phrase7339:
the observation 
dt - nn - 
Phrase7340:
inactive in 
jj - nn - 
Phrase7341:
the importance 
dt - nn - 
Phrase7342:
the lt-kappa 
dt - nn - 
Phrase7343:
lesser extent 
jjr - nn - 
Phrase7344:
the increase 
dt - nn - 
Phrase7345:
the increase 
dt - nn - 
Phrase7346:
biologic activity 
jj - nn - 
Phrase7347:
these conditions 
dt - nns - 
Phrase7348:
these studies 
dt - nns - 
Phrase7349:
basal levels 
jj - nns - 
Phrase7350:
low-level activation 
jj - nn - 
Phrase7351:
both endogenous lt 
dt - jj - nn - 
Phrase7352:
the lt 
dt - nn - 
Phrase7353:
least in 
jjs - nn - 
Phrase7354:
epstein-barr viral dna 
jj - jj - nn - 
Phrase7355:
the replicative 
dt - nn - 
Phrase7356:
epstein-barr virus 
jj - nn - 
Phrase7357:
epstein-barr virus 
jj - nn - 
Phrase7358:
the lytic cycle 
dt - jj - nn - 
Phrase7359:
the cells 
dt - nns - 
Phrase7360:
the brlf1/bzlf1 
dt - nn - 
Phrase7361:
the p3hr-1 
dt - nn - 
Phrase7362:
defective genome 
jj - nn - 
Phrase7363:
we 
prp - 
Phrase7364:
the productive replicative 
dt - jj - nn - 
Phrase7365:
epstein-barr viral dna 
jj - jj - nn - 
Phrase7366:
the lytic cycle-induced 
dt - jj - nn - 
Phrase7367:
significant increase 
jj - nn - 
Phrase7368:
an increase 
dt - nn - 
Phrase7369:
the cellular content 
dt - jj - nn - 
Phrase7370:
the initiation 
dt - nn - 
Phrase7371:
the viral lytic cycle 
dt - jj - jj - nn - 
Phrase7372:
the amount 
dt - nn - 
Phrase7373:
circular dna 
jj - nn - 
Phrase7374:
we 
prp - 
Phrase7375:
these results 
dt - nns - 
Phrase7376:
the source 
dt - nn - 
Phrase7377:
such a 
jj - nn - 
Phrase7378:
the thyrotropin 
dt - nn - 
Phrase7379:
autoimmune thyroid 
jj - nn - 
Phrase7380:
major histocompatibility 
jj - nn - 
Phrase7381:
we 
prp - 
Phrase7382:
endemic goiter 
jj - nn - 
Phrase7383:
healthy thyroid 
jj - nn - 
Phrase7384:
close correlation 
jj - nn - 
Phrase7385:
the expression 
dt - nn - 
Phrase7386:
= 0.703 
jj - nn - 
Phrase7387:
= 0.817 
jj - nn - 
Phrase7388:
the nuclear oncogene 
dt - jj - nn - 
Phrase7389:
= 0.935 
jj - nn - 
Phrase7390:
absent in 
jj - nn - 
Phrase7391:
those thyroids 
dt - nn - 
Phrase7392:
the major histocompatibility 
dt - jj - nn - 
Phrase7393:
an inverse 
dt - nn - 
Phrase7394:
= -0.791 
jj - nn - 
Phrase7395:
= -0.784 
jj - nn - 
Phrase7396:
themselves 
prp - 
Phrase7397:
the source 
dt - nn - 
Phrase7398:
detectable in 
jj - nn - 
Phrase7399:
our 
prp$ - 
Phrase7400:
active regulatory events 
jj - jj - nns - 
Phrase7401:
the thyrocyte 
dt - nn - 
Phrase7402:
the inverse 
dt - nn - 
Phrase7403:
functional parameters 
jj - nns - 
Phrase7404:
immunological markers 
jj - nns - 
Phrase7405:
functional antagonism 
jj - nn - 
Phrase7406:
retinoic acid 
jj - nn - 
Phrase7407:
the regulation 
dt - nn - 
Phrase7408:
monocytic differentiation 
jj - nn - 
Phrase7409:
retinoic acid 
jj - nn - 
Phrase7410:
important regulators 
jj - nns - 
Phrase7411:
the proliferation 
dt - nn - 
Phrase7412:
several cell 
jj - nn - 
Phrase7413:
the expression 
dt - nn - 
Phrase7414:
the monocyte-macrophage ag 
dt - jj - nn - 
Phrase7415:
the low affinity 
dt - jj - nn - 
Phrase7416:
ra-induced monocytic differentiation 
jj - jj - nn - 
Phrase7417:
the expression 
dt - nn - 
Phrase7418:
both cd14 
dt - nn - 
Phrase7419:
the addition 
dt - nn - 
Phrase7420:
the vitd3 
dt - nn - 
Phrase7421:
the induction 
dt - nn - 
Phrase7422:
ongoing protein 
jj - nn - 
Phrase7423:
ra-inducible cd23 
jj - nn - 
Phrase7424:
dose-dependent manner 
jj - nn - 
Phrase7425:
their 
prp$ - 
Phrase7426:
they 
prp - 
Phrase7427:
detectable cd14 
jj - nn - 
Phrase7428:
the vitd3- 
dt - nn - 
Phrase7429:
the pma-induced 
dt - nn - 
Phrase7430:
temporal consequence 
jj - nn - 
Phrase7431:
the ra-induced differentiation 
dt - jj - nn - 
Phrase7432:
the results 
dt - nns - 
Phrase7433:
functional antagonism 
jj - nn - 
Phrase7434:
important implications 
jj - nns - 
Phrase7435:
the regulation 
dt - nn - 
Phrase7436:
inflammatory responses 
jj - nns - 
Phrase7437:
their 
prp$ - 
Phrase7438:
cell-specific bifunctional role 
jj - jj - nn - 
Phrase7439:
receptor-dependent transcription 
jj - nn - 
Phrase7440:
-mediated signaling 
jj - nn - 
Phrase7441:
the ability 
dt - nn - 
Phrase7442:
the pkc 
dt - nn - 
Phrase7443:
gr-dependent transcription 
dt - nn - 
Phrase7444:
the mouse 
dt - nn - 
Phrase7445:
mammary tumor 
jj - nn - 
Phrase7446:
long terminal 
jj - nn - 
Phrase7447:
we 
prp - 
Phrase7448:
this interference 
dt - nn - 
Phrase7449:
dexamethasone-induced transcriptional activation 
jj - jj - nn - 
Phrase7450:
the mmtv 
dt - nn - 
Phrase7451:
several t 
jj - nn - 
Phrase7452:
inhibitory in 
jj - nn - 
Phrase7453:
the gr-responsive 
dt - nn - 
Phrase7454:
functional analysis 
jj - nn - 
Phrase7455:
synthetic gre 
jj - nn - 
Phrase7456:
an intact gr 
dt - jj - nn - 
Phrase7457:
carboxyl-terminal domains 
jj - nns - 
Phrase7458:
the effect 
dt - nn - 
Phrase7459:
the pkc 
dt - nn - 
Phrase7460:
basal levels 
jj - nns - 
Phrase7461:
transcriptional activity 
jj - nn - 
Phrase7462:
responsive elements 
jj - nns - 
Phrase7463:
the ability 
dt - nn - 
Phrase7464:
either mmtv 
dt - nn - 
Phrase7465:
the presence 
dt - nn - 
Phrase7466:
negative influence 
jj - nn - 
Phrase7467:
antagonistic activity 
jj - nn - 
Phrase7468:
high basal expression 
jj - jj - nn - 
Phrase7469:
transcriptional activity 
jj - nn - 
Phrase7470:
exogenous c-fos 
jj - nn - 
Phrase7471:
an inhibitory effect 
dt - jj - nn - 
Phrase7472:
we 
prp - 
Phrase7473:
bifunctional role 
jj - nn - 
Phrase7474:
transcriptional activation 
jj - nn - 
Phrase7475:
antagonistic activity 
jj - nn - 
Phrase7476:
the cell-specific microenvironment 
dt - jj - nn - 
Phrase7477:
this regard 
dt - nn - 
Phrase7478:
intracellular levels 
jj - nns - 
Phrase7479:
stage-specific expression 
jj - nn - 
Phrase7480:
the cd20/b1 
dt - nn - 
Phrase7481:
the activity 
dt - nn - 
Phrase7482:
its 
prp$ - 
Phrase7483:
the cd20 
dt - nn - 
Phrase7484:
cell-specific protein 
jj - nn - 
Phrase7485:
the regulation 
dt - nn - 
Phrase7486:
the promoter 
dt - nn - 
Phrase7487:
positive regulatory elements 
jj - jj - nns - 
Phrase7488:
this study 
dt - nn - 
Phrase7489:
we 
prp - 
Phrase7490:
proximal region 
jj - nn - 
Phrase7491:
important in 
jj - nn - 
Phrase7492:
the high constitutive expression 
dt - jj - jj - nn - 
Phrase7493:
mature b 
jj - nn - 
Phrase7494:
the induction 
dt - nn - 
Phrase7495:
the bat 
dt - nn - 
Phrase7496:
its 
prp$ - 
Phrase7497:
the activity 
dt - nn - 
Phrase7498:
various mutant 
jj - nn - 
Phrase7499:
nuclear extracts 
jj - nns - 
Phrase7500:
the core 
dt - nn - 
Phrase7501:
this site 
dt - nn - 
Phrase7502:
an octamer 
dt - nn - 
Phrase7503:
the ig 
dt - nn - 
Phrase7504:
heavy chain 
jj - nn - 
Phrase7505:
the bat 
dt - nn - 
Phrase7506:
the cd21 
dt - nn - 
Phrase7507:
the same nuclear proteins 
dt - jj - jj - nns - 
Phrase7508:
the bat 
dt - nn - 
Phrase7509:
the bat 
dt - nn - 
Phrase7510:
the affinity 
dt - nn - 
Phrase7511:
the bat 
dt - nn - 
Phrase7512:
the bat 
dt - nn - 
Phrase7513:
the octamer 
dt - nn - 
Phrase7514:
the bat 
dt - nn - 
Phrase7515:
the bat 
dt - nn - 
Phrase7516:
the octamer 
dt - nn - 
Phrase7517:
this lower affinity 
dt - jjr - nn - 
Phrase7518:
the bat 
dt - nn - 
Phrase7519:
an oct-2 
dt - nn - 
Phrase7520:
the octamer 
dt - nn - 
Phrase7521:
the bat 
dt - nn - 
Phrase7522:
the induction 
dt - nn - 
Phrase7523:
the pre-b 
dt - nn - 
Phrase7524:
the induction 
dt - nn - 
Phrase7525:
the wild type 
dt - jj - nn - 
Phrase7526:
these results 
dt - nns - 
Phrase7527:
the bat 
dt - nn - 
Phrase7528:
important in 
jj - nn - 
Phrase7529:
the b 
dt - nn - 
Phrase7530:
specific expression 
jj - nn - 
Phrase7531:
the fusion 
dt - nn - 
Phrase7532:
the hybrid 
dt - nn - 
Phrase7533:
acute promyelocytic leukemia 
jj - jj - nn - 
Phrase7534:
leukemic cells 
jj - nns - 
Phrase7535:
the fusion 
dt - nn - 
Phrase7536:
we 
prp - 
Phrase7537:
the fusion 
dt - nn - 
Phrase7538:
the hybrid 
dt - nn - 
Phrase7539:
acute promyelocytic leukemia 
jj - jj - nn - 
Phrase7540:
cd4+ lymphocytes 
jj - nns - 
Phrase7541:
clonal level 
jj - nn - 
Phrase7542:
an hla-dr 
dt - nn - 
Phrase7543:
restricted fashion 
jj - nn - 
Phrase7544:
autologous antigen-presenting cell 
jj - jj - nn - 
Phrase7545:
the hla-dr11 
dt - nn - 
Phrase7546:
the normal pml 
dt - jj - nn - 
Phrase7547:
specific cytotoxicity 
jj - nn - 
Phrase7548:
autologous cells 
jj - nns - 
Phrase7549:
the pml/rar 
dt - nn - 
Phrase7550:
the proliferation 
dt - nn - 
Phrase7551:
it 
prp - 
Phrase7552:
the bcr1 
dt - nn - 
Phrase7553:
an antigenic site 
dt - jj - nn - 
Phrase7554:
the normal parent 
dt - jj - nn - 
Phrase7555:
cd4+ lymphocytes 
jj - nns - 
Phrase7556:
the zinc 
dt - nn - 
Phrase7557:
the macrophage 
dt - nn - 
Phrase7558:
we 
prp - 
Phrase7559:
primary response 
jj - nn - 
Phrase7560:
the absence 
dt - nn - 
Phrase7561:
either macrophage 
dt - nn - 
Phrase7562:
myeloblastic leukemia 
jj - nn - 
Phrase7563:
primary response 
jj - nn - 
Phrase7564:
the egr-1 
dt - nn - 
Phrase7565:
silent in 
jj - nn - 
Phrase7566:
active in 
jj - nn - 
Phrase7567:
antisense oligomers 
jj - nns - 
Phrase7568:
the culture 
dt - nn - 
Phrase7569:
normal myeloblasts 
jj - nn - 
Phrase7570:
an egr-1 
dt - nn - 
Phrase7571:
these observations 
dt - nns - 
Phrase7572:
the macrophage 
dt - nn - 
Phrase7573:
the epstein-barr virus 
dt - jj - nn - 
Phrase7574:
nuclear antigen 
jj - nn - 
Phrase7575:
an ebna2 
dt - nn - 
Phrase7576:
responsive cis-element 
jj - nn - 
Phrase7577:
the terminal 
dt - nn - 
Phrase7578:
the epstein-barr virus 
dt - jj - nn - 
Phrase7579:
transcriptional activator 
jj - nn - 
Phrase7580:
viral genes 
jj - nns - 
Phrase7581:
crucial role 
jj - nn - 
Phrase7582:
the immortalization 
dt - nn - 
Phrase7583:
primary b-cells 
jj - nns - 
Phrase7584:
we 
prp - 
Phrase7585:
the promoters 
dt - nns - 
Phrase7586:
the latent membrane 
dt - jj - nn - 
Phrase7587:
the promoter 
dt - nn - 
Phrase7588:
the tp1 
dt - nn - 
Phrase7589:
the molecular 
dt - nn - 
Phrase7590:
an ebna2 
dt - nn - 
Phrase7591:
dependent cis-acting element 
jj - jj - nn - 
Phrase7592:
various tp1 
jj - nn - 
Phrase7593:
the absence 
dt - nn - 
Phrase7594:
an ebna2 
dt - nn - 
Phrase7595:
the established b-cell 
dt - jj - nn - 
Phrase7596:
we 
prp - 
Phrase7597:
responsive region 
jj - nn - 
Phrase7598:
the tp1 
dt - nn - 
Phrase7599:
the element 
dt - nn - 
Phrase7600:
dependent transactivation 
jj - nn - 
Phrase7601:
heterologous promoter 
jj - nn - 
Phrase7602:
electrophoretic mobility 
jj - nn - 
Phrase7603:
specific protein-dna complexes 
jj - jj - nns - 
Phrase7604:
the ebna2 
dt - nn - 
Phrase7605:
responsive element 
jj - nn - 
Phrase7606:
positive cell 
jj - nn - 
Phrase7607:
gel-shift analysis 
jj - nn - 
Phrase7608:
the presence 
dt - nn - 
Phrase7609:
specific monoclonal antibodies 
jj - jj - nns - 
Phrase7610:
the third complex 
dt - jj - nn - 
Phrase7611:
these experiments 
dt - nns - 
Phrase7612:
an ebna2 
dt - nn - 
Phrase7613:
responsive cis-element 
jj - nn - 
Phrase7614:
the tp1 
dt - nn - 
Phrase7615:
low density 
jj - nn - 
Phrase7616:
inflammatory responses 
jj - nns - 
Phrase7617:
cyclic adenosine 
jj - nn - 
Phrase7618:
we 
prp - 
Phrase7619:
their 
prp$ - 
Phrase7620:
colony-stimulating factor 
jj - nn - 
Phrase7621:
the present 
dt - nn - 
Phrase7622:
we 
prp - 
Phrase7623:
the signaling 
dt - nn - 
Phrase7624:
this monocyte-specific response 
dt - jj - nn - 
Phrase7625:
our 
prp$ - 
Phrase7626:
the second 
dt - nn - 
Phrase7627:
the effects 
dt - nns - 
Phrase7628:
intracellular camp 
jj - nn - 
Phrase7629:
the actions 
dt - nns - 
Phrase7630:
this transcription 
dt - nn - 
Phrase7631:
we 
prp - 
Phrase7632:
elevated camp 
jj - nn - 
Phrase7633:
transcriptional activating 
jj - nn - 
Phrase7634:
the gata 
dt - nn - 
Phrase7635:
this multigene 
dt - nn - 
Phrase7636:
cellular target 
jj - nn - 
Phrase7637:
the u3 
dt - nn - 
Phrase7638:
the transcriptional regulatory domain 
dt - jj - jj - nn - 
Phrase7639:
the hiv-1 
dt - nn - 
Phrase7640:
an hgata-3 
dt - nn - 
Phrase7641:
the hiv-1 
dt - nn - 
Phrase7642:
10-fold stimulation 
jj - nn - 
Phrase7643:
ltr-mediated transcription 
jj - nn - 
Phrase7644:
specific mutation 
jj - nn - 
Phrase7645:
these gata 
dt - nn - 
Phrase7646:
virtual abrogation 
jj - nn - 
Phrase7647:
the activation 
dt - nn - 
Phrase7648:
the hgata-3 
dt - nn - 
Phrase7649:
transcriptional activation 
jj - nn - 
Phrase7650:
the stimulation 
dt - nn - 
Phrase7651:
viral transcription 
jj - nn - 
Phrase7652:
direct effect 
jj - nn - 
Phrase7653:
the hiv-1 
dt - nn - 
Phrase7654:
the gata 
dt - nn - 
Phrase7655:
significant reduction 
jj - nn - 
Phrase7656:
ltr-mediated transcription 
jj - nn - 
Phrase7657:
the basal level 
dt - jj - nn - 
Phrase7658:
these observations 
dt - nns - 
Phrase7659:
its 
prp$ - 
Phrase7660:
normal role 
jj - nn - 
Phrase7661:
significant role 
jj - nn - 
Phrase7662:
transcriptional activation 
jj - nn - 
Phrase7663:
the peptide 
dt - nn - 
Phrase7664:
the homeostasis 
dt - nn - 
Phrase7665:
the immune system 
dt - jj - nn - 
Phrase7666:
fundamental role 
jj - nn - 
Phrase7667:
immune mediated reactions 
jj - jj - nns - 
Phrase7668:
multiple levels 
jj - nns - 
Phrase7669:
the pathogenesis 
dt - nn - 
Phrase7670:
immune deficiency 
jj - nn - 
Phrase7671:
the human 
dt - nn - 
Phrase7672:
several cytokines 
jj - nns - 
Phrase7673:
several cytokines 
jj - nns - 
Phrase7674:
the levels 
dt - nns - 
Phrase7675:
infected cells 
jj - nns - 
Phrase7676:
both t 
dt - nn - 
Phrase7677:
phagocytic lineage 
jj - nn - 
Phrase7678:
chronic activation 
jj - nn - 
Phrase7679:
infected individuals 
jj - nns - 
Phrase7680:
important role 
jj - nn - 
Phrase7681:
the pathogenesis 
dt - nn - 
Phrase7682:
functional characterization 
jj - nn - 
Phrase7683:
early b-cell 
jj - nn - 
Phrase7684:
lymphocyte-specific gene 
jj - nn - 
Phrase7685:
early b-cell 
jj - nn - 
Phrase7686:
stage-specific dna-binding 
jj - nn - 
Phrase7687:
the regulation 
dt - nn - 
Phrase7688:
the pre-b 
dt - nn - 
Phrase7689:
lymphocyte-specific mb-1 
jj - nn - 
Phrase7690:
partial amino 
jj - nn - 
Phrase7691:
multiple criteria 
jj - nns - 
Phrase7692:
the recombinant 
dt - nn - 
Phrase7693:
sequence-specific complexes 
jj - nns - 
Phrase7694:
the ebf-binding 
dt - nn - 
Phrase7695:
the mb-1 
dt - nn - 
Phrase7696:
the cdna 
dt - nn - 
Phrase7697:
multiple transcripts 
jj - nns - 
Phrase7698:
significant levels 
jj - nns - 
Phrase7699:
nonlymphoid cell 
jj - nn - 
Phrase7700:
nonlymphoid cells 
jj - nns - 
Phrase7701:
functional ebf-binding 
jj - nn - 
Phrase7702:
an amino-terminal cysteine-rich dna-binding 
dt - jj - jj - nn - 
Phrase7703:
obvious sequence 
jj - nn - 
Phrase7704:
the protein 
dt - nn - 
Phrase7705:
its 
prp$ - 
Phrase7706:
carboxy-terminal dimerization 
jj - nn - 
Phrase7707:
the dimerization 
dt - nn - 
Phrase7708:
basic-helix-loop-helix proteins 
jj - nns - 
Phrase7709:
these data 
dt - nns - 
Phrase7710:
novel regulator 
jj - nn - 
Phrase7711:
lymphocyte-specific gene 
jj - nn - 
Phrase7712:
cell-specific expression 
jj - nn - 
Phrase7713:
helix-loop-helix transcription 
jj - nn - 
Phrase7714:
the e2a 
dt - nn - 
Phrase7715:
the e2a 
dt - nn - 
Phrase7716:
the helix-loop-helix family 
dt - jj - nn - 
Phrase7717:
cell-specific gene 
jj - nn - 
Phrase7718:
dimeric complexes 
jj - nns - 
Phrase7719:
it 
prp - 
Phrase7720:
the e2a 
dt - nn - 
Phrase7721:
we 
prp - 
Phrase7722:
the mouse 
dt - nn - 
Phrase7723:
the protein 
dt - nn - 
Phrase7724:
polyclonal antisera 
jj - nn - 
Phrase7725:
distinct portions 
jj - nns - 
Phrase7726:
the e2a 
dt - nn - 
Phrase7727:
cellular extracts 
jj - nns - 
Phrase7728:
this analysis 
dt - nn - 
Phrase7729:
this protein 
dt - nn - 
Phrase7730:
lymphoid origin 
jj - nn - 
Phrase7731:
pancreatic beta-cells 
jj - nns - 
Phrase7732:
the detection 
dt - nn - 
Phrase7733:
this protein 
dt - nn - 
Phrase7734:
lymphoid cells 
jj - nns - 
Phrase7735:
the presence 
dt - nn - 
Phrase7736:
the e 
dt - nn - 
Phrase7737:
these cells 
dt - nns - 
Phrase7738:
this binding 
dt - nn - 
Phrase7739:
full length 
jj - nn - 
Phrase7740:
the 73 
dt - nn - 
Phrase7741:
our 
prp$ - 
Phrase7742:
the view 
dt - nn - 
Phrase7743:
the dna-binding 
dt - nn - 
Phrase7744:
the selective appearance 
dt - jj - nn - 
Phrase7745:
this putative cell-specific transcription 
dt - jj - jj - nn - 
Phrase7746:
lymphoid cells 
jj - nns - 
Phrase7747:
least in 
jjs - nn - 
Phrase7748:
the elevated e2a 
dt - jj - nn - 
Phrase7749:
these cells 
dt - nns - 
Phrase7750:
frequent cause 
jj - nn - 
Phrase7751:
neonatal morbidity 
jj - nn - 
Phrase7752:
the present 
dt - nn - 
Phrase7753:
we 
prp - 
Phrase7754:
the pathophysiology 
dt - nn - 
Phrase7755:
the role 
dt - nn - 
Phrase7756:
continuous monitoring 
jj - nn - 
Phrase7757:
the preeclamptic 
dt - nn - 
Phrase7758:
the first results 
dt - jj - nns - 
Phrase7759:
the role 
dt - nn - 
Phrase7760:
the pathophysiology 
dt - nn - 
Phrase7761:
we 
prp - 
Phrase7762:
healthy pregnant women 
jj - jj - nns - 
Phrase7763:
we 
prp - 
Phrase7764:
the mineralocorticoid 
dt - nn - 
Phrase7765:
the mr-count 
dt - nn - 
Phrase7766:
the pih-group 
dt - nn - 
Phrase7767:
the values 
dt - nns - 
Phrase7768:
these results 
dt - nns - 
Phrase7769:
higher level 
jjr - nn - 
Phrase7770:
the zona 
dt - nn - 
Phrase7771:
unknown mineralocorticoid 
jj - nn - 
Phrase7772:
the hypertension 
dt - nn - 
Phrase7773:
altered mr-status 
jj - nn - 
Phrase7774:
the first results 
dt - jj - nns - 
Phrase7775:
continuous blood 
jj - nn - 
Phrase7776:
real-time blood 
jj - nn - 
Phrase7777:
the comparison 
dt - nn - 
Phrase7778:
good correlation 
jj - nn - 
Phrase7779:
we 
prp - 
Phrase7780:
the first experiences 
dt - jj - nn - 
Phrase7781:
the treatment 
dt - nn - 
Phrase7782:
severe preeclampsia 
jj - nn - 
Phrase7783:
the data 
dt - nns - 
Phrase7784:
cellular differentiation 
jj - nn - 
Phrase7785:
cell-specific transcription 
jj - nn - 
Phrase7786:
an enhancer 
dt - nn - 
Phrase7787:
an erythroid-specific gene 
dt - jj - nn - 
Phrase7788:
erythroid-specific gene 
jj - nn - 
Phrase7789:
the human 
dt - nn - 
Phrase7790:
we 
prp - 
Phrase7791:
the effects 
dt - nns - 
Phrase7792:
the binding 
dt - nn - 
Phrase7793:
regulatory element 
jj - nn - 
Phrase7794:
the transcriptional regulatory sequences 
dt - jj - jj - nns - 
Phrase7795:
many erythroid-specific genes 
jj - jj - nns - 
Phrase7796:
the binding 
dt - nn - 
Phrase7797:
ubiquitous ap-1 
jj - nn - 
Phrase7798:
this element 
dt - nn - 
Phrase7799:
the binding 
dt - nn - 
Phrase7800:
the lineage 
dt - nn - 
Phrase7801:
limited transcription 
jj - nn - 
Phrase7802:
this transcriptional control 
dt - jj - nn - 
Phrase7803:
the binding 
dt - nn - 
Phrase7804:
its 
prp$ - 
Phrase7805:
the expression 
dt - nn - 
Phrase7806:
this nonspecific increase 
dt - jj - nn - 
Phrase7807:
the activity 
dt - nn - 
Phrase7808:
the lineage 
dt - nn - 
Phrase7809:
limited transcription 
jj - nn - 
Phrase7810:
the divergent effects 
dt - jj - nns - 
Phrase7811:
their 
prp$ - 
Phrase7812:
the transcription 
dt - nn - 
Phrase7813:
t-cell-specific factor 
jj - nn - 
Phrase7814:
an octamer 
dt - nn - 
Phrase7815:
natural killer 
jj - nn - 
Phrase7816:
we 
prp - 
Phrase7817:
the protein 
dt - nn - 
Phrase7818:
functional importance 
jj - nn - 
Phrase7819:
the act-1-activating 
dt - nn - 
Phrase7820:
the il-3 
dt - nn - 
Phrase7821:
t-cell-specific factor 
jj - nn - 
Phrase7822:
its 
prp$ - 
Phrase7823:
the expression 
dt - nn - 
Phrase7824:
the absence 
dt - nn - 
Phrase7825:
other upstream elements 
jj - jj - nns - 
Phrase7826:
its 
prp$ - 
Phrase7827:
3' end 
jj - nn - 
Phrase7828:
it 
prp - 
Phrase7829:
related octamer-binding protein 
jj - jj - nn - 
Phrase7830:
it 
prp - 
Phrase7831:
the activity 
dt - nn - 
Phrase7832:
several regulatory elements 
jj - jj - nns - 
Phrase7833:
these characteristics 
dt - nns - 
Phrase7834:
the act-1 
dt - nn - 
Phrase7835:
the activating 
dt - nn - 
Phrase7836:
the il-2 
dt - nn - 
Phrase7837:
the promoters 
dt - nns - 
Phrase7838:
an organizational 
dt - nn - 
Phrase7839:
regulatory elements 
jj - nns - 
Phrase7840:
the t-cell-specific expression 
dt - jj - nn - 
Phrase7841:
these genes 
dt - nns - 
Phrase7842:
the lipopolysaccharide-induced expression 
dt - jj - nn - 
Phrase7843:
we 
prp - 
Phrase7844:
the effect 
dt - nn - 
Phrase7845:
the lipopolysaccharide 
dt - nn - 
Phrase7846:
immediate early genes 
jj - jj - nns - 
Phrase7847:
these genes 
dt - nns - 
Phrase7848:
the dimeric complex 
dt - jj - nn - 
Phrase7849:
transcriptional factor 
jj - nn - 
Phrase7850:
maximal accumulation 
jj - nn - 
Phrase7851:
either c-fos 
dt - nn - 
Phrase7852:
the c-fos 
dt - nn - 
Phrase7853:
the c-jun 
dt - nn - 
Phrase7854:
the inhibition 
dt - nn - 
Phrase7855:
lps-treated cells 
jj - nns - 
Phrase7856:
lower transcription 
jjr - nn - 
Phrase7857:
the c-fos 
dt - nn - 
Phrase7858:
the stability 
dt - nn - 
Phrase7859:
the c-fos 
dt - nn - 
Phrase7860:
electrophoretic mobility 
jj - nn - 
Phrase7861:
lps-induced expression 
jj - nn - 
Phrase7862:
these data 
dt - nns - 
Phrase7863:
the induction 
dt - nn - 
Phrase7864:
renal disease 
jj - nn - 
Phrase7865:
lymphocytic aldosterone 
jj - nn - 
Phrase7866:
we 
prp - 
Phrase7867:
renal disease 
jj - nn - 
Phrase7868:
adrenal insufficiency 
jj - nn - 
Phrase7869:
the second 
dt - nn - 
Phrase7870:
biochemical parameters 
jj - nns - 
Phrase7871:
normal in 
jj - nn - 
Phrase7872:
rapid non-genomic actions 
jj - jj - nns - 
Phrase7873:
functional studies 
jj - nns - 
Phrase7874:
classical genomic effects 
jj - jj - nns - 
Phrase7875:
non-genomic effects 
jj - nns - 
Phrase7876:
the sodium/proton 
dt - nn - 
Phrase7877:
the cell 
dt - nn - 
Phrase7878:
physiological concentrations 
jj - nns - 
Phrase7879:
an acute onset 
dt - jj - nn - 
Phrase7880:
the inositol 
dt - nn - 
Phrase7881:
the same rapid time 
dt - jj - jj - nn - 
Phrase7882:
genomic mechanisms 
jj - nns - 
Phrase7883:
later effects 
jj - nns - 
Phrase7884:
the membrane 
dt - nn - 
Phrase7885:
related rapid responses 
jj - jj - nns - 
Phrase7886:
the mechanisms 
dt - nns - 
Phrase7887:
these rapid effects 
dt - jj - nns - 
Phrase7888:
valuable tools 
jj - nns - 
Phrase7889:
the delineation 
dt - nn - 
Phrase7890:
the receptor-effector 
dt - nn - 
Phrase7891:
the unique characteristics 
dt - jj - nns - 
Phrase7892:
this new 
dt - nn - 
Phrase7893:
its 
prp$ - 
Phrase7894:
rapid time 
jj - nn - 
Phrase7895:
the ineffectiveness 
dt - nn - 
Phrase7896:
classical mineralocorticoid 
jj - nn - 
Phrase7897:
the response 
dt - nn - 
Phrase7898:
latent infection 
jj - nn - 
Phrase7899:
cd4+ t 
jj - nn - 
Phrase7900:
science 
nnp - 
Phrase7901:
martin 
nnp - 
Phrase7902:
science 
nnp - 
Phrase7903:
j. 
nnp - 
Phrase7904:
science 
nnp - 
Phrase7905:
the host 
dt - nn - 
Phrase7906:
we 
prp - 
Phrase7907:
the hiv-1-encoded 
dt - nn - 
Phrase7908:
the induction 
dt - nn - 
Phrase7909:
the dna-binding 
dt - nn - 
Phrase7910:
other transcription 
jj - nn - 
Phrase7911:
the induction 
dt - nn - 
Phrase7912:
the effect 
dt - nn - 
Phrase7913:
an intact nf-kappa 
dt - jj - nn - 
Phrase7914:
these results 
dt - nns - 
Phrase7915:
defective recruitment 
jj - nn - 
Phrase7916:
negative transcriptional effects 
jj - jj - nns - 
Phrase7917:
the hiv-1 
dt - nn - 
Phrase7918:
the t-cell 
dt - nn - 
Phrase7919:
peripheral blood 
jj - nn - 
Phrase7920:
elderly adults 
jj - nns - 
Phrase7921:
the expression 
dt - nn - 
Phrase7922:
peripheral blood 
jj - nn - 
Phrase7923:
aged humans 
jj - nns - 
Phrase7924:
specific mrnas 
jj - nns - 
Phrase7925:
maximal levels 
jj - nns - 
Phrase7926:
pha-activated pbl 
jj - nn - 
Phrase7927:
age-related differences 
jj - nns - 
Phrase7928:
elderly individuals 
jj - nns - 
Phrase7929:
previous work 
jj - nn - 
Phrase7930:
elderly individuals 
jj - nns - 
Phrase7931:
normal proliferative 
jj - nn - 
Phrase7932:
the anti-cd2 
dt - nn - 
Phrase7933:
age-related differences 
jj - nns - 
Phrase7934:
the expression 
dt - nn - 
Phrase7935:
these results 
dt - nns - 
Phrase7936:
pha-activated pbl 
jj - nn - 
Phrase7937:
elderly adults 
jj - nns - 
Phrase7938:
age-related changes 
jj - nns - 
Phrase7939:
the ratio 
dt - nn - 
Phrase7940:
remote enhancer 
jj - nn - 
Phrase7941:
b-cell-restricted activity 
jj - nn - 
Phrase7942:
previous cotransfection 
jj - nn - 
Phrase7943:
ectopic expression 
jj - nn - 
Phrase7944:
the lymphocyte-specific transcription 
dt - jj - nn - 
Phrase7945:
an octamer 
dt - nn - 
Phrase7946:
multimerized octamer 
jj - nn - 
Phrase7947:
we 
prp - 
Phrase7948:
the capability 
dt - nn - 
Phrase7949:
an octamer 
dt - nn - 
Phrase7950:
nonlymphoid cells 
jj - nns - 
Phrase7951:
our 
prp$ - 
Phrase7952:
several oct2 
jj - nn - 
Phrase7953:
remote position 
jj - nn - 
Phrase7954:
this stimulation 
dt - nn - 
Phrase7955:
the involvement 
dt - nn - 
Phrase7956:
either a 
dt - nn - 
Phrase7957:
b-cell-specific cofactor 
jj - nn - 
Phrase7958:
specific modification 
jj - nn - 
Phrase7959:
the oct2 
dt - nn - 
Phrase7960:
mutational analyses 
jj - nns - 
Phrase7961:
the carboxy-terminal domain 
dt - jj - nn - 
Phrase7962:
this domain 
dt - nn - 
Phrase7963:
the oct1 
dt - nn - 
Phrase7964:
itself 
prp - 
Phrase7965:
remote position 
jj - nn - 
Phrase7966:
the glutamine-rich activation 
dt - jj - nn - 
Phrase7967:
the amino-terminal portion 
dt - jj - nn - 
Phrase7968:
the pou 
dt - nn - 
Phrase7969:
the transactivation 
dt - nn - 
Phrase7970:
distal position 
jj - nn - 
Phrase7971:
the promoter 
dt - nn - 
Phrase7972:
the cd19 
dt - nn - 
Phrase7973:
the b-cell-specific transcription 
dt - jj - nn - 
Phrase7974:
the cd19 
dt - nn - 
Phrase7975:
the surface 
dt - nn - 
Phrase7976:
b-lymphoid cells 
jj - nns - 
Phrase7977:
the exception 
dt - nn - 
Phrase7978:
signal-transducing receptor 
jj - nn - 
Phrase7979:
the control 
dt - nn - 
Phrase7980:
we 
prp - 
Phrase7981:
complete correlation 
jj - nn - 
Phrase7982:
the expression 
dt - nn - 
Phrase7983:
the cd19 
dt - nn - 
Phrase7984:
the b-cell-specific transcription 
dt - jj - nn - 
Phrase7985:
large panel 
jj - nn - 
Phrase7986:
b-lymphoid cell 
jj - nn - 
Phrase7987:
the human 
dt - nn - 
Phrase7988:
several bsap-binding 
jj - nn - 
Phrase7989:
protein-dna binding 
jj - nn - 
Phrase7990:
located in 
jj - nn - 
Phrase7991:
heterogeneous transcription 
jj - nn - 
Phrase7992:
this site 
dt - nn - 
Phrase7993:
the promoters 
dt - nns - 
Phrase7994:
both human 
dt - nn - 
Phrase7995:
abundant dna-binding 
jj - nn - 
Phrase7996:
nuclear extracts 
jj - nns - 
Phrase7997:
the cd19 
dt - nn - 
Phrase7998:
this evidence 
dt - nn - 
Phrase7999:
the regulation 
dt - nn - 
Phrase8000:
the cd19 
dt - nn - 
Phrase8001:
malignant breast 
jj - nn - 
Phrase8002:
the eicosanoid 
dt - nn - 
Phrase8003:
benign tumors 
jj - nns - 
Phrase8004:
mammary reduction 
jj - nn - 
Phrase8005:
peripheral blood 
jj - nn - 
Phrase8006:
mammary tissue 
jj - nn - 
Phrase8007:
such differences 
jj - nns - 
Phrase8008:
the control 
dt - nn - 
Phrase8009:
benign tumor 
jj - nn - 
Phrase8010:
mammary reduction 
jj - nn - 
Phrase8011:
the eicosanoid 
dt - nn - 
Phrase8012:
malignant mammary tumors 
jj - jj - nns - 
Phrase8013:
important differences 
jj - nns - 
Phrase8014:
detectable quantities 
jj - nns - 
Phrase8015:
the non-tumor 
dt - nn - 
Phrase8016:
the malignant tumor 
dt - jj - nn - 
Phrase8017:
substantial quantities 
jj - nns - 
Phrase8018:
significant correlations 
jj - nns - 
Phrase8019:
the results 
dt - nns - 
Phrase8020:
the platelet 
dt - nn - 
Phrase8021:
menopausal status 
jj - nn - 
Phrase8022:
arachidonic acid 
jj - nn - 
Phrase8023:
inflammatory cell 
jj - nn - 
Phrase8024:
arachidonic acid 
jj - nn - 
Phrase8025:
the results 
dt - nns - 
Phrase8026:
mammary cancer 
jj - nn - 
Phrase8027:
benign mammary tissue 
jj - jj - nn - 
Phrase8028:
the implications 
dt - nns - 
Phrase8029:
future prognosis 
jj - nn - 
Phrase8030:
the patient 
dt - nn - 
Phrase8031:
the role 
dt - nn - 
Phrase8032:
the pathophysiology 
dt - nn - 
Phrase8033:
we 
prp - 
Phrase8034:
normal pregnant women 
jj - jj - nns - 
Phrase8035:
we 
prp - 
Phrase8036:
the mineralocorticoid 
dt - nn - 
Phrase8037:
the pih 
dt - nn - 
Phrase8038:
the control 
dt - nn - 
Phrase8039:
normal pregnant women 
jj - jj - nns - 
Phrase8040:
it 
prp - 
Phrase8041:
these values 
dt - nns - 
Phrase8042:
the onset 
dt - nn - 
Phrase8043:
clinical symptoms 
jj - nns - 
Phrase8044:
these results 
dt - nns - 
Phrase8045:
higher levels 
jjr - nns - 
Phrase8046:
unknown mineralocorticoid 
jj - nn - 
Phrase8047:
the hypertension 
dt - nn - 
Phrase8048:
altered mr 
jj - nn - 
Phrase8049:
small apolar 
jj - nn - 
Phrase8050:
the affinity 
dt - nn - 
Phrase8051:
the vitamin 
dt - nn - 
Phrase8052:
polar substitutions 
jj - nns - 
Phrase8053:
the affinity 
dt - nn - 
Phrase8054:
their 
prp$ - 
Phrase8055:
the vitamin 
dt - nn - 
Phrase8056:
the biological activity 
dt - jj - nn - 
Phrase8057:
the natural hormone 
dt - jj - nn - 
Phrase8058:
leukemic cell 
jj - nn - 
Phrase8059:
its 
prp$ - 
Phrase8060:
the rachitic 
dt - nn - 
Phrase8061:
10-fold lower activity 
jj - jjr - nn - 
Phrase8062:
the other c-11 
dt - jj - nn - 
Phrase8063:
promyeloid leukemia 
jj - nn - 
Phrase8064:
their 
prp$ - 
Phrase8065:
they 
prp - 
Phrase8066:
lower calcemic effects 
jjr - jj - nns - 
Phrase8067:
the binding 
dt - nn - 
Phrase8068:
the vitamin 
dt - nn - 
Phrase8069:
the affinity 
dt - nn - 
Phrase8070:
the effects 
dt - nns - 
Phrase8071:
many c-11-substituted 
jj - nn - 
Phrase8072:
their 
prp$ - 
Phrase8073:
different cell 
jj - nn - 
Phrase8074:
major depressive disorder 
jj - jj - nn - 
Phrase8075:
the apparent glucocorticoid 
dt - jj - nn - 
Phrase8076:
major depressive disorder 
jj - jj - nn - 
Phrase8077:
polymorphonuclear leukocytes 
jj - nns - 
Phrase8078:
major depressive disorder 
jj - jj - nn - 
Phrase8079:
psychiatric controls 
jj - nns - 
Phrase8080:
polymorphonuclear leukocytes 
jj - nns - 
Phrase8081:
both determinations 
dt - nn - 
Phrase8082:
major depressive disorder 
jj - jj - nn - 
Phrase8083:
major depressive disorder 
jj - jj - nn - 
Phrase8084:
the phenomenon 
dt - nn - 
Phrase8085:
major depressive disorder 
jj - jj - nn - 
Phrase8086:
high affinity 
jj - nn - 
Phrase8087:
rich fractions 
jj - nns - 
Phrase8088:
the intracellular concentrations 
dt - jj - nns - 
Phrase8089:
the sodium-proton-antiport 
dt - nn - 
Phrase8090:
intact human 
jj - nn - 
Phrase8091:
the present 
dt - nn - 
Phrase8092:
the binding 
dt - nn - 
Phrase8093:
rich fractions 
jj - nns - 
Phrase8094:
high affinity 
jj - nn - 
Phrase8095:
the radioligand 
dt - nn - 
Phrase8096:
an apparent kd 
dt - jj - nn - 
Phrase8097:
the tracer 
dt - nn - 
Phrase8098:
similar kd 
jj - nn - 
Phrase8099:
the findings 
dt - nns - 
Phrase8100:
high affinity 
jj - nn - 
Phrase8101:
these data 
dt - nns - 
Phrase8102:
major properties 
jj - nns - 
Phrase8103:
the sodium-proton-antiport 
dt - nn - 
Phrase8104:
natural variants 
jj - nns - 
Phrase8105:
the hiv-1 
dt - nn - 
Phrase8106:
long terminal 
jj - nn - 
Phrase8107:
regulatory motifs 
jj - nns - 
Phrase8108:
the long terminal 
dt - jj - nn - 
Phrase8109:
viral isolates 
jj - nns - 
Phrase8110:
infected individuals 
jj - nns - 
Phrase8111:
an additional binding 
dt - jj - nn - 
Phrase8112:
the transcription 
dt - nn - 
Phrase8113:
another ltr 
dt - nn - 
Phrase8114:
the nf-kappa 
dt - nn - 
Phrase8115:
the result 
dt - nn - 
Phrase8116:
short dna 
jj - nn - 
Phrase8117:
the natural variant 
dt - jj - nn - 
Phrase8118:
higher promoter 
jjr - nn - 
Phrase8119:
viral replication 
jj - nn - 
Phrase8120:
the isogenic control 
dt - jj - nn - 
Phrase8121:
positive effect 
jj - nn - 
Phrase8122:
the duplicated 
dt - nn - 
Phrase8123:
small differences 
jj - nns - 
Phrase8124:
equal amounts 
jj - nns - 
Phrase8125:
the wild-type plasmid 
dt - jj - nn - 
Phrase8126:
the virus 
dt - nn - 
Phrase8127:
the ctg-dimer 
dt - nn - 
Phrase8128:
these results 
dt - nns - 
Phrase8129:
we 
prp - 
Phrase8130:
the ltr 
dt - nn - 
Phrase8131:
novel b 
jj - nn - 
Phrase8132:
cell-derived coactivator 
jj - nn - 
Phrase8133:
the activation 
dt - nn - 
Phrase8134:
octamer-binding transcription 
jj - nn - 
Phrase8135:
novel b 
jj - nn - 
Phrase8136:
high levels 
jj - nns - 
Phrase8137:
an immunoglobulin 
dt - nn - 
Phrase8138:
heavy chain 
jj - nn - 
Phrase8139:
an in 
dt - nn - 
Phrase8140:
cell-derived extracts 
jj - nns - 
Phrase8141:
nuclear proteins 
jj - nns - 
Phrase8142:
the factor 
dt - nn - 
Phrase8143:
this activity 
dt - nn - 
Phrase8144:
the transcription 
dt - nn - 
Phrase8145:
an igh 
dt - nn - 
Phrase8146:
either oct-1 
dt - nn - 
Phrase8147:
significant effect 
jj - nn - 
Phrase8148:
the octamer/oct-dependent 
dt - nn - 
Phrase8149:
the transcription 
dt - nn - 
Phrase8150:
our 
prp$ - 
Phrase8151:
major determinant 
jj - nn - 
Phrase8152:
cell-specific activation 
jj - nn - 
Phrase8153:
the evidence 
dt - nn - 
Phrase8154:
functional interactions 
jj - nns - 
Phrase8155:
we 
prp - 
Phrase8156:
the implications 
dt - nns - 
Phrase8157:
the transcriptional regulation 
dt - jj - nn - 
Phrase8158:
other tissue-specific promoters 
jj - jj - nns - 
Phrase8159:
related hemopoietic helix-loop-helix transcription 
jj - jj - jj - nn - 
Phrase8160:
this family 
dt - nn - 
Phrase8161:
oncogenic events 
jj - nns - 
Phrase8162:
lymphoid tumors 
jj - nns - 
Phrase8163:
their 
prp$ - 
Phrase8164:
consistent involvement 
jj - nn - 
Phrase8165:
undetectable in 
jj - nn - 
Phrase8166:
normal t 
jj - nn - 
Phrase8167:
the same cell 
dt - jj - nn - 
Phrase8168:
erythroid differentiation 
jj - nn - 
Phrase8169:
erythroid differentiation 
jj - nn - 
Phrase8170:
the function 
dt - nn - 
Phrase8171:
it 
prp - 
Phrase8172:
important in 
jj - nn - 
Phrase8173:
erythroid cells 
jj - nns - 
Phrase8174:
the pou 
dt - nn - 
Phrase8175:
the promoters 
dt - nns - 
Phrase8176:
the b-cell 
dt - nn - 
Phrase8177:
the t-cell 
dt - nn - 
Phrase8178:
the role 
dt - nn - 
Phrase8179:
the t-cell 
dt - nn - 
Phrase8180:
we 
prp - 
Phrase8181:
the expression 
dt - nn - 
Phrase8182:
nontransformed human 
jj - nn - 
Phrase8183:
cd8+ t 
jj - nn - 
Phrase8184:
peripheral blood 
jj - nn - 
Phrase8185:
the context 
dt - nn - 
Phrase8186:
the increase 
dt - nn - 
Phrase8187:
these results 
dt - nns - 
Phrase8188:
transcriptional regulation 
jj - nn - 
Phrase8189:
the changes 
dt - nns - 
Phrase8190:
many hours 
jj - nns - 
Phrase8191:
we 
prp - 
Phrase8192:
the clinical significance 
dt - jj - nn - 
Phrase8193:
systemic lupus 
jj - nn - 
Phrase8194:
these patients 
dt - nns - 
Phrase8195:
those in 
dt - nn - 
Phrase8196:
other patients 
jj - nns - 
Phrase8197:
healthy persons 
jj - nns - 
Phrase8198:
urinary protein 
jj - nn - 
Phrase8199:
the sle 
dt - nn - 
Phrase8200:
the university 
dt - nn - 
Phrase8201:
the glucocorticoid 
dt - nn - 
Phrase8202:
the corresponding patients 
dt - jj - nns - 
Phrase8203:
predictive clue 
jj - nn - 
Phrase8204:
their 
prp$ - 
Phrase8205:
possible relationship 
jj - nn - 
Phrase8206:
the changes 
dt - nns - 
Phrase8207:
aged long-distance runner 
jj - jj - nn - 
Phrase8208:
the study 
dt - nn - 
Phrase8209:
the changes 
dt - nns - 
Phrase8210:
their 
prp$ - 
Phrase8211:
possible relationship 
jj - nn - 
Phrase8212:
the changes 
dt - nns - 
Phrase8213:
peripheral blood 
jj - nn - 
Phrase8214:
aged long-distance runner 
jj - jj - nn - 
Phrase8215:
the activity 
dt - nn - 
Phrase8216:
its 
prp$ - 
Phrase8217:
3h-tdr incorporation 
dt - nn - 
Phrase8218:
the thymocytes 
dt - nns - 
Phrase8219:
whole cell 
jj - nn - 
Phrase8220:
the results 
dt - nns - 
Phrase8221:
the activity 
dt - nn - 
Phrase8222:
aged long-distance runner 
jj - jj - nn - 
Phrase8223:
the control 
dt - nn - 
Phrase8224:
the gr 
dt - nn - 
Phrase8225:
peripheral blood 
jj - nn - 
Phrase8226:
aged runner 
jj - nn - 
Phrase8227:
the control 
dt - nn - 
Phrase8228:
possible relationship 
jj - nn - 
Phrase8229:
the changes 
dt - nns - 
Phrase8230:
aged long-distance runner 
jj - jj - nn - 
Phrase8231:
its 
prp$ - 
Phrase8232:
physiological significance 
jj - nn - 
Phrase8233:
minus oral values 
jj - jj - nns - 
Phrase8234:
significant differences 
jj - nns - 
Phrase8235:
we 
prp - 
Phrase8236:
both parameters 
dt - nns - 
Phrase8237:
normal nonpregnant 
jj - nn - 
Phrase8238:
these data 
dt - nns - 
Phrase8239:
an important role 
dt - jj - nn - 
Phrase8240:
the etiology 
dt - nn - 
Phrase8241:
an useful marker 
dt - jj - nn - 
Phrase8242:
nuclear translocation 
jj - nn - 
Phrase8243:
the vitamin 
dt - nn - 
Phrase8244:
peripheral blood 
jj - nn - 
Phrase8245:
coincident rise 
jj - nn - 
Phrase8246:
nuclear extracts 
jj - nns - 
Phrase8247:
high affinity 
jj - nn - 
Phrase8248:
low numbers 
jj - nns - 
Phrase8249:
peripheral blood 
jj - nn - 
Phrase8250:
some characteristics 
dt - nns - 
Phrase8251:
specific nuclear translocation 
jj - jj - nn - 
Phrase8252:
whole cells 
jj - nns - 
Phrase8253:
the presence 
dt - nn - 
Phrase8254:
unlabeled ligand 
jj - nn - 
Phrase8255:
subsequent isolation 
jj - nn - 
Phrase8256:
specific nuclear translocation 
jj - jj - nn - 
Phrase8257:
nuclear retention 
jj - nn - 
Phrase8258:
the nuclear compartment 
dt - jj - nn - 
Phrase8259:
identical concentrations 
jj - nns - 
Phrase8260:
unlabeled hormone 
jj - nn - 
Phrase8261:
the pulse 
dt - nn - 
Phrase8262:
specific translocation 
jj - nn - 
Phrase8263:
the nuclear compartment 
dt - jj - nn - 
Phrase8264:
identical experiments 
jj - nns - 
Phrase8265:
intact cells 
jj - nns - 
Phrase8266:
the nuclear compartment 
dt - jj - nn - 
Phrase8267:
identical concentrations 
jj - nns - 
Phrase8268:
the unlabeled compound 
dt - jj - nn - 
Phrase8269:
the activity 
dt - nn - 
Phrase8270:
nuclear extracts 
jj - nns - 
Phrase8271:
nuclear extracts 
jj - nns - 
Phrase8272:
final ethanol 
jj - nn - 
Phrase8273:
it 
prp - 
Phrase8274:
we 
prp - 
Phrase8275:
specific nuclear translocation 
jj - jj - nn - 
Phrase8276:
limited number 
jj - nn - 
Phrase8277:
specific nuclear binding 
jj - jj - nn - 
Phrase8278:
nuclear extracts 
jj - nns - 
Phrase8279:
the nuclear compartment 
dt - jj - nn - 
Phrase8280:
lymphokine-activated killer 
jj - nn - 
Phrase8281:
the design 
dt - nn - 
Phrase8282:
immunotherapeutic protocols 
jj - nns - 
Phrase8283:
preclinical in 
jj - nn - 
Phrase8284:
the effects 
dt - nns - 
Phrase8285:
lymphokine-activated killer 
jj - nn - 
Phrase8286:
corresponding tam-treated 
jj - nn - 
Phrase8287:
either e2 
dt - nn - 
Phrase8288:
their 
prp$ - 
Phrase8289:
this immune-mediated lysis 
dt - jj - nn - 
Phrase8290:
an adenocarcinoma 
dt - nn - 
Phrase8291:
reactive human-mouse 
jj - nn - 
Phrase8292:
chimeric monoclonal antibody 
jj - jj - nn - 
Phrase8293:
cell-mediated lysis 
jj - nn - 
Phrase8294:
these in 
dt - nn - 
Phrase8295:
preclinical rationale 
jj - nn - 
Phrase8296:
reactive antibody-dependent 
jj - nn - 
Phrase8297:
cellular cytotoxicity 
jj - nn - 
Phrase8298:
high risk 
jj - nn - 
Phrase8299:
the cellular oncogene 
dt - jj - nn - 
Phrase8300:
the epstein-barr virus 
dt - jj - nn - 
Phrase8301:
lymphoid cells 
jj - nns - 
Phrase8302:
the epstein-barr virus 
dt - jj - nn - 
Phrase8303:
we 
prp - 
Phrase8304:
the z 
dt - nn - 
Phrase8305:
the ebv 
dt - nn - 
Phrase8306:
early promoter 
jj - nn - 
Phrase8307:
certain cell 
jj - nn - 
Phrase8308:
we 
prp - 
Phrase8309:
the c-myb 
dt - nn - 
Phrase8310:
itself 
prp - 
Phrase8311:
transcriptional transactivator 
jj - nn - 
Phrase8312:
the bmrf1 
dt - nn - 
Phrase8313:
an ebv-positive b-cell 
dt - jj - nn - 
Phrase8314:
the c-myb 
dt - nn - 
Phrase8315:
itself 
prp - 
Phrase8316:
little effect 
jj - nn - 
Phrase8317:
the simian virus 
dt - jj - nn - 
Phrase8318:
early promoter 
jj - nn - 
Phrase8319:
the z/c-myb 
dt - nn - 
Phrase8320:
synergistic transactivation 
jj - nn - 
Phrase8321:
the bmrf1 
dt - nn - 
Phrase8322:
the z/c-myb 
dt - nn - 
Phrase8323:
direct binding 
jj - nn - 
Phrase8324:
the z 
dt - nn - 
Phrase8325:
the c-myb 
dt - nn - 
Phrase8326:
the bmrf1 
dt - nn - 
Phrase8327:
high-level lymphoid-specific responsiveness 
jj - jj - nn - 
Phrase8328:
the z/c-myb 
dt - nn - 
Phrase8329:
heterologous promoter 
jj - nn - 
Phrase8330:
the c-myb 
dt - nn - 
Phrase8331:
an ebv-encoded member 
dt - jj - nn - 
Phrase8332:
the leucine 
dt - nn - 
Phrase8333:
similar interactions 
jj - nns - 
Phrase8334:
alpha-lipoic acid 
jj - nn - 
Phrase8335:
the long terminal 
dt - jj - nn - 
Phrase8336:
proviral dna 
jj - nn - 
Phrase8337:
nuclear factor 
jj - nn - 
Phrase8338:
this transcriptional activator 
dt - jj - nn - 
Phrase8339:
recent findings 
jj - nns - 
Phrase8340:
an involvement 
dt - nn - 
Phrase8341:
reactive oxygen 
jj - nn - 
Phrase8342:
the present 
dt - nn - 
Phrase8343:
the activation 
dt - nn - 
Phrase8344:
therapeutic agents 
jj - nns - 
Phrase8345:
natural thiol 
jj - nn - 
Phrase8346:
alpha-lipoic acid 
jj - nn - 
Phrase8347:
the stimulation 
dt - nn - 
Phrase8348:
the inhibitory action 
dt - jj - nn - 
Phrase8349:
alpha-lipoic acid 
jj - nn - 
Phrase8350:
complete inhibition 
jj - nn - 
Phrase8351:
these results 
dt - nns - 
Phrase8352:
alpha-lipoic acid 
jj - nn - 
Phrase8353:
effective in 
jj - nn - 
Phrase8354:
long terminal 
jj - nn - 
Phrase8355:
efficient promoters 
jj - nns - 
Phrase8356:
various species 
jj - nns - 
Phrase8357:
lymphoid cells 
jj - nns - 
Phrase8358:
transcriptional activity 
jj - nn - 
Phrase8359:
the reticuloendotheliosis 
dt - nn - 
Phrase8360:
long terminal 
jj - nn - 
Phrase8361:
diverse species 
jj - nns - 
Phrase8362:
different rev 
jj - nn - 
Phrase8363:
the respective viruses 
dt - jj - nns - 
Phrase8364:
the viral ltr 
dt - jj - nn - 
Phrase8365:
an overlapping host 
dt - jj - nn - 
Phrase8366:
avian sarcoma/leukemia 
jj - nn - 
Phrase8367:
lymphoid cells 
jj - nns - 
Phrase8368:
viable alternatives 
jj - nn - 
Phrase8369:
they 
prp - 
Phrase8370:
useful in 
jj - nn - 
Phrase8371:
the identification 
dt - nn - 
Phrase8372:
ubiquitous cellular transcription 
jj - jj - nn - 
Phrase8373:
novel ets-related transcription 
jj - jj - nn - 
Phrase8374:
regulatory elements 
jj - nns - 
Phrase8375:
inducible trans 
jj - nn - 
Phrase8376:
related retroviruses 
jj - nns - 
Phrase8377:
both cause 
dt - nn - 
Phrase8378:
both viruses 
dt - nns - 
Phrase8379:
quiescent human-peripheral-blood 
jj - nn - 
Phrase8380:
the asymptomatic phase 
dt - jj - nn - 
Phrase8381:
the latent phases 
dt - jj - nns - 
Phrase8382:
both hiv-1 
dt - nn - 
Phrase8383:
the case 
dt - nn - 
Phrase8384:
the transcription 
dt - nn - 
Phrase8385:
inducible transcriptional activation 
jj - jj - nn - 
Phrase8386:
infected t 
jj - nn - 
Phrase8387:
this report 
dt - nn - 
Phrase8388:
we 
prp - 
Phrase8389:
novel ets-related transcription 
jj - jj - nn - 
Phrase8390:
purine-rich motifs 
jj - nns - 
Phrase8391:
the hiv-2 
dt - nn - 
Phrase8392:
these elf-1 
dt - nn - 
Phrase8393:
nuclear extracts 
jj - nns - 
Phrase8394:
these sites 
dt - nns - 
Phrase8395:
electrophoretic mobility 
jj - nn - 
Phrase8396:
novel transcription 
jj - nn - 
Phrase8397:
the t-cell-receptor-mediated 
dt - nn - 
Phrase8398:
these results 
dt - nns - 
Phrase8399:
the clinical spectra 
dt - jj - nn - 
Phrase8400:
the design 
dt - nn - 
Phrase8401:
therapeutic approaches 
jj - nns - 
Phrase8402:
okadaic acid 
jj - nn - 
Phrase8403:
an optimal concentration 
dt - jj - nn - 
Phrase8404:
okadaic acid 
jj - nn - 
Phrase8405:
an inhibitor 
dt - nn - 
Phrase8406:
the induction 
dt - nn - 
Phrase8407:
the transcription 
dt - nn - 
Phrase8408:
marked increase 
jj - nn - 
Phrase8409:
the levels 
dt - nns - 
Phrase8410:
the octamer 
dt - nn - 
Phrase8411:
both ap-1 
dt - nn - 
Phrase8412:
important in 
jj - nn - 
Phrase8413:
the induction 
dt - nn - 
Phrase8414:
the tumor 
dt - nn - 
Phrase8415:
we 
prp - 
Phrase8416:
the effects 
dt - nns - 
Phrase8417:
okadaic acid 
jj - nn - 
Phrase8418:
okadaic acid 
jj - nn - 
Phrase8419:
striking increase 
jj - nn - 
Phrase8420:
large amounts 
jj - nns - 
Phrase8421:
the culture 
dt - nn - 
Phrase8422:
okadaic acid 
jj - nn - 
Phrase8423:
inductive signal 
jj - nn - 
Phrase8424:
it 
prp - 
Phrase8425:
either b 
dt - nn - 
Phrase8426:
transcriptional activation 
jj - nn - 
Phrase8427:
the nf-kappa 
dt - nn - 
Phrase8428:
multiple dna 
jj - nn - 
Phrase8429:
related polypeptides 
jj - nns - 
Phrase8430:
immune responsiveness 
jj - nn - 
Phrase8431:
the hiv 
dt - nn - 
Phrase8432:
long terminal 
jj - nn - 
Phrase8433:
this study 
dt - nn - 
Phrase8434:
multiple nf-kappa 
jj - nn - 
Phrase8435:
related polypeptides 
jj - nns - 
Phrase8436:
their 
prp$ - 
Phrase8437:
the prdii 
dt - nn - 
Phrase8438:
regulatory element 
jj - nn - 
Phrase8439:
distinct intrinsic dna 
jj - jj - nn - 
Phrase8440:
this nf-kappa 
dt - nn - 
Phrase8441:
multiple dna 
jj - nn - 
Phrase8442:
the prdii 
dt - nn - 
Phrase8443:
the rabbit 
dt - nn - 
Phrase8444:
dependent transcription 
jj - nn - 
Phrase8445:
an in 
dt - nn - 
Phrase8446:
these experiments 
dt - nns - 
Phrase8447:
the role 
dt - nn - 
Phrase8448:
distinct level 
jj - nn - 
Phrase8449:
transcriptional control 
jj - nn - 
Phrase8450:
functional diversification 
jj - nn - 
Phrase8451:
limited number 
jj - nn - 
Phrase8452:
regulatory proteins 
jj - nns - 
Phrase8453:
minor salivary 
jj - nn - 
Phrase8454:
the pathogenesis 
dt - nn - 
Phrase8455:
lymphoid malignancies 
jj - nns - 
Phrase8456:
high levels 
jj - nns - 
Phrase8457:
lymphocytic infiltrates 
jj - nn - 
Phrase8458:
exocrine glands 
jj - nns - 
Phrase8459:
remarkable b 
jj - nn - 
Phrase8460:
strong predisposition 
jj - nn - 
Phrase8461:
this study 
dt - nn - 
Phrase8462:
minor salivary 
jj - nn - 
Phrase8463:
primary ss 
jj - nn - 
Phrase8464:
the 1st 
dt - nn - 
Phrase8465:
the 2nd 
dt - nn - 
Phrase8466:
the c-myc 
dt - nn - 
Phrase8467:
the origin 
dt - nn - 
Phrase8468:
the cell 
dt - nn - 
Phrase8469:
combined immunochemistry 
jj - nn - 
Phrase8470:
high c-myc 
jj - nn - 
Phrase8471:
acinar epithelial 
jj - nn - 
Phrase8472:
stronger c-myc 
jjr - nn - 
Phrase8473:
longer disease 
jjr - nn - 
Phrase8474:
intense t 
jj - nn - 
Phrase8475:
these patients 
dt - nns - 
Phrase8476:
strong c-myc 
jj - nn - 
Phrase8477:
primary ss 
jj - nn - 
Phrase8478:
our 
prp$ - 
Phrase8479:
the presence 
dt - nn - 
Phrase8480:
these cells 
dt - nns - 
Phrase8481:
related receptors 
jj - nns - 
Phrase8482:
healthy aged subjects 
jj - jj - nns - 
Phrase8483:
an index 
dt - nn - 
Phrase8484:
the mean 
dt - nn - 
Phrase8485:
lower in 
jjr - nn - 
Phrase8486:
aged subjects 
jj - nns - 
Phrase8487:
different in 
jj - nn - 
Phrase8488:
the parameters 
dt - nns - 
Phrase8489:
significant inverse 
jj - nn - 
Phrase8490:
the aged group 
dt - jj - nn - 
Phrase8491:
these data 
dt - nns - 
Phrase8492:
aged subjects 
jj - nns - 
Phrase8493:
related steroids 
jj - nns - 
Phrase8494:
this situation 
dt - nn - 
Phrase8495:
the normal aging 
dt - jj - nn - 
Phrase8496:
cell-specific negative regulation 
jj - jj - nn - 
Phrase8497:
the human 
dt - nn - 
Phrase8498:
pleiotropic cytokine 
jj - nn - 
Phrase8499:
diverse cell 
jj - nn - 
Phrase8500:
we 
prp - 
Phrase8501:
the upstream regulatory elements 
dt - jj - jj - nns - 
Phrase8502:
the human 
dt - nn - 
Phrase8503:
novel t 
jj - nn - 
Phrase8504:
cell-specific negative regulatory element 
jj - jj - jj - nn - 
Phrase8505:
protein-binding sites 
jj - nns - 
Phrase8506:
the 5' 
dt - nn - 
Phrase8507:
flanking region 
jj - nn - 
Phrase8508:
the il-4 
dt - nn - 
Phrase8509:
cell-specific protein 
jj - nn - 
Phrase8510:
ubiquitous protein 
jj - nn - 
Phrase8511:
positive regulatory element 
jj - jj - nn - 
Phrase8512:
the nre 
dt - nn - 
Phrase8513:
the enhancer 
dt - nn - 
Phrase8514:
the pre 
dt - nn - 
Phrase8515:
the nre 
dt - nn - 
Phrase8516:
these data 
dt - nns - 
Phrase8517:
an nre 
dt - nn - 
Phrase8518:
the enhancer 
dt - nn - 
Phrase8519:
positive regulatory element 
jj - jj - nn - 
Phrase8520:
these data 
dt - nns - 
Phrase8521:
the stringent control 
dt - jj - nn - 
Phrase8522:
the role 
dt - nn - 
Phrase8523:
the protooncogene 
dt - nn - 
Phrase8524:
early stimulation 
jj - nn - 
Phrase8525:
the effect 
dt - nn - 
Phrase8526:
basal levels 
jj - nns - 
Phrase8527:
the addition 
dt - nn - 
Phrase8528:
antisense oligonucleotides 
jj - nns - 
Phrase8529:
inhibitory effect 
jj - nn - 
Phrase8530:
these results 
dt - nns - 
Phrase8531:
transcriptional regulation 
jj - nn - 
Phrase8532:
the alpha 
dt - nn - 
Phrase8533:
the regulation 
dt - nn - 
Phrase8534:
negative transcriptional regulatory elements 
jj - jj - jj - nns - 
Phrase8535:
this article 
dt - nn - 
Phrase8536:
transcriptional regulation 
jj - nn - 
Phrase8537:
the archetypal 
dt - nn - 
Phrase8538:
t-cell-specific gene 
jj - nn - 
Phrase8539:
major recent developments 
jj - jj - nn - 
Phrase8540:
the identification 
dt - nn - 
Phrase8541:
novel families 
jj - nns - 
Phrase8542:
multiple t-cell 
jj - nn - 
Phrase8543:
non-genomic effects 
jj - nns - 
Phrase8544:
the sodium-proton-antiport 
dt - nn - 
Phrase8545:
the present 
dt - nn - 
Phrase8546:
sulfate-polyacrylamide gel 
jj - nn - 
Phrase8547:
significant aldosterone 
jj - nn - 
Phrase8548:
cold aldosterone 
jj - nn - 
Phrase8549:
the binding 
dt - nn - 
Phrase8550:
the presence 
dt - nn - 
Phrase8551:
the sulfhydryl 
dt - nn - 
Phrase8552:
the absence 
dt - nn - 
Phrase8553:
the steroid 
dt - nn - 
Phrase8554:
the receptor 
dt - nn - 
Phrase8555:
these data 
dt - nns - 
Phrase8556:
the molecular 
dt - nn - 
Phrase8557:
the membrane 
dt - nn - 
Phrase8558:
long terminal 
jj - nn - 
Phrase8559:
monocytic cell 
jj - nn - 
Phrase8560:
we 
prp - 
Phrase8561:
the hypothesis 
dt - nn - 
Phrase8562:
cellular activation 
jj - nn - 
Phrase8563:
the transcription 
dt - nn - 
Phrase8564:
the constitutive redox 
dt - jj - nn - 
Phrase8565:
these cells 
dt - nns - 
Phrase8566:
we 
prp - 
Phrase8567:
chain-breaking antioxidants 
jj - nns - 
Phrase8568:
tnf-stimulated cells 
jj - nns - 
Phrase8569:
the functions 
dt - nns - 
Phrase8570:
an inhibition 
dt - nn - 
Phrase8571:
the product 
dt - nn - 
Phrase8572:
another nf-kappa 
dt - nn - 
Phrase8573:
b-dependent gene 
jj - nn - 
Phrase8574:
pma-stimulated u937 
jj - nn - 
Phrase8575:
the anti-oxidative 
dt - nn - 
Phrase8576:
an increase 
dt - nn - 
Phrase8577:
unstimulated t 
jj - nn - 
Phrase8578:
itself 
prp - 
Phrase8579:
the cellular thiol 
dt - jj - nn - 
Phrase8580:
oxidative stress 
jj - nn - 
Phrase8581:
the addition 
dt - nn - 
Phrase8582:
the culture 
dt - nn - 
Phrase8583:
itself 
prp - 
Phrase8584:
these observations 
dt - nns - 
Phrase8585:
the cell 
dt - nn - 
Phrase8586:
their 
prp$ - 
Phrase8587:
an appropriate redox 
dt - jj - nn - 
Phrase8588:
prior modification 
jj - nn - 
Phrase8589:
this activation 
dt - nn - 
Phrase8590:
it 
prp - 
Phrase8591:
basal redox 
jj - nn - 
Phrase8592:
full activation 
jj - nn - 
Phrase8593:
the activity 
dt - nn - 
Phrase8594:
b-dependent genes 
jj - nns - 
Phrase8595:
optimal kappa 
jj - nn - 
Phrase8596:
both subunits 
dt - nns - 
Phrase8597:
transcriptional activation 
jj - nn - 
Phrase8598:
the p50 
dt - nn - 
Phrase8599:
the nf-kappa 
dt - nn - 
Phrase8600:
both proteins 
dt - nns - 
Phrase8601:
related dna 
jj - nn - 
Phrase8602:
either homo- 
dt - nn - 
Phrase8603:
the product 
dt - nn - 
Phrase8604:
the proto-oncogene 
dt - nn - 
Phrase8605:
similar dna 
jj - nn - 
Phrase8606:
itself 
prp - 
Phrase8607:
these studies 
dt - nns - 
Phrase8608:
limited number 
jj - nn - 
Phrase8609:
the question 
dt - nn - 
Phrase8610:
the optimal dna 
dt - jj - nn - 
Phrase8611:
each homodimer 
dt - nn - 
Phrase8612:
optimal dna-binding 
jj - nn - 
Phrase8613:
random oligonucleotides 
jj - nns - 
Phrase8614:
us 
prp - 
Phrase8615:
the individual 
dt - nn - 
Phrase8616:
homodimeric rel-related proteins 
jj - jj - nns - 
Phrase8617:
the proteins 
dt - nns - 
Phrase8618:
previous assumptions 
jj - nn - 
Phrase8619:
we 
prp - 
Phrase8620:
differential binding 
jj - nn - 
Phrase8621:
either a 
dt - nn - 
Phrase8622:
differential binding 
jj - nn - 
Phrase8623:
the other protein 
dt - jj - nn - 
Phrase8624:
the heterodimeric nf-kappa 
dt - jj - nn - 
Phrase8625:
the selective kappa 
dt - jj - nn - 
Phrase8626:
the expression 
dt - nn - 
Phrase8627:
the p65- 
dt - nn - 
Phrase8628:
the presence 
dt - nn - 
Phrase8629:
chimeric protein 
jj - nn - 
Phrase8630:
the p50 
dt - nn - 
Phrase8631:
significant response 
jj - nn - 
Phrase8632:
these findings 
dt - nns - 
Phrase8633:
both subunits 
dt - nns - 
Phrase8634:
the heterodimeric nf-kappa 
dt - jj - nn - 
Phrase8635:
transcriptional activation 
jj - nn - 
Phrase8636:
transcriptional activation 
jj - nn - 
Phrase8637:
the individual 
dt - nn - 
Phrase8638:
rel-related proteins 
jj - nns - 
Phrase8639:
the specific kappa 
dt - jj - nn - 
Phrase8640:
b-dependent induction 
jj - nn - 
Phrase8641:
the nf-kappa 
dt - nn - 
Phrase8642:
monocytic cells 
jj - nns - 
Phrase8643:
the molecular 
dt - nn - 
Phrase8644:
the sustained nuclear translocation 
dt - jj - jj - nn - 
Phrase8645:
monocytic cells 
jj - nns - 
Phrase8646:
the activity 
dt - nn - 
Phrase8647:
the promoter 
dt - nn - 
Phrase8648:
the synthesis 
dt - nn - 
Phrase8649:
the p105 
dt - nn - 
Phrase8650:
the nf-kappa 
dt - nn - 
Phrase8651:
these cells 
dt - nns - 
Phrase8652:
this promoter 
dt - nn - 
Phrase8653:
this upregulation 
dt - nn - 
Phrase8654:
the nf-kappa 
dt - nn - 
Phrase8655:
the ap-1-binding motif 
dt - jj - nn - 
Phrase8656:
cytosolic extracts 
jj - nns - 
Phrase8657:
hiv-infected cells 
jj - nns - 
Phrase8658:
the transient 
dt - nn - 
Phrase8659:
the permanent nf-kappa 
dt - jj - nn - 
Phrase8660:
the use 
dt - nn - 
Phrase8661:
specific inhibitor 
jj - nn - 
Phrase8662:
these observations 
dt - nns - 
Phrase8663:
chronic hiv 
jj - nn - 
Phrase8664:
continuous nf-kappa 
jj - nn - 
Phrase8665:
subsequent cytosolic nf-kappa 
jj - jj - nn - 
Phrase8666:
further translocation 
jj - nn - 
Phrase8667:
hiv-mediated mechanism 
jj - nn - 
Phrase8668:
we 
prp - 
Phrase8669:
the transcription 
dt - nn - 
Phrase8670:
its 
prp$ - 
Phrase8671:
the 5' 
dt - nn - 
Phrase8672:
regulatory enhancer 
jj - nn - 
Phrase8673:
the il-2 
dt - nn - 
Phrase8674:
the human 
dt - nn - 
Phrase8675:
monocytic cell 
jj - nn - 
Phrase8676:
functional activation 
jj - nn - 
Phrase8677:
the il-2 
dt - nn - 
Phrase8678:
heterologous promoter 
jj - nn - 
Phrase8679:
the nf-kappa 
dt - nn - 
Phrase8680:
the il-2 
dt - nn - 
Phrase8681:
the p50 
dt - nn - 
Phrase8682:
the p50 
dt - nn - 
Phrase8683:
the nf-kappa 
dt - nn - 
Phrase8684:
the p65 
dt - nn - 
Phrase8685:
the biological activity 
dt - jj - nn - 
Phrase8686:
hepatic microsomes 
jj - nns - 
Phrase8687:
short term 
jj - nn - 
Phrase8688:
we 
prp - 
Phrase8689:
the action 
dt - nn - 
Phrase8690:
the activity 
dt - nn - 
Phrase8691:
effective dose 
jj - nn - 
Phrase8692:
nuclear receptors 
jj - nns - 
Phrase8693:
intact cells 
jj - nns - 
Phrase8694:
soluble preparations 
jj - nns - 
Phrase8695:
nuclear receptor 
jj - nn - 
Phrase8696:
dermal fibroblasts 
jj - nns - 
Phrase8697:
the activity 
dt - nn - 
Phrase8698:
the same level 
dt - jj - nn - 
Phrase8699:
microsomal p-nitrophenyl 
jj - nn - 
Phrase8700:
hepatic microsomes 
jj - nns - 
Phrase8701:
the action 
dt - nn - 
Phrase8702:
this activity 
dt - nn - 
Phrase8703:
it 
prp - 
Phrase8704:
intrinsic biological activity 
jj - jj - nn - 
Phrase8705:
certain circumstances 
jj - nns - 
Phrase8706:
the activation-inducer 
dt - nn - 
Phrase8707:
the activity 
dt - nn - 
Phrase8708:
the induction 
dt - nn - 
Phrase8709:
the ap-1 
dt - nn - 
Phrase8710:
the early events 
dt - jj - nns - 
Phrase8711:
we 
prp - 
Phrase8712:
the regulation 
dt - nn - 
Phrase8713:
peripheral blood 
jj - nn - 
Phrase8714:
the activation 
dt - nn - 
Phrase8715:
aim/cd69 cell-surface 
dt - nn - 
Phrase8716:
the proliferation 
dt - nn - 
Phrase8717:
pma-treated t 
jj - nn - 
Phrase8718:
the binding 
dt - nn - 
Phrase8719:
its 
prp$ - 
Phrase8720:
the phorbol 
dt - nn - 
Phrase8721:
any change 
dt - nn - 
Phrase8722:
the binding 
dt - nn - 
Phrase8723:
the increase 
dt - nn - 
Phrase8724:
ap-1-binding activity 
jj - nn - 
Phrase8725:
the marked stimulation 
dt - jj - nn - 
Phrase8726:
the transcription 
dt - nn - 
Phrase8727:
the dna-binding 
dt - nn - 
Phrase8728:
an anti-fos mab 
dt - jj - nn - 
Phrase8729:
direct participation 
jj - nn - 
Phrase8730:
the ap-1 
dt - nn - 
Phrase8731:
the ap-1 
dt - nn - 
Phrase8732:
the anti-aim 
dt - nn - 
Phrase8733:
the culture 
dt - nn - 
Phrase8734:
the presence 
dt - nn - 
Phrase8735:
the induction 
dt - nn - 
Phrase8736:
ap-1-binding activity 
jj - nn - 
Phrase8737:
these data 
dt - nns - 
Phrase8738:
the evidence 
dt - nn - 
Phrase8739:
peripheral blood 
jj - nn - 
Phrase8740:
the aim 
dt - nn - 
Phrase8741:
the activity 
dt - nn - 
Phrase8742:
this pathway 
dt - nn - 
Phrase8743:
crucial step 
jj - nn - 
Phrase8744:
the initiation 
dt - nn - 
Phrase8745:
early t 
jj - nn - 
Phrase8746:
malignant cells 
jj - nns - 
Phrase8747:
important cell 
jj - nn - 
Phrase8748:
the immune system 
dt - jj - nn - 
Phrase8749:
we 
prp - 
Phrase8750:
the impact 
dt - nn - 
Phrase8751:
the expression 
dt - nn - 
Phrase8752:
the monocytic cell 
dt - jj - nn - 
Phrase8753:
lps-stimulated tnf 
jj - nn - 
Phrase8754:
serum-free conditions 
jj - nns - 
Phrase8755:
effective in 
jj - nn - 
Phrase8756:
the suppressive activity 
dt - jj - nn - 
Phrase8757:
the sugar 
dt - nn - 
Phrase8758:
the lipid 
dt - nn - 
Phrase8759:
an early step 
dt - jj - nn - 
Phrase8760:
the mobilization 
dt - nn - 
Phrase8761:
the nuclear factor 
dt - jj - nn - 
Phrase8762:
the expression 
dt - nn - 
Phrase8763:
the cd14 
dt - nn - 
Phrase8764:
the other hand 
dt - jj - nn - 
Phrase8765:
ester-induced production 
jj - nn - 
Phrase8766:
similar in 
jj - nn - 
Phrase8767:
our 
prp$ - 
Phrase8768:
different types 
jj - nns - 
Phrase8769:
an early step 
dt - jj - nn - 
Phrase8770:
novel mitogen-inducible 
jj - nn - 
Phrase8771:
an immediate-early activation 
dt - jj - nn - 
Phrase8772:
peripheral blood 
jj - nn - 
Phrase8773:
the cdna 
dt - nn - 
Phrase8774:
an open 
dt - nn - 
Phrase8775:
97-kda protein 
jj - nn - 
Phrase8776:
the 105-kda precursor 
dt - jj - nn - 
Phrase8777:
the 105-kda precursor 
dt - jj - nn - 
Phrase8778:
it 
prp - 
Phrase8779:
an amino-terminal rel-related domain 
dt - jj - jj - nn - 
Phrase8780:
carboxy-terminal domain 
jj - nn - 
Phrase8781:
full cell 
jj - nn - 
Phrase8782:
the rel 
dt - nn - 
Phrase8783:
the repeats 
dt - nns - 
Phrase8784:
we 
prp - 
Phrase8785:
the kappa 
dt - nn - 
Phrase8786:
the full-length 
dt - nn - 
Phrase8787:
heteromeric kappa 
jj - nn - 
Phrase8788:
embryonal carcinoma 
jj - nn - 
Phrase8789:
functional cooperation 
jj - nn - 
Phrase8790:
the data 
dt - nns - 
Phrase8791:
the existence 
dt - nn - 
Phrase8792:
b-like transcription 
jj - nn - 
Phrase8793:
the surface 
dt - nn - 
Phrase8794:
specific antigens 
jj - nns - 
Phrase8795:
monoclonal antibody 
jj - nn - 
Phrase8796:
the cell 
dt - nn - 
Phrase8797:
we 
prp - 
Phrase8798:
monoclonal antibody 
jj - nn - 
Phrase8799:
we 
prp - 
Phrase8800:
endogenous tg 
jj - nn - 
Phrase8801:
the efficient binding 
dt - jj - nn - 
Phrase8802:
we 
prp - 
Phrase8803:
the ability 
dt - nn - 
Phrase8804:
such cells 
jj - nns - 
Phrase8805:
low frequency 
jj - nn - 
Phrase8806:
autologous dendritic cells 
jj - jj - nns - 
Phrase8807:
the successful generation 
dt - jj - nn - 
Phrase8808:
more efficient tg 
jjr - jj - nn - 
Phrase8809:
the significance 
dt - nn - 
Phrase8810:
the present 
dt - nn - 
Phrase8811:
the t 
dt - nn - 
Phrase8812:
the antigen-presenting cells 
dt - jj - nns - 
Phrase8813:
the t 
dt - nn - 
Phrase8814:
other thyroid 
jj - nn - 
Phrase8815:
phosphorylation-dependent signal 
jj - nn - 
Phrase8816:
the proto-oncogene 
dt - nn - 
Phrase8817:
their 
prp$ - 
Phrase8818:
the ap-1 
dt - nn - 
Phrase8819:
the transcriptional activity 
dt - jj - nn - 
Phrase8820:
the heterodimer 
dt - nn - 
Phrase8821:
the stability 
dt - nn - 
Phrase8822:
intracellular signal 
jj - nn - 
Phrase8823:
the stability 
dt - nn - 
Phrase8824:
the protein 
dt - nn - 
Phrase8825:
phosphorylated c-jun 
jj - nn - 
Phrase8826:
ester-induced cells 
jj - nns - 
Phrase8827:
the retroviral counterpart 
dt - jj - nn - 
Phrase8828:
the regulation 
dt - nn - 
Phrase8829:
the human 
dt - nn - 
Phrase8830:
the 1311-base 
dt - nn - 
Phrase8831:
the luciferase 
dt - nn - 
Phrase8832:
the u937 
dt - nn - 
Phrase8833:
the mla 
dt - nn - 
Phrase8834:
the 729-6 
dt - nn - 
Phrase8835:
full length 
jj - nn - 
Phrase8836:
these cell 
dt - nn - 
Phrase8837:
the presence 
dt - nn - 
Phrase8838:
negative regulatory elements 
jj - jj - nns - 
Phrase8839:
responsive element 
jj - nn - 
Phrase8840:
the transcription 
dt - nn - 
Phrase8841:
this region 
dt - nn - 
Phrase8842:
single ap-2- 
jj - nn - 
Phrase8843:
ap-1-like consensus 
jj - nn - 
Phrase8844:
these ap-2 
dt - nn - 
Phrase8845:
double point 
jj - nn - 
Phrase8846:
the ap-2 
dt - nn - 
Phrase8847:
the ap-1 
dt - nn - 
Phrase8848:
pma-activated promoter 
jj - nn - 
Phrase8849:
the wild-type promoter 
dt - jj - nn - 
Phrase8850:
an ap-1/c-jun 
dt - nn - 
Phrase8851:
stable expression 
jj - nn - 
Phrase8852:
transdominant rev 
jj - nn - 
Phrase8853:
the human 
dt - nn - 
Phrase8854:
viral structural protein 
jj - jj - nn - 
Phrase8855:
viral replication 
jj - nn - 
Phrase8856:
wild-type rev 
jj - nn - 
Phrase8857:
viral replication 
jj - nn - 
Phrase8858:
such transdominant rev 
jj - jj - nn - 
Phrase8859:
long-term protection 
jj - nn - 
Phrase8860:
retroviral vector 
jj - nn - 
Phrase8861:
transdominant mutant 
jj - nn - 
Phrase8862:
the rev 
dt - nn - 
Phrase8863:
the m10-expressing 
dt - nn - 
Phrase8864:
these same cells 
dt - jj - nns - 
Phrase8865:
productive replication 
jj - nn - 
Phrase8866:
productive infection 
jj - nn - 
Phrase8867:
heterogeneous hiv-1 
jj - nn - 
Phrase8868:
the kappa 
dt - nn - 
Phrase8869:
regulatory element 
jj - nn - 
Phrase8870:
constitutive expression 
jj - nn - 
Phrase8871:
the secretion 
dt - nn - 
Phrase8872:
the inhibition 
dt - nn - 
Phrase8873:
transdominant rev 
jj - nn - 
Phrase8874:
the absence 
dt - nn - 
Phrase8875:
any deleterious effect 
dt - jj - nn - 
Phrase8876:
such a 
jj - nn - 
Phrase8877:
therapeutic effect 
jj - nn - 
Phrase8878:
the t 
dt - nn - 
Phrase8879:
simple derivation 
jj - nn - 
Phrase8880:
other organisms 
jj - nns - 
Phrase8881:
transcriptional activation 
jj - nn - 
Phrase8882:
whole cell 
jj - nn - 
Phrase8883:
single protein 
jj - nn - 
Phrase8884:
the addition 
dt - nn - 
Phrase8885:
the initiation 
dt - nn - 
Phrase8886:
the convenient generation 
dt - jj - nn - 
Phrase8887:
acidic activator 
jj - nn - 
Phrase8888:
s. 
nnp - 
Phrase8889:
further fraction 
jj - nn - 
Phrase8890:
the mediator 
dt - nn - 
Phrase8891:
transcriptional activation 
jj - nn - 
Phrase8892:
general initiation 
jj - nn - 
Phrase8893:
acidic activators 
jj - nns - 
Phrase8894:
monocytic differentiation 
jj - nn - 
Phrase8895:
okadaic acid 
jj - nn - 
Phrase8896:
the present 
dt - nn - 
Phrase8897:
the effects 
dt - nns - 
Phrase8898:
okadaic acid 
jj - nn - 
Phrase8899:
an inhibitor 
dt - nn - 
Phrase8900:
the regulation 
dt - nn - 
Phrase8901:
monocytic differentiation 
jj - nn - 
Phrase8902:
the results 
dt - nns - 
Phrase8903:
okadaic acid 
jj - nn - 
Phrase8904:
monocytic differentiation 
jj - nn - 
Phrase8905:
maximal at 
jj - nn - 
Phrase8906:
similar effects 
jj - nns - 
Phrase8907:
the c-fos 
dt - nn - 
Phrase8908:
run-on analysis 
jj - nn - 
Phrase8909:
detectable levels 
jj - nns - 
Phrase8910:
this rate 
dt - nn - 
Phrase8911:
okadaic acid 
jj - nn - 
Phrase8912:
both okadaic acid 
dt - jj - nn - 
Phrase8913:
okadaic acid-induced c-jun 
jj - jj - nn - 
Phrase8914:
the half-life 
dt - nn - 
Phrase8915:
okadaic acid-induced cells 
jj - jj - nns - 
Phrase8916:
both okadaic acid 
dt - jj - nn - 
Phrase8917:
these findings 
dt - nns - 
Phrase8918:
the induction 
dt - nn - 
Phrase8919:
okadaic acid 
jj - nn - 
Phrase8920:
transcriptional mechanism 
jj - nn - 
Phrase8921:
previous studies 
jj - nns - 
Phrase8922:
the c-jun 
dt - nn - 
Phrase8923:
we 
prp - 
Phrase8924:
transcriptional activity 
jj - nn - 
Phrase8925:
we 
prp - 
Phrase8926:
the effect 
dt - nn - 
Phrase8927:
mitogenic lectins 
jj - nns - 
Phrase8928:
both intracellular ca2+ 
dt - jj - nn - 
Phrase8929:
the possible involvement 
dt - jj - nn - 
Phrase8930:
these intracellular messengers 
dt - jj - nns - 
Phrase8931:
the effect 
dt - nn - 
Phrase8932:
the lectins 
dt - nns - 
Phrase8933:
either intracellular ca2+ 
dt - jj - nn - 
Phrase8934:
the mitogen-induced increase 
dt - jj - nn - 
Phrase8935:
high specificity 
jj - nn - 
Phrase8936:
related kinase 
jj - nn - 
Phrase8937:
cyclic nucleotide-dependent 
jj - nn - 
Phrase8938:
the ap-1 
dt - nn - 
Phrase8939:
the ap-1 
dt - nn - 
Phrase8940:
minor effects 
jj - nns - 
Phrase8941:
we 
prp - 
Phrase8942:
mitogenic lectins 
jj - nns - 
Phrase8943:
they 
prp - 
Phrase8944:
the activation 
dt - nn - 
Phrase8945:
an 11-base-pair 
dt - nn - 
Phrase8946:
the human 
dt - nn - 
Phrase8947:
we 
prp - 
Phrase8948:
the human 
dt - nn - 
Phrase8949:
the human 
dt - nn - 
Phrase8950:
cis-acting element 
jj - nn - 
Phrase8951:
the 5' 
dt - nn - 
Phrase8952:
upstream region 
jj - nn - 
Phrase8953:
additional dna 
jj - nn - 
Phrase8954:
the human 
dt - nn - 
Phrase8955:
further mapping 
jj - nn - 
Phrase8956:
the granulocyte/macrophage 
dt - nn - 
Phrase8957:
colony-stimulating factor 
jj - nn - 
Phrase8958:
basic promoter 
jj - nn - 
Phrase8959:
the cap 
dt - nn - 
Phrase8960:
the mouse 
dt - nn - 
Phrase8961:
colony-stimulating factor 
jj - nn - 
Phrase8962:
various lengths 
jj - nns - 
Phrase8963:
the 5' 
dt - nn - 
Phrase8964:
upstream sequence 
jj - nn - 
Phrase8965:
the il-4 
dt - nn - 
Phrase8966:
the p 
dt - nn - 
Phrase8967:
the transcription 
dt - nn - 
Phrase8968:
the human 
dt - nn - 
Phrase8969:
this location 
dt - nn - 
Phrase8970:
the plasmids 
dt - nns - 
Phrase8971:
multiple copies 
jj - nns - 
Phrase8972:
the p 
dt - nn - 
Phrase8973:
higher responsiveness 
jjr - nn - 
Phrase8974:
the stimulation 
dt - nn - 
Phrase8975:
the binding 
dt - nn - 
Phrase8976:
the p 
dt - nn - 
Phrase8977:
the il-4 
dt - nn - 
Phrase8978:
the binding 
dt - nn - 
Phrase8979:
the p 
dt - nn - 
Phrase8980:
the p 
dt - nn - 
Phrase8981:
the nf 
dt - nn - 
Phrase8982:
the protein 
dt - nn - 
Phrase8983:
the sequence 
dt - nn - 
Phrase8984:
the p 
dt - nn - 
Phrase8985:
the 5' 
dt - nn - 
Phrase8986:
upstream sequence 
jj - nn - 
Phrase8987:
the il-2 
dt - nn - 
Phrase8988:
the il-4 
dt - nn - 
Phrase8989:
high homology 
jj - nn - 
Phrase8990:
the il-2 
dt - nn - 
Phrase8991:
we 
prp - 
Phrase8992:
different set 
jj - nn - 
Phrase8993:
we 
prp - 
Phrase8994:
the effect 
dt - nn - 
Phrase8995:
proinflammatory mediator 
jj - nn - 
Phrase8996:
the expression 
dt - nn - 
Phrase8997:
the proto-oncogenes 
dt - nns - 
Phrase8998:
we 
prp - 
Phrase8999:
the modulation 
dt - nn - 
Phrase9000:
nuclear factors 
jj - nn - 
Phrase9001:
the ap-1 
dt - nn - 
Phrase9002:
the expression 
dt - nn - 
Phrase9003:
the c-fos 
dt - nn - 
Phrase9004:
concentration-dependent manner 
jj - nn - 
Phrase9005:
the c-jun 
dt - nn - 
Phrase9006:
peripheral-blood monocytes 
jj - nns - 
Phrase9007:
high levels 
jj - nns - 
Phrase9008:
lower extent 
jjr - nn - 
Phrase9009:
the kinetics 
dt - nn - 
Phrase9010:
the c-fos 
dt - nn - 
Phrase9011:
nuclear transcription 
jj - nn - 
Phrase9012:
the transcription 
dt - nn - 
Phrase9013:
the c-fos 
dt - nn - 
Phrase9014:
the c-jun 
dt - nn - 
Phrase9015:
nuclear factors 
jj - nn - 
Phrase9016:
the ap-1 
dt - nn - 
Phrase9017:
greater ap-1-binding activity 
jjr - jj - nn - 
Phrase9018:
nuclear proteins 
jj - nns - 
Phrase9019:
these results 
dt - nns - 
Phrase9020:
the production 
dt - nn - 
Phrase9021:
different cytokines 
jj - nns - 
Phrase9022:
the yield 
dt - nn - 
Phrase9023:
the function 
dt - nn - 
Phrase9024:
ap-1-binding proto-oncogene 
jj - nn - 
Phrase9025:
normal erythroid differentiation 
jj - jj - nn - 
Phrase9026:
the endogenous thyroid 
dt - jj - nn - 
Phrase9027:
retinoic acid 
jj - nn - 
Phrase9028:
possible target 
jj - nn - 
Phrase9029:
the v-erba 
dt - nn - 
Phrase9030:
the thyroid 
dt - nn - 
Phrase9031:
erythroid differentiation 
jj - nn - 
Phrase9032:
certain erythrocyte 
jj - nn - 
Phrase9033:
normal function 
jj - nn - 
Phrase9034:
the proto-oncogene 
dt - nn - 
Phrase9035:
we 
prp - 
Phrase9036:
the endogenous thyroid 
dt - jj - nn - 
Phrase9037:
related retinoic acid 
jj - jj - nn - 
Phrase9038:
the regulation 
dt - nn - 
Phrase9039:
normal erythroid differentiation 
jj - jj - nn - 
Phrase9040:
retinoic acid 
jj - nn - 
Phrase9041:
the erythroid differentiation 
dt - jj - nn - 
Phrase9042:
normal erythroid progenitors 
jj - jj - nns - 
Phrase9043:
conditional tyrosine 
jj - nn - 
Phrase9044:
immature cells 
jj - nns - 
Phrase9045:
more mature cells 
jjr - jj - nns - 
Phrase9046:
premature cell 
jj - nn - 
Phrase9047:
weaker effects 
jjr - nns - 
Phrase9048:
the action 
dt - nn - 
Phrase9049:
cooperative action 
jj - nn - 
Phrase9050:
erythroid differentiation 
jj - nn - 
Phrase9051:
the human 
dt - nn - 
Phrase9052:
receptor-negative erythroblasts 
jj - nns - 
Phrase9053:
ra-induced regulation 
jj - nn - 
Phrase9054:
the otherwise unresponsive cells 
dt - jj - jj - nns - 
Phrase9055:
the rar-alpha 
dt - nn - 
Phrase9056:
the ra 
dt - nn - 
Phrase9057:
exogenous c-erba/tr-alpha 
jj - nn - 
Phrase9058:
them 
prp - 
Phrase9059:
similar function 
jj - nn - 
Phrase9060:
both receptors 
dt - nns - 
Phrase9061:
cis-acting dna 
jj - nn - 
Phrase9062:
the recognition 
dt - nn - 
Phrase9063:
the effector 
dt - nn - 
Phrase9064:
inflammatory responses 
jj - nns - 
Phrase9065:
the basis 
dt - nn - 
Phrase9066:
different patterns 
jj - nn - 
Phrase9067:
they 
prp - 
Phrase9068:
the outcome 
dt - nn - 
Phrase9069:
an antigenic response 
dt - jj - nn - 
Phrase9070:
cell-mediated immunity 
jj - nn - 
Phrase9071:
they 
prp - 
Phrase9072:
the mechanisms 
dt - nns - 
Phrase9073:
each gene 
dt - nn - 
Phrase9074:
most lymphokine 
jjs - nn - 
Phrase9075:
their 
prp$ - 
Phrase9076:
maximal induction 
jj - nn - 
Phrase9077:
several lymphokines 
jj - nns - 
Phrase9078:
the production 
dt - nn - 
Phrase9079:
the granulocyte-macrophage 
dt - nn - 
Phrase9080:
we 
prp - 
Phrase9081:
cis-acting region 
jj - nn - 
Phrase9082:
the gm-csf 
dt - nn - 
Phrase9083:
efficient induction 
jj - nn - 
Phrase9084:
the transcription 
dt - nn - 
Phrase9085:
viral trans-activators 
jj - nn - 
Phrase9086:
other agents 
jj - nns - 
Phrase9087:
the trans-activation 
dt - nn - 
Phrase9088:
they 
prp - 
Phrase9089:
obvious sequence 
jj - nn - 
Phrase9090:
them 
prp - 
Phrase9091:
the viral trans-activators 
dt - jj - nn - 
Phrase9092:
specific dna 
jj - nn - 
Phrase9093:
cis-acting dna 
jj - nn - 
Phrase9094:
tcr-mediated stimulation 
jj - nn - 
Phrase9095:
the pit-1 
dt - nn - 
Phrase9096:
combined pituitary 
jj - nn - 
Phrase9097:
pituitary-specific transcription 
jj - nn - 
Phrase9098:
unrelated japanese children 
jj - jj - nns - 
Phrase9099:
combined pituitary 
jj - nn - 
Phrase9100:
we 
prp - 
Phrase9101:
the pit-1 
dt - nn - 
Phrase9102:
the major transactivation 
dt - jj - nn - 
Phrase9103:
pou-specific domain 
jj - nn - 
Phrase9104:
we 
prp - 
Phrase9105:
the cyclic adenosine 
dt - jj - nn - 
Phrase9106:
we 
prp - 
Phrase9107:
the effect 
dt - nn - 
Phrase9108:
the phorbol 
dt - nn - 
Phrase9109:
the adenosine 
dt - nn - 
Phrase9110:
the levels 
dt - nns - 
Phrase9111:
the binding 
dt - nn - 
Phrase9112:
transcriptional activity 
jj - nn - 
Phrase9113:
the transcription 
dt - nn - 
Phrase9114:
time-dependent increase 
jj - nn - 
Phrase9115:
slight effect 
jj - nn - 
Phrase9116:
the combination 
dt - nn - 
Phrase9117:
gel-shift assay 
jj - nn - 
Phrase9118:
transcriptional activity 
jj - nn - 
Phrase9119:
clear-cut synergy 
jj - nn - 
Phrase9120:
the pkc 
dt - nn - 
Phrase9121:
the camp 
dt - nn - 
Phrase9122:
the results 
dt - nns - 
Phrase9123:
the simultaneous activation 
dt - jj - nn - 
Phrase9124:
transcriptional activity 
jj - nn - 
Phrase9125:
the parallel 
dt - nn - 
Phrase9126:
functional consequences 
jj - nns - 
Phrase9127:
the level 
dt - nn - 
Phrase9128:
monoclonal antibody-induced 
jj - nn - 
Phrase9129:
the purpose 
dt - nn - 
Phrase9130:
these studies 
dt - nns - 
Phrase9131:
the modulation 
dt - nn - 
Phrase9132:
the proliferation 
dt - nn - 
Phrase9133:
peripheral blood 
jj - nn - 
Phrase9134:
the glucocorticoid 
dt - nn - 
Phrase9135:
beta-adrenergic receptors 
jj - nns - 
Phrase9136:
their 
prp$ - 
Phrase9137:
natural ligands 
jj - nns - 
Phrase9138:
these receptors 
dt - nns - 
Phrase9139:
the inflammatory response 
dt - jj - nn - 
Phrase9140:
their 
prp$ - 
Phrase9141:
immobilized anti-cd3 
jj - nn - 
Phrase9142:
monoclonal antibody 
jj - nn - 
Phrase9143:
the presence 
dt - nn - 
Phrase9144:
an additional costimulatory 
dt - jj - nn - 
Phrase9145:
various physiologic concentrations 
jj - jj - nns - 
Phrase9146:
the time 
dt - nn - 
Phrase9147:
the cultures 
dt - nns - 
Phrase9148:
subsequent proliferation 
jj - nn - 
Phrase9149:
the unstimulated t 
dt - jj - nn - 
Phrase9150:
the results 
dt - nns - 
Phrase9151:
physiologic concentrations 
jj - nns - 
Phrase9152:
these agents 
dt - nns - 
Phrase9153:
the anti-cd3 
dt - nn - 
Phrase9154:
concomitant elevations 
jj - nn - 
Phrase9155:
the peripheral levels 
dt - jj - nns - 
Phrase9156:
these substances 
dt - nns - 
Phrase9157:
the t-cell 
dt - nn - 
Phrase9158:
inhibitory effects 
jj - nns - 
Phrase9159:
either pge2 
dt - nn - 
Phrase9160:
synergistic suppression 
jj - nn - 
Phrase9161:
various concentrations 
jj - nns - 
Phrase9162:
synergistic suppression 
jj - nn - 
Phrase9163:
an increase 
dt - nn - 
Phrase9164:
the addition 
dt - nn - 
Phrase9165:
the suppression 
dt - nn - 
Phrase9166:
the hla-dra 
dt - nn - 
Phrase9167:
cell-specific interaction 
jj - nn - 
Phrase9168:
the octamer 
dt - nn - 
Phrase9169:
the major histocompatibility 
dt - jj - nn - 
Phrase9170:
cis-acting regions 
jj - nns - 
Phrase9171:
maximal expression 
jj - nn - 
Phrase9172:
we 
prp - 
Phrase9173:
the dra 
dt - nn - 
Phrase9174:
protein-dna interactions 
jj - nns - 
Phrase9175:
the intact cell 
dt - jj - nn - 
Phrase9176:
transcriptional activation 
jj - nn - 
Phrase9177:
genomic footprinting 
jj - nn - 
Phrase9178:
we 
prp - 
Phrase9179:
the octamer 
dt - nn - 
Phrase9180:
the y 
dt - nn - 
Phrase9181:
ii-negative t-cell 
jj - nn - 
Phrase9182:
lymphoid cell 
jj - nn - 
Phrase9183:
the octamer 
dt - nn - 
Phrase9184:
maximal expression 
jj - nn - 
Phrase9185:
the presence 
dt - nn - 
Phrase9186:
the lymphoid-specific otf-2 
dt - jj - nn - 
Phrase9187:
the class 
dt - nn - 
Phrase9188:
ii-positive nonlymphoid glioblastoma 
jj - jj - nn - 
Phrase9189:
the octamer 
dt - nn - 
Phrase9190:
the presence 
dt - nn - 
Phrase9191:
the ubiquitous otf-1 
dt - jj - nn - 
Phrase9192:
an open 
dt - nn - 
Phrase9193:
the dra 
dt - nn - 
Phrase9194:
the level 
dt - nn - 
Phrase9195:
the glioblastoma 
dt - nn - 
Phrase9196:
this glioblastoma 
dt - nn - 
Phrase9197:
protein-dna interactions 
jj - nns - 
Phrase9198:
other interactions 
jj - nns - 
Phrase9199:
these results 
dt - nns - 
Phrase9200:
nonproductive interactions 
jj - nns - 
Phrase9201:
the x 
dt - nn - 
Phrase9202:
strong interactions 
jj - nns - 
Phrase9203:
these findings 
dt - nns - 
Phrase9204:
direct in 
jj - nn - 
Phrase9205:
the modulation 
dt - nn - 
Phrase9206:
an important constituent 
dt - jj - nn - 
Phrase9207:
the interferon 
dt - nn - 
Phrase9208:
peripheral blood 
jj - nn - 
Phrase9209:
their 
prp$ - 
Phrase9210:
the presence 
dt - nn - 
Phrase9211:
high affinity 
jj - nn - 
Phrase9212:
low capacity 
jj - nn - 
Phrase9213:
low affinity 
jj - nn - 
Phrase9214:
high capacity 
jj - nn - 
Phrase9215:
peripheral blood 
jj - nn - 
Phrase9216:
the effects 
dt - nns - 
Phrase9217:
these sites 
dt - nns - 
Phrase9218:
peripheral blood 
jj - nn - 
Phrase9219:
these sites 
dt - nns - 
Phrase9220:
high concentration 
jj - nn - 
Phrase9221:
clinical serum 
jj - nn - 
Phrase9222:
the number 
dt - nn - 
Phrase9223:
both sites 
dt - nns - 
Phrase9224:
it 
prp - 
Phrase9225:
an anti-estrogenic 
dt - nn - 
Phrase9226:
the monocytes 
dt - nns - 
Phrase9227:
the competition 
dt - nn - 
Phrase9228:
the estrogen 
dt - nn - 
Phrase9229:
myocardial infarction 
jj - nn - 
Phrase9230:
major difficulty 
jj - nn - 
Phrase9231:
we 
prp - 
Phrase9232:
whole-cell competitive binding 
jj - jj - nn - 
Phrase9233:
the test 
dt - nn - 
Phrase9234:
multiple blood 
jj - nn - 
Phrase9235:
we 
prp - 
Phrase9236:
cardiac infarction 
jj - nn - 
Phrase9237:
12-day period 
jj - nn - 
Phrase9238:
the first day 
dt - jj - nn - 
Phrase9239:
the disease 
dt - nn - 
Phrase9240:
the receptor-ligand 
dt - nn - 
Phrase9241:
the general observation 
dt - jj - nn - 
Phrase9242:
stress-induced down-regulation 
jj - nn - 
Phrase9243:
immune responses 
jj - nns - 
Phrase9244:
primary human 
jj - nn - 
Phrase9245:
the cooperative activity 
dt - jj - nn - 
Phrase9246:
specific trans-activating factors 
jj - jj - nn - 
Phrase9247:
the il-2 
dt - nn - 
Phrase9248:
the production 
dt - nn - 
Phrase9249:
the level 
dt - nn - 
Phrase9250:
the src 
dt - nn - 
Phrase9251:
the lymphocyte-specific protein 
dt - jj - nn - 
Phrase9252:
the activity 
dt - nn - 
Phrase9253:
the lck 
dt - nn - 
Phrase9254:
the appearance 
dt - nn - 
Phrase9255:
the nf-at 
dt - nn - 
Phrase9256:
the il-2 
dt - nn - 
Phrase9257:
the induction 
dt - nn - 
Phrase9258:
the same stimuli 
dt - jj - nns - 
Phrase9259:
these results 
dt - nns - 
Phrase9260:
the immunosuppressant 
dt - nn - 
Phrase9261:
the level 
dt - nn - 
Phrase9262:
these trans-activating factors 
dt - jj - nn - 
Phrase9263:
the ap-1 
dt - nn - 
Phrase9264:
the nf-kappa 
dt - nn - 
Phrase9265:
the major target 
dt - jj - nn - 
Phrase9266:
the interleukin 
dt - nn - 
Phrase9267:
several kinases 
jj - nns - 
Phrase9268:
the later induction 
dt - jj - nn - 
Phrase9269:
we 
prp - 
Phrase9270:
the potential 
dt - nn - 
Phrase9271:
the interleukin 
dt - nn - 
Phrase9272:
the t 
dt - nn - 
Phrase9273:
we 
prp - 
Phrase9274:
prolonged treatment 
jj - nn - 
Phrase9275:
the untransformed 
dt - nn - 
Phrase9276:
the alpha 
dt - nn - 
Phrase9277:
we 
prp - 
Phrase9278:
the il-2 
dt - nn - 
Phrase9279:
this reporter 
dt - nn - 
Phrase9280:
the il-2 
dt - nn - 
Phrase9281:
nuclear factors 
jj - nn - 
Phrase9282:
we 
prp - 
Phrase9283:
the nfat 
dt - nn - 
Phrase9284:
the nf-kappa 
dt - nn - 
Phrase9285:
the il-2 
dt - nn - 
Phrase9286:
the ap-1 
dt - nn - 
Phrase9287:
located at 
jj - nn - 
Phrase9288:
the il-2 
dt - nn - 
Phrase9289:
an inducible nuclear factor 
dt - jj - jj - nn - 
Phrase9290:
this site 
dt - nn - 
Phrase9291:
the il-2 
dt - nn - 
Phrase9292:
our 
prp$ - 
Phrase9293:
the ap-1 
dt - nn - 
Phrase9294:
the il-2 
dt - nn - 
Phrase9295:
peripheral blood 
jj - nn - 
Phrase9296:
hypertensive patients 
jj - nns - 
Phrase9297:
various age 
jj - nn - 
Phrase9298:
peripheral lymphocyte 
jj - nn - 
Phrase9299:
healthy persons 
jj - nns - 
Phrase9300:
hypertensive patients 
jj - nns - 
Phrase9301:
the number 
dt - nn - 
Phrase9302:
the treatment 
dt - nn - 
Phrase9303:
the ace 
dt - nn - 
Phrase9304:
more marked rise 
jjr - jj - nn - 
Phrase9305:
the number 
dt - nn - 
Phrase9306:
the use 
dt - nn - 
Phrase9307:
red cell 
jj - nn - 
Phrase9308:
clinical significance 
jj - nn - 
Phrase9309:
the chemiluminescent 
dt - nn - 
Phrase9310:
red cell 
jj - nn - 
Phrase9311:
high levels 
jj - nns - 
Phrase9312:
the cl 
dt - nn - 
Phrase9313:
peripheral blood 
jj - nn - 
Phrase9314:
red cells 
jj - nns - 
Phrase9315:
comparable sensitivity 
jj - nn - 
Phrase9316:
the use 
dt - nn - 
Phrase9317:
interassay variation 
jj - nn - 
Phrase9318:
simplified assay 
jj - nn - 
Phrase9319:
the potential 
dt - nn - 
Phrase9320:
clinical usefulness 
jj - nn - 
Phrase9321:
these cl 
dt - nn - 
Phrase9322:
the ability 
dt - nn - 
Phrase9323:
both monocytes 
dt - nns - 
Phrase9324:
red cells 
jj - nns - 
Phrase9325:
pregnant women 
jj - nns - 
Phrase9326:
either haemolytic 
dt - nn - 
Phrase9327:
red cells 
jj - nns - 
Phrase9328:
clinical significance 
jj - nn - 
Phrase9329:
red cells 
jj - nns - 
Phrase9330:
either anti-d in 
dt - jj - nn - 
Phrase9331:
high titre 
jj - nn - 
Phrase9332:
red cell 
jj - nn - 
Phrase9333:
antisense inhibition 
jj - nn - 
Phrase9334:
science 
nnp - 
Phrase9335:
mar 
nnp - 
Phrase9336:
the human 
dt - nn - 
Phrase9337:
early genes 
jj - nns - 
Phrase9338:
antisense oligodeoxynucleotides 
jj - nns - 
Phrase9339:
these culture-adapted 
dt - nn - 
Phrase9340:
an htlv-i-transformed human 
dt - jj - nn - 
Phrase9341:
antisense inhibition 
jj - nn - 
Phrase9342:
itself 
prp - 
Phrase9343:
apparent effect 
jj - nn - 
Phrase9344:
rapid regression 
jj - nn - 
Phrase9345:
the maintenance 
dt - nn - 
Phrase9346:
the malignant phenotype 
dt - jj - nn - 
Phrase9347:
therapeutic approach 
jj - nn - 
Phrase9348:
htlv-i-associated disease 
jj - nn - 
Phrase9349:
novel pathway 
jj - nn - 
Phrase9350:
rapid nongenomic in 
jj - jj - nn - 
Phrase9351:
intracellular electrolytes 
jj - nn - 
Phrase9352:
125i-labeled aldosterone 
jj - nn - 
Phrase9353:
important features 
jj - nns - 
Phrase9354:
these functional data 
dt - jj - nns - 
Phrase9355:
low apparent dissociation 
jj - jj - nn - 
Phrase9356:
both aldosterone 
dt - nn - 
Phrase9357:
the effect 
dt - nn - 
Phrase9358:
the na(+)-h(+)-antiport 
dt - nn - 
Phrase9359:
high turnover 
jj - nn - 
Phrase9360:
exclusive binding 
jj - nn - 
Phrase9361:
an intermediate 
dt - nn - 
Phrase9362:
an apparent kd 
dt - jj - nn - 
Phrase9363:
these findings 
dt - nns - 
Phrase9364:
major aspects 
jj - nns - 
Phrase9365:
its 
prp$ - 
Phrase9366:
nongenomic effects 
jj - nns - 
Phrase9367:
notable participant 
jj - nn - 
Phrase9368:
it 
prp - 
Phrase9369:
this regard 
dt - nn - 
Phrase9370:
the release 
dt - nn - 
Phrase9371:
inflammatory cytokines 
jj - nns - 
Phrase9372:
we 
prp - 
Phrase9373:
transcriptional activation 
jj - nn - 
Phrase9374:
the il-6 
dt - nn - 
Phrase9375:
we 
prp - 
Phrase9376:
this process 
dt - nn - 
Phrase9377:
the transcription 
dt - nn - 
Phrase9378:
lesser extent 
jjr - nn - 
Phrase9379:
the activity 
dt - nn - 
Phrase9380:
the transcription 
dt - nn - 
Phrase9381:
deleted forms 
jj - nns - 
Phrase9382:
the il-6 
dt - nn - 
Phrase9383:
the il-6 
dt - nn - 
Phrase9384:
the respective transcripts 
dt - jj - nns - 
Phrase9385:
functional il-6 
jj - nn - 
Phrase9386:
heterologous promoter 
jj - nn - 
Phrase9387:
the nf-chi 
dt - nn - 
Phrase9388:
the nf-il6 
dt - nn - 
Phrase9389:
the ap-1 
dt - nn - 
Phrase9390:
the signaling 
dt - nn - 
Phrase9391:
this effect 
dt - nn - 
Phrase9392:
the release 
dt - nn - 
Phrase9393:
the presence 
dt - nn - 
Phrase9394:
the scavenger 
dt - nn - 
Phrase9395:
the genes 
dt - nns - 
Phrase9396:
the subject 
dt - nn - 
Phrase9397:
intense study 
jj - nn - 
Phrase9398:
the bcl-2 
dt - nn - 
Phrase9399:
brief overview 
jj - nn - 
Phrase9400:
its 
prp$ - 
Phrase9401:
cytoplasmic domain 
jj - nn - 
Phrase9402:
related immunoglobulin 
jj - nn - 
Phrase9403:
the structures 
dt - nns - 
Phrase9404:
their 
prp$ - 
Phrase9405:
cytoplasmic domains 
jj - nns - 
Phrase9406:
type-specific alternative 
jj - nn - 
Phrase9407:
an insertion 
dt - nn - 
Phrase9408:
these cells 
dt - nns - 
Phrase9409:
an fc 
dt - nn - 
Phrase9410:
complementary dna 
jj - nn - 
Phrase9411:
various receptor 
jj - nn - 
Phrase9412:
the insertion 
dt - nn - 
Phrase9413:
both fc 
dt - nn - 
Phrase9414:
the insertion 
dt - nn - 
Phrase9415:
the cytoplasmic domain 
dt - jj - nn - 
Phrase9416:
both lymphocyte 
dt - nn - 
Phrase9417:
the insertion 
dt - nn - 
Phrase9418:
the formation 
dt - nn - 
Phrase9419:
the lymphocyte 
dt - nn - 
Phrase9420:
the receptor 
dt - nn - 
Phrase9421:
the detergent-insoluble 
dt - nn - 
Phrase9422:
age-related changes 
jj - nns - 
Phrase9423:
healthy persons 
jj - nns - 
Phrase9424:
it 
prp - 
Phrase9425:
the number 
dt - nn - 
Phrase9426:
the peripheral blood 
dt - jj - nn - 
Phrase9427:
healthy elderly subjects 
jj - jj - nns - 
Phrase9428:
the number 
dt - nn - 
Phrase9429:
the mechanisms 
dt - nns - 
Phrase9430:
the number 
dt - nn - 
Phrase9431:
hypertensive patients 
jj - nns - 
Phrase9432:
more essential rise 
jjr - jj - nn - 
Phrase9433:
the number 
dt - nn - 
Phrase9434:
hypertensive patients 
jj - nns - 
Phrase9435:
elderly ones 
jj - nns - 
Phrase9436:
the mechanism 
dt - nn - 
Phrase9437:
powerful suppressors 
jj - nn - 
Phrase9438:
the immune system 
dt - jj - nn - 
Phrase9439:
they 
prp - 
Phrase9440:
the transcription 
dt - nn - 
Phrase9441:
early genes 
jj - nns - 
Phrase9442:
recent findings 
jj - nns - 
Phrase9443:
they 
prp - 
Phrase9444:
endogenous intracellular receptors 
jj - jj - nns - 
Phrase9445:
the immunophilins 
dt - nns - 
Phrase9446:
the protein 
dt - nn - 
Phrase9447:
the immunosuppressive effect 
dt - jj - nn - 
Phrase9448:
monocytic differentiation 
jj - nn - 
Phrase9449:
b-like activities 
jj - nns - 
Phrase9450:
myelomonoblastic cells 
jj - nns - 
Phrase9451:
the effects 
dt - nns - 
Phrase9452:
cellular differentiation 
jj - nn - 
Phrase9453:
bipotential myelomonoblastic cell 
jj - jj - nn - 
Phrase9454:
monocytic differentiation 
jj - nn - 
Phrase9455:
appropriate inducers 
jj - nns - 
Phrase9456:
the presence 
dt - nn - 
Phrase9457:
the cell 
dt - nn - 
Phrase9458:
more monocytic phenotype 
jjr - jj - nn - 
Phrase9459:
the parental myeloblasts 
dt - jj - nn - 
Phrase9460:
differential staining 
jj - nn - 
Phrase9461:
the myeloid-specific surface 
dt - jj - nn - 
Phrase9462:
the c-fms 
dt - nn - 
Phrase9463:
constitutive expression 
jj - nn - 
Phrase9464:
novel nf-kappa 
jj - nn - 
Phrase9465:
these proteins 
dt - nns - 
Phrase9466:
the symmetric 
dt - nn - 
Phrase9467:
the interferon 
dt - nn - 
Phrase9468:
the 5' 
dt - nn - 
Phrase9469:
the kappa 
dt - nn - 
Phrase9470:
these nf-kappa 
dt - nn - 
Phrase9471:
b-related proteins 
jj - nns - 
Phrase9472:
endogenous ifn-beta 
jj - nn - 
Phrase9473:
these studies 
dt - nns - 
Phrase9474:
myelomonoblastic cells 
jj - nns - 
Phrase9475:
more mature monocytic phenotype 
jjr - jj - jj - nn - 
Phrase9476:
unique subunit 
jj - nn - 
Phrase9477:
differential nf-kappa 
jj - nn - 
Phrase9478:
b-mediated gene 
jj - nn - 
Phrase9479:
the variability 
dt - nn - 
Phrase9480:
its 
prp$ - 
Phrase9481:
clinical presentation 
jj - nn - 
Phrase9482:
asymptomatic family 
jj - nn - 
Phrase9483:
its 
prp$ - 
Phrase9484:
the present 
dt - nn - 
Phrase9485:
we 
prp - 
Phrase9486:
the syndrome 
dt - nn - 
Phrase9487:
the first male 
dt - jj - nn - 
Phrase9488:
mild hypertension 
jj - nn - 
Phrase9489:
life-threatening hypokalemia 
jj - nn - 
Phrase9490:
the second 
dt - nn - 
Phrase9491:
slight hypertension 
jj - nn - 
Phrase9492:
the age 
dt - nn - 
Phrase9493:
irregular menstruations 
jj - nn - 
Phrase9494:
low dose 
jj - nn - 
Phrase9495:
clinical benefit 
jj - nn - 
Phrase9496:
these patients 
dt - nns - 
Phrase9497:
insufficient suppression 
jj - nn - 
Phrase9498:
the overnight 1-mg 
dt - jj - nn - 
Phrase9499:
the diurnal 
dt - nn - 
Phrase9500:
an elevated level 
dt - jj - nn - 
Phrase9501:
normal increase 
jj - nn - 
Phrase9502:
insulin-induced hypoglycemia 
jj - nn - 
Phrase9503:
adrenal androgen 
jj - nn - 
Phrase9504:
whole cell 
jj - nn - 
Phrase9505:
the first male 
dt - jj - nn - 
Phrase9506:
the number 
dt - nn - 
Phrase9507:
the affinity 
dt - nn - 
Phrase9508:
lowered affinity 
jj - nn - 
Phrase9509:
lowered number 
jj - nn - 
Phrase9510:
the second 
dt - nn - 
Phrase9511:
we 
prp - 
Phrase9512:
mitogen-stimulated incorporation 
jj - nn - 
Phrase9513:
the male 
dt - nn - 
Phrase9514:
normal receptor 
jj - nn - 
Phrase9515:
healthy controls 
jj - nns - 
Phrase9516:
both maximal suppression 
dt - jj - nn - 
Phrase9517:
partial cortisol 
jj - nn - 
Phrase9518:
different forms 
jj - nns - 
Phrase9519:
successful in 
jj - nn - 
Phrase9520:
the secondary increase 
dt - jj - nn - 
Phrase9521:
the production 
dt - nn - 
Phrase9522:
adrenal androgens 
jj - nns - 
Phrase9523:
the development 
dt - nn - 
Phrase9524:
responsive t 
jj - nn - 
Phrase9525:
the work 
dt - nn - 
Phrase9526:
this article 
dt - nn - 
Phrase9527:
an expansion 
dt - nn - 
Phrase9528:
least response 
jjs - nn - 
Phrase9529:
some extent 
dt - nn - 
Phrase9530:
the thymus 
dt - nn - 
Phrase9531:
the profound t 
dt - jj - nn - 
Phrase9532:
nude mice 
jj - nns - 
Phrase9533:
the thymus 
dt - nn - 
Phrase9534:
potent site 
jj - nn - 
Phrase9535:
the expansion 
dt - nn - 
Phrase9536:
other sites 
jj - nns - 
Phrase9537:
some response 
dt - nn - 
Phrase9538:
the details 
dt - nn - 
Phrase9539:
the regulatory mechanism 
dt - jj - nn - 
Phrase9540:
particular loci 
jj - nns - 
Phrase9541:
it 
prp - 
Phrase9542:
the rearrangement 
dt - nn - 
Phrase9543:
the tcr 
dt - nn - 
Phrase9544:
the gamma 
dt - nn - 
Phrase9545:
developmental stage 
jj - nn - 
Phrase9546:
the rearrangement 
dt - nn - 
Phrase9547:
the alpha 
dt - nn - 
Phrase9548:
it 
prp - 
Phrase9549:
the tcr 
dt - nn - 
Phrase9550:
the final gene 
dt - jj - nn - 
Phrase9551:
rapid proliferation 
jj - nn - 
Phrase9552:
an interruption 
dt - nn - 
Phrase9553:
cellular response 
jj - nn - 
Phrase9554:
the loss 
dt - nn - 
Phrase9555:
conventional responsiveness 
jj - nn - 
Phrase9556:
the level 
dt - nn - 
Phrase9557:
the physiological state 
dt - jj - nn - 
Phrase9558:
third 
nnp - 
Phrase9559:
the complex 
dt - nn - 
Phrase9560:
peripheral t 
jj - nn - 
Phrase9561:
positive selection 
jj - nn - 
Phrase9562:
clonal expansion 
jj - nn - 
Phrase9563:
negative selection 
jj - nn - 
Phrase9564:
the same phenomenon 
dt - jj - nn - 
Phrase9565:
the thymic cortex 
dt - jj - nn - 
Phrase9566:
negative selection 
jj - nn - 
Phrase9567:
the cortex 
dt - nn - 
Phrase9568:
its 
prp$ - 
Phrase9569:
own chromatin 
jj - nn - 
Phrase9570:
the genes 
dt - nns - 
Phrase9571:
this response 
dt - nn - 
Phrase9572:
it 
prp - 
Phrase9573:
unquestionably a 
dt - nn - 
Phrase9574:
it 
prp - 
Phrase9575:
cortical thymocytes 
jj - nns - 
Phrase9576:
negative selection 
jj - nn - 
Phrase9577:
exogenous il-2 
jj - nn - 
Phrase9578:
this form 
dt - nn - 
Phrase9579:
they 
prp - 
Phrase9580:
an earlier stage 
dt - jjr - nn - 
Phrase9581:
they 
prp - 
Phrase9582:
uncommonly bcl-2 
dt - nn - 
Phrase9583:
medullary thymocytes 
jj - nns - 
Phrase9584:
negative selection 
jj - nn - 
Phrase9585:
they 
prp - 
Phrase9586:
the nuclear localization 
dt - jj - nn - 
Phrase9587:
the transactivation 
dt - nn - 
Phrase9588:
the active nuclear form 
dt - jj - jj - nn - 
Phrase9589:
the nf-kappa 
dt - nn - 
Phrase9590:
extensive n-terminal sequence 
jj - jj - nn - 
Phrase9591:
the v-rel 
dt - nn - 
Phrase9592:
the nf-kappa 
dt - nn - 
Phrase9593:
the transactivation 
dt - nn - 
Phrase9594:
this complex 
dt - nn - 
Phrase9595:
an intracellular receptor 
dt - jj - nn - 
Phrase9596:
cytoplasmic inhibitor 
jj - nn - 
Phrase9597:
b-directed transcription 
jj - nn - 
Phrase9598:
prior in 
jj - nn - 
Phrase9599:
the molecular 
dt - nn - 
Phrase9600:
the critical regulatory interaction 
dt - jj - jj - nn - 
Phrase9601:
b-mediated inhibition 
jj - nn - 
Phrase9602:
nuclear exclusion 
jj - nn - 
Phrase9603:
this transcription 
dt - nn - 
Phrase9604:
these nf-kappa 
dt - nn - 
Phrase9605:
the following 
dt - nn - 
Phrase9606:
transcriptional activation 
jj - nn - 
Phrase9607:
the human 
dt - nn - 
Phrase9608:
the binding 
dt - nn - 
Phrase9609:
the nucleus 
dt - nn - 
Phrase9610:
the cytoplasm 
dt - nn - 
Phrase9611:
selective deletion 
jj - nn - 
Phrase9612:
the functional nuclear localization 
dt - jj - jj - nn - 
Phrase9613:
the rel 
dt - nn - 
Phrase9614:
its 
prp$ - 
Phrase9615:
the unique c-terminus 
dt - jj - nn - 
Phrase9616:
its 
prp$ - 
Phrase9617:
own nuclear localization 
jj - jj - nn - 
Phrase9618:
b-mediated inhibition 
jj - nn - 
Phrase9619:
these findings 
dt - nns - 
Phrase9620:
the nuclear localization 
dt - jj - nn - 
Phrase9621:
bipartite system 
jj - nn - 
Phrase9622:
the inhibitory function 
dt - jj - nn - 
Phrase9623:
our 
prp$ - 
Phrase9624:
it 
prp - 
Phrase9625:
the nucleus 
dt - nn - 
Phrase9626:
the cytoplasm 
dt - nn - 
Phrase9627:
the unique c-terminal domain 
dt - jj - jj - nn - 
Phrase9628:
tissue-specific transcription 
jj - nn - 
Phrase9629:
the simian virus 
dt - jj - nn - 
Phrase9630:
we 
prp - 
Phrase9631:
unstimulated t 
jj - nn - 
Phrase9632:
nonhematopoietic cells 
jj - nns - 
Phrase9633:
other rel 
jj - nn - 
Phrase9634:
biochemical criteria 
jj - nns - 
Phrase9635:
it 
prp - 
Phrase9636:
lymphocyte-specific dna-binding 
jj - nn - 
Phrase9637:
the candidate 
dt - nn - 
Phrase9638:
an antagonist 
dt - nn - 
Phrase9639:
b-mediated inhibition 
jj - nn - 
Phrase9640:
the candidate 
dt - nn - 
Phrase9641:
the immunoglobulin 
dt - nn - 
Phrase9642:
some cases 
dt - nns - 
Phrase9643:
chronic lymphocytic leukaemias 
jj - jj - nns - 
Phrase9644:
the protein 
dt - nn - 
Phrase9645:
so-called ankyrin 
jj - nn - 
Phrase9646:
similar repeat 
jj - nn - 
Phrase9647:
diverse regulatory proteins 
jj - jj - nns - 
Phrase9648:
the motifs 
dt - nns - 
Phrase9649:
the ankyrin 
dt - nn - 
Phrase9650:
biological function 
jj - nn - 
Phrase9651:
it 
prp - 
Phrase9652:
the p50 
dt - nn - 
Phrase9653:
we 
prp - 
Phrase9654:
site-dependent transcription 
jj - nn - 
Phrase9655:
the inhibitory effects 
dt - jj - nns - 
Phrase9656:
select nf-kappa 
jj - nn - 
Phrase9657:
b-regulated genes 
jj - nns - 
Phrase9658:
the human 
dt - nn - 
Phrase9659:
the steroid 
dt - nn - 
Phrase9660:
versatile molecules 
jj - nns - 
Phrase9661:
they 
prp - 
Phrase9662:
them 
prp - 
Phrase9663:
their 
prp$ - 
Phrase9664:
chemical structure 
jj - nn - 
Phrase9665:
they 
prp - 
Phrase9666:
diverse functions 
jj - nns - 
Phrase9667:
their 
prp$ - 
Phrase9668:
the estrogens 
dt - nns - 
Phrase9669:
the regulation 
dt - nn - 
Phrase9670:
sexual events 
jj - nns - 
Phrase9671:
the female 
dt - nn - 
Phrase9672:
the intracellular actions 
dt - jj - nns - 
Phrase9673:
they 
prp - 
Phrase9674:
the proposed models 
dt - jj - nns - 
Phrase9675:
the questions 
dt - nn - 
Phrase9676:
it 
prp - 
Phrase9677:
the existence 
dt - nn - 
Phrase9678:
nuclear receptor 
jj - nn - 
Phrase9679:
the hormones 
dt - nns - 
Phrase9680:
the nucleus 
dt - nn - 
Phrase9681:
the endocrine 
dt - nn - 
Phrase9682:
possible interaction 
jj - nn - 
Phrase9683:
cellular membrane 
jj - nn - 
Phrase9684:
the purpose 
dt - nn - 
Phrase9685:
this review 
dt - nn - 
Phrase9686:
the mechanism 
dt - nn - 
Phrase9687:
their 
prp$ - 
Phrase9688:
we 
prp - 
Phrase9689:
the isolation 
dt - nn - 
Phrase9690:
soluble gp120 
jj - nn - 
Phrase9691:
an abnormal response 
dt - jj - nn - 
Phrase9692:
the protein 
dt - nn - 
Phrase9693:
the parental line 
dt - jj - nn - 
Phrase9694:
other ethyl-methanesulfonate-derived 
jj - nn - 
Phrase9695:
direct assays 
jj - nn - 
Phrase9696:
cellular pkc 
jj - nn - 
Phrase9697:
enzymatic activity 
jj - nn - 
Phrase9698:
normal in 
jj - nn - 
Phrase9699:
these subclones 
dt - nns - 
Phrase9700:
long terminal 
jj - nn - 
Phrase9701:
functional nuclear factor 
jj - jj - nn - 
Phrase9702:
regulatory elements 
jj - nns - 
Phrase9703:
we 
prp - 
Phrase9704:
the ability 
dt - nn - 
Phrase9705:
different assays 
jj - nn - 
Phrase9706:
the hiv-1 
dt - nn - 
Phrase9707:
long terminal 
jj - nn - 
Phrase9708:
these subclones 
dt - nns - 
Phrase9709:
the parental line 
dt - jj - nn - 
Phrase9710:
other subclones 
jj - nns - 
Phrase9711:
okadaic acid 
jj - nn - 
Phrase9712:
an inhibitor 
dt - nn - 
Phrase9713:
the defect 
dt - nn - 
Phrase9714:
these subclones 
dt - nns - 
Phrase9715:
the hiv-1 
dt - nn - 
Phrase9716:
nuclear extracts 
jj - nns - 
Phrase9717:
pma-treated cells 
jj - nns - 
Phrase9718:
nuclear nf-kb 
jj - nn - 
Phrase9719:
wild type 
jj - nn - 
Phrase9720:
cytoplasmic extracts 
jj - nns - 
Phrase9721:
these subclones 
dt - nns - 
Phrase9722:
their 
prp$ - 
Phrase9723:
cytoplasmic pools 
jj - nns - 
Phrase9724:
nuclear nf-kb 
jj - nn - 
Phrase9725:
their 
prp$ - 
Phrase9726:
normal cell 
jj - nn - 
Phrase9727:
pronounced reduction 
jj - nn - 
Phrase9728:
their 
prp$ - 
Phrase9729:
nuclear factor 
jj - nn - 
Phrase9730:
the nuclear factor 
dt - jj - nn - 
Phrase9731:
the t-cell 
dt - nn - 
Phrase9732:
it 
prp - 
Phrase9733:
major target 
jj - nn - 
Phrase9734:
activation-dependent events 
jj - nns - 
Phrase9735:
the csa-sensitive translocation 
dt - jj - nn - 
Phrase9736:
pre-existing component 
jj - nn - 
Phrase9737:
the csa-resistant synthesis 
dt - jj - nn - 
Phrase9738:
nuclear component 
jj - nn - 
Phrase9739:
we 
prp - 
Phrase9740:
nuclear component 
jj - nn - 
Phrase9741:
the transcription 
dt - nn - 
Phrase9742:
we 
prp - 
Phrase9743:
the inducible nuclear form 
dt - jj - jj - nn - 
Phrase9744:
we 
prp - 
Phrase9745:
pre-existing nf-at-binding factor 
jj - jj - nn - 
Phrase9746:
hypotonic extracts 
jj - nns - 
Phrase9747:
unstimulated t 
jj - nn - 
Phrase9748:
the basis 
dt - nn - 
Phrase9749:
we 
prp - 
Phrase9750:
csa-sensitive stage 
jj - nn - 
Phrase9751:
the pre-existing nf-at 
dt - jj - nn - 
Phrase9752:
the addition 
dt - nn - 
Phrase9753:
the pre-existing complex 
dt - jj - nn - 
Phrase9754:
lymphoid cell-specific nuclear factor 
jj - jj - jj - nn - 
Phrase9755:
b-related motifs 
jj - nns - 
Phrase9756:
lymphoid cells 
jj - nns - 
Phrase9757:
the proto-oncoprotein 
dt - nn - 
Phrase9758:
the nuclear factor 
dt - jj - nn - 
Phrase9759:
the p50 
dt - nn - 
Phrase9760:
nuclear factor 
jj - nn - 
Phrase9761:
we 
prp - 
Phrase9762:
these homodimers 
dt - nns - 
Phrase9763:
distinct dna-binding 
jj - nn - 
Phrase9764:
various kappa 
jj - nn - 
Phrase9765:
the c-rel 
dt - nn - 
Phrase9766:
high affinity 
jj - nn - 
Phrase9767:
its 
prp$ - 
Phrase9768:
we 
prp - 
Phrase9769:
lymphoid cell-specific nuclear factor 
jj - jj - jj - nn - 
Phrase9770:
this factor 
dt - nn - 
Phrase9771:
the c-rel 
dt - nn - 
Phrase9772:
several il-6 
jj - nn - 
Phrase9773:
b-related kappa 
jj - nn - 
Phrase9774:
it 
prp - 
Phrase9775:
the il-6 
dt - nn - 
Phrase9776:
factor-responsive element 
jj - nn - 
Phrase9777:
nonlymphoid cells 
jj - nns - 
Phrase9778:
its 
prp$ - 
Phrase9779:
lymphoid cells 
jj - nns - 
Phrase9780:
we 
prp - 
Phrase9781:
b-related kappa 
jj - nn - 
Phrase9782:
lymphoid cells 
jj - nns - 
Phrase9783:
this study 
dt - nn - 
Phrase9784:
the clinical signs 
dt - jj - nns - 
Phrase9785:
metabolic consequences 
jj - nns - 
Phrase9786:
an addisonian 
dt - nn - 
Phrase9787:
intense mucocutaneous 
jj - nn - 
Phrase9788:
peripheral resistance 
jj - nn - 
Phrase9789:
we 
prp - 
Phrase9790:
the effect 
dt - nn - 
Phrase9791:
the effects 
dt - nns - 
Phrase9792:
an addisonian 
dt - nn - 
Phrase9793:
an addisonian 
dt - nn - 
Phrase9794:
age-matched controls 
jj - nns - 
Phrase9795:
the affinity 
dt - nn - 
Phrase9796:
the effect 
dt - nn - 
Phrase9797:
the glucocorticoid 
dt - nn - 
Phrase9798:
clinical features 
jj - nns - 
Phrase9799:
peripheral resistance 
jj - nn - 
Phrase9800:
abnormal glucocorticoid 
jj - nn - 
Phrase9801:
immune-endocrine function 
jj - nn - 
Phrase9802:
important in 
jj - nn - 
Phrase9803:
the course 
dt - nn - 
Phrase9804:
novel primer 
jj - nn - 
Phrase9805:
the number 
dt - nn - 
Phrase9806:
the androgen 
dt - nn - 
Phrase9807:
bulbar muscular atrophy 
jj - jj - nn - 
Phrase9808:
bulbar muscular atrophy 
jj - jj - nn - 
Phrase9809:
an adult-onset 
dt - nn - 
Phrase9810:
the cag 
dt - nn - 
Phrase9811:
the androgen 
dt - nn - 
Phrase9812:
we 
prp - 
Phrase9813:
rapid strategy 
jj - nn - 
Phrase9814:
the precise number 
dt - jj - nn - 
Phrase9815:
the cags 
dt - nn - 
Phrase9816:
the dna 
dt - nn - 
Phrase9817:
the cag 
dt - nn - 
Phrase9818:
the polymerase 
dt - nn - 
Phrase9819:
the extension 
dt - nn - 
Phrase9820:
the end-labelled 
dt - nn - 
Phrase9821:
3' end 
jj - nn - 
Phrase9822:
the first t 
dt - jj - nn - 
Phrase9823:
the incorporation 
dt - nn - 
Phrase9824:
the reaction 
dt - nn - 
Phrase9825:
the resultant primer 
dt - jj - nn - 
Phrase9826:
other polymorphic dinucleotide 
jj - jj - nn - 
Phrase9827:
septic shock 
jj - nn - 
Phrase9828:
the cellular immune response 
dt - jj - jj - nn - 
Phrase9829:
they 
prp - 
Phrase9830:
inflammatory effector 
jj - nn - 
Phrase9831:
the antigen 
dt - nn - 
Phrase9832:
the response 
dt - nn - 
Phrase9833:
the t 
dt - nn - 
Phrase9834:
independent forms 
jj - nns - 
Phrase9835:
cellular collaboration 
jj - nn - 
Phrase9836:
we 
prp - 
Phrase9837:
the control 
dt - nn - 
Phrase9838:
the tissue 
dt - nn - 
Phrase9839:
the function 
dt - nn - 
Phrase9840:
the tf 
dt - nn - 
Phrase9841:
the tf 
dt - nn - 
Phrase9842:
an enhancer 
dt - nn - 
Phrase9843:
both ap-1 
dt - nn - 
Phrase9844:
heterodimeric complexes 
jj - nns - 
Phrase9845:
heterodimeric complexes 
jj - nns - 
Phrase9846:
the tf 
dt - nn - 
Phrase9847:
other inflammatory genes 
jj - jj - nns - 
Phrase9848:
extracellular matrix 
jj - nn - 
Phrase9849:
the biological effects 
dt - jj - nns - 
Phrase9850:
vascular cells 
jj - nns - 
Phrase9851:
the use 
dt - nn - 
Phrase9852:
full length 
jj - nn - 
Phrase9853:
the rules 
dt - nn - 
Phrase9854:
the cognate 
dt - nn - 
Phrase9855:
the zymogen 
dt - nn - 
Phrase9856:
the serine 
dt - nn - 
Phrase9857:
the soluble surface 
dt - jj - nn - 
Phrase9858:
free solution 
jj - nn - 
Phrase9859:
the presence 
dt - nn - 
Phrase9860:
the anchored 
dt - nn - 
Phrase9861:
it 
prp - 
Phrase9862:
the surface 
dt - nn - 
Phrase9863:
the binary 
dt - nn - 
Phrase9864:
significant increase 
jj - nn - 
Phrase9865:
the kcat 
dt - nn - 
Phrase9866:
the catalytic domain 
dt - jj - nn - 
Phrase9867:
small peptidyl 
jj - nn - 
Phrase9868:
substantial evidence 
jj - nn - 
Phrase9869:
an allosteric 
dt - nn - 
Phrase9870:
the catalytic cleft 
dt - jj - nn - 
Phrase9871:
its 
prp$ - 
Phrase9872:
catalytic cofactor 
jj - nn - 
Phrase9873:
it 
prp - 
Phrase9874:
the tf.viia 
dt - nn - 
Phrase9875:
the zymogen 
dt - nn - 
Phrase9876:
the serine 
dt - nn - 
Phrase9877:
free solution 
jj - nn - 
Phrase9878:
structural loci 
jj - nns - 
Phrase9879:
the tf.viia 
dt - nn - 
Phrase9880:
both proteins 
dt - nns - 
Phrase9881:
it 
prp - 
Phrase9882:
the proteolytic activation 
dt - jj - nn - 
Phrase9883:
this zymogen 
dt - nn - 
Phrase9884:
the sessile 
dt - nn - 
Phrase9885:
constitutive nuclear nf 
jj - jj - nn - 
Phrase9886:
mature human 
jj - nn - 
Phrase9887:
monocytic cells 
jj - nns - 
Phrase9888:
specific gene 
jj - nn - 
Phrase9889:
the hiv-1 
dt - nn - 
Phrase9890:
promonocytic leukemias 
jj - nn - 
Phrase9891:
little information 
jj - nn - 
Phrase9892:
the response 
dt - nn - 
Phrase9893:
normal human 
jj - nn - 
Phrase9894:
we 
prp - 
Phrase9895:
32p-labeled oligonucleotide 
jj - nn - 
Phrase9896:
long terminal 
jj - nn - 
Phrase9897:
tandem repeat 
jj - nn - 
Phrase9898:
the nf 
dt - nn - 
Phrase9899:
this transcription 
dt - nn - 
Phrase9900:
this assay 
dt - nn - 
Phrase9901:
we 
prp - 
Phrase9902:
normal human 
jj - nn - 
Phrase9903:
normal monocytes 
jj - nns - 
Phrase9904:
the complete disappearance 
dt - jj - nn - 
Phrase9905:
nuclear extracts 
jj - nns - 
Phrase9906:
similar result 
jj - nn - 
Phrase9907:
the mature monocytic leukemia 
dt - jj - jj - nn - 
Phrase9908:
the constitutive transcription 
dt - jj - nn - 
Phrase9909:
the disappearance 
dt - nn - 
Phrase9910:
the nucleus 
dt - nn - 
Phrase9911:
faster-migrating nf 
jj - nn - 
Phrase9912:
cyclic nucleotide-dependent 
jj - nn - 
Phrase9913:
constitutive levels 
jj - nns - 
Phrase9914:
nuclear nf 
jj - nn - 
Phrase9915:
concentration-dependent manner 
jj - nn - 
Phrase9916:
these results 
dt - nns - 
Phrase9917:
striking contrast 
jj - nn - 
Phrase9918:
the increase 
dt - nn - 
Phrase9919:
nuclear nf 
jj - nn - 
Phrase9920:
promonocytic leukemia 
jj - nn - 
Phrase9921:
the importance 
dt - nn - 
Phrase9922:
normal monocytes 
jj - nns - 
Phrase9923:
the antiinflammatory effects 
dt - jj - nns - 
Phrase9924:
the glucocorticoid 
dt - nn - 
Phrase9925:
endothelial-leukocyte adhesion 
jj - nn - 
Phrase9926:
intercellular adhesion 
jj - nn - 
Phrase9927:
the preeminent 
dt - nn - 
Phrase9928:
antiinflammatory agents 
jj - nns - 
Phrase9929:
the molecular 
dt - nn - 
Phrase9930:
their 
prp$ - 
Phrase9931:
the endothelium 
dt - nn - 
Phrase9932:
critical role 
jj - nn - 
Phrase9933:
extravascular tissues 
jj - nns - 
Phrase9934:
adhesive molecules 
jj - nns - 
Phrase9935:
endothelial-leukocyte adhesion 
jj - nn - 
Phrase9936:
intercellular adhesion 
jj - nn - 
Phrase9937:
we 
prp - 
Phrase9938:
polymorphonuclear leukocytes 
jj - nns - 
Phrase9939:
subsequent adherence 
jj - nn - 
Phrase9940:
polymorphonuclear leukocytes 
jj - nns - 
Phrase9941:
an increase 
dt - nn - 
Phrase9942:
the steroid 
dt - nn - 
Phrase9943:
its 
prp$ - 
Phrase9944:
inactive metabolite 
jj - nn - 
Phrase9945:
lps-induced endothelial 
jj - nn - 
Phrase9946:
the action 
dt - nn - 
Phrase9947:
the steroid 
dt - nn - 
Phrase9948:
the nucleus 
dt - nn - 
Phrase9949:
the effect 
dt - nn - 
Phrase9950:
membrane-associated elam-1 
jj - nn - 
Phrase9951:
quantitative immunofluorescence 
jj - nn - 
Phrase9952:
lps-stimulated accumulation 
jj - nn - 
Phrase9953:
= 4-9 
jj - nn - 
Phrase9954:
the adhesion 
dt - nn - 
Phrase9955:
neither adhesion 
dt - nn - 
Phrase9956:
these adhesion 
dt - nn - 
Phrase9957:
these studies 
dt - nns - 
Phrase9958:
specific instance 
jj - nn - 
Phrase9959:
the general biological principle 
dt - jj - jj - nn - 
Phrase9960:
the glucocorticoid 
dt - nn - 
Phrase9961:
the transcription 
dt - nn - 
Phrase9962:
biochemical purification 
jj - nn - 
Phrase9963:
the family 
dt - nn - 
Phrase9964:
paired domain 
jj - nn - 
Phrase9965:
the pax-5 
dt - nn - 
Phrase9966:
intact paired domain 
jj - jj - nn - 
Phrase9967:
several bsap 
jj - nn - 
Phrase9968:
the sequence 
dt - nn - 
Phrase9969:
related paired domain 
jj - jj - nn - 
Phrase9970:
the bsap 
dt - nn - 
Phrase9971:
the mesencephalon 
dt - nn - 
Phrase9972:
spinal cord 
jj - nn - 
Phrase9973:
temporal expression 
jj - nn - 
Phrase9974:
other pax 
jj - nn - 
Phrase9975:
central nervous system 
jj - jj - nn - 
Phrase9976:
the expression 
dt - nn - 
Phrase9977:
the bsap 
dt - nn - 
Phrase9978:
the fetal liver 
dt - jj - nn - 
Phrase9979:
it 
prp - 
Phrase9980:
the onset 
dt - nn - 
Phrase9981:
the testis 
dt - nn - 
Phrase9982:
the adult 
dt - nn - 
Phrase9983:
this evidence 
dt - nn - 
Phrase9984:
the transcription 
dt - nn - 
Phrase9985:
an important role 
dt - jj - nn - 
Phrase9986:
neural development 
jj - nn - 
Phrase9987:
cycle-dependent initiation 
jj - nn - 
Phrase9988:
hematopoietic progenitors 
jj - nns - 
Phrase9989:
early hematopoietic differentiation 
jj - jj - nn - 
Phrase9990:
the dna-binding 
dt - nn - 
Phrase9991:
normal erythroid development 
jj - jj - nn - 
Phrase9992:
erythroid-expressed genes 
dt - nns - 
Phrase9993:
we 
prp - 
Phrase9994:
early human 
jj - nn - 
Phrase9995:
an in 
dt - nn - 
Phrase9996:
early hematopoietic progenitors 
jj - jj - nns - 
Phrase9997:
synchronized differentiation 
jj - nn - 
Phrase9998:
differential treatment 
jj - nn - 
Phrase9999:
hematopoietic growth 
jj - nn - 
Phrase10000:
the gata-1 
dt - nn - 
Phrase10001:
silent in 
jj - nn - 
Phrase10002:
quiescent progenitors 
jj - nns - 
Phrase10003:
the cell 
dt - nn - 
Phrase10004:
hematopoietic growth 
jj - nn - 
Phrase10005:
the erythroid pathway 
dt - jj - nn - 
Phrase10006:
an abrupt 
dt - nn - 
Phrase10007:
the granulocyte-macrophage 
dt - nn - 
Phrase10008:
these results 
dt - nns - 
Phrase10009:
two-step model 
jj - nn - 
Phrase10010:
hematopoietic progenitors 
jj - nns - 
Phrase10011:
cycle-dependent initiation 
jj - nn - 
Phrase10012:
lineage-restricted transactivators 
jj - nns - 
Phrase10013:
the binary 
dt - nn - 
Phrase10014:
hematopoietic progenitors 
jj - nns - 
Phrase10015:
specific nf-kappa 
jj - nn - 
Phrase10016:
the tat-i 
dt - nn - 
Phrase10017:
specific members 
jj - nns - 
Phrase10018:
the nf-kappa 
dt - nn - 
Phrase10019:
this effect 
dt - nn - 
Phrase10020:
we 
prp - 
Phrase10021:
the abilities 
dt - nns - 
Phrase10022:
different nf-kappa 
jj - nn - 
Phrase10023:
we 
prp - 
Phrase10024:
the p49 
dt - nn - 
Phrase10025:
the expression 
dt - nn - 
Phrase10026:
little effect 
jj - nn - 
Phrase10027:
the hiv 
dt - nn - 
Phrase10028:
these cells 
dt - nns - 
Phrase10029:
these findings 
dt - nns - 
Phrase10030:
the combination 
dt - nn - 
Phrase10031:
the tat-i 
dt - nn - 
Phrase10032:
the synthesis 
dt - nn - 
Phrase10033:
stable expression 
jj - nn - 
Phrase10034:
the control 
dt - nn - 
Phrase10035:
constitutive promoter 
jj - nn - 
Phrase10036:
stable transfectants 
jj - nns - 
Phrase10037:
high levels 
jj - nns - 
Phrase10038:
an altered phenotype 
dt - jj - nn - 
Phrase10039:
the transfectants 
dt - nns - 
Phrase10040:
the hb24 
dt - nn - 
Phrase10041:
constitutive expression 
jj - nn - 
Phrase10042:
the kappa 
dt - nn - 
Phrase10043:
the il-2r 
dt - nn - 
Phrase10044:
the jurkat 
dt - nn - 
Phrase10045:
stable expression 
jj - nn - 
Phrase10046:
an activation 
dt - nn - 
Phrase10047:
this gene 
dt - nn - 
Phrase10048:
an important transcriptional factor 
dt - jj - jj - nn - 
Phrase10049:
functional interaction 
jj - nn - 
Phrase10050:
the v-erb 
dt - nn - 
Phrase10051:
the v-erb 
dt - nn - 
Phrase10052:
avian erythroblastosis 
jj - nn - 
Phrase10053:
the protein 
dt - nn - 
Phrase10054:
the v-erb 
dt - nn - 
Phrase10055:
dominant negative inhibitor 
jj - jj - nn - 
Phrase10056:
both thyroid 
dt - nn - 
Phrase10057:
related retinoic acid 
jj - jj - nn - 
Phrase10058:
the v-erb 
dt - nn - 
Phrase10059:
its 
prp$ - 
Phrase10060:
the neoplastic cell 
dt - jj - nn - 
Phrase10061:
we 
prp - 
Phrase10062:
the second 
dt - nn - 
Phrase10063:
the sequence 
dt - nn - 
Phrase10064:
it 
prp - 
Phrase10065:
an intragenic suppressor 
dt - jj - nn - 
Phrase10066:
the d-box 
dt - nn - 
Phrase10067:
the v-erb 
dt - nn - 
Phrase10068:
receptor-receptor dimerizations 
dt - nn - 
Phrase10069:
physical proximity 
jj - nn - 
Phrase10070:
the serine 
dt - nn - 
Phrase10071:
it 
prp - 
Phrase10072:
an indirect interaction 
dt - jj - nn - 
Phrase10073:
this interaction 
dt - nn - 
Phrase10074:
cis-acting sequences 
jj - nns - 
Phrase10075:
inducible interleukin-2 
jj - nn - 
Phrase10076:
novel ets-related protein 
jj - jj - nn - 
Phrase10077:
the recent definition 
dt - jj - nn - 
Phrase10078:
the ets 
dt - nn - 
Phrase10079:
the identification 
dt - nn - 
Phrase10080:
the promoters 
dt - nns - 
Phrase10081:
many inducible t-cell 
jj - jj - nn - 
Phrase10082:
the studies 
dt - nns - 
Phrase10083:
this report 
dt - nn - 
Phrase10084:
we 
prp - 
Phrase10085:
the human 
dt - nn - 
Phrase10086:
the human 
dt - nn - 
Phrase10087:
electrophoretic mobility 
jj - nn - 
Phrase10088:
the formation 
dt - nn - 
Phrase10089:
the nfat-1 
dt - nn - 
Phrase10090:
nuclear protein 
jj - nn - 
Phrase10091:
inducible interleukin-2 
jj - nn - 
Phrase10092:
the presence 
dt - nn - 
Phrase10093:
either ebs1 
dt - nn - 
Phrase10094:
well-characterized ets 
jj - nn - 
Phrase10095:
these proteins 
dt - nns - 
Phrase10096:
we 
prp - 
Phrase10097:
the dna 
dt - nn - 
Phrase10098:
novel ets 
jj - nn - 
Phrase10099:
the ecdysone-inducible 
dt - nn - 
Phrase10100:
the name 
dt - nn - 
Phrase10101:
both ebs1 
dt - nn - 
Phrase10102:
electrophoretic mobility 
jj - nn - 
Phrase10103:
it 
prp - 
Phrase10104:
the purine-rich cd3r 
dt - jj - nn - 
Phrase10105:
the human 
dt - nn - 
Phrase10106:
long terminal 
jj - nn - 
Phrase10107:
inducible virus 
jj - nn - 
Phrase10108:
the t-cell 
dt - nn - 
Phrase10109:
these results 
dt - nns - 
Phrase10110:
multiple ets 
jj - nn - 
Phrase10111:
distinct dna 
jj - nn - 
Phrase10112:
differential gene 
jj - nn - 
Phrase10113:
non-erythroid nuclear proteins 
jj - jj - nns - 
Phrase10114:
the silencer 
dt - nn - 
Phrase10115:
the human 
dt - nn - 
Phrase10116:
the molecular 
dt - nn - 
Phrase10117:
the developmental control 
dt - jj - nn - 
Phrase10118:
we 
prp - 
Phrase10119:
the expression 
dt - nn - 
Phrase10120:
these genes 
dt - nns - 
Phrase10121:
continuous culture 
jj - nn - 
Phrase10122:
we 
prp - 
Phrase10123:
the presence 
dt - nn - 
Phrase10124:
transcriptional control 
jj - nn - 
Phrase10125:
the properties 
dt - nns - 
Phrase10126:
the cap 
dt - nn - 
Phrase10127:
the human 
dt - nn - 
Phrase10128:
we 
prp - 
Phrase10129:
this silencer 
dt - nn - 
Phrase10130:
stronger inhibitory activity 
jjr - jj - nn - 
Phrase10131:
synthetic oligodeoxyribonucleotides 
jj - nn - 
Phrase10132:
this effect 
dt - nn - 
Phrase10133:
these negative regulatory sequences 
dt - jj - jj - nns - 
Phrase10134:
nuclear extracts 
jj - nns - 
Phrase10135:
nuclear extracts 
jj - nns - 
Phrase10136:
possible mechanisms 
jj - nns - 
Phrase10137:
these proteins 
dt - nns - 
Phrase10138:
the epsilon-globin-encoding 
dt - nn - 
Phrase10139:
non-erythroid cells 
jj - nns - 
Phrase10140:
the english-language 
dt - nn - 
Phrase10141:
the indexing 
dt - nn - 
Phrase10142:
primary immunomodulator 
jj - nn - 
Phrase10143:
these reports 
dt - nns - 
Phrase10144:
this review 
dt - nn - 
Phrase10145:
the data 
dt - nns - 
Phrase10146:
an endocrine 
dt - nn - 
Phrase10147:
immune regulation 
jj - nn - 
Phrase10148:
this collection 
dt - nn - 
Phrase10149:
brief review 
jj - nn - 
Phrase10150:
immune properties 
jj - nns - 
Phrase10151:
the hypersensitive site 
dt - jj - nn - 
Phrase10152:
erythroid cells 
jj - nns - 
Phrase10153:
the human 
dt - nn - 
Phrase10154:
the erythroid-specific hypersensitive site 
dt - jj - jj - nn - 
Phrase10155:
the transcription 
dt - nn - 
Phrase10156:
the downstream beta-like globin 
dt - jj - jj - nn - 
Phrase10157:
the mechanism 
dt - nn - 
Phrase10158:
the present 
dt - nn - 
Phrase10159:
the transcriptional status 
dt - jj - nn - 
Phrase10160:
the hs2 
dt - nn - 
Phrase10161:
erythroid k562 
jj - nn - 
Phrase10162:
the hs2 
dt - nn - 
Phrase10163:
the hs2 
dt - nn - 
Phrase10164:
the synthesis 
dt - nn - 
Phrase10165:
long enhancer 
jj - nn - 
Phrase10166:
the enhancer 
dt - nn - 
Phrase10167:
the cis-linked 
dt - nn - 
Phrase10168:
nonerythroid hl-60 
jj - nn - 
Phrase10169:
the hs2 
dt - nn - 
Phrase10170:
long enhancer 
jj - nn - 
Phrase10171:
the hs2 
dt - nn - 
Phrase10172:
tandem ap1 
jj - nn - 
Phrase10173:
the synthesis 
dt - nn - 
Phrase10174:
long enhancer 
jj - nn - 
Phrase10175:
transcriptional silencing 
jj - nn - 
Phrase10176:
the cis-linked 
dt - nn - 
Phrase10177:
the synthesis 
dt - nn - 
Phrase10178:
the gene 
dt - nn - 
Phrase10179:
the hs2 
dt - nn - 
Phrase10180:
the chromatin 
dt - nn - 
Phrase10181:
the promoter 
dt - nn - 
Phrase10182:
they 
prp - 
Phrase10183:
the transcription 
dt - nn - 
Phrase10184:
the gene 
dt - nn - 
Phrase10185:
the cap 
dt - nn - 
Phrase10186:
novel t 
jj - nn - 
Phrase10187:
the negative regulatory sequence 
dt - jj - jj - nn - 
Phrase10188:
the human 
dt - nn - 
Phrase10189:
long terminal 
jj - nn - 
Phrase10190:
we 
prp - 
Phrase10191:
the ltr 
dt - nn - 
Phrase10192:
the human 
dt - nn - 
Phrase10193:
an inhibitory effect 
dt - jj - nn - 
Phrase10194:
the palindromic site 
dt - jj - nn - 
Phrase10195:
this protein 
dt - nn - 
Phrase10196:
the palindromic binding 
dt - jj - nn - 
Phrase10197:
the steroid/thyroid 
dt - nn - 
Phrase10198:
we 
prp - 
Phrase10199:
the t 
dt - nn - 
Phrase10200:
this site 
dt - nn - 
Phrase10201:
abundant in 
jj - nn - 
Phrase10202:
other members 
jj - nns - 
Phrase10203:
the steroid/thyroid 
dt - nn - 
Phrase10204:
the coup 
dt - nn - 
Phrase10205:
related dna 
jj - nn - 
Phrase10206:
tar-independent transactivation 
jj - nn - 
Phrase10207:
the cns 
dt - nn - 
Phrase10208:
novel mechanism 
jj - nn - 
Phrase10209:
the tat 
dt - nn - 
Phrase10210:
productive infection 
jj - nn - 
Phrase10211:
antiviral therapy 
jj - nn - 
Phrase10212:
the rate 
dt - nn - 
Phrase10213:
the viral promoter 
dt - jj - nn - 
Phrase10214:
an important component 
dt - jj - nn - 
Phrase10215:
the progression 
dt - nn - 
Phrase10216:
immune deficiency 
jj - nn - 
Phrase10217:
transcriptional initiation 
jj - nn - 
Phrase10218:
transcriptional elongation 
jj - nn - 
Phrase10219:
these processes 
dt - nns - 
Phrase10220:
the interaction 
dt - nn - 
Phrase10221:
specific rna 
jj - nn - 
Phrase10222:
the leader 
dt - nn - 
Phrase10223:
an important component 
dt - jj - nn - 
Phrase10224:
the mechanism 
dt - nn - 
Phrase10225:
this report 
dt - nn - 
Phrase10226:
we 
prp - 
Phrase10227:
certain cns-derived 
jj - nn - 
Phrase10228:
tar-independent pathway 
jj - nn - 
Phrase10229:
the viral promoter 
dt - jj - nn - 
Phrase10230:
the absence 
dt - nn - 
Phrase10231:
the viral long terminal 
dt - jj - jj - nn - 
Phrase10232:
the hiv-1 
dt - nn - 
Phrase10233:
glial cells 
jj - nns - 
Phrase10234:
lymphoid cells 
jj - nns - 
Phrase10235:
we 
prp - 
Phrase10236:
tar-deleted mutants 
jj - nns - 
Phrase10237:
normal late gene 
jj - jj - nn - 
Phrase10238:
glial cells 
jj - nns - 
Phrase10239:
viral p24 
jj - nn - 
Phrase10240:
the htlv-i 
dt - nn - 
Phrase10241:
regulatory elements 
jj - nns - 
Phrase10242:
the transactivator 
dt - nn - 
Phrase10243:
the level 
dt - nn - 
Phrase10244:
the a 
dt - nn - 
Phrase10245:
strong homology 
jj - nn - 
Phrase10246:
the transcription 
dt - nn - 
Phrase10247:
we 
prp - 
Phrase10248:
cellular factors 
jj - nn - 
Phrase10249:
both non-transformed 
dt - nn - 
Phrase10250:
the consensus 
dt - nn - 
Phrase10251:
the role 
dt - nn - 
Phrase10252:
the regulation 
dt - nn - 
Phrase10253:
the htlv-i 
dt - nn - 
Phrase10254:
we 
prp - 
Phrase10255:
an ap-2 
dt - nn - 
Phrase10256:
high affinity 
jj - nn - 
Phrase10257:
it 
prp - 
Phrase10258:
the core 
dt - nn - 
Phrase10259:
specific binding 
jj - nn - 
Phrase10260:
the subsequent binding 
dt - jj - nn - 
Phrase10261:
the creb/atf 
dt - nn - 
Phrase10262:
an adjacent regulatory motif 
dt - jj - jj - nn - 
Phrase10263:
an ap-2 
dt - nn - 
Phrase10264:
the htlv-i 
dt - nn - 
Phrase10265:
high levels 
jj - nns - 
Phrase10266:
the ap-2 
dt - nn - 
Phrase10267:
this activation 
dt - nn - 
Phrase10268:
the human 
dt - nn - 
Phrase10269:
the function 
dt - nn - 
Phrase10270:
putative nfat-1 
jj - nn - 
Phrase10271:
the human 
dt - nn - 
Phrase10272:
the t-cell 
dt - nn - 
Phrase10273:
minimal in 
jj - nn - 
Phrase10274:
the kappa 
dt - nn - 
Phrase10275:
the putative nfat-1 
dt - jj - nn - 
Phrase10276:
the response 
dt - nn - 
Phrase10277:
it 
prp - 
Phrase10278:
cis-acting negative regulatory element 
jj - jj - jj - nn - 
Phrase10279:
the b 
dt - nn - 
Phrase10280:
cell-specific nuclear factor 
jj - jj - nn - 
Phrase10281:
the human 
dt - nn - 
Phrase10282:
the promoter 
dt - nn - 
Phrase10283:
the major histocompatibility 
dt - jj - nn - 
Phrase10284:
an octamer 
dt - nn - 
Phrase10285:
efficient dra 
jj - nn - 
Phrase10286:
several dna-binding 
jj - nn - 
Phrase10287:
this sequence 
dt - nn - 
Phrase10288:
the b 
dt - nn - 
Phrase10289:
cell-specific otf-2 
jj - nn - 
Phrase10290:
the ubiquitous otf-1 
dt - jj - nn - 
Phrase10291:
the dra 
dt - nn - 
Phrase10292:
the octamer-binding protein 
dt - jj - nn - 
Phrase10293:
positive functional role 
jj - jj - nn - 
Phrase10294:
it 
prp - 
Phrase10295:
the transcription 
dt - nn - 
Phrase10296:
another gene 
dt - nn - 
Phrase10297:
an otf-2 
dt - nn - 
Phrase10298:
similar findings 
jj - nns - 
Phrase10299:
this effect 
dt - nn - 
Phrase10300:
an intact octamer 
dt - jj - nn - 
Phrase10301:
these results 
dt - nns - 
Phrase10302:
the first direct evidence 
dt - jj - jj - nn - 
Phrase10303:
positive role 
jj - nn - 
Phrase10304:
the lymphoid-specific octamer-binding factor 
dt - jj - jj - nn - 
Phrase10305:
the antiviral activity 
dt - jj - nn - 
Phrase10306:
the expression 
dt - nn - 
Phrase10307:
interferon-stimulated genes 
jj - nns - 
Phrase10308:
specific receptors 
jj - nns - 
Phrase10309:
the rapid transcriptional activation 
dt - jj - jj - nn - 
Phrase10310:
the binding 
dt - nn - 
Phrase10311:
ifn-stimulated gene 
jj - nn - 
Phrase10312:
ifn-stimulated response 
jj - nn - 
Phrase10313:
transcriptional activation 
jj - nn - 
Phrase10314:
the cytoplasm 
dt - nn - 
Phrase10315:
other ifn-alpha-activated 
jj - nn - 
Phrase10316:
latent cytoplasmic precursors 
jj - jj - nns - 
Phrase10317:
we 
prp - 
Phrase10318:
the monocytic u937 
dt - jj - nn - 
Phrase10319:
most cell 
jjs - nn - 
Phrase10320:
antiviral protection 
jj - nn - 
Phrase10321:
these cells 
dt - nns - 
Phrase10322:
the ifn-alpha-induced protection 
dt - jj - nn - 
Phrase10323:
any antiviral activity 
dt - jj - nn - 
Phrase10324:
isg expression 
dt - nn - 
Phrase10325:
transcriptional induction 
jj - nn - 
Phrase10326:
nuclear extracts 
jj - nns - 
Phrase10327:
the presence 
dt - nn - 
Phrase10328:
electrophoretic mobility 
jj - nn - 
Phrase10329:
undetectable basal levels 
jj - jj - nns - 
Phrase10330:
untreated u937 
jj - nn - 
Phrase10331:
the latent component 
dt - jj - nn - 
Phrase10332:
the increase 
dt - nn - 
Phrase10333:
the accumulation 
dt - nn - 
Phrase10334:
single point 
jj - nn - 
Phrase10335:
normal subjects 
jj - nns - 
Phrase10336:
long term 
jj - nn - 
Phrase10337:
single point 
jj - nn - 
Phrase10338:
the measurement 
dt - nn - 
Phrase10339:
specific dexamethasone 
jj - nn - 
Phrase10340:
the assay 
dt - nn - 
Phrase10341:
the ligand 
dt - nn - 
Phrase10342:
the cell 
dt - nn - 
Phrase10343:
the assay 
dt - nn - 
Phrase10344:
the separation 
dt - nn - 
Phrase10345:
whole-cell assay 
jj - nn - 
Phrase10346:
lower values 
jjr - nns - 
Phrase10347:
the latter method 
dt - jj - nn - 
Phrase10348:
it 
prp - 
Phrase10349:
the results 
dt - nns - 
Phrase10350:
healthy volunteers 
jj - nns - 
Phrase10351:
the scatchard 
dt - nn - 
Phrase10352:
the single point 
dt - jj - nn - 
Phrase10353:
large doses 
jj - nns - 
Phrase10354:
the average 
dt - nn - 
Phrase10355:
healthy volunteers 
jj - nns - 
Phrase10356:
these children 
dt - nns - 
Phrase10357:
much broader range 
jj - jjr - nn - 
Phrase10358:
peripheral blood 
jj - nn - 
Phrase10359:
normal humans 
jj - nns - 
Phrase10360:
we 
prp - 
Phrase10361:
the glucocorticoid 
dt - nn - 
Phrase10362:
polymorphonuclear leukocytes 
jj - nns - 
Phrase10363:
peripheral blood 
jj - nn - 
Phrase10364:
healthy male 
jj - nn - 
Phrase10365:
the inhibitory effect 
dt - jj - nn - 
Phrase10366:
the corresponding mononuclear 
dt - jj - nn - 
Phrase10367:
the glucocorticoid 
dt - nn - 
Phrase10368:
those in 
dt - nn - 
Phrase10369:
polymorphonuclear leukocytes 
jj - nns - 
Phrase10370:
the cellular glucocorticoid 
dt - jj - nn - 
Phrase10371:
glucocorticoid-mediated inhibition 
jj - nn - 
Phrase10372:
the uptake 
dt - nn - 
Phrase10373:
the presence 
dt - nn - 
Phrase10374:
cellular glucocorticoid 
jj - nn - 
Phrase10375:
more pronounced inhibitory effect 
jjr - jj - jj - nn - 
Phrase10376:
the transport 
dt - nn - 
Phrase10377:
we 
prp - 
Phrase10378:
the cellular glucocorticoid 
dt - jj - nn - 
Phrase10379:
peripheral blood 
jj - nn - 
Phrase10380:
healthy males 
jj - nns - 
Phrase10381:
the individual 
dt - nn - 
Phrase10382:
the cellular levels 
dt - jj - nns - 
Phrase10383:
functional stimulation 
jj - nn - 
Phrase10384:
transcriptional complex 
jj - nn - 
Phrase10385:
it 
prp - 
Phrase10386:
the data 
dt - nns - 
Phrase10387:
functional responses 
jj - nns - 
Phrase10388:
different routes 
jj - nn - 
Phrase10389:
nuclear signalling 
jj - nn - 
Phrase10390:
the factors 
dt - nn - 
Phrase10391:
the mechanism 
dt - nn - 
Phrase10392:
the activation 
dt - nn - 
Phrase10393:
monocytic cells 
jj - nns - 
Phrase10394:
different mechanims 
jj - nn - 
Phrase10395:
direct inhibition 
jj - nn - 
Phrase10396:
the gene 
dt - nn - 
Phrase10397:
the preformed interleukin-1 
dt - jj - nn - 
Phrase10398:
we 
prp - 
Phrase10399:
the effect 
dt - nn - 
Phrase10400:
the nature 
dt - nn - 
Phrase10401:
the monocyte 
dt - nn - 
Phrase10402:
inhibitory mechanims 
jj - nn - 
Phrase10403:
bacterial lipopolysaccharide 
jj - nn - 
Phrase10404:
it 
prp - 
Phrase10405:
the lipopolysaccharide-induced interleukin-1 
dt - jj - nn - 
Phrase10406:
the phorbol 
dt - nn - 
Phrase10407:
the mrna 
dt - nn - 
Phrase10408:
the cultures 
dt - nns - 
Phrase10409:
the stimulators 
dt - nns - 
Phrase10410:
it 
prp - 
Phrase10411:
the interleukin-1 
dt - nn - 
Phrase10412:
the stimulator 
dt - nn - 
Phrase10413:
the effect 
dt - nn - 
Phrase10414:
the pma-induced 
dt - nn - 
Phrase10415:
these data 
dt - nns - 
Phrase10416:
the phorbol 
dt - nn - 
Phrase10417:
prolonged protein 
jj - nn - 
Phrase10418:
prior incubation 
jj - nn - 
Phrase10419:
it 
prp - 
Phrase10420:
the degradative action 
dt - jj - nn - 
Phrase10421:
nuclear transcription 
jj - nn - 
Phrase10422:
the il-2 
dt - nn - 
Phrase10423:
primary human 
jj - nn - 
Phrase10424:
prior studies 
jj - nns - 
Phrase10425:
several elements 
jj - nns - 
Phrase10426:
the activity 
dt - nn - 
Phrase10427:
the il-2 
dt - nn - 
Phrase10428:
the stimulated 
dt - nn - 
Phrase10429:
the sites 
dt - nns - 
Phrase10430:
their 
prp$ - 
Phrase10431:
corresponding nuclear binding 
jj - jj - nn - 
Phrase10432:
nuclear factor 
jj - nn - 
Phrase10433:
the tissue 
dt - nn - 
Phrase10434:
electrophoretic mobility 
jj - nn - 
Phrase10435:
we 
prp - 
Phrase10436:
these transcription 
dt - nn - 
Phrase10437:
primary t 
jj - nn - 
Phrase10438:
their 
prp$ - 
Phrase10439:
the signals 
dt - nns - 
Phrase10440:
the nuclei 
dt - nns - 
Phrase10441:
exogenous il-2 
jj - nn - 
Phrase10442:
the signaling 
dt - nn - 
Phrase10443:
the activities 
dt - nns - 
Phrase10444:
optimal induction 
jj - nn - 
Phrase10445:
the cd3 
dt - nn - 
Phrase10446:
other factors 
jj - nn - 
Phrase10447:
appropriate stimulation 
jj - nn - 
Phrase10448:
the protein 
dt - nn - 
Phrase10449:
our 
prp$ - 
Phrase10450:
the activity 
dt - nn - 
Phrase10451:
the tax 
dt - nn - 
Phrase10452:
the effect 
dt - nn - 
Phrase10453:
constitutive tax 
jj - nn - 
Phrase10454:
the interaction 
dt - nn - 
Phrase10455:
its 
prp$ - 
Phrase10456:
b-dependent gene 
jj - nn - 
Phrase10457:
lymphoid jurkat 
jj - nn - 
Phrase10458:
constitutive level 
jj - nn - 
Phrase10459:
palindromic nf-kappa 
jj - nn - 
Phrase10460:
the interferon 
dt - nn - 
Phrase10461:
the appearance 
dt - nn - 
Phrase10462:
the 85-kda protein 
dt - jj - nn - 
Phrase10463:
92-kda dna 
jj - nn - 
Phrase10464:
the endogenous nf-kappa 
dt - jj - nn - 
Phrase10465:
b-dependent granulocyte-macrophage 
jj - nn - 
Phrase10466:
basal level 
jj - nn - 
Phrase10467:
b-regulated promoters 
jj - nns - 
Phrase10468:
the stoichiometry 
dt - nn - 
Phrase10469:
the expression 
dt - nn - 
Phrase10470:
b-regulated promoters 
jj - nns - 
Phrase10471:
nuclear factor 
jj - nn - 
Phrase10472:
regulatory region 
jj - nn - 
Phrase10473:
the gm-csf 
dt - nn - 
Phrase10474:
its 
prp$ - 
Phrase10475:
the induction 
dt - nn - 
Phrase10476:
colony-stimulating factor 
jj - nn - 
Phrase10477:
we 
prp - 
Phrase10478:
earlier studies 
jjr - nns - 
Phrase10479:
the upstream region 
dt - jj - nn - 
Phrase10480:
the mouse 
dt - nn - 
Phrase10481:
transcriptional activation 
jj - nn - 
Phrase10482:
the gm2 
dt - nn - 
Phrase10483:
an inducible factor 
dt - jj - nn - 
Phrase10484:
constitutive factors 
jj - nn - 
Phrase10485:
the mechanism 
dt - nn - 
Phrase10486:
we 
prp - 
Phrase10487:
the inducible factor 
dt - jj - nn - 
Phrase10488:
the nuclear extract 
dt - jj - nn - 
Phrase10489:
the basis 
dt - nn - 
Phrase10490:
specific dna-binding 
jj - nn - 
Phrase10491:
both gm-csf 
dt - nn - 
Phrase10492:
protein-dna complex 
jj - nn - 
Phrase10493:
the mixture 
dt - nn - 
Phrase10494:
the nf-gm2 
dt - nn - 
Phrase10495:
low affinity 
jj - nn - 
Phrase10496:
protein-dna complex 
jj - nn - 
Phrase10497:
native nf-gm2 
jj - nn - 
Phrase10498:
an antiserum 
dt - nn - 
Phrase10499:
the p50 
dt - nn - 
Phrase10500:
the nf-gm2 
dt - nn - 
Phrase10501:
the kappa 
dt - nn - 
Phrase10502:
it 
prp - 
Phrase10503:
the gm-csf 
dt - nn - 
Phrase10504:
the gm2 
dt - nn - 
Phrase10505:
the activation 
dt - nn - 
Phrase10506:
the gm-csf 
dt - nn - 
Phrase10507:
the gm2/gc-box 
dt - nn - 
Phrase10508:
the kappa 
dt - nn - 
Phrase10509:
an immediate-early gene 
dt - jj - nn - 
Phrase10510:
adherent monocytes 
jj - nns - 
Phrase10511:
b-like activity 
jj - nn - 
Phrase10512:
we 
prp - 
Phrase10513:
tandem repeats 
jj - nns - 
Phrase10514:
the cdc10/ankyrin 
dt - nn - 
Phrase10515:
the ankyrin 
dt - nn - 
Phrase10516:
the precursor 
dt - nn - 
Phrase10517:
the c-terminus 
dt - nn - 
Phrase10518:
putative protein 
jj - nn - 
Phrase10519:
the dna-binding 
dt - nn - 
Phrase10520:
the p50/p65 
dt - nn - 
Phrase10521:
the p50/p50 
dt - nn - 
Phrase10522:
other dna-binding 
jj - nn - 
Phrase10523:
the mad-3 
dt - nn - 
Phrase10524:
an i 
dt - nn - 
Phrase10525:
b-like protein 
jj - nn - 
Phrase10526:
transcriptional responses 
jj - nns - 
Phrase10527:
high potency 
jj - nn - 
Phrase10528:
unusual structure 
jj - nn - 
Phrase10529:
the human 
dt - nn - 
Phrase10530:
leukemic cell 
jj - nn - 
Phrase10531:
it 
prp - 
Phrase10532:
wild-type cem 
jj - nn - 
Phrase10533:
the hypothesis 
dt - nn - 
Phrase10534:
the residual gr 
dt - jj - nn - 
Phrase10535:
various concentrations 
jj - nns - 
Phrase10536:
the normal cem-c7 
dt - jj - nn - 
Phrase10537:
the dex-resistant 
dt - nn - 
Phrase10538:
the normal cells 
dt - jj - nns - 
Phrase10539:
significant gr 
jj - nn - 
Phrase10540:
general correlation 
jj - nn - 
Phrase10541:
positive induction 
jj - nn - 
Phrase10542:
the earliest crucial steps 
dt - jjs - jj - nns - 
Phrase10543:
the lysis 
dt - nn - 
Phrase10544:
the process 
dt - nn - 
Phrase10545:
the lysis 
dt - nn - 
Phrase10546:
the dex-resistant 
dt - nn - 
Phrase10547:
defective in 
jj - nn - 
Phrase10548:
the normal cells 
dt - jj - nns - 
Phrase10549:
the cells 
dt - nns - 
Phrase10550:
normal t 
jj - nn - 
Phrase10551:
basal activity 
jj - nn - 
Phrase10552:
the hiv 
dt - nn - 
Phrase10553:
low nuclear expression 
jj - jj - nn - 
Phrase10554:
transcriptional activator 
jj - nn - 
Phrase10555:
the hiv 
dt - nn - 
Phrase10556:
fixed tissue 
jj - nn - 
Phrase10557:
detectable hiv 
jj - nn - 
Phrase10558:
permanent virus 
jj - nn - 
Phrase10559:
the perpetuation 
dt - nn - 
Phrase10560:
sustained nuclear nf-kappa 
jj - jj - nn - 
Phrase10561:
the u937 
dt - nn - 
Phrase10562:
monocytic cell 
jj - nn - 
Phrase10563:
low levels 
jj - nns - 
Phrase10564:
nuclear nf-kappa 
jj - nn - 
Phrase10565:
we 
prp - 
Phrase10566:
chronic hiv 
jj - nn - 
Phrase10567:
nuclear factor 
jj - nn - 
Phrase10568:
antigenic properties 
jj - nns - 
Phrase10569:
least in 
jjs - nn - 
Phrase10570:
the perpetuation 
dt - nn - 
Phrase10571:
rel-related human 
jj - nn - 
Phrase10572:
the 65-kd 
dt - nn - 
Phrase10573:
science 
nnp - 
Phrase10574:
the proto-oncogene 
dt - nn - 
Phrase10575:
the drosophila 
dt - nn - 
Phrase10576:
the p50 
dt - nn - 
Phrase10577:
complementary dna 
jj - nn - 
Phrase10578:
the polymerase 
dt - nn - 
Phrase10579:
degenerate oligonucleotides 
jj - nns - 
Phrase10580:
rel-related complementary dna 
jj - jj - nn - 
Phrase10581:
the complementary dna 
dt - jj - nn - 
Phrase10582:
the synthesis 
dt - nn - 
Phrase10583:
an apparent molecular 
dt - jj - nn - 
Phrase10584:
weak dna 
jj - nn - 
Phrase10585:
the kappa 
dt - nn - 
Phrase10586:
protein-dna complex 
jj - nn - 
Phrase10587:
the complex 
dt - nn - 
Phrase10588:
the 65-kd 
dt - nn - 
Phrase10589:
the p50 
dt - nn - 
Phrase10590:
the kappa 
dt - nn - 
Phrase10591:
the same electrophoretic mobility 
dt - jj - jj - nn - 
Phrase10592:
the nf-kappa 
dt - nn - 
Phrase10593:
the rel-related 65-kd 
dt - jj - nn - 
Phrase10594:
the p65 
dt - nn - 
Phrase10595:
the active nf-kappa 
dt - jj - nn - 
Phrase10596:
the human 
dt - nn - 
Phrase10597:
myelomonocytic cell 
jj - nn - 
Phrase10598:
steroid-induced monokine 
jj - nn - 
Phrase10599:
marked enhancement 
jj - nn - 
Phrase10600:
lipopolysaccharide-stimulated interleukin-1 
jj - nn - 
Phrase10601:
the active metabolite 
dt - jj - nn - 
Phrase10602:
the presence 
dt - nn - 
Phrase10603:
functional 1,25-(oh)2d3 
jj - nn - 
Phrase10604:
the accumulation 
dt - nn - 
Phrase10605:
the regulation 
dt - nn - 
Phrase10606:
this response 
dt - nn - 
Phrase10607:
these data 
dt - nns - 
Phrase10608:
their 
prp$ - 
Phrase10609:
the cell 
dt - nn - 
Phrase10610:
we 
prp - 
Phrase10611:
saturating concentration 
jj - nn - 
Phrase10612:
the time 
dt - nn - 
Phrase10613:
the level 
dt - nn - 
Phrase10614:
the concentration 
dt - nn - 
Phrase10615:
steady state 
jj - nn - 
Phrase10616:
the hormone.2+o 
dt - nn - 
Phrase10617:
the survival 
dt - nn - 
Phrase10618:
functional activity 
jj - nn - 
Phrase10619:
single class 
jj - nn - 
Phrase10620:
the product 
dt - nn - 
Phrase10621:
the c-fms 
dt - nn - 
Phrase10622:
the detection 
dt - nn - 
Phrase10623:
both m-csf 
dt - nn - 
Phrase10624:
the monocyte 
dt - nn - 
Phrase10625:
an autocrine 
dt - nn - 
Phrase10626:
it 
prp - 
Phrase10627:
the expression 
dt - nn - 
Phrase10628:
its 
prp$ - 
Phrase10629:
own gene 
jj - nn - 
Phrase10630:
the intracellular pathway 
dt - jj - nn - 
Phrase10631:
we 
prp - 
Phrase10632:
the changes 
dt - nns - 
Phrase10633:
we 
prp - 
Phrase10634:
the isoquinoline 
dt - nn - 
Phrase10635:
the detection 
dt - nn - 
Phrase10636:
an nf 
dt - nn - 
Phrase10637:
nuclear extracts 
jj - nns - 
Phrase10638:
the results 
dt - nns - 
Phrase10639:
another human 
dt - nn - 
Phrase10640:
factor-induced genes 
jj - nns - 
Phrase10641:
identical zinc-finger 
jj - nn - 
Phrase10642:
we 
prp - 
Phrase10643:
the structure 
dt - nn - 
Phrase10644:
the early phase 
dt - jj - nn - 
Phrase10645:
the cell 
dt - nn - 
Phrase10646:
the pat 
dt - nn - 
Phrase10647:
primary structure 
jj - nn - 
Phrase10648:
tandem zinc-finger 
jj - nn - 
Phrase10649:
the type 
dt - nn - 
Phrase10650:
sequence-specific manner 
jj - nn - 
Phrase10651:
the amino 
dt - nn - 
Phrase10652:
the amino 
dt - nn - 
Phrase10653:
structural similarity 
jj - nn - 
Phrase10654:
the pat 
dt - nn - 
Phrase10655:
specific biological function 
jj - jj - nn - 
Phrase10656:
the regulation 
dt - nn - 
Phrase10657:
these related zinc-finger-encoding 
dt - jj - nn - 
Phrase10658:
mitogenic stimulation 
jj - nn - 
Phrase10659:
the cell 
dt - nn - 
Phrase10660:
histiocytic u937 
jj - nn - 
Phrase10661:
these cells 
dt - nns - 
Phrase10662:
distinct biological roles 
jj - jj - nns - 
Phrase10663:
the control 
dt - nn - 
Phrase10664:
the respective proteins 
dt - jj - nns - 
Phrase10665:
c-erba function 
dt - nn - 
Phrase10666:
erythroid cell 
jj - nn - 
Phrase10667:
the erba 
dt - nn - 
Phrase10668:
the v-erba 
dt - nn - 
Phrase10669:
oncogenic version 
jj - nn - 
Phrase10670:
the thyroid 
dt - nn - 
Phrase10671:
it 
prp - 
Phrase10672:
virus-induced erythroleukemia 
jj - nn - 
Phrase10673:
red cell 
jj - nn - 
Phrase10674:
we 
prp - 
Phrase10675:
the promoter 
dt - nn - 
Phrase10676:
the erythrocyte-specific 
dt - nn - 
Phrase10677:
heterologous promoter 
jj - nn - 
Phrase10678:
efficient down-regulation 
jj - nn - 
Phrase10679:
the v-erba 
dt - nn - 
Phrase10680:
the v-erba 
dt - nn - 
Phrase10681:
the c-erba/t3 
dt - nn - 
Phrase10682:
erythroid differentiation 
jj - nn - 
Phrase10683:
these cells 
dt - nns - 
Phrase10684:
the v-erba-mediated 
dt - nn - 
Phrase10685:
the caii-specific 
dt - nn - 
Phrase10686:
the c-erba-dependent 
dt - nn - 
Phrase10687:
this caii 
dt - nn - 
Phrase10688:
high amounts 
jj - nns - 
Phrase10689:
our 
prp$ - 
Phrase10690:
its 
prp$ - 
Phrase10691:
an oncoprotein 
dt - nn - 
Phrase10692:
the hiv 
dt - nn - 
Phrase10693:
long terminal 
jj - nn - 
Phrase10694:
the cd2 
dt - nn - 
Phrase10695:
both cell 
dt - nn - 
Phrase10696:
the spread 
dt - nn - 
Phrase10697:
hiv-infected pbmc 
jj - nn - 
Phrase10698:
the expression 
dt - nn - 
Phrase10699:
infectious virus 
jj - nn - 
Phrase10700:
these cultures 
dt - nns - 
Phrase10701:
this study 
dt - nn - 
Phrase10702:
we 
prp - 
Phrase10703:
the mechanisms 
dt - nns - 
Phrase10704:
viral production 
jj - nn - 
Phrase10705:
we 
prp - 
Phrase10706:
the hiv 
dt - nn - 
Phrase10707:
long terminal 
jj - nn - 
Phrase10708:
long terminal 
jj - nn - 
Phrase10709:
this activation 
dt - nn - 
Phrase10710:
the nf-kappa 
dt - nn - 
Phrase10711:
these studies 
dt - nns - 
Phrase10712:
its 
prp$ - 
Phrase10713:
natural ligand 
jj - nn - 
Phrase10714:
reactive oxygen 
jj - nn - 
Phrase10715:
the activation 
dt - nn - 
Phrase10716:
the nf-kappa 
dt - nn - 
Phrase10717:
inflammatory processes 
jj - nns - 
Phrase10718:
this study 
dt - nn - 
Phrase10719:
we 
prp - 
Phrase10720:
micromolar concentrations 
jj - nns - 
Phrase10721:
the expression 
dt - nn - 
Phrase10722:
the effect 
dt - nn - 
Phrase10723:
the nf-kappa 
dt - nn - 
Phrase10724:
an h2o2 
dt - nn - 
Phrase10725:
its 
prp$ - 
Phrase10726:
inactive cytoplasmic form 
jj - jj - nn - 
Phrase10727:
the effects 
dt - nns - 
Phrase10728:
reactive oxygen 
jj - nn - 
Phrase10729:
the activation 
dt - nn - 
Phrase10730:
other thiol 
jj - nn - 
Phrase10731:
the activation 
dt - nn - 
Phrase10732:
double-stranded rna 
jj - nn - 
Phrase10733:
active phorbol 
jj - nn - 
Phrase10734:
diverse agents 
jj - nns - 
Phrase10735:
distinct intracellular pathways 
jj - jj - nns - 
Phrase10736:
the synthesis 
dt - nn - 
Phrase10737:
the release 
dt - nn - 
Phrase10738:
the inhibitory subunit 
dt - jj - nn - 
Phrase10739:
the rel/nf-kappa 
dt - nn - 
Phrase10740:
transdominant negative mutant 
jj - jj - nn - 
Phrase10741:
the kbf1 
dt - nn - 
Phrase10742:
the enhancer 
dt - nn - 
Phrase10743:
located in 
jj - nn - 
Phrase10744:
the promoter 
dt - nn - 
Phrase10745:
the mouse 
dt - nn - 
Phrase10746:
the p50 
dt - nn - 
Phrase10747:
the transcription 
dt - nn - 
Phrase10748:
inflammatory responses 
jj - nns - 
Phrase10749:
the kbf1/p50 
dt - nn - 
Phrase10750:
the products 
dt - nns - 
Phrase10751:
other members 
jj - nns - 
Phrase10752:
the same family 
dt - jj - nn - 
Phrase10753:
the c-rel 
dt - nn - 
Phrase10754:
the dimerization 
dt - nn - 
Phrase10755:
the dna 
dt - nn - 
Phrase10756:
wild-type proteins 
jj - nns - 
Phrase10757:
the same family 
dt - jj - nn - 
Phrase10758:
trans-acting dominant negative regulator 
jj - jj - jj - nn - 
Phrase10759:
the transcriptional inducibility 
dt - jj - nn - 
Phrase10760:
the hiv 
dt - nn - 
Phrase10761:
long terminal 
jj - nn - 
Phrase10762:
it 
prp - 
Phrase10763:
cd4+ t 
jj - nn - 
Phrase10764:
the delta 
dt - nn - 
Phrase10765:
the mhc 
dt - nn - 
Phrase10766:
this mutant 
dt - nn - 
Phrase10767:
different cell 
jj - nn - 
Phrase10768:
these results 
dt - nns - 
Phrase10769:
the first formal demonstration 
dt - jj - jj - nn - 
Phrase10770:
these genes 
dt - nns - 
Phrase10771:
the rel/nf-kappa 
dt - nn - 
Phrase10772:
tissue-specific expression 
jj - nn - 
Phrase10773:
the platelet 
dt - nn - 
Phrase10774:
the major objectives 
dt - jj - nns - 
Phrase10775:
the study 
dt - nn - 
Phrase10776:
the mechanisms 
dt - nns - 
Phrase10777:
hematopoietic progenitor 
jj - nn - 
Phrase10778:
the megakaryocytic lineage 
dt - jj - nn - 
Phrase10779:
recent development 
jj - nn - 
Phrase10780:
primary cultures 
jj - nns - 
Phrase10781:
the molecular 
dt - nn - 
Phrase10782:
this lineage 
dt - nn - 
Phrase10783:
the possibility 
dt - nn - 
Phrase10784:
some insights 
dt - nns - 
Phrase10785:
the genetic mechanisms 
dt - jj - nns - 
Phrase10786:
the glycoprotein 
dt - nn - 
Phrase10787:
the alpha 
dt - nn - 
Phrase10788:
the platelet 
dt - nn - 
Phrase10789:
an early stage 
dt - jj - nn - 
Phrase10790:
the differentiation 
dt - nn - 
Phrase10791:
the other subunit 
dt - jj - nn - 
Phrase10792:
this complex 
dt - nn - 
Phrase10793:
other cells 
jj - nns - 
Phrase10794:
these reasons 
dt - nns - 
Phrase10795:
the 5'-flanking region 
dt - jj - nn - 
Phrase10796:
the gpiib 
dt - nn - 
Phrase10797:
the regions 
dt - nns - 
Phrase10798:
nuclear factors 
jj - nn - 
Phrase10799:
the tissue-specific expression 
dt - jj - nn - 
Phrase10800:
the cat 
dt - nn - 
Phrase10801:
this region 
dt - nn - 
Phrase10802:
we 
prp - 
Phrase10803:
several sequences 
jj - nns - 
Phrase10804:
centered at 
jj - nn - 
Phrase10805:
nuclear factor 
jj - nn - 
Phrase10806:
located at 
jj - nn - 
Phrase10807:
megakaryocytic cells 
jj - nns - 
Phrase10808:
other domains 
jj - nns - 
Phrase10809:
located at 
jj - nn - 
Phrase10810:
megakaryocytic cells 
jj - nns - 
Phrase10811:
the region 
dt - nn - 
Phrase10812:
significant decrease 
jj - nn - 
Phrase10813:
the promoter 
dt - nn - 
Phrase10814:
it 
prp - 
Phrase10815:
these domains 
dt - nns - 
Phrase10816:
megakaryocyte-specific nuclear proteins 
jj - jj - nns - 
Phrase10817:
positive transcription 
jj - nn - 
Phrase10818:
clinical recovery 
jj - nn - 
Phrase10819:
depressed patients 
jj - nns - 
Phrase10820:
clinical recovery 
jj - nn - 
Phrase10821:
healthy controls 
jj - nns - 
Phrase10822:
depressed patients 
jj - nns - 
Phrase10823:
these data 
dt - nns - 
Phrase10824:
the view 
dt - nn - 
Phrase10825:
an impaired ligand-induced plasticity 
dt - jj - jj - nn - 
Phrase10826:
the hypothesis 
dt - nn - 
Phrase10827:
every enhancer 
dt - nn - 
Phrase10828:
every promoter 
dt - nn - 
Phrase10829:
the combinations 
dt - nns - 
Phrase10830:
regulatory pathways 
jj - nns - 
Phrase10831:
the promoters 
dt - nns - 
Phrase10832:
type-specific genes 
jj - nns - 
Phrase10833:
its 
prp$ - 
Phrase10834:
own promoter 
jj - nn - 
Phrase10835:
this expectation 
dt - nn - 
Phrase10836:
some cases 
dt - nns - 
Phrase10837:
we 
prp - 
Phrase10838:
it 
prp - 
Phrase10839:
different promoters 
jj - nns - 
Phrase10840:
we 
prp - 
Phrase10841:
the relative 
dt - nn - 
Phrase10842:
the enhancers 
dt - nns - 
Phrase10843:
the type 
dt - nn - 
Phrase10844:
strong preference 
jj - nn - 
Phrase10845:
we 
prp - 
Phrase10846:
strong transcription 
jj - nn - 
Phrase10847:
the immunoglobulin 
dt - nn - 
Phrase10848:
the immunoglobulin 
dt - nn - 
Phrase10849:
heavy chain 
jj - nn - 
Phrase10850:
we 
prp - 
Phrase10851:
permissive enhancer/promoter 
jj - nn - 
Phrase10852:
evolutionary benefit 
jj - nn - 
Phrase10853:
lymphoid differentiation 
jj - nn - 
Phrase10854:
mammalian development 
jj - nn - 
Phrase10855:
the cloning 
dt - nn - 
Phrase10856:
the genes 
dt - nns - 
Phrase10857:
t-cell-specific membrane 
jj - nn - 
Phrase10858:
the identification 
dt - nn - 
Phrase10859:
the expression 
dt - nn - 
Phrase10860:
these t-cell 
dt - nn - 
Phrase10861:
key role 
jj - nn - 
Phrase10862:
the development 
dt - nn - 
Phrase10863:
the mature t-cell 
dt - jj - nn - 
Phrase10864:
the circadian 
dt - nn - 
Phrase10865:
the rat 
dt - nn - 
Phrase10866:
peripheral leukocytes 
jj - nns - 
Phrase10867:
natural environmental photic 
jj - jj - nn - 
Phrase10868:
artificial light 
jj - nn - 
Phrase10869:
hepatic gr 
jj - nn - 
Phrase10870:
the peak 
dt - nn - 
Phrase10871:
similar circadian 
jj - nn - 
Phrase10872:
hepatic gr 
jj - nn - 
Phrase10873:
the peak 
dt - nn - 
Phrase10874:
low values 
jj - nns - 
Phrase10875:
the circadian 
dt - nn - 
Phrase10876:
the normal subjects 
dt - jj - nns - 
Phrase10877:
the base 
dt - nn - 
Phrase10878:
the brain 
dt - nn - 
Phrase10879:
the diurnal 
dt - nn - 
Phrase10880:
the cerebral cortex 
dt - jj - nn - 
Phrase10881:
we 
prp - 
Phrase10882:
the circadian 
dt - nn - 
Phrase10883:
the diurnal 
dt - nn - 
Phrase10884:
the circadian 
dt - nn - 
Phrase10885:
environmental lighting 
jj - nn - 
Phrase10886:
the rhythmicity 
dt - nn - 
Phrase10887:
circadian pacemaker 
jj - nn - 
Phrase10888:
located in 
jj - nn - 
Phrase10889:
the human 
dt - nn - 
Phrase10890:
basal brain 
jj - nn - 
Phrase10891:
these diurnal 
dt - nn - 
Phrase10892:
the reactivity 
dt - nn - 
Phrase10893:
the target 
dt - nn - 
Phrase10894:
the diurnal 
dt - nn - 
Phrase10895:
gr-mediated response 
jj - nn - 
Phrase10896:
the fractional 
dt - nn - 
Phrase10897:
polymorphonuclear leukocytes 
jj - nns - 
Phrase10898:
lymphoid cells 
jj - nns - 
Phrase10899:
small nuclear rna 
jj - jj - nn - 
Phrase10900:
distal enhancer 
jj - nn - 
Phrase10901:
1-binding sites 
jj - nns - 
Phrase10902:
the transcription 
dt - nn - 
Phrase10903:
different u2 
jj - nn - 
Phrase10904:
the lymphoid cell 
dt - jj - nn - 
Phrase10905:
the results 
dt - nns - 
Phrase10906:
the activation 
dt - nn - 
Phrase10907:
an enhancer 
dt - nn - 
Phrase10908:
both oct 
dt - nn - 
Phrase10909:
least one 
jjs - nn - 
Phrase10910:
1-binding site 
jj - nn - 
Phrase10911:
the sp 
dt - nn - 
Phrase10912:
1-binding sites 
jj - nns - 
Phrase10913:
the enhancer 
dt - nn - 
Phrase10914:
the removal 
dt - nn - 
Phrase10915:
the octamer-binding site 
dt - jj - nn - 
Phrase10916:
single oct 
jj - nn - 
Phrase10917:
the capacity 
dt - nn - 
Phrase10918:
octamer-binding factor 
jj - nn - 
Phrase10919:
likely interpretation 
jj - nn - 
Phrase10920:
our 
prp$ - 
Phrase10921:
both ubiquitous transcription 
dt - jj - nn - 
Phrase10922:
the b-cell-specific transcription 
dt - jj - nn - 
Phrase10923:
the results 
dt - nns - 
Phrase10924:
similar functional cooperation 
jj - jj - nn - 
Phrase10925:
the transcription 
dt - nn - 
Phrase10926:
the oct 
dt - nn - 
Phrase10927:
the adjacent sp 
dt - jj - nn - 
Phrase10928:
1-binding site 
jj - nn - 
Phrase10929:
weak binding 
jj - nn - 
Phrase10930:
wild-type levels 
jj - nns - 
Phrase10931:
the weak octamer-binding site 
dt - jj - jj - nn - 
Phrase10932:
1-binding site 
jj - nn - 
Phrase10933:
the t 
dt - nn - 
Phrase10934:
the interleukin 
dt - nn - 
Phrase10935:
cell-specific enhancers 
jj - nns - 
Phrase10936:
the kb-like 
dt - nn - 
Phrase10937:
an essential cis-acting enhancer 
dt - jj - jj - nn - 
Phrase10938:
multiple copies 
jj - nns - 
Phrase10939:
this so-called tced 
dt - jj - nn - 
Phrase10940:
distal t 
jj - nn - 
Phrase10941:
an inducible proto-enhancer 
dt - jj - nn - 
Phrase10942:
the binding 
dt - nn - 
Phrase10943:
prominent factor 
jj - nn - 
Phrase10944:
the proto-enhancer 
dt - nn - 
Phrase10945:
the tced 
dt - nn - 
Phrase10946:
the conversion 
dt - nn - 
Phrase10947:
the tced 
dt - nn - 
Phrase10948:
functional consequence 
jj - nn - 
Phrase10949:
the activity 
dt - nn - 
Phrase10950:
the substitution 
dt - nn - 
Phrase10951:
the gggatttcacc 
dt - nn - 
Phrase10952:
its 
prp$ - 
Phrase10953:
its 
prp$ - 
Phrase10954:
these results 
dt - nns - 
Phrase10955:
lymphocyte-specific factors 
jj - nn - 
Phrase10956:
the tced 
dt - nn - 
Phrase10957:
the control 
dt - nn - 
Phrase10958:
the il-2 
dt - nn - 
Phrase10959:
an erythroid specific enhancer 
dt - jj - jj - nn - 
Phrase10960:
the gene 
dt - nn - 
Phrase10961:
the cell-type 
dt - nn - 
Phrase10962:
specific transcription 
jj - nn - 
Phrase10963:
the transcription 
dt - nn - 
Phrase10964:
hemopoietic cells 
jj - nns - 
Phrase10965:
it 
prp - 
Phrase10966:
the cell-type 
dt - nn - 
Phrase10967:
specific expression 
jj - nn - 
Phrase10968:
several genes 
jj - nns - 
Phrase10969:
we 
prp - 
Phrase10970:
the mouse 
dt - nn - 
Phrase10971:
the first exon 
dt - jj - nn - 
Phrase10972:
an erythroid specific enhancer 
dt - jj - jj - nn - 
Phrase10973:
the gata-1 
dt - nn - 
Phrase10974:
the sv40 
dt - nn - 
Phrase10975:
the activity 
dt - nn - 
Phrase10976:
the enhancer 
dt - nn - 
Phrase10977:
the integrity 
dt - nn - 
Phrase10978:
dimeric gata-1 
jj - nn - 
Phrase10979:
d3-responsive protein 
jj - nn - 
Phrase10980:
immunologic crossreactivity 
jj - nn - 
Phrase10981:
the vitamin 
dt - nn - 
Phrase10982:
monoclonal antibody 
jj - nn - 
Phrase10983:
the 1,25-dihydroxyvitamin 
dt - nn - 
Phrase10984:
we 
prp - 
Phrase10985:
normal human 
jj - nn - 
Phrase10986:
the classical 1,25(oh)2d3 
dt - jj - nn - 
Phrase10987:
the classical 1,25(oh)2d3 
dt - jj - nn - 
Phrase10988:
dose-dependent fashion 
jj - nn - 
Phrase10989:
an electrophoretic mobility 
dt - jj - nn - 
Phrase10990:
the cell 
dt - nn - 
Phrase10991:
it 
prp - 
Phrase10992:
several other human 
jj - jj - nn - 
Phrase10993:
the 80-kda protein 
dt - jj - nn - 
Phrase10994:
dose-dependent fashion 
jj - nn - 
Phrase10995:
this effect 
dt - nn - 
Phrase10996:
the mode 
dt - nn - 
Phrase10997:
the 1,25(oh)2d3 
dt - nn - 
Phrase10998:
immunosuppressive agents 
jj - nns - 
Phrase10999:
the 80-kda protein 
dt - jj - nn - 
Phrase11000:
whole cell 
jj - nn - 
Phrase11001:
systemic diseases 
jj - nns - 
Phrase11002:
prolonged corticosteroid 
jj - nn - 
Phrase11003:
the mean 
dt - nn - 
Phrase11004:
this group 
dt - nn - 
Phrase11005:
negative correlation 
jj - nn - 
Phrase11006:
subtle down-regulatory effect 
jj - jj - nn - 
Phrase11007:
these patients 
dt - nns - 
Phrase11008:
marked reduction 
jj - nn - 
Phrase11009:
urinary free cortisol 
jj - jj - nn - 
Phrase11010:
we 
prp - 
Phrase11011:
weak competitor 
jj - nn - 
Phrase11012:
intact cells 
jj - nns - 
Phrase11013:
it 
prp - 
Phrase11014:
cytosolic preparations 
jj - nns - 
Phrase11015:
the results 
dt - nns - 
Phrase11016:
synthetic steroids 
jj - nns - 
Phrase11017:
they 
prp - 
Phrase11018:
mild down-regulation 
jj - nn - 
Phrase11019:
hypercortisolemic patients 
jj - nns - 
Phrase11020:
we 
prp - 
Phrase11021:
the time 
dt - nn - 
Phrase11022:
the beneficial effects 
dt - jj - nns - 
Phrase11023:
adrenal cortisol 
jj - nn - 
Phrase11024:
the process 
dt - nn - 
Phrase11025:
various immediate early serum 
jj - jj - jj - nn - 
Phrase11026:
responsive genes 
jj - nns - 
Phrase11027:
an etiological agent 
dt - jj - nn - 
Phrase11028:
we 
prp - 
Phrase11029:
the virus 
dt - nn - 
Phrase11030:
high levels 
jj - nns - 
Phrase11031:
this result 
dt - nn - 
Phrase11032:
these cell 
dt - nn - 
Phrase11033:
the ap-1 
dt - nn - 
Phrase11034:
the c-fos 
dt - nn - 
Phrase11035:
the viral transcription 
dt - jj - nn - 
Phrase11036:
the human 
dt - nn - 
Phrase11037:
the tax1 
dt - nn - 
Phrase11038:
we 
prp - 
Phrase11039:
other transcription 
jj - nn - 
Phrase11040:
the same cells 
dt - jj - nns - 
Phrase11041:
the tax1-inducible transcription 
dt - jj - nn - 
Phrase11042:
the members 
dt - nns - 
Phrase11043:
immediate early genes 
jj - jj - nns - 
Phrase11044:
the control 
dt - nn - 
Phrase11045:
least in 
jjs - nn - 
Phrase11046:
this mechanism 
dt - nn - 
Phrase11047:
bronchial asthma 
jj - nn - 
Phrase11048:
the mechanism 
dt - nn - 
Phrase11049:
bronchial asthma 
jj - nn - 
Phrase11050:
the rank 
dt - nn - 
Phrase11051:
different corticosteroids 
jj - nns - 
Phrase11052:
the generation 
dt - nn - 
Phrase11053:
peripheral blood 
jj - nn - 
Phrase11054:
asthmatic subjects 
jj - nns - 
Phrase11055:
the dissociation 
dt - nn - 
Phrase11056:
the monocytes 
dt - nns - 
Phrase11057:
the concentration 
dt - nn - 
Phrase11058:
weak inhibition 
jj - nn - 
Phrase11059:
the generation 
dt - nn - 
Phrase11060:
the corticosteroids 
dt - nns - 
Phrase11061:
the cr 
dt - nn - 
Phrase11062:
asthmatic individuals 
jj - nns - 
Phrase11063:
the dexamethasone 
dt - nn - 
Phrase11064:
the cs 
dt - nn - 
Phrase11065:
the cr 
dt - nn - 
Phrase11066:
= 0.14 
jj - nn - 
Phrase11067:
the ro 
dt - nn - 
Phrase11068:
the cs 
dt - nn - 
Phrase11069:
the cr 
dt - nn - 
Phrase11070:
these findings 
dt - nns - 
Phrase11071:
bronchial asthma 
jj - nn - 
Phrase11072:
the signals 
dt - nns - 
Phrase11073:
the expression 
dt - nn - 
Phrase11074:
the receptor 
dt - nn - 
Phrase11075:
normal human 
jj - nn - 
Phrase11076:
the relationship 
dt - nn - 
Phrase11077:
this protein 
dt - nn - 
Phrase11078:
the classical vitamin 
dt - jj - nn - 
Phrase11079:
the okt3 
dt - nn - 
Phrase11080:
the t-cell 
dt - nn - 
Phrase11081:
fewer binding 
jjr - nn - 
Phrase11082:
the polyclonal activator 
dt - jj - nn - 
Phrase11083:
the pha-activated cells 
dt - jj - nns - 
Phrase11084:
the receptor 
dt - nn - 
Phrase11085:
pha-activated lymphocytes 
jj - nns - 
Phrase11086:
monoclonal antibody 
jj - nn - 
Phrase11087:
the intestinal vitamin 
dt - jj - nn - 
Phrase11088:
long region 
jj - nn - 
Phrase11089:
the dna-binding 
dt - nn - 
Phrase11090:
the human 
dt - nn - 
Phrase11091:
intestinal receptor 
jj - nn - 
Phrase11092:
an identical nucleotide 
dt - jj - nn - 
Phrase11093:
the dna-binding 
dt - nn - 
Phrase11094:
the human 
dt - nn - 
Phrase11095:
intestinal receptor 
jj - nn - 
Phrase11096:
these findings 
dt - nns - 
Phrase11097:
the 1,25-(oh)2d3 
dt - nn - 
Phrase11098:
the protein 
dt - nn - 
Phrase11099:
the mrna 
dt - nn - 
Phrase11100:
it 
prp - 
Phrase11101:
the classical vitamin 
dt - jj - nn - 
Phrase11102:
inducible transcriptional enhancement 
jj - jj - nn - 
Phrase11103:
b-related sequences 
jj - nns - 
Phrase11104:
the kappa 
dt - nn - 
Phrase11105:
its 
prp$ - 
Phrase11106:
indistinguishable sequence 
jj - nn - 
Phrase11107:
many other cell 
jj - jj - nn - 
Phrase11108:
it 
prp - 
Phrase11109:
inducible gene 
jj - nn - 
Phrase11110:
b-related sequences 
jj - nns - 
Phrase11111:
the transcription 
dt - nn - 
Phrase11112:
few inducible genes 
jj - jj - nns - 
Phrase11113:
the interleukin 
dt - nn - 
Phrase11114:
the beta-interferon 
dt - nn - 
Phrase11115:
these genes 
dt - nns - 
Phrase11116:
active in 
jj - nn - 
Phrase11117:
other regulatory mechanisms 
jj - jj - nns - 
Phrase11118:
the patterns 
dt - nn - 
Phrase11119:
we 
prp - 
Phrase11120:
inducible transcriptional activity 
jj - jj - nn - 
Phrase11121:
b-related sequence 
jj - nn - 
Phrase11122:
different cell 
jj - nn - 
Phrase11123:
we 
prp - 
Phrase11124:
the activity 
dt - nn - 
Phrase11125:
each element 
dt - nn - 
Phrase11126:
the relative 
dt - nn - 
Phrase11127:
b-cell-derived nf-kappa 
jj - nn - 
Phrase11128:
lower transcription 
jjr - nn - 
Phrase11129:
the interleukin 
dt - nn - 
Phrase11130:
the tax 
dt - nn - 
Phrase11131:
this factor 
dt - nn - 
Phrase11132:
specific depletion 
jj - nn - 
Phrase11133:
the b-cell 
dt - nn - 
Phrase11134:
regulatory factor 
jj - nn - 
Phrase11135:
transgenic mice 
jj - nns - 
Phrase11136:
antiviral proteins 
jj - nns - 
Phrase11137:
nuclear factor 
jj - nn - 
Phrase11138:
regulatory factor 
jj - nn - 
Phrase11139:
some ifn-inducible gene 
dt - jj - nn - 
Phrase11140:
the irf-1 
dt - nn - 
Phrase11141:
both virus 
dt - nn - 
Phrase11142:
an intriguing issue 
dt - jj - nn - 
Phrase11143:
the irf-1 
dt - nn - 
Phrase11144:
this study 
dt - nn - 
Phrase11145:
we 
prp - 
Phrase11146:
transgenic mice 
jj - nns - 
Phrase11147:
the human 
dt - nn - 
Phrase11148:
the human 
dt - nn - 
Phrase11149:
the transgenic mice 
dt - jj - nns - 
Phrase11150:
the lymphoid tissues 
dt - jj - nns - 
Phrase11151:
dramatic reduction 
jj - nn - 
Phrase11152:
the number 
dt - nn - 
Phrase11153:
the chimeric mice 
dt - jj - nns - 
Phrase11154:
the bone 
dt - nn - 
Phrase11155:
the effective site 
dt - jj - nn - 
Phrase11156:
specific depletion 
jj - nn - 
Phrase11157:
the b-cell 
dt - nn - 
Phrase11158:
transgenic bone 
jj - nn - 
Phrase11159:
marrow-derived stromal cell 
jj - jj - nn - 
Phrase11160:
an altered b-cell 
dt - jj - nn - 
Phrase11161:
mammalian homeodomain 
jj - nn - 
Phrase11162:
recurrent theme 
jj - nn - 
Phrase11163:
the regulation 
dt - nn - 
Phrase11164:
eukaryotic gene 
jj - nn - 
Phrase11165:
nuclear factor-1 
jj - nn - 
Phrase11166:
restricted tissue 
jj - nn - 
Phrase11167:
the formation 
dt - nn - 
Phrase11168:
stable tetrameric 
jj - nn - 
Phrase11169:
the dimerization 
dt - nn - 
Phrase11170:
the dna 
dt - nn - 
Phrase11171:
its 
prp$ - 
Phrase11172:
transcriptional activity 
jj - nn - 
Phrase11173:
transcriptional activation 
jj - nn - 
Phrase11174:
the gal4 
dt - nn - 
Phrase11175:
these results 
dt - nns - 
Phrase11176:
active tetrameric 
jj - nn - 
Phrase11177:
the developmental specificity 
dt - jj - nn - 
Phrase11178:
the complex 
dt - nn - 
Phrase11179:
chronic asthma 
jj - nn - 
Phrase11180:
peripheral blood 
jj - nn - 
Phrase11181:
asthmatic patients 
jj - nns - 
Phrase11182:
reversible airways 
jj - nns - 
Phrase11183:
the basis 
dt - nn - 
Phrase11184:
expiratory flow 
jj - nn - 
Phrase11185:
oral prednisolone 
jj - nn - 
Phrase11186:
the resistant patients 
dt - jj - nns - 
Phrase11187:
significant improvements 
jj - nn - 
Phrase11188:
-induced proliferation 
jj - nn - 
Phrase11189:
peripheral blood 
jj - nn - 
Phrase11190:
the resistant asthmatic patients 
dt - jj - jj - nns - 
Phrase11191:
the dose-response 
dt - nn - 
Phrase11192:
the asthmatic patients 
dt - jj - nns - 
Phrase11193:
significant correlation 
jj - nn - 
Phrase11194:
the degree 
dt - nn - 
Phrase11195:
the clinical responsiveness 
dt - jj - nn - 
Phrase11196:
resistant patients 
jj - nns - 
Phrase11197:
the clearance 
dt - nn - 
Phrase11198:
peripheral blood 
jj - nn - 
Phrase11199:
resistant patients 
jj - nns - 
Phrase11200:
the numbers 
dt - nns - 
Phrase11201:
these receptors 
dt - nns - 
Phrase11202:
the susceptibility 
dt - nn - 
Phrase11203:
these cells 
dt - nns - 
Phrase11204:
functional inhibition 
jj - nn - 
Phrase11205:
these results 
dt - nns - 
Phrase11206:
clinical glucocorticoid 
jj - nn - 
Phrase11207:
chronic asthma 
jj - nn - 
Phrase11208:
abnormal glucocorticoid 
jj - nn - 
Phrase11209:
due at 
jj - nn - 
Phrase11210:
cellular glucocorticoid 
jj - nn - 
Phrase11211:
ester-induced monocytic differentiation 
jj - jj - nn - 
Phrase11212:
previous studies 
jj - nns - 
Phrase11213:
monocytic differentiation 
jj - nn - 
Phrase11214:
the c-jun 
dt - nn - 
Phrase11215:
early response 
jj - nn - 
Phrase11216:
the present 
dt - nn - 
Phrase11217:
the glucocorticoid 
dt - nn - 
Phrase11218:
tpa-induced increases 
jj - nns - 
Phrase11219:
these findings 
dt - nns - 
Phrase11220:
the monocytic phenotype 
dt - jj - nn - 
Phrase11221:
tpa-induced increases 
jj - nns - 
Phrase11222:
other studies 
jj - nns - 
Phrase11223:
tpa-induced monocytic differentiation 
jj - jj - nn - 
Phrase11224:
the c-jun 
dt - nn - 
Phrase11225:
the finding 
dt - nn - 
Phrase11226:
tpa-induced activation 
jj - nn - 
Phrase11227:
this glucocorticoid 
dt - nn - 
Phrase11228:
this enzyme 
dt - nn - 
Phrase11229:
nuclear run-on assays 
jj - jj - nn - 
Phrase11230:
transcriptional mechanisms 
jj - nns - 
Phrase11231:
tpa-induced expression 
jj - nn - 
Phrase11232:
tpa-induced expression 
jj - nn - 
Phrase11233:
both genes 
dt - nns - 
Phrase11234:
the transcriptional level 
dt - jj - nn - 
Phrase11235:
the effects 
dt - nns - 
Phrase11236:
the molecular 
dt - nn - 
Phrase11237:
we 
prp - 
Phrase11238:
the chloramphenicol 
dt - nn - 
Phrase11239:
these constructs 
dt - nns - 
Phrase11240:
tpa-treated u-937 
jj - nn - 
Phrase11241:
the region 
dt - nn - 
Phrase11242:
the promoter 
dt - nn - 
Phrase11243:
the ap-1 
dt - nn - 
Phrase11244:
these findings 
dt - nns - 
Phrase11245:
tpa-induced transcription 
jj - nn - 
Phrase11246:
the c-jun 
dt - nn - 
Phrase11247:
monocytic differentiation 
jj - nn - 
Phrase11248:
the ap-1 
dt - nn - 
Phrase11249:
myelomonocytic cell 
jj - nn - 
Phrase11250:
transcriptional regulation 
jj - nn - 
Phrase11251:
the cytokine 
dt - nn - 
Phrase11252:
the pathologic signs 
dt - jj - nns - 
Phrase11253:
the current work 
dt - jj - nn - 
Phrase11254:
the regulation 
dt - nn - 
Phrase11255:
myelomonocytic cell 
jj - nn - 
Phrase11256:
the cell 
dt - nn - 
Phrase11257:
low level 
jj - nn - 
Phrase11258:
constitutive tnf 
jj - nn - 
Phrase11259:
steady state 
jj - nn - 
Phrase11260:
myelomonocytic cell 
jj - nn - 
Phrase11261:
an overall increase 
dt - jj - nn - 
Phrase11262:
the level 
dt - nn - 
Phrase11263:
the genomic tnf 
dt - jj - nn - 
Phrase11264:
hypersensitive site 
jj - nn - 
Phrase11265:
the tnf 
dt - nn - 
Phrase11266:
the transcription 
dt - nn - 
Phrase11267:
absent in 
jj - nn - 
Phrase11268:
nonexpressing erythroleukemia 
jj - nn - 
Phrase11269:
the dnase 
dt - nn - 
Phrase11270:
uninduced myelomonocytic cell 
jj - jj - nn - 
Phrase11271:
the pma 
dt - nn - 
Phrase11272:
other proteins 
jj - nns - 
Phrase11273:
the ap-1 
dt - nn - 
Phrase11274:
the nuclear extracts 
dt - jj - nns - 
Phrase11275:
the ap-1 
dt - nn - 
Phrase11276:
the tnf 
dt - nn - 
Phrase11277:
the level 
dt - nn - 
Phrase11278:
specific binding 
jj - nn - 
Phrase11279:
the resting 
dt - nn - 
Phrase11280:
the regulatory mechanisms 
dt - jj - nns - 
Phrase11281:
the human 
dt - nn - 
Phrase11282:
tight regulatory control 
jj - jj - nn - 
Phrase11283:
we 
prp - 
Phrase11284:
the replication 
dt - nn - 
Phrase11285:
peripheral blood 
jj - nn - 
Phrase11286:
unfractionated peripheral blood 
jj - jj - nn - 
Phrase11287:
potent regulators 
jj - nns - 
Phrase11288:
their 
prp$ - 
Phrase11289:
the 1,25(oh)2d3 
dt - nn - 
Phrase11290:
intracellular receptor 
jj - nn - 
Phrase11291:
this receptor 
dt - nn - 
Phrase11292:
these studies 
dt - nns - 
Phrase11293:
important implications 
jj - nns - 
Phrase11294:
the design 
dt - nn - 
Phrase11295:
effective therapy 
jj - nn - 
Phrase11296:
the switch 
dt - nn - 
Phrase11297:
the membrane 
dt - nn - 
Phrase11298:
the addition 
dt - nn - 
Phrase11299:
minimal effects 
jj - nns - 
Phrase11300:
other b 
jj - nn - 
Phrase11301:
internal labeling 
jj - nn - 
Phrase11302:
striking reduction 
jj - nn - 
Phrase11303:
the presence 
dt - nn - 
Phrase11304:
less pronounced reduction 
jjr - jj - nn - 
Phrase11305:
significant decrease 
jj - nn - 
Phrase11306:
steady state 
jj - nn - 
Phrase11307:
significant decrease 
jj - nn - 
Phrase11308:
the switch 
dt - nn - 
Phrase11309:
the membrane 
dt - nn - 
Phrase11310:
their 
prp$ - 
Phrase11311:
the presence 
dt - nn - 
Phrase11312:
nuclear run-on experiments 
jj - jj - nns - 
Phrase11313:
the effects 
dt - nns - 
Phrase11314:
transcriptional regulatory factors 
jj - jj - nn - 
Phrase11315:
nuclear factor 
jj - nn - 
Phrase11316:
important in 
jj - nn - 
Phrase11317:
both oct-2 
dt - nn - 
Phrase11318:
nuclear extracts 
jj - nns - 
Phrase11319:
the transcriptional factor 
dt - jj - nn - 
Phrase11320:
important in 
jj - nn - 
Phrase11321:
these findings 
dt - nns - 
Phrase11322:
the synthesis 
dt - nn - 
Phrase11323:
the switch 
dt - nn - 
Phrase11324:
the membrane 
dt - nn - 
Phrase11325:
the mechanism 
dt - nn - 
Phrase11326:
it 
prp - 
Phrase11327:
the binding 
dt - nn - 
Phrase11328:
their 
prp$ - 
Phrase11329:
respective target 
jj - nn - 
Phrase11330:
cis-regulatory element 
jj - nn - 
Phrase11331:
the human 
dt - nn - 
Phrase11332:
transcriptional activators 
jj - nns - 
Phrase11333:
these transcriptional activators 
dt - jj - nns - 
Phrase11334:
the members 
dt - nns - 
Phrase11335:
this multigene 
dt - nn - 
Phrase11336:
the t-lymphocyte 
dt - nn - 
Phrase11337:
striking degree 
jj - nn - 
Phrase11338:
similar patterns 
jj - nn - 
Phrase11339:
the murine 
dt - nn - 
Phrase11340:
tissue-specific gata-binding 
jj - nn - 
Phrase11341:
the human 
dt - nn - 
Phrase11342:
we 
prp - 
Phrase11343:
the murine 
dt - nn - 
Phrase11344:
t-cell-specific transcriptional regulation 
jj - jj - nn - 
Phrase11345:
the precursor 
dt - nn - 
Phrase11346:
the hiv-1 
dt - nn - 
Phrase11347:
acute infection 
jj - nn - 
Phrase11348:
the human 
dt - nn - 
Phrase11349:
cellular factors 
jj - nn - 
Phrase11350:
the induction 
dt - nn - 
Phrase11351:
the factor 
dt - nn - 
Phrase11352:
adjacent sites 
jj - nns - 
Phrase11353:
the hiv-1 
dt - nn - 
Phrase11354:
long terminal 
jj - nn - 
Phrase11355:
it 
prp - 
Phrase11356:
located in 
jj - nn - 
Phrase11357:
the nucleus 
dt - nn - 
Phrase11358:
mature b 
jj - nn - 
Phrase11359:
other cell 
jj - nn - 
Phrase11360:
an inactive cytoplasmic complex 
dt - jj - jj - nn - 
Phrase11361:
external stimuli 
jj - nns - 
Phrase11362:
nuclear translocation 
jj - nn - 
Phrase11363:
active nf-kappa 
jj - nn - 
Phrase11364:
the cloning 
dt - nn - 
Phrase11365:
the complementary dna 
dt - jj - nn - 
Phrase11366:
the 50k 
dt - nn - 
Phrase11367:
cytoplasmic 105k 
jj - nn - 
Phrase11368:
the expression 
dt - nn - 
Phrase11369:
active nf-kappa 
jj - nn - 
Phrase11370:
the extent 
dt - nn - 
Phrase11371:
active nf-kappa 
jj - nn - 
Phrase11372:
efficient transcription 
jj - nn - 
Phrase11373:
we 
prp - 
Phrase11374:
the effect 
dt - nn - 
Phrase11375:
the processing 
dt - nn - 
Phrase11376:
the human 
dt - nn - 
Phrase11377:
we 
prp - 
Phrase11378:
the hiv-1 
dt - nn - 
Phrase11379:
active nuclear nf-kappa 
jj - jj - nn - 
Phrase11380:
hematopoietic cells 
jj - nns - 
Phrase11381:
leukemic cells 
jj - nns - 
Phrase11382:
various lines 
jj - nns - 
Phrase11383:
these effects 
dt - nns - 
Phrase11384:
the 1,25(oh)2d3 
dt - nn - 
Phrase11385:
hematopoietic cells 
jj - nns - 
Phrase11386:
we 
prp - 
Phrase11387:
the expression 
dt - nn - 
Phrase11388:
nonproliferating hematopoietic cells 
jj - jj - nns - 
Phrase11389:
constitutive expression 
jj - nn - 
Phrase11390:
various kinds 
jj - nns - 
Phrase11391:
hematopoietic cells 
jj - nns - 
Phrase11392:
this group 
dt - nn - 
Phrase11393:
negligible levels 
jj - nns - 
Phrase11394:
somatic hybrid 
jj - nn - 
Phrase11395:
dominant characteristic 
jj - nn - 
Phrase11396:
its 
prp$ - 
Phrase11397:
the receptor 
dt - nn - 
Phrase11398:
high levels 
jj - nns - 
Phrase11399:
these hl-60 
dt - nn - 
Phrase11400:
the total 
dt - nn - 
Phrase11401:
normal at 
jj - nn - 
Phrase11402:
either granulocytes 
dt - nns - 
Phrase11403:
normal individuals 
jj - nns - 
Phrase11404:
peripheral blood 
jj - nn - 
Phrase11405:
normal individuals 
jj - nns - 
Phrase11406:
these cells 
dt - nns - 
Phrase11407:
the message 
dt - nn - 
Phrase11408:
this short t1/2 
dt - jj - nn - 
Phrase11409:
their 
prp$ - 
Phrase11410:
the physiologic role 
dt - jj - nn - 
Phrase11411:
peripheral-blood granulocytes 
jj - nns - 
Phrase11412:
we 
prp - 
Phrase11413:
peripheral-blood granulocytes 
jj - nns - 
Phrase11414:
significant levels 
jj - nns - 
Phrase11415:
functional activation 
jj - nn - 
Phrase11416:
the levels 
dt - nns - 
Phrase11417:
similar time 
jj - nn - 
Phrase11418:
their 
prp$ - 
Phrase11419:
maximal mrna 
jj - nn - 
Phrase11420:
these results 
dt - nns - 
Phrase11421:
the 29-kda proteins 
dt - jj - nns - 
Phrase11422:
the estrogen 
dt - nn - 
Phrase11423:
critical role 
jj - nn - 
Phrase11424:
cellular activation 
jj - nn - 
Phrase11425:
the phosphorylation 
dt - nn - 
Phrase11426:
multiple proteins 
jj - nns - 
Phrase11427:
we 
prp - 
Phrase11428:
several 29-kda proteins 
jj - jj - nns - 
Phrase11429:
intact human 
jj - nn - 
Phrase11430:
monoclonal antibody 
jj - nn - 
Phrase11431:
an unidentified estrogen 
dt - jj - nn - 
Phrase11432:
29-kda protein 
jj - nn - 
Phrase11433:
these proteins 
dt - nns - 
Phrase11434:
unphosphorylated 27-kda 
jj - nn - 
Phrase11435:
cellular activation 
jj - nn - 
Phrase11436:
marked shift 
jj - nn - 
Phrase11437:
the proportion 
dt - nn - 
Phrase11438:
the 27-kda 
dt - nn - 
Phrase11439:
unphosphorylated form 
jj - nn - 
Phrase11440:
the 29-kda phosphoprotein 
dt - jj - nn - 
Phrase11441:
this antibody 
dt - nn - 
Phrase11442:
we 
prp - 
Phrase11443:
the mammalian 27-kda 
dt - jj - nn - 
Phrase11444:
uncertain function 
jj - nn - 
Phrase11445:
several forms 
jj - nns - 
Phrase11446:
the 29-kda proteins 
dt - jj - nns - 
Phrase11447:
major 29-kda proteins 
jj - jj - nns - 
Phrase11448:
these data 
dt - nns - 
Phrase11449:
the signal 
dt - nn - 
Phrase11450:
the immunoglobulin 
dt - nn - 
Phrase11451:
3' enhancer 
jj - nn - 
Phrase11452:
the immunoglobulin 
dt - nn - 
Phrase11453:
we 
prp - 
Phrase11454:
the developmental control 
dt - jj - nn - 
Phrase11455:
3' enhancer 
jj - nn - 
Phrase11456:
the result 
dt - nn - 
Phrase11457:
the combined influence 
dt - jj - nn - 
Phrase11458:
we 
prp - 
Phrase11459:
central core 
jj - nn - 
Phrase11460:
the kappa 
dt - nn - 
Phrase11461:
active at 
jj - nn - 
Phrase11462:
the pre-b-cell 
dt - nn - 
Phrase11463:
flanking negative-acting 
jj - nn - 
Phrase11464:
the negative-acting 
dt - nn - 
Phrase11465:
orientation-independent manner 
jj - nn - 
Phrase11466:
the pre-b-cell 
dt - nn - 
Phrase11467:
we 
prp - 
Phrase11468:
the negative-acting 
dt - nn - 
Phrase11469:
the kappa 
dt - nn - 
Phrase11470:
the immunoglobulin 
dt - nn - 
Phrase11471:
the same gene 
dt - jj - nn - 
Phrase11472:
the yy-1 
dt - nn - 
Phrase11473:
the adeno-associated virus 
dt - jj - nn - 
Phrase11474:
the human 
dt - nn - 
Phrase11475:
the mouse 
dt - nn - 
Phrase11476:
ribosomal protein 
jj - nn - 
Phrase11477:
this protein 
dt - nn - 
Phrase11478:
transcriptional activators 
jj - nns - 
Phrase11479:
transcriptional repressors 
jj - nns - 
Phrase11480:
this cdna 
dt - nn - 
Phrase11481:
it 
prp - 
Phrase11482:
basal promoter 
jj - nn - 
Phrase11483:
the apparent dual function 
dt - jj - jj - nn - 
Phrase11484:
this protein 
dt - nn - 
Phrase11485:
putative lymphocyte 
jj - nn - 
Phrase11486:
small basic protein 
jj - jj - nn - 
Phrase11487:
the potential 
dt - nn - 
Phrase11488:
the g0/g1 
dt - nn - 
Phrase11489:
the lectin-induced 
dt - nn - 
Phrase11490:
the g0 
dt - nn - 
Phrase11491:
the g1 
dt - nn - 
Phrase11492:
the cell 
dt - nn - 
Phrase11493:
putative g0s 
jj - nn - 
Phrase11494:
the basis 
dt - nn - 
Phrase11495:
differential cdna 
jj - nn - 
Phrase11496:
the addition 
dt - nn - 
Phrase11497:
the corresponding genomic sequence 
dt - jj - jj - nn - 
Phrase11498:
small intron 
jj - nn - 
Phrase11499:
an open 
dt - nn - 
Phrase11500:
the second 
dt - nn - 
Phrase11501:
basic protein 
jj - nn - 
Phrase11502:
hydrophobic region 
jj - nn - 
Phrase11503:
the potential 
dt - nn - 
Phrase11504:
the g0/g1 
dt - nn - 
Phrase11505:
the protein 
dt - nn - 
Phrase11506:
the gene 
dt - nn - 
Phrase11507:
the germ 
dt - nn - 
Phrase11508:
upstream segment 
jj - nn - 
Phrase11509:
tandem dinucleotide 
jj - nn - 
Phrase11510:
located tata 
jj - nn - 
Phrase11511:
embedded in 
jj - nn - 
Phrase11512:
rapid transcriptional activation 
jj - jj - nn - 
Phrase11513:
the transcription 
dt - nn - 
Phrase11514:
the enhancer 
dt - nn - 
Phrase11515:
the human 
dt - nn - 
Phrase11516:
the hiv 
dt - nn - 
Phrase11517:
long terminal 
jj - nn - 
Phrase11518:
the hiv 
dt - nn - 
Phrase11519:
the hiv-tf1-binding 
dt - nn - 
Phrase11520:
the site 
dt - nn - 
Phrase11521:
upstream stimulatory factor 
jj - jj - nn - 
Phrase11522:
the adenovirus 
dt - nn - 
Phrase11523:
major late promoter 
jj - jj - nn - 
Phrase11524:
its 
prp$ - 
Phrase11525:
the disruption 
dt - nn - 
Phrase11526:
the level 
dt - nn - 
Phrase11527:
the hiv 
dt - nn - 
Phrase11528:
these results 
dt - nns - 
Phrase11529:
transcriptional regulation 
jj - nn - 
Phrase11530:
severe 5-fluorouracil 
jj - nn - 
Phrase11531:
this study 
dt - nn - 
Phrase11532:
the inheritance 
dt - nn - 
Phrase11533:
its 
prp$ - 
Phrase11534:
drug-induced toxicity 
jj - nn - 
Phrase11535:
adjuvant chemotherapy 
jj - nn - 
Phrase11536:
the study 
dt - nn - 
Phrase11537:
her 
prp$ - 
Phrase11538:
healthy volunteers 
jj - nns - 
Phrase11539:
the activity 
dt - nn - 
Phrase11540:
the initial enzyme 
dt - jj - nn - 
Phrase11541:
peripheral blood 
jj - nn - 
Phrase11542:
each subject 
dt - nn - 
Phrase11543:
specific radiometric 
jj - nn - 
Phrase11544:
the substrate 
dt - nn - 
Phrase11545:
the proband 
dt - nn - 
Phrase11546:
detectable dpd 
jj - nn - 
Phrase11547:
the proband 
dt - nn - 
Phrase11548:
an autosomal recessive pattern 
dt - jj - jj - nn - 
Phrase11549:
the third patient 
dt - jj - nn - 
Phrase11550:
severe fura 
jj - nn - 
Phrase11551:
an alteration 
dt - nn - 
Phrase11552:
the second 
dt - nn - 
Phrase11553:
our 
prp$ - 
Phrase11554:
the frequency 
dt - nn - 
Phrase11555:
this genetic defect 
dt - jj - nn - 
Phrase11556:
important in 
jj - nn - 
Phrase11557:
the management 
dt - nn - 
Phrase11558:
severe toxicity 
jj - nn - 
Phrase11559:
the human 
dt - nn - 
Phrase11560:
primary human 
jj - nn - 
Phrase11561:
the human 
dt - nn - 
Phrase11562:
cytopathic effects 
jj - nns - 
Phrase11563:
hiv-infected human 
jj - nn - 
Phrase11564:
the regions 
dt - nns - 
Phrase11565:
the hiv 
dt - nn - 
Phrase11566:
heterogeneous population 
jj - nn - 
Phrase11567:
primary human 
jj - nn - 
Phrase11568:
antigenic stimulation 
jj - nn - 
Phrase11569:
different strains 
jj - nns - 
Phrase11570:
the hiv 
dt - nn - 
Phrase11571:
the gs 
dt - nn - 
Phrase11572:
the promoter 
dt - nn - 
Phrase11573:
the z29 
dt - nn - 
Phrase11574:
genomic fragments 
jj - nns - 
Phrase11575:
the hiv 
dt - nn - 
Phrase11576:
the highest transactivating 
dt - jjs - nn - 
Phrase11577:
other dna 
jj - nn - 
Phrase11578:
lower activity 
jjr - nn - 
Phrase11579:
these clones 
dt - nns - 
Phrase11580:
the hiv 
dt - nn - 
Phrase11581:
the nf 
dt - nn - 
Phrase11582:
these data 
dt - nns - 
Phrase11583:
the nf 
dt - nn - 
Phrase11584:
the hiv 
dt - nn - 
Phrase11585:
its 
prp$ - 
Phrase11586:
primary t 
jj - nn - 
Phrase11587:
an increase 
dt - nn - 
Phrase11588:
the cytopathic effect 
dt - jj - nn - 
Phrase11589:
proviral dna 
jj - nn - 
Phrase11590:
the transcription 
dt - nn - 
Phrase11591:
hiv-1-infected individuals 
jj - nns - 
Phrase11592:
high levels 
jj - nns - 
Phrase11593:
low plasma 
jj - nn - 
Phrase11594:
we 
prp - 
Phrase11595:
the effects 
dt - nns - 
Phrase11596:
related thiols 
jj - nns - 
Phrase11597:
the experiments 
dt - nns - 
Phrase11598:
this report 
dt - nn - 
Phrase11599:
the intracellular glutathione 
dt - jj - nn - 
Phrase11600:
electrophoretic mobility 
jj - nn - 
Phrase11601:
uninfected cells 
jj - nns - 
Phrase11602:
the cysteine 
dt - nn - 
Phrase11603:
hiv-1-infected individuals 
jj - nns - 
Phrase11604:
an over-expression 
dt - nn - 
Phrase11605:
b-dependent genes 
jj - nns - 
Phrase11606:
the treatment 
dt - nn - 
Phrase11607:
hiv-1-infected individuals 
jj - nns - 
Phrase11608:
the hmg 
dt - nn - 
Phrase11609:
the human 
dt - nn - 
Phrase11610:
the human 
dt - nn - 
Phrase11611:
cell-specific transcription 
jj - nn - 
Phrase11612:
key role 
jj - nn - 
Phrase11613:
the tissue-specific activation 
dt - jj - nn - 
Phrase11614:
the t 
dt - nn - 
Phrase11615:
pyrimidine-rich elements 
jj - nns - 
Phrase11616:
other t 
jj - nn - 
Phrase11617:
cell-specific control 
jj - nn - 
Phrase11618:
the dna 
dt - nn - 
Phrase11619:
we 
prp - 
Phrase11620:
the tcf-1 
dt - nn - 
Phrase11621:
single 68-amino-acid 
jj - nn - 
Phrase11622:
the single hmg 
dt - jj - nn - 
Phrase11623:
the sequence-specific binding 
dt - jj - nn - 
Phrase11624:
the thymus 
dt - nn - 
Phrase11625:
the immature cem 
dt - jj - nn - 
Phrase11626:
low levels 
jj - nns - 
Phrase11627:
these cells 
dt - nns - 
Phrase11628:
transcriptional activator 
jj - nn - 
Phrase11629:
the human 
dt - nn - 
Phrase11630:
nonlymphoid cell 
jj - nn - 
Phrase11631:
the activity 
dt - nn - 
Phrase11632:
the endogenous protein 
dt - jj - nn - 
Phrase11633:
an additional t 
dt - jj - nn - 
Phrase11634:
cell-specific protein 
jj - nn - 
Phrase11635:
the core 
dt - nn - 
Phrase11636:
regulatory proteins 
jj - nns - 
Phrase11637:
the hmg 
dt - nn - 
Phrase11638:
it 
prp - 
Phrase11639:
tissue-specific rna 
jj - nn - 
Phrase11640:
novel hiv-1 
jj - nn - 
Phrase11641:
the nf-kappa 
dt - nn - 
Phrase11642:
single isolate 
jj - nn - 
Phrase11643:
distinct replicative 
jj - nn - 
Phrase11644:
cytopathic properties 
jj - nns - 
Phrase11645:
the phenotypic differences 
dt - jj - nns - 
Phrase11646:
large part 
jj - nn - 
Phrase11647:
the viral ltr 
dt - jj - nn - 
Phrase11648:
the presence 
dt - nn - 
Phrase11649:
novel duplications 
jj - nn - 
Phrase11650:
the nf-kappa 
dt - nn - 
Phrase11651:
these changes 
dt - nns - 
Phrase11652:
the enhancer 
dt - nn - 
Phrase11653:
the original al1 
dt - jj - nn - 
Phrase11654:
the variant 
dt - nn - 
Phrase11655:
ltr-driven cat 
jj - nn - 
Phrase11656:
multiple oct2 
jj - nn - 
Phrase11657:
the interaction 
dt - nn - 
Phrase11658:
the oct2 
dt - nn - 
Phrase11659:
the cognate 
dt - nn - 
Phrase11660:
critical determinant 
jj - nn - 
Phrase11661:
the lymphoid-specific expression 
dt - jj - nn - 
Phrase11662:
ectopic expression 
jj - nn - 
Phrase11663:
least aspects 
jjs - nns - 
Phrase11664:
this regulation 
dt - nn - 
Phrase11665:
non-lymphoid cells 
jj - nns - 
Phrase11666:
we 
prp - 
Phrase11667:
the isolation 
dt - nn - 
Phrase11668:
multiple cdnas 
jj - nns - 
Phrase11669:
mature b-cell 
jj - nn - 
Phrase11670:
we 
prp - 
Phrase11671:
this transcription 
dt - nn - 
Phrase11672:
single gene 
jj - nn - 
Phrase11673:
an alternative 
dt - nn - 
Phrase11674:
the isoforms 
dt - nns - 
Phrase11675:
the octamer 
dt - nn - 
Phrase11676:
different amounts 
jj - nns - 
Phrase11677:
the various isoforms 
dt - jj - nns - 
Phrase11678:
the same b-cell 
dt - jj - nn - 
Phrase11679:
the developmental stage 
dt - jj - nn - 
Phrase11680:
the isoforms 
dt - nns - 
Phrase11681:
we 
prp - 
Phrase11682:
the isoforms 
dt - nns - 
Phrase11683:
an octamer 
dt - nn - 
Phrase11684:
an unexpected functional redundancy 
dt - jj - jj - nn - 
Phrase11685:
we 
prp - 
Phrase11686:
the isoforms 
dt - nns - 
Phrase11687:
lymphoid-specific oct2b 
jj - nn - 
Phrase11688:
the function 
dt - nn - 
Phrase11689:
the octamer 
dt - nn - 
Phrase11690:
the context 
dt - nn - 
Phrase11691:
the immunoglobulin 
dt - nn - 
Phrase11692:
intracellular cholesterol 
jj - nn - 
Phrase11693:
the rate 
dt - nn - 
Phrase11694:
endogenous cholesterol 
jj - nn - 
Phrase11695:
healthy donors 
jj - nns - 
Phrase11696:
the cells 
dt - nns - 
Phrase11697:
partial loss 
jj - nn - 
Phrase11698:
their 
prp$ - 
Phrase11699:
homozygous type 
jj - nn - 
Phrase11700:
the number 
dt - nn - 
Phrase11701:
their 
prp$ - 
Phrase11702:
normal cells 
jj - nns - 
Phrase11703:
the decrease 
dt - nn - 
Phrase11704:
the number 
dt - nn - 
Phrase11705:
endogenous cholesterol 
jj - nn - 
Phrase11706:
negative regulation 
jj - nn - 
Phrase11707:
the 65-kda 
dt - nn - 
Phrase11708:
monocytic cells 
jj - nns - 
Phrase11709:
viral production 
jj - nn - 
Phrase11710:
their 
prp$ - 
Phrase11711:
these differences 
dt - nns - 
Phrase11712:
restricted hiv 
jj - nn - 
Phrase11713:
an absence 
dt - nn - 
Phrase11714:
the hiv-1 
dt - nn - 
Phrase11715:
viral rna 
jj - nn - 
Phrase11716:
the nf-kappa 
dt - nn - 
Phrase11717:
the hiv-1 
dt - nn - 
Phrase11718:
the 65-kda 
dt - nn - 
Phrase11719:
nuclear extracts 
jj - nns - 
Phrase11720:
restricted expression 
jj - nn - 
Phrase11721:
this lack 
dt - nn - 
Phrase11722:
these nuclear extracts 
dt - jj - nns - 
Phrase11723:
their 
prp$ - 
Phrase11724:
the heterodimer 
dt - nn - 
Phrase11725:
the presence 
dt - nn - 
Phrase11726:
an inhibitor 
dt - nn - 
Phrase11727:
nuclear extracts 
jj - nns - 
Phrase11728:
these cells 
dt - nns - 
Phrase11729:
restricted expression 
jj - nn - 
Phrase11730:
viral production 
jj - nn - 
Phrase11731:
optimal viral transcription 
jj - jj - nn - 
Phrase11732:
the 65-kda 
dt - nn - 
Phrase11733:
the hiv-1 
dt - nn - 
Phrase11734:
normal leukocytes 
jj - nns - 
Phrase11735:
we 
prp - 
Phrase11736:
peripheral blood 
jj - nn - 
Phrase11737:
healthy volunteers 
jj - nns - 
Phrase11738:
age-related decrease 
jj - nn - 
Phrase11739:
the number 
dt - nn - 
Phrase11740:
elderly subjects 
jj - nns - 
Phrase11741:
apparent seasonal 
jj - nn - 
Phrase11742:
the number 
dt - nn - 
Phrase11743:
fewer gr 
jjr - nn - 
Phrase11744:
the number 
dt - nn - 
Phrase11745:
their 
prp$ - 
Phrase11746:
the number 
dt - nn - 
Phrase11747:
these patients 
dt - nns - 
Phrase11748:
the initiation 
dt - nn - 
Phrase11749:
normal subjects 
jj - nns - 
Phrase11750:
the gr 
dt - nn - 
Phrase11751:
distinct elements 
jj - nns - 
Phrase11752:
the htlv-i 
dt - nn - 
Phrase11753:
the trans-activator 
dt - nn - 
Phrase11754:
we 
prp - 
Phrase11755:
functional studies 
jj - nns - 
Phrase11756:
the enhancer 
dt - nn - 
Phrase11757:
the human 
dt - nn - 
Phrase11758:
the proviral genome 
dt - jj - nn - 
Phrase11759:
distinct elements 
jj - nns - 
Phrase11760:
the htlv-i 
dt - nn - 
Phrase11761:
the 21-base-pair 
dt - nn - 
Phrase11762:
the htlv-i 
dt - nn - 
Phrase11763:
the ability 
dt - nn - 
Phrase11764:
responsive element 
jj - nn - 
Phrase11765:
-like factor 
jj - nn - 
Phrase11766:
the 21-bp elements 
dt - jj - nns - 
Phrase11767:
this study 
dt - nn - 
Phrase11768:
we 
prp - 
Phrase11769:
the region 
dt - nn - 
Phrase11770:
the 21-bp elements 
dt - jj - nns - 
Phrase11771:
an nf-kappa 
dt - nn - 
Phrase11772:
b-like nuclear factor 
jj - jj - nn - 
Phrase11773:
the protein-dna complex 
dt - jj - nn - 
Phrase11774:
the c26 
dt - nn - 
Phrase11775:
the c26 
dt - nn - 
Phrase11776:
partial responsiveness 
jj - nn - 
Phrase11777:
the 21-bp element 
dt - jj - nn - 
Phrase11778:
itself 
prp - 
Phrase11779:
little activation 
jj - nn - 
Phrase11780:
the c26 
dt - nn - 
Phrase11781:
other nf-kappa 
jj - nn - 
Phrase11782:
the c26 
dt - nn - 
Phrase11783:
itself 
prp - 
Phrase11784:
these findings 
dt - nns - 
Phrase11785:
the htlv-i 
dt - nn - 
Phrase11786:
multiple functional elements 
jj - jj - nns - 
Phrase11787:
least creb- 
jjs - nn - 
Phrase11788:
b-like factors 
jj - nn - 
Phrase11789:
the htlv-i 
dt - nn - 
Phrase11790:
our 
prp$ - 
Phrase11791:
the htlv-i 
dt - nn - 
Phrase11792:
the c26 
dt - nn - 
Phrase11793:
the minimal region 
dt - jj - nn - 
Phrase11794:
the human 
dt - nn - 
Phrase11795:
its 
prp$ - 
Phrase11796:
transcriptional induction 
jj - nn - 
Phrase11797:
the gene 
dt - nn - 
Phrase11798:
transcriptional start 
jj - nn - 
Phrase11799:
these sequences 
dt - nns - 
Phrase11800:
the gene 
dt - nn - 
Phrase11801:
significant differences 
jj - nns - 
Phrase11802:
the sequence 
dt - nn - 
Phrase11803:
the tnf-alpha 
dt - nn - 
Phrase11804:
the transcription 
dt - nn - 
Phrase11805:
lymphoid nuclear extracts 
jj - jj - nns - 
Phrase11806:
different t 
jj - nn - 
Phrase11807:
the tnf-alpha 
dt - nn - 
Phrase11808:
little effect 
jj - nn - 
Phrase11809:
the gene 
dt - nn - 
Phrase11810:
its 
prp$ - 
Phrase11811:
other sequences 
jj - nns - 
Phrase11812:
heterologous promoter 
jj - nn - 
Phrase11813:
they 
prp - 
Phrase11814:
the pma 
dt - nn - 
Phrase11815:
inducible function 
jj - nn - 
Phrase11816:
these nf-kappa 
dt - nn - 
Phrase11817:
differentiation-associated expression 
jj - nn - 
Phrase11818:
the epstein-barr virus 
dt - jj - nn - 
Phrase11819:
oral hairy leukoplakia 
jj - jj - nn - 
Phrase11820:
the bzlf1 
dt - nn - 
Phrase11821:
epstein-barr virus 
jj - nn - 
Phrase11822:
key immediate-early protein 
jj - jj - nn - 
Phrase11823:
ebv-infected b 
jj - nn - 
Phrase11824:
we 
prp - 
Phrase11825:
monoclonal antibody 
jj - nn - 
Phrase11826:
dimeric form 
jj - nn - 
Phrase11827:
monomeric form 
jj - nn - 
Phrase11828:
the protein 
dt - nn - 
Phrase11829:
oral hairy leukoplakia 
jj - jj - nn - 
Phrase11830:
an aids-associated 
dt - nn - 
Phrase11831:
high-level ebv 
jj - nn - 
Phrase11832:
the bz1 
dt - nn - 
Phrase11833:
monoclonal antibody 
jj - nn - 
Phrase11834:
differentiation-associated pattern 
jj - nn - 
Phrase11835:
the upper 
dt - nn - 
Phrase11836:
the lesion 
dt - nn - 
Phrase11837:
the bzlf1 
dt - nn - 
Phrase11838:
the degree 
dt - nn - 
Phrase11839:
squamous differentiation 
jj - nn - 
Phrase11840:
viral capsid 
jj - nn - 
Phrase11841:
rampant virus 
dt - nn - 
Phrase11842:
the inability 
dt - nn - 
Phrase11843:
the lower epithelial 
dt - jjr - nn - 
Phrase11844:
oral hairy leukoplakia 
jj - jj - nn - 
Phrase11845:
the nature 
dt - nn - 
Phrase11846:
squamous epithelium 
jj - nn - 
Phrase11847:
menopausal type 
jj - nn - 
Phrase11848:
its 
prp$ - 
Phrase11849:
the number 
dt - nn - 
Phrase11850:
peripheral leucocytes 
jj - nns - 
Phrase11851:
menopausal type 
jj - nn - 
Phrase11852:
the results 
dt - nns - 
Phrase11853:
menopausal women 
jj - nns - 
Phrase11854:
normal women 
jj - nns - 
Phrase11855:
it 
prp - 
Phrase11856:
the number 
dt - nn - 
Phrase11857:
the patients 
dt - nns - 
Phrase11858:
our 
prp$ - 
Phrase11859:
the pathogenesis 
dt - nn - 
Phrase11860:
menopausal period 
jj - nn - 
Phrase11861:
the authors 
dt - nns - 
Phrase11862:
the possibility 
dt - nn - 
Phrase11863:
the dysregulation 
dt - nn - 
Phrase11864:
they 
prp - 
Phrase11865:
the number 
dt - nn - 
Phrase11866:
cytosolic glucocorticoid 
jj - nn - 
Phrase11867:
normal comparison 
jj - nn - 
Phrase11868:
both patients 
dt - nns - 
Phrase11869:
the normal comparison 
dt - jj - nn - 
Phrase11870:
the normal diurnal 
dt - jj - nn - 
Phrase11871:
the number 
dt - nn - 
Phrase11872:
greater in 
jjr - nn - 
Phrase11873:
the morning 
dt - nn - 
Phrase11874:
greater in 
jjr - nn - 
Phrase11875:
the afternoon 
dt - nn - 
Phrase11876:
the patients 
dt - nns - 
Phrase11877:
the normal subjects 
dt - jj - nns - 
Phrase11878:
the number 
dt - nn - 
Phrase11879:
these results 
dt - nns - 
Phrase11880:
the hpa 
dt - nn - 
Phrase11881:
the finding 
dt - nn - 
Phrase11882:
greater number 
jjr - nn - 
Phrase11883:
normal comparison 
jj - nn - 
Phrase11884:
the authors 
dt - nns - 
Phrase11885:
previous observations 
jj - nns - 
Phrase11886:
low 24-hour urinary cortisol 
jj - jj - jj - nn - 
Phrase11887:
the receptor 
dt - nn - 
Phrase11888:
major depressive disorder 
jj - jj - nn - 
Phrase11889:
the present 
dt - nn - 
Phrase11890:
other findings 
jj - nns - 
Phrase11891:
the possibility 
dt - nn - 
Phrase11892:
greater negative feedback 
jjr - jj - nn - 
Phrase11893:
the hpa 
dt - nn - 
Phrase11894:
the monocyte-macrophage lineage 
dt - jj - nn - 
Phrase11895:
important targets 
jj - nns - 
Phrase11896:
we 
prp - 
Phrase11897:
the phenotypic differentiation 
dt - jj - nn - 
Phrase11898:
nuclear factor 
jj - nn - 
Phrase11899:
such differentiation 
jj - nn - 
Phrase11900:
an hiv 
dt - nn - 
Phrase11901:
long terminal 
jj - nn - 
Phrase11902:
such cells 
jj - nns - 
Phrase11903:
the influence 
dt - nn - 
Phrase11904:
a process 
dt - nn - 
Phrase11905:
fundamental implications 
jj - nns - 
Phrase11906:
important in 
jj - nn - 
Phrase11907:
single tumor 
jj - nn - 
Phrase11908:
pleural effusions 
jj - nn - 
Phrase11909:
we 
prp - 
Phrase11910:
the demonstration 
dt - nn - 
Phrase11911:
the nucleus 
dt - nn - 
Phrase11912:
white blood 
jj - nn - 
Phrase11913:
single tumor 
jj - nn - 
Phrase11914:
malignant effusions 
jj - nn - 
Phrase11915:
the antibodies 
dt - nns - 
Phrase11916:
nucleolar staining 
jj - nn - 
Phrase11917:
malignant lymphomas 
jj - nns - 
Phrase11918:
identical reaction 
jj - nn - 
Phrase11919:
malignant effusions 
jj - nn - 
Phrase11920:
the blood 
dt - nn - 
Phrase11921:
leukemic spread 
jj - nn - 
Phrase11922:
low malignancy 
jj - nn - 
Phrase11923:
weak staining 
jj - nn - 
Phrase11924:
normal mesothelial 
jj - nn - 
Phrase11925:
the detection 
dt - nn - 
Phrase11926:
the cell 
dt - nn - 
Phrase11927:
the same assay 
dt - jj - nn - 
Phrase11928:
the reaction 
dt - nn - 
Phrase11929:
the tumor 
dt - nn - 
Phrase11930:
pleural effusions 
jj - nn - 
Phrase11931:
positive in 
jj - nn - 
Phrase11932:
positive in 
jj - nn - 
Phrase11933:
divergent reaction 
jj - nn - 
Phrase11934:
the hormone 
dt - nn - 
Phrase11935:
the primary tumor 
dt - jj - nn - 
Phrase11936:
each cohort 
dt - nn - 
Phrase11937:
negative reaction 
jj - nn - 
Phrase11938:
the primary tumor 
dt - jj - nn - 
Phrase11939:
positive reaction 
jj - nn - 
Phrase11940:
the pleural effusions 
dt - jj - nn - 
Phrase11941:
these results 
dt - nns - 
Phrase11942:
the demonstration 
dt - nn - 
Phrase11943:
malignant effusions 
jj - nn - 
Phrase11944:
the status 
dt - nn - 
Phrase11945:
the primary site 
dt - jj - nn - 
Phrase11946:
constitutive activation 
jj - nn - 
Phrase11947:
eukaryotic transcription 
jj - nn - 
Phrase11948:
regulatory factor 
jj - nn - 
Phrase11949:
cytoplasmic proteic 
jj - nn - 
Phrase11950:
the ikb 
dt - nn - 
Phrase11951:
nuclear translocation 
jj - nn - 
Phrase11952:
the subsequent expression 
dt - jj - nn - 
Phrase11953:
dependent t 
jj - nn - 
Phrase11954:
we 
prp - 
Phrase11955:
the activation 
dt - nn - 
Phrase11956:
thymic progenitors 
jj - nns - 
Phrase11957:
we 
prp - 
Phrase11958:
mature t 
jj - nn - 
Phrase11959:
our 
prp$ - 
Phrase11960:
active form 
jj - nn - 
Phrase11961:
they 
prp - 
Phrase11962:
cell-specific transcription 
jj - nn - 
Phrase11963:
the hmg 
dt - nn - 
Phrase11964:
the tcr 
dt - nn - 
Phrase11965:
we 
prp - 
Phrase11966:
cell-specific transcription 
jj - nn - 
Phrase11967:
the aacaaag 
dt - nn - 
Phrase11968:
the cd3 
dt - nn - 
Phrase11969:
the ttcaaag 
dt - nn - 
Phrase11970:
the tcr 
dt - nn - 
Phrase11971:
the family 
dt - nn - 
Phrase11972:
the hmg-box 
dt - nn - 
Phrase11973:
we 
prp - 
Phrase11974:
the t 
dt - nn - 
Phrase11975:
the tcr 
dt - nn - 
Phrase11976:
the t 
dt - nn - 
Phrase11977:
the tcr 
dt - nn - 
Phrase11978:
the sequences 
dt - nns - 
Phrase11979:
these observations 
dt - nns - 
Phrase11980:
the control 
dt - nn - 
Phrase11981:
several t 
jj - nn - 
Phrase11982:
cell-specific genes 
jj - nns - 
Phrase11983:
an important role 
dt - jj - nn - 
Phrase11984:
the establishment 
dt - nn - 
Phrase11985:
the mature t 
dt - jj - nn - 
Phrase11986:
regulatory effect 
jj - nn - 
Phrase11987:
peripheral leukocytes 
jj - nns - 
Phrase11988:
the regulatory effect 
dt - jj - nn - 
Phrase11989:
the specific binding 
dt - jj - nn - 
Phrase11990:
the unoccupied receptor 
dt - jj - nn - 
Phrase11991:
various concentrations 
jj - nns - 
Phrase11992:
the medium 
dt - nn - 
Phrase11993:
the specific binding 
dt - jj - nn - 
Phrase11994:
the control 
dt - nn - 
Phrase11995:
the absence 
dt - nn - 
Phrase11996:
the presence 
dt - nn - 
Phrase11997:
physiological testing 
jj - nn - 
Phrase11998:
physiological upper 
jj - nn - 
Phrase11999:
pharmacological concentration 
jj - nn - 
Phrase12000:
the incubation 
dt - nn - 
Phrase12001:
the decrease 
dt - nn - 
Phrase12002:
these values 
dt - nns - 
Phrase12003:
the inhibitory effect 
dt - jj - nn - 
Phrase12004:
the gr 
dt - nn - 
Phrase12005:
both dose- 
dt - nn - 
Phrase12006:
physiological conditions 
jj - nns - 
Phrase12007:
the effect 
dt - nn - 
Phrase12008:
the number 
dt - nn - 
Phrase12009:
-secreting cells 
jj - nns - 
Phrase12010:
-stimulated lymphocyte 
jj - nn - 
Phrase12011:
similar enhancement 
jj - nn - 
Phrase12012:
this study 
dt - nn - 
Phrase12013:
the effect 
dt - nn - 
Phrase12014:
the therapy 
dt - nn - 
Phrase12015:
unexpected finding 
jj - nn - 
Phrase12016:
the ig 
dt - nn - 
Phrase12017:
the follow-up 
dt - nn - 
Phrase12018:
the therapy 
dt - nn - 
Phrase12019:
those who 
dt - nn - 
Phrase12020:
erythroid 5-aminolevulinate 
jj - nn - 
Phrase12021:
an iron-responsive 
dt - nn - 
Phrase12022:
the mrna 
dt - nn - 
Phrase12023:
the first step 
dt - jj - nn - 
Phrase12024:
the heme 
dt - nn - 
Phrase12025:
the human 
dt - nn - 
Phrase12026:
erythroid alas 
jj - nn - 
Phrase12027:
fetal liver 
jj - nn - 
Phrase12028:
it 
prp - 
Phrase12029:
the erythroid alas 
dt - jj - nn - 
Phrase12030:
similar in 
jj - nn - 
Phrase12031:
housekeeping alas 
jj - nn - 
Phrase12032:
the mature mitochondrial forms 
dt - jj - jj - nns - 
Phrase12033:
housekeeping alas 
jj - nn - 
Phrase12034:
little amino 
jj - nn - 
Phrase12035:
their 
prp$ - 
Phrase12036:
n-terminal signal 
jj - nn - 
Phrase12037:
considerable sequence 
jj - nn - 
Phrase12038:
the c-terminal two-thirds 
dt - jj - nn - 
Phrase12039:
their 
prp$ - 
Phrase12040:
the immediate promoter 
dt - jj - nn - 
Phrase12041:
the human 
dt - nn - 
Phrase12042:
erythroid alas 
jj - nn - 
Phrase12043:
several putative erythroid-specific cis-acting elements 
jj - jj - jj - jj - nns - 
Phrase12044:
both a 
dt - nn - 
Phrase12045:
an nf-e2 
dt - nn - 
Phrase12046:
the 5'-untranslated region 
dt - jj - nn - 
Phrase12047:
the human 
dt - nn - 
Phrase12048:
erythroid alas 
jj - nn - 
Phrase12049:
the housekeeping alas 
dt - jj - nn - 
Phrase12050:
this ire 
dt - nn - 
Phrase12051:
cytosolic extracts 
jj - nns - 
Phrase12052:
this binding 
dt - nn - 
Phrase12053:
the alas 
dt - nn - 
Phrase12054:
the ire 
dt - nn - 
Phrase12055:
this protein - rna 
dt - nn - 
Phrase12056:
these results 
dt - nns - 
Phrase12057:
the ire 
dt - nn - 
Phrase12058:
the alas 
dt - nn - 
Phrase12059:
the mrna 
dt - nn - 
Phrase12060:
cellular iron 
jj - nn - 
Phrase12061:
the macrophage 
dt - nn - 
Phrase12062:
colony-stimulating factor 
jj - nn - 
Phrase12063:
the macrophage 
dt - nn - 
Phrase12064:
colony-stimulating factor 
jj - nn - 
Phrase12065:
the growth 
dt - nn - 
Phrase12066:
the signaling 
dt - nn - 
Phrase12067:
these effects 
dt - nns - 
Phrase12068:
the present 
dt - nn - 
Phrase12069:
the effects 
dt - nns - 
Phrase12070:
the jun 
dt - nn - 
Phrase12071:
early response 
jj - nn - 
Phrase12072:
low levels 
jj - nns - 
Phrase12073:
detectable in 
jj - nn - 
Phrase12074:
peripheral blood 
jj - nn - 
Phrase12075:
these cells 
dt - nns - 
Phrase12076:
nuclear run-on assays 
jj - jj - nn - 
Phrase12077:
both increase 
dt - nn - 
Phrase12078:
the half-life 
dt - nn - 
Phrase12079:
rapid induction 
jj - nn - 
Phrase12080:
the jun-b 
dt - nn - 
Phrase12081:
this gene 
dt - nn - 
Phrase12082:
we 
prp - 
Phrase12083:
posttranscriptional levels 
jj - nns - 
Phrase12084:
maximal induction 
jj - nn - 
Phrase12085:
the c-fos 
dt - nn - 
Phrase12086:
the fos-b 
dt - nn - 
Phrase12087:
the fos-related gene 
dt - jj - nn - 
Phrase12088:
both c-fos 
dt - nn - 
Phrase12089:
the results 
dt - nns - 
Phrase12090:
differential activation 
jj - nn - 
Phrase12091:
multiple members 
jj - nns - 
Phrase12092:
the jun/fos 
dt - nn - 
Phrase12093:
these genes 
dt - nns - 
Phrase12094:
nuclear signaling 
jj - nn - 
Phrase12095:
specific program 
jj - nn - 
Phrase12096:
systemic lupus 
jj - nn - 
Phrase12097:
the major treatment 
dt - jj - nn - 
Phrase12098:
systemic lupus 
jj - nn - 
Phrase12099:
their 
prp$ - 
Phrase12100:
the past 
dt - nn - 
Phrase12101:
it 
prp - 
Phrase12102:
significant role 
jj - nn - 
Phrase12103:
the mechanism 
dt - nn - 
Phrase12104:
we 
prp - 
Phrase12105:
peripheral blood 
jj - nn - 
Phrase12106:
the glucocorticosteroid 
dt - nn - 
Phrase12107:
healthy controls 
jj - nns - 
Phrase12108:
the sle 
dt - nn - 
Phrase12109:
healthy controls 
jj - nns - 
Phrase12110:
the binding 
dt - nn - 
Phrase12111:
an il-2 
dt - nn - 
Phrase12112:
the il-2 
dt - nn - 
Phrase12113:
the il-2-r 
dt - nn - 
Phrase12114:
normal t 
jj - nn - 
Phrase12115:
the human 
dt - nn - 
Phrase12116:
we 
prp - 
Phrase12117:
its 
prp$ - 
Phrase12118:
the autocrine 
dt - nn - 
Phrase12119:
this t 
dt - nn - 
Phrase12120:
high affinity 
jj - nn - 
Phrase12121:
the molecular 
dt - nn - 
Phrase12122:
the unusual persistent expression 
dt - jj - jj - nn - 
Phrase12123:
the il-2 
dt - nn - 
Phrase12124:
these iarc 
dt - nn - 
Phrase12125:
we 
prp - 
Phrase12126:
the interactions 
dt - nns - 
Phrase12127:
nuclear proteins 
jj - nns - 
Phrase12128:
the 5' 
dt - nn - 
Phrase12129:
flanking regions 
jj - nns - 
Phrase12130:
the il-2 
dt - nn - 
Phrase12131:
both dnase 
dt - nn - 
Phrase12132:
we 
prp - 
Phrase12133:
nuclear proteins 
jj - nns - 
Phrase12134:
this finding 
dt - nn - 
Phrase12135:
the il-2 
dt - nn - 
Phrase12136:
active in 
jj - nn - 
Phrase12137:
the kappa 
dt - nn - 
Phrase12138:
both promoters 
dt - nns - 
Phrase12139:
the kappa 
dt - nn - 
Phrase12140:
they 
prp - 
Phrase12141:
the kappa 
dt - nn - 
Phrase12142:
different relative 
jj - nn - 
Phrase12143:
their 
prp$ - 
Phrase12144:
different contribution 
jj - nn - 
Phrase12145:
the expression 
dt - nn - 
Phrase12146:
various promoters 
jj - nns - 
Phrase12147:
we 
prp - 
Phrase12148:
electrophoretic mobility 
jj - nn - 
Phrase12149:
different factors 
jj - nn - 
Phrase12150:
the kb-enhancer 
dt - nn - 
Phrase12151:
nuclear extracts 
jj - nns - 
Phrase12152:
the b2 
dt - nn - 
Phrase12153:
the nuclei 
dt - nns - 
Phrase12154:
these cells 
dt - nns - 
Phrase12155:
the b3 
dt - nn - 
Phrase12156:
evident in 
jj - nn - 
Phrase12157:
uninfected cells 
jj - nns - 
Phrase12158:
detectable in 
jj - nn - 
Phrase12159:
infected monocytes 
jj - nns - 
Phrase12160:
its 
prp$ - 
Phrase12161:
low in 
jj - nn - 
Phrase12162:
this paper 
dt - nn - 
Phrase12163:
we 
prp - 
Phrase12164:
the b2 
dt - nn - 
Phrase12165:
the cytosol 
dt - nn - 
Phrase12166:
it 
prp - 
Phrase12167:
an inhibitor 
dt - nn - 
Phrase12168:
the cytosol 
dt - nn - 
Phrase12169:
the nuclei 
dt - nns - 
Phrase12170:
the b3 
dt - nn - 
Phrase12171:
the cytosol 
dt - nn - 
Phrase12172:
the role 
dt - nn - 
Phrase12173:
the expression 
dt - nn - 
Phrase12174:
the translocation 
dt - nn - 
Phrase12175:
these factors 
dt - nn - 
Phrase12176:
lymphocyte-specific transcription 
jj - nn - 
Phrase12177:
sequence-specific hmg 
jj - nn - 
Phrase12178:
downstream t 
jj - nn - 
Phrase12179:
lymphocyte-specific enhancer 
jj - nn - 
Phrase12180:
we 
prp - 
Phrase12181:
the identification 
dt - nn - 
Phrase12182:
cell-specific transcription 
jj - nn - 
Phrase12183:
this element 
dt - nn - 
Phrase12184:
the multimerized recognition 
dt - jj - nn - 
Phrase12185:
cell-specific enhancer 
jj - nn - 
Phrase12186:
subsequent cloning 
jj - nn - 
Phrase12187:
single dna-binding 
jj - nn - 
Phrase12188:
similar boxes 
jj - nns - 
Phrase12189:
the putative mammalian sex-determining gene 
dt - jj - jj - jj - nn - 
Phrase12190:
the schizosaccharomyces 
dt - nn - 
Phrase12191:
its 
prp$ - 
Phrase12192:
these results 
dt - nns - 
Phrase12193:
cell-specific transcription 
jj - nn - 
Phrase12194:
the establishment 
dt - nn - 
Phrase12195:
the mature t 
dt - jj - nn - 
Phrase12196:
transcriptional suppressor 
jj - nn - 
Phrase12197:
the negative regulatory element 
dt - jj - jj - nn - 
Phrase12198:
the human 
dt - nn - 
Phrase12199:
different proteins 
jj - nns - 
Phrase12200:
neighboring sequences 
jj - nns - 
Phrase12201:
the negative regulatory element 
dt - jj - jj - nn - 
Phrase12202:
the nuclear extract 
dt - jj - nn - 
Phrase12203:
virus-infected human 
jj - nn - 
Phrase12204:
the factors 
dt - nn - 
Phrase12205:
novel dyad 
jj - nn - 
Phrase12206:
various hiv-1 
jj - nn - 
Phrase12207:
partial homology 
jj - nn - 
Phrase12208:
the promoter 
dt - nn - 
Phrase12209:
the human 
dt - nn - 
Phrase12210:
similar dna 
jj - nn - 
Phrase12211:
the other factor 
dt - jj - nn - 
Phrase12212:
putative ap-1 
jj - nn - 
Phrase12213:
the hiv-1 
dt - nn - 
Phrase12214:
this factor 
dt - nn - 
Phrase12215:
typical ap-1 
jj - nn - 
Phrase12216:
the insertion 
dt - nn - 
Phrase12217:
multiple copies 
jj - nns - 
Phrase12218:
the binding 
dt - nn - 
Phrase12219:
latter factor 
jj - nn - 
Phrase12220:
heterologous promoter 
jj - nn - 
Phrase12221:
the promoter 
dt - nn - 
Phrase12222:
each factor 
dt - nn - 
Phrase12223:
novel negative regulator 
jj - jj - nn - 
Phrase12224:
the monocytic lineage 
dt - jj - nn - 
Phrase12225:
differentiation-associated genes 
jj - nns - 
Phrase12226:
long term 
jj - nn - 
Phrase12227:
the absence 
dt - nn - 
Phrase12228:
the retrodifferentiated 
dt - nn - 
Phrase12229:
the substrate 
dt - nn - 
Phrase12230:
other cellular parameters 
jj - jj - nns - 
Phrase12231:
uninduced cells 
jj - nns - 
Phrase12232:
rapid translocation 
jj - nn - 
Phrase12233:
the cytosol 
dt - nn - 
Phrase12234:
membrane-associated pkc 
jj - nn - 
Phrase12235:
the distribution 
dt - nn - 
Phrase12236:
the regulation 
dt - nn - 
Phrase12237:
certain immediate early response 
jj - jj - jj - nn - 
Phrase12238:
the present 
dt - nn - 
Phrase12239:
the cells 
dt - nns - 
Phrase12240:
nonspecific inhibitor 
jj - nn - 
Phrase12241:
tpa-induced adherence 
jj - nn - 
Phrase12242:
tpa-induced c-fos 
jj - nn - 
Phrase12243:
b-specific dna 
jj - nn - 
Phrase12244:
biological oxidation 
jj - nn - 
Phrase12245:
the nuclei 
dt - nns - 
Phrase12246:
distinct nucleoprotein 
jj - nn - 
Phrase12247:
the kappa 
dt - nn - 
Phrase12248:
the interleukin-2 
dt - nn - 
Phrase12249:
structural similarity 
jj - nn - 
Phrase12250:
the v-rel 
dt - nn - 
Phrase12251:
nuclear expression 
jj - nn - 
Phrase12252:
these proteins 
dt - nns - 
Phrase12253:
biphasic kinetics 
jj - nn - 
Phrase12254:
migrating b2 
jj - nn - 
Phrase12255:
both p50 
dt - nn - 
Phrase12256:
migrating b1 
jj - nn - 
Phrase12257:
site-directed mutagenesis 
jj - nn - 
Phrase12258:
the wild-type il-2r 
dt - jj - nn - 
Phrase12259:
the binding 
dt - nn - 
Phrase12260:
the 5' 
dt - nn - 
Phrase12261:
the b1 
dt - nn - 
Phrase12262:
the binding 
dt - nn - 
Phrase12263:
3' sequences 
jj - nns - 
Phrase12264:
this enhancer 
dt - nn - 
Phrase12265:
these rel-related factors 
dt - jj - nn - 
Phrase12266:
selective chemical modification 
jj - jj - nn - 
Phrase12267:
these basic amino 
dt - jj - nn - 
Phrase12268:
the kappa 
dt - nn - 
Phrase12269:
covalent modification 
jj - nn - 
Phrase12270:
free sulfhydryl 
jj - nn - 
Phrase12271:
complete loss 
jj - nn - 
Phrase12272:
mild oxidation 
jj - nn - 
Phrase12273:
these findings 
dt - nns - 
Phrase12274:
an important role 
dt - jj - nn - 
Phrase12275:
the dna 
dt - nn - 
Phrase12276:
this family 
dt - nn - 
Phrase12277:
rel-related transcription 
jj - nn - 
Phrase12278:
therapeutic effect 
jj - nn - 
Phrase12279:
the numbers 
dt - nns - 
Phrase12280:
peripheral leucocytes 
jj - nns - 
Phrase12281:
the results 
dt - nns - 
Phrase12282:
normal child-bearing-age 
jj - nn - 
Phrase12283:
it 
prp - 
Phrase12284:
the contents 
dt - nns - 
Phrase12285:
normal child-bearing-age 
jj - nn - 
Phrase12286:
the authors 
dt - nns - 
Phrase12287:
the patients 
dt - nns - 
Phrase12288:
the numbers 
dt - nns - 
Phrase12289:
the data 
dt - nns - 
Phrase12290:
the pathogenesis 
dt - nn - 
Phrase12291:
the leucocytic 
dt - nn - 
Phrase12292:
the basis 
dt - nn - 
Phrase12293:
the therapeutic effect 
dt - jj - nn - 
Phrase12294:
the disease 
dt - nn - 
Phrase12295:
the role 
dt - nn - 
Phrase12296:
specific dna 
jj - nn - 
Phrase12297:
we 
prp - 
Phrase12298:
the capacity 
dt - nn - 
Phrase12299:
native hgr 
jj - nn - 
Phrase12300:
sulfate-polyacrylamide gels 
jj - nns - 
Phrase12301:
specific binding 
jj - nn - 
Phrase12302:
this assay 
dt - nn - 
Phrase12303:
we 
prp - 
Phrase12304:
the contributions 
dt - nns - 
Phrase12305:
these glucocorticoid 
dt - nn - 
Phrase12306:
selective dna 
jj - nn - 
Phrase12307:
the absence 
dt - nn - 
Phrase12308:
the antiglucocorticoid 
dt - nn - 
Phrase12309:
additional effect 
jj - nn - 
Phrase12310:
the dna-binding 
dt - nn - 
Phrase12311:
either ligand 
dt - nn - 
Phrase12312:
effective in 
jj - nn - 
Phrase12313:
specific dna 
jj - nn - 
Phrase12314:
the addition 
dt - nn - 
Phrase12315:
the receptor 
dt - nn - 
Phrase12316:
less dna 
jjr - nn - 
Phrase12317:
the complexes 
dt - nns - 
Phrase12318:
the specificity 
dt - nn - 
Phrase12319:
the abilities 
dt - nns - 
Phrase12320:
various dnas 
jj - nns - 
Phrase12321:
the mouse 
dt - nn - 
Phrase12322:
mammary tumor 
jj - nn - 
Phrase12323:
the consensus 
dt - nn - 
Phrase12324:
efficient competitors 
jj - nns - 
Phrase12325:
regulatory sequences 
jj - nns - 
Phrase12326:
single stranded oligonucleotides 
jj - jj - nns - 
Phrase12327:
mammary tumor 
jj - nn - 
Phrase12328:
high concentrations 
jj - nns - 
Phrase12329:
these studies 
dt - nns - 
Phrase12330:
the same properties 
dt - jj - nns - 
Phrase12331:
cytosolic extracts 
jj - nns - 
Phrase12332:
mammalian cells 
jj - nns - 
Phrase12333:
the effects 
dt - nns - 
Phrase12334:
the antiglucocorticoid 
dt - nn - 
Phrase12335:
the level 
dt - nn - 
Phrase12336:
specific dna 
jj - nn - 
Phrase12337:
pulmonary granulomatous 
jj - nn - 
Phrase12338:
the cell 
dt - nn - 
Phrase12339:
this immunoregulatory hormone 
dt - jj - nn - 
Phrase12340:
we 
prp - 
Phrase12341:
the expression 
dt - nn - 
Phrase12342:
peripheral blood 
jj - nn - 
Phrase12343:
the lung 
dt - nn - 
Phrase12344:
bronchoalveolar lavage 
jj - nn - 
Phrase12345:
pulmonary granulomatous 
jj - nn - 
Phrase12346:
normal control 
jj - nn - 
Phrase12347:
combined autoradiographic 
jj - nn - 
Phrase12348:
immunohistochemical techniques 
jj - nns - 
Phrase12349:
normal control 
jj - nn - 
Phrase12350:
the presence 
dt - nn - 
Phrase12351:
unlabeled 1,25(oh)2d3 
jj - nn - 
Phrase12352:
the presence 
dt - nn - 
Phrase12353:
receptor-positive lymphocytes 
jj - nns - 
Phrase12354:
detectable 1,25(oh)2d3 
jj - nn - 
Phrase12355:
the percentage 
dt - nn - 
Phrase12356:
pulmonary infiltrates 
jj - nn - 
Phrase12357:
greater extent 
jjr - nn - 
Phrase12358:
cd8+ t-lymphocytes 
jj - nns - 
Phrase12359:
cd4+ t-lymphocytes 
jj - nns - 
Phrase12360:
greater proportion 
jjr - nn - 
Phrase12361:
cd8+ t-lymphocytes 
jj - nns - 
Phrase12362:
these findings 
dt - nns - 
Phrase12363:
the conclusion 
dt - nn - 
Phrase12364:
the interaction 
dt - nn - 
Phrase12365:
its 
prp$ - 
Phrase12366:
an important role 
dt - jj - nn - 
Phrase12367:
the regulation 
dt - nn - 
Phrase12368:
these receptors 
dt - nns - 
Phrase12369:
different lymphocyte 
jj - nn - 
Phrase12370:
the net 
dt - nn - 
Phrase12371:
this potent 
dt - nn - 
Phrase12372:
immunoregulatory molecule 
jj - nn - 
Phrase12373:
different in 
jj - nn - 
Phrase12374:
the epstein-barr virus 
dt - jj - nn - 
Phrase12375:
nuclear antigen 
jj - nn - 
Phrase12376:
viral promoter 
jj - nn - 
Phrase12377:
initial stages 
jj - nns - 
Phrase12378:
latent epstein-barr virus 
jj - jj - nn - 
Phrase12379:
viral nuclear antigen 
jj - jj - nn - 
Phrase12380:
long primary transcripts 
jj - jj - nns - 
Phrase12381:
these transcripts 
dt - nns - 
Phrase12382:
exclusive fashion 
jj - nn - 
Phrase12383:
the initial stages 
dt - jj - nns - 
Phrase12384:
primary b 
jj - nn - 
Phrase12385:
these studies 
dt - nns - 
Phrase12386:
the gene 
dt - nn - 
Phrase12387:
primary b 
jj - nn - 
Phrase12388:
the virus 
dt - nn - 
Phrase12389:
functional cp 
jj - nn - 
Phrase12390:
the context 
dt - nn - 
Phrase12391:
downstream sequences 
jj - nns - 
Phrase12392:
this region 
dt - nn - 
Phrase12393:
an ebna 
dt - nn - 
Phrase12394:
nuclear extracts 
jj - nns - 
Phrase12395:
b-cell-specific footprint 
jj - nn - 
Phrase12396:
the region 
dt - nn - 
Phrase12397:
the ebna 
dt - nn - 
Phrase12398:
these results 
dt - nns - 
Phrase12399:
viral promoter 
jj - nn - 
Phrase12400:
the initial stages 
dt - jj - nns - 
Phrase12401:
the expression 
dt - nn - 
Phrase12402:
the ebna 
dt - nn - 
Phrase12403:
immune response 
jj - nn - 
Phrase12404:
peripheral blood 
jj - nn - 
Phrase12405:
the hepatitis 
dt - nn - 
Phrase12406:
transcriptional transactivator 
jj - nn - 
Phrase12407:
we 
prp - 
Phrase12408:
this antigen 
dt - nn - 
Phrase12409:
we 
prp - 
Phrase12410:
peripheral blood 
jj - nn - 
Phrase12411:
acute hepatitis 
jj - nn - 
Phrase12412:
chronic hepatitis 
jj - nn - 
Phrase12413:
healthy individuals 
jj - nns - 
Phrase12414:
synthetic polypeptides 
jj - nns - 
Phrase12415:
several t-cell 
jj - nn - 
Phrase12416:
located in 
jj - nn - 
Phrase12417:
the carboxyterminal 
dt - nn - 
Phrase12418:
the hbxag 
dt - nn - 
Phrase12419:
located at 
jj - nn - 
Phrase12420:
the carboxyterminal 
dt - nn - 
Phrase12421:
the cd2/cd4-positive 
dt - nn - 
Phrase12422:
these data 
dt - nns - 
Phrase12423:
the first time 
dt - jj - nn - 
Phrase12424:
an antigen 
dt - nn - 
Phrase12425:
the cellular immune response 
dt - jj - jj - nn - 
Phrase12426:
the number 
dt - nn - 
Phrase12427:
peripheral leucocytes 
jj - nns - 
Phrase12428:
the results 
dt - nns - 
Phrase12429:
age-matched healthy subjects 
jj - jj - nns - 
Phrase12430:
it 
prp - 
Phrase12431:
the number 
dt - nn - 
Phrase12432:
it 
prp - 
Phrase12433:
an important role 
dt - jj - nn - 
Phrase12434:
the pathogenesis 
dt - nn - 
Phrase12435:
the nf 
dt - nn - 
Phrase12436:
independent cis-acting sequences 
jj - jj - nns - 
Phrase12437:
the rate 
dt - nn - 
Phrase12438:
the long terminal 
dt - jj - nn - 
Phrase12439:
mitogenic stimuli 
jj - nns - 
Phrase12440:
we 
prp - 
Phrase12441:
the response 
dt - nn - 
Phrase12442:
the hiv-1 
dt - nn - 
Phrase12443:
independent sequences 
jj - nns - 
Phrase12444:
located 5' 
jj - nn - 
Phrase12445:
the site 
dt - nn - 
Phrase12446:
either nfat-1 
dt - nn - 
Phrase12447:
the rate 
dt - nn - 
Phrase12448:
ltr-directed gene 
jj - nn - 
Phrase12449:
either a 
dt - nn - 
Phrase12450:
either nfat-1 
dt - nn - 
Phrase12451:
these mitogenic stimuli 
dt - jj - nns - 
Phrase12452:
both sequences 
dt - nns - 
Phrase12453:
the hiv-1 
dt - nn - 
Phrase12454:
the deletion 
dt - nn - 
Phrase12455:
the viral growth 
dt - jj - nn - 
Phrase12456:
viral replication 
jj - nn - 
Phrase12457:
camp-dependent regulation 
jj - nn - 
Phrase12458:
negative effects 
jj - nns - 
Phrase12459:
we 
prp - 
Phrase12460:
the ap-1 
dt - nn - 
Phrase12461:
the human 
dt - nn - 
Phrase12462:
the camp-dependent protein 
dt - jj - nn - 
Phrase12463:
the enhancer 
dt - nn - 
Phrase12464:
another component 
dt - nn - 
Phrase12465:
the ap-1 
dt - nn - 
Phrase12466:
the enhancer 
dt - nn - 
Phrase12467:
the presence 
dt - nn - 
Phrase12468:
both camp 
dt - nn - 
Phrase12469:
the distinction 
dt - nn - 
Phrase12470:
these response 
dt - nn - 
Phrase12471:
these results 
dt - nns - 
Phrase12472:
the transcriptional activity 
dt - jj - nn - 
Phrase12473:
an ap-1-related 
dt - nn - 
Phrase12474:
the camp-dependent second-messenger 
dt - jj - nn - 
Phrase12475:
other ap-1-related 
jj - nn - 
Phrase12476:
an important role 
dt - jj - nn - 
Phrase12477:
the regulation 
dt - nn - 
Phrase12478:
camp-dependent intracellular signaling 
jj - jj - nn - 
Phrase12479:
cold in 
jj - nn - 
Phrase12480:
hot in 
jj - nn - 
Phrase12481:
healthy individuals 
jj - nns - 
Phrase12482:
normal control 
jj - nn - 
Phrase12483:
the purpose 
dt - nn - 
Phrase12484:
the nature 
dt - nn - 
Phrase12485:
the cases 
dt - nns - 
Phrase12486:
normal concentration 
jj - nn - 
Phrase12487:
lowered content 
jj - nn - 
Phrase12488:
the normal control 
dt - jj - nn - 
Phrase12489:
the cases 
dt - nns - 
Phrase12490:
higher concentration 
jjr - nn - 
Phrase12491:
the normal control 
dt - jj - nn - 
Phrase12492:
higher content 
jjr - nn - 
Phrase12493:
it 
prp - 
Phrase12494:
the dcs 
dt - nns - 
Phrase12495:
biological effects 
jj - nns - 
Phrase12496:
the dhs 
dt - nn - 
Phrase12497:
augmented biological effects 
jj - jj - nns - 
Phrase12498:
the role 
dt - nn - 
Phrase12499:
hemopoietic differentiation 
jj - nn - 
Phrase12500:
the leukemic cell 
dt - jj - nn - 
Phrase12501:
marked changes 
jj - nns - 
Phrase12502:
this study 
dt - nn - 
Phrase12503:
we 
prp - 
Phrase12504:
the expression 
dt - nn - 
Phrase12505:
variable kinetics 
jj - nn - 
Phrase12506:
the generation 
dt - nn - 
Phrase12507:
morphological differentiation 
jj - nn - 
Phrase12508:
the ability 
dt - nn - 
Phrase12509:
these complexes 
dt - nns - 
Phrase12510:
an ap-1 
dt - nn - 
Phrase12511:
marked increases 
jj - nns - 
Phrase12512:
the expression 
dt - nn - 
Phrase12513:
endogenous ap-1 
jj - nn - 
Phrase12514:
soluble phorbol 
jj - nn - 
Phrase12515:
tight correlation 
jj - nn - 
Phrase12516:
the generation 
dt - nn - 
Phrase12517:
critical role 
jj - nn - 
Phrase12518:
this gene 
dt - nn - 
Phrase12519:
transcriptional complex 
jj - nn - 
Phrase12520:
this process 
dt - nn - 
Phrase12521:
nuclear association 
jj - nn - 
Phrase12522:
other processes 
jj - nns - 
Phrase12523:
an effective immune response 
dt - jj - jj - nn - 
Phrase12524:
these drugs 
dt - nns - 
Phrase12525:
an unknown step 
dt - jj - nn - 
Phrase12526:
the transmission 
dt - nn - 
Phrase12527:
the t-cell 
dt - nn - 
Phrase12528:
the immune response 
dt - jj - nn - 
Phrase12529:
the putative intracellular receptors 
dt - jj - jj - nns - 
Phrase12530:
the drug 
dt - nn - 
Phrase12531:
other prolyl 
jj - nn - 
Phrase12532:
the effects 
dt - nns - 
Phrase12533:
the drug 
dt - nn - 
Phrase12534:
the formation 
dt - nn - 
Phrase12535:
an inhibitory complex 
dt - jj - nn - 
Phrase12536:
the drug 
dt - nn - 
Phrase12537:
early t-cell 
jj - nn - 
Phrase12538:
specific target 
jj - nn - 
Phrase12539:
this protein 
dt - nn - 
Phrase12540:
these drugs 
dt - nns - 
Phrase12541:
other transcription 
jj - nn - 
Phrase12542:
we 
prp - 
Phrase12543:
the antigen 
dt - nn - 
Phrase12544:
pre-existing cytoplasmic subunit 
jj - jj - nn - 
Phrase12545:
the nucleus 
dt - nn - 
Phrase12546:
nuclear subunit 
jj - nn - 
Phrase12547:
the cytoplasmic component 
dt - jj - nn - 
Phrase12548:
the nuclear subunit 
dt - jj - nn - 
Phrase12549:
the aim 
dt - nn - 
Phrase12550:
the down-regulation 
dt - nn - 
Phrase12551:
the glucocorticoid 
dt - nn - 
Phrase12552:
aged 16-27 
jj - nn - 
Phrase12553:
normal women 
jj - nns - 
Phrase12554:
significant weight 
jj - nn - 
Phrase12555:
the binding 
dt - nn - 
Phrase12556:
the glucocorticoid 
dt - nn - 
Phrase12557:
free plasma 
jj - nn - 
Phrase12558:
the normal women 
dt - jj - nns - 
Phrase12559:
their 
prp$ - 
Phrase12560:
urinary free cortisol 
jj - jj - nn - 
Phrase12561:
the number 
dt - nn - 
Phrase12562:
the binding 
dt - nn - 
Phrase12563:
the kd 
dt - nn - 
Phrase12564:
the lymphocyte 
dt - nn - 
Phrase12565:
post-receptor defect 
jj - nn - 
Phrase12566:
peripheral tissue 
jj - nn - 
Phrase12567:
the effects 
dt - nns - 
Phrase12568:
okadaic acid 
jj - nn - 
Phrase12569:
the role 
dt - nn - 
Phrase12570:
okadaic acid 
jj - nn - 
Phrase12571:
an inhibitor 
dt - nn - 
Phrase12572:
nuclear extracts 
jj - nns - 
Phrase12573:
the presence 
dt - nn - 
Phrase12574:
early t 
jj - nn - 
Phrase12575:
okadaic acid 
jj - nn - 
Phrase12576:
the induction 
dt - nn - 
Phrase12577:
okadaic acid 
jj - nn - 
Phrase12578:
transcriptional activation 
jj - nn - 
Phrase12579:
the jun 
dt - nn - 
Phrase12580:
the addition 
dt - nn - 
Phrase12581:
the induction 
dt - nn - 
Phrase12582:
the addition 
dt - nn - 
Phrase12583:
it 
prp - 
Phrase12584:
okadaic acid 
jj - nn - 
Phrase12585:
the jun 
dt - nn - 
Phrase12586:
lesser extent 
jjr - nn - 
Phrase12587:
the fos 
dt - nn - 
Phrase12588:
inefficient inducer 
jj - nn - 
Phrase12589:
the jun 
dt - nn - 
Phrase12590:
its 
prp$ - 
Phrase12591:
the induction 
dt - nn - 
Phrase12592:
okadaic acid 
jj - nn - 
Phrase12593:
the induction 
dt - nn - 
Phrase12594:
okadaic acid 
jj - nn - 
Phrase12595:
the marked difference 
dt - jj - nn - 
Phrase12596:
okadaic acid 
jj - nn - 
Phrase12597:
the induction 
dt - nn - 
Phrase12598:
okadaic acid 
jj - nn - 
Phrase12599:
important negative regulators 
jj - jj - nns - 
Phrase12600:
the transcription 
dt - nn - 
Phrase12601:
cell-specific transcription 
jj - nn - 
Phrase12602:
functional motifs 
jj - nns - 
Phrase12603:
the cd3-epsilon 
dt - nn - 
Phrase12604:
the t 
dt - nn - 
Phrase12605:
we 
prp - 
Phrase12606:
functional element 
jj - nn - 
Phrase12607:
the t 
dt - nn - 
Phrase12608:
lymphocyte-specific enhancer 
jj - nn - 
Phrase12609:
novel family 
jj - nn - 
Phrase12610:
the so-called high mobility 
dt - jj - jj - nn - 
Phrase12611:
we 
prp - 
Phrase12612:
the cloning 
dt - nn - 
Phrase12613:
the same sequence 
dt - jj - nn - 
Phrase12614:
the cd3-epsilon 
dt - nn - 
Phrase12615:
the murine 
dt - nn - 
Phrase12616:
several aspects 
jj - nns - 
Phrase12617:
the hmg 
dt - nn - 
Phrase12618:
sequence-specific binding 
jj - nn - 
Phrase12619:
high stringency 
jj - nn - 
Phrase12620:
the thymus 
dt - nn - 
Phrase12621:
the t 
dt - nn - 
Phrase12622:
the spleen 
dt - nn - 
Phrase12623:
third 
nnp - 
Phrase12624:
functional t 
jj - nn - 
Phrase12625:
cell-specific element 
jj - nn - 
Phrase12626:
the t 
dt - nn - 
Phrase12627:
the t 
dt - nn - 
Phrase12628:
lineage-specific expression 
jj - nn - 
Phrase12629:
the affinity 
dt - nn - 
Phrase12630:
functional motifs 
jj - nns - 
Phrase12631:
the tcr-alpha 
dt - nn - 
Phrase12632:
an important role 
dt - jj - nn - 
Phrase12633:
the establishment 
dt - nn - 
Phrase12634:
the mature t 
dt - jj - nn - 
Phrase12635:
single mrna 
jj - nn - 
Phrase12636:
single methionine 
jj - nn - 
Phrase12637:
the open 
dt - nn - 
Phrase12638:
the homeodomain 
dt - nn - 
Phrase12639:
it 
prp - 
Phrase12640:
it 
prp - 
Phrase12641:
it 
prp - 
Phrase12642:
the hb24 
dt - nn - 
Phrase12643:
low levels 
jj - nns - 
Phrase12644:
normal b 
jj - nn - 
Phrase12645:
the appropriate activation 
dt - jj - nn - 
Phrase12646:
several hours 
jj - nns - 
Phrase12647:
the presence 
dt - nn - 
Phrase12648:
positive hybridization 
jj - nn - 
Phrase12649:
fetal brain 
jj - nn - 
Phrase12650:
an important role 
dt - jj - nn - 
Phrase12651:
platelet-activating factor 
jj - nn - 
Phrase12652:
arachidonic acid 
jj - nn - 
Phrase12653:
platelet-activating factor 
jj - nn - 
Phrase12654:
the inflammatory response 
dt - jj - nn - 
Phrase12655:
the actions 
dt - nns - 
Phrase12656:
platelet-activating factor 
jj - nn - 
Phrase12657:
this report 
dt - nn - 
Phrase12658:
we 
prp - 
Phrase12659:
the influence 
dt - nn - 
Phrase12660:
platelet-activating factor 
jj - nn - 
Phrase12661:
the ebv-transformed 
dt - nn - 
Phrase12662:
we 
prp - 
Phrase12663:
platelet-activating factor 
jj - nn - 
Phrase12664:
the incorporation 
dt - nn - 
Phrase12665:
phosphatidic acid 
jj - nn - 
Phrase12666:
the inactive precursor 
dt - jj - nn - 
Phrase12667:
the membrane 
dt - nn - 
Phrase12668:
we 
prp - 
Phrase12669:
platelet-activating factor 
jj - nn - 
Phrase12670:
significant elevation 
jj - nn - 
Phrase12671:
intracellular calcium 
jj - nn - 
Phrase12672:
we 
prp - 
Phrase12673:
the impact 
dt - nn - 
Phrase12674:
platelet-activating factor 
jj - nn - 
Phrase12675:
platelet-activating factor 
jj - nn - 
Phrase12676:
arachidonic acid 
jj - nn - 
Phrase12677:
platelet-activating factor 
jj - nn - 
Phrase12678:
the nuclear proto-oncogenes 
dt - jj - nns - 
Phrase12679:
we 
prp - 
Phrase12680:
the possible role 
dt - jj - nn - 
Phrase12681:
arachidonic acid 
jj - nn - 
Phrase12682:
endogenous 5-lipoxygenase 
jj - nn - 
Phrase12683:
platelet-activating factor 
jj - nn - 
Phrase12684:
arachidonic acid 
jj - nn - 
Phrase12685:
the level 
dt - nn - 
Phrase12686:
platelet-activating factor 
jj - nn - 
Phrase12687:
profound effect 
jj - nn - 
Phrase12688:
pure b 
jj - nn - 
Phrase12689:
negative regulation 
jj - nn - 
Phrase12690:
novel b-cell-specific enhancer 
jj - jj - nn - 
Phrase12691:
b-cell-specific enhancer 
jj - nn - 
Phrase12692:
the octamerlike 
dt - nn - 
Phrase12693:
the human 
dt - nn - 
Phrase12694:
tandem copies 
jj - nns - 
Phrase12695:
this 67-bp 
dt - nn - 
Phrase12696:
the chloramphenicol 
dt - nn - 
Phrase12697:
the conalbumin 
dt - nn - 
Phrase12698:
the identical sequence 
dt - jj - nn - 
Phrase12699:
nuclear extracts 
jj - nns - 
Phrase12700:
synthetic e6 
jj - nn - 
Phrase12701:
b-cell-specific complex 
jj - nn - 
Phrase12702:
ubiquitous band 
jj - nn - 
Phrase12703:
the results 
dt - nns - 
Phrase12704:
tandem copies 
jj - nns - 
Phrase12705:
the e6 
dt - nn - 
Phrase12706:
both in 
dt - nn - 
Phrase12707:
striking contrast 
jj - nn - 
Phrase12708:
the mouse 
dt - nn - 
Phrase12709:
the octamer 
dt - nn - 
Phrase12710:
b-cell-specific enhancer 
jj - nn - 
Phrase12711:
the human 
dt - nn - 
Phrase12712:
an octamerlike 
dt - nn - 
Phrase12713:
octamer-binding proteins 
jj - nns - 
Phrase12714:
low affinity 
jj - nn - 
Phrase12715:
its 
prp$ - 
Phrase12716:
the mnli-alui 
dt - nn - 
Phrase12717:
the basal-level 
dt - nn - 
Phrase12718:
the conalbumin 
dt - nn - 
Phrase12719:
simian virus 
jj - nn - 
Phrase12720:
the mnli-alui 
dt - nn - 
Phrase12721:
the novel enhancer 
dt - jj - nn - 
Phrase12722:
this study 
dt - nn - 
Phrase12723:
negative factors 
jj - nn - 
Phrase12724:
ca(2+)-dependent membrane 
jj - nn - 
Phrase12725:
the involvement 
dt - nn - 
Phrase12726:
many reports 
jj - nns - 
Phrase12727:
the change 
dt - nn - 
Phrase12728:
free cytosolic calcium 
jj - jj - nn - 
Phrase12729:
the hyperpolarization 
dt - nn - 
Phrase12730:
we 
prp - 
Phrase12731:
ca(2+)-dependent k+ 
jj - nn - 
Phrase12732:
the role 
dt - nn - 
Phrase12733:
these channels 
dt - nns - 
Phrase12734:
we 
prp - 
Phrase12735:
the ligand-induced transient 
dt - jj - nn - 
Phrase12736:
dose-dependent fashion 
jj - nn - 
Phrase12737:
cytosolic ca2+ 
jj - nn - 
Phrase12738:
the ca(2+)-activated 
dt - nn - 
Phrase12739:
cell-cycle gene 
jj - nn - 
Phrase12740:
these results 
dt - nns - 
Phrase12741:
the ligand-dependent opening 
dt - jj - nn - 
Phrase12742:
the kappa 
dt - nn - 
Phrase12743:
the interleukin-2 
dt - nn - 
Phrase12744:
somatic cell 
jj - nn - 
Phrase12745:
the nuclear localization 
dt - jj - nn - 
Phrase12746:
nuclear proteins 
jj - nns - 
Phrase12747:
an dp65 
dt - nn - 
Phrase12748:
the dna-binding 
dt - nn - 
Phrase12749:
itself 
prp - 
Phrase12750:
localized in 
jj - nn - 
Phrase12751:
the nucleus 
dt - nn - 
Phrase12752:
the human 
dt - nn - 
Phrase12753:
the roles 
dt - nns - 
Phrase12754:
the same kappa 
dt - jj - nn - 
Phrase12755:
we 
prp - 
Phrase12756:
somatic cell 
jj - nn - 
Phrase12757:
their 
prp$ - 
Phrase12758:
the kappa 
dt - nn - 
Phrase12759:
the gene 
dt - nn - 
Phrase12760:
the interleukin-2 
dt - nn - 
Phrase12761:
the hybrids 
dt - nns - 
Phrase12762:
nuclear nf-kappa 
jj - nn - 
Phrase12763:
these findings 
dt - nns - 
Phrase12764:
nuclear nf-kappa 
jj - nn - 
Phrase12765:
the kappa 
dt - nn - 
Phrase12766:
itself 
prp - 
Phrase12767:
we 
prp - 
Phrase12768:
competitive inhibitor 
jj - nn - 
Phrase12769:
these factors 
dt - nn - 
Phrase12770:
the transient 
dt - nn - 
Phrase12771:
the immune response 
dt - jj - nn - 
Phrase12772:
located in 
jj - nn - 
Phrase12773:
cysteine-rich antigen 
jj - nn - 
Phrase12774:
proteolytic cleavage 
jj - nn - 
Phrase12775:
we 
prp - 
Phrase12776:
the location 
dt - nn - 
Phrase12777:
the ag 
dt - nn - 
Phrase12778:
the algorithm 
dt - nn - 
Phrase12779:
the aim 
dt - nn - 
Phrase12780:
proteolytic degradation 
jj - nn - 
Phrase12781:
the enzymes 
dt - nns - 
Phrase12782:
prominent enzymes 
jj - nns - 
Phrase12783:
the endocytic 
dt - nn - 
Phrase12784:
soluble protein 
jj - nn - 
Phrase12785:
resistant segments 
jj - nns - 
Phrase12786:
susceptible segments 
jj - nns - 
Phrase12787:
available in 
jj - nn - 
Phrase12788:
the literature 
dt - nn - 
Phrase12789:
the substrate 
dt - nn - 
Phrase12790:
it 
prp - 
Phrase12791:
the s2 
dt - nn - 
Phrase12792:
the s1 
dt - nn - 
Phrase12793:
we 
prp - 
Phrase12794:
rich in 
jj - nn - 
Phrase12795:
the amino 
dt - nn - 
Phrase12796:
the other amino 
dt - jj - nn - 
Phrase12797:
we 
prp - 
Phrase12798:
the ag 
dt - nn - 
Phrase12799:
low number 
jj - nn - 
Phrase12800:
we 
prp - 
Phrase12801:
our 
prp$ - 
Phrase12802:
lower number 
jjr - nn - 
Phrase12803:
positive predictions 
jj - nn - 
Phrase12804:
the principle 
dt - nn - 
Phrase12805:
discrete fourier 
jj - nn - 
Phrase12806:
the replicative 
dt - nn - 
Phrase12807:
distinct patterns 
jj - nn - 
Phrase12808:
viral growth 
jj - nn - 
Phrase12809:
the nf-kappa 
dt - nn - 
Phrase12810:
the native long terminal 
dt - jj - jj - nn - 
Phrase12811:
their 
prp$ - 
Phrase12812:
these experiments 
dt - nns - 
Phrase12813:
different human 
jj - nn - 
Phrase12814:
the ltr 
dt - nn - 
Phrase12815:
proviral clones 
jj - nns - 
Phrase12816:
cellular permissivity 
jj - nn - 
Phrase12817:
peripheral blood 
jj - nn - 
Phrase12818:
= mt4 
jj - nn - 
Phrase12819:
an alteration 
dt - nn - 
Phrase12820:
the tata 
dt - nn - 
Phrase12821:
these results 
dt - nns - 
Phrase12822:
the human 
dt - nn - 
Phrase12823:
functional redundancy 
jj - nn - 
Phrase12824:
different t-cell 
jj - nn - 
Phrase12825:
the particular combination 
dt - jj - nn - 
Phrase12826:
transcriptional factors 
jj - nn - 
Phrase12827:
novel th 
jj - nn - 
Phrase12828:
the human 
dt - nn - 
Phrase12829:
regulatory element 
jj - nn - 
Phrase12830:
multiple enhanson 
jj - nn - 
Phrase12831:
inducible expression 
jj - nn - 
Phrase12832:
the promoter 
dt - nn - 
Phrase12833:
the protein-dna interactions 
dt - jj - nns - 
Phrase12834:
positive regulatory domain 
jj - jj - nn - 
Phrase12835:
major proteins 
jj - nns - 
Phrase12836:
major protein 
jj - nn - 
Phrase12837:
minor proteins 
jj - nns - 
Phrase12838:
an induction 
dt - nn - 
Phrase12839:
specific dna 
jj - nn - 
Phrase12840:
the prdi 
dt - nn - 
Phrase12841:
the prdii 
dt - nn - 
Phrase12842:
the uninduced extract 
dt - jj - nn - 
Phrase12843:
negative regulation 
jj - nn - 
Phrase12844:
the promoter 
dt - nn - 
Phrase12845:
these experiments 
dt - nns - 
Phrase12846:
it 
prp - 
Phrase12847:
additional proteins 
jj - nns - 
Phrase12848:
the rhombotin 
dt - nn - 
Phrase12849:
cysteine-rich lim-domain 
jj - nn - 
Phrase12850:
distinct members 
jj - nns - 
Phrase12851:
the short arm 
dt - jj - nn - 
Phrase12852:
the rhombotin 
dt - nn - 
Phrase12853:
cysteine-rich regions 
jj - nns - 
Phrase12854:
the rhombotin 
dt - nn - 
Phrase12855:
leukemia-specific translocations 
jj - nns - 
Phrase12856:
the rhom-2 
dt - nn - 
Phrase12857:
tandem cysteine-rich lim 
jj - jj - nn - 
Phrase12858:
early mouse 
jj - nn - 
Phrase12859:
central nervous system 
jj - jj - nn - 
Phrase12860:
low levels 
jj - nns - 
Phrase12861:
the other gene 
dt - jj - nn - 
Phrase12862:
the lim 
dt - nn - 
Phrase12863:
the rhom-2 
dt - nn - 
Phrase12864:
such a 
jj - nn - 
Phrase12865:
the consistency 
dt - nn - 
Phrase12866:
the rhombotin 
dt - nn - 
Phrase12867:
the same position 
dt - jj - nn - 
Phrase12868:
the previous example 
dt - jj - nn - 
Phrase12869:
consistent sites 
jj - nns - 
Phrase12870:
the 11p15 
dt - nn - 
Phrase12871:
the results 
dt - nns - 
Phrase12872:
the rhombotin 
dt - nn - 
Phrase12873:
cysteine-rich lim 
jj - nn - 
Phrase12874:
the jurkat 
dt - nn - 
Phrase12875:
ca(2+)-regulated kinases 
jj - nns - 
Phrase12876:
regulatory factor 
jj - nn - 
Phrase12877:
cellular treatment 
jj - nn - 
Phrase12878:
the cytokine 
dt - nn - 
Phrase12879:
the present 
dt - nn - 
Phrase12880:
we 
prp - 
Phrase12881:
the molecular 
dt - nn - 
Phrase12882:
its 
prp$ - 
Phrase12883:
the pka 
dt - nn - 
Phrase12884:
we 
prp - 
Phrase12885:
the pkc 
dt - nn - 
Phrase12886:
the tnf 
dt - nn - 
Phrase12887:
its 
prp$ - 
Phrase12888:
alpha-induced nf-kappa 
jj - nn - 
Phrase12889:
the major signal-mediating 
dt - jj - nn - 
Phrase12890:
ca(2+)-regulated kinases 
jj - nns - 
Phrase12891:
we 
prp - 
Phrase12892:
cytoplasmic acidification 
jj - nn - 
Phrase12893:
both tnf 
dt - nn - 
Phrase12894:
the nf-kappa 
dt - nn - 
Phrase12895:
the functional domains 
dt - jj - nns - 
Phrase12896:
the murine 
dt - nn - 
Phrase12897:
the thy-1 
dt - nn - 
Phrase12898:
it 
prp - 
Phrase12899:
canonical tata 
jj - nn - 
Phrase12900:
the 5'-end 
dt - nn - 
Phrase12901:
the mrna 
dt - nn - 
Phrase12902:
transgenic mice 
jj - nns - 
Phrase12903:
we 
prp - 
Phrase12904:
this promoter 
dt - nn - 
Phrase12905:
any tissue 
dt - nn - 
Phrase12906:
position-dependent manner 
jj - nn - 
Phrase12907:
it 
prp - 
Phrase12908:
tissue-specific manner 
jj - nn - 
Phrase12909:
the initiation 
dt - nn - 
Phrase12910:
we 
prp - 
Phrase12911:
the functional domains 
dt - jj - nns - 
Phrase12912:
the minimal thy-1 
dt - jj - nn - 
Phrase12913:
the dominant promoter 
dt - jj - nn - 
Phrase12914:
multiple binding 
jj - nn - 
Phrase12915:
the transcription 
dt - nn - 
Phrase12916:
the transcription 
dt - nn - 
Phrase12917:
the binding 
dt - nn - 
Phrase12918:
nuclear factors 
jj - nn - 
Phrase12919:
these elements 
dt - nns - 
Phrase12920:
our 
prp$ - 
Phrase12921:
the structure 
dt - nn - 
Phrase12922:
this promoter 
dt - nn - 
Phrase12923:
productive interactions 
jj - nns - 
Phrase12924:
the basal transcription 
dt - jj - nn - 
Phrase12925:
the presence 
dt - nn - 
Phrase12926:
nuclear factor 
jj - nn - 
Phrase12927:
proenkephalin transcription 
dt - nn - 
Phrase12928:
high levels 
jj - nns - 
Phrase12929:
the neuropeptide 
dt - nn - 
Phrase12930:
high levels 
jj - nns - 
Phrase12931:
the cells 
dt - nns - 
Phrase12932:
we 
prp - 
Phrase12933:
the transcriptional basis 
dt - jj - nn - 
Phrase12934:
these changes 
dt - nns - 
Phrase12935:
the proenkephalin 
dt - nn - 
Phrase12936:
the kappa 
dt - nn - 
Phrase12937:
the binding 
dt - nn - 
Phrase12938:
the transcription 
dt - nn - 
Phrase12939:
nuclear factor 
jj - nn - 
Phrase12940:
an nf-kappa 
dt - nn - 
Phrase12941:
b-like binding 
jj - nn - 
Phrase12942:
the b2 
dt - nn - 
Phrase12943:
the proenkephalin 
dt - nn - 
Phrase12944:
the b2 
dt - nn - 
Phrase12945:
this transcriptional activation 
dt - jj - nn - 
Phrase12946:
the dna-binding 
dt - nn - 
Phrase12947:
the b2 
dt - nn - 
Phrase12948:
the heterotetramer 
dt - nn - 
Phrase12949:
the factor 
dt - nn - 
Phrase12950:
it 
prp - 
Phrase12951:
the t-cell-specific activation 
dt - jj - nn - 
Phrase12952:
the proenkephalin 
dt - nn - 
Phrase12953:
the transcriptional activation 
dt - jj - nn - 
Phrase12954:
the b2 
dt - nn - 
Phrase12955:
another t-cell-specific factor 
dt - jj - nn - 
Phrase12956:
the production 
dt - nn - 
Phrase12957:
the u937 
dt - nn - 
Phrase12958:
promonocytic cell 
jj - nn - 
Phrase12959:
retinoic acid 
jj - nn - 
Phrase12960:
electrophoretic mobility 
jj - nn - 
Phrase12961:
the binding 
dt - nn - 
Phrase12962:
cellular transactivation 
jj - nn - 
Phrase12963:
the double repeat-kb 
dt - jj - nn - 
Phrase12964:
located in 
jj - nn - 
Phrase12965:
the long terminal 
dt - jj - nn - 
Phrase12966:
retinoic acid 
jj - nn - 
Phrase12967:
the u937 
dt - nn - 
Phrase12968:
the nuclei 
dt - nns - 
Phrase12969:
nuclear extracts 
jj - nns - 
Phrase12970:
the cells 
dt - nns - 
Phrase12971:
high level 
jj - nn - 
Phrase12972:
this factor 
dt - nn - 
Phrase12973:
viral replication 
jj - nn - 
Phrase12974:
these results 
dt - nns - 
Phrase12975:
monocytic cell 
jj - nn - 
Phrase12976:
some differentiation/activation 
dt - nn - 
Phrase12977:
nuclear nf-kb 
jj - nn - 
Phrase12978:
the human 
dt - nn - 
Phrase12979:
complementary dna 
jj - nn - 
Phrase12980:
the t 
dt - nn - 
Phrase12981:
the disruption 
dt - nn - 
Phrase12982:
the putative hematopoietic transcription 
dt - jj - jj - nn - 
Phrase12983:
the fusion 
dt - nn - 
Phrase12984:
an interstitial deletion 
dt - jj - nn - 
Phrase12985:
unknown locus 
jj - nn - 
Phrase12986:
the 5' 
dt - nn - 
Phrase12987:
untranslated region 
jj - nn - 
Phrase12988:
this deletion 
dt - nn - 
Phrase12989:
the scl 
dt - nn - 
Phrase12990:
regulatory region 
jj - nn - 
Phrase12991:
neither locus 
dt - nn - 
Phrase12992:
an immunoglobulin 
dt - nn - 
Phrase12993:
other t 
jj - nn - 
Phrase12994:
identical deletions 
jj - nns - 
Phrase12995:
immune receptors 
jj - nns - 
Phrase12996:
distinct nuclear protein-dependent 
jj - jj - nn - 
Phrase12997:
independent complexes 
jj - nns - 
Phrase12998:
we 
prp - 
Phrase12999:
the binding 
dt - nn - 
Phrase13000:
nuclear proteins 
jj - nns - 
Phrase13001:
the palindromic thyroid 
dt - jj - nn - 
Phrase13002:
responsive element 
jj - nn - 
Phrase13003:
electrophoretic mobility 
jj - nn - 
Phrase13004:
specific protein-dna complexes 
jj - jj - nns - 
Phrase13005:
nuclear extracts 
jj - nns - 
Phrase13006:
the trep 
dt - nn - 
Phrase13007:
single major tr 
jj - jj - nn - 
Phrase13008:
multiple complexes 
jj - nns - 
Phrase13009:
it 
prp - 
Phrase13010:
an oligomer 
dt - nn - 
Phrase13011:
unlabeled trep 
jj - nn - 
Phrase13012:
the 35s-tr 
dt - nn - 
Phrase13013:
the trs 
dt - nn - 
Phrase13014:
sufficient endogenous trs 
jj - jj - nn - 
Phrase13015:
the tr 
dt - nn - 
Phrase13016:
high concentration 
jj - nn - 
Phrase13017:
the tr 
dt - nn - 
Phrase13018:
the absence 
dt - nn - 
Phrase13019:
additional complex 
jj - nn - 
Phrase13020:
the presence 
dt - nn - 
Phrase13021:
the carboxyl-terminus 
dt - nn - 
Phrase13022:
the trs 
dt - nn - 
Phrase13023:
nuclear proteins 
jj - nns - 
Phrase13024:
cell-specific differences 
jj - nns - 
Phrase13025:
regulatory elements 
jj - nns - 
Phrase13026:
the involvement 
dt - nn - 
Phrase13027:
monocytic u937 
jj - nn - 
Phrase13028:
infected u937 
jj - nn - 
Phrase13029:
undetectable in 
jj - nn - 
Phrase13030:
low constitutive level 
jj - jj - nn - 
Phrase13031:
10-fold increase 
jj - nn - 
Phrase13032:
the steady-state 
dt - nn - 
Phrase13033:
hiv-infected monocytic cells 
jj - jj - nns - 
Phrase13034:
higher levels 
jjr - nns - 
Phrase13035:
normal cells 
jj - nns - 
Phrase13036:
secondary virus 
jj - nn - 
Phrase13037:
the effects 
dt - nns - 
Phrase13038:
regulatory elements 
jj - nns - 
Phrase13039:
the hiv 
dt - nn - 
Phrase13040:
long terminal 
jj - nn - 
Phrase13041:
the beta 
dt - nn - 
Phrase13042:
lymphoid cells 
jj - nns - 
Phrase13043:
the inducibility 
dt - nn - 
Phrase13044:
the different hybrid 
dt - jj - nn - 
Phrase13045:
the levels 
dt - nns - 
Phrase13046:
the intact beta 
dt - jj - nn - 
Phrase13047:
the prdii 
dt - nn - 
Phrase13048:
both agents 
dt - nns - 
Phrase13049:
the hiv 
dt - nn - 
Phrase13050:
monocytic cells 
jj - nns - 
Phrase13051:
the hiv 
dt - nn - 
Phrase13052:
constitutive level 
jj - nn - 
Phrase13053:
b-independent activity 
jj - nn - 
Phrase13054:
the kinetics 
dt - nn - 
Phrase13055:
viral rna 
jj - nn - 
Phrase13056:
the spread 
dt - nn - 
Phrase13057:
the cell 
dt - nn - 
Phrase13058:
viral rna 
jj - nn - 
Phrase13059:
functional analysis 
jj - nn - 
Phrase13060:
regulatory sequences 
jj - nns - 
Phrase13061:
the hla 
dt - nn - 
Phrase13062:
nuclear proteins 
jj - nns - 
Phrase13063:
the immediate upstream region 
dt - jj - jj - nn - 
Phrase13064:
major histocompatibility 
jj - nn - 
Phrase13065:
other class 
jj - nn - 
Phrase13066:
the hla-dr 
dt - nn - 
Phrase13067:
variable region 
jj - nn - 
Phrase13068:
cell-specific transcription 
jj - nn - 
Phrase13069:
the context 
dt - nn - 
Phrase13070:
least one 
jjs - nn - 
Phrase13071:
the function 
dt - nn - 
Phrase13072:
cis-acting elements 
jj - nns - 
Phrase13073:
we 
prp - 
Phrase13074:
an in 
dt - nn - 
Phrase13075:
ii-negative hela 
jj - nn - 
Phrase13076:
the y 
dt - nn - 
Phrase13077:
internal deletion 
jj - nn - 
Phrase13078:
the y 
dt - nn - 
Phrase13079:
we 
prp - 
Phrase13080:
the x 
dt - nn - 
Phrase13081:
random replacement 
jj - nn - 
Phrase13082:
the complete dependence 
dt - jj - nn - 
Phrase13083:
the y 
dt - nn - 
Phrase13084:
this system 
dt - nn - 
Phrase13085:
its 
prp$ - 
Phrase13086:
the dra 
dt - nn - 
Phrase13087:
the dra 
dt - nn - 
Phrase13088:
monocyte/macrophage-like cell 
jj - nn - 
Phrase13089:
the induction 
dt - nn - 
Phrase13090:
nuclear factor 
jj - nn - 
Phrase13091:
electrophoretic mobility 
jj - nn - 
Phrase13092:
low levels 
jj - nns - 
Phrase13093:
the stimulation 
dt - nn - 
Phrase13094:
viral production 
jj - nn - 
Phrase13095:
this cell 
dt - nn - 
Phrase13096:
these cells 
dt - nns - 
Phrase13097:
colony-stimulating factor 
jj - nn - 
Phrase13098:
an increase 
dt - nn - 
Phrase13099:
the level 
dt - nn - 
Phrase13100:
the effect 
dt - nn - 
Phrase13101:
significant in 
jj - nn - 
Phrase13102:
the variability 
dt - nn - 
Phrase13103:
the natural history 
dt - jj - nn - 
Phrase13104:
pharmacodynamic responses 
jj - nns - 
Phrase13105:
inhibitory drug 
jj - nn - 
Phrase13106:
the metabolism 
dt - nn - 
Phrase13107:
either steroid 
dt - nn - 
Phrase13108:
adverse effects 
jj - nns - 
Phrase13109:
the exposure 
dt - nn - 
Phrase13110:
the steroid 
dt - nn - 
Phrase13111:
single mp 
jj - nn - 
Phrase13112:
later ) 
jjr - nn - 
Phrase13113:
healthy male 
jj - nn - 
Phrase13114:
the suppression 
dt - nn - 
Phrase13115:
whole blood 
jj - nn - 
Phrase13116:
the 37.5 
dt - nn - 
Phrase13117:
pharmacodynamic model 
jj - nn - 
Phrase13118:
an extravascular compartment 
dt - jj - nn - 
Phrase13119:
the effects 
dt - nns - 
Phrase13120:
both regimens 
dt - nns - 
Phrase13121:
slower initial decline 
jjr - jj - nn - 
Phrase13122:
incomplete suppression 
jj - nn - 
Phrase13123:
inhibitory concentrations 
jj - nns - 
Phrase13124:
both regimens 
dt - nns - 
Phrase13125:
the decline 
dt - nn - 
Phrase13126:
inhibitory concentrations 
jj - nns - 
Phrase13127:
adrenal suppression 
jj - nn - 
Phrase13128:
pharmacodynamic modeling 
jj - nn - 
Phrase13129:
useful in 
jj - nn - 
Phrase13130:
previous clinical observations 
jj - jj - nns - 
Phrase13131:
adrenal suppression 
jj - nn - 
Phrase13132:
extra-renal 1,25(oh)2d3 
jj - nn - 
Phrase13133:
different types 
jj - nns - 
Phrase13134:
the cell 
dt - nn - 
Phrase13135:
we 
prp - 
Phrase13136:
the conversion 
dt - nn - 
Phrase13137:
uncultured cells 
jj - nns - 
Phrase13138:
bronchoalveolar lavage 
jj - nn - 
Phrase13139:
greater amounts 
jjr - nns - 
Phrase13140:
the number 
dt - nn - 
Phrase13141:
cd8+ t 
jj - nn - 
Phrase13142:
other cell 
jj - nn - 
Phrase13143:
an important source 
dt - jj - nn - 
Phrase13144:
these cells 
dt - nns - 
Phrase13145:
the capacity 
dt - nn - 
Phrase13146:
our 
prp$ - 
Phrase13147:
the conclusion 
dt - nn - 
Phrase13148:
least in 
jjs - nn - 
Phrase13149:
an important component 
dt - jj - nn - 
Phrase13150:
successful antituberculous 
jj - nn - 
Phrase13151:
immune response 
jj - nn - 
Phrase13152:
erythrocytic lineages 
jj - nns - 
Phrase13153:
specific transcription 
jj - nn - 
Phrase13154:
erythroid-specific genes 
jj - nns - 
Phrase13155:
the principal dna-binding 
dt - jj - nn - 
Phrase13156:
the erythrocytic lineage 
dt - jj - nn - 
Phrase13157:
the erythrocytic lineage 
dt - jj - nn - 
Phrase13158:
megakaryocytic cell 
jj - nn - 
Phrase13159:
it 
prp - 
Phrase13160:
the binding 
dt - nn - 
Phrase13161:
partial proteolysis 
jj - nn - 
Phrase13162:
this protein 
dt - nn - 
Phrase13163:
the erythroid protein 
dt - jj - nn - 
Phrase13164:
the same size 
dt - jj - nn - 
Phrase13165:
erythroid cell 
jj - nn - 
Phrase13166:
the transcriptional activity 
dt - jj - nn - 
Phrase13167:
we 
prp - 
Phrase13168:
another trans-acting factor 
dt - jj - nn - 
Phrase13169:
the erythrocytic lineage 
dt - jj - nn - 
Phrase13170:
transcriptional effects 
jj - nns - 
Phrase13171:
the same specific trans-acting factors 
dt - jj - jj - jj - nn - 
Phrase13172:
our 
prp$ - 
Phrase13173:
the idea 
dt - nn - 
Phrase13174:
close association 
jj - nn - 
Phrase13175:
the megakaryocytic lineages 
dt - jj - nns - 
Phrase13176:
the expression 
dt - nn - 
Phrase13177:
megakaryocytic lineages 
jj - nns - 
Phrase13178:
megakaryoblastic permanent cell 
jj - jj - nn - 
Phrase13179:
transcriptional down-regulation 
jj - nn - 
Phrase13180:
-independent pathways 
jj - nns - 
Phrase13181:
lymphoblastic tumor 
jj - nn - 
Phrase13182:
we 
prp - 
Phrase13183:
the human 
dt - nn - 
Phrase13184:
lymphoblastic tumor 
jj - nn - 
Phrase13185:
the calcium 
dt - nn - 
Phrase13186:
the intracellular calcium 
dt - jj - nn - 
Phrase13187:
negative regulation 
jj - nn - 
Phrase13188:
the phorbol 
dt - nn - 
Phrase13189:
some extent 
dt - nn - 
Phrase13190:
the calcium 
dt - nn - 
Phrase13191:
different negative regulatory pathways 
jj - jj - jj - nns - 
Phrase13192:
the latter one 
dt - jj - nn - 
Phrase13193:
calcium-dependent induced gene 
jj - jj - nn - 
Phrase13194:
chronic lymphocytic leukemia 
jj - jj - nn - 
Phrase13195:
immunocytochemical methods 
jj - nns - 
Phrase13196:
neoplastic lymphoid cells 
jj - jj - nns - 
Phrase13197:
physiological marker 
jj - nn - 
Phrase13198:
an oestrogen 
dt - nn - 
Phrase13199:
some patients 
dt - nns - 
Phrase13200:
dramatic response 
jj - nn - 
Phrase13201:
single cases 
jj - nns - 
Phrase13202:
many inherent problems 
jj - jj - nns - 
Phrase13203:
the development 
dt - nn - 
Phrase13204:
monoclonal antibodies 
jj - nns - 
Phrase13205:
the study 
dt - nn - 
Phrase13206:
good correlation 
jj - nn - 
Phrase13207:
the quantitative sba 
dt - jj - nn - 
Phrase13208:
we 
prp - 
Phrase13209:
chronic lymphocytic leukemia 
jj - jj - nn - 
Phrase13210:
these cases 
dt - nns - 
Phrase13211:
pleural effusion 
jj - nn - 
Phrase13212:
high levels 
jj - nns - 
Phrase13213:
positive control 
jj - nn - 
Phrase13214:
positive cells 
jj - nns - 
Phrase13215:
the cll 
dt - nn - 
Phrase13216:
positive cases 
jj - nns - 
Phrase13217:
granular er 
jj - nn - 
Phrase13218:
the nucleus 
dt - nn - 
Phrase13219:
positive cells 
jj - nns - 
Phrase13220:
it 
prp - 
Phrase13221:
immunocytochemical staining 
jj - nn - 
Phrase13222:
the measurement 
dt - nn - 
Phrase13223:
it 
prp - 
Phrase13224:
the positive cases 
dt - jj - nns - 
Phrase13225:
growth-inhibitory effect 
jj - nn - 
Phrase13226:
the human 
dt - nn - 
Phrase13227:
whole-cell assay 
jj - nn - 
Phrase13228:
the anti-estrogen 
dt - nn - 
Phrase13229:
the flavonoids 
dt - nns - 
Phrase13230:
reversible dose-dependent inhibition 
jj - jj - nn - 
Phrase13231:
the range 
dt - nn - 
Phrase13232:
the relative 
dt - nn - 
Phrase13233:
their 
prp$ - 
Phrase13234:
ineffective in 
jj - nn - 
Phrase13235:
cell-cycle analysis 
jj - nn - 
Phrase13236:
the growth-inhibitory effect 
dt - jj - nn - 
Phrase13237:
the g0-g1 
dt - nn - 
Phrase13238:
our 
prp$ - 
Phrase13239:
high estrogen 
jj - nn - 
Phrase13240:
peripheral blood 
jj - nn - 
Phrase13241:
bronchial asthma 
jj - nn - 
Phrase13242:
the study 
dt - nn - 
Phrase13243:
their 
prp$ - 
Phrase13244:
peripheral blood 
jj - nn - 
Phrase13245:
bronchial asthma 
jj - nn - 
Phrase13246:
endogenous cortisol 
jj - nn - 
Phrase13247:
it 
prp - 
Phrase13248:
healthy controls 
jj - nns - 
Phrase13249:
endogenous cortisol 
jj - nn - 
Phrase13250:
the human 
dt - nn - 
Phrase13251:
lytic effect 
jj - nn - 
Phrase13252:
leukemic cells 
jj - nns - 
Phrase13253:
the glucocorticoid 
dt - nn - 
Phrase13254:
various synthetic glucocorticoids 
jj - jj - nns - 
Phrase13255:
the gr 
dt - nn - 
Phrase13256:
high potency 
jj - nn - 
Phrase13257:
synthetic glucocorticoid 
jj - nn - 
Phrase13258:
the a-ring 
dt - nn - 
Phrase13259:
the steroid 
dt - nn - 
Phrase13260:
the cytosol 
dt - nn - 
Phrase13261:
acute lymphoblastic t-cell 
jj - jj - nn - 
Phrase13262:
it 
prp - 
Phrase13263:
the lower affinity 
dt - jjr - nn - 
Phrase13264:
similar in 
jj - nn - 
Phrase13265:
the higher affinity 
dt - jjr - nn - 
Phrase13266:
50-fold greater affinity 
jj - jjr - nn - 
Phrase13267:
biological effects 
jj - nns - 
Phrase13268:
leukemic cells 
jj - nns - 
Phrase13269:
the lytic effects 
dt - jj - nns - 
Phrase13270:
the cells 
dt - nns - 
Phrase13271:
single class 
jj - nn - 
Phrase13272:
the high affinity 
dt - jj - nn - 
Phrase13273:
we 
prp - 
Phrase13274:
the nature 
dt - nn - 
Phrase13275:
the higher affinity 
dt - jjr - nn - 
Phrase13276:
we 
prp - 
Phrase13277:
the antiglucocorticoid 
dt - nn - 
Phrase13278:
lower affinity 
jjr - nn - 
Phrase13279:
the human 
dt - nn - 
Phrase13280:
these data 
dt - nns - 
Phrase13281:
the human 
dt - nn - 
Phrase13282:
it 
prp - 
Phrase13283:
retroviral mediated transfer 
jj - jj - nn - 
Phrase13284:
exogenous genes 
jj - nns - 
Phrase13285:
primary lymphoid cells 
jj - jj - nns - 
Phrase13286:
viral transactivator 
jj - nn - 
Phrase13287:
malignant cells 
jj - nns - 
Phrase13288:
this report 
dt - nn - 
Phrase13289:
we 
prp - 
Phrase13290:
the use 
dt - nn - 
Phrase13291:
the activity 
dt - nn - 
Phrase13292:
an exogenous promoter 
dt - jj - nn - 
Phrase13293:
primary cells 
jj - nns - 
Phrase13294:
lymphoproliferative disorders 
jj - nns - 
Phrase13295:
the infection 
dt - nn - 
Phrase13296:
primary lymphoid cells 
jj - jj - nns - 
Phrase13297:
promoter-driven beta-galactosidase 
jj - nn - 
Phrase13298:
the expression 
dt - nn - 
Phrase13299:
the cells 
dt - nns - 
Phrase13300:
similar infection 
jj - nn - 
Phrase13301:
the beta-galactosidase 
dt - nn - 
Phrase13302:
an adenovirus 
dt - nn - 
Phrase13303:
limited number 
jj - nn - 
Phrase13304:
primary cells 
jj - nns - 
Phrase13305:
the adenovirus 
dt - nn - 
Phrase13306:
many viruses 
jj - nns - 
Phrase13307:
the activity 
dt - nn - 
Phrase13308:
this promoter 
dt - nn - 
Phrase13309:
specific cell 
jj - nn - 
Phrase13310:
both biology 
dt - nn - 
Phrase13311:
the cell 
dt - nn - 
Phrase13312:
the possible presence 
dt - jj - nn - 
Phrase13313:
viral gene 
jj - nn - 
Phrase13314:
the effect 
dt - nn - 
Phrase13315:
immune status 
jj - nn - 
Phrase13316:
chronic kidney 
jj - nn - 
Phrase13317:
active metabolite 
jj - nn - 
Phrase13318:
chronic glomerulonephritis 
jj - nn - 
Phrase13319:
the drug 
dt - nn - 
Phrase13320:
distinct normalizing 
jj - nn - 
Phrase13321:
immunological parameters 
jj - nns - 
Phrase13322:
hormonal form 
jj - nn - 
Phrase13323:
minimal in 
jj - nn - 
Phrase13324:
chronic kidney 
jj - nn - 
Phrase13325:
their 
prp$ - 
Phrase13326:
the dioxyvit 
dt - nn - 
Phrase13327:
specific calcitropic 
jj - nn - 
Phrase13328:
simultaneous correction 
jj - nn - 
Phrase13329:
high efficacy 
jj - nn - 
Phrase13330:
the drug 
dt - nn - 
Phrase13331:
renal deteriorations 
jj - nn - 
Phrase13332:
the step 
dt - nn - 
Phrase13333:
chronic kidney 
jj - nn - 
Phrase13334:
the role 
dt - nn - 
Phrase13335:
the pathogenesis 
dt - nn - 
Phrase13336:
lymphocytic levels 
jj - nns - 
Phrase13337:
them 
prp - 
Phrase13338:
significant rise 
jj - nn - 
Phrase13339:
that in 
dt - nn - 
Phrase13340:
normal subjects 
jj - nns - 
Phrase13341:
these antigens 
dt - nns - 
Phrase13342:
genetic markers 
jj - nns - 
Phrase13343:
the levels 
dt - nns - 
Phrase13344:
the patients 
dt - nns - 
Phrase13345:
normal subjects 
jj - nns - 
Phrase13346:
the active stage 
dt - jj - nn - 
Phrase13347:
the disease 
dt - nn - 
Phrase13348:
the patients 
dt - nns - 
Phrase13349:
lymphocytic receptor 
jj - nn - 
Phrase13350:
the levels 
dt - nns - 
Phrase13351:
such in 
jj - nn - 
Phrase13352:
the antigen 
dt - nn - 
Phrase13353:
lower levels 
jjr - nns - 
Phrase13354:
the human 
dt - nn - 
Phrase13355:
chronic myelogenous leukemia 
jj - jj - nn - 
Phrase13356:
the effects 
dt - nns - 
Phrase13357:
the new 
dt - nn - 
Phrase13358:
chromosome-positive chronic myelogenous leukemia 
jj - jj - jj - nn - 
Phrase13359:
half-maximal binding 
jj - nn - 
Phrase13360:
many tissues 
jj - nns - 
Phrase13361:
effective dose 
jj - nn - 
Phrase13362:
the cells 
dt - nns - 
Phrase13363:
nitroblue tetrazolium 
jj - nn - 
Phrase13364:
progressive expression 
jj - nn - 
Phrase13365:
the monocyte/macrophage 
dt - nn - 
Phrase13366:
cellular proliferation 
jj - nn - 
Phrase13367:
detectable levels 
jj - nns - 
Phrase13368:
the in 
dt - nn - 
Phrase13369:
the p210bcr-abl 
dt - nn - 
Phrase13370:
the presence 
dt - nn - 
Phrase13371:
functional receptor-effector 
jj - nn - 
Phrase13372:
multiple biological responses 
jj - jj - nns - 
Phrase13373:
the hormone 
dt - nn - 
Phrase13374:
these cells 
dt - nns - 
Phrase13375:
unique model 
jj - nn - 
Phrase13376:
the specific effects 
dt - jj - nns - 
Phrase13377:
chronic myelogenous leukemia 
jj - jj - nn - 
Phrase13378:
the leucine 
dt - nn - 
Phrase13379:
the hla 
dt - nn - 
Phrase13380:
several mutants 
jj - nns - 
Phrase13381:
defective in 
jj - nn - 
Phrase13382:
major histocompatibility 
jj - nn - 
Phrase13383:
the failure 
dt - nn - 
Phrase13384:
least one 
jjs - nn - 
Phrase13385:
such mutant 
jj - nn - 
Phrase13386:
the mhc 
dt - nn - 
Phrase13387:
transcriptional element 
jj - nn - 
Phrase13388:
the promoter 
dt - nn - 
Phrase13389:
complementary dna 
jj - nn - 
Phrase13390:
the human 
dt - nn - 
Phrase13391:
the 3' flanking region 
dt - jj - jj - nn - 
Phrase13392:
complementary dna 
jj - nn - 
Phrase13393:
structural similarities 
jj - nns - 
Phrase13394:
the c-jun 
dt - nn - 
Phrase13395:
its 
prp$ - 
Phrase13396:
the palindromic target 
dt - jj - nn - 
Phrase13397:
the hxbp-1 
dt - nn - 
Phrase13398:
these studies 
dt - nns - 
Phrase13399:
the hxbp-1 
dt - nn - 
Phrase13400:
different forms 
jj - nns - 
Phrase13401:
various genetic defects 
jj - jj - nns - 
Phrase13402:
early infancy 
jj - nn - 
Phrase13403:
renal salt 
jj - nn - 
Phrase13404:
high levels 
jj - nns - 
Phrase13405:
the patients 
dt - nns - 
Phrase13406:
correct electrolyte 
jj - nn - 
Phrase13407:
peripheral mononuclear 
jj - nn - 
Phrase13408:
the lack 
dt - nn - 
Phrase13409:
we 
prp - 
Phrase13410:
the mode 
dt - nn - 
Phrase13411:
an autosomal recessive form 
dt - jj - jj - nn - 
Phrase13412:
an autosomal dominant mode 
dt - jj - jj - nn - 
Phrase13413:
the autosomal recessive form 
dt - jj - jj - nn - 
Phrase13414:
normal receptor 
jj - nn - 
Phrase13415:
an autosomal dominant mode 
dt - jj - jj - nn - 
Phrase13416:
peripheral mononuclear 
jj - nn - 
Phrase13417:
elevated serum 
jj - nn - 
Phrase13418:
these parents 
dt - nns - 
Phrase13419:
we 
prp - 
Phrase13420:
an aunt 
dt - nn - 
Phrase13421:
her 
prp$ - 
Phrase13422:
newborn daughter 
jj - nn - 
Phrase13423:
it 
prp - 
Phrase13424:
this dual pattern 
dt - jj - nn - 
Phrase13425:
genetic transmission 
jj - nn - 
Phrase13426:
genetic defects 
jj - nns - 
Phrase13427:
the same clinical picture 
dt - jj - jj - nn - 
Phrase13428:
natural killer 
jj - nn - 
Phrase13429:
this report 
dt - nn - 
Phrase13430:
the prediction 
dt - nn - 
Phrase13431:
natural killer 
jj - nn - 
Phrase13432:
the ages 
dt - nn - 
Phrase13433:
this project 
dt - nn - 
Phrase13434:
the hospital 
dt - nnp - 
Phrase13435:
hospital 
nnp - 
Phrase13436:
their 
prp$ - 
Phrase13437:
first outpatient 
jj - nn - 
Phrase13438:
major interest 
jj - nn - 
Phrase13439:
this project 
dt - nn - 
Phrase13440:
the predictive value 
dt - jj - nn - 
Phrase13441:
the main model 
dt - jj - nn - 
Phrase13442:
we 
prp - 
Phrase13443:
significant amount 
jj - nn - 
Phrase13444:
higher nk 
jjr - nn - 
Phrase13445:
the perception 
dt - nn - 
Phrase13446:
high quality 
jj - nn - 
Phrase13447:
the patient 
dt - nn - 
Phrase13448:
receptor-negative tumor 
jj - nn - 
Phrase13449:
an excisional 
dt - nn - 
Phrase13450:
major coping 
jj - nn - 
Phrase13451:
the role 
dt - nn - 
Phrase13452:
such activity 
jj - nn - 
Phrase13453:
peripheral blood 
jj - nn - 
Phrase13454:
systemic lupus 
jj - nn - 
Phrase13455:
peripheral blood 
jj - nn - 
Phrase13456:
healthy controls 
jj - nns - 
Phrase13457:
each sample 
dt - nn - 
Phrase13458:
both fmol/mg 
dt - nn - 
Phrase13459:
cytosolic protein 
jj - nn - 
Phrase13460:
the results 
dt - nns - 
Phrase13461:
significant difference 
jj - nn - 
Phrase13462:
the er 
dt - nn - 
Phrase13463:
the controls 
dt - nns - 
Phrase13464:
the logarithmic mean 
dt - jj - nn - 
Phrase13465:
cytosolic protein 
jj - nn - 
Phrase13466:
active sle 
jj - nn - 
Phrase13467:
inactive sle 
jj - nn - 
Phrase13468:
the controls 
dt - nns - 
Phrase13469:
the normal upper 
dt - jj - nn - 
Phrase13470:
the elevated rate 
dt - jj - nn - 
Phrase13471:
active sle 
jj - nn - 
Phrase13472:
the controls 
dt - nns - 
Phrase13473:
the elevated level 
dt - jj - nn - 
Phrase13474:
the positive antidsdna 
dt - jj - nn - 
Phrase13475:
an in 
dt - nn - 
Phrase13476:
embryonic stem 
jj - nn - 
Phrase13477:
we 
prp - 
Phrase13478:
embryonic stem 
jj - nn - 
Phrase13479:
we 
prp - 
Phrase13480:
the full complement 
dt - jj - nn - 
Phrase13481:
embryonic globin 
jj - nn - 
Phrase13482:
the correct temporal order 
dt - jj - jj - nn - 
Phrase13483:
further differentiation 
jj - nn - 
Phrase13484:
the fetal/adult 
dt - nn - 
Phrase13485:
the erythroid-specific transcription 
dt - jj - nn - 
Phrase13486:
we 
prp - 
Phrase13487:
these experiments 
dt - nns - 
Phrase13488:
the es 
dt - nn - 
Phrase13489:
good model 
jj - nn - 
Phrase13490:
hematopoietic development 
jj - nn - 
Phrase13491:
the human 
dt - nn - 
Phrase13492:
the dominant control 
dt - jj - nn - 
Phrase13493:
this system 
dt - nn - 
Phrase13494:
the human 
dt - nn - 
Phrase13495:
the beta-globin 
dt - nn - 
Phrase13496:
the presence 
dt - nn - 
Phrase13497:
the dcr 
dt - nn - 
Phrase13498:
an embryonic gene 
dt - jj - nn - 
Phrase13499:
we 
prp - 
Phrase13500:
the epsilon-globin 
dt - nn - 
Phrase13501:
other genes 
jj - nns - 
Phrase13502:
the human 
dt - nn - 
Phrase13503:
the rel 
dt - nn - 
Phrase13504:
cell-cycle motifs 
jj - nns - 
Phrase13505:
we 
prp - 
Phrase13506:
the amino-terminal domain 
dt - jj - nn - 
Phrase13507:
the oncogene 
dt - nn - 
Phrase13508:
important gene 
jj - nn - 
Phrase13509:
the carboxy-terminal domain 
dt - jj - nn - 
Phrase13510:
cell-cycle control 
jj - nn - 
Phrase13511:
the putative human 
dt - jj - nn - 
Phrase13512:
the ankyrin 
dt - nn - 
Phrase13513:
the product 
dt - nn - 
Phrase13514:
this gene 
dt - nn - 
Phrase13515:
the kappa 
dt - nn - 
Phrase13516:
many inducible genes 
jj - jj - nns - 
Phrase13517:
the enhancer 
dt - nn - 
Phrase13518:
another in 
dt - nn - 
Phrase13519:
important regulatory molecules 
jj - jj - nns - 
Phrase13520:
cellular activation 
jj - nn - 
Phrase13521:
the sequence 
dt - nn - 
Phrase13522:
the cellular electrolyte 
dt - jj - nn - 
Phrase13523:
their 
prp$ - 
Phrase13524:
the water 
dt - nn - 
Phrase13525:
high affinity 
jj - nn - 
Phrase13526:
the classic target 
dt - jj - nn - 
Phrase13527:
the renal tubules 
dt - jj - nns - 
Phrase13528:
the hippocampus 
dt - nn - 
Phrase13529:
mammary gland 
jj - nn - 
Phrase13530:
intracellular sodium 
jj - nn - 
Phrase13531:
the absence 
dt - nn - 
Phrase13532:
the intracellular na+ 
dt - jj - nn - 
Phrase13533:
the cell 
dt - nn - 
Phrase13534:
the incubation 
dt - nn - 
Phrase13535:
these effects 
dt - nns - 
Phrase13536:
the aldosterone 
dt - nn - 
Phrase13537:
the sodium/proton 
dt - nn - 
Phrase13538:
the cell 
dt - nn - 
Phrase13539:
the primary target 
dt - jj - nn - 
Phrase13540:
the aldosterone 
dt - nn - 
Phrase13541:
the clinical significance 
dt - jj - nn - 
Phrase13542:
this model 
dt - nn - 
Phrase13543:
the demonstration 
dt - nn - 
Phrase13544:
the lack 
dt - nn - 
Phrase13545:
an abnormal effector 
dt - jj - nn - 
Phrase13546:
essential hypertensives 
jj - nn - 
Phrase13547:
these studies 
dt - nns - 
Phrase13548:
the significance 
dt - nn - 
Phrase13549:
nonepithelial mineralocorticoid 
jj - nn - 
Phrase13550:
the related effector 
dt - jj - nn - 
Phrase13551:
different disorders 
jj - nns - 
Phrase13552:
the water 
dt - nn - 
Phrase13553:
immunohistochemical study 
jj - nn - 
Phrase13554:
an estrogen 
dt - nn - 
Phrase13555:
malignant soft tissue 
jj - jj - nn - 
Phrase13556:
the immunoreaction 
dt - nn - 
Phrase13557:
the malignant soft tissue 
dt - jj - jj - nn - 
Phrase13558:
malignant fibrous 
jj - nn - 
Phrase13559:
distinct immunostaining 
jj - nn - 
Phrase13560:
the area 
dt - nn - 
Phrase13561:
the majority 
dt - nn - 
Phrase13562:
the positive cases 
dt - jj - nns - 
Phrase13563:
the existence 
dt - nn - 
Phrase13564:
it 
prp - 
Phrase13565:
we 
prp - 
Phrase13566:
some malignant soft tissue 
dt - jj - jj - nn - 
Phrase13567:
cyclic amp-dependent 
jj - nn - 
Phrase13568:
the signal 
dt - nn - 
Phrase13569:
specific protein 
jj - nn - 
Phrase13570:
cyclic amp-dependent 
jj - nn - 
Phrase13571:
-responsive cells 
jj - nns - 
Phrase13572:
il-1-induced gene 
jj - nn - 
Phrase13573:
the kappa 
dt - nn - 
Phrase13574:
the human 
dt - nn - 
Phrase13575:
long terminal 
jj - nn - 
Phrase13576:
c-mediated gene 
jj - nn - 
Phrase13577:
cyclic amp-dependent 
jj - nn - 
Phrase13578:
the signal 
dt - nn - 
Phrase13579:
responsive cell 
jj - nn - 
Phrase13580:
the epstein-barr virus 
dt - jj - nn - 
Phrase13581:
the ebv 
dt - nn - 
Phrase13582:
the epstein-barr virus 
dt - jj - nn - 
Phrase13583:
the psti 
dt - nn - 
Phrase13584:
the tata 
dt - nn - 
Phrase13585:
it 
prp - 
Phrase13586:
an upstream region 
dt - jj - nn - 
Phrase13587:
the bzlf1-encoded 
dt - nn - 
Phrase13588:
an enhancer 
dt - nn - 
Phrase13589:
distinct domains 
jj - nns - 
Phrase13590:
b-cell-specific eb1-responsive 
jj - nn - 
Phrase13591:
an ebv 
dt - nn - 
Phrase13592:
early product 
jj - nn - 
Phrase13593:
the open 
dt - nn - 
Phrase13594:
we 
prp - 
Phrase13595:
an r-responsive 
dt - nn - 
Phrase13596:
an eb1-responsive 
dt - nn - 
Phrase13597:
b-cell-specific element 
jj - nn - 
Phrase13598:
an eb1-binding 
dt - nn - 
Phrase13599:
the r-responsive 
dt - nn - 
Phrase13600:
the r-dependent 
dt - nn - 
Phrase13601:
the b 
dt - nn - 
Phrase13602:
the r-responsive 
dt - nn - 
Phrase13603:
an enhancer 
dt - nn - 
Phrase13604:
the r- inducible 
dt - nn - 
Phrase13605:
we 
prp - 
Phrase13606:
several subregions 
jj - nns - 
Phrase13607:
the dr 
dt - nn - 
Phrase13608:
their 
prp$ - 
Phrase13609:
the r-activating 
dt - nn - 
Phrase13610:
the rabbit 
dt - nn - 
Phrase13611:
we 
prp - 
Phrase13612:
the r-responsive 
dt - nn - 
Phrase13613:
the whole b 
dt - jj - nn - 
Phrase13614:
these protoenhancers 
dt - nn - 
Phrase13615:
the protoenhancers 
dt - nn - 
Phrase13616:
the overlapping palindromes 
dt - jj - nn - 
Phrase13617:
the overlapping palindromes 
dt - jj - nn - 
Phrase13618:
nuclear 3,5,3'-triiodothyronine 
jj - nn - 
Phrase13619:
the clinical implications 
dt - jj - nns - 
Phrase13620:
nuclear t3r 
jj - nn - 
Phrase13621:
nuclear t3r 
jj - nn - 
Phrase13622:
the results 
dt - nns - 
Phrase13623:
the nuclear affinity 
dt - jj - nn - 
Phrase13624:
normal subjects 
jj - nns - 
Phrase13625:
nuclear t3 
jj - nn - 
Phrase13626:
maximal binding 
jj - nn - 
Phrase13627:
the mbc 
dt - nn - 
Phrase13628:
the patients 
dt - nns - 
Phrase13629:
chronic renal failure 
jj - jj - nn - 
Phrase13630:
hepatic cirrhosis 
jj - nn - 
Phrase13631:
the nuclear t3r 
dt - jj - nn - 
Phrase13632:
the normal controls 
dt - jj - nns - 
Phrase13633:
it 
prp - 
Phrase13634:
hormonal regulation 
jj - nn - 
Phrase13635:
nuclear t3r 
jj - nn - 
Phrase13636:
low t3 
jj - nn - 
Phrase13637:
d-dependent rickets 
jj - nn - 
Phrase13638:
functional defects 
jj - nns - 
Phrase13639:
d-dependent rickets 
jj - nn - 
Phrase13640:
these lines 
dt - nns - 
Phrase13641:
its 
prp$ - 
Phrase13642:
these cell 
dt - nn - 
Phrase13643:
normal individual 
jj - nn - 
Phrase13644:
the 1,25(oh)2d3 
dt - nn - 
Phrase13645:
the well-characterized chick 
dt - jj - nn - 
Phrase13646:
intestinal 1,25(oh)2d3 
jj - nn - 
Phrase13647:
its 
prp$ - 
Phrase13648:
its 
prp$ - 
Phrase13649:
its 
prp$ - 
Phrase13650:
specific binding 
jj - nn - 
Phrase13651:
the presence 
dt - nn - 
Phrase13652:
functional 1,25(oh)2d3 
jj - nn - 
Phrase13653:
the receptor 
dt - nn - 
Phrase13654:
low binding 
jj - nn - 
Phrase13655:
the fifth cell 
dt - jj - nn - 
Phrase13656:
the sensitivity 
dt - nn - 
Phrase13657:
the control 
dt - nn - 
Phrase13658:
normal donor 
jj - nn - 
Phrase13659:
the capacity 
dt - nn - 
Phrase13660:
the receptor 
dt - nn - 
Phrase13661:
low in 
jj - nn - 
Phrase13662:
the receptor 
dt - nn - 
Phrase13663:
the typical sedimentation 
dt - jj - nn - 
Phrase13664:
normal in 
jj - nn - 
Phrase13665:
lower salt 
jjr - nn - 
Phrase13666:
the 1,25(oh)2d3 
dt - nn - 
Phrase13667:
typical nuclear localization 
jj - jj - nn - 
Phrase13668:
the unoccupied 1,25(oh)2d3 
dt - jj - nn - 
Phrase13669:
the nucleus 
dt - nn - 
Phrase13670:
functional studies 
jj - nns - 
Phrase13671:
we 
prp - 
Phrase13672:
the level 
dt - nn - 
Phrase13673:
the mrnas 
dt - nns - 
Phrase13674:
both c-myc 
dt - nn - 
Phrase13675:
the growth 
dt - nn - 
Phrase13676:
the 1,25(oh)2d3 
dt - nn - 
Phrase13677:
these cells 
dt - nns - 
Phrase13678:
these cell 
dt - nn - 
Phrase13679:
the molecular 
dt - nn - 
Phrase13680:
the receptor 
dt - nn - 
Phrase13681:
d-dependent rickets 
jj - nn - 
Phrase13682:
cellular functions 
jj - nns - 
Phrase13683:
post-transcriptional regulation 
jj - nn - 
Phrase13684:
monocytic differentiation 
jj - nn - 
Phrase13685:
leukemic cells 
jj - nns - 
Phrase13686:
the polypeptide 
dt - nn - 
Phrase13687:
specific dna 
jj - nn - 
Phrase13688:
certain growth 
jj - nn - 
Phrase13689:
we 
prp - 
Phrase13690:
the effects 
dt - nns - 
Phrase13691:
the regulation 
dt - nn - 
Phrase13692:
monocytic differentiation 
jj - nn - 
Phrase13693:
low levels 
jj - nns - 
Phrase13694:
detectable in 
jj - nn - 
Phrase13695:
untreated hl-60 
jj - nn - 
Phrase13696:
leukemic cells 
jj - nns - 
Phrase13697:
maximal levels 
jj - nns - 
Phrase13698:
similar kinetics 
jj - nn - 
Phrase13699:
monocytic leukemia 
jj - nn - 
Phrase13700:
similar findings 
jj - nns - 
Phrase13701:
another activator 
dt - nn - 
Phrase13702:
monocytic differentiation 
jj - nn - 
Phrase13703:
distinct agent 
jj - nn - 
Phrase13704:
monocytic differentiation 
jj - nn - 
Phrase13705:
the presence 
dt - nn - 
Phrase13706:
run-on analysis 
jj - nn - 
Phrase13707:
detectable levels 
jj - nns - 
Phrase13708:
untreated hl-60 
jj - nn - 
Phrase13709:
this rate 
dt - nn - 
Phrase13710:
both tpa 
dt - nn - 
Phrase13711:
the rates 
dt - nns - 
Phrase13712:
the half-life 
dt - nn - 
Phrase13713:
the half-life 
dt - nn - 
Phrase13714:
tpa-treated hl-60 
jj - nn - 
Phrase13715:
these findings 
dt - nns - 
Phrase13716:
the increase 
dt - nn - 
Phrase13717:
tpa-induced monocytic differentiation 
jj - jj - nn - 
Phrase13718:
post-transcriptional mechanisms 
jj - nns - 
Phrase13719:
hormonal interactions 
jj - nns - 
Phrase13720:
the nephrotic 
dt - nn - 
Phrase13721:
the thyroid 
dt - nn - 
Phrase13722:
different variants 
jj - nns - 
Phrase13723:
biochemical signs 
jj - nns - 
Phrase13724:
primary hypothyroidism 
jj - nn - 
Phrase13725:
biochemical signs 
jj - nns - 
Phrase13726:
secondary hypothyroidism 
jj - nn - 
Phrase13727:
low content 
jj - nn - 
Phrase13728:
the hypophyseal 
dt - nn - 
Phrase13729:
it 
prp - 
Phrase13730:
the low level 
dt - jj - nn - 
Phrase13731:
the low level 
dt - jj - nn - 
Phrase13732:
the signs 
dt - nns - 
Phrase13733:
renal dysplasia 
jj - nn - 
Phrase13734:
it 
prp - 
Phrase13735:
such conditions 
jj - nns - 
Phrase13736:
immune glomerulopathy 
jj - nn - 
Phrase13737:
the resistance 
dt - nn - 
Phrase13738:
the treatment 
dt - nn - 
Phrase13739:
lymphoid specific gene 
jj - jj - nn - 
Phrase13740:
the adenovirus 
dt - nn - 
Phrase13741:
early region 
jj - nn - 
Phrase13742:
primary site 
jj - nn - 
Phrase13743:
lymphoid cells 
jj - nns - 
Phrase13744:
the viral control 
dt - jj - nn - 
Phrase13745:
the cellular factors 
dt - jj - nn - 
Phrase13746:
adenoviral gene 
jj - nn - 
Phrase13747:
the adenovirus 
dt - nn - 
Phrase13748:
early region 
jj - nn - 
Phrase13749:
the maintenance 
dt - nn - 
Phrase13750:
viral persistence 
jj - nn - 
Phrase13751:
the class 
dt - nn - 
Phrase13752:
their 
prp$ - 
Phrase13753:
resultant decrease 
jj - nn - 
Phrase13754:
immunologic destruction 
jj - nn - 
Phrase13755:
different cellular factors 
jj - jj - nn - 
Phrase13756:
the e3 
dt - nn - 
Phrase13757:
these studies 
dt - nns - 
Phrase13758:
novel domains 
jj - nns - 
Phrase13759:
these domains 
dt - nns - 
Phrase13760:
strong homology 
jj - nn - 
Phrase13761:
the cellular factor 
dt - jj - nn - 
Phrase13762:
the chloramphenicol 
dt - nn - 
Phrase13763:
the distal nf-kappa 
dt - jj - nn - 
Phrase13764:
minimal effects 
jj - nns - 
Phrase13765:
dramatic decreases 
jj - nns - 
Phrase13766:
lymphoid cells 
jj - nns - 
Phrase13767:
minimal effects 
jj - nns - 
Phrase13768:
lymphoid cells 
jj - nns - 
Phrase13769:
lymphoid cells 
jj - nns - 
Phrase13770:
the l2 
dt - nn - 
Phrase13771:
the position 
dt - nn - 
Phrase13772:
subsequent mutagenesis 
jj - nn - 
Phrase13773:
the l1 
dt - nn - 
Phrase13774:
the primary sequence 
dt - jj - nn - 
Phrase13775:
these motifs 
dt - nns - 
Phrase13776:
their 
prp$ - 
Phrase13777:
the e3 
dt - nn - 
Phrase13778:
the phop 
dt - nn - 
Phrase13779:
the defensin 
dt - nn - 
Phrase13780:
the phop/phoq 
dt - nn - 
Phrase13781:
the regulatory pair 
dt - jj - nn - 
Phrase13782:
transcriptional activator 
jj - nn - 
Phrase13783:
the phoq 
dt - nn - 
Phrase13784:
anionic domain 
jj - nn - 
Phrase13785:
we 
prp - 
Phrase13786:
the phoq 
dt - nn - 
Phrase13787:
the absence 
dt - nn - 
Phrase13788:
the phoq 
dt - nn - 
Phrase13789:
we 
prp - 
Phrase13790:
the function 
dt - nn - 
Phrase13791:
both components 
dt - nns - 
Phrase13792:
this regulatory system 
dt - jj - nn - 
Phrase13793:
we 
prp - 
Phrase13794:
the ability 
dt - nn - 
Phrase13795:
pag expression 
dt - nn - 
Phrase13796:
these peptides 
dt - nns - 
Phrase13797:
the phop-phoq 
dt - nn - 
Phrase13798:
the phop 
dt - nn - 
Phrase13799:
constitutive pag 
jj - nn - 
Phrase13800:
they 
prp - 
Phrase13801:
the organism 
dt - nn - 
Phrase13802:
deficient in 
jj - nn - 
Phrase13803:
the virulence 
dt - nn - 
Phrase13804:
the phop-phoq 
dt - nn - 
Phrase13805:
regulatory system 
jj - nn - 
Phrase13806:
the control 
dt - nn - 
Phrase13807:
other proteins 
jj - nns - 
Phrase13808:
s. 
nnp - 
Phrase13809:
enhancer-dependent transcription 
jj - nn - 
Phrase13810:
the expression 
dt - nn - 
Phrase13811:
the control 
dt - nn - 
Phrase13812:
the long terminal 
dt - jj - nn - 
Phrase13813:
the human 
dt - nn - 
Phrase13814:
its 
prp$ - 
Phrase13815:
the translocation 
dt - nn - 
Phrase13816:
the hiv 
dt - nn - 
Phrase13817:
enhancer-binding protein 
jj - nn - 
Phrase13818:
their 
prp$ - 
Phrase13819:
we 
prp - 
Phrase13820:
either hiv 
dt - nn - 
Phrase13821:
the hiv 
dt - nn - 
Phrase13822:
specific antigen 
jj - nn - 
Phrase13823:
latter signals 
jj - nns - 
Phrase13824:
the band-shift 
dt - nn - 
Phrase13825:
our 
prp$ - 
Phrase13826:
enhancer-dependent transcription 
jj - nn - 
Phrase13827:
lymphoblastoid t-cell 
jj - nn - 
Phrase13828:
normal t 
jj - nn - 
Phrase13829:
our 
prp$ - 
Phrase13830:
functional interactions 
jj - nns - 
Phrase13831:
the nf-kappa 
dt - nn - 
Phrase13832:
the hiv 
dt - nn - 
Phrase13833:
peripheral mononuclear 
jj - nn - 
Phrase13834:
x-linked hypophosphatemic 
jj - nn - 
Phrase13835:
abnormal renal tubular 
jj - jj - nn - 
Phrase13836:
the primary defect 
dt - jj - nn - 
Phrase13837:
x-linked hypophosphatemic 
jj - nn - 
Phrase13838:
the resistance 
dt - nn - 
Phrase13839:
the actions 
dt - nns - 
Phrase13840:
its 
prp$ - 
Phrase13841:
this possibility 
dt - nn - 
Phrase13842:
we 
prp - 
Phrase13843:
the concentration 
dt - nn - 
Phrase13844:
pha-activated peripheral mononuclear 
jj - jj - nn - 
Phrase13845:
lower concentration 
jjr - nn - 
Phrase13846:
the normal controls 
dt - jj - nns - 
Phrase13847:
the contrary 
dt - nn - 
Phrase13848:
significant difference 
jj - nn - 
Phrase13849:
the phosphate-supplemented 
dt - nn - 
Phrase13850:
significant positive correlation 
jj - jj - nn - 
Phrase13851:
these results 
dt - nns - 
Phrase13852:
persistent hypophosphatemia 
jj - nn - 
Phrase13853:
distinct forms 
jj - nns - 
Phrase13854:
active transcription 
jj - nn - 
Phrase13855:
mammalian cells 
jj - nns - 
Phrase13856:
distinct forms 
jj - nns - 
Phrase13857:
the products 
dt - nns - 
Phrase13858:
the creb 
dt - nn - 
Phrase13859:
the creb 
dt - nn - 
Phrase13860:
we 
prp - 
Phrase13861:
both creb 
dt - nn - 
Phrase13862:
many cell 
jj - nn - 
Phrase13863:
mammalian species 
jj - nns - 
Phrase13864:
this class 
dt - nn - 
Phrase13865:
the creb 
dt - nn - 
Phrase13866:
camp-regulated transcriptional activity 
jj - jj - nn - 
Phrase13867:
heterologous dna-binding 
jj - nn - 
Phrase13868:
the transcriptional stimulatory activity 
dt - jj - jj - nn - 
Phrase13869:
the presence 
dt - nn - 
Phrase13870:
multiple creb 
jj - nn - 
Phrase13871:
identical dna-binding 
jj - nn - 
Phrase13872:
regulatory domain 
jj - nn - 
Phrase13873:
the possibility 
dt - nn - 
Phrase13874:
distinct regulatory signals 
jj - jj - nns - 
Phrase13875:
the level 
dt - nn - 
Phrase13876:
regulatory protein 
jj - nn - 
Phrase13877:
the vpr 
dt - nn - 
Phrase13878:
the human 
dt - nn - 
Phrase13879:
cytopathic effect 
jj - nn - 
Phrase13880:
it 
prp - 
Phrase13881:
the hiv-1 
dt - nn - 
Phrase13882:
viral particle 
jj - nn - 
Phrase13883:
multiple copies 
jj - nns - 
Phrase13884:
the vpr 
dt - nn - 
Phrase13885:
the vpr 
dt - nn - 
Phrase13886:
the first regulatory protein 
dt - jj - jj - nn - 
Phrase13887:
the virus 
dt - nn - 
Phrase13888:
the possibility 
dt - nn - 
Phrase13889:
the early steps 
dt - jj - nns - 
Phrase13890:
viral protein 
jj - nn - 
Phrase13891:
novel b-cell 
jj - nn - 
Phrase13892:
lineage-specific transcription 
jj - nn - 
Phrase13893:
late stages 
jj - nns - 
Phrase13894:
novel b-cell-specific transcription 
jj - jj - nn - 
Phrase13895:
mammalian homolog 
jj - nn - 
Phrase13896:
the sea 
dt - nn - 
Phrase13897:
the promoters 
dt - nns - 
Phrase13898:
tissue-specific late histone 
jj - jj - nn - 
Phrase13899:
mutational analyses 
jj - nns - 
Phrase13900:
the mammalian protein 
dt - jj - nn - 
Phrase13901:
the b-cell 
dt - nn - 
Phrase13902:
lymphoid differentiation 
jj - nn - 
Phrase13903:
its 
prp$ - 
Phrase13904:
pro-b-cell development 
jj - nn - 
Phrase13905:
abundant at 
jj - nn - 
Phrase13906:
the pre-b- 
dt - nn - 
Phrase13907:
mature b-cell 
jj - nn - 
Phrase13908:
absent in 
jj - nn - 
Phrase13909:
b-cell-specific transcription 
jj - nn - 
Phrase13910:
the sea 
dt - nn - 
Phrase13911:
an upstream promoter 
dt - jj - nn - 
Phrase13912:
any high-affinity 
dt - nn - 
Phrase13913:
regulatory regions 
jj - nns - 
Phrase13914:
major histocompatibility 
jj - nn - 
Phrase13915:
different set 
jj - nn - 
Phrase13916:
the cell 
dt - nn - 
Phrase13917:
the expression 
dt - nn - 
Phrase13918:
the antibody-encoding 
dt - nn - 
Phrase13919:
the immunoglobulin 
dt - nn - 
Phrase13920:
the octamer 
dt - nn - 
Phrase13921:
the promoter 
dt - nn - 
Phrase13922:
the enhancer 
dt - nn - 
Phrase13923:
an important role 
dt - jj - nn - 
Phrase13924:
its 
prp$ - 
Phrase13925:
tissue-specific expression 
jj - nn - 
Phrase13926:
nuclear proteins 
jj - nns - 
Phrase13927:
the so-called octamer 
dt - jj - nn - 
Phrase13928:
the oct-1 
dt - nn - 
Phrase13929:
the same sequence 
dt - jj - nn - 
Phrase13930:
it 
prp - 
Phrase13931:
the b 
dt - nn - 
Phrase13932:
cell-specific expression 
jj - nn - 
Phrase13933:
least in 
jjs - nn - 
Phrase13934:
type-specific oct 
jj - nn - 
Phrase13935:
qualitative differences 
jj - nns - 
Phrase13936:
other octamer 
jj - nn - 
Phrase13937:
these may 
dt - nn - 
Phrase13938:
primary transcript 
jj - nn - 
Phrase13939:
specific function 
jj - nn - 
Phrase13940:
the fine 
dt - nn - 
Phrase13941:
endogenous ig 
jj - nn - 
Phrase13942:
heavy chain 
jj - nn - 
Phrase13943:
active transcription 
jj - nn - 
Phrase13944:
the transcriptional enhancer 
dt - jj - nn - 
Phrase13945:
located in 
jj - nn - 
Phrase13946:
the first intron 
dt - jj - nn - 
Phrase13947:
the immunoglobulin 
dt - nn - 
Phrase13948:
heavy chain 
jj - nn - 
Phrase13949:
major determinant 
jj - nn - 
Phrase13950:
b-cell-specific expression 
jj - nn - 
Phrase13951:
other enhancers 
jj - nns - 
Phrase13952:
the ig 
dt - nn - 
Phrase13953:
heavy chain 
jj - nn - 
Phrase13954:
several short sequence 
jj - jj - nn - 
Phrase13955:
specific transcription 
jj - nn - 
Phrase13956:
each binding 
dt - nn - 
Phrase13957:
the overall activity 
dt - jj - nn - 
Phrase13958:
the enhancer 
dt - nn - 
Phrase13959:
single element 
jj - nn - 
Phrase13960:
better understanding 
jjr - nn - 
Phrase13961:
the ig 
dt - nn - 
Phrase13962:
heavy chain 
jj - nn - 
Phrase13963:
we 
prp - 
Phrase13964:
we 
prp - 
Phrase13965:
the factor 
dt - nn - 
Phrase13966:
the e3 
dt - nn - 
Phrase13967:
ubiquitous transcription 
jj - nn - 
Phrase13968:
it 
prp - 
Phrase13969:
an active form 
dt - jj - nn - 
Phrase13970:
non-b cells 
jj - nns - 
Phrase13971:
it 
prp - 
Phrase13972:
transcriptional activation 
jj - nn - 
Phrase13973:
its 
prp$ - 
Phrase13974:
the factor 
dt - nn - 
Phrase13975:
the endogenous ig 
dt - jj - nn - 
Phrase13976:
heavy chain 
jj - nn - 
Phrase13977:
non-lymphoid cells 
jj - nns - 
Phrase13978:
previous experiments 
jj - nns - 
Phrase13979:
the characteristic 
dt - nn - 
Phrase13980:
this factor 
dt - nn - 
Phrase13981:
non-b cells 
jj - nns - 
Phrase13982:
other findings 
jj - nns - 
Phrase13983:
the picture 
dt - nn - 
Phrase13984:
cell-type-specific transcription 
jj - nn - 
Phrase13985:
cell-specific factors 
jj - nn - 
Phrase13986:
other cell 
jj - nn - 
Phrase13987:
ubiquitous factors 
jj - nn - 
Phrase13988:
active in 
jj - nn - 
Phrase13989:
an inactive form 
dt - jj - nn - 
Phrase13990:
other cells 
jj - nns - 
Phrase13991:
active factors 
jj - nn - 
Phrase13992:
the one 
dt - nn - 
Phrase13993:
the e3 
dt - nn - 
Phrase13994:
an active form 
dt - jj - nn - 
Phrase13995:
the endogenous ig 
dt - jj - nn - 
Phrase13996:
heavy chain 
jj - nn - 
Phrase13997:
non-b cells 
jj - nns - 
Phrase13998:
the ig 
dt - nn - 
Phrase13999:
heavy chain 
jj - nn - 
Phrase14000:
bronchial asthma 
jj - nn - 
Phrase14001:
bronchial asthma 
jj - nn - 
Phrase14002:
the authors 
dt - nns - 
Phrase14003:
the functional activity 
dt - jj - nn - 
Phrase14004:
the intensity 
dt - nn - 
Phrase14005:
bronchial patency 
jj - nn - 
Phrase14006:
the nature 
dt - nn - 
Phrase14007:
the therapeutic measures 
dt - jj - nns - 
Phrase14008:
independent activation 
jj - nn - 
Phrase14009:
the human 
dt - nn - 
Phrase14010:
multiple regulatory elements 
jj - jj - nns - 
Phrase14011:
the human 
dt - nn - 
Phrase14012:
long terminal 
jj - nn - 
Phrase14013:
previous transfection 
jj - nn - 
Phrase14014:
the chloramphenicol 
dt - nn - 
Phrase14015:
multiple regulatory regions 
jj - jj - nns - 
Phrase14016:
the enhancer 
dt - nn - 
Phrase14017:
these regulatory elements 
dt - jj - nns - 
Phrase14018:
these regions 
dt - nns - 
Phrase14019:
both 5' 
dt - nn - 
Phrase14020:
3' hiv 
jj - nn - 
Phrase14021:
infectious proviral constructs 
jj - jj - nns - 
Phrase14022:
these constructs 
dt - nns - 
Phrase14023:
either hela 
dt - nn - 
Phrase14024:
the presence 
dt - nn - 
Phrase14025:
viral gene 
jj - nn - 
Phrase14026:
the level 
dt - nn - 
Phrase14027:
the proviral constructs 
dt - jj - nns - 
Phrase14028:
the sp1 
dt - nn - 
Phrase14029:
the tar 
dt - nn - 
Phrase14030:
secondary structure 
jj - nn - 
Phrase14031:
marked decreases 
jj - nns - 
Phrase14032:
the enhancer 
dt - nn - 
Phrase14033:
primary sequence 
jj - nn - 
Phrase14034:
slight decreases 
jj - nns - 
Phrase14035:
the tar 
dt - nn - 
Phrase14036:
secondary structure 
jj - nn - 
Phrase14037:
untreated jurkat 
jj - nn - 
Phrase14038:
wild-type levels 
jj - nns - 
Phrase14039:
high level 
jj - nn - 
Phrase14040:
these tar 
dt - nn - 
Phrase14041:
the enhancer 
dt - nn - 
Phrase14042:
the tat 
dt - nn - 
Phrase14043:
nuclear triiodothyronine 
jj - nn - 
Phrase14044:
52-year-old male 
jj - nn - 
Phrase14045:
the thyroid 
dt - nn - 
Phrase14046:
free t4 
jj - nn - 
Phrase14047:
the tsh 
dt - nn - 
Phrase14048:
the lymphocyte 
dt - nn - 
Phrase14049:
nuclear t3 
jj - nn - 
Phrase14050:
an affinity 
dt - nn - 
Phrase14051:
normal volunteers 
jj - nns - 
Phrase14052:
the dysrhythmia 
dt - nn - 
Phrase14053:
the antithyroid drug 
dt - jj - nn - 
Phrase14054:
the plasma 
dt - nn - 
Phrase14055:
the patient 
dt - nn - 
Phrase14056:
the clinical course 
dt - jj - nn - 
Phrase14057:
the laboratory 
dt - nn - 
Phrase14058:
the tachycardia 
dt - nn - 
Phrase14059:
the consequence 
dt - nn - 
Phrase14060:
the heart 
dt - nn - 
Phrase14061:
nuclear receptor 
jj - nn - 
Phrase14062:
immediate early response 
jj - jj - nn - 
Phrase14063:
colony-stimulating factor 
jj - nn - 
Phrase14064:
normal human 
jj - nn - 
Phrase14065:
extracellular matrix 
jj - nn - 
Phrase14066:
immediate early response 
jj - jj - nn - 
Phrase14067:
their 
prp$ - 
Phrase14068:
we 
prp - 
Phrase14069:
the induction 
dt - nn - 
Phrase14070:
these genes 
dt - nns - 
Phrase14071:
the factor 
dt - nn - 
Phrase14072:
optimal cell 
jj - nn - 
Phrase14073:
normal human 
jj - nn - 
Phrase14074:
fetal bovine 
jj - nn - 
Phrase14075:
serum-containing medium 
jj - nn - 
Phrase14076:
the end 
dt - nn - 
Phrase14077:
this incubation 
dt - nn - 
Phrase14078:
the resting 
dt - nn - 
Phrase14079:
undetectable levels 
jj - nns - 
Phrase14080:
dramatic coordinate 
jj - nn - 
Phrase14081:
these genes 
dt - nns - 
Phrase14082:
the c-jun 
dt - nn - 
Phrase14083:
the expression 
dt - nn - 
Phrase14084:
the expression 
dt - nn - 
Phrase14085:
these genes 
dt - nns - 
Phrase14086:
we 
prp - 
Phrase14087:
the induction 
dt - nn - 
Phrase14088:
the myelomonocytic specific tyrosine 
dt - jj - jj - nn - 
Phrase14089:
the other immediate early response 
dt - jj - jj - jj - nn - 
Phrase14090:
the protein 
dt - nn - 
Phrase14091:
the induction 
dt - nn - 
Phrase14092:
these genes 
dt - nns - 
Phrase14093:
the expression 
dt - nn - 
Phrase14094:
nuclear run 
jj - nn - 
Phrase14095:
the c-jun 
dt - nn - 
Phrase14096:
normal human 
jj - nn - 
Phrase14097:
immediate early response 
jj - jj - nn - 
Phrase14098:
these genes 
dt - nns - 
Phrase14099:
the physiologic status 
dt - jj - nn - 
Phrase14100:
the cells 
dt - nns - 
Phrase14101:
inducible nuclear factor 
jj - jj - nn - 
Phrase14102:
the kappa 
dt - nn - 
Phrase14103:
the human 
dt - nn - 
Phrase14104:
its 
prp$ - 
Phrase14105:
immunosuppressive effects 
jj - nns - 
Phrase14106:
the expression 
dt - nn - 
Phrase14107:
distinct set 
jj - nn - 
Phrase14108:
them 
prp - 
Phrase14109:
the gene 
dt - nn - 
Phrase14110:
the activation 
dt - nn - 
Phrase14111:
the human 
dt - nn - 
Phrase14112:
the molecular 
dt - nn - 
Phrase14113:
we 
prp - 
Phrase14114:
the effects 
dt - nns - 
Phrase14115:
this drug 
dt - nn - 
Phrase14116:
we 
prp - 
Phrase14117:
the formation 
dt - nn - 
Phrase14118:
distinct mitogen-inducible 
jj - nn - 
Phrase14119:
the kappa 
dt - nn - 
Phrase14120:
the hiv 
dt - nn - 
Phrase14121:
the nfat-1 
dt - nn - 
Phrase14122:
the interleukin-2 
dt - nn - 
Phrase14123:
the presence 
dt - nn - 
Phrase14124:
the kappa 
dt - nn - 
Phrase14125:
the hiv 
dt - nn - 
Phrase14126:
it 
prp - 
Phrase14127:
the mitogen 
dt - nn - 
Phrase14128:
the drug 
dt - nn - 
Phrase14129:
indistinguishable kappa 
jj - nn - 
Phrase14130:
separate pathways 
jj - nns - 
Phrase14131:
t-cell-specific transcription 
jj - nn - 
Phrase14132:
the t-cell 
dt - nn - 
Phrase14133:
context-dependent manner 
jj - nn - 
Phrase14134:
the differentiation 
dt - nn - 
Phrase14135:
diverse subpopulations 
jj - nns - 
Phrase14136:
transcriptional activation 
jj - nn - 
Phrase14137:
the proteins 
dt - nns - 
Phrase14138:
this developmental process 
dt - jj - nn - 
Phrase14139:
we 
prp - 
Phrase14140:
t-cell-specific factor 
jj - nn - 
Phrase14141:
the activation 
dt - nn - 
Phrase14142:
major component 
jj - nn - 
Phrase14143:
the human 
dt - nn - 
Phrase14144:
its 
prp$ - 
Phrase14145:
the hiv-1 
dt - nn - 
Phrase14146:
the tcr 
dt - nn - 
Phrase14147:
several genes 
jj - nns - 
Phrase14148:
earlier stages 
jjr - nns - 
Phrase14149:
the tcr 
dt - nn - 
Phrase14150:
the tcf-1 
dt - nn - 
Phrase14151:
the human 
dt - nn - 
Phrase14152:
the use 
dt - nn - 
Phrase14153:
immature t-cell 
jj - nn - 
Phrase14154:
mature b 
jj - nn - 
Phrase14155:
small 95-bp 
jj - nn - 
Phrase14156:
the tcr 
dt - nn - 
Phrase14157:
the tcf-1 
dt - nn - 
Phrase14158:
the cre 
dt - nn - 
Phrase14159:
the binding 
dt - nn - 
Phrase14160:
distinct lymphoid-specific protein 
jj - jj - nn - 
Phrase14161:
t-cell-specific enhancer 
jj - nn - 
Phrase14162:
tandem copies 
jj - nns - 
Phrase14163:
this enhancer 
dt - nn - 
Phrase14164:
the tcf-1 
dt - nn - 
Phrase14165:
the synergism 
dt - nn - 
Phrase14166:
tandem enhancer 
jj - nn - 
Phrase14167:
the tcf-1 
dt - nn - 
Phrase14168:
active extracts 
jj - nns - 
Phrase14169:
t-cell-specific transcription 
jj - nn - 
Phrase14170:
the tcf-1 
dt - nn - 
Phrase14171:
inactive in 
jj - nn - 
Phrase14172:
its 
prp$ - 
Phrase14173:
neighboring elements 
jj - nns - 
Phrase14174:
the tcr 
dt - nn - 
Phrase14175:
positioned in 
jj - nn - 
Phrase14176:
heterologous promoter 
jj - nn - 
Phrase14177:
the transcriptional activity 
dt - jj - nn - 
Phrase14178:
the tcf-2 
dt - nn - 
Phrase14179:
the context 
dt - nn - 
Phrase14180:
its 
prp$ - 
Phrase14181:
the tcr 
dt - nn - 
Phrase14182:
tandem ap-1-binding sites 
jj - jj - nns - 
Phrase14183:
the human 
dt - nn - 
Phrase14184:
dominant control 
jj - nn - 
Phrase14185:
an inducible enhancer 
dt - jj - nn - 
Phrase14186:
erythroid cells 
jj - nns - 
Phrase14187:
powerful enhancer 
jj - nn - 
Phrase14188:
an 18-bp 
dt - nn - 
Phrase14189:
the human 
dt - nn - 
Phrase14190:
the dominant control 
dt - jj - nn - 
Phrase14191:
inducible in 
jj - nn - 
Phrase14192:
an enhancerless construct 
dt - jj - nn - 
Phrase14193:
the enhancer 
dt - nn - 
Phrase14194:
tandem ap-1-binding sites 
jj - jj - nns - 
Phrase14195:
full activity 
jj - nn - 
Phrase14196:
nuclear extracts 
jj - nns - 
Phrase14197:
high molecular 
jj - nn - 
Phrase14198:
the enhancer 
dt - nn - 
Phrase14199:
the formation 
dt - nn - 
Phrase14200:
this complex 
dt - nn - 
Phrase14201:
both ap-1 
dt - nn - 
Phrase14202:
maximal enhancer 
jj - nn - 
Phrase14203:
the enhancer 
dt - nn - 
Phrase14204:
the increase 
dt - nn - 
Phrase14205:
erythroid maturation 
jj - nn - 
Phrase14206:
the binding 
dt - nn - 
Phrase14207:
the jun 
dt - nn - 
Phrase14208:
tandem ap-1 
jj - nn - 
Phrase14209:
novel factor 
jj - nn - 
Phrase14210:
an immunoglobulin 
dt - nn - 
Phrase14211:
the lymphoid cell-specific factor 
dt - jj - jj - nn - 
Phrase14212:
the tissue-specific expression 
dt - jj - nn - 
Phrase14213:
the mopc 
dt - nn - 
Phrase14214:
b-cell-specific transcription 
jj - nn - 
Phrase14215:
this gene 
dt - nn - 
Phrase14216:
the octamer 
dt - nn - 
Phrase14217:
located in 
jj - nn - 
Phrase14218:
the upstream region 
dt - jj - nn - 
Phrase14219:
this promoter 
dt - nn - 
Phrase14220:
the promoters 
dt - nns - 
Phrase14221:
other immunoglobulin 
jj - nn - 
Phrase14222:
the interaction 
dt - nn - 
Phrase14223:
the mopc 
dt - nn - 
Phrase14224:
electrophoretic mobility 
jj - nn - 
Phrase14225:
identical sequences 
jj - nns - 
Phrase14226:
the heavy-chain 
dt - nn - 
Phrase14227:
the otf 
dt - nn - 
Phrase14228:
we 
prp - 
Phrase14229:
the heptamer 
dt - nn - 
Phrase14230:
it 
prp - 
Phrase14231:
the binding 
dt - nn - 
Phrase14232:
this promoter 
dt - nn - 
Phrase14233:
these elements 
dt - nns - 
Phrase14234:
we 
prp - 
Phrase14235:
regulatory element 
jj - nn - 
Phrase14236:
the n 
dt - nn - 
Phrase14237:
the sequence 
dt - nn - 
Phrase14238:
the n 
dt - nn - 
Phrase14239:
low levels 
jj - nns - 
Phrase14240:
the octamer 
dt - nn - 
Phrase14241:
it 
prp - 
Phrase14242:
high levels 
jj - nns - 
Phrase14243:
the n 
dt - nn - 
Phrase14244:
ubiquitous in 
jj - nn - 
Phrase14245:
similar sequences 
jj - nns - 
Phrase14246:
these results 
dt - nns - 
Phrase14247:
we 
prp - 
Phrase14248:
their 
prp$ - 
Phrase14249:
the protein-protein level 
dt - jj - nn - 
Phrase14250:
b-cell-specific expression 
jj - nn - 
Phrase14251:
these interactions 
dt - nns - 
Phrase14252:
additional pathways 
jj - nns - 
Phrase14253:
inducible transcriptional activator 
jj - jj - nn - 
Phrase14254:
the granulocyte-macrophage 
dt - nn - 
Phrase14255:
colony-stimulating factor 
jj - nn - 
Phrase14256:
the expression 
dt - nn - 
Phrase14257:
the gene 
dt - nn - 
Phrase14258:
the granulocyte-macrophage 
dt - nn - 
Phrase14259:
colony-stimulating factor 
jj - nn - 
Phrase14260:
active phorbolester 
jj - nn - 
Phrase14261:
the human 
dt - nn - 
Phrase14262:
the same agents 
dt - jj - nns - 
Phrase14263:
the interleukin-2 
dt - nn - 
Phrase14264:
the inducible transcription 
dt - jj - nn - 
Phrase14265:
an nf-kappa 
dt - nn - 
Phrase14266:
b-like factor 
jj - nn - 
Phrase14267:
we 
prp - 
Phrase14268:
the possibility 
dt - nn - 
Phrase14269:
the gm-csf 
dt - nn - 
Phrase14270:
the nf-kappa 
dt - nn - 
Phrase14271:
recent functional analysis 
jj - jj - nn - 
Phrase14272:
s. 
nnp - 
Phrase14273:
biol. 
nnp - 
Phrase14274:
short promoter 
jj - nn - 
Phrase14275:
the gm-csf 
dt - nn - 
Phrase14276:
strong inducibility 
jj - nn - 
Phrase14277:
t-cell-activating signals 
jj - nns - 
Phrase14278:
electrophoretic mobility 
jj - nn - 
Phrase14279:
we 
prp - 
Phrase14280:
the nf-kappa 
dt - nn - 
Phrase14281:
an oligonucleotide 
dt - nn - 
Phrase14282:
the gm-csf 
dt - nn - 
Phrase14283:
t-cell-activating signals 
jj - nns - 
Phrase14284:
the gm-csf 
dt - nn - 
Phrase14285:
an affinity 
dt - nn - 
Phrase14286:
it 
prp - 
Phrase14287:
functional kappa 
jj - nn - 
Phrase14288:
the beta 
dt - nn - 
Phrase14289:
b-like motifs 
jj - nns - 
Phrase14290:
the gm-csf 
dt - nn - 
Phrase14291:
much lower affinities 
jj - jjr - nns - 
Phrase14292:
our 
prp$ - 
Phrase14293:
strong evidence 
jj - nn - 
Phrase14294:
the expression 
dt - nn - 
Phrase14295:
the gm-csf 
dt - nn - 
Phrase14296:
the nf-kappa 
dt - nn - 
Phrase14297:
the gm-csf 
dt - nn - 
Phrase14298:
mitogenic agents 
jj - nns - 
Phrase14299:
tonsillar t-lymphocytes 
jj - nns - 
Phrase14300:
the treatment 
dt - nn - 
Phrase14301:
tonsillar t-lymphocytes 
jj - nns - 
Phrase14302:
any significant change 
dt - jj - nn - 
Phrase14303:
the receptor 
dt - nn - 
Phrase14304:
the presence 
dt - nn - 
Phrase14305:
the stimulatory effect 
dt - jj - nn - 
Phrase14306:
these agents 
dt - nns - 
Phrase14307:
the suppressive effect 
dt - jj - nn - 
Phrase14308:
the suppression 
dt - nn - 
Phrase14309:
ubiquitous oligopeptides 
jj - nn - 
Phrase14310:
the same language 
dt - jj - nn - 
Phrase14311:
the same set 
dt - jj - nn - 
Phrase14312:
unrelated proteins 
jj - nns - 
Phrase14313:
the reason 
dt - nn - 
Phrase14314:
certain individuals 
jj - nns - 
Phrase14315:
particular major histocompatibility 
jj - jj - nn - 
Phrase14316:
the fact 
dt - nn - 
Phrase14317:
18-20 residue-long 
dt - nn - 
Phrase14318:
this range 
dt - nn - 
Phrase14319:
the remainders 
dt - nn - 
Phrase14320:
distinct signal 
jj - nn - 
Phrase14321:
an immunophilin 
dt - nn - 
Phrase14322:
either fk506 
dt - nn - 
Phrase14323:
immunologic function 
jj - nn - 
Phrase14324:
the antigen 
dt - nn - 
Phrase14325:
the immunosuppressant 
dt - nn - 
Phrase14326:
its 
prp$ - 
Phrase14327:
structural analog 
jj - nn - 
Phrase14328:
the other hand 
dt - jj - nn - 
Phrase14329:
-induced signals 
jj - nns - 
Phrase14330:
the possibility 
dt - nn - 
Phrase14331:
we 
prp - 
Phrase14332:
the dissociation 
dt - nn - 
Phrase14333:
the fk506 
dt - nn - 
Phrase14334:
the dissociation 
dt - nn - 
Phrase14335:
their 
prp$ - 
Phrase14336:
effective biologic inhibitory concentrations 
jj - jj - jj - nns - 
Phrase14337:
an excess 
dt - nn - 
Phrase14338:
fk506-mediated inhibition 
dt - nn - 
Phrase14339:
transcriptional activation 
jj - nn - 
Phrase14340:
t-cell-specific transcription 
jj - nn - 
Phrase14341:
an excess 
dt - nn - 
Phrase14342:
rapamycin-mediated inhibition 
dt - nn - 
Phrase14343:
il-2-induced proliferation 
jj - nn - 
Phrase14344:
the drug 
dt - nn - 
Phrase14345:
the relative 
dt - nn - 
Phrase14346:
the drugs 
dt - nns - 
Phrase14347:
the abundance 
dt - nn - 
Phrase14348:
the immunophilin 
dt - nn - 
Phrase14349:
the interconversion 
dt - nn - 
Phrase14350:
the peptidyl-prolyl 
dt - nn - 
Phrase14351:
we 
prp - 
Phrase14352:
the rotamase 
dt - nn - 
Phrase14353:
the biologic actions 
dt - jj - nns - 
Phrase14354:
these drugs 
dt - nns - 
Phrase14355:
these findings 
dt - nns - 
Phrase14356:
receptor-induced signals 
jj - nns - 
Phrase14357:
the immunophilin 
dt - nn - 
Phrase14358:
il-2-induced signals 
jj - nns - 
Phrase14359:
adherence-dependent increase 
jj - nn - 
Phrase14360:
an important initial step 
dt - jj - jj - nn - 
Phrase14361:
the transition 
dt - nn - 
Phrase14362:
an augmented capacity 
dt - jj - nn - 
Phrase14363:
we 
prp - 
Phrase14364:
itself 
prp - 
Phrase14365:
an important trigger 
dt - jj - nn - 
Phrase14366:
biphasic increase 
jj - nn - 
Phrase14367:
the 6-h 
dt - nn - 
Phrase14368:
the cytoskeletal integrity 
dt - jj - nn - 
Phrase14369:
the 6-h 
dt - nn - 
Phrase14370:
the presence 
dt - nn - 
Phrase14371:
the monocyte 
dt - nn - 
Phrase14372:
either fibronectin 
dt - nn - 
Phrase14373:
little consistent effect 
jj - jj - nn - 
Phrase14374:
adherent monocytes 
jj - nns - 
Phrase14375:
the early growth 
dt - jj - nn - 
Phrase14376:
maximal at 
jj - nn - 
Phrase14377:
maximal at 
jj - nn - 
Phrase14378:
the increase 
dt - nn - 
Phrase14379:
these observations 
dt - nns - 
Phrase14380:
the increases 
dt - nns - 
Phrase14381:
cytoskeletal rearrangement 
jj - nn - 
Phrase14382:
these events 
dt - nns - 
Phrase14383:
the time 
dt - nn - 
Phrase14384:
differential priming 
jj - nn - 
Phrase14385:
the cells 
dt - nns - 
Phrase14386:
single cell 
jj - nn - 
Phrase14387:
the t-cell 
dt - nn - 
Phrase14388:
their 
prp$ - 
Phrase14389:
the appearance 
dt - nn - 
Phrase14390:
several transcription 
jj - nn - 
Phrase14391:
immunologic activation 
jj - nn - 
Phrase14392:
the activity 
dt - nn - 
Phrase14393:
single transcription 
jj - nn - 
Phrase14394:
viable cells 
jj - nns - 
Phrase14395:
we 
prp - 
Phrase14396:
an assay 
dt - nn - 
Phrase14397:
the fluorescence-activated 
dt - nn - 
Phrase14398:
we 
prp - 
Phrase14399:
the distribution 
dt - nn - 
Phrase14400:
transcriptional activity 
jj - nn - 
Phrase14401:
tandem copies 
jj - nns - 
Phrase14402:
the nf-at-binding site 
dt - jj - nn - 
Phrase14403:
the lacz 
dt - nn - 
Phrase14404:
bimodal pattern 
jj - nn - 
Phrase14405:
some cells 
dt - nns - 
Phrase14406:
high levels 
jj - nns - 
Phrase14407:
cell-cycle position 
jj - nn - 
Phrase14408:
nf-at-binding activity 
jj - nn - 
Phrase14409:
the concentration 
dt - nn - 
Phrase14410:
critical threshold 
jj - nn - 
Phrase14411:
the nf-at 
dt - nn - 
Phrase14412:
concentration-dependent assembly 
jj - nn - 
Phrase14413:
the promoter 
dt - nn - 
Phrase14414:
similar constructs 
jj - nns - 
Phrase14415:
the entire interleukin-2 
dt - jj - nn - 
Phrase14416:
bimodal expression 
jj - nn - 
Phrase14417:
the concentration 
dt - nn - 
Phrase14418:
inducible genes 
jj - nns - 
Phrase14419:
the epstein-barr virus 
dt - jj - nn - 
Phrase14420:
early antigen 
jj - nn - 
Phrase14421:
the ebv 
dt - nn - 
Phrase14422:
cell-specific manner 
jj - nn - 
Phrase14423:
the epstein-barr virus 
dt - jj - nn - 
Phrase14424:
early antigen 
jj - nn - 
Phrase14425:
diffuse component 
jj - nn - 
Phrase14426:
epstein-barr virus 
jj - nn - 
Phrase14427:
its 
prp$ - 
Phrase14428:
latent infection 
jj - nn - 
Phrase14429:
we 
prp - 
Phrase14430:
the regulation 
dt - nn - 
Phrase14431:
the promoter 
dt - nn - 
Phrase14432:
this early gene 
dt - jj - nn - 
Phrase14433:
its 
prp$ - 
Phrase14434:
immediate-early viral transactivators 
jj - jj - nns - 
Phrase14435:
the differences 
dt - nns - 
Phrase14436:
lymphoid cells 
jj - nns - 
Phrase14437:
lymphoid cells 
jj - nns - 
Phrase14438:
small increases 
jj - nns - 
Phrase14439:
both transactivators 
dt - nns - 
Phrase14440:
large stimulatory effect 
jj - jj - nn - 
Phrase14441:
the z 
dt - nn - 
Phrase14442:
maximal stimulation 
jj - nn - 
Phrase14443:
the ea-d 
dt - nn - 
Phrase14444:
the effect 
dt - nn - 
Phrase14445:
deletional analysis 
jj - nn - 
Phrase14446:
site-directed mutagenesis 
jj - nn - 
Phrase14447:
the ea-d 
dt - nn - 
Phrase14448:
the potential 
dt - nn - 
Phrase14449:
an essential role 
dt - jj - nn - 
Phrase14450:
lymphoid cells 
jj - nns - 
Phrase14451:
the upstream sequences 
dt - jj - nns - 
Phrase14452:
the z/r 
dt - nn - 
Phrase14453:
the ap-1 
dt - nn - 
Phrase14454:
these data 
dt - nns - 
Phrase14455:
different mechanisms 
jj - nns - 
Phrase14456:
each cell 
dt - nn - 
Phrase14457:
complementary dna 
jj - nn - 
Phrase14458:
the human 
dt - nn - 
Phrase14459:
immunosuppressive activity 
jj - nn - 
Phrase14460:
cyclic undecapeptide 
jj - nn - 
Phrase14461:
the recent discovery 
dt - jj - nn - 
Phrase14462:
the cyclosporin 
dt - nn - 
Phrase14463:
a-binding protein 
jj - nn - 
Phrase14464:
cis-trans isomerase 
dt - nn - 
Phrase14465:
cellular binding 
jj - nn - 
Phrase14466:
the same enzymatic activity 
dt - jj - jj - nn - 
Phrase14467:
this study 
dt - nn - 
Phrase14468:
we 
prp - 
Phrase14469:
peripheral blood 
jj - nn - 
Phrase14470:
mixed 20-mer 
jj - nn - 
Phrase14471:
the basis 
dt - nn - 
Phrase14472:
the sequence 
dt - nn - 
Phrase14473:
the dna 
dt - nn - 
Phrase14474:
an open 
dt - nn - 
Phrase14475:
amino-terminal sequence 
jj - nn - 
Phrase14476:
the dna 
dt - nn - 
Phrase14477:
the gene 
dt - nn - 
Phrase14478:
computer-assisted analysis 
jj - nn - 
Phrase14479:
internal homology 
jj - nn - 
Phrase14480:
significant sequence 
jj - nn - 
Phrase14481:
any other amino 
dt - jj - nn - 
Phrase14482:
similar proteins 
jj - nns - 
Phrase14483:
placental cells 
jj - nns - 
Phrase14484:
leukemic t 
jj - nn - 
Phrase14485:
the level 
dt - nn - 
Phrase14486:
genomic dna 
jj - nn - 
Phrase14487:
different restriction 
jj - nn - 
Phrase14488:
the existence 
dt - nn - 
Phrase14489:
few copies 
jj - nns - 
Phrase14490:
the dna 
dt - nn - 
Phrase14491:
the result 
dt - nn - 
Phrase14492:
the cyclophilin 
dt - nn - 
Phrase14493:
possible pseudogenes 
jj - nn - 
Phrase14494:
the mammalian genome 
dt - jj - nn - 
Phrase14495:
lymphoid-specific enhancer 
jj - nn - 
Phrase14496:
the regulation 
dt - nn - 
Phrase14497:
lymphoid-specific expression 
jj - nn - 
Phrase14498:
the immunoglobulin 
dt - nn - 
Phrase14499:
we 
prp - 
Phrase14500:
the effect 
dt - nn - 
Phrase14501:
the binding 
dt - nn - 
Phrase14502:
putative additional lymphoid-specific transcription 
jj - jj - jj - nn - 
Phrase14503:
the murine 
dt - nn - 
Phrase14504:
we 
prp - 
Phrase14505:
the nf-microb-binding 
dt - nn - 
Phrase14506:
critical role 
jj - nn - 
Phrase14507:
the igh 
dt - nn - 
Phrase14508:
the microb 
dt - nn - 
Phrase14509:
transcriptional activity 
jj - nn - 
Phrase14510:
the igh 
dt - nn - 
Phrase14511:
the b-cell 
dt - nn - 
Phrase14512:
nonlymphoid cells 
jj - nns - 
Phrase14513:
the effect 
dt - nn - 
Phrase14514:
the octa 
dt - nn - 
Phrase14515:
combined mutation 
jj - nn - 
Phrase14516:
both microb 
dt - nn - 
Phrase14517:
lymphoid cells 
jj - nns - 
Phrase14518:
either microb 
dt - nn - 
Phrase14519:
the igh 
dt - nn - 
Phrase14520:
the binding 
dt - nn - 
Phrase14521:
lymphoid cells 
jj - nns - 
Phrase14522:
the microb 
dt - nn - 
Phrase14523:
the functional data 
dt - jj - nns - 
Phrase14524:
lymphoid-specific protein 
jj - nn - 
Phrase14525:
the microb 
dt - nn - 
Phrase14526:
our 
prp$ - 
Phrase14527:
the microb 
dt - nn - 
Phrase14528:
crucial element 
jj - nn - 
Phrase14529:
lymphoid-specific expression 
jj - nn - 
Phrase14530:
the igh 
dt - nn - 
Phrase14531:
another enhancer 
dt - nn - 
Phrase14532:
its 
prp$ - 
Phrase14533:
the human 
dt - nn - 
Phrase14534:
the cytomegalovirus 
dt - nn - 
Phrase14535:
latent infection 
jj - nn - 
Phrase14536:
some dna 
dt - nn - 
Phrase14537:
the transactivator 
dt - nn - 
Phrase14538:
the human 
dt - nn - 
Phrase14539:
the hiv-2 
dt - nn - 
Phrase14540:
cd4+ lymphocytes 
jj - nns - 
Phrase14541:
the hiv-2 
dt - nn - 
Phrase14542:
independent modes 
jj - nns - 
Phrase14543:
the cmv 
dt - nn - 
Phrase14544:
the hiv-2 
dt - nn - 
Phrase14545:
some common 
dt - nn - 
Phrase14546:
some distinct components 
dt - jj - nns - 
Phrase14547:
transcriptional activation 
jj - nn - 
Phrase14548:
the initiation 
dt - nn - 
Phrase14549:
significant proportion 
jj - nn - 
Phrase14550:
prematurely in 
dt - nn - 
Phrase14551:
the absence 
dt - nn - 
Phrase14552:
the hiv-2 
dt - nn - 
Phrase14553:
long terminal 
jj - nn - 
Phrase14554:
the element 
dt - nn - 
Phrase14555:
cd4+ lymphocytes 
jj - nns - 
Phrase14556:
either a 
dt - nn - 
Phrase14557:
diffuse one 
jj - nn - 
Phrase14558:
the hiv-2 
dt - nn - 
Phrase14559:
quantitative immunohistochemical analysis 
jj - jj - nn - 
Phrase14560:
inflammatory infiltrates 
jj - nn - 
Phrase14561:
the percentage 
dt - nn - 
Phrase14562:
their 
prp$ - 
Phrase14563:
natural killer 
jj - nn - 
Phrase14564:
the infiltrates 
dt - nn - 
Phrase14565:
these parameters 
dt - nns - 
Phrase14566:
nuclear grade 
jj - nn - 
Phrase14567:
direct correlation 
jj - nn - 
Phrase14568:
the extent 
dt - nn - 
Phrase14569:
nuclear grade 
jj - nn - 
Phrase14570:
an inverse 
dt - nn - 
Phrase14571:
the percentage 
dt - nn - 
Phrase14572:
the okt8+ 
dt - nn - 
Phrase14573:
the inflammation 
dt - nn - 
Phrase14574:
the diameter 
dt - nn - 
Phrase14575:
the pcvs 
dt - nn - 
Phrase14576:
inflammatory infiltrate 
jj - nn - 
Phrase14577:
direct correlation 
jj - nn - 
Phrase14578:
the diameter 
dt - nn - 
Phrase14579:
the pcvs 
dt - nn - 
Phrase14580:
both percentage 
dt - nn - 
Phrase14581:
the okt8+ 
dt - nn - 
Phrase14582:
the leu-7+ 
dt - nn - 
Phrase14583:
natural killer 
jj - nn - 
Phrase14584:
monoclonal antibody 
jj - nn - 
Phrase14585:
this study 
dt - nn - 
Phrase14586:
we 
prp - 
Phrase14587:
the progesterone 
dt - nn - 
Phrase14588:
monoclonal antibody 
jj - nn - 
Phrase14589:
an avidin-biotin 
dt - nn - 
Phrase14590:
we 
prp - 
Phrase14591:
nuclear staining 
jj - nn - 
Phrase14592:
the antibody 
dt - nn - 
Phrase14593:
the receptor-bearing subset 
dt - jj - nn - 
Phrase14594:
cd4+ cells 
jj - nns - 
Phrase14595:
complement-dependent lysis 
jj - nn - 
Phrase14596:
cd8+ cells 
jj - nns - 
Phrase14597:
receptor-bearing cells 
jj - nns - 
Phrase14598:
cd4+ cells 
jj - nns - 
Phrase14599:
the number 
dt - nn - 
Phrase14600:
allogeneic stimulation 
jj - nn - 
Phrase14601:
significant increase 
jj - nn - 
Phrase14602:
the number 
dt - nn - 
Phrase14603:
these results 
dt - nns - 
Phrase14604:
the ap-1 
dt - nn - 
Phrase14605:
serum-free culture 
jj - nn - 
Phrase14606:
this cd4 
dt - nn - 
Phrase14607:
this system 
dt - nn - 
Phrase14608:
the combination 
dt - nn - 
Phrase14609:
an analysis 
dt - nn - 
Phrase14610:
the molecular 
dt - nn - 
Phrase14611:
we 
prp - 
Phrase14612:
an independent signal 
dt - jj - nn - 
Phrase14613:
the cd3 
dt - nn - 
Phrase14614:
the induction 
dt - nn - 
Phrase14615:
an ap-1 
dt - nn - 
Phrase14616:
transcriptional factor 
jj - nn - 
Phrase14617:
the vla-5 
dt - nn - 
Phrase14618:
complementary role 
jj - nn - 
Phrase14619:
its 
prp$ - 
Phrase14620:
several lines 
jj - nns - 
Phrase14621:
an exploration 
dt - nn - 
Phrase14622:
the potential 
dt - nn - 
Phrase14623:
the glucocorticoid 
dt - nn - 
Phrase14624:
healthy controls 
jj - nns - 
Phrase14625:
clinical features 
jj - nns - 
Phrase14626:
these data 
dt - nns - 
Phrase14627:
the abnormalities 
dt - nns - 
Phrase14628:
the hpa 
dt - nn - 
Phrase14629:
dense lymphocyte 
jj - nn - 
Phrase14630:
hematopoietic growth 
jj - nn - 
Phrase14631:
primary breast 
jj - nn - 
Phrase14632:
strong negative association 
jj - jj - nn - 
Phrase14633:
high levels 
jj - nns - 
Phrase14634:
= .0009 
jj - nn - 
Phrase14635:
= .011 
jj - nn - 
Phrase14636:
high levels 
jj - nns - 
Phrase14637:
each oncogene 
dt - nn - 
Phrase14638:
statistical significance 
jj - nn - 
Phrase14639:
positive lymph 
jj - nn - 
Phrase14640:
= 0.09 
jj - nn - 
Phrase14641:
surprising finding 
jj - nn - 
Phrase14642:
strong association 
jj - nn - 
Phrase14643:
dense lymphocyte 
jj - nn - 
Phrase14644:
the tumor 
dt - nn - 
Phrase14645:
this correlation 
dt - nn - 
Phrase14646:
high levels 
jj - nns - 
Phrase14647:
each oncogene 
dt - nn - 
Phrase14648:
= .0048 
jj - nn - 
Phrase14649:
= .0007 
jj - nn - 
Phrase14650:
we 
prp - 
Phrase14651:
malignant cell 
jj - nn - 
Phrase14652:
this observation 
dt - nn - 
Phrase14653:
the htlv-i 
dt - nn - 
Phrase14654:
short-term expression 
jj - nn - 
Phrase14655:
the tax 
dt - nn - 
Phrase14656:
the pleiotropic transcription 
dt - jj - nn - 
Phrase14657:
we 
prp - 
Phrase14658:
marked accumulation 
jj - nn - 
Phrase14659:
the transcription 
dt - nn - 
Phrase14660:
the nucleus 
dt - nn - 
Phrase14661:
lymphoid cells 
jj - nns - 
Phrase14662:
the nucleus 
dt - nn - 
Phrase14663:
long-term expression 
jj - nn - 
Phrase14664:
the ability 
dt - nn - 
Phrase14665:
both mitogens 
dt - nns - 
Phrase14666:
the activation 
dt - nn - 
Phrase14667:
other mitogen-inducible 
jj - nn - 
Phrase14668:
the cellular environment 
dt - jj - nn - 
Phrase14669:
the short- 
dt - nn - 
Phrase14670:
long-term effects 
jj - nns - 
Phrase14671:
cell-type-specific suppression 
jj - nn - 
Phrase14672:
distinct signal 
jj - nn - 
Phrase14673:
the cells 
dt - nns - 
Phrase14674:
the delineation 
dt - nn - 
Phrase14675:
the selective regulation 
dt - jj - nn - 
Phrase14676:
the sexual dimorphism 
dt - jj - nn - 
Phrase14677:
the sexual difference 
dt - jj - nn - 
Phrase14678:
the incidence 
dt - nn - 
Phrase14679:
autoimmune diseases 
jj - nns - 
Phrase14680:
an enigma 
dt - nn - 
Phrase14681:
many years 
jj - nns - 
Phrase14682:
the examination 
dt - nn - 
Phrase14683:
the induction 
dt - nn - 
Phrase14684:
transgenic mice 
jj - nns - 
Phrase14685:
the lymphokine 
dt - nn - 
Phrase14686:
the etiology 
dt - nn - 
Phrase14687:
the production 
dt - nn - 
Phrase14688:
this molecule 
dt - nn - 
Phrase14689:
other cytokines 
jj - nns - 
Phrase14690:
the gender-specific 
dt - nn - 
Phrase14691:
the immune system 
dt - jj - nn - 
Phrase14692:
active human 
jj - nn - 
Phrase14693:
the tata 
dt - nn - 
Phrase14694:
the expression 
dt - nn - 
Phrase14695:
most eukaryotic genes 
jjs - jj - nns - 
Phrase14696:
complementary dna 
jj - nn - 
Phrase14697:
the human 
dt - nn - 
Phrase14698:
339 amino 
dt - nn - 
Phrase14699:
the carboxyl-terminal 181 
dt - jj - nn - 
Phrase14700:
the human 
dt - nn - 
Phrase14701:
the tfiid 
dt - nn - 
Phrase14702:
the amino 
dt - nn - 
Phrase14703:
an unusual repeat 
dt - jj - nn - 
Phrase14704:
consecutive glutamine 
jj - nn - 
Phrase14705:
an x-thr-pro 
dt - nn - 
Phrase14706:
both dna 
dt - nn - 
Phrase14707:
novel t-cell 
jj - nn - 
Phrase14708:
ester-inducible element 
jj - nn - 
Phrase14709:
the interleukin-2 
dt - nn - 
Phrase14710:
the interleukin 
dt - nn - 
Phrase14711:
ubiquitous transcriptional regulators 
jj - jj - nns - 
Phrase14712:
various signaling 
jj - nn - 
Phrase14713:
protein-dna binding 
jj - nn - 
Phrase14714:
we 
prp - 
Phrase14715:
the novel t-cell-specific transcriptional activator 
dt - jj - jj - jj - nn - 
Phrase14716:
t-cell-specific response 
jj - nn - 
Phrase14717:
the il-2 
dt - nn - 
Phrase14718:
the tce 
dt - nn - 
Phrase14719:
similar in 
jj - nn - 
Phrase14720:
several criteria 
jj - nns - 
Phrase14721:
other t-cell 
jj - nn - 
Phrase14722:
postmenopausal patients 
jj - nns - 
Phrase14723:
ductal cancers 
jj - nns - 
Phrase14724:
local failure 
jj - nn - 
Phrase14725:
clinical stage 
jj - nn - 
Phrase14726:
ductal carcinomas 
jj - nns - 
Phrase14727:
conservative surgery 
jj - nn - 
Phrase14728:
the following 
dt - nn - 
Phrase14729:
high histologic grade 
jj - jj - nn - 
Phrase14730:
extensive intraductal component 
jj - jj - nn - 
Phrase14731:
vascular invasion 
jj - nn - 
Phrase14732:
significant in 
jj - nn - 
Phrase14733:
these risk 
dt - nn - 
Phrase14734:
prevalent in 
jj - nn - 
Phrase14735:
separate cox 
jj - nn - 
Phrase14736:
neither risk 
dt - nn - 
Phrase14737:
low failure 
jj - nn - 
Phrase14738:
postmenopausal patients 
jj - nns - 
Phrase14739:
high local failure 
jj - jj - nn - 
Phrase14740:
the authors 
dt - nns - 
Phrase14741:
the microscopic examination 
dt - jj - nn - 
Phrase14742:
useful tool 
jj - nn - 
Phrase14743:
the risk 
dt - nn - 
Phrase14744:
local failure 
jj - nn - 
Phrase14745:
the majority 
dt - nn - 
Phrase14746:
the age 
dt - nn - 
Phrase14747:
morphologic risk 
jj - nn - 
Phrase14748:
the high local failure 
dt - jj - jj - nn - 
Phrase14749:
tax-independent binding 
jj - nn - 
Phrase14750:
multiple cellular factors 
jj - jj - nn - 
Phrase14751:
the human 
dt - nn - 
Phrase14752:
we 
prp - 
Phrase14753:
nuclear proteins 
jj - nns - 
Phrase14754:
an htlv-i 
dt - nn - 
Phrase14755:
tax-expressing human 
jj - nn - 
Phrase14756:
the tre-dna 
dt - nn - 
Phrase14757:
the tax-protein 
dt - nn - 
Phrase14758:
the proteins 
dt - nns - 
Phrase14759:
different methods 
jj - nns - 
Phrase14760:
the proteins 
dt - nns - 
Phrase14761:
different cell 
jj - nn - 
Phrase14762:
the nuclear proteins 
dt - jj - nns - 
Phrase14763:
the radioactively 
dt - nn - 
Phrase14764:
native molecular 
jj - nn - 
Phrase14765:
third 
nnp - 
Phrase14766:
the dna 
dt - nn - 
Phrase14767:
the tre-dna 
dt - nn - 
Phrase14768:
extensive purification 
jj - nn - 
Phrase14769:
several cycles 
jj - nns - 
Phrase14770:
abundant proteins 
jj - nns - 
Phrase14771:
the camp-response 
dt - nn - 
Phrase14772:
base-pair sequence 
jj - nn - 
Phrase14773:
specific protein-tre-dna 
jj - nn - 
Phrase14774:
this complex 
dt - nn - 
Phrase14775:
the camp 
dt - nn - 
Phrase14776:
the protein-tre-dna 
dt - nn - 
Phrase14777:
the tax 
dt - nn - 
Phrase14778:
distinct transcription 
jj - nn - 
Phrase14779:
the immunoglobulin 
dt - nn - 
Phrase14780:
the immunoglobulin 
dt - nn - 
Phrase14781:
complementary dnas 
jj - nns - 
Phrase14782:
the microe5/kappa 
dt - nn - 
Phrase14783:
the complementary dnas 
dt - jj - nns - 
Phrase14784:
the products 
dt - nns - 
Phrase14785:
distinct genes 
jj - nns - 
Phrase14786:
their 
prp$ - 
Phrase14787:
putative helix-loop-helix motifs 
jj - jj - nns - 
Phrase14788:
distinct domain 
jj - nn - 
Phrase14789:
elevated glucocorticoid 
jj - nn - 
Phrase14790:
peripheral mononuclear 
jj - nn - 
Phrase14791:
atopic dermatitis 
jj - nn - 
Phrase14792:
the number 
dt - nn - 
Phrase14793:
peripheral mononuclear 
jj - nn - 
Phrase14794:
atopic dermatitis 
jj - nn - 
Phrase14795:
healthy controls 
jj - nns - 
Phrase14796:
oral glucocorticoid 
jj - nn - 
Phrase14797:
the control 
dt - nn - 
Phrase14798:
the gr 
dt - nn - 
Phrase14799:
significant reduction 
jj - nn - 
Phrase14800:
the gr 
dt - nn - 
Phrase14801:
the steroid-treated control 
dt - jj - nn - 
Phrase14802:
the patients 
dt - nns - 
Phrase14803:
the dissociation 
dt - nn - 
Phrase14804:
the therapeutic efficiency 
dt - jj - nn - 
Phrase14805:
abnormal camp 
jj - nn - 
Phrase14806:
the elevated gr 
dt - jj - nn - 
Phrase14807:
the hypothesis 
dt - nn - 
Phrase14808:
an insufficient action 
dt - jj - nn - 
Phrase14809:
endogenous cortisol 
jj - nn - 
Phrase14810:
altered camp-induced gr 
jj - jj - nn - 
Phrase14811:
the actions 
dt - nns - 
Phrase14812:
novel step 
jj - nn - 
Phrase14813:
the activation 
dt - nn - 
Phrase14814:
immunosuppressive compounds 
jj - nns - 
Phrase14815:
similar inhibitory effects 
jj - jj - nns - 
Phrase14816:
the expression 
dt - nn - 
Phrase14817:
several lymphokines 
jj - nns - 
Phrase14818:
their 
prp$ - 
Phrase14819:
similar effects 
jj - nns - 
Phrase14820:
the drugs 
dt - nns - 
Phrase14821:
different cytosolic protein 
jj - jj - nn - 
Phrase14822:
the possibility 
dt - nn - 
Phrase14823:
they 
prp - 
Phrase14824:
different modes 
jj - nns - 
Phrase14825:
specific transcription 
jj - nn - 
Phrase14826:
we 
prp - 
Phrase14827:
both cyclosporin 
dt - nn - 
Phrase14828:
transcriptional activation 
jj - nn - 
Phrase14829:
dependent expression 
jj - nn - 
Phrase14830:
these drugs 
dt - nns - 
Phrase14831:
we 
prp - 
Phrase14832:
any qualitative differences 
dt - jj - nns - 
Phrase14833:
the effect 
dt - nn - 
Phrase14834:
different transcription 
jj - nn - 
Phrase14835:
these drugs 
dt - nns - 
Phrase14836:
the activity 
dt - nn - 
Phrase14837:
novel ca2+ 
jj - nn - 
Phrase14838:
dependent step 
jj - nn - 
Phrase14839:
several transcription 
jj - nn - 
Phrase14840:
the internal methionine 
dt - jj - nn - 
Phrase14841:
nonstructural trans-acting regulatory genes 
jj - jj - jj - nns - 
Phrase14842:
located in 
jj - nn - 
Phrase14843:
the 3' region 
dt - jj - nn - 
Phrase14844:
the viral genome 
dt - jj - nn - 
Phrase14845:
the tax 
dt - nn - 
Phrase14846:
the transcriptional activator 
dt - jj - nn - 
Phrase14847:
the viral long terminal 
dt - jj - jj - nn - 
Phrase14848:
the rex 
dt - nn - 
Phrase14849:
the cytoplasm 
dt - nn - 
Phrase14850:
previous studies 
jj - nns - 
Phrase14851:
the first atg 
dt - jj - nn - 
Phrase14852:
the rex 
dt - nn - 
Phrase14853:
the importance 
dt - nn - 
Phrase14854:
the internal atgs 
dt - jj - nn - 
Phrase14855:
the htlv-i 
dt - nn - 
Phrase14856:
indirect evidence 
jj - nn - 
Phrase14857:
an internal aug 
dt - jj - nn - 
Phrase14858:
the tax/rex 
dt - nn - 
Phrase14859:
an infectious molecular 
dt - jj - nn - 
Phrase14860:
we 
prp - 
Phrase14861:
the importance 
dt - nn - 
Phrase14862:
the internal atgs 
dt - jj - nn - 
Phrase14863:
the rex 
dt - nn - 
Phrase14864:
our 
prp$ - 
Phrase14865:
an internal aug 
dt - jj - nn - 
Phrase14866:
the internal methionine 
dt - jj - nn - 
Phrase14867:
the function 
dt - nn - 
Phrase14868:
the rex 
dt - nn - 
Phrase14869:
the transforming 
dt - nn - 
Phrase14870:
the virus 
dt - nn - 
Phrase14871:
novel octamer-dna 
jj - nn - 
Phrase14872:
the ubiquitous oct-1 
dt - jj - nn - 
Phrase14873:
its 
prp$ - 
Phrase14874:
key element 
jj - nn - 
Phrase14875:
the transcriptional regulation 
dt - jj - nn - 
Phrase14876:
housekeeping genes 
jj - nns - 
Phrase14877:
the octamer-binding protein 
dt - jj - nn - 
Phrase14878:
the b-cell 
dt - nn - 
Phrase14879:
specific gene 
jj - nn - 
Phrase14880:
the ubiquitous protein 
dt - jj - nn - 
Phrase14881:
general octamer 
jj - nn - 
Phrase14882:
site-dependent transcription 
jj - nn - 
Phrase14883:
various other genes 
jj - jj - nns - 
Phrase14884:
an octamer 
dt - nn - 
Phrase14885:
the promoter 
dt - nn - 
Phrase14886:
nervous systems 
jj - nns - 
Phrase14887:
us 
prp - 
Phrase14888:
the octamer-binding proteins 
dt - jj - nns - 
Phrase14889:
the latter cells 
dt - jj - nns - 
Phrase14890:
the electrophoretic mobility 
dt - jj - nn - 
Phrase14891:
novel octamer 
jj - nn - 
Phrase14892:
nuclear extracts 
jj - nns - 
Phrase14893:
these proteins 
dt - nns - 
Phrase14894:
the octamer 
dt - nn - 
Phrase14895:
the oct-1 
dt - nn - 
Phrase14896:
the relationship 
dt - nn - 
Phrase14897:
the n-oct 
dt - nn - 
Phrase14898:
proteolytic clipping 
jj - nn - 
Phrase14899:
their 
prp$ - 
Phrase14900:
the basis 
dt - nn - 
Phrase14901:
these assays 
dt - nn - 
Phrase14902:
the ubiquitous oct-1 
dt - jj - nn - 
Phrase14903:
the lymphoid-specific oct-2a 
dt - jj - nn - 
Phrase14904:
the n-oct-3 
dt - nn - 
Phrase14905:
lymphocyte-specific promoter 
jj - nn - 
Phrase14906:
it 
prp - 
Phrase14907:
an oct-2a 
dt - nn - 
Phrase14908:
we 
prp - 
Phrase14909:
other n-oct 
jj - nn - 
Phrase14910:
specific role 
jj - nn - 
Phrase14911:
the nervous system 
dt - jj - nn - 
Phrase14912:
non-erythroid cells 
jj - nns - 
Phrase14913:
the binding 
dt - nn - 
Phrase14914:
the erythroid cell 
dt - jj - nn - 
Phrase14915:
the erythroid transcription 
dt - jj - nn - 
Phrase14916:
erythroid factor-1 
jj - nn - 
Phrase14917:
critical role 
jj - nn - 
Phrase14918:
the transcription 
dt - nn - 
Phrase14919:
erythroid-specific genes 
jj - nns - 
Phrase14920:
we 
prp - 
Phrase14921:
the presence 
dt - nn - 
Phrase14922:
the mobility 
dt - nn - 
Phrase14923:
sequence-specific dna-binding 
jj - nn - 
Phrase14924:
low abundance 
jj - nn - 
Phrase14925:
non-erythroid cell 
jj - nn - 
Phrase14926:
the first report 
dt - jj - nn - 
Phrase14927:
an ef1-like 
dt - nn - 
Phrase14928:
non-erythroid cells 
jj - nns - 
Phrase14929:
this factor 
dt - nn - 
Phrase14930:
the regulation 
dt - nn - 
Phrase14931:
such cells 
jj - nns - 
Phrase14932:
unspliced mrna 
jj - nn - 
Phrase14933:
the post-transcriptional regulator 
dt - jj - nn - 
Phrase14934:
the unspliced viral gag-pol 
dt - jj - jj - nn - 
Phrase14935:
the cell 
dt - nn - 
Phrase14936:
its 
prp$ - 
Phrase14937:
we 
prp - 
Phrase14938:
the role 
dt - nn - 
Phrase14939:
an htlv-i 
dt - nn - 
Phrase14940:
infected human 
jj - nn - 
Phrase14941:
the unspliced gag-pol 
dt - jj - nn - 
Phrase14942:
cellular products 
jj - nns - 
Phrase14943:
the level 
dt - nn - 
Phrase14944:
the phosphorylation 
dt - nn - 
Phrase14945:
the viral rna 
dt - jj - nn - 
Phrase14946:
cd4+ t-cell 
jj - nn - 
Phrase14947:
clonal lines 
jj - nns - 
Phrase14948:
serum-free media 
jj - nns - 
Phrase14949:
leukemic cd4+ t-lymphocyte 
jj - jj - nn - 
Phrase14950:
its 
prp$ - 
Phrase14951:
fetal bovine 
jj - nn - 
Phrase14952:
serum-free media 
jj - nns - 
Phrase14953:
each transferrin 
dt - nn - 
Phrase14954:
the several clonal lines 
dt - jj - jj - nns - 
Phrase14955:
serum-supplemented cultures 
jj - nns - 
Phrase14956:
serum-free media 
jj - nns - 
Phrase14957:
doubling times 
jj - nns - 
Phrase14958:
serum-free cultures 
jj - nns - 
Phrase14959:
the same in 
dt - jj - nn - 
Phrase14960:
the expression 
dt - nn - 
Phrase14961:
lymphoid cells 
jj - nns - 
Phrase14962:
different in 
jj - nn - 
Phrase14963:
serum-free medium 
jj - nn - 
Phrase14964:
serum-free medium 
jj - nn - 
Phrase14965:
lower concentrations 
jjr - nns - 
Phrase14966:
micromolar concentrations 
jj - nns - 
Phrase14967:
serum-supplemented medium 
jj - nn - 
Phrase14968:
the hormone 
dt - nn - 
Phrase14969:
its 
prp$ - 
Phrase14970:
serum-free medium 
jj - nn - 
Phrase14971:
previous levels 
jj - nns - 
Phrase14972:
these cells 
dt - nns - 
Phrase14973:
serum-containing medium 
jj - nn - 
Phrase14974:
our 
prp$ - 
Phrase14975:
these cells 
dt - nns - 
Phrase14976:
the molecular 
dt - nn - 
Phrase14977:
peripheral mononuclear 
jj - nn - 
Phrase14978:
polymorphonuclear leucocytes 
jj - nns - 
Phrase14979:
it 
prp - 
Phrase14980:
the glucocorticoid 
dt - nn - 
Phrase14981:
peripheral mixed leucocytes 
jj - jj - nns - 
Phrase14982:
this work 
dt - nn - 
Phrase14983:
the mixed leucocytes 
dt - jj - nns - 
Phrase14984:
each part 
dt - nn - 
Phrase14985:
deficient patients 
jj - nns - 
Phrase14986:
the normal control 
dt - jj - nn - 
Phrase14987:
mixed leucocytes 
jj - nns - 
Phrase14988:
the control 
dt - nn - 
Phrase14989:
the results 
dt - nns - 
Phrase14990:
the lowest gcr 
dt - jjs - nn - 
Phrase14991:
the ubiquitous octamer-binding protein 
dt - jj - jj - nn - 
Phrase14992:
their 
prp$ - 
Phrase14993:
normal b-cell-specific transcription 
jj - jj - nn - 
Phrase14994:
this octamer 
dt - nn - 
Phrase14995:
octamer-binding proteins 
jj - nns - 
Phrase14996:
these proteins 
dt - nns - 
Phrase14997:
least one 
jjs - nn - 
Phrase14998:
the exact role 
dt - jj - nn - 
Phrase14999:
these different proteins 
dt - jj - nns - 
Phrase15000:
the tissue-specific expression 
dt - jj - nn - 
Phrase15001:
we 
prp - 
Phrase15002:
low levels 
jj - nns - 
Phrase15003:
high levels 
jj - nns - 
Phrase15004:
an immunoglobulin 
dt - nn - 
Phrase15005:
these pre-b 
dt - nn - 
Phrase15006:
an immunoglobulin 
dt - nn - 
Phrase15007:
the same transactivation 
dt - jj - nn - 
Phrase15008:
these results 
dt - nns - 
Phrase15009:
the b-cell-specific regulation 
dt - jj - nn - 
Phrase15010:
essential hypertension 
jj - nn - 
Phrase15011:
its 
prp$ - 
Phrase15012:
the intracellular sodium 
dt - jj - nn - 
Phrase15013:
the present 
dt - nn - 
Phrase15014:
essential hypertension 
jj - nn - 
Phrase15015:
the range 
dt - nn - 
Phrase15016:
normal persons 
jj - nns - 
Phrase15017:
intracellular sodium 
jj - nn - 
Phrase15018:
the addition 
dt - nn - 
Phrase15019:
this loss 
dt - nn - 
Phrase15020:
normal persons 
jj - nns - 
Phrase15021:
the electrolyte 
dt - nn - 
Phrase15022:
the normal limits 
dt - jj - nns - 
Phrase15023:
the number 
dt - nn - 
Phrase15024:
the normal range 
dt - jj - nn - 
Phrase15025:
the independence 
dt - nn - 
Phrase15026:
intracellular electrolytes 
jj - nn - 
Phrase15027:
normal number 
jj - nn - 
Phrase15028:
an impairment 
dt - nn - 
Phrase15029:
the mineralocorticoid 
dt - nn - 
Phrase15030:
the hml 
dt - nn - 
Phrase15031:
essential hypertension 
jj - nn - 
Phrase15032:
differential diagnostic 
jj - nn - 
Phrase15033:
the authors 
dt - nns - 
Phrase15034:
the results 
dt - nns - 
Phrase15035:
it 
prp - 
Phrase15036:
the character 
dt - nn - 
Phrase15037:
their 
prp$ - 
Phrase15038:
the influence 
dt - nn - 
Phrase15039:
differential diagnostic 
jj - nn - 
Phrase15040:
double-stranded phosphorothioate 
jj - nn - 
Phrase15041:
specific transcriptional regulatory proteins 
jj - jj - jj - nns - 
Phrase15042:
these factors 
dt - nn - 
Phrase15043:
cellular differentiation 
jj - nn - 
Phrase15044:
the functions 
dt - nns - 
Phrase15045:
these proteins 
dt - nns - 
Phrase15046:
several methods 
jj - nns - 
Phrase15047:
specific limitations 
jj - nns - 
Phrase15048:
sequence-specific dna-binding 
jj - nn - 
Phrase15049:
the phosphorothioate 
dt - nn - 
Phrase15050:
nuclear factor 
jj - nn - 
Phrase15051:
specific manner 
jj - nn - 
Phrase15052:
octamer-dependent activation 
jj - nn - 
Phrase15053:
b-dependent activation 
jj - nn - 
Phrase15054:
the human 
dt - nn - 
Phrase15055:
the appropriate phosphorothioate 
dt - jj - nn - 
Phrase15056:
the octamer 
dt - nn - 
Phrase15057:
the il-2 
dt - nn - 
Phrase15058:
the ds 
dt - nn - 
Phrase15059:
specific transcription 
jj - nn - 
Phrase15060:
other therapeutic effects 
jj - jj - nns - 
Phrase15061:
the regimen 
dt - nns - 
Phrase15062:
the plasma 
dt - nn - 
Phrase15063:
the sites 
dt - nns - 
Phrase15064:
the peripheral lymphocytes 
dt - jj - nns - 
Phrase15065:
healthy aged persons 
jj - jj - nns - 
Phrase15066:
young adults 
jj - nns - 
Phrase15067:
lymphocytic cell 
jj - nn - 
Phrase15068:
aged rats 
jj - nns - 
Phrase15069:
young rats 
jj - nns - 
Phrase15070:
the results 
dt - nns - 
Phrase15071:
lower in 
jjr - nn - 
Phrase15072:
the aged persons 
dt - jj - nns - 
Phrase15073:
the plasma 
dt - nn - 
Phrase15074:
we 
prp - 
Phrase15075:
the plasma 
dt - nn - 
Phrase15076:
the aging 
dt - nn - 
Phrase15077:
the adrenal cortex 
dt - jj - nn - 
Phrase15078:
the treatment 
dt - nn - 
Phrase15079:
the regimen 
dt - nns - 
Phrase15080:
the gcr 
dt - nn - 
Phrase15081:
the aged persons 
dt - jj - nns - 
Phrase15082:
this way 
dt - nn - 
Phrase15083:
the function 
dt - nn - 
Phrase15084:
the aged adrenal cortex 
dt - jj - jj - nn - 
Phrase15085:
nuclear proteins 
jj - nns - 
Phrase15086:
sensitive chronic myelogenous leukemia 
jj - jj - jj - nn - 
Phrase15087:
cytoplasmic protein 
jj - nn - 
Phrase15088:
chronic myelogenous leukemia 
jj - jj - nn - 
Phrase15089:
an activity 
dt - nn - 
Phrase15090:
altered electrophoretic mobility 
jj - jj - nn - 
Phrase15091:
nuclear proteins 
jj - nns - 
Phrase15092:
the transcriptional enhancers 
dt - jj - nns - 
Phrase15093:
-inducible genes 
jj - nns - 
Phrase15094:
the effect 
dt - nn - 
Phrase15095:
the cml 
dt - nn - 
Phrase15096:
cytoplasmic proteins 
jj - nns - 
Phrase15097:
these nuclear protein-dna complexes 
dt - jj - jj - nns - 
Phrase15098:
the presence 
dt - nn - 
Phrase15099:
clinical responsiveness 
jj - nn - 
Phrase15100:
the sensitivity 
dt - nn - 
Phrase15101:
the ifn-induced change 
dt - jj - nn - 
Phrase15102:
the electrophoretic mobility 
dt - jj - nn - 
Phrase15103:
nuclear protein-dna complexes 
jj - jj - nns - 
Phrase15104:
these data 
dt - nns - 
Phrase15105:
the action 
dt - nn - 
Phrase15106:
posttranslational modification 
jj - nn - 
Phrase15107:
nuclear proteins 
jj - nns - 
Phrase15108:
epstein-barr virus 
jj - nn - 
Phrase15109:
nuclear antigen 
jj - nn - 
Phrase15110:
latent membrane 
jj - nn - 
Phrase15111:
several lines 
jj - nns - 
Phrase15112:
the hypothesis 
dt - nn - 
Phrase15113:
epstein-barr virus 
jj - nn - 
Phrase15114:
nuclear antigen 
jj - nn - 
Phrase15115:
the ebv 
dt - nn - 
Phrase15116:
latent infection 
jj - nn - 
Phrase15117:
we 
prp - 
Phrase15118:
the following 
dt - nn - 
Phrase15119:
acute transfection 
jj - nn - 
Phrase15120:
simian virus 
jj - nn - 
Phrase15121:
the p3hr-1 
dt - nn - 
Phrase15122:
the mrna 
dt - nn - 
Phrase15123:
other ebv 
jj - nn - 
Phrase15124:
genomic lmp1 
jj - nn - 
Phrase15125:
the ebv-negative b-lymphoma 
dt - jj - nn - 
Phrase15126:
an ebna-2-responsive element 
dt - jj - nn - 
Phrase15127:
the -512 
dt - nn - 
Phrase15128:
this dna 
dt - nn - 
Phrase15129:
an ebna-2 
dt - nn - 
Phrase15130:
the ebv 
dt - nn - 
Phrase15131:
the ebv 
dt - nn - 
Phrase15132:
the ebna-2 
dt - nn - 
Phrase15133:
cellular cd23 
jj - nn - 
Phrase15134:
the biological impact 
dt - jj - nn - 
Phrase15135:
its 
prp$ - 
Phrase15136:
central role 
jj - nn - 
Phrase15137:
the expression 
dt - nn - 
Phrase15138:
lymphoid cells 
jj - nns - 
Phrase15139:
the effect 
dt - nn - 
Phrase15140:
the expression 
dt - nn - 
Phrase15141:
the nuclear protooncogenes 
dt - jj - nn - 
Phrase15142:
lymphoid cells 
jj - nns - 
Phrase15143:
an increase 
dt - nn - 
Phrase15144:
normal human 
jj - nn - 
Phrase15145:
the changes 
dt - nns - 
Phrase15146:
the mrna 
dt - nn - 
Phrase15147:
these protooncogenes 
dt - nn - 
Phrase15148:
pronounced at 
jj - nn - 
Phrase15149:
kinetic analysis 
jj - nn - 
Phrase15150:
the changes 
dt - nns - 
Phrase15151:
the primary effect 
dt - jj - nn - 
Phrase15152:
the c-myc 
dt - nn - 
Phrase15153:
its 
prp$ - 
Phrase15154:
the overall effect 
dt - jj - nn - 
Phrase15155:
marked inhibition 
jj - nn - 
Phrase15156:
its 
prp$ - 
Phrase15157:
these results 
dt - nns - 
Phrase15158:
the transcription 
dt - nn - 
Phrase15159:
nuclear protooncogenes 
jj - nn - 
Phrase15160:
nuclear protooncogenes 
jj - nn - 
Phrase15161:
the stress 
dt - nn - 
Phrase15162:
lymphoid cells 
jj - nns - 
Phrase15163:
the human 
dt - nn - 
Phrase15164:
the immune response 
dt - jj - nn - 
Phrase15165:
the x 
dt - nn - 
Phrase15166:
synthetic peptides 
jj - nns - 
Phrase15167:
chronic hbv 
jj - nn - 
Phrase15168:
immune response 
jj - nn - 
Phrase15169:
each serum 
dt - nn - 
Phrase15170:
different set 
jj - nn - 
Phrase15171:
the hbx 
dt - nn - 
Phrase15172:
the epitopes 
dt - nns - 
Phrase15173:
an enzyme-linked immunosorbent assay 
dt - jj - jj - nn - 
Phrase15174:
synthetic peptides 
jj - nns - 
Phrase15175:
the carboxy-terminal half 
dt - jj - nn - 
Phrase15176:
the hbx 
dt - nn - 
Phrase15177:
chronic hepatitis 
jj - nn - 
Phrase15178:
short immunodominant antigenic region 
jj - jj - jj - nn - 
Phrase15179:
major nonoverlapping epitopes 
jj - jj - nns - 
Phrase15180:
most frequent in 
jjs - jj - nn - 
Phrase15181:
chronic hepatitis 
jj - nn - 
Phrase15182:
low in 
jj - nn - 
Phrase15183:
asymptomatic carriers 
jj - nns - 
Phrase15184:
the data 
dt - nns - 
Phrase15185:
quantitative heterogeneity 
jj - nn - 
Phrase15186:
the humoral hbx 
dt - jj - nn - 
Phrase15187:
immune response 
jj - nn - 
Phrase15188:
useful diagnostic 
jj - nn - 
Phrase15189:
the inhibitory effect 
dt - jj - nn - 
Phrase15190:
the chemotactic 
dt - nn - 
Phrase15191:
random migration 
jj - nn - 
Phrase15192:
the difference 
dt - nn - 
Phrase15193:
the peak 
dt - nn - 
Phrase15194:
physiological concentration 
jj - nn - 
Phrase15195:
the competitive antagonist 
dt - jj - nn - 
Phrase15196:
the inhibitory effect 
dt - jj - nn - 
Phrase15197:
higher dose 
jjr - nn - 
Phrase15198:
it 
prp - 
Phrase15199:
it 
prp - 
Phrase15200:
physiological regulator 
jj - nn - 
Phrase15201:
the activity 
dt - nn - 
Phrase15202:
its 
prp$ - 
Phrase15203:
inhibitory action 
jj - nn - 
Phrase15204:
antiinflammatory mechanisms 
jj - nns - 
Phrase15205:
pharmacological doses 
jj - nns - 
Phrase15206:
the action 
dt - nn - 
Phrase15207:
pharmacological concentration 
jj - nn - 
Phrase15208:
low affinity 
jj - nn - 
Phrase15209:
specific binding 
jj - nn - 
Phrase15210:
monoclonal antibody 
jj - nn - 
Phrase15211:
related retroviruses 
jj - nns - 
Phrase15212:
monoclonal antibody 
jj - nn - 
Phrase15213:
we 
prp - 
Phrase15214:
the expression 
dt - nn - 
Phrase15215:
related antigens 
jj - nns - 
Phrase15216:
related retroviruses 
jj - nns - 
Phrase15217:
simian t 
jj - nn - 
Phrase15218:
simian cell 
jj - nn - 
Phrase15219:
an htlv-ii-bearing 
dt - nn - 
Phrase15220:
the stlv-i-bearing 
dt - nn - 
Phrase15221:
the range 
dt - nn - 
Phrase15222:
the human 
dt - nn - 
Phrase15223:
enhancer-binding proteins 
jj - nns - 
Phrase15224:
the human 
dt - nn - 
Phrase15225:
the transcription 
dt - nn - 
Phrase15226:
the human 
dt - nn - 
Phrase15227:
the control 
dt - nn - 
Phrase15228:
cellular proteins 
jj - nns - 
Phrase15229:
the viral long terminal 
dt - jj - jj - nn - 
Phrase15230:
the protein-binding regions 
dt - jj - nns - 
Phrase15231:
the hiv-1 
dt - nn - 
Phrase15232:
the transcription-enhancer 
dt - nn - 
Phrase15233:
we 
prp - 
Phrase15234:
least one 
jjs - nn - 
Phrase15235:
the hiv 
dt - nn - 
Phrase15236:
their 
prp$ - 
Phrase15237:
they 
prp - 
Phrase15238:
bivalent cations 
jj - nns - 
Phrase15239:
their 
prp$ - 
Phrase15240:
the hiv-enhancer 
dt - nn - 
Phrase15241:
similar sequence 
jj - nn - 
Phrase15242:
the interleukin-2-receptor 
dt - nn - 
Phrase15243:
the inducible c1 
dt - jj - nn - 
Phrase15244:
transcriptional enhancers 
jj - nns - 
Phrase15245:
high levels 
jj - nns - 
Phrase15246:
the conversion 
dt - nn - 
Phrase15247:
active viral infection 
jj - jj - nn - 
Phrase15248:
the sequences 
dt - nns - 
Phrase15249:
these signaling 
dt - nn - 
Phrase15250:
the long terminal 
dt - jj - nn - 
Phrase15251:
the transcriptional enhancer 
dt - jj - nn - 
Phrase15252:
the nuclear factor 
dt - jj - nn - 
Phrase15253:
the corresponding region 
dt - jj - nn - 
Phrase15254:
the second 
dt - nn - 
Phrase15255:
divergent nf 
jj - nn - 
Phrase15256:
we 
prp - 
Phrase15257:
the hiv-1 
dt - nn - 
Phrase15258:
the hiv-2 
dt - nn - 
Phrase15259:
these qualitative differences 
dt - jj - nns - 
Phrase15260:
the response 
dt - nn - 
Phrase15261:
heterologous promoter 
jj - nn - 
Phrase15262:
these enhancers 
dt - nns - 
Phrase15263:
their 
prp$ - 
Phrase15264:
respective ltr 
jj - nn - 
Phrase15265:
electrophoretic mobility 
jj - nn - 
Phrase15266:
the hiv-1 
dt - nn - 
Phrase15267:
transcriptional enhancer 
jj - nn - 
Phrase15268:
the hiv-2 
dt - nn - 
Phrase15269:
transcriptional enhancer 
jj - nn - 
Phrase15270:
the activator 
dt - nn - 
Phrase15271:
the divergent site 
dt - jj - nn - 
Phrase15272:
this difference 
dt - nn - 
Phrase15273:
viral latency 
jj - nn - 
Phrase15274:
the dra 
dt - nn - 
Phrase15275:
their 
prp$ - 
Phrase15276:
constitutive expression 
jj - nn - 
Phrase15277:
thymic epithelial 
jj - nn - 
Phrase15278:
many other cells 
jj - jj - nns - 
Phrase15279:
this tissue-specific expression 
dt - jj - nn - 
Phrase15280:
the dra 
dt - nn - 
Phrase15281:
these cis-acting regulatory motifs 
dt - jj - jj - nns - 
Phrase15282:
the x2-box 
dt - nn - 
Phrase15283:
nuclear factor 
jj - nn - 
Phrase15284:
we 
prp - 
Phrase15285:
the isolation 
dt - nn - 
Phrase15286:
the full-length 
dt - nn - 
Phrase15287:
the human 
dt - nn - 
Phrase15288:
the heterodimeric activator 
dt - jj - nn - 
Phrase15289:
they 
prp - 
Phrase15290:
the x2-box 
dt - nn - 
Phrase15291:
nonexpressing cells 
jj - nns - 
Phrase15292:
the repression 
dt - nn - 
Phrase15293:
some corticosteroid 
dt - nn - 
Phrase15294:
several new 
jj - nn - 
Phrase15295:
hot acetic 
jj - nn - 
Phrase15296:
the 9,11-dihydro 
dt - nn - 
Phrase15297:
its 
prp$ - 
Phrase15298:
the 4,5-dihydro 
dt - nn - 
Phrase15299:
its 
prp$ - 
Phrase15300:
the 3,4-diacetoxy 
dt - nn - 
Phrase15301:
low relative 
jj - nn - 
Phrase15302:
other rba 
jj - nn - 
Phrase15303:
this system 
dt - nn - 
Phrase15304:
nuclear factor 
jj - nn - 
Phrase15305:
transcriptional activity 
jj - nn - 
Phrase15306:
transgenic mice 
jj - nns - 
Phrase15307:
transcriptional activity 
jj - nn - 
Phrase15308:
an individual 
dt - nn - 
Phrase15309:
nuclear factor 
jj - nn - 
Phrase15310:
nuclear factor 
jj - nn - 
Phrase15311:
an important regulator 
dt - jj - nn - 
Phrase15312:
early t-cell 
jj - nn - 
Phrase15313:
we 
prp - 
Phrase15314:
the transcriptional activity 
dt - jj - nn - 
Phrase15315:
the single cell 
dt - jj - nn - 
Phrase15316:
whole animals 
jj - nns - 
Phrase15317:
the system 
dt - nn - 
Phrase15318:
the use 
dt - nn - 
Phrase15319:
an oligomerized 
dt - nn - 
Phrase15320:
transgenic mice 
jj - nns - 
Phrase15321:
the first demonstration 
dt - jj - nn - 
Phrase15322:
multimerized short binding 
jj - jj - nn - 
Phrase15323:
transgenic mice 
jj - nns - 
Phrase15324:
intracellular calcium 
jj - nn - 
Phrase15325:
transgenic mice 
jj - nns - 
Phrase15326:
we 
prp - 
Phrase15327:
both release 
dt - nn - 
Phrase15328:
intracellular calcium 
jj - nn - 
Phrase15329:
the time 
dt - nn - 
Phrase15330:
constitutive expression 
jj - nn - 
Phrase15331:
small population 
jj - nn - 
Phrase15332:
the dermis 
dt - nn - 
Phrase15333:
some mice 
dt - nns - 
Phrase15334:
the tissue 
dt - nn - 
Phrase15335:
the nfat-1 
dt - nn - 
Phrase15336:
the expression 
dt - nn - 
Phrase15337:
transgenic mice 
jj - nns - 
Phrase15338:
j. 
nnp - 
Phrase15339:
s. 
nnp - 
Phrase15340:
h. 
nnp - 
Phrase15341:
r. 
nnp - 
Phrase15342:
g. 
nnp - 
Phrase15343:
the fact 
dt - nn - 
Phrase15344:
functional sequences 
jj - nns - 
Phrase15345:
dermal activation 
jj - nn - 
Phrase15346:
the hiv-ltr 
dt - nn - 
Phrase15347:
novel t-cell 
jj - nn - 
Phrase15348:
palindromic sequence 
jj - nn - 
Phrase15349:
the negative regulatory element 
dt - jj - jj - nn - 
Phrase15350:
the human 
dt - nn - 
Phrase15351:
long terminal 
jj - nn - 
Phrase15352:
major protein-binding sites 
jj - jj - nns - 
Phrase15353:
the negative regulatory element 
dt - jj - jj - nn - 
Phrase15354:
the human 
dt - nn - 
Phrase15355:
long terminal 
jj - nn - 
Phrase15356:
palindromic sequence 
jj - nn - 
Phrase15357:
this class 
dt - nn - 
Phrase15358:
novel t-cell 
jj - nn - 
Phrase15359:
the palindromic sequence 
dt - jj - nn - 
Phrase15360:
lower affinity 
jjr - nn - 
Phrase15361:
the site 
dt - nn - 
Phrase15362:
the human 
dt - nn - 
Phrase15363:
long terminal 
jj - nn - 
Phrase15364:
this study 
dt - nn - 
Phrase15365:
the suppressive effect 
dt - jj - nn - 
Phrase15366:
specific progesterone 
jj - nn - 
Phrase15367:
the effects 
dt - nns - 
Phrase15368:
competitive progesterone 
jj - nn - 
Phrase15369:
specific glucocorticoid 
jj - nn - 
Phrase15370:
the release 
dt - nn - 
Phrase15371:
an equal concentration 
dt - jj - nn - 
Phrase15372:
the production 
dt - nn - 
Phrase15373:
the blocking 
dt - nn - 
Phrase15374:
these data 
dt - nns - 
Phrase15375:
specific progesterone 
jj - nn - 
Phrase15376:
the 56-59-kilodalton 
dt - nn - 
Phrase15377:
unique protein 
jj - nn - 
Phrase15378:
both 70- 
dt - nn - 
Phrase15379:
it 
prp - 
Phrase15380:
this work 
dt - nn - 
Phrase15381:
we 
prp - 
Phrase15382:
the monoclonal antibody 
dt - jj - nn - 
Phrase15383:
the rabbit 
dt - nn - 
Phrase15384:
the human 
dt - nn - 
Phrase15385:
the ec1 
dt - nn - 
Phrase15386:
moderate abundance 
jj - nn - 
Phrase15387:
the cytoplasm 
dt - nn - 
Phrase15388:
indirect immunofluorescence 
jj - nn - 
Phrase15389:
two-dimensional gel 
jj - nn - 
Phrase15390:
n-terminal sequencing 
jj - nn - 
Phrase15391:
unique human 
jj - nn - 
Phrase15392:
the 70- 
dt - nn - 
Phrase15393:
90-kda heat 
jj - nn - 
Phrase15394:
an immune-specific 
dt - nn - 
Phrase15395:
the ec1 
dt - nn - 
Phrase15396:
we 
prp - 
Phrase15397:
higher order 
jjr - nn - 
Phrase15398:
sequence-specific dna 
jj - nn - 
Phrase15399:
the proto-oncoprotein 
dt - nn - 
Phrase15400:
transcriptional activator 
jj - nn - 
Phrase15401:
the long terminal 
dt - jj - nn - 
Phrase15402:
the moloney 
dt - nn - 
Phrase15403:
the ets 
dt - nn - 
Phrase15404:
normal cellular function 
jj - jj - nn - 
Phrase15405:
cellular proteins 
jj - nns - 
Phrase15406:
the transcriptional regulation 
dt - jj - nn - 
Phrase15407:
we 
prp - 
Phrase15408:
the ets 
dt - nn - 
Phrase15409:
sequence-specific dna-binding 
jj - nn - 
Phrase15410:
double-stranded oligonucleotide 
jj - nn - 
Phrase15411:
the moloney 
dt - nn - 
Phrase15412:
long terminal 
jj - nn - 
Phrase15413:
the cdna 
dt - nn - 
Phrase15414:
an 813-bp 
dt - nn - 
Phrase15415:
97.6 % 
dt - nn - 
Phrase15416:
the 272 
dt - nn - 
Phrase15417:
carboxy-terminal amino 
jj - nn - 
Phrase15418:
the human 
dt - nn - 
Phrase15419:
the orf 
dt - nn - 
Phrase15420:
the 30-kd 
dt - nn - 
Phrase15421:
sequence-specific manner 
jj - nn - 
Phrase15422:
the ets-1 
dt - nn - 
Phrase15423:
transcriptional efficiency 
jj - nn - 
Phrase15424:
the msv 
dt - nn - 
Phrase15425:
the activity 
dt - nn - 
Phrase15426:
wild-type promoter 
jj - nn - 
Phrase15427:
we 
prp - 
Phrase15428:
transcriptional activator 
jj - nn - 
Phrase15429:
mammalian type-c 
jj - nn - 
Phrase15430:
ets-related genes 
jj - nns - 
Phrase15431:
eukaryotic dna-binding 
jj - nn - 
Phrase15432:
peripheral blood 
jj - nn - 
Phrase15433:
the menstrual cycle 
dt - jj - nn - 
Phrase15434:
we 
prp - 
Phrase15435:
peripheral blood 
jj - nn - 
Phrase15436:
this study 
dt - nn - 
Phrase15437:
the fluctuations 
dt - nn - 
Phrase15438:
the menstrual cycle 
dt - jj - nn - 
Phrase15439:
higher levels 
jjr - nns - 
Phrase15440:
the periovulatory 
dt - nn - 
Phrase15441:
postmenopausal women 
jj - nns - 
Phrase15442:
the mean 
dt - nn - 
Phrase15443:
the follicular phase 
dt - jj - nn - 
Phrase15444:
the cycle 
dt - nn - 
Phrase15445:
postmenopausal patients 
jj - nns - 
Phrase15446:
short course 
jj - nn - 
Phrase15447:
marked increase 
jj - nn - 
Phrase15448:
lesser extent 
jjr - nn - 
Phrase15449:
major depression 
jj - nn - 
Phrase15450:
some patients 
dt - nns - 
Phrase15451:
major depressive disorder 
jj - jj - nn - 
Phrase15452:
elevated plasma 
jj - nn - 
Phrase15453:
they 
prp - 
Phrase15454:
cushingoid features 
jj - nns - 
Phrase15455:
the gc 
dt - nn - 
Phrase15456:
the mdd 
dt - nn - 
Phrase15457:
any cellular defect 
dt - jj - nn - 
Phrase15458:
the mdd 
dt - nn - 
Phrase15459:
the initial receptor 
dt - jj - nn - 
Phrase15460:
the control 
dt - nn - 
Phrase15461:
fewer depressed subjects 
jjr - jj - nns - 
Phrase15462:
paired t-test 
jj - nn - 
Phrase15463:
the control 
dt - nn - 
Phrase15464:
the depressed group 
dt - jj - nn - 
Phrase15465:
the control 
dt - nn - 
Phrase15466:
the degree 
dt - nn - 
Phrase15467:
the subjects 
dt - nns - 
Phrase15468:
these results 
dt - nns - 
Phrase15469:
previous reports 
jj - nns - 
Phrase15470:
they 
prp - 
Phrase15471:
the importance 
dt - nn - 
Phrase15472:
the context 
dt - nn - 
Phrase15473:
gc-mediated cell 
jj - nn - 
Phrase15474:
the exact cellular defect 
dt - jj - jj - nn - 
Phrase15475:
ras-related gtp-binding proteins 
jj - jj - nns - 
Phrase15476:
many aspects 
jj - nns - 
Phrase15477:
ras-related gtp-binding proteins 
jj - jj - nns - 
Phrase15478:
little definite information 
jj - jj - nn - 
Phrase15479:
their 
prp$ - 
Phrase15480:
recent progress 
jj - nn - 
Phrase15481:
the regulation 
dt - nn - 
Phrase15482:
the phagocyte 
dt - nn - 
Phrase15483:
the rac 
dt - nn - 
Phrase15484:
gtp-binding proteins 
jj - nns - 
Phrase15485:
the operational characteristics 
dt - jj - nns - 
Phrase15486:
such phagocyte 
jj - nn - 
Phrase15487:
it 
prp - 
Phrase15488:
various studies 
jj - nns - 
Phrase15489:
the activity 
dt - nn - 
Phrase15490:
the nadph 
dt - nn - 
Phrase15491:
the regulation 
dt - nn - 
Phrase15492:
the gtp-gdp 
dt - nn - 
Phrase15493:
gtp-binding protein 
jj - nn - 
Phrase15494:
this manner 
dt - nn - 
Phrase15495:
their 
prp$ - 
Phrase15496:
the ras 
dt - nn - 
Phrase15497:
normal phagocyte 
jj - nn - 
Phrase15498:
their 
prp$ - 
Phrase15499:
the assembly 
dt - nn - 
Phrase15500:
direct vesicle 
jj - nn - 
Phrase15501:
key regulator 
jj - nn - 
Phrase15502:
b-cell-specific activator 
jj - nn - 
Phrase15503:
the pax-gene 
dt - nn - 
Phrase15504:
the lymphoid system 
dt - jj - nn - 
Phrase15505:
the molecular 
dt - nn - 
Phrase15506:
the ability 
dt - nn - 
Phrase15507:
this protein 
dt - nn - 
Phrase15508:
the expression 
dt - nn - 
Phrase15509:
b-cell-specific genes 
jj - nns - 
Phrase15510:
they 
prp - 
Phrase15511:
key protein 
jj - nn - 
Phrase15512:
it 
prp - 
Phrase15513:
the balance 
dt - nn - 
Phrase15514:
later stages 
jjr - nns - 
Phrase15515:
proc 
nnp - 
Phrase15516:
acad 
nnp - 
Phrase15517:
sci 
nnp - 
Phrase15518:
the effect 
dt - nn - 
Phrase15519:
immunomodulating properties 
jj - nns - 
Phrase15520:
nuclear factor 
jj - nn - 
Phrase15521:
normal human 
jj - nn - 
Phrase15522:
the expression 
dt - nn - 
Phrase15523:
the 50-kda 
dt - nn - 
Phrase15524:
its 
prp$ - 
Phrase15525:
the presence 
dt - nn - 
Phrase15526:
the levels 
dt - nns - 
Phrase15527:
the mature protein 
dt - jj - nn - 
Phrase15528:
its 
prp$ - 
Phrase15529:
the effect 
dt - nn - 
Phrase15530:
the hormone 
dt - nn - 
Phrase15531:
the levels 
dt - nns - 
Phrase15532:
demonstrable in 
jj - nn - 
Phrase15533:
nuclear compartments 
jj - nns - 
Phrase15534:
it 
prp - 
Phrase15535:
the levels 
dt - nns - 
Phrase15536:
another nf-kappa 
dt - nn - 
Phrase15537:
the abundance 
dt - nn - 
Phrase15538:
specific dna-protein 
jj - nn - 
Phrase15539:
nuclear extracts 
jj - nns - 
Phrase15540:
the transcriptional activity 
dt - jj - nn - 
Phrase15541:
tandem repeats 
jj - nns - 
Phrase15542:
the nf-kappa 
dt - nn - 
Phrase15543:
the immunoglobulin 
dt - nn - 
Phrase15544:
the chloramphenicol 
dt - nn - 
Phrase15545:
these observations 
dt - nns - 
Phrase15546:
this process 
dt - nn - 
Phrase15547:
the myeloid 
dt - nn - 
Phrase15548:
the cd34 
dt - nn - 
Phrase15549:
putative transcriptional regulator 
jj - jj - nn - 
Phrase15550:
the mzf-1 
dt - nn - 
Phrase15551:
bipartite dna 
jj - nn - 
Phrase15552:
the carboxy-terminus 
dt - nn - 
Phrase15553:
we 
prp - 
Phrase15554:
the dna 
dt - nn - 
Phrase15555:
the transcription 
dt - nn - 
Phrase15556:
regulatory function 
jj - nn - 
Phrase15557:
the full-length 
dt - nn - 
Phrase15558:
the dna 
dt - nn - 
Phrase15559:
the yeast 
dt - nn - 
Phrase15560:
the expression 
dt - nn - 
Phrase15561:
the chloramphenicol 
dt - nn - 
Phrase15562:
the thymidine 
dt - nn - 
Phrase15563:
the nonhematopoietic cell 
dt - jj - nn - 
Phrase15564:
the hematopoietic cell 
dt - jj - nn - 
Phrase15565:
the mzf-1 
dt - nn - 
Phrase15566:
the promoters 
dt - nns - 
Phrase15567:
several genes 
jj - nns - 
Phrase15568:
the cd34 
dt - nn - 
Phrase15569:
transcriptional regulation 
jj - nn - 
Phrase15570:
relevant promoter 
jj - nn - 
Phrase15571:
nonhematopoietic cell 
jj - nn - 
Phrase15572:
the consensus 
dt - nn - 
Phrase15573:
the cd34 
dt - nn - 
Phrase15574:
the luciferase 
dt - nn - 
Phrase15575:
the cd34 
dt - nn - 
Phrase15576:
hematopoietic cell 
jj - nn - 
Phrase15577:
the heterologous dna 
dt - jj - nn - 
Phrase15578:
nonhematopoietic cell 
jj - nn - 
Phrase15579:
hematopoietic cell 
jj - nn - 
Phrase15580:
hematopoietic cell 
jj - nn - 
Phrase15581:
the presence 
dt - nn - 
Phrase15582:
intact mzf-1 
jj - nn - 
Phrase15583:
the cell 
dt - nn - 
Phrase15584:
type-specific regulation 
jj - nn - 
Phrase15585:
the cd34 
dt - nn - 
Phrase15586:
the presence 
dt - nn - 
Phrase15587:
tissue-specific regulators/adapters 
jj - nn - 
Phrase15588:
differential mzf-1 
jj - nn - 
Phrase15589:
transcriptional regulatory function 
jj - jj - nn - 
Phrase15590:
the murine 
dt - nn - 
Phrase15591:
an immediate early gene 
dt - jj - jj - nn - 
Phrase15592:
the chromosomal 
dt - nn - 
Phrase15593:
the bcl6 
dt - nn - 
Phrase15594:
the chromosomal 
dt - nn - 
Phrase15595:
these lymphomas 
dt - nns - 
Phrase15596:
we 
prp - 
Phrase15597:
the murine 
dt - nn - 
Phrase15598:
the muscle 
dt - nn - 
Phrase15599:
the human 
dt - nn - 
Phrase15600:
it 
prp - 
Phrase15601:
the kruppel-like zinc-finger 
dt - jj - nn - 
Phrase15602:
the bcl6 
dt - nn - 
Phrase15603:
the mbcl6 
dt - nn - 
Phrase15604:
lymphatic organs 
jj - nns - 
Phrase15605:
it 
prp - 
Phrase15606:
the cells 
dt - nns - 
Phrase15607:
these results 
dt - nns - 
Phrase15608:
an immediate early gene 
dt - jj - jj - nn - 
Phrase15609:
the role 
dt - nn - 
Phrase15610:
the hierarchy 
dt - nn - 
Phrase15611:
transcriptional control 
jj - nn - 
Phrase15612:
the mouse 
dt - nn - 
Phrase15613:
this manner 
dt - nn - 
Phrase15614:
the paired box 
dt - jj - nn - 
Phrase15615:
the b 
dt - nn - 
Phrase15616:
specific transcription 
jj - nn - 
Phrase15617:
key role 
jj - nn - 
Phrase15618:
early b 
jj - nn - 
Phrase15619:
other experimental strategies 
jj - jj - nns - 
Phrase15620:
the control 
dt - nn - 
Phrase15621:
the immunoglobulin 
dt - nn - 
Phrase15622:
late stages 
jj - nns - 
Phrase15623:
the dna-binding 
dt - nn - 
Phrase15624:
the avian erythroblast 
dt - jj - nn - 
Phrase15625:
avian cells 
jj - nns - 
Phrase15626:
novel factor 
jj - nn - 
Phrase15627:
biological properties 
jj - nns - 
Phrase15628:
these hsfs 
dt - nn - 
Phrase15629:
both hsf1 
dt - nn - 
Phrase15630:
the erythroblast 
dt - nn - 
Phrase15631:
the lymphoblast 
dt - nn - 
Phrase15632:
its 
prp$ - 
Phrase15633:
the effect 
dt - nn - 
Phrase15634:
an inert monomer 
dt - jj - nn - 
Phrase15635:
the translocation 
dt - nn - 
Phrase15636:
the nucleus 
dt - nn - 
Phrase15637:
the properties 
dt - nns - 
Phrase15638:
transcriptional activator 
jj - nn - 
Phrase15639:
the stimulatory activity 
dt - jj - nn - 
Phrase15640:
element-containing reporter 
jj - nn - 
Phrase15641:
the activity 
dt - nn - 
Phrase15642:
chimeric gal4-hsf3 
jj - nn - 
Phrase15643:
these results 
dt - nns - 
Phrase15644:
avian cells 
jj - nns - 
Phrase15645:
certain cells 
jj - nns - 
Phrase15646:
direct demonstration 
jj - nn - 
Phrase15647:
nuclear localization 
jj - nn - 
Phrase15648:
specific nfatp 
jj - nn - 
Phrase15649:
polyclonal antibody 
jj - nn - 
Phrase15650:
nuclear factor 
jj - nn - 
Phrase15651:
several lines 
jj - nns - 
Phrase15652:
polyclonal antibody 
jj - nn - 
Phrase15653:
various mouse 
jj - nn - 
Phrase15654:
the 110-130-kda 
dt - nn - 
Phrase15655:
untreated ht-2 
jj - nn - 
Phrase15656:
the dephosphorylation 
dt - nn - 
Phrase15657:
an in 
dt - nn - 
Phrase15658:
32p-labeled ht-2 
jj - nn - 
Phrase15659:
the cytosol 
dt - nn - 
Phrase15660:
the cells 
dt - nns - 
Phrase15661:
the cells 
dt - nns - 
Phrase15662:
the molecular 
dt - nn - 
Phrase15663:
the dephosphorylation 
dt - nn - 
Phrase15664:
the protein 
dt - nn - 
Phrase15665:
the nuclear fraction 
dt - jj - nn - 
Phrase15666:
these events 
dt - nns - 
Phrase15667:
the cells 
dt - nns - 
Phrase15668:
the hypothesis 
dt - nn - 
Phrase15669:
the nuclear factors 
dt - jj - nn - 
Phrase15670:
natural killer 
jj - nn - 
Phrase15671:
the putative factors 
dt - jj - nn - 
Phrase15672:
the signal 
dt - nn - 
Phrase15673:
the activation 
dt - nn - 
Phrase15674:
natural killer 
jj - nn - 
Phrase15675:
we 
prp - 
Phrase15676:
the nuclear factor 
dt - jj - nn - 
Phrase15677:
the transcription 
dt - nn - 
Phrase15678:
several cytokines 
jj - nns - 
Phrase15679:
cd16-induced activation 
jj - nn - 
Phrase15680:
-induced expression 
jj - nn - 
Phrase15681:
ca(2+)-dependent mechanism 
jj - nn - 
Phrase15682:
nfat-like dna 
jj - nn - 
Phrase15683:
the nuclear extracts 
dt - jj - nns - 
Phrase15684:
these cells 
dt - nns - 
Phrase15685:
electrophoretic mobility 
jj - nn - 
Phrase15686:
fast kinetics 
jj - nn - 
Phrase15687:
ca(2+)-dependent mechanism 
jj - nn - 
Phrase15688:
the cytosol 
dt - nn - 
Phrase15689:
nonstimulated cells 
jj - nns - 
Phrase15690:
the nucleus 
dt - nn - 
Phrase15691:
distinct molecules 
jj - nns - 
Phrase15692:
the results 
dt - nns - 
Phrase15693:
the same electrophoretic mobility 
dt - jj - jj - nn - 
Phrase15694:
these cells 
dt - nns - 
Phrase15695:
the available mab 
dt - jj - nn - 
Phrase15696:
the t 
dt - nn - 
Phrase15697:
detectable nfatc 
jj - nn - 
Phrase15698:
cytoplasmic extracts 
jj - nns - 
Phrase15699:
any time 
dt - nn - 
Phrase15700:
these results 
dt - nns - 
Phrase15701:
the first direct evidence 
dt - jj - jj - nn - 
Phrase15702:
both csa-sensitive transcription 
dt - jj - nn - 
Phrase15703:
their 
prp$ - 
Phrase15704:
primary cells 
jj - nns - 
Phrase15705:
single stimulus 
jj - nn - 
Phrase15706:
the case 
dt - nn - 
Phrase15707:
early activation 
jj - nn - 
Phrase15708:
the phosphorylation 
dt - nn - 
Phrase15709:
important cytokines 
jj - nns - 
Phrase15710:
immune response 
jj - nn - 
Phrase15711:
the proliferation 
dt - nn - 
Phrase15712:
natural killer 
jj - nn - 
Phrase15713:
the mechanisms 
dt - nns - 
Phrase15714:
the effects 
dt - nns - 
Phrase15715:
the binding 
dt - nn - 
Phrase15716:
its 
prp$ - 
Phrase15717:
the activation 
dt - nn - 
Phrase15718:
subsequent steps 
jj - nns - 
Phrase15719:
the signaling 
dt - nn - 
Phrase15720:
the nucleus 
dt - nn - 
Phrase15721:
the activation 
dt - nn - 
Phrase15722:
specific genes 
jj - nns - 
Phrase15723:
many cytokines 
jj - nns - 
Phrase15724:
the tyrosine 
dt - nn - 
Phrase15725:
the stat 
dt - nn - 
Phrase15726:
the ability 
dt - nn - 
Phrase15727:
natural killer 
jj - nn - 
Phrase15728:
the phosphorylation 
dt - nn - 
Phrase15729:
stat-related proteins 
jj - nns - 
Phrase15730:
the phosphorylation 
dt - nn - 
Phrase15731:
the src 
dt - nn - 
Phrase15732:
these stat 
dt - nn - 
Phrase15733:
the nucleus 
dt - nn - 
Phrase15734:
specific dna 
jj - nn - 
Phrase15735:
these findings 
dt - nns - 
Phrase15736:
its 
prp$ - 
Phrase15737:
specific genes 
jj - nns - 
Phrase15738:
immune cell 
jj - nn - 
Phrase15739:
positive chronic myelogenous leukemia 
jj - jj - jj - nn - 
Phrase15740:
this study 
dt - nn - 
Phrase15741:
constitutive levels 
jj - nns - 
Phrase15742:
chronic phase 
jj - nn - 
Phrase15743:
peripheral blood 
jj - nn - 
Phrase15744:
the hybrid 
dt - nn - 
Phrase15745:
constitutive c-fos 
jj - nn - 
Phrase15746:
higher in 
jjr - nn - 
Phrase15747:
the proportion 
dt - nn - 
Phrase15748:
= 0.6895 
jj - nn - 
Phrase15749:
the proportion 
dt - nn - 
Phrase15750:
immature cells 
jj - nns - 
Phrase15751:
= -0.568 
jj - nn - 
Phrase15752:
the pbmc 
dt - nn - 
Phrase15753:
constitutive mrna 
jj - nn - 
Phrase15754:
the hybrid 
dt - nn - 
Phrase15755:
chronic in 
jj - nn - 
Phrase15756:
significant increase 
jj - nn - 
Phrase15757:
the expression 
dt - nn - 
Phrase15758:
peripheral monocytes 
jj - nns - 
Phrase15759:
the clinical significance 
dt - jj - nn - 
Phrase15760:
the differential expression 
dt - jj - nn - 
Phrase15761:
peripheral blood 
jj - nn - 
Phrase15762:
postmenopausal females 
jj - nns - 
Phrase15763:
postmenopausal females 
jj - nns - 
Phrase15764:
the monocyte 
dt - nn - 
Phrase15765:
the blood 
dt - nn - 
Phrase15766:
each patient 
dt - nn - 
Phrase15767:
significant decrease 
jj - nn - 
Phrase15768:
the percentage 
dt - nn - 
Phrase15769:
positive monocytes 
jj - nns - 
Phrase15770:
an increase 
dt - nn - 
Phrase15771:
these findings 
dt - nns - 
Phrase15772:
the monocyte 
dt - nn - 
Phrase15773:
its 
prp$ - 
Phrase15774:
the er 
dt - nn - 
Phrase15775:
the monocytes 
dt - nns - 
Phrase15776:
ligand-induced tyrosine 
jj - nn - 
Phrase15777:
the janus 
dt - nn - 
Phrase15778:
protein-tyrosine kinase 
jj - nn - 
Phrase15779:
the appropriate variable region 
dt - jj - jj - nn - 
Phrase15780:
the pathogenesis 
dt - nn - 
Phrase15781:
several autoimmune diseases 
jj - jj - nns - 
Phrase15782:
either proliferation 
dt - nn - 
Phrase15783:
an interleukin-2 
dt - nn - 
Phrase15784:
nonresponsive state 
jj - nn - 
Phrase15785:
we 
prp - 
Phrase15786:
the expression 
dt - nn - 
Phrase15787:
the il-2 
dt - nn - 
Phrase15788:
antigen-specific cd4+ t-cell 
jj - jj - nn - 
Phrase15789:
the expression 
dt - nn - 
Phrase15790:
the changes 
dt - nns - 
Phrase15791:
the composition 
dt - nn - 
Phrase15792:
il-2-induced tyrosine 
jj - nn - 
Phrase15793:
the janus 
dt - nn - 
Phrase15794:
protein-tyrosine kinase 
jj - nn - 
Phrase15795:
il-2-driven proliferation 
jj - nn - 
Phrase15796:
the expression 
dt - nn - 
Phrase15797:
ligand-induced tyrosine 
jj - nn - 
Phrase15798:
il-2-driven proliferation 
jj - nn - 
Phrase15799:
our 
prp$ - 
Phrase15800:
the jak/stat 
dt - nn - 
Phrase15801:
cd4+ t-cell 
jj - nn - 
Phrase15802:
constitutive nf-kappa 
jj - nn - 
Phrase15803:
neonatal lethality 
jj - nn - 
Phrase15804:
the nf-kappa 
dt - nn - 
Phrase15805:
inhibitory i 
jj - nn - 
Phrase15806:
normal at 
jj - nn - 
Phrase15807:
severe runting 
jj - nn - 
Phrase15808:
extensive granulopoiesis 
jj - nn - 
Phrase15809:
hematopoietic tissues 
jj - nns - 
Phrase15810:
these mice 
dt - nns - 
Phrase15811:
elevated levels 
jj - nns - 
Phrase15812:
both nuclear nf-kappa 
dt - jj - nn - 
Phrase15813:
these phenotypic abnormalities 
dt - jj - nns - 
Phrase15814:
the p50 
dt - nn - 
Phrase15815:
hematopoietic cells 
jj - nns - 
Phrase15816:
embryonic fibroblasts 
jj - nns - 
Phrase15817:
minimal constitutive nf-kappa 
jj - jj - nn - 
Phrase15818:
normal signal-dependent 
jj - nn - 
Phrase15819:
our 
prp$ - 
Phrase15820:
the signal-dependent 
dt - nn - 
Phrase15821:
the postinduction 
dt - nn - 
Phrase15822:
these results 
dt - nns - 
Phrase15823:
distinct roles 
jj - nns - 
Phrase15824:
the necessity 
dt - nn - 
Phrase15825:
stringent control 
jj - nn - 
Phrase15826:
the activation 
dt - nn - 
Phrase15827:
the activation 
dt - nn - 
Phrase15828:
the signal 
dt - nn - 
Phrase15829:
several cytokines 
jj - nns - 
Phrase15830:
dose-dependent tyrosine 
jj - nn - 
Phrase15831:
the tyrosine 
dt - nn - 
Phrase15832:
multiple stat 
jj - nn - 
Phrase15833:
the stat 
dt - nn - 
Phrase15834:
various stat 
jj - nn - 
Phrase15835:
the induction 
dt - nn - 
Phrase15836:
both jak 
dt - nn - 
Phrase15837:
the growth-promoting 
dt - nn - 
Phrase15838:
this signal 
dt - nn - 
Phrase15839:
key role 
jj - nn - 
Phrase15840:
il-7-induced proliferation 
jj - nn - 
Phrase15841:
dual cyclooxygenase/5-lipoxygenase 
jj - nn - 
Phrase15842:
anti-inflammatory compound 
jj - nn - 
Phrase15843:
clinical investigation 
jj - nn - 
Phrase15844:
it 
prp - 
Phrase15845:
anti-inflammatory activity 
jj - nn - 
Phrase15846:
the current study 
dt - jj - nn - 
Phrase15847:
the cytokine 
dt - nn - 
Phrase15848:
the role 
dt - nn - 
Phrase15849:
these effects 
dt - nns - 
Phrase15850:
peripheral blood 
jj - nn - 
Phrase15851:
an ic50 
dt - nn - 
Phrase15852:
it 
prp - 
Phrase15853:
the production 
dt - nn - 
Phrase15854:
the cytokines 
dt - nns - 
Phrase15855:
= 10-12 
jj - nn - 
Phrase15856:
these concentrations 
dt - nns - 
Phrase15857:
either cytokines 
dt - nns - 
Phrase15858:
conditioned media 
jj - nns - 
Phrase15859:
the proliferative 
dt - nn - 
Phrase15860:
the presence 
dt - nn - 
Phrase15861:
the concurrent addition 
dt - jj - nn - 
Phrase15862:
the form 
dt - nn - 
Phrase15863:
other iron 
jj - nn - 
Phrase15864:
the inhibition 
dt - nn - 
Phrase15865:
the activation 
dt - nn - 
Phrase15866:
several cytokine 
jj - nn - 
Phrase15867:
the addition 
dt - nn - 
Phrase15868:
these data 
dt - nns - 
Phrase15869:
the action 
dt - nn - 
Phrase15870:
least in 
jjs - nn - 
Phrase15871:
its 
prp$ - 
Phrase15872:
the amount 
dt - nn - 
Phrase15873:
available iron 
jj - nn - 
Phrase15874:
subsequent inhibition 
jj - nn - 
Phrase15875:
c-terminal sequences 
jj - nns - 
Phrase15876:
the proteolytic degradation 
dt - jj - nn - 
Phrase15877:
the inhibitory protein 
dt - jj - nn - 
Phrase15878:
extracellular stimulation 
jj - nn - 
Phrase15879:
the activation 
dt - nn - 
Phrase15880:
the transcription 
dt - nn - 
Phrase15881:
the expression 
dt - nn - 
Phrase15882:
stable transfectants 
jj - nns - 
Phrase15883:
the endogenous murine 
dt - jj - nn - 
Phrase15884:
exogenous i 
jj - nn - 
Phrase15885:
the cells 
dt - nns - 
Phrase15886:
the proteasome 
dt - nn - 
Phrase15887:
this ligand-induced degradation 
dt - jj - nn - 
Phrase15888:
previous studies 
jj - nns - 
Phrase15889:
the human 
dt - nn - 
Phrase15890:
the human 
dt - nn - 
Phrase15891:
this cell 
dt - nn - 
Phrase15892:
we 
prp - 
Phrase15893:
the sequences 
dt - nns - 
Phrase15894:
both ligand-induced phosphorylation 
dt - jj - nn - 
Phrase15895:
the degradation 
dt - nn - 
Phrase15896:
our 
prp$ - 
Phrase15897:
the c 
dt - nn - 
Phrase15898:
the i 
dt - nn - 
Phrase15899:
ligand-inducible phosphorylation 
jj - nn - 
Phrase15900:
ligand-inducible degradation 
jj - nn - 
Phrase15901:
the inducible phosphorylation 
dt - jj - nn - 
Phrase15902:
the n 
dt - nn - 
Phrase15903:
the protein 
dt - nn - 
Phrase15904:
the mutation 
dt - nn - 
Phrase15905:
either residue 
dt - nn - 
Phrase15906:
ligand-induced degradation 
jj - nn - 
Phrase15907:
both residues 
dt - nns - 
Phrase15908:
inducible phosphorylation 
jj - nn - 
Phrase15909:
the protein 
dt - nn - 
Phrase15910:
cellular 25-hydroxyvitamin 
jj - nn - 
Phrase15911:
the genomic response 
dt - jj - nn - 
Phrase15912:
normal human 
jj - nn - 
Phrase15913:
the genomic actions 
dt - jj - nns - 
Phrase15914:
the intracellular vitamin 
dt - jj - nn - 
Phrase15915:
nuclear access 
jj - nn - 
Phrase15916:
the sterol-vdr 
dt - nn - 
Phrase15917:
the role 
dt - nn - 
Phrase15918:
the response 
dt - nn - 
Phrase15919:
viable cells 
jj - nns - 
Phrase15920:
our 
prp$ - 
Phrase15921:
this interaction 
dt - nn - 
Phrase15922:
normal human 
jj - nn - 
Phrase15923:
the ability 
dt - nn - 
Phrase15924:
exogenous 1,25(oh)2d3 
jj - nn - 
Phrase15925:
its 
prp$ - 
Phrase15926:
own synthesis 
jj - nn - 
Phrase15927:
either total 
dt - nn - 
Phrase15928:
maximal 1,25(oh)2d3-vdr binding 
jj - jj - nn - 
Phrase15929:
intact microtubules 
jj - nn - 
Phrase15930:
the vmax 
dt - nn - 
Phrase15931:
an increase 
dt - nn - 
Phrase15932:
the km 
dt - nn - 
Phrase15933:
we 
prp - 
Phrase15934:
cellular 25(oh)d3 
jj - nn - 
Phrase15935:
its 
prp$ - 
Phrase15936:
intracellular trafficking 
jj - nn - 
Phrase15937:
the mitochondria 
dt - nn - 
Phrase15938:
intracellular 25(oh)d3 
jj - nn - 
Phrase15939:
their 
prp$ - 
Phrase15940:
normal 1,25(oh)2d3 
jj - nn - 
Phrase15941:
the interrelationship 
dt - nn - 
Phrase15942:
cyclic amp 
jj - nn - 
Phrase15943:
its 
prp$ - 
Phrase15944:
we 
prp - 
Phrase15945:
the question 
dt - nn - 
Phrase15946:
the regulation 
dt - nn - 
Phrase15947:
cyclic amp 
jj - nn - 
Phrase15948:
the phosphorylation 
dt - nn - 
Phrase15949:
the rap1 
dt - nn - 
Phrase15950:
pathological model 
jj - nn - 
Phrase15951:
we 
prp - 
Phrase15952:
experimental conditions 
jj - nns - 
Phrase15953:
the phosphorylation 
dt - nn - 
Phrase15954:
the rap1 
dt - nn - 
Phrase15955:
we 
prp - 
Phrase15956:
their 
prp$ - 
Phrase15957:
the potential 
dt - nn - 
Phrase15958:
the rap1 
dt - nn - 
Phrase15959:
the phosphorylation 
dt - nn - 
Phrase15960:
the rap1 
dt - nn - 
Phrase15961:
the catalytic subunit 
dt - jj - nn - 
Phrase15962:
the cyclic amp-dependent 
dt - jj - nn - 
Phrase15963:
the first patients 
dt - jj - nns - 
Phrase15964:
we 
prp - 
Phrase15965:
significant modification 
jj - nn - 
Phrase15966:
the expression 
dt - nn - 
Phrase15967:
the pl/im 
dt - nn - 
Phrase15968:
monoclonal antibody 
jj - nn - 
Phrase15969:
this isoform 
dt - nn - 
Phrase15970:
the rap1 
dt - nn - 
Phrase15971:
the c. 
dt - nn - 
Phrase15972:
these results 
dt - nns - 
Phrase15973:
us 
prp - 
Phrase15974:
these pathological platelets 
dt - jj - nns - 
Phrase15975:
the relationship 
dt - nn - 
Phrase15976:
the expression 
dt - nn - 
Phrase15977:
the regulation 
dt - nn - 
Phrase15978:
severe heart 
jj - nn - 
Phrase15979:
we 
prp - 
Phrase15980:
the expression 
dt - nn - 
Phrase15981:
the phosphorylation 
dt - nn - 
Phrase15982:
lower effect 
jjr - nn - 
Phrase15983:
we 
prp - 
Phrase15984:
the decrease 
dt - nn - 
Phrase15985:
its 
prp$ - 
Phrase15986:
the expression 
dt - nn - 
Phrase15987:
the stimulatory effect 
dt - jj - nn - 
Phrase15988:
the evidence 
dt - nn - 
Phrase15989:
the expression 
dt - nn - 
Phrase15990:
the rap1 
dt - nn - 
Phrase15991:
these findings 
dt - nns - 
Phrase15992:
the regulation 
dt - nn - 
Phrase15993:
the phosphorylation 
dt - nn - 
Phrase15994:
the rap1 
dt - nn - 
Phrase15995:
an irf-1-dependent 
dt - nn - 
Phrase15996:
mitogen-activated t 
jj - nn - 
Phrase15997:
altruistic suicide 
jj - nn - 
Phrase15998:
their 
prp$ - 
Phrase15999:
intrinsic high potential 
jj - jj - nn - 
Phrase16000:
clonal expansion 
jj - nn - 
Phrase16001:
the tumour 
dt - nn - 
Phrase16002:
this type 
dt - nn - 
Phrase16003:
p53-independent pathway 
jj - nn - 
Phrase16004:
the same event 
dt - jj - nn - 
Phrase16005:
mitogen-activated mature t 
jj - jj - nn - 
Phrase16006:
we 
prp - 
Phrase16007:
these t 
dt - nn - 
Phrase16008:
the antioncogenic 
dt - nn - 
Phrase16009:
regulatory factor 
jj - nn - 
Phrase16010:
different anti-onco-genic 
jj - nn - 
Phrase16011:
distinct apoptotic pathways 
jj - jj - nns - 
Phrase16012:
we 
prp - 
Phrase16013:
the interleukin-1 
dt - nn - 
Phrase16014:
mammalian homologue 
jj - nn - 
Phrase16015:
the caenorhabditis 
dt - nn - 
Phrase16016:
ectopic overexpression 
jj - nn - 
Phrase16017:
the activation 
dt - nn - 
Phrase16018:
the endogenous gene 
dt - jj - nn - 
Phrase16019:
the sensitivity 
dt - nn - 
Phrase16020:
peripheral leukocytes 
jj - nns - 
Phrase16021:
their 
prp$ - 
Phrase16022:
the peak 
dt - nn - 
Phrase16023:
the trough 
dt - nn - 
Phrase16024:
the difference 
dt - nn - 
Phrase16025:
them 
prp - 
Phrase16026:
the fi 
dt - nn - 
Phrase16027:
the chemotactic 
dt - nn - 
Phrase16028:
the cr 
dt - nn - 
Phrase16029:
functional significance 
jj - nn - 
Phrase16030:
the cr 
dt - nn - 
Phrase16031:
normal in 
jj - nn - 
Phrase16032:
the fact 
dt - nn - 
Phrase16033:
the cr 
dt - nn - 
Phrase16034:
the independency 
dt - nn - 
Phrase16035:
the cr 
dt - nn - 
Phrase16036:
the cr 
dt - nn - 
Phrase16037:
basal lesions 
jj - nns - 
Phrase16038:
the lesions 
dt - nns - 
Phrase16039:
located in 
jj - nn - 
Phrase16040:
the cerebral cortex 
dt - jj - nn - 
Phrase16041:
these results 
dt - nns - 
Phrase16042:
located in 
jj - nn - 
Phrase16043:
the basal brain 
dt - jj - nn - 
Phrase16044:
the suprachiasmatic 
dt - nn - 
Phrase16045:
b-lymphoblastoid cell 
jj - nn - 
Phrase16046:
multiple sclerosis 
jj - nn - 
Phrase16047:
healthy control 
jj - nn - 
Phrase16048:
putative new 
jj - nn - 
Phrase16049:
epstein-barr virus 
jj - nn - 
Phrase16050:
several occasions 
jj - nn - 
Phrase16051:
we 
prp - 
Phrase16052:
later we 
jjr - nn - 
Phrase16053:
b-lymphoblastoid cell 
jj - nn - 
Phrase16054:
an ms-like 
dt - nn - 
Phrase16055:
another patient 
dt - nn - 
Phrase16056:
epstein-barr virus 
jj - nn - 
Phrase16057:
positive in 
jj - nn - 
Phrase16058:
viral material 
jj - nn - 
Phrase16059:
both lcls 
dt - nn - 
Phrase16060:
these findings 
dt - nns - 
Phrase16061:
we 
prp - 
Phrase16062:
an intensified 
dt - nn - 
Phrase16063:
consecutive ms 
jj - nn - 
Phrase16064:
consecutive healthy controls 
jj - jj - nns - 
Phrase16065:
both rvlp 
dt - nn - 
Phrase16066:
the putative new 
dt - jj - nn - 
Phrase16067:
any causal relationship 
dt - jj - nn - 
Phrase16068:
the findings 
dt - nns - 
Phrase16069:
this possibility 
dt - nn - 
Phrase16070:
an ionomycin/cyclosporin 
dt - nn - 
Phrase16071:
the human 
dt - nn - 
Phrase16072:
the ca2+ 
dt - nn - 
Phrase16073:
the transcription 
dt - nn - 
Phrase16074:
many cytokine 
jj - nn - 
Phrase16075:
cis-acting sequence 
jj - nn - 
Phrase16076:
this sequence 
dt - nn - 
Phrase16077:
the response 
dt - nn - 
Phrase16078:
intracellular ca2+ 
jj - nn - 
Phrase16079:
we 
prp - 
Phrase16080:
the identification 
dt - nn - 
Phrase16081:
the same sequence 
dt - jj - nn - 
Phrase16082:
non-cytokine gene 
jj - nn - 
Phrase16083:
the human 
dt - nn - 
Phrase16084:
site-directed mutations 
jj - nns - 
Phrase16085:
electrophoretic mobility 
jj - nn - 
Phrase16086:
this sequence 
dt - nn - 
Phrase16087:
the ionomycin-induced 
dt - nn - 
Phrase16088:
the tcrg 
dt - nn - 
Phrase16089:
our 
prp$ - 
Phrase16090:
an explanation 
dt - nn - 
Phrase16091:
previous observation 
jj - nn - 
Phrase16092:
dendritic cell-t-cell 
jj - nn - 
Phrase16093:
productive infection 
jj - nn - 
Phrase16094:
the t 
dt - nn - 
Phrase16095:
the activation 
dt - nn - 
Phrase16096:
the transcription 
dt - nn - 
Phrase16097:
the constitutive transcription 
dt - jj - nn - 
Phrase16098:
the hiv-1 
dt - nn - 
Phrase16099:
we 
prp - 
Phrase16100:
nonactivated memory 
jj - nn - 
Phrase16101:
dendritic cells 
jj - nns - 
Phrase16102:
these syncytia 
dt - nn - 
Phrase16103:
an absence 
dt - nn - 
Phrase16104:
the expression 
dt - nn - 
Phrase16105:
we 
prp - 
Phrase16106:
electrophoretic mobility 
jj - nn - 
Phrase16107:
active nf-kappa 
jj - nn - 
Phrase16108:
high levels 
jj - nns - 
Phrase16109:
the failure 
dt - nn - 
Phrase16110:
the heterologous dc-t-cell 
dt - jj - nn - 
Phrase16111:
these unusual heterologous syncytia 
dt - jj - jj - nn - 
Phrase16112:
infected individuals 
jj - nns - 
Phrase16113:
chronic hiv-1 
jj - nn - 
Phrase16114:
immune stimulation 
jj - nn - 
Phrase16115:
the signal-induced phosphorylation 
dt - jj - nn - 
Phrase16116:
various cellular genes 
jj - jj - nns - 
Phrase16117:
immune responses 
jj - nns - 
Phrase16118:
viral genes 
jj - nns - 
Phrase16119:
the cytoplasm 
dt - nn - 
Phrase16120:
an inhibitory protein 
dt - jj - nn - 
Phrase16121:
various extracellular signals 
jj - jj - nns - 
Phrase16122:
rapid degradation 
jj - nn - 
Phrase16123:
the activation 
dt - nn - 
Phrase16124:
the cytoplasmic extract 
dt - jj - nn - 
Phrase16125:
the presence 
dt - nn - 
Phrase16126:
the release 
dt - nn - 
Phrase16127:
the dissociation 
dt - nn - 
Phrase16128:
the nf 
dt - nn - 
Phrase16129:
the presence 
dt - nn - 
Phrase16130:
these results 
dt - nns - 
Phrase16131:
the release 
dt - nn - 
Phrase16132:
the phosphorylation 
dt - nn - 
Phrase16133:
high proline 
jj - nn - 
Phrase16134:
natural killer 
jj - nn - 
Phrase16135:
minus t 
jj - nn - 
Phrase16136:
subtractive library 
jj - nn - 
Phrase16137:
the b4-2 
dt - nn - 
Phrase16138:
an mrna 
dt - nn - 
Phrase16139:
it 
prp - 
Phrase16140:
various databases 
jj - nn - 
Phrase16141:
high homology 
jj - nn - 
Phrase16142:
other sequences 
jj - nns - 
Phrase16143:
high proline 
jj - nn - 
Phrase16144:
putative nuclear targeting 
jj - jj - nn - 
Phrase16145:
several spxx 
jj - nn - 
Phrase16146:
regulatory proteins 
jj - nns - 
Phrase16147:
the stretches 
dt - nns - 
Phrase16148:
the ligand 
dt - nn - 
Phrase16149:
lymphoid specific gene 
jj - jj - nn - 
Phrase16150:
absent in 
jj - nn - 
Phrase16151:
other cells 
jj - nns - 
Phrase16152:
polyclonal antiserum 
jj - nn - 
Phrase16153:
il-2-induced proliferation 
jj - nn - 
Phrase16154:
cooh-terminal region 
jj - nn - 
Phrase16155:
the il-2 
dt - nn - 
Phrase16156:
the jak-stat 
dt - nn - 
Phrase16157:
the cell 
dt - nn - 
Phrase16158:
the nucleus 
dt - nn - 
Phrase16159:
single form 
jj - nn - 
Phrase16160:
several multicomponent cytokine 
jj - jj - nn - 
Phrase16161:
simultaneous activation 
jj - nn - 
Phrase16162:
different jak 
jj - nn - 
Phrase16163:
recent evidence 
jj - nn - 
Phrase16164:
preferential coupling 
jj - nn - 
Phrase16165:
the concept 
dt - nn - 
Phrase16166:
il-2-induced heterodimerization 
jj - nn - 
Phrase16167:
their 
prp$ - 
Phrase16168:
the present 
dt - nn - 
Phrase16169:
the ability 
dt - nn - 
Phrase16170:
larger extent 
jjr - nn - 
Phrase16171:
the yt 
dt - nn - 
Phrase16172:
several independent criteria 
jj - jj - nns - 
Phrase16173:
vigorous tyrosine 
jj - nn - 
Phrase16174:
marked enzymatic activation 
jj - jj - nn - 
Phrase16175:
higher abundance 
jjr - nn - 
Phrase16176:
robust il-2-induced proliferation 
jj - jj - nn - 
Phrase16177:
detectable involvement 
jj - nn - 
Phrase16178:
either jak1 
dt - nn - 
Phrase16179:
we 
prp - 
Phrase16180:
il-2-induced heterodimerization 
jj - nn - 
Phrase16181:
membrane-proximal region 
jj - nn - 
Phrase16182:
the amount 
dt - nn - 
Phrase16183:
the receptor 
dt - nn - 
Phrase16184:
both il-2r 
dt - nn - 
Phrase16185:
the predominant stat 
dt - jj - nn - 
Phrase16186:
cooh-terminal region 
jj - nn - 
Phrase16187:
direct physiological effects 
jj - jj - nns - 
Phrase16188:
its 
prp$ - 
Phrase16189:
whole-cell binding 
jj - nn - 
Phrase16190:
lymphoid cell 
jj - nn - 
Phrase16191:
single class 
jj - nn - 
Phrase16192:
= 7.4 
jj - nn - 
Phrase16193:
the ca2+ 
dt - nn - 
Phrase16194:
other steroids 
jj - nns - 
Phrase16195:
these results 
dt - nns - 
Phrase16196:
the existence 
dt - nn - 
Phrase16197:
the process 
dt - nn - 
Phrase16198:
signal-induced activation 
jj - nn - 
Phrase16199:
transcriptional activator 
jj - nn - 
Phrase16200:
cell-free system 
jj - nn - 
Phrase16201:
the ubiquitin-carrier 
dt - nn - 
Phrase16202:
novel ubiquitin-protein 
jj - nn - 
Phrase16203:
the transcriptional factor 
dt - jj - nn - 
Phrase16204:
distinct genes 
jj - nns - 
Phrase16205:
the rel 
dt - nn - 
Phrase16206:
the c-terminal domain 
dt - jj - nn - 
Phrase16207:
the precursor 
dt - nn - 
Phrase16208:
the mature p50 
dt - jj - nn - 
Phrase16209:
the n-terminal region 
dt - jj - nn - 
Phrase16210:
the molecule 
dt - nn - 
Phrase16211:
the mechanism 
dt - nn - 
Phrase16212:
it 
prp - 
Phrase16213:
the ubiquitin-proteasome system 
dt - jj - nn - 
Phrase16214:
the process 
dt - nn - 
Phrase16215:
the specific enzymes 
dt - jj - nns - 
Phrase16216:
the mechanism 
dt - nn - 
Phrase16217:
limited proteolysis 
jj - nn - 
Phrase16218:
the molecule 
dt - nn - 
Phrase16219:
t. 
nnp - 
Phrase16220:
the processing 
dt - nn - 
Phrase16221:
cell-free system 
jj - nn - 
Phrase16222:
60-kda precursor 
jj - nn - 
Phrase16223:
they 
prp - 
Phrase16224:
the processing 
dt - nn - 
Phrase16225:
this study 
dt - nn - 
Phrase16226:
we 
prp - 
Phrase16227:
cell-free processing 
jj - nn - 
Phrase16228:
the ubiquitin-proteasome system 
dt - jj - nn - 
Phrase16229:
the intact p105 
dt - jj - nn - 
Phrase16230:
the precursor 
dt - nn - 
Phrase16231:
an essential intermediate 
dt - jj - nn - 
Phrase16232:
the processing 
dt - nn - 
Phrase16233:
novel species 
jj - nns - 
Phrase16234:
the ubiquitin-carrier 
dt - nn - 
Phrase16235:
the conjugation 
dt - nn - 
Phrase16236:
the limited processing 
dt - jj - nn - 
Phrase16237:
the p105 
dt - nn - 
Phrase16238:
the process 
dt - nn - 
Phrase16239:
novel enzyme 
jj - nn - 
Phrase16240:
the p53-conjugating 
dt - nn - 
Phrase16241:
n-end rule 
jj - nn - 
Phrase16242:
the treatment 
dt - nn - 
Phrase16243:
long-term clinical effects 
jj - jj - nns - 
Phrase16244:
the long-term effects 
dt - jj - nns - 
Phrase16245:
low doses 
jj - nns - 
Phrase16246:
hormonal parameters 
jj - nns - 
Phrase16247:
the androgen 
dt - nn - 
Phrase16248:
regular menses 
jj - nn - 
Phrase16249:
the study 
dt - nn - 
Phrase16250:
active women 
jj - nns - 
Phrase16251:
the study 
dt - nn - 
Phrase16252:
hormonal parameters 
jj - nns - 
Phrase16253:
the concentration 
dt - nn - 
Phrase16254:
the menstrual cycle 
dt - jj - nn - 
Phrase16255:
the noticeable exception 
dt - jj - nn - 
Phrase16256:
the treatment 
dt - nn - 
Phrase16257:
the cortisol 
dt - nn - 
Phrase16258:
the number 
dt - nn - 
Phrase16259:
higher in 
jjr - nn - 
Phrase16260:
the luteal 
dt - nn - 
Phrase16261:
the follicular phase 
dt - jj - nn - 
Phrase16262:
the patients 
dt - nns - 
Phrase16263:
the antiandrogen drug 
dt - jj - nn - 
Phrase16264:
effective in 
jj - nn - 
Phrase16265:
the treatment 
dt - nn - 
Phrase16266:
the menstrual cycle 
dt - jj - nn - 
Phrase16267:
the meaning 
dt - nn - 
Phrase16268:
this finding 
dt - nn - 
Phrase16269:
constitutive expression 
jj - nn - 
Phrase16270:
the production 
dt - nn - 
Phrase16271:
functional human 
jj - nn - 
Phrase16272:
immune deficiency 
jj - nn - 
Phrase16273:
these jurkat-tat 
dt - nn - 
Phrase16274:
its 
prp$ - 
Phrase16275:
an osteoblast-specific 
dt - nn - 
Phrase16276:
cis-acting element 
jj - nn - 
Phrase16277:
osteoblast-specific cis-acting elements 
dt - jj - nns - 
Phrase16278:
trans-acting factors 
jj - nn - 
Phrase16279:
we 
prp - 
Phrase16280:
an analysis 
dt - nn - 
Phrase16281:
the promoter 
dt - nn - 
Phrase16282:
an osteoblast-specific 
dt - nn - 
Phrase16283:
this promoter 
dt - nn - 
Phrase16284:
we 
prp - 
Phrase16285:
cis-acting elements 
jj - nns - 
Phrase16286:
p. 
nnp - 
Phrase16287:
g. 
nnp - 
Phrase16288:
the sequence 
dt - nn - 
Phrase16289:
these elements 
dt - nns - 
Phrase16290:
the dna-binding 
dt - nn - 
Phrase16291:
the pebp2 
dt - nn - 
Phrase16292:
the mammalian homologues 
dt - jj - nns - 
Phrase16293:
the drosophila 
dt - nn - 
Phrase16294:
we 
prp - 
Phrase16295:
nuclear extracts 
jj - nns - 
Phrase16296:
specific antiserum 
jj - nn - 
Phrase16297:
this family 
dt - nn - 
Phrase16298:
the factor 
dt - nn - 
Phrase16299:
nuclear extracts 
jj - nns - 
Phrase16300:
we 
prp - 
Phrase16301:
the activity 
dt - nn - 
Phrase16302:
short osteocalcin 
jj - nn - 
Phrase16303:
its 
prp$ - 
Phrase16304:
the different mobilities 
dt - jj - nns - 
Phrase16305:
nuclear extract-dna 
jj - nn - 
Phrase16306:
nuclear extract-dna 
jj - nn - 
Phrase16307:
the inability 
dt - nn - 
Phrase16308:
retinoic acid 
jj - nn - 
Phrase16309:
the other pebp2 
dt - jj - nn - 
Phrase16310:
this family 
dt - nn - 
Phrase16311:
this study 
dt - nn - 
Phrase16312:
an osteoblast-specific 
dt - nn - 
Phrase16313:
its 
prp$ - 
Phrase16314:
an osteoblast-specific 
dt - nn - 
Phrase16315:
cis-acting element 
jj - nn - 
Phrase16316:
the pebp2 
dt - nn - 
Phrase16317:
the transcription 
dt - nn - 
Phrase16318:
the histone 
dt - nn - 
Phrase16319:
biol 
nnp - 
Phrase16320:
feb 
nnp - 
Phrase16321:
apparent molecular 
jj - nn - 
Phrase16322:
the sequences 
dt - nns - 
Phrase16323:
the transcription 
dt - nn - 
Phrase16324:
the histone 
dt - nn - 
Phrase16325:
its 
prp$ - 
Phrase16326:
other cells 
jj - nns - 
Phrase16327:
erythroid precursors 
jj - nns - 
Phrase16328:
the same ibr 
dt - jj - nn - 
Phrase16329:
we 
prp - 
Phrase16330:
the ibr 
dt - nn - 
Phrase16331:
the relationship 
dt - nn - 
Phrase16332:
acidic protein 
jj - nn - 
Phrase16333:
99.0 % 
dt - nn - 
Phrase16334:
the invertebrate 
dt - nn - 
Phrase16335:
we 
prp - 
Phrase16336:
likely identical proteins 
jj - jj - nns - 
Phrase16337:
their 
prp$ - 
Phrase16338:
we 
prp - 
Phrase16339:
several molecular 
jj - nn - 
Phrase16340:
the factor 
dt - nn - 
Phrase16341:
stable homodimers 
jj - nns - 
Phrase16342:
the dimer 
dt - nn - 
Phrase16343:
the relevant dna-binding 
dt - jj - nn - 
Phrase16344:
n-terminal half 
jj - nn - 
Phrase16345:
the dna-binding/dimerization 
dt - nn - 
Phrase16346:
outer limits 
jj - nns - 
Phrase16347:
several casein 
jj - nn - 
Phrase16348:
bipartite nuclear localization 
jj - jj - nn - 
Phrase16349:
nuclear targeting 
jj - nn - 
Phrase16350:
the alternating 
dt - nn - 
Phrase16351:
the direct-repeat 
dt - nn - 
Phrase16352:
the optimal site 
dt - jj - nn - 
Phrase16353:
this family 
dt - nn - 
Phrase16354:
growth-related metabolism 
jj - nn - 
Phrase16355:
the human 
dt - nn - 
Phrase16356:
monocytic cells 
jj - nns - 
Phrase16357:
regulatory factor-1 
jj - nn - 
Phrase16358:
we 
prp - 
Phrase16359:
the molecular 
dt - nn - 
Phrase16360:
the synergistic induction 
dt - jj - nn - 
Phrase16361:
monocytic cells 
jj - nns - 
Phrase16362:
it 
prp - 
Phrase16363:
the basis 
dt - nn - 
Phrase16364:
this induction 
dt - nn - 
Phrase16365:
functional studies 
jj - nns - 
Phrase16366:
the targets 
dt - nns - 
Phrase16367:
the ifn-gamma 
dt - nn - 
Phrase16368:
these regions 
dt - nns - 
Phrase16369:
the minimal element 
dt - jj - nn - 
Phrase16370:
an element 
dt - nn - 
Phrase16371:
the response 
dt - nn - 
Phrase16372:
distal element 
jj - nn - 
Phrase16373:
the p50 
dt - nn - 
Phrase16374:
synergistic induction 
jj - nn - 
Phrase16375:
the il-6 
dt - nn - 
Phrase16376:
monocytic cells 
jj - nns - 
Phrase16377:
the irf-1 
dt - nn - 
Phrase16378:
concomitant removal 
jj - nn - 
Phrase16379:
the negative effect 
dt - jj - nn - 
Phrase16380:
the retinoblastoma 
dt - nn - 
Phrase16381:
the il-6 
dt - nn - 
Phrase16382:
the constitutive sp1 
dt - jj - nn - 
Phrase16383:
essential role 
jj - nn - 
Phrase16384:
lymphoid development 
jj - nn - 
Phrase16385:
x-linked severe combined immunodeficiency 
jj - jj - jj - nn - 
Phrase16386:
the common 
dt - nn - 
Phrase16387:
essential component 
jj - nn - 
Phrase16388:
the receptors 
dt - nns - 
Phrase16389:
the janus 
dt - nn - 
Phrase16390:
it 
prp - 
Phrase16391:
an xscid-like 
dt - nn - 
Phrase16392:
immunological features 
jj - nns - 
Phrase16393:
epstein-barr virus 
jj - nn - 
Phrase16394:
-transformed cell 
jj - nn - 
Phrase16395:
her 
prp$ - 
Phrase16396:
normal gamma 
jj - nn - 
Phrase16397:
different mutation 
jj - nn - 
Phrase16398:
each allele 
dt - nn - 
Phrase16399:
single nucleotide 
jj - nn - 
Phrase16400:
premature termination 
jj - nn - 
Phrase16401:
the jak3 
dt - nn - 
Phrase16402:
the jak3 
dt - nn - 
Phrase16403:
the lack 
dt - nn - 
Phrase16404:
impaired b 
jj - nn - 
Phrase16405:
the inability 
dt - nn - 
Phrase16406:
the ebv-transformed 
dt - nn - 
Phrase16407:
the patient 
dt - nn - 
Phrase16408:
these observations 
dt - nns - 
Phrase16409:
the functions 
dt - nns - 
Phrase16410:
lymphoid development 
jj - nn - 
Phrase16411:
constitutive overexpression 
jj - nn - 
Phrase16412:
the l-selectin 
dt - nn - 
Phrase16413:
fresh leukemic cells 
jj - jj - nns - 
Phrase16414:
an adhesion 
dt - nn - 
Phrase16415:
the selectin 
dt - nn - 
Phrase16416:
the initial step 
dt - jj - nn - 
Phrase16417:
vascular endothelium 
jj - nn - 
Phrase16418:
cellular activation 
jj - nn - 
Phrase16419:
the l-selectin 
dt - nn - 
Phrase16420:
the protein 
dt - nn - 
Phrase16421:
the mechanism 
dt - nn - 
Phrase16422:
leukemic cell 
jj - nn - 
Phrase16423:
we 
prp - 
Phrase16424:
the expression 
dt - nn - 
Phrase16425:
fresh leukemic cells 
jj - jj - nns - 
Phrase16426:
the response 
dt - nn - 
Phrase16427:
the l-selectin 
dt - nn - 
Phrase16428:
viral transcriptional transactivator 
jj - jj - nn - 
Phrase16429:
fresh atl 
jj - nn - 
Phrase16430:
other activation 
jj - nn - 
Phrase16431:
the level 
dt - nn - 
Phrase16432:
the l-selectin 
dt - nn - 
Phrase16433:
the infiltrating leukemic cells 
dt - jj - jj - nns - 
Phrase16434:
the liver 
dt - nn - 
Phrase16435:
intravenous injection 
jj - nn - 
Phrase16436:
the induction 
dt - nn - 
Phrase16437:
the mrna 
dt - nn - 
Phrase16438:
the basal level 
dt - jj - nn - 
Phrase16439:
fivefold transactivation 
jj - nn - 
Phrase16440:
the l-selectin 
dt - nn - 
Phrase16441:
the serum 
dt - nn - 
Phrase16442:
asymptomatic carriers 
jj - nns - 
Phrase16443:
healthy blood 
jj - nn - 
Phrase16444:
these results 
dt - nns - 
Phrase16445:
the l-selectin 
dt - nn - 
Phrase16446:
the overexpression 
dt - nn - 
Phrase16447:
inflammatory cytokines 
jj - nns - 
Phrase16448:
the vascular endothelium 
dt - jj - nn - 
Phrase16449:
ebv-positive b 
jj - nn - 
Phrase16450:
lymphoid cells 
jj - nns - 
Phrase16451:
the latent ebv 
dt - jj - nn - 
Phrase16452:
some ebv 
dt - nn - 
Phrase16453:
-positive b 
jj - nn - 
Phrase16454:
them 
prp - 
Phrase16455:
the activation 
dt - nn - 
Phrase16456:
the ebv 
dt - nn - 
Phrase16457:
lytic cycle 
jj - nn - 
Phrase16458:
we 
prp - 
Phrase16459:
such observations 
jj - nns - 
Phrase16460:
this phenomenon 
dt - nn - 
Phrase16461:
the variant 
dt - nn - 
Phrase16462:
the hhv-6 
dt - nn - 
Phrase16463:
any b 
dt - nn - 
Phrase16464:
the ebv 
dt - nn - 
Phrase16465:
the ebv 
dt - nn - 
Phrase16466:
the p3hr1 
dt - nn - 
Phrase16467:
the infection 
dt - nn - 
Phrase16468:
the variant 
dt - nn - 
Phrase16469:
the presence 
dt - nn - 
Phrase16470:
the ebv 
dt - nn - 
Phrase16471:
the susceptibility 
dt - nn - 
Phrase16472:
the b 
dt - nn - 
Phrase16473:
the binding 
dt - nn - 
Phrase16474:
the percentage 
dt - nn - 
Phrase16475:
infected t 
jj - nn - 
Phrase16476:
the promoter 
dt - nn - 
Phrase16477:
the ebv 
dt - nn - 
Phrase16478:
early genes 
jj - nns - 
Phrase16479:
strong transactivation 
jj - nn - 
Phrase16480:
these promoters 
dt - nns - 
Phrase16481:
normal vitamin 
jj - nn - 
Phrase16482:
these features 
dt - nns - 
Phrase16483:
we 
prp - 
Phrase16484:
the vitamin 
dt - nn - 
Phrase16485:
an abnormality 
dt - nn - 
Phrase16486:
this gene 
dt - nn - 
Phrase16487:
intestinal hyperabsorption 
jj - nn - 
Phrase16488:
we 
prp - 
Phrase16489:
the frequency 
dt - nn - 
Phrase16490:
different alleles 
jj - nns - 
Phrase16491:
the vdr 
dt - nn - 
Phrase16492:
normal race- 
jj - nn - 
Phrase16493:
age-matched control 
jj - nn - 
Phrase16494:
the distribution 
dt - nn - 
Phrase16495:
the vdr 
dt - nn - 
Phrase16496:
the patient 
dt - nn - 
Phrase16497:
the normal population 
dt - jj - nn - 
Phrase16498:
the coding 
dt - nn - 
Phrase16499:
both dna 
dt - nn - 
Phrase16500:
chemical mismatch 
jj - nn - 
Phrase16501:
the basis 
dt - nn - 
Phrase16502:
these results 
dt - nns - 
Phrase16503:
we 
prp - 
Phrase16504:
intestinal calcium 
jj - nn - 
Phrase16505:
this disorder 
dt - nn - 
Phrase16506:
the vdr 
dt - nn - 
Phrase16507:
transcriptional regulation 
jj - nn - 
Phrase16508:
the gene 
dt - nn - 
Phrase16509:
the human 
dt - nn - 
Phrase16510:
c-type lectin 
jj - nn - 
Phrase16511:
functional characterization 
jj - nn - 
Phrase16512:
its 
prp$ - 
Phrase16513:
the human 
dt - nn - 
Phrase16514:
the c-type animal 
dt - jj - nn - 
Phrase16515:
the expression 
dt - nn - 
Phrase16516:
most hematopoietic lineages 
jjs - jj - nns - 
Phrase16517:
located in 
jj - nn - 
Phrase16518:
the inflammatory infiltrates 
dt - jj - nn - 
Phrase16519:
several human 
jj - nn - 
Phrase16520:
the mechanisms 
dt - nns - 
Phrase16521:
inducible expression 
jj - nn - 
Phrase16522:
we 
prp - 
Phrase16523:
the promoter 
dt - nn - 
Phrase16524:
the cd69 
dt - nn - 
Phrase16525:
its 
prp$ - 
Phrase16526:
functional characterization 
jj - nn - 
Phrase16527:
the 5'-flanking region 
dt - jj - nn - 
Phrase16528:
the cd69 
dt - nn - 
Phrase16529:
the presence 
dt - nn - 
Phrase16530:
the major transcription 
dt - jj - nn - 
Phrase16531:
several putative binding 
jj - jj - nn - 
Phrase16532:
inducible transcription 
jj - nn - 
Phrase16533:
the inducible expression 
dt - jj - nn - 
Phrase16534:
this gene 
dt - nn - 
Phrase16535:
the proximal 
dt - nn - 
Phrase16536:
the cis-acting sequences 
dt - jj - nns - 
Phrase16537:
the cd69 
dt - nn - 
Phrase16538:
the upstream sequences 
dt - jj - nns - 
Phrase16539:
the response 
dt - nn - 
Phrase16540:
we 
prp - 
Phrase16541:
the surface 
dt - nn - 
Phrase16542:
the cd69 
dt - nn - 
Phrase16543:
the promoter 
dt - nn - 
Phrase16544:
5'-flanking sequences 
jj - nns - 
Phrase16545:
the cd69 
dt - nn - 
Phrase16546:
this cytokine 
dt - nn - 
Phrase16547:
the expression 
dt - nn - 
Phrase16548:
responsive elements 
jj - nns - 
Phrase16549:
acute myocardial infarction 
jj - jj - nn - 
Phrase16550:
transcriptional control 
jj - nn - 
Phrase16551:
we 
prp - 
Phrase16552:
genomic dna 
jj - nn - 
Phrase16553:
the 5' 
dt - nn - 
Phrase16554:
flanking region 
jj - nn - 
Phrase16555:
the thromboxane 
dt - nn - 
Phrase16556:
the exon-intron 
dt - nn - 
Phrase16557:
the 5' 
dt - nn - 
Phrase16558:
the thromboxane 
dt - nn - 
Phrase16559:
the nucleotide 
dt - nn - 
Phrase16560:
the 5' 
dt - nn - 
Phrase16561:
flanking genomic clone 
jj - jj - nn - 
Phrase16562:
novel human 
jj - nn - 
Phrase16563:
the mrna 
dt - nn - 
Phrase16564:
placental cdna 
jj - nn - 
Phrase16565:
major transcription 
jj - nn - 
Phrase16566:
located in 
jj - nn - 
Phrase16567:
the translation 
dt - nn - 
Phrase16568:
the thromboxane 
dt - nn - 
Phrase16569:
neither a 
dt - nn - 
Phrase16570:
the 5' 
dt - nn - 
Phrase16571:
flanking region 
jj - nn - 
Phrase16572:
the thromboxane 
dt - nn - 
Phrase16573:
platelet-like k562 
jj - nn - 
Phrase16574:
functional analysis 
jj - nn - 
Phrase16575:
the major phorbol 
dt - jj - nn - 
Phrase16576:
ester-responsive motifs 
jj - nns - 
Phrase16577:
the thromboxane 
dt - nn - 
Phrase16578:
the transcription 
dt - nn - 
Phrase16579:
these studies 
dt - nns - 
Phrase16580:
the structure 
dt - nn - 
Phrase16581:
the 5' 
dt - nn - 
Phrase16582:
the thromboxane 
dt - nn - 
Phrase16583:
an ap-2-like nuclear factor 
dt - jj - jj - nn - 
Phrase16584:
upstream promoter 
jj - nn - 
Phrase16585:
these findings 
dt - nns - 
Phrase16586:
the mechanism 
dt - nn - 
Phrase16587:
acute myocardial infarction 
jj - jj - nn - 
Phrase16588:
natural killer 
jj - nn - 
Phrase16589:
previous work 
jj - nn - 
Phrase16590:
significant amount 
jj - nn - 
Phrase16591:
natural killer 
jj - nn - 
Phrase16592:
both estrogen 
dt - nn - 
Phrase16593:
the tumor 
dt - nn - 
Phrase16594:
general coping 
jj - nn - 
Phrase16595:
considerable evidence 
jj - nn - 
Phrase16596:
we 
prp - 
Phrase16597:
the reliability 
dt - nn - 
Phrase16598:
this regression 
dt - nn - 
Phrase16599:
concurrent follow-up 
jj - nn - 
Phrase16600:
it 
prp - 
Phrase16601:
higher nk 
jjr - nn - 
Phrase16602:
the model 
dt - nn - 
Phrase16603:
significant amount 
jj - nn - 
Phrase16604:
= 5.25 
jj - nn - 
Phrase16605:
the literature 
dt - nn - 
Phrase16606:
we 
prp - 
Phrase16607:
such tumors 
jj - nns - 
Phrase16608:
they 
prp - 
Phrase16609:
the ability 
dt - nn - 
Phrase16610:
an accumulation 
dt - nn - 
Phrase16611:
the tumor 
dt - nn - 
Phrase16612:
the site 
dt - nn - 
Phrase16613:
the tumor 
dt - nn - 
Phrase16614:
local tumor 
jj - nn - 
Phrase16615:
the site 
dt - nn - 
Phrase16616:
the finding 
dt - nn - 
Phrase16617:
an independent sample 
dt - jj - nn - 
Phrase16618:
other evidence 
jj - nn - 
Phrase16619:
this social 
dt - nn - 
Phrase16620:
longer survival 
jjr - nn - 
Phrase16621:
the potential 
dt - nn - 
Phrase16622:
this social 
dt - nn - 
Phrase16623:
our 
prp$ - 
Phrase16624:
clinical significance 
jj - nn - 
Phrase16625:
this patient 
dt - nn - 
Phrase16626:
the sequence-specific hmg 
dt - jj - nn - 
Phrase16627:
the lymphocyte 
dt - nn - 
Phrase16628:
transcriptional activator 
jj - nn - 
Phrase16629:
the first group 
dt - jj - nn - 
Phrase16630:
multiple hmg 
jj - nn - 
Phrase16631:
structural features 
jj - nns - 
Phrase16632:
the abundant chromosomal 
dt - jj - nn - 
Phrase16633:
this subgroup 
dt - nn - 
Phrase16634:
the second 
dt - nn - 
Phrase16635:
single hmg 
jj - nn - 
Phrase16636:
the minor groove 
dt - jj - nn - 
Phrase16637:
the heptamer 
dt - nn - 
Phrase16638:
the non-sequence-specific 
dt - nn - 
Phrase16639:
c-terminal hmg 
jj - nn - 
Phrase16640:
we 
prp - 
Phrase16641:
the solution 
dt - nn - 
Phrase16642:
the sequence-specific hmg-box 
dt - jj - nn - 
Phrase16643:
the sry-related protein 
dt - jj - nn - 
Phrase16644:
the presence 
dt - nn - 
Phrase16645:
an antiparallel 
dt - nn - 
Phrase16646:
the hmg 
dt - nn - 
Phrase16647:
an average 
dt - nn - 
Phrase16648:
the other arm 
dt - jj - nn - 
Phrase16649:
the molecule 
dt - nn - 
Phrase16650:
the overall structure 
dt - jj - nn - 
Phrase16651:
the sox-4 
dt - nn - 
Phrase16652:
aromatic residues 
jj - nns - 
Phrase16653:
nuclear factor-il6 
jj - nn - 
Phrase16654:
the human 
dt - nn - 
Phrase16655:
positive regulatory element 
jj - jj - nn - 
Phrase16656:
strong enhancer 
jj - nn - 
Phrase16657:
the human 
dt - nn - 
Phrase16658:
we 
prp - 
Phrase16659:
nuclear factor 
jj - nn - 
Phrase16660:
the mouse 
dt - nn - 
Phrase16661:
multiple dna-protein 
jj - nn - 
Phrase16662:
nuclear extracts 
jj - nns - 
Phrase16663:
these complexes 
dt - nns - 
Phrase16664:
the chloramphenicol 
dt - nn - 
Phrase16665:
the pre-i-thymidine 
dt - nn - 
Phrase16666:
the human 
dt - nn - 
Phrase16667:
10-fold in 
jj - nn - 
Phrase16668:
additional nf-il6 
jj - nn - 
Phrase16669:
located at 
jj - nn - 
Phrase16670:
our 
prp$ - 
Phrase16671:
transcriptional activation 
jj - nn - 
Phrase16672:
the human 
dt - nn - 
Phrase16673:
an i 
dt - nn - 
Phrase16674:
alpha-associated protein 
jj - nn - 
Phrase16675:
monocytic cell 
jj - nn - 
Phrase16676:
its 
prp$ - 
Phrase16677:
nuclear factor 
jj - nn - 
Phrase16678:
the cytoplasm 
dt - nn - 
Phrase16679:
an inactive form 
dt - jj - nn - 
Phrase16680:
rapid phosphorylation 
jj - nn - 
Phrase16681:
the subsequent degradation 
dt - jj - nn - 
Phrase16682:
we 
prp - 
Phrase16683:
the establishment 
dt - nn - 
Phrase16684:
-dependent cell-free activation 
jj - jj - nn - 
Phrase16685:
the induction 
dt - nn - 
Phrase16686:
this study 
dt - nn - 
Phrase16687:
we 
prp - 
Phrase16688:
the lps-stimulated human 
dt - jj - nn - 
Phrase16689:
monocytic cell 
jj - nn - 
Phrase16690:
the i 
dt - nn - 
Phrase16691:
mutational analyses 
jj - nns - 
Phrase16692:
the synthetic peptides 
dt - jj - nns - 
Phrase16693:
major phosphorylation 
jj - nn - 
Phrase16694:
the c-terminal acidic domain 
dt - jj - jj - nn - 
Phrase16695:
we 
prp - 
Phrase16696:
the peptide 
dt - nn - 
Phrase16697:
the c-terminal acidic domain 
dt - jj - jj - nn - 
Phrase16698:
the lps-induced nf-kappa 
dt - jj - nn - 
Phrase16699:
inducible phosphorylation 
jj - nn - 
Phrase16700:
endogenous i 
jj - nn - 
Phrase16701:
cell-free system 
jj - nn - 
Phrase16702:
these results 
dt - nns - 
Phrase16703:
the signaling 
dt - nn - 
Phrase16704:
the phosphorylation 
dt - nn - 
Phrase16705:
the c-terminal region 
dt - jj - nn - 
Phrase16706:
subsequent dissociation 
jj - nn - 
Phrase16707:
the nf-kappa 
dt - nn - 
Phrase16708:
novel death-inducing protein 
jj - jj - nn - 
Phrase16709:
distinct sequence 
jj - nn - 
Phrase16710:
cellular survival-promoting 
jj - nn - 
Phrase16711:
the survival-promoting 
dt - nn - 
Phrase16712:
the bcl-2 
dt - nn - 
Phrase16713:
various cellular proteins 
jj - jj - nns - 
Phrase16714:
we 
prp - 
Phrase16715:
novel cellular protein 
jj - jj - nn - 
Phrase16716:
the cellular survival-promoting 
dt - jj - nn - 
Phrase16717:
the viral survival-promoting 
dt - jj - nn - 
Phrase16718:
the death-promoting 
dt - nn - 
Phrase16719:
the bcl-2 
dt - nn - 
Phrase16720:
viral anti-apoptotic proteins 
jj - jj - nns - 
Phrase16721:
overt homology 
jj - nn - 
Phrase16722:
the bh1 
dt - nn - 
Phrase16723:
the bcl-2 
dt - nn - 
Phrase16724:
it 
prp - 
Phrase16725:
critical determinant 
jj - nn - 
Phrase16726:
the death-promoting 
dt - nn - 
Phrase16727:
these proteins 
dt - nns - 
Phrase16728:
the human 
dt - nn - 
Phrase16729:
nuclear dna-binding 
jj - nn - 
Phrase16730:
neoplastic t-lineage 
jj - nn - 
Phrase16731:
the tcf-1 
dt - nn - 
Phrase16732:
putative transcription 
jj - nn - 
Phrase16733:
cell-specific fashion 
jj - nn - 
Phrase16734:
multiple nonlymphoid tissues 
jj - jj - nns - 
Phrase16735:
we 
prp - 
Phrase16736:
monoclonal antibody 
jj - nn - 
Phrase16737:
the human 
dt - nn - 
Phrase16738:
the tcf-1 
dt - nn - 
Phrase16739:
its 
prp$ - 
Phrase16740:
the nucleus 
dt - nn - 
Phrase16741:
the tcf-1 
dt - nn - 
Phrase16742:
cd3+ t 
jj - nn - 
Phrase16743:
peripheral lymphoid tissues 
jj - jj - nns - 
Phrase16744:
extensive alternative 
jj - nn - 
Phrase16745:
the tcf-1 
dt - nn - 
Phrase16746:
detectable in 
jj - nn - 
Phrase16747:
various stages 
jj - nns - 
Phrase16748:
large number 
jj - nn - 
Phrase16749:
other hematologic neoplasms 
jj - jj - nns - 
Phrase16750:
these observations 
dt - nns - 
Phrase16751:
cell-specific function 
jj - nn - 
Phrase16752:
recent observations 
jj - nns - 
Phrase16753:
these results 
dt - nns - 
Phrase16754:
nuclear tcf-1 
jj - nn - 
Phrase16755:
the diagnosis 
dt - nn - 
Phrase16756:
lymphoid malignancies 
jj - nns - 
Phrase16757:
long terminal 
jj - nn - 
Phrase16758:
repeat-driven transcription 
jj - nn - 
Phrase16759:
the levels 
dt - nns - 
Phrase16760:
immune complexes 
jj - nns - 
Phrase16761:
prognostic indicator 
jj - nn - 
Phrase16762:
clinical progression 
jj - nn - 
Phrase16763:
asymptomatic infection 
jj - nn - 
Phrase16764:
we 
prp - 
Phrase16765:
adherent human 
jj - nn - 
Phrase16766:
specific anti-fc 
jj - nn - 
Phrase16767:
the human 
dt - nn - 
Phrase16768:
monocytic cell 
jj - nn - 
Phrase16769:
infected patients 
jj - nns - 
Phrase16770:
the regulatory region 
dt - jj - nn - 
Phrase16771:
the long terminal 
dt - jj - nn - 
Phrase16772:
anti-il-1 beta 
jj - nn - 
Phrase16773:
the induction 
dt - nn - 
Phrase16774:
hiv-1-ltr-driven transcription 
jj - nn - 
Phrase16775:
the induction 
dt - nn - 
Phrase16776:
these results 
dt - nns - 
Phrase16777:
immune complexes 
jj - nns - 
Phrase16778:
the pathophysiology 
dt - nn - 
Phrase16779:
viral replication 
jj - nn - 
Phrase16780:
naive neonatal t 
jj - jj - nn - 
Phrase16781:
crucial role 
jj - nn - 
Phrase16782:
the development 
dt - nn - 
Phrase16783:
the t 
dt - nn - 
Phrase16784:
antigenic challenge 
jj - nn - 
Phrase16785:
we 
prp - 
Phrase16786:
the role 
dt - nn - 
Phrase16787:
neonatal t 
jj - nn - 
Phrase16788:
the role 
dt - nn - 
Phrase16789:
mitogenic anti-cd2 
jj - nn - 
Phrase16790:
the presence 
dt - nn - 
Phrase16791:
neonatal t 
jj - nn - 
Phrase16792:
detectable il-2 
jj - nn - 
Phrase16793:
significant il-2 
jj - nn - 
Phrase16794:
the proliferative 
dt - nn - 
Phrase16795:
neonatal t 
jj - nn - 
Phrase16796:
slight increases 
jj - nns - 
Phrase16797:
the presence 
dt - nn - 
Phrase16798:
neonatal t 
jj - nn - 
Phrase16799:
the cellular mechanism 
dt - jj - nn - 
Phrase16800:
neonatal t 
jj - nn - 
Phrase16801:
deficient il-2 
jj - nn - 
Phrase16802:
the above signals 
dt - jj - nns - 
Phrase16803:
the need 
dt - nn - 
Phrase16804:
further activation 
jj - nn - 
Phrase16805:
the neonate 
dt - nn - 
Phrase16806:
preleukemic t 
jj - nn - 
Phrase16807:
the tcl1 
dt - nn - 
Phrase16808:
it 
prp - 
Phrase16809:
an immunodeficiency 
dt - nn - 
Phrase16810:
similar chromosomal 
jj - nn - 
Phrase16811:
the appearance 
dt - nn - 
Phrase16812:
the overt leukemia 
dt - jj - nn - 
Phrase16813:
we 
prp - 
Phrase16814:
the expression 
dt - nn - 
Phrase16815:
peripheral blood 
jj - nn - 
Phrase16816:
healthy controls 
jj - nns - 
Phrase16817:
we 
prp - 
Phrase16818:
the tcl1 
dt - nn - 
Phrase16819:
the pbls 
dt - nns - 
Phrase16820:
an at 
dt - nn - 
Phrase16821:
large clonal t-cell 
jj - jj - nn - 
Phrase16822:
the t(14;14) 
dt - nn - 
Phrase16823:
the lymphocytes 
dt - nns - 
Phrase16824:
the other cases 
dt - jj - nns - 
Phrase16825:
the tcl1 
dt - nn - 
Phrase16826:
genomic locus 
jj - nn - 
Phrase16827:
the at 
dt - nn - 
Phrase16828:
the t-cell 
dt - nn - 
Phrase16829:
clonal expansion 
jj - nn - 
Phrase16830:
the breakpoint 
dt - nn - 
Phrase16831:
the t(14;14) 
dt - nn - 
Phrase16832:
the tcl1 
dt - nn - 
Phrase16833:
the distal part 
dt - jj - nn - 
Phrase16834:
these data 
dt - nns - 
Phrase16835:
preleukemic clonal cells 
jj - jj - nns - 
Phrase16836:
the tcr 
dt - nn - 
Phrase16837:
the first event 
dt - jj - nn - 
Phrase16838:
the initiation 
dt - nn - 
Phrase16839:
these types 
dt - nns - 
Phrase16840:
clinical evaluation 
jj - nn - 
Phrase16841:
the human 
dt - nn - 
Phrase16842:
long terminal 
jj - nn - 
Phrase16843:
the human 
dt - nn - 
Phrase16844:
long terminal 
jj - nn - 
Phrase16845:
we 
prp - 
Phrase16846:
the functional role 
dt - jj - nn - 
Phrase16847:
the hiv- 1 
dt - nn - 
Phrase16848:
endogenous c/ebp 
jj - nn - 
Phrase16849:
either excess 
dt - nn - 
Phrase16850:
negative inhibitor 
jj - nn - 
Phrase16851:
the promonocytic cell 
dt - jj - nn - 
Phrase16852:
mutational analyses 
jj - nns - 
Phrase16853:
the hiv-1 
dt - nn - 
Phrase16854:
normal ltr 
jj - nn - 
Phrase16855:
cellular activation 
jj - nn - 
Phrase16856:
3' c/ebp 
jj - nn - 
Phrase16857:
several models 
jj - nns - 
Phrase16858:
an autostimulatory 
dt - nn - 
Phrase16859:
their 
prp$ - 
Phrase16860:
the human 
dt - nn - 
Phrase16861:
their 
prp$ - 
Phrase16862:
long periods 
jj - nns - 
Phrase16863:
latent infection 
jj - nn - 
Phrase16864:
the viruses 
dt - nns - 
Phrase16865:
large part 
jj - nn - 
Phrase16866:
the sequence 
dt - nn - 
Phrase16867:
their 
prp$ - 
Phrase16868:
long terminal 
jj - nn - 
Phrase16869:
this study 
dt - nn - 
Phrase16870:
an analysis 
dt - nn - 
Phrase16871:
the regulatory elements 
dt - jj - nns - 
Phrase16872:
the hiv-2 
dt - nn - 
Phrase16873:
the hiv-2 
dt - nn - 
Phrase16874:
these enhancers 
dt - nns - 
Phrase16875:
the hiv-1 
dt - nn - 
Phrase16876:
the t-cell 
dt - nn - 
Phrase16877:
it 
prp - 
Phrase16878:
the second 
dt - nn - 
Phrase16879:
the second 
dt - nn - 
Phrase16880:
nuclear binding 
jj - nn - 
Phrase16881:
optimal enhancer 
jj - nn - 
Phrase16882:
these encourage 
dt - nn - 
Phrase16883:
the speculation 
dt - nn - 
Phrase16884:
subtle differences 
jj - nns - 
Phrase16885:
the regulation 
dt - nn - 
Phrase16886:
the possible longer latency 
dt - jj - jjr - nn - 
Phrase16887:
eosinophilic differentiation 
jj - nn - 
Phrase16888:
hematopoietic progenitor 
jj - nn - 
Phrase16889:
transcriptional activators 
jj - nns - 
Phrase16890:
the differentiation 
dt - nn - 
Phrase16891:
various cell 
jj - nn - 
Phrase16892:
we 
prp - 
Phrase16893:
the chicken 
dt - nn - 
Phrase16894:
eosinophilic cells 
jj - nns - 
Phrase16895:
the hematopoietic system 
dt - jj - nn - 
Phrase16896:
the role 
dt - nn - 
Phrase16897:
hematopoietic cell 
jj - nn - 
Phrase16898:
we 
prp - 
Phrase16899:
conditional form 
jj - nn - 
Phrase16900:
the protein 
dt - nn - 
Phrase16901:
it 
prp - 
Phrase16902:
the hormone 
dt - nn - 
Phrase16903:
the human 
dt - nn - 
Phrase16904:
multipotent progenitor 
jj - nn - 
Phrase16905:
the myb-ets 
dt - nn - 
Phrase16906:
we 
prp - 
Phrase16907:
both nf-m-dependent 
dt - nn - 
Phrase16908:
resident genes 
jj - nns - 
Phrase16909:
the nf-m-estrogen 
dt - nn - 
Phrase16910:
the same time 
dt - jj - nn - 
Phrase16911:
we 
prp - 
Phrase16912:
the up-regulation 
dt - nn - 
Phrase16913:
the eosinophil 
dt - nn - 
Phrase16914:
the onset 
dt - nn - 
Phrase16915:
typical apoptotic features 
jj - jj - nns - 
Phrase16916:
our 
prp$ - 
Phrase16917:
an important role 
dt - jj - nn - 
Phrase16918:
the eosinophil 
dt - nn - 
Phrase16919:
the induction 
dt - nn - 
Phrase16920:
the cell 
dt - nn - 
Phrase16921:
regulatory tasks 
jj - nn - 
Phrase16922:
they 
prp - 
Phrase16923:
the jak/stat 
dt - nn - 
Phrase16924:
we 
prp - 
Phrase16925:
the ability 
dt - nn - 
Phrase16926:
different t 
jj - nn - 
Phrase16927:
the dna 
dt - nn - 
Phrase16928:
the reactivities 
dt - nns - 
Phrase16929:
the mol 
dt - nn - 
Phrase16930:
prl-induced dna-binding 
jj - nn - 
Phrase16931:
the stat 
dt - nn - 
Phrase16932:
mammary tumor 
jj - nn - 
Phrase16933:
we 
prp - 
Phrase16934:
these parameters 
dt - nns - 
Phrase16935:
the prl- 
dt - nn - 
Phrase16936:
il-2-induced factors 
jj - nn - 
Phrase16937:
mammary gland 
jj - nn - 
Phrase16938:
their 
prp$ - 
Phrase16939:
respective receptors 
jj - nns - 
Phrase16940:
our 
prp$ - 
Phrase16941:
the role 
dt - nn - 
Phrase16942:
the immune response 
dt - jj - nn - 
Phrase16943:
the stat 
dt - nn - 
Phrase16944:
mammary gland 
jj - nn - 
Phrase16945:
the regulation 
dt - nn - 
Phrase16946:
the human 
dt - nn - 
Phrase16947:
the haematopoietic system 
dt - jj - nn - 
Phrase16948:
colony-stimulating factor 
jj - nn - 
Phrase16949:
such cytokine 
jj - nn - 
Phrase16950:
cis-acting elements 
jj - nns - 
Phrase16951:
ets-like motifs 
jj - nns - 
Phrase16952:
the promoter 
dt - nn - 
Phrase16953:
the gm-csf 
dt - nn - 
Phrase16954:
transcriptional activity 
jj - nn - 
Phrase16955:
the ets 
dt - nn - 
Phrase16956:
we 
prp - 
Phrase16957:
the ability 
dt - nn - 
Phrase16958:
these factors 
dt - nn - 
Phrase16959:
the cle0 
dt - nn - 
Phrase16960:
the gm-csf 
dt - nn - 
Phrase16961:
exogenous ets1 
jj - nn - 
Phrase16962:
the gm5 
dt - nn - 
Phrase16963:
dependent manner 
jj - nn - 
Phrase16964:
other unidentified ets-like factors 
jj - jj - jj - nn - 
Phrase16965:
the core 
dt - nn - 
Phrase16966:
the binding 
dt - nn - 
Phrase16967:
ets-like factors 
jj - nn - 
Phrase16968:
the exception 
dt - nn - 
Phrase16969:
the gm-csf 
dt - nn - 
Phrase16970:
this way 
dt - nn - 
Phrase16971:
the presence 
dt - nn - 
Phrase16972:
these data 
dt - nns - 
Phrase16973:
competitive reverse 
jj - nn - 
Phrase16974:
nuclear receptor 
jj - nn - 
Phrase16975:
the thyroid 
dt - nn - 
Phrase16976:
such adaptive changes 
jj - jj - nns - 
Phrase16977:
we 
prp - 
Phrase16978:
the mrna 
dt - nn - 
Phrase16979:
the htr 
dt - nn - 
Phrase16980:
various thyroid 
jj - nn - 
Phrase16981:
overt hypo- 
jj - nn - 
Phrase16982:
the study 
dt - nn - 
Phrase16983:
peripheral blood 
jj - nn - 
Phrase16984:
quantitative competitive reverse 
jj - jj - nn - 
Phrase16985:
normal thyroid 
jj - nn - 
Phrase16986:
euthyroid patients 
jj - nns - 
Phrase16987:
the mean 
dt - nn - 
Phrase16988:
lower in 
jjr - nn - 
Phrase16989:
euthyroid subjects 
jj - nns - 
Phrase16990:
this difference 
dt - nn - 
Phrase16991:
statistical significance 
jj - nn - 
Phrase16992:
similar levels 
jj - nns - 
Phrase16993:
euthyroid patients 
jj - nns - 
Phrase16994:
we 
prp - 
Phrase16995:
an assay 
dt - nn - 
Phrase16996:
the quantitative determination 
dt - jj - nn - 
Phrase16997:
small human 
jj - nn - 
Phrase16998:
absolute htr 
jj - nn - 
Phrase16999:
euthyroid patients 
jj - nns - 
Phrase17000:
multiple proteins 
jj - nns - 
Phrase17001:
the nuclear inhibitory protein 
dt - jj - jj - nn - 
Phrase17002:
the human 
dt - nn - 
Phrase17003:
negative cis-acting dna 
jj - jj - nn - 
Phrase17004:
the transcriptional start 
dt - jj - nn - 
Phrase17005:
strong repressor 
jj - nn - 
Phrase17006:
nuclear inhibitory protein 
jj - jj - nn - 
Phrase17007:
the il-3 
dt - nn - 
Phrase17008:
functional characterization 
jj - nn - 
Phrase17009:
this element 
dt - nn - 
Phrase17010:
it 
prp - 
Phrase17011:
heterologous promoter 
jj - nn - 
Phrase17012:
the repressor 
dt - nn - 
Phrase17013:
distinct complexes 
jj - nns - 
Phrase17014:
the nip 
dt - nn - 
Phrase17015:
ubiquitous polypeptide 
jj - nn - 
Phrase17016:
the 3' portion 
dt - jj - nn - 
Phrase17017:
this sequence 
dt - nn - 
Phrase17018:
upstream stimulatory factor 
jj - jj - nn - 
Phrase17019:
an e-box 
dt - nn - 
Phrase17020:
the 5' 
dt - nn - 
Phrase17021:
the nip 
dt - nn - 
Phrase17022:
upstream stimulatory factor 
jj - jj - nn - 
Phrase17023:
we 
prp - 
Phrase17024:
small alterations 
jj - nns - 
Phrase17025:
the nip 
dt - nn - 
Phrase17026:
an il-3 
dt - nn - 
Phrase17027:
their 
prp$ - 
Phrase17028:
functional specificity 
jj - nn - 
Phrase17029:
the dna 
dt - nn - 
Phrase17030:
both repressor 
dt - nn - 
Phrase17031:
the consensus 
dt - nn - 
Phrase17032:
the hematopoietic transcription 
dt - jj - nn - 
Phrase17033:
multiple myeloma 
jj - nn - 
Phrase17034:
hematopoietic transcription 
jj - nn - 
Phrase17035:
the ets-family 
dt - nn - 
Phrase17036:
it 
prp - 
Phrase17037:
the spi-1 
dt - nn - 
Phrase17038:
focus-forming virus-induced murine 
jj - jj - nn - 
Phrase17039:
early development 
jj - nn - 
Phrase17040:
multiple hematopoietic lineages 
jj - jj - nns - 
Phrase17041:
its 
prp$ - 
Phrase17042:
mature cells 
jj - nns - 
Phrase17043:
the b-cell-and 
dt - nn - 
Phrase17044:
it 
prp - 
Phrase17045:
the so-called pu 
dt - jj - nn - 
Phrase17046:
an important tissue-specific regulatory dna 
dt - jj - jj - jj - nn - 
Phrase17047:
these cell 
dt - nn - 
Phrase17048:
we 
prp - 
Phrase17049:
the expression 
dt - nn - 
Phrase17050:
different stages 
jj - nns - 
Phrase17051:
early precursors 
jj - nns - 
Phrase17052:
electrophoretic mobility 
jj - nn - 
Phrase17053:
evident in 
jj - nn - 
Phrase17054:
mature b 
jj - nn - 
Phrase17055:
we 
prp - 
Phrase17056:
these cell 
dt - nn - 
Phrase17057:
multiple myeloma 
jj - nn - 
Phrase17058:
detectable at 
jj - nn - 
Phrase17059:
low level 
jj - nn - 
Phrase17060:
an intermediate 
dt - nn - 
Phrase17061:
the findings 
dt - nns - 
Phrase17062:
the human 
dt - nn - 
Phrase17063:
multiple myeloma 
jj - nn - 
Phrase17064:
the first examples 
dt - jj - nns - 
Phrase17065:
the murine 
dt - nn - 
Phrase17066:
active in 
jj - nn - 
Phrase17067:
it 
prp - 
Phrase17068:
the lack 
dt - nn - 
Phrase17069:
multiple myeloma 
jj - nn - 
Phrase17070:
these cells 
dt - nns - 
Phrase17071:
normal developmental regulation 
jj - jj - nn - 
Phrase17072:
colony-stimulating factor 
jj - nn - 
Phrase17073:
the t-cell 
dt - nn - 
Phrase17074:
nuclear factor 
jj - nn - 
Phrase17075:
t-cell-specific transcription 
jj - nn - 
Phrase17076:
the activation 
dt - nn - 
Phrase17077:
the immunoregulatory effects 
dt - jj - nns - 
Phrase17078:
we 
prp - 
Phrase17079:
we 
prp - 
Phrase17080:
the antiinflammatory properties 
dt - jj - nns - 
Phrase17081:
the induction 
dt - nn - 
Phrase17082:
the activity 
dt - nn - 
Phrase17083:
colony-stimulating factor 
jj - nn - 
Phrase17084:
regulatory elements 
jj - nns - 
Phrase17085:
vascular cell 
jj - nn - 
Phrase17086:
the e-selectin 
dt - nn - 
Phrase17087:
this leukocyte 
dt - nn - 
Phrase17088:
the presence 
dt - nn - 
Phrase17089:
the effects 
dt - nns - 
Phrase17090:
the chromatin 
dt - nn - 
Phrase17091:
hypersensitive sites 
jj - nns - 
Phrase17092:
both gm-csf 
dt - nn - 
Phrase17093:
the e-selectin 
dt - nn - 
Phrase17094:
the first report 
dt - jj - nn - 
Phrase17095:
an antiinflammatory agent 
dt - jj - nn - 
Phrase17096:
the transcriptional activity 
dt - jj - nn - 
Phrase17097:
the il-2 
dt - nn - 
Phrase17098:
the tcr 
dt - nn - 
Phrase17099:
the auxiliary 
dt - nn - 
Phrase17100:
several transcription 
jj - nn - 
Phrase17101:
ap-1-like factors 
jj - nn - 
Phrase17102:
an important role 
dt - jj - nn - 
Phrase17103:
the regulation 
dt - nn - 
Phrase17104:
it 
prp - 
Phrase17105:
the transactivating 
dt - nn - 
Phrase17106:
the ap-1 
dt - nn - 
Phrase17107:
it 
prp - 
Phrase17108:
the release 
dt - nn - 
Phrase17109:
the cytoplasmic inhibitor 
dt - jj - nn - 
Phrase17110:
the nucleus 
dt - nn - 
Phrase17111:
we 
prp - 
Phrase17112:
both phosphorylation 
dt - nn - 
Phrase17113:
the kinetics 
dt - nn - 
Phrase17114:
our 
prp$ - 
Phrase17115:
the kinases 
dt - nns - 
Phrase17116:
distinct entities 
jj - nn - 
Phrase17117:
it 
prp - 
Phrase17118:
the activity 
dt - nn - 
Phrase17119:
the map 
dt - nn - 
Phrase17120:
the transactivation 
dt - nn - 
Phrase17121:
we 
prp - 
Phrase17122:
the activation 
dt - nn - 
Phrase17123:
the activation 
dt - nn - 
Phrase17124:
the simultaneous induction 
dt - jj - nn - 
Phrase17125:
the signals 
dt - nns - 
Phrase17126:
this pathway 
dt - nn - 
Phrase17127:
the one 
dt - nn - 
Phrase17128:
we 
prp - 
Phrase17129:
the ap-1 
dt - nn - 
Phrase17130:
cd4+ macrophages 
jj - nns - 
Phrase17131:
promyelocytic cells 
jj - nns - 
Phrase17132:
peripheral blood 
jj - nn - 
Phrase17133:
important targets 
jj - nns - 
Phrase17134:
hiv-1-infected myeloid 
jj - nn - 
Phrase17135:
their 
prp$ - 
Phrase17136:
intracellular killing 
jj - nn - 
Phrase17137:
the expression 
dt - nn - 
Phrase17138:
cellular activation 
jj - nn - 
Phrase17139:
the responsiveness 
dt - nn - 
Phrase17140:
these cells 
dt - nns - 
Phrase17141:
neighboring cells 
jj - nns - 
Phrase17142:
other pathogens 
jj - nns - 
Phrase17143:
related in 
jj - nn - 
Phrase17144:
cellular transcription 
jj - nn - 
Phrase17145:
the hiv-1 
dt - nn - 
Phrase17146:
the long terminal 
dt - jj - nn - 
Phrase17147:
the inducibility 
dt - nn - 
Phrase17148:
multiple activating 
jj - nn - 
Phrase17149:
the cytoplasmic inhibitor 
dt - jj - nn - 
Phrase17150:
crucial regulatory events 
jj - jj - nns - 
Phrase17151:
the activation 
dt - nn - 
Phrase17152:
c-terminal residues 
jj - nns - 
Phrase17153:
inducer-mediated degradation 
jj - nn - 
Phrase17154:
chronic hiv-1 
jj - nn - 
Phrase17155:
constitutive nf-kappa 
jj - nn - 
Phrase17156:
an intranuclear environment 
dt - jj - nn - 
Phrase17157:
intracellular stores 
jj - nns - 
Phrase17158:
latent nf-kappa 
jj - nn - 
Phrase17159:
rapid inducibility 
jj - nn - 
Phrase17160:
b-dependent cytokine 
jj - nn - 
Phrase17161:
secondary pathogenic infections 
jj - jj - nns - 
Phrase17162:
antigenic challenge 
jj - nn - 
Phrase17163:
prolonged periods 
jj - nns - 
Phrase17164:
hiv-1-infected myeloid 
jj - nn - 
Phrase17165:
uninfected cells 
jj - nns - 
Phrase17166:
elevated levels 
jj - nns - 
Phrase17167:
several inflammatory cytokines 
jj - jj - nns - 
Phrase17168:
the sera 
dt - nn - 
Phrase17169:
hiv-1-infected individuals 
jj - nns - 
Phrase17170:
cell-derived cytokines 
jj - nns - 
Phrase17171:
the dna 
dt - nn - 
Phrase17172:
the steroid 
dt - nn - 
Phrase17173:
certain types 
jj - nns - 
Phrase17174:
the mechanisms 
dt - nns - 
Phrase17175:
it 
prp - 
Phrase17176:
sufficient numbers 
jj - nns - 
Phrase17177:
functional glucocorticoid 
jj - nn - 
Phrase17178:
they 
prp - 
Phrase17179:
the classical model 
dt - jj - nn - 
Phrase17180:
this report 
dt - nn - 
Phrase17181:
we 
prp - 
Phrase17182:
the steroid 
dt - nn - 
Phrase17183:
leukemic t 
jj - nn - 
Phrase17184:
leukemic lymphoblasts 
jj - nns - 
Phrase17185:
functional glucocorticoid 
jj - nn - 
Phrase17186:
various receptor 
jj - nn - 
Phrase17187:
we 
prp - 
Phrase17188:
our 
prp$ - 
Phrase17189:
the lysis 
dt - nn - 
Phrase17190:
the icr27 
dt - nn - 
Phrase17191:
functional receptor 
jj - nn - 
Phrase17192:
the dna 
dt - nn - 
Phrase17193:
high affinity 
jj - nn - 
Phrase17194:
any steroid 
dt - nn - 
Phrase17195:
the receptor 
dt - nn - 
Phrase17196:
such a 
jj - nn - 
Phrase17197:
our 
prp$ - 
Phrase17198:
the view 
dt - nn - 
Phrase17199:
direct interaction 
jj - nn - 
Phrase17200:
the genome 
dt - nn - 
Phrase17201:
functional characterization 
jj - nn - 
Phrase17202:
the murine 
dt - nn - 
Phrase17203:
the b 
dt - nn - 
Phrase17204:
cell-specific coactivator 
jj - nn - 
Phrase17205:
cell-specific transcriptional promoter 
jj - jj - nn - 
Phrase17206:
the octamer 
dt - nn - 
Phrase17207:
the oct1 
dt - nn - 
Phrase17208:
additional b 
jj - nn - 
Phrase17209:
such cofactor 
jj - nn - 
Phrase17210:
we 
prp - 
Phrase17211:
the isolation 
dt - nn - 
Phrase17212:
detailed characterization 
jj - nn - 
Phrase17213:
the murine 
dt - nn - 
Phrase17214:
genomic clones 
jj - nns - 
Phrase17215:
the gene 
dt - nn - 
Phrase17216:
the nh2-terminal 126 
dt - jj - nn - 
Phrase17217:
the pou 
dt - nn - 
Phrase17218:
either oct1 
dt - nn - 
Phrase17219:
protein-protein interaction 
jj - nn - 
Phrase17220:
the simultaneous binding 
dt - jj - nn - 
Phrase17221:
high resolution 
jj - nn - 
Phrase17222:
the oct-dna 
dt - nn - 
Phrase17223:
the interaction 
dt - nn - 
Phrase17224:
octamer-dependent promoters 
jj - nns - 
Phrase17225:
it 
prp - 
Phrase17226:
octamer-dependent enhancer 
jj - nn - 
Phrase17227:
the gal4 
dt - nn - 
Phrase17228:
both nh2- 
dt - nn - 
Phrase17229:
cooh-terminal domains 
jj - nns - 
Phrase17230:
full transactivation 
jj - nn - 
Phrase17231:
the cooh-terminal domain 
dt - jj - nn - 
Phrase17232:
efficient in 
jj - nn - 
Phrase17233:
this transactivation 
dt - nn - 
Phrase17234:
the failure 
dt - nn - 
Phrase17235:
octamer-dependent enhancer 
jj - nn - 
Phrase17236:
non b 
jj - nn - 
Phrase17237:
the gal4 
dt - nn - 
Phrase17238:
promoter-proximal position 
jj - nn - 
Phrase17239:
anti-immunoglobulin m 
jj - nn - 
Phrase17240:
nuclear calcium 
jj - nn - 
Phrase17241:
we 
prp - 
Phrase17242:
the nuclear protein 
dt - jj - nn - 
Phrase17243:
calcium-dependent manner 
jj - nn - 
Phrase17244:
this phosphorylation 
dt - nn - 
Phrase17245:
we 
prp - 
Phrase17246:
the ets-1 
dt - nn - 
Phrase17247:
intracellular free calcium 
jj - jj - nn - 
Phrase17248:
the dephosphorylated form 
dt - jj - nn - 
Phrase17249:
the operative 
dt - nn - 
Phrase17250:
detectable in 
jj - nn - 
Phrase17251:
the nucleus 
dt - nn - 
Phrase17252:
we 
prp - 
Phrase17253:
nuclear extracts 
jj - nns - 
Phrase17254:
intracellular free calcium 
jj - jj - nn - 
Phrase17255:
the ets-1 
dt - nn - 
Phrase17256:
the cam 
dt - nn - 
Phrase17257:
synthetic peptide 
jj - nn - 
Phrase17258:
the absence 
dt - nn - 
Phrase17259:
an inhibitor 
dt - nn - 
Phrase17260:
the cam 
dt - nn - 
Phrase17261:
nuclear kinase 
jj - nn - 
Phrase17262:
the peptide 
dt - nn - 
Phrase17263:
this activity 
dt - nn - 
Phrase17264:
an antibody 
dt - nn - 
Phrase17265:
two-dimensional phosphopeptide 
jj - nn - 
Phrase17266:
the ets-1 
dt - nn - 
Phrase17267:
unique phosphopeptides 
jj - nn - 
Phrase17268:
absent in 
jj - nn - 
Phrase17269:
untreated cells 
jj - nns - 
Phrase17270:
either anti-igm 
dt - nn - 
Phrase17271:
these data 
dt - nns - 
Phrase17272:
the antigen 
dt - nn - 
Phrase17273:
intracellular free calcium 
jj - jj - nn - 
Phrase17274:
nuclear cam 
jj - nn - 
Phrase17275:
transcriptional activation 
jj - nn - 
Phrase17276:
the lymphoid-specific transcription 
dt - jj - nn - 
Phrase17277:
the lymphoid-specific transcription 
dt - jj - nn - 
Phrase17278:
transcriptional activation 
jj - nn - 
Phrase17279:
c-terminal regions 
jj - nns - 
Phrase17280:
their 
prp$ - 
Phrase17281:
differential activation 
jj - nn - 
Phrase17282:
we 
prp - 
Phrase17283:
the gal4 
dt - nn - 
Phrase17284:
we 
prp - 
Phrase17285:
both activating 
dt - nn - 
Phrase17286:
their 
prp$ - 
Phrase17287:
natural context 
jj - nn - 
Phrase17288:
the c-terminus 
dt - nn - 
Phrase17289:
the n-terminal domain 
dt - jj - nn - 
Phrase17290:
unidentified factor 
jj - nn - 
Phrase17291:
the simian virus 
dt - jj - nn - 
Phrase17292:
the results 
dt - nns - 
Phrase17293:
their 
prp$ - 
Phrase17294:
mixed combination 
jj - nn - 
Phrase17295:
the domains 
dt - nns - 
Phrase17296:
remote position 
jj - nn - 
Phrase17297:
the c-terminus 
dt - nn - 
Phrase17298:
lymphoid cells 
jj - nns - 
Phrase17299:
higher activation 
jjr - nn - 
Phrase17300:
distinct b-cell-specific cofactors 
jj - jj - nn - 
Phrase17301:
the effector 
dt - nn - 
Phrase17302:
remote positions 
jj - nns - 
Phrase17303:
we 
prp - 
Phrase17304:
the n-terminus 
dt - nn - 
Phrase17305:
transcriptional stimulation 
jj - nn - 
Phrase17306:
these results 
dt - nns - 
Phrase17307:
the modular 
dt - nn - 
Phrase17308:
separable domains 
jj - nns - 
Phrase17309:
regulatory functions 
jj - nns - 
Phrase17310:
polymorphonuclear leukocytes 
jj - nns - 
Phrase17311:
the presence 
dt - nn - 
Phrase17312:
the bacterial flagellum 
dt - jj - nn - 
Phrase17313:
the mechanism 
dt - nn - 
Phrase17314:
the bacterial ligands 
dt - jj - nns - 
Phrase17315:
the requisite bacterial ligands 
dt - jj - jj - nns - 
Phrase17316:
isogenic mutants 
jj - nns - 
Phrase17317:
p. 
nnp - 
Phrase17318:
the rpon 
dt - nn - 
Phrase17319:
the rpon 
dt - nn - 
Phrase17320:
both macrophages 
dt - nns - 
Phrase17321:
p. 
nnp - 
Phrase17322:
the presence 
dt - nn - 
Phrase17323:
p. 
nnp - 
Phrase17324:
the subsequent internalization 
dt - jj - nn - 
Phrase17325:
the bacterium 
dt - nn - 
Phrase17326:
this factor 
dt - nn - 
Phrase17327:
its 
prp$ - 
Phrase17328:
essential gata 
jj - nn - 
Phrase17329:
the promoter 
dt - nn - 
Phrase17330:
the platelet 
dt - nn - 
Phrase17331:
vascular injury 
jj - nn - 
Phrase17332:
the congenital absence 
dt - jj - nn - 
Phrase17333:
the receptor 
dt - nn - 
Phrase17334:
the expression 
dt - nn - 
Phrase17335:
the complex 
dt - nn - 
Phrase17336:
the expression 
dt - nn - 
Phrase17337:
the gp 
dt - nn - 
Phrase17338:
the essential genetic elements 
dt - jj - jj - nns - 
Phrase17339:
the expression 
dt - nn - 
Phrase17340:
the alpha-subunit 
dt - nn - 
Phrase17341:
the complex 
dt - nn - 
Phrase17342:
the enzyme 
dt - nn - 
Phrase17343:
the transcription 
dt - nn - 
Phrase17344:
the identification 
dt - nn - 
Phrase17345:
full promoter 
jj - nn - 
Phrase17346:
nonhematopoietic lineage 
jj - nn - 
Phrase17347:
the gp 
dt - nn - 
Phrase17348:
site-directed mutagenesis 
jj - nn - 
Phrase17349:
essential gata 
jj - nn - 
Phrase17350:
the transcription 
dt - nn - 
Phrase17351:
these elements 
dt - nns - 
Phrase17352:
important determinants 
jj - nns - 
Phrase17353:
megakaryocytic gene 
jj - nn - 
Phrase17354:
the results 
dt - nns - 
Phrase17355:
essential cis-acting elements 
jj - jj - nns - 
Phrase17356:
the expression 
dt - nn - 
Phrase17357:
the release 
dt - nn - 
Phrase17358:
normal platelets 
jj - nns - 
Phrase17359:
the bloodstream 
dt - nn - 
Phrase17360:
nuclear factor-kappa 
jj - nn - 
Phrase17361:
the tumor 
dt - nn - 
Phrase17362:
this report 
dt - nn - 
Phrase17363:
we 
prp - 
Phrase17364:
the agonistic anti-cd30 
dt - jj - nn - 
Phrase17365:
monoclonal antibodies 
jj - nns - 
Phrase17366:
nuclear factor 
jj - nn - 
Phrase17367:
nuclear extracts 
jj - nns - 
Phrase17368:
the effect 
dt - nn - 
Phrase17369:
the mab 
dt - nn - 
Phrase17370:
it 
prp - 
Phrase17371:
an isotype-matched antibody 
dt - jj - nn - 
Phrase17372:
the type 
dt - nn - 
Phrase17373:
the extent 
dt - nn - 
Phrase17374:
the proportion 
dt - nn - 
Phrase17375:
the nf-kappa 
dt - nn - 
Phrase17376:
other transcription 
jj - nn - 
Phrase17377:
our 
prp$ - 
Phrase17378:
nuclear translocation 
jj - nn - 
Phrase17379:
the short-term cellular responses 
dt - jj - jj - nns - 
Phrase17380:
the earliest lesion 
dt - jjs - nn - 
Phrase17381:
the development 
dt - nn - 
Phrase17382:
an atherosclerotic plaque 
dt - jj - nn - 
Phrase17383:
the fatty streak 
dt - jj - nn - 
Phrase17384:
chronic inflammatory reaction 
jj - jj - nn - 
Phrase17385:
the trapping 
dt - nn - 
Phrase17386:
low density 
jj - nn - 
Phrase17387:
the subendothelial 
dt - nn - 
Phrase17388:
the artery 
dt - nn - 
Phrase17389:
the trapped 
dt - nn - 
Phrase17390:
oxidative species 
jj - nns - 
Phrase17391:
the overlying 
dt - nn - 
Phrase17392:
the ldl 
dt - nn - 
Phrase17393:
the lipids 
dt - nns - 
Phrase17394:
the activation 
dt - nn - 
Phrase17395:
the expression 
dt - nn - 
Phrase17396:
the subendothelial 
dt - nn - 
Phrase17397:
major gene 
jj - nn - 
Phrase17398:
the oxidation 
dt - nn - 
Phrase17399:
the biologic response 
dt - jj - nn - 
Phrase17400:
these lipids 
dt - nns - 
Phrase17401:
the inverse 
dt - nn - 
Phrase17402:
high density 
jj - nn - 
Phrase17403:
atherosclerotic events 
jj - nns - 
Phrase17404:
active lipids 
jj - nns - 
Phrase17405:
the pathogenesis 
dt - nn - 
Phrase17406:
an allergic eosinophilic disease 
dt - jj - jj - nn - 
Phrase17407:
the authors 
dt - nns - 
Phrase17408:
bulbar conjunctival 
jj - nn - 
Phrase17409:
the presence 
dt - nn - 
Phrase17410:
monoclonal antibodies 
jj - nns - 
Phrase17411:
both epithelium 
dt - nn - 
Phrase17412:
the tarsal 
dt - nn - 
Phrase17413:
bulbar conjunctiva 
jj - nn - 
Phrase17414:
nonatopic control 
jj - nn - 
Phrase17415:
intense positive staining 
jj - jj - nn - 
Phrase17416:
both estrogen 
dt - nn - 
Phrase17417:
positive cells 
jj - nns - 
Phrase17418:
sexual hormones 
jj - nns - 
Phrase17419:
their 
prp$ - 
Phrase17420:
the activity 
dt - nn - 
Phrase17421:
the expression 
dt - nn - 
Phrase17422:
it 
prp - 
Phrase17423:
this expression 
dt - nn - 
Phrase17424:
the cell 
dt - nn - 
Phrase17425:
immune response 
jj - nn - 
Phrase17426:
the mhc 
dt - nn - 
Phrase17427:
major regulatory factor 
jj - jj - nn - 
Phrase17428:
inducible expression 
jj - nn - 
Phrase17429:
we 
prp - 
Phrase17430:
ii-negative human 
jj - nn - 
Phrase17431:
the expression 
dt - nn - 
Phrase17432:
the human 
dt - nn - 
Phrase17433:
these data 
dt - nns - 
Phrase17434:
the expression 
dt - nn - 
Phrase17435:
the expression 
dt - nn - 
Phrase17436:
systemic lupus 
jj - nn - 
Phrase17437:
the heterogeneous clinical manifestations 
dt - jj - jj - nns - 
Phrase17438:
systemic lupus 
jj - nn - 
Phrase17439:
specific autoantibodies 
jj - nns - 
Phrase17440:
the ribonucleoproteins 
dt - nn - 
Phrase17441:
these patients 
dt - nns - 
Phrase17442:
we 
prp - 
Phrase17443:
the production 
dt - nn - 
Phrase17444:
the tcr 
dt - nn - 
Phrase17445:
the c 
dt - nn - 
Phrase17446:
these may 
dt - nn - 
Phrase17447:
genotypic markers 
jj - nns - 
Phrase17448:
the tcr 
dt - nn - 
Phrase17449:
the patients 
dt - nns - 
Phrase17450:
= 0.0004 
jj - nn - 
Phrase17451:
disproportionate occurrence 
jj - nn - 
Phrase17452:
these rflps 
dt - nns - 
Phrase17453:
important markers 
jj - nns - 
Phrase17454:
the production 
dt - nn - 
Phrase17455:
the majority 
dt - nn - 
Phrase17456:
these rflps 
dt - nns - 
Phrase17457:
the anti-ro(ssa) 
dt - nn - 
Phrase17458:
this antibody 
dt - nn - 
Phrase17459:
these loci 
dt - nns - 
Phrase17460:
nf-at-dependent transcription 
jj - nn - 
Phrase17461:
differential gene 
jj - nn - 
Phrase17462:
cd4+ t 
jj - nn - 
Phrase17463:
differential lymphokine 
jj - nn - 
Phrase17464:
cell-mediated immune responses 
jj - jj - nns - 
Phrase17465:
humoral immunity 
jj - nn - 
Phrase17466:
the ca(2+)-dependent factor 
dt - jj - nn - 
Phrase17467:
key role 
jj - nn - 
Phrase17468:
the inducible transcription 
dt - jj - nn - 
Phrase17469:
both lymphokine 
dt - nn - 
Phrase17470:
the contribution 
dt - nn - 
Phrase17471:
c-dependent signals 
jj - nns - 
Phrase17472:
we 
prp - 
Phrase17473:
the ca(2+)-dependent pathway 
dt - jj - nn - 
Phrase17474:
exclusive binding 
jj - nn - 
Phrase17475:
the p 
dt - nn - 
Phrase17476:
an element 
dt - nn - 
Phrase17477:
the il4 
dt - nn - 
Phrase17478:
the nf-kappa 
dt - nn - 
Phrase17479:
the activity 
dt - nn - 
Phrase17480:
general transcriptional activators 
jj - jj - nns - 
Phrase17481:
the inhibitory effect 
dt - jj - nn - 
Phrase17482:
differential gene 
jj - nn - 
Phrase17483:
the balance 
dt - nn - 
Phrase17484:
the signal 
dt - nn - 
Phrase17485:
inflammatory synovial 
jj - nn - 
Phrase17486:
the balance 
dt - nn - 
Phrase17487:
an important role 
dt - jj - nn - 
Phrase17488:
several animal 
jj - nn - 
Phrase17489:
skewed patterns 
jj - nn - 
Phrase17490:
inflammatory diseases 
jj - nns - 
Phrase17491:
many cytokines 
jj - nns - 
Phrase17492:
inflammatory effector 
jj - nn - 
Phrase17493:
we 
prp - 
Phrase17494:
inflammatory synovial 
jj - nn - 
Phrase17495:
the regulation 
dt - nn - 
Phrase17496:
an inflammatory synovial 
dt - jj - nn - 
Phrase17497:
it 
prp - 
Phrase17498:
dominant fashion 
jj - nn - 
Phrase17499:
exogenous il-12 
jj - nn - 
Phrase17500:
the sustained activity 
dt - jj - nn - 
Phrase17501:
the priming 
dt - nn - 
Phrase17502:
their 
prp$ - 
Phrase17503:
negative regulation 
jj - nn - 
Phrase17504:
active stat3 
jj - nn - 
Phrase17505:
inflamed joints 
jj - nns - 
Phrase17506:
these results 
dt - nns - 
Phrase17507:
altered balance 
jj - nn - 
Phrase17508:
transcriptional activity 
jj - nn - 
Phrase17509:
the regulation 
dt - nn - 
Phrase17510:
the pathogenesis 
dt - nn - 
Phrase17511:
inflammatory synovitis 
jj - nn - 
Phrase17512:
nuclear translocation 
jj - nn - 
Phrase17513:
viral replication 
jj - nn - 
Phrase17514:
hiv-infected monocytic cells 
jj - jj - nns - 
Phrase17515:
nonproductive fashion 
jj - nn - 
Phrase17516:
prolonged periods 
jj - nns - 
Phrase17517:
viral gene 
jj - nn - 
Phrase17518:
the cells 
dt - nns - 
Phrase17519:
the effect 
dt - nn - 
Phrase17520:
their 
prp$ - 
Phrase17521:
nuclear translocation 
jj - nn - 
Phrase17522:
the dna-binding 
dt - nn - 
Phrase17523:
specific sequence 
jj - nn - 
Phrase17524:
the hiv-long 
dt - nn - 
Phrase17525:
the present 
dt - nn - 
Phrase17526:
viral replication 
jj - nn - 
Phrase17527:
hiv-infected human 
jj - nn - 
Phrase17528:
monocytic cells 
jj - nns - 
Phrase17529:
monocytic cell 
jj - nn - 
Phrase17530:
normal peripheral blood 
jj - jj - nn - 
Phrase17531:
the presence 
dt - nn - 
Phrase17532:
monoclonal anti-cr1 
jj - nn - 
Phrase17533:
the amount 
dt - nn - 
Phrase17534:
we 
prp - 
Phrase17535:
the nuclear translocation 
dt - jj - nn - 
Phrase17536:
infected cells 
jj - nns - 
Phrase17537:
uninfected peripheral blood 
jj - jj - nn - 
Phrase17538:
the amount 
dt - nn - 
Phrase17539:
the translocation 
dt - nn - 
Phrase17540:
these observations 
dt - nns - 
Phrase17541:
infected monocytes 
jj - nns - 
Phrase17542:
the cells 
dt - nns - 
Phrase17543:
viral replication 
jj - nn - 
Phrase17544:
receptor-mediated nuclear translocation 
jj - jj - nn - 
Phrase17545:
the nf-kappa 
dt - nn - 
Phrase17546:
interferon-induced tyrosine 
jj - nn - 
Phrase17547:
selective inhibition 
jj - nn - 
Phrase17548:
the induction 
dt - nn - 
Phrase17549:
impaired in 
jj - nn - 
Phrase17550:
the mechanisms 
dt - nns - 
Phrase17551:
the changes 
dt - nns - 
Phrase17552:
the activities 
dt - nns - 
Phrase17553:
cellular protein 
jj - nn - 
Phrase17554:
the janus 
dt - nn - 
Phrase17555:
the transcription 
dt - nn - 
Phrase17556:
the mechanisms 
dt - nns - 
Phrase17557:
the impaired responses 
dt - jj - nns - 
Phrase17558:
overall changes 
jj - nns - 
Phrase17559:
whole-cell lysates 
jj - nns - 
Phrase17560:
antiphosphotyrosine immunoblotting 
jj - nn - 
Phrase17561:
specific increases 
jj - nns - 
Phrase17562:
several proteins 
jj - nns - 
Phrase17563:
these proteins 
dt - nns - 
Phrase17564:
similar extents 
jj - nn - 
Phrase17565:
these proteins 
dt - nns - 
Phrase17566:
antiphosphotyrosine immunoblotting 
jj - nn - 
Phrase17567:
their 
prp$ - 
Phrase17568:
dose-dependent manner 
jj - nn - 
Phrase17569:
the duration 
dt - nn - 
Phrase17570:
complete at 
jj - nn - 
Phrase17571:
peripheral blood 
jj - nn - 
Phrase17572:
these findings 
dt - nns - 
Phrase17573:
impaired gamma 
jj - nn - 
Phrase17574:
selective effects 
jj - nns - 
Phrase17575:
the jak-stat1 
dt - nn - 
Phrase17576:
this pathway 
dt - nn - 
Phrase17577:
impaired transcriptional responses 
jj - jj - nns - 
Phrase17578:
exclusive interaction 
jj - nn - 
Phrase17579:
novel matrix 
jj - nn - 
Phrase17580:
the nf-munr 
dt - nn - 
Phrase17581:
heavy chain 
jj - nn - 
Phrase17582:
the immunoglobulin 
dt - nn - 
Phrase17583:
heavy chain 
jj - nn - 
Phrase17584:
intronic enhancer 
jj - nn - 
Phrase17585:
functional promoters 
jj - nns - 
Phrase17586:
other cell 
jj - nn - 
Phrase17587:
the observation 
dt - nn - 
Phrase17588:
the nuclear factor-mu 
dt - jj - nn - 
Phrase17589:
negative regulator 
jj - nn - 
Phrase17590:
nuclear matrix 
jj - nn - 
Phrase17591:
this enhancer 
dt - nn - 
Phrase17592:
the hypothesis 
dt - nn - 
Phrase17593:
the cell 
dt - nn - 
Phrase17594:
the enhancer 
dt - nn - 
Phrase17595:
nuclear matrix 
jj - nn - 
Phrase17596:
r. 
nnp - 
Phrase17597:
h. 
nnp - 
Phrase17598:
chen 
nnp - 
Phrase17599:
the role 
dt - nn - 
Phrase17600:
we 
prp - 
Phrase17601:
novel mar-binding 
jj - nn - 
Phrase17602:
soluble nuclear matrix 
jj - jj - nn - 
Phrase17603:
its 
prp$ - 
Phrase17604:
the mars 
dt - nn - 
Phrase17605:
the igh 
dt - nn - 
Phrase17606:
it 
prp - 
Phrase17607:
nuclear matrix 
jj - nn - 
Phrase17608:
different types 
jj - nns - 
Phrase17609:
lymphoid cell 
jj - nn - 
Phrase17610:
specific binding 
jj - nn - 
Phrase17611:
enzymatic footprinting 
jj - nn - 
Phrase17612:
efficient mar-bp1 
jj - nn - 
Phrase17613:
the igh 
dt - nn - 
Phrase17614:
either intact nuclear matrix 
dt - jj - jj - nn - 
Phrase17615:
these results 
dt - nns - 
Phrase17616:
specific regulation 
jj - nn - 
Phrase17617:
the nf-munr 
dt - nn - 
Phrase17618:
the igh 
dt - nn - 
Phrase17619:
nuclear matrix 
jj - nn - 
Phrase17620:
inappropriate cells 
jj - nns - 
Phrase17621:
the granulocyte-macrophage 
dt - nn - 
Phrase17622:
colony-stimulating factor 
jj - nn - 
Phrase17623:
an important role 
dt - jj - nn - 
Phrase17624:
the mechanisms 
dt - nns - 
Phrase17625:
the expression 
dt - nn - 
Phrase17626:
these key regulators 
dt - jj - nns - 
Phrase17627:
we 
prp - 
Phrase17628:
the transcription 
dt - nn - 
Phrase17629:
the expression 
dt - nn - 
Phrase17630:
the granulocyte-macrophage 
dt - nn - 
Phrase17631:
colony-stimulating factor 
jj - nn - 
Phrase17632:
we 
prp - 
Phrase17633:
the human 
dt - nn - 
Phrase17634:
tissue-specific fashion 
jj - nn - 
Phrase17635:
myelomonocytic cells 
jj - nns - 
Phrase17636:
its 
prp$ - 
Phrase17637:
the gm-csf 
dt - nn - 
Phrase17638:
an important functional site 
dt - jj - jj - nn - 
Phrase17639:
we 
prp - 
Phrase17640:
the myeloid 
dt - nn - 
Phrase17641:
this site 
dt - nn - 
Phrase17642:
we 
prp - 
Phrase17643:
the pu.1 
dt - nn - 
Phrase17644:
the gm-csf 
dt - nn - 
Phrase17645:
the major ccaat/enhancer-binding protein 
dt - jj - jj - nn - 
Phrase17646:
this site 
dt - nn - 
Phrase17647:
nuclear extracts 
jj - nns - 
Phrase17648:
either pu.1 
dt - nn - 
Phrase17649:
the c/ebp 
dt - nn - 
Phrase17650:
the binding 
dt - nn - 
Phrase17651:
the respective factors 
dt - jj - nn - 
Phrase17652:
significant decrease 
jj - nn - 
Phrase17653:
myelomonocytic cells 
jj - nns - 
Phrase17654:
we 
prp - 
Phrase17655:
migrating complex 
jj - nn - 
Phrase17656:
the gm-csf 
dt - nn - 
Phrase17657:
the first demonstration 
dt - jj - nn - 
Phrase17658:
specific interaction 
jj - nn - 
Phrase17659:
the novel complex 
dt - jj - nn - 
Phrase17660:
certain nonmyeloid cell 
jj - jj - nn - 
Phrase17661:
erythroid cells 
jj - nns - 
Phrase17662:
we 
prp - 
Phrase17663:
the pu-sf 
dt - nn - 
Phrase17664:
its 
prp$ - 
Phrase17665:
an intact pu.1 
dt - jj - nn - 
Phrase17666:
nonmyeloid cells 
jj - nns - 
Phrase17667:
the gm-csf 
dt - nn - 
Phrase17668:
the amino-terminal region 
dt - jj - nn - 
Phrase17669:
the pu-sf 
dt - nn - 
Phrase17670:
concomitant loss 
jj - nn - 
Phrase17671:
the pu-sf 
dt - nn - 
Phrase17672:
functional importance 
jj - nn - 
Phrase17673:
the activity 
dt - nn - 
Phrase17674:
the gm-csf 
dt - nn - 
Phrase17675:
we 
prp - 
Phrase17676:
active gm-csf 
jj - nn - 
Phrase17677:
nonmyeloid cells 
jj - nns - 
Phrase17678:
an hpfh 
dt - nn - 
Phrase17679:
we 
prp - 
Phrase17680:
the nuclear protein 
dt - jj - nn - 
Phrase17681:
the human 
dt - nn - 
Phrase17682:
we 
prp - 
Phrase17683:
the gamma-globin 
dt - nn - 
Phrase17684:
this paired motif 
dt - jj - nn - 
Phrase17685:
the erythroid factor 
dt - jj - nn - 
Phrase17686:
the area 
dt - nn - 
Phrase17687:
red blood 
jj - nn - 
Phrase17688:
the gamma-globin 
dt - nn - 
Phrase17689:
this mutant 
dt - nn - 
Phrase17690:
other globin 
jj - nn - 
Phrase17691:
them 
prp - 
Phrase17692:
these findings 
dt - nns - 
Phrase17693:
the hpfh 
dt - nn - 
Phrase17694:
we 
prp - 
Phrase17695:
it 
prp - 
Phrase17696:
the formation 
dt - nn - 
Phrase17697:
constitutive activation 
jj - nn - 
Phrase17698:
different jak 
jj - nn - 
Phrase17699:
virus-transformed cells 
jj - nns - 
Phrase17700:
an adult 
dt - nn - 
Phrase17701:
an important role 
dt - jj - nn - 
Phrase17702:
our 
prp$ - 
Phrase17703:
previous data 
jj - nns - 
Phrase17704:
transgenic mouse 
jj - nn - 
Phrase17705:
comparable levels 
jj - nns - 
Phrase17706:
constitutive tyrosine 
jj - nn - 
Phrase17707:
130-kd protein 
jj - nn - 
Phrase17708:
the tax 
dt - nn - 
Phrase17709:
lymphoid lines 
jj - nns - 
Phrase17710:
transgenic mice 
jj - nns - 
Phrase17711:
specific antibodies 
jj - nns - 
Phrase17712:
the tax 
dt - nn - 
Phrase17713:
high expression 
jj - nn - 
Phrase17714:
this protein 
dt - nn - 
Phrase17715:
the b 
dt - nn - 
Phrase17716:
constitutive phosphorylation 
jj - nn - 
Phrase17717:
infected human 
jj - nn - 
Phrase17718:
the transgenic mouse 
dt - jj - nn - 
Phrase17719:
erythroid differentiation 
jj - nn - 
Phrase17720:
dec 
nnp - 
Phrase17721:
an antitumor 
dt - nn - 
Phrase17722:
erythroid differentiation 
jj - nn - 
Phrase17723:
the synthesis 
dt - nn - 
Phrase17724:
fetal hemoglobin 
jj - nn - 
Phrase17725:
its 
prp$ - 
Phrase17726:
we 
prp - 
Phrase17727:
the effects 
dt - nns - 
Phrase17728:
the onset 
dt - nn - 
Phrase17729:
erythroid differentiation 
jj - nn - 
Phrase17730:
dose-dependent stimulation 
jj - nn - 
Phrase17731:
the levels 
dt - nns - 
Phrase17732:
gradual decline 
jj - nn - 
Phrase17733:
the basal level 
dt - jj - nn - 
Phrase17734:
the rate 
dt - nn - 
Phrase17735:
the c-jun 
dt - nn - 
Phrase17736:
the level 
dt - nn - 
Phrase17737:
the 5x 
dt - nn - 
Phrase17738:
these results 
dt - nns - 
Phrase17739:
erythroid differentiation 
jj - nn - 
Phrase17740:
the hypothalamic-pituitary-adrenal system 
dt - jj - nn - 
Phrase17741:
the immune system 
dt - jj - nn - 
Phrase17742:
biological phenomenon 
jj - nn - 
Phrase17743:
-induced t-cell 
jj - nn - 
Phrase17744:
-driven b-cell 
jj - nn - 
Phrase17745:
the link 
dt - nn - 
Phrase17746:
the hpa 
dt - nn - 
Phrase17747:
the immune system 
dt - jj - nn - 
Phrase17748:
-induced t-cell 
jj - nn - 
Phrase17749:
spontaneous lymphocyte 
jj - nn - 
Phrase17750:
healthy controls 
jj - nns - 
Phrase17751:
endogenous glucocorticoids 
jj - nns - 
Phrase17752:
oral administration 
jj - nn - 
Phrase17753:
subsequent glucocorticoid 
jj - nn - 
Phrase17754:
the cells 
dt - nns - 
Phrase17755:
different doses 
jj - nns - 
Phrase17756:
significant decrease 
jj - nn - 
Phrase17757:
more pronounced effect 
jjr - jj - nn - 
Phrase17758:
spontaneous lymphocyte 
jj - nn - 
Phrase17759:
the dex 
dt - nn - 
Phrase17760:
these data 
dt - nns - 
Phrase17761:
the inhibition 
dt - nn - 
Phrase17762:
spontaneous lymphocyte 
jj - nn - 
Phrase17763:
the decrease 
dt - nn - 
Phrase17764:
impaired glucocorticoid-mediated induction 
jj - jj - nn - 
Phrase17765:
specific differences 
jj - nns - 
Phrase17766:
different cell 
jj - nn - 
Phrase17767:
the cdna 
dt - nn - 
Phrase17768:
the myf3 
dt - nn - 
Phrase17769:
the following 
dt - nn - 
Phrase17770:
high expression 
jj - nn - 
Phrase17771:
intensive hybridization 
jj - nn - 
Phrase17772:
their 
prp$ - 
Phrase17773:
the size 
dt - nn - 
Phrase17774:
this signals 
dt - nns - 
Phrase17775:
the expression 
dt - nn - 
Phrase17776:
this gene 
dt - nn - 
Phrase17777:
specific gene 
jj - nn - 
Phrase17778:
higher hybridization 
jjr - nn - 
Phrase17779:
the corresponding cell 
dt - jj - nn - 
Phrase17780:
natural killer 
jj - nn - 
Phrase17781:
the reasons 
dt - nns - 
Phrase17782:
the dissimilar 
dt - nn - 
Phrase17783:
the capacities 
dt - nns - 
Phrase17784:
the e1a 
dt - nn - 
Phrase17785:
the host 
dt - nn - 
Phrase17786:
natural killer 
jj - nn - 
Phrase17787:
this hypothesis 
dt - nn - 
Phrase17788:
we 
prp - 
Phrase17789:
the abilities 
dt - nns - 
Phrase17790:
the e1a 
dt - nn - 
Phrase17791:
unstimulated nk 
jj - nn - 
Phrase17792:
the same parental cells 
dt - jj - jj - nns - 
Phrase17793:
the hpv 
dt - nn - 
Phrase17794:
the ability 
dt - nn - 
Phrase17795:
cytolytic resistance 
jj - nn - 
Phrase17796:
the selective lysis 
dt - jj - nn - 
Phrase17797:
the extent 
dt - nn - 
Phrase17798:
ifn-induced nk 
jj - nn - 
Phrase17799:
the level 
dt - nn - 
Phrase17800:
the ability 
dt - nn - 
Phrase17801:
ifn-stimulated gene 
jj - nn - 
Phrase17802:
neither ifn-stimulated gene 
dt - jj - nn - 
Phrase17803:
cytolytic resistance 
jj - nn - 
Phrase17804:
the selective lysis 
dt - jj - nn - 
Phrase17805:
the host 
dt - nn - 
Phrase17806:
the e7 
dt - nn - 
Phrase17807:
this activity 
dt - nn - 
Phrase17808:
ca(2+)-dependent signal 
jj - nn - 
Phrase17809:
the ca(2+)-dependent phosphatase 
dt - jj - nn - 
Phrase17810:
nuclear factor 
jj - nn - 
Phrase17811:
we 
prp - 
Phrase17812:
this synergy 
dt - nn - 
Phrase17813:
other cell 
jj - nn - 
Phrase17814:
the mechanism 
dt - nn - 
Phrase17815:
this synergy 
dt - nn - 
Phrase17816:
other cell 
jj - nn - 
Phrase17817:
the monocytic cell 
dt - jj - nn - 
Phrase17818:
dependent pathways 
jj - nns - 
Phrase17819:
the degradation 
dt - nn - 
Phrase17820:
we 
prp - 
Phrase17821:
the regulation 
dt - nn - 
Phrase17822:
pkc-dependent pathways 
jj - nns - 
Phrase17823:
the phosphorylation 
dt - nn - 
Phrase17824:
an incomplete degradation 
dt - jj - nn - 
Phrase17825:
ca(2+)-dependent pathways 
jj - nns - 
Phrase17826:
the rate 
dt - nn - 
Phrase17827:
its 
prp$ - 
Phrase17828:
complete degradation 
jj - nn - 
Phrase17829:
ca(2+)-dependent pathways 
jj - nns - 
Phrase17830:
the phosphorylation 
dt - nn - 
Phrase17831:
the selective pkc 
dt - jj - nn - 
Phrase17832:
the pma-induced 
dt - nn - 
Phrase17833:
ca(2+)-dependent pathways 
jj - nns - 
Phrase17834:
the phosphorylation 
dt - nn - 
Phrase17835:
pkc-independent stimulus 
jj - nn - 
Phrase17836:
the interaction 
dt - nn - 
Phrase17837:
ca(2+)-dependent pathways 
jj - nns - 
Phrase17838:
the level 
dt - nn - 
Phrase17839:
the level 
dt - nn - 
Phrase17840:
its 
prp$ - 
Phrase17841:
these results 
dt - nns - 
Phrase17842:
ca(2+)-dependent pathways 
jj - nns - 
Phrase17843:
the phosphatase 
dt - nn - 
Phrase17844:
the regulation 
dt - nn - 
Phrase17845:
specific fashion 
jj - nn - 
Phrase17846:
-independent pathways 
jj - nns - 
Phrase17847:
the level 
dt - nn - 
Phrase17848:
acute ccl4-induced hepatic injury 
jj - jj - jj - nn - 
Phrase17849:
nuclear factor 
jj - nn - 
Phrase17850:
oxidative stress 
jj - nn - 
Phrase17851:
reactive oxygen 
jj - nn - 
Phrase17852:
diverse etiologies 
jj - nn - 
Phrase17853:
oxidative stress 
jj - nn - 
Phrase17854:
nuclear factor 
jj - nn - 
Phrase17855:
the expression 
dt - nn - 
Phrase17856:
cytotoxic cytokines 
jj - nns - 
Phrase17857:
acute hepatic injury 
jj - jj - nn - 
Phrase17858:
reactive oxygen 
jj - nn - 
Phrase17859:
an intraperitoneal injection 
dt - jj - nn - 
Phrase17860:
intravenous pretreatment 
jj - nn - 
Phrase17861:
the mice 
dt - nns - 
Phrase17862:
the mice 
dt - nns - 
Phrase17863:
the ccl4 
dt - nn - 
Phrase17864:
the nf-kappa 
dt - nn - 
Phrase17865:
normal mice 
jj - nns - 
Phrase17866:
an increase 
dt - nn - 
Phrase17867:
acute fulminant 
jj - nn - 
Phrase17868:
the binding 
dt - nn - 
Phrase17869:
normal livers 
jj - nns - 
Phrase17870:
these data 
dt - nns - 
Phrase17871:
acute hepatic injury 
jj - jj - nn - 
Phrase17872:
free radical 
jj - nn - 
Phrase17873:
it 
prp - 
Phrase17874:
free radical 
jj - nn - 
Phrase17875:
an effect 
dt - nn - 
Phrase17876:
cytotoxic cytokine 
jj - nn - 
Phrase17877:
immunosuppressive agents 
jj - nns - 
Phrase17878:
they 
prp - 
Phrase17879:
several cell 
jj - nn - 
Phrase17880:
immune function 
jj - nn - 
Phrase17881:
the mechanism 
dt - nn - 
Phrase17882:
this activity 
dt - nn - 
Phrase17883:
it 
prp - 
Phrase17884:
nuclear factor 
jj - nn - 
Phrase17885:
the i 
dt - nn - 
Phrase17886:
inhibitory protein 
jj - nn - 
Phrase17887:
inactive cytoplasmic complexes 
jj - jj - nns - 
Phrase17888:
many immunoregulatory genes 
jj - jj - nns - 
Phrase17889:
pro-inflammatory stimuli 
jj - nns - 
Phrase17890:
the inhibition 
dt - nn - 
Phrase17891:
its 
prp$ - 
Phrase17892:
major component 
jj - nn - 
Phrase17893:
the anti-inflammatory activity 
dt - jj - nn - 
Phrase17894:
transcriptional repression 
jj - nn - 
Phrase17895:
the interleukin-2 
dt - nn - 
Phrase17896:
direct inhibition 
jj - nn - 
Phrase17897:
nuclear hormone 
jj - nn - 
Phrase17898:
the active metabolite 
dt - jj - nn - 
Phrase17899:
colony-stimulating factor 
jj - nn - 
Phrase17900:
we 
prp - 
Phrase17901:
it 
prp - 
Phrase17902:
direct transcriptional repressive effect 
jj - jj - jj - nn - 
Phrase17903:
the vitamin 
dt - nn - 
Phrase17904:
we 
prp - 
Phrase17905:
d3-mediated repression 
jj - nn - 
Phrase17906:
we 
prp - 
Phrase17907:
an element 
dt - nn - 
Phrase17908:
both dna 
dt - nn - 
Phrase17909:
the receptor 
dt - nn - 
Phrase17910:
short 40-bp 
jj - nn - 
Phrase17911:
an important positive regulatory element 
dt - jj - jj - jj - nn - 
Phrase17912:
t-cell-specific transcription 
jj - nn - 
Phrase17913:
this element 
dt - nn - 
Phrase17914:
the vdr 
dt - nn - 
Phrase17915:
the element 
dt - nn - 
Phrase17916:
these results 
dt - nns - 
Phrase17917:
we 
prp - 
Phrase17918:
the loss 
dt - nn - 
Phrase17919:
the vdr-retinoid 
dt - nn - 
Phrase17920:
the nf-at-1 
dt - nn - 
Phrase17921:
direct inhibition 
jj - nn - 
Phrase17922:
nuclear hormone 
jj - nn - 
Phrase17923:
transcriptional activators 
jj - nns - 
Phrase17924:
the il-2 
dt - nn - 
Phrase17925:
mechanistic explanation 
jj - nn - 
Phrase17926:
immunosuppressive agents 
jj - nns - 
Phrase17927:
tissue-specific regulation 
jj - nn - 
Phrase17928:
the rabbit 
dt - nn - 
Phrase17929:
erythroid cells 
jj - nns - 
Phrase17930:
transcriptional silencer 
jj - nn - 
Phrase17931:
the 15-lipoxygenase 
dt - nn - 
Phrase17932:
tissue-specific manner 
jj - nn - 
Phrase17933:
erythroid cells 
jj - nns - 
Phrase17934:
we 
prp - 
Phrase17935:
this report 
dt - nn - 
Phrase17936:
the 5' 
dt - nn - 
Phrase17937:
flanking dna 
jj - nn - 
Phrase17938:
the 15-lox 
dt - nn - 
Phrase17939:
its 
prp$ - 
Phrase17940:
non-erythroid cell 
jj - nn - 
Phrase17941:
erythroid cell 
jj - nn - 
Phrase17942:
the element 
dt - nn - 
Phrase17943:
it 
prp - 
Phrase17944:
the main activity 
dt - jj - nn - 
Phrase17945:
the silencer 
dt - nn - 
Phrase17946:
flanking dna 
jj - nn - 
Phrase17947:
nuclear factor 
jj - nn - 
Phrase17948:
non-erythroid cells 
jj - nns - 
Phrase17949:
erythroid cells 
jj - nns - 
Phrase17950:
these binding 
dt - nn - 
Phrase17951:
similar sequences 
jj - nns - 
Phrase17952:
multiple copies 
jj - nns - 
Phrase17953:
the binding 
dt - nn - 
Phrase17954:
tissue-specific down-regulation 
jj - nn - 
Phrase17955:
minimal lox 
jj - nn - 
Phrase17956:
the 5' 
dt - nn - 
Phrase17957:
flanking dna 
jj - nn - 
Phrase17958:
the gata 
dt - nn - 
Phrase17959:
the transcription 
dt - nn - 
Phrase17960:
its 
prp$ - 
Phrase17961:
its 
prp$ - 
Phrase17962:
immunosuppressive effect 
jj - nn - 
Phrase17963:
the activity 
dt - nn - 
Phrase17964:
nuclear factor 
jj - nn - 
Phrase17965:
transcriptional induction 
jj - nn - 
Phrase17966:
several cytokine 
jj - nn - 
Phrase17967:
the phosphatase 
dt - nn - 
Phrase17968:
an nfat 
dt - nn - 
Phrase17969:
the nucleus 
dt - nn - 
Phrase17970:
we 
prp - 
Phrase17971:
its 
prp$ - 
Phrase17972:
an nfat 
dt - nn - 
Phrase17973:
metabolic labeling 
jj - nn - 
Phrase17974:
sds-polyacrylamide gel 
jj - nn - 
Phrase17975:
its 
prp$ - 
Phrase17976:
subcellular distribution 
jj - nn - 
Phrase17977:
its 
prp$ - 
Phrase17978:
an nfat 
dt - nn - 
Phrase17979:
these data 
dt - nns - 
Phrase17980:
csa-sensitive regulation 
jj - nn - 
Phrase17981:
oxidative signalling 
jj - nn - 
Phrase17982:
we 
prp - 
Phrase17983:
oxidative events 
jj - nns - 
Phrase17984:
reactive oxygen 
jj - nn - 
Phrase17985:
intracellular signalling 
jj - nn - 
Phrase17986:
the current study 
dt - jj - nn - 
Phrase17987:
an aminothiol 
dt - nn - 
Phrase17988:
the role 
dt - nn - 
Phrase17989:
oxidative signalling 
jj - nn - 
Phrase17990:
normal human 
jj - nn - 
Phrase17991:
peripheral blood 
jj - nn - 
Phrase17992:
dose-dependent manner 
jj - nn - 
Phrase17993:
complete inhibition 
jj - nn - 
Phrase17994:
inhibitory effect 
jj - nn - 
Phrase17995:
mitogenic activation 
jj - nn - 
Phrase17996:
the time-frame 
dt - nn - 
Phrase17997:
the commitment 
dt - nn - 
Phrase17998:
it 
prp - 
Phrase17999:
oxidative signalling 
jj - nn - 
Phrase18000:
the il-2 
dt - nn - 
Phrase18001:
we 
prp - 
Phrase18002:
the effect 
dt - nn - 
Phrase18003:
early gene 
jj - nn - 
Phrase18004:
the activity 
dt - nn - 
Phrase18005:
the il-2 
dt - nn - 
Phrase18006:
both expression 
dt - nn - 
Phrase18007:
the il-2 
dt - nn - 
Phrase18008:
the culture 
dt - nn - 
Phrase18009:
the inhibitory effect 
dt - jj - nn - 
Phrase18010:
least in 
jjs - nn - 
Phrase18011:
an effect 
dt - nn - 
Phrase18012:
the dna 
dt - nn - 
Phrase18013:
mitogen-stimulated cells 
jj - nns - 
Phrase18014:
oxidative signalling 
jj - nn - 
Phrase18015:
selective manner 
jj - nn - 
Phrase18016:
the identification 
dt - nn - 
Phrase18017:
regulatory proteins 
jj - nns - 
Phrase18018:
oxidative signalling 
jj - nn - 
Phrase18019:
oxidative signalling 
jj - nn - 
Phrase18020:
the g0 
dt - nn - 
Phrase18021:
peripheral blood 
jj - nn - 
Phrase18022:
normal human 
jj - nn - 
Phrase18023:
specific receptors 
jj - nns - 
Phrase18024:
peripheral blood 
jj - nn - 
Phrase18025:
we 
prp - 
Phrase18026:
these receptors 
dt - nns - 
Phrase18027:
any difference 
dt - nn - 
Phrase18028:
healthy men 
jj - nns - 
Phrase18029:
aged 21-66 
jj - nn - 
Phrase18030:
healthy women 
jj - nns - 
Phrase18031:
aged 22-60 
jj - nn - 
Phrase18032:
the mean 
dt - nn - 
Phrase18033:
similar in 
jj - nn - 
Phrase18034:
the concentration 
dt - nn - 
Phrase18035:
lower in 
jjr - nn - 
Phrase18036:
postmenopausal women 
jj - nns - 
Phrase18037:
this sex 
dt - nn - 
Phrase18038:
any pathophysiological relevance 
dt - jj - nn - 
Phrase18039:
cellular growth 
jj - nn - 
Phrase18040:
the id 
dt - nn - 
Phrase18041:
hlh proteins 
jj - nns - 
Phrase18042:
negative fashion 
jj - nn - 
Phrase18043:
transcriptional activities 
jj - nns - 
Phrase18044:
basic hlh proteins 
jj - jj - nns - 
Phrase18045:
we 
prp - 
Phrase18046:
the expression 
dt - nn - 
Phrase18047:
normal human 
jj - nn - 
Phrase18048:
peripheral blood 
jj - nn - 
Phrase18049:
the id2 
dt - nn - 
Phrase18050:
another unexpected finding 
dt - jj - nn - 
Phrase18051:
prominent levels 
jj - nns - 
Phrase18052:
biphasic kinetics 
jj - nn - 
Phrase18053:
our 
prp$ - 
Phrase18054:
unexpected findings 
jj - nns - 
Phrase18055:
lymphocytic transformation 
jj - nn - 
Phrase18056:
normal pbl 
jj - nn - 
Phrase18057:
high levels 
jj - nns - 
Phrase18058:
the onset 
dt - nn - 
Phrase18059:
cellular proliferation 
jj - nn - 
Phrase18060:
related genes 
jj - nns - 
Phrase18061:
lipopolysaccharide-induced transcriptional activation 
jj - jj - nn - 
Phrase18062:
the tissue 
dt - nn - 
Phrase18063:
monocytic cells 
jj - nns - 
Phrase18064:
the tissue 
dt - nn - 
Phrase18065:
the coagulation 
dt - nn - 
Phrase18066:
inflammatory complications 
jj - nns - 
Phrase18067:
transcriptional activation 
jj - nn - 
Phrase18068:
the human 
dt - nn - 
Phrase18069:
monocytic cells 
jj - nns - 
Phrase18070:
bacterial lipopolysaccharide 
jj - nn - 
Phrase18071:
the tf 
dt - nn - 
Phrase18072:
we 
prp - 
Phrase18073:
anti-inflammatory agents 
jj - nns - 
Phrase18074:
the salicylates 
dt - nns - 
Phrase18075:
monocytic thp-1 
jj - nn - 
Phrase18076:
relevant doses 
jj - nns - 
Phrase18077:
the lps-induced proteolytic degradation 
dt - jj - jj - nn - 
Phrase18078:
the nuclear translocation 
dt - jj - nn - 
Phrase18079:
other nonsteroidal anti-inflammatory drugs 
jj - jj - jj - nns - 
Phrase18080:
the tf 
dt - nn - 
Phrase18081:
these results 
dt - nns - 
Phrase18082:
monocytic cells 
jj - nns - 
Phrase18083:
nuclear translocation 
jj - nn - 
Phrase18084:
the clinical benefits 
dt - jj - nns - 
Phrase18085:
the treatment 
dt - nn - 
Phrase18086:
several diseases 
jj - nns - 
Phrase18087:
their 
prp$ - 
Phrase18088:
the signal 
dt - nn - 
Phrase18089:
primary t 
jj - nn - 
Phrase18090:
critical role 
jj - nn - 
Phrase18091:
the t 
dt - nn - 
Phrase18092:
specific ags 
jj - nn - 
Phrase18093:
intracellular biochemical events 
jj - jj - nns - 
Phrase18094:
several genes 
jj - nns - 
Phrase18095:
the activation 
dt - nn - 
Phrase18096:
primary tcr-mediated activation 
jj - jj - nn - 
Phrase18097:
peripheral blood 
jj - nn - 
Phrase18098:
nuclear stat 
jj - nn - 
Phrase18099:
cross-linked anti-cd3 
jj - nn - 
Phrase18100:
these stat 
dt - nn - 
Phrase18101:
the ifn-gamma-activated sequence 
dt - jj - nn - 
Phrase18102:
related oligonucleotides 
jj - nns - 
Phrase18103:
electrophoretic mobility 
jj - nn - 
Phrase18104:
the nuclear extracts 
dt - jj - nns - 
Phrase18105:
anti-stat abs 
jj - nn - 
Phrase18106:
they 
prp - 
Phrase18107:
additional proteins 
jj - nns - 
Phrase18108:
the stat 
dt - nn - 
Phrase18109:
the induction 
dt - nn - 
Phrase18110:
either cycloheximide 
dt - nn - 
Phrase18111:
the induction 
dt - nn - 
Phrase18112:
secondary factor 
jj - nn - 
Phrase18113:
anti-il-6 abs 
jj - nn - 
Phrase18114:
the early induction 
dt - jj - nn - 
Phrase18115:
tcr-mediated bindings 
jj - nns - 
Phrase18116:
it 
prp - 
Phrase18117:
the factor 
dt - nn - 
Phrase18118:
the activation 
dt - nn - 
Phrase18119:
primary t 
jj - nn - 
Phrase18120:
the normal cell 
dt - jj - nn - 
Phrase18121:
the infection 
dt - nn - 
Phrase18122:
quiescent b 
jj - nn - 
Phrase18123:
epstein-barr virus 
jj - nn - 
Phrase18124:
the peripheral circulation 
dt - jj - nn - 
Phrase18125:
non-proliferative state 
jj - nn - 
Phrase18126:
limited proliferation 
jj - nn - 
Phrase18127:
epstein-barr virus 
jj - nn - 
Phrase18128:
the outgrowth 
dt - nn - 
Phrase18129:
it 
prp - 
Phrase18130:
clear at 
jj - nn - 
Phrase18131:
the peripheral b 
dt - jj - nn - 
Phrase18132:
we 
prp - 
Phrase18133:
the expression 
dt - nn - 
Phrase18134:
several cell 
jj - nn - 
Phrase18135:
we 
prp - 
Phrase18136:
the expression 
dt - nn - 
Phrase18137:
ebv-mediated immortalization 
jj - nn - 
Phrase18138:
these genes 
dt - nns - 
Phrase18139:
positive role 
jj - nn - 
Phrase18140:
we 
prp - 
Phrase18141:
this regulatory switch 
dt - jj - nn - 
Phrase18142:
the cell 
dt - nn - 
Phrase18143:
quiescent b 
jj - nn - 
Phrase18144:
either a 
dt - nn - 
Phrase18145:
the rapid expression 
dt - jj - nn - 
Phrase18146:
the normal program 
dt - jj - nn - 
Phrase18147:
the chemokine 
dt - nn - 
Phrase18148:
epstein-barr virus 
jj - nn - 
Phrase18149:
nuclear antigen 
jj - nn - 
Phrase18150:
our 
prp$ - 
Phrase18151:
we 
prp - 
Phrase18152:
the isolation 
dt - nn - 
Phrase18153:
the protein 
dt - nn - 
Phrase18154:
significant sequence 
jj - nn - 
Phrase18155:
the family 
dt - nn - 
Phrase18156:
peripheral blood 
jj - nn - 
Phrase18157:
epstein-barr virus 
jj - nn - 
Phrase18158:
positive b 
jj - nn - 
Phrase18159:
we 
prp - 
Phrase18160:
the blr2 
dt - nn - 
Phrase18161:
epstein-barr virus 
jj - nn - 
Phrase18162:
negative bl 
jj - nn - 
Phrase18163:
epstein-barr virus 
jj - nn - 
Phrase18164:
nuclear antigen 
jj - nn - 
Phrase18165:
key regulator 
jj - nn - 
Phrase18166:
cellular genes 
jj - nns - 
Phrase18167:
our 
prp$ - 
Phrase18168:
an involvement 
dt - nn - 
Phrase18169:
the regulation 
dt - nn - 
Phrase18170:
viral pathogenesis 
jj - nn - 
Phrase18171:
central role 
jj - nn - 
Phrase18172:
single c-myb 
jj - nn - 
Phrase18173:
thymic locus 
jj - nn - 
Phrase18174:
powerful assemblies 
jj - nn - 
Phrase18175:
the actions 
dt - nns - 
Phrase18176:
cell-type-specific trans-acting factors 
jj - jj - nn - 
Phrase18177:
2.3-kb lcr 
jj - nn - 
Phrase18178:
the human 
dt - nn - 
Phrase18179:
first intron 
jj - nn - 
Phrase18180:
flanking sequences 
jj - nns - 
Phrase18181:
the enhancer 
dt - nn - 
Phrase18182:
local adjacent augmentative 
jj - jj - nn - 
Phrase18183:
we 
prp - 
Phrase18184:
the core 
dt - nn - 
Phrase18185:
single critical c-myb 
jj - jj - nn - 
Phrase18186:
stable chromatin-integrated yeast 
jj - jj - nn - 
Phrase18187:
polymerized core 
jj - nn - 
Phrase18188:
evident in 
jj - nn - 
Phrase18189:
the enhancer 
dt - nn - 
Phrase18190:
discrete nuclear structures 
jj - jj - nns - 
Phrase18191:
fetal murine 
jj - nn - 
Phrase18192:
striking concordance 
jj - nn - 
Phrase18193:
endogenous c-myb 
jj - nn - 
Phrase18194:
the c-myb 
dt - nn - 
Phrase18195:
the intact 2.3-kb lcr 
dt - jj - jj - nn - 
Phrase18196:
transgenic thymocytes 
jj - nns - 
Phrase18197:
the context 
dt - nn - 
Phrase18198:
an organizer 
dt - nn - 
Phrase18199:
thymocyte-specific gene 
jj - nn - 
Phrase18200:
single binding 
jj - nn - 
Phrase18201:
regulatory element 
jj - nn - 
Phrase18202:
the human 
dt - nn - 
Phrase18203:
the zinc 
dt - nn - 
Phrase18204:
the interleukin 
dt - nn - 
Phrase18205:
critical event 
jj - nn - 
Phrase18206:
several transcription 
jj - nn - 
Phrase18207:
the activity 
dt - nn - 
Phrase18208:
the il-2 
dt - nn - 
Phrase18209:
we 
prp - 
Phrase18210:
novel regulatory element 
jj - jj - nn - 
Phrase18211:
the il-2 
dt - nn - 
Phrase18212:
the nuclear factor 
dt - jj - nn - 
Phrase18213:
the zinc 
dt - nn - 
Phrase18214:
the inducible early growth 
dt - jj - jj - nn - 
Phrase18215:
unstimulated cells 
jj - nns - 
Phrase18216:
this region 
dt - nn - 
Phrase18217:
the inducible egr-1 
dt - jj - nn - 
Phrase18218:
this element 
dt - nn - 
Phrase18219:
the zip 
dt - nn - 
Phrase18220:
an activator 
dt - nn - 
Phrase18221:
maximal il-2 
jj - nn - 
Phrase18222:
these results 
dt - nns - 
Phrase18223:
critical role 
jj - nn - 
Phrase18224:
the zip 
dt - nn - 
Phrase18225:
the hiv-1 
dt - nn - 
Phrase18226:
the lef-1 
dt - nn - 
Phrase18227:
lymphoid enhancer-binding factor 
jj - jj - nn - 
Phrase18228:
regulatory high mobility 
jj - jj - nn - 
Phrase18229:
the t 
dt - nn - 
Phrase18230:
this paper 
dt - nn - 
Phrase18231:
we 
prp - 
Phrase18232:
the distal region 
dt - jj - nn - 
Phrase18233:
the human 
dt - nn - 
Phrase18234:
functional context 
jj - nn - 
Phrase18235:
we 
prp - 
Phrase18236:
the lef-1-binding 
dt - nn - 
Phrase18237:
the activity 
dt - nn - 
Phrase18238:
multimerized copies 
jj - nns - 
Phrase18239:
the hiv-1 
dt - nn - 
Phrase18240:
we 
prp - 
Phrase18241:
the packaging 
dt - nn - 
Phrase18242:
the dna 
dt - nn - 
Phrase18243:
the promoter-binding protein 
dt - jj - nn - 
Phrase18244:
an e-box 
dt - nn - 
Phrase18245:
the lef-1 
dt - nn - 
Phrase18246:
this system 
dt - nn - 
Phrase18247:
enhancer-binding proteins 
jj - nns - 
Phrase18248:
the absence 
dt - nn - 
Phrase18249:
the hmg 
dt - nn - 
Phrase18250:
the trans-activation 
dt - nn - 
Phrase18251:
the hmg 
dt - nn - 
Phrase18252:
we 
prp - 
Phrase18253:
chromatin-dependent process 
jj - nn - 
Phrase18254:
functional trans-activation 
jj - nn - 
Phrase18255:
the hmg 
dt - nn - 
Phrase18256:
cd4+ t 
jj - nn - 
Phrase18257:
biol 
nnp - 
Phrase18258:
chem 
nnp - 
Phrase18259:
dec 
nnp - 
Phrase18260:
positive t 
jj - nn - 
Phrase18261:
primary requirement 
jj - nn - 
Phrase18262:
efficient hiv 
jj - nn - 
Phrase18263:
positive t 
jj - nn - 
Phrase18264:
normal individuals 
jj - nns - 
Phrase18265:
we 
prp - 
Phrase18266:
native envelope 
jj - nn - 
Phrase18267:
the stimulatory effects 
dt - jj - nns - 
Phrase18268:
the cd4 
dt - nn - 
Phrase18269:
soluble cd4-igg 
jj - nn - 
Phrase18270:
its 
prp$ - 
Phrase18271:
negative t 
jj - nn - 
Phrase18272:
the gp 
dt - nn - 
Phrase18273:
nuclear extracts 
jj - nns - 
Phrase18274:
polyclonal antibodies 
jj - nns - 
Phrase18275:
these family 
dt - nn - 
Phrase18276:
the gp160-induced ap-1 
dt - jj - nn - 
Phrase18277:
it 
prp - 
Phrase18278:
the functional capabilities 
dt - jj - nns - 
Phrase18279:
cd4+ t 
jj - nn - 
Phrase18280:
anti-cd3-induced interleukin-2 
jj - nn - 
Phrase18281:
anti-cd4 mab 
jj - nn - 
Phrase18282:
the aberrant 
dt - nn - 
Phrase18283:
positive t 
jj - nn - 
Phrase18284:
colony-stimulating factor 
jj - nn - 
